PMID,OWN,STAT,DCOM,LR,IS,VI,DP,TI,PG,LID,FAU,AU,AD,LA,PT,DEP,PL,TA,JT,JID,SB,MH,EDAT,MHDA,CRDT,PHST,AID,PST,SO,IP,AB,AUID,PMC,COIS,OTO,OT,GR,RN,CI,RF,CON,MID,CIN,CN,TT,PS,FPS,SPIN,EIN,OID,ORI
35961405,NLM,MEDLINE,20220913,20220920,1873-1740 (Electronic) 0033-0620 (Linking),73,2022 Jul-Aug,Progress in Cardiovascular Diseases Statistics 2022.,94-95,S0033-0620(22)00087-1 [pii] 10.1016/j.pcad.2022.08.005 [doi],"['Lavie, Carl J']",['Lavie CJ'],"['Ochsner Heart and Vascular Institute, New Orleans, LA, United States of America. Electronic address: clavie@ochsner.org.']",['eng'],['Editorial'],20220809,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans']",2022/08/13 06:00,2022/09/14 06:00,['2022/08/12 19:23'],"['2022/08/13 06:00 [pubmed]', '2022/09/14 06:00 [medline]', '2022/08/12 19:23 [entrez]']","['S0033-0620(22)00087-1 [pii]', '10.1016/j.pcad.2022.08.005 [doi]']",ppublish,Prog Cardiovasc Dis. 2022 Jul-Aug;73:94-95. doi: 10.1016/j.pcad.2022.08.005. Epub 2022 Aug 9.,,,,,,,,,,,,,,,,,,,,,,
35563086,NLM,MEDLINE,20220517,20220518,1422-0067 (Electronic) 1422-0067 (Linking),23,2022 Apr 23,"Cardiovascular Diseases-A Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies.",,10.3390/ijms23094695 [doi] 4695,"['Buldak, Lukasz']",['Buldak L'],"['Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland.']",['eng'],['Editorial'],20220423,Switzerland,Int J Mol Sci,International journal of molecular sciences,101092791,IM,"['*Atherosclerosis/drug therapy/etiology/prevention & control', '*Cardiovascular Diseases/drug therapy/etiology/prevention & control', 'Humans']",2022/05/15 06:00,2022/05/18 06:00,['2022/05/14 01:03'],"['2022/04/10 00:00 [received]', '2022/04/20 00:00 [accepted]', '2022/05/14 01:03 [entrez]', '2022/05/15 06:00 [pubmed]', '2022/05/18 06:00 [medline]']","['ijms23094695 [pii]', 'ijms-23-04695 [pii]', '10.3390/ijms23094695 [doi]']",epublish,Int J Mol Sci. 2022 Apr 23;23(9):4695. doi: 10.3390/ijms23094695.,9,Long-term consequences of atherosclerosis remain the major culprit of mortality in developed and developing countries [...].,['ORCID: 0000-0002-2017-5516'],PMC9103939,['The author declares no conflict of interest.'],,,,,,,,,,,,,,,,,
25176558,NLM,MEDLINE,20150219,20160307,1784-3286 (Print) 1784-3286 (Linking),69,2014 Dec,Cardiovascular disease prevention.,407-11,10.1179/2295333714Y.0000000069 [doi],"['Van Camp, G']",['Van Camp G'],,['eng'],"['Journal Article', 'Review']",20140831,England,Acta Clin Belg,Acta clinica Belgica,0370306,IM,"['Cardiovascular Diseases/diagnosis/etiology/*prevention & control', 'Europe', 'Humans', 'Prognosis', 'Risk Assessment/methods']",2014/09/02 06:00,2015/02/20 06:00,['2014/09/02 06:00'],"['2014/09/02 06:00 [entrez]', '2014/09/02 06:00 [pubmed]', '2015/02/20 06:00 [medline]']",['10.1179/2295333714Y.0000000069 [doi]'],ppublish,Acta Clin Belg. 2014 Dec;69(6):407-11. doi: 10.1179/2295333714Y.0000000069. Epub 2014 Aug 31.,6,"Cardiovascular diseases remain the first killer in the Western countries. Equivalent contributions of prevention initiatives, pharmaceutical developments and technological improvements have led to an important success in the reduction of mortality related to cardiovascular diseases in some of the countries of the Western world. However, increase in life expectance, incomplete adherence to guidelines, difficulties in convincing governments and the population to support and adhere to prevention measures make that the burden of cardiovascular diseases is still extremely high. This review gives a restricted summary of the most important prevention guidelines supported by the European Society of Cardiology. It also illustrates the still very incomplete adherence to these guidelines in the different European countries as published in the EUROASPIRE surveys.",,,,['NOTNLM'],"['Cardiology,', 'Cardiovascular diseases', 'Prevention,']",,,,,,,,,,,,,,,
31942675,NLM,MEDLINE,20200914,20200914,1937-5395 (Electronic) 1937-5387 (Linking),13,2020 Feb,Editorial: Gender Differences in Cardiovascular Diseases.,1-2,10.1007/s12265-020-09956-9 [doi],"['Zhou, Qiulian', 'Bei, Yihua']","['Zhou Q', 'Bei Y']","['Shanghai Applied Radiation Institute, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China.', 'Cardiac Regeneration and Ageing Lab, Institute of Cardiovascular Sciences, School of Life Science, Shanghai University, 333 Nan Chen Road, Shanghai, 200444, China.', 'Cardiac Regeneration and Ageing Lab, Institute of Cardiovascular Sciences, School of Life Science, Shanghai University, 333 Nan Chen Road, Shanghai, 200444, China. beiyh36@shu.edu.cn.']",['eng'],"['Editorial', 'Introductory Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,J Cardiovasc Transl Res,Journal of cardiovascular translational research,101468585,IM,"['Animals', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Female', 'Health Status Disparities', 'Healthcare Disparities', 'Humans', 'Male', 'Risk Factors', 'Sex Distribution', 'Sex Factors']",2020/01/17 06:00,2020/09/15 06:00,['2020/01/17 06:00'],"['2020/01/17 06:00 [pubmed]', '2020/09/15 06:00 [medline]', '2020/01/17 06:00 [entrez]']","['10.1007/s12265-020-09956-9 [pii]', '10.1007/s12265-020-09956-9 [doi]']",ppublish,J Cardiovasc Transl Res. 2020 Feb;13(1):1-2. doi: 10.1007/s12265-020-09956-9.,1,,,,,,,,,,,,,,,,,,,,,
34443563,NLM,MEDLINE,20210906,20210906,1420-3049 (Electronic) 1420-3049 (Linking),26,2021 Aug 17,Biological Activities of Paeonol in Cardiovascular Diseases: A Review.,,10.3390/molecules26164976 [doi] 4976,"['Vellasamy, Shalini', 'Murugan, Dharmani', 'Abas, Razif', 'Alias, Aspalilah', 'Seng, Wu Yuan', 'Woon, Choy Ker']","['Vellasamy S', 'Murugan D', 'Abas R', 'Alias A', 'Seng WY', 'Woon CK']","['Department of Microbiology and Parasitology, School of Medicine, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jenjarum 42610, Selangor, Malaysia.', 'Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.', 'Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Seri Kembangan 43400, Selangor, Malaysia.', 'Department of Basic Sciences and Oral Biology, Faculty of Dentistry, Universiti Sains Islam Malaysia, Kuala Lumpur 55100, Malaysia.', 'Fakultas Kedokteran Gigi, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 60132, Indonesia.', 'Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway 47500, Selangor, Malaysia.', 'Department of Biological Sciences, Sunway University, Bandar Sunway 47500, Selangor, Malaysia.', 'Department of Anatomy, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh 47000, Selangor, Malaysia.']",['eng'],"['Journal Article', 'Review']",20210817,Switzerland,Molecules,"Molecules (Basel, Switzerland)",100964009,IM,"['Acetophenones/*pharmacology/therapeutic use', 'Animals', 'Cardiovascular Diseases/*drug therapy/metabolism/pathology/physiopathology', 'Humans']",2021/08/28 06:00,2021/09/07 06:00,['2021/08/27 01:16'],"['2021/07/15 00:00 [received]', '2021/08/11 00:00 [revised]', '2021/08/14 00:00 [accepted]', '2021/08/27 01:16 [entrez]', '2021/08/28 06:00 [pubmed]', '2021/09/07 06:00 [medline]']","['molecules26164976 [pii]', 'molecules-26-04976 [pii]', '10.3390/molecules26164976 [doi]']",epublish,Molecules. 2021 Aug 17;26(16):4976. doi: 10.3390/molecules26164976.,16,"Paeonol is a naturally existing bioactive compound found in the root bark of Paeonia suffruticosa and it is traditionally used in Chinese medicine for the prevention and management of cardiovascular diseases. To date, a great deal of studies has been reported on the pharmacological effects of paeonol and its mechanisms of action in various diseases and conditions. In this review, the underlying mechanism of action of paeonol in cardiovascular disease has been elucidated. Recent studies have revealed that paeonol treatment improved endothelium injury, demoted inflammation, ameliorated oxidative stress, suppressed vascular smooth muscle cell proliferation, and repressed platelet activation. Paeonol has been reported to effectively protect the cardiovascular system either employed alone or in combination with other traditional medicines, thus, signifying it could be a hypothetically alternative or complementary atherosclerosis treatment. This review summarizes the biological and pharmacological activities of paeonol in the treatment of cardiovascular diseases and its associated underlying mechanisms for a better insight for future clinical practices.","['ORCID: 0000-0003-0309-6573', 'ORCID: 0000-0001-5574-8049', 'ORCID: 0000-0002-8432-9035']",PMC8400614,"['We confirm that there are no conflict of interest associated with this', 'publication and there has been no significant financial support for this work', 'that could have influenced its outcome.']",['NOTNLM'],"['anti-apoptotic', 'anti-inflammatory', 'anti-oxidant', 'cardiovascular diseases', 'paeonol', 'vascular tone regulation']",['600-RMC/GPK 5/3 (269/2020)/Universiti Teknologi MARA/'],"['0 (Acetophenones)', '3R834EPI82 (paeonol)']",,,,,,,,,,,,,
29744009,NLM,MEDLINE,20190314,20200511,1947-6108 (Electronic) 1947-6094 (Print) 1947-6108 (Linking),13,2017 Oct-Dec,Cardiovascular Disease in Women.,183-184,10.14797/mdcj-13-4-183 [doi],"['Kurrelmeyer, Karla']",['Kurrelmeyer K'],"['HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Methodist Debakey Cardiovasc J,Methodist DeBakey cardiovascular journal,101508600,IM,"['Age Factors', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Female', 'Health Status Disparities', 'Healthcare Disparities', 'Humans', 'Menopause', 'Pregnancy', 'Prognosis', 'Risk Factors', 'Sex Factors', ""*Women's Health""]",2018/05/11 06:00,2019/03/15 06:00,['2018/05/11 06:00'],"['2018/05/11 06:00 [entrez]', '2018/05/11 06:00 [pubmed]', '2019/03/15 06:00 [medline]']",['10.14797/mdcj-13-4-183 [doi]'],ppublish,Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):183-184. doi: 10.14797/mdcj-13-4-183.,4,,,PMC5935276,,,,,,,,,,,,,,,,,,
31781356,NLM,MEDLINE,20200420,20200420,1942-0994 (Electronic) 1942-0900 (Print) 1942-0994 (Linking),2019,2019,Oxidative Stress in Cell Death and Cardiovascular Diseases.,9030563,10.1155/2019/9030563 [doi] 9030563,"['Xu, Tao', 'Ding, Wei', 'Ji, Xiaoyu', 'Ao, Xiang', 'Liu, Ying', 'Yu, Wanpeng', 'Wang, Jianxun']","['Xu T', 'Ding W', 'Ji X', 'Ao X', 'Liu Y', 'Yu W', 'Wang J']","['School of Basic Medical Sciences, Qingdao University, Qingdao, China.', 'Center for Regenerative Medicine, Institute for Translational Medicine, College of Medicine, Qingdao University, Qingdao, China.', 'Department of Comprehensive Internal Medicine, Affiliated Hospital, Qingdao University, Qingdao, China.', 'School of Basic Medical Sciences, Qingdao University, Qingdao, China.', 'Center for Regenerative Medicine, Institute for Translational Medicine, College of Medicine, Qingdao University, Qingdao, China.', 'Center for Regenerative Medicine, Institute for Translational Medicine, College of Medicine, Qingdao University, Qingdao, China.', 'School of Basic Medical Sciences, Qingdao University, Qingdao, China.', 'School of Basic Medical Sciences, Qingdao University, Qingdao, China.', 'Center for Regenerative Medicine, Institute for Translational Medicine, College of Medicine, Qingdao University, Qingdao, China.']",['eng'],"['Journal Article', 'Review']",20191104,United States,Oxid Med Cell Longev,Oxidative medicine and cellular longevity,101479826,IM,"['Animals', 'Cardiovascular Diseases/*metabolism/pathology/*therapy', 'Humans', '*Oxidative Stress', 'Reactive Oxygen Species/*metabolism']",2019/11/30 06:00,2020/04/21 06:00,['2019/11/30 06:00'],"['2019/05/23 00:00 [received]', '2019/09/11 00:00 [accepted]', '2019/11/30 06:00 [entrez]', '2019/11/30 06:00 [pubmed]', '2020/04/21 06:00 [medline]']",['10.1155/2019/9030563 [doi]'],epublish,Oxid Med Cell Longev. 2019 Nov 4;2019:9030563. doi: 10.1155/2019/9030563. eCollection 2019.,,"ROS functions as a second messenger and modulates multiple signaling pathways under the physiological conditions. However, excessive intracellular ROS causes damage to the molecular components of the cell, which promotes the pathogenesis of various human diseases. Cardiovascular diseases are serious threats to human health with extremely high rates of morbidity and mortality. Dysregulation of cell death promotes the pathogenesis of cardiovascular diseases and is the clinical target during the disease treatment. Numerous studies show that ROS production is closely linked to the cell death process and promotes the occurrence and development of the cardiovascular diseases. In this review, we summarize the regulation of intracellular ROS, the roles of ROS played in the development of cardiovascular diseases, and the programmed cell death induced by intracellular ROS. We also focus on anti-ROS system and the potential application of anti-ROS strategy in the treatment of cardiovascular diseases.","['ORCID: 0000-0003-1698-5556', 'ORCID: 0000-0003-1699-9309', 'ORCID: 0000-0002-3731-6514']",PMC6875219,['The authors confirm that there are no conflicts of interest.'],,,,['0 (Reactive Oxygen Species)'],['Copyright (c) 2019 Tao Xu et al.'],,,,,,,,,,,,
25872853,NLM,MEDLINE,20170118,20170118,2047-9018 (Electronic) 0029-6570 (Linking),29,2015 Apr 15,Cardiovascular disease.,60,10.7748/ns.29.33.60.s44 [doi],"['Thiara, Balvinder']",['Thiara B'],"[""St Michael's Hospital, Warwick, England.""]",['eng'],['Journal Article'],,England,Nurs Stand,Nursing standard (Royal College of Nursing (Great Britain) : 1987),9012906,,"['Cardiovascular Diseases/complications/diet therapy/prevention & control/*therapy', 'Exercise', 'Feeding Behavior', 'Humans', 'Hypertension/complications', 'Obesity/complications', 'Smoking/adverse effects']",2015/04/16 06:00,2017/01/19 06:00,['2015/04/16 06:00'],"['2015/04/16 06:00 [entrez]', '2015/04/16 06:00 [pubmed]', '2017/01/19 06:00 [medline]']",['10.7748/ns.29.33.60.s44 [doi]'],ppublish,Nurs Stand. 2015 Apr 15;29(33):60. doi: 10.7748/ns.29.33.60.s44.,33,,,,,,,,,,,,,,,,,,,,,
19131035,NLM,MEDLINE,20090427,20090109,1094-9194 (Print) 1094-9194 (Linking),12,2009 Jan,Cardiovascular physiology and diseases of the rabbit.,"135-44, vii",10.1016/j.cvex.2008.08.004 [doi],"['Pariaut, Romain']",['Pariaut R'],"['Department of Clinical Sciences, School of Veterinary Medicine, Skip Bertman Drive, Louisiana State University, Baton Rouge, LA 70803, USA. rpariaut@vetmed.lsu.edu']",['eng'],"['Journal Article', 'Review']",,United States,Vet Clin North Am Exot Anim Pract,The veterinary clinics of North America. Exotic animal practice,9815628,IM,"['Animals', 'Cardiovascular Diseases/diagnosis/therapy/*veterinary', '*Cardiovascular Physiological Phenomena', '*Disease Models, Animal', 'Heart/*physiology', '*Rabbits/physiology']",2009/01/10 09:00,2009/04/28 09:00,['2009/01/10 09:00'],"['2009/01/10 09:00 [entrez]', '2009/01/10 09:00 [pubmed]', '2009/04/28 09:00 [medline]']","['S1094-9194(08)00057-1 [pii]', '10.1016/j.cvex.2008.08.004 [doi]']",ppublish,"Vet Clin North Am Exot Anim Pract. 2009 Jan;12(1):135-44, vii. doi: 10.1016/j.cvex.2008.08.004.",1,"This article reviews what is known about the diagnosis and management of cardiovascular diseases in the pet rabbit. Current knowledge is based on anecdotal reports, derived from research data using the rabbit as an animal model of human cardiovascular diseases, but most importantly canine and feline cardiology. It is likely that, as cardiovascular diseases are more often recognized, more specific information will soon become available for the treatment of the pet rabbit with cardiac disease.",,,,,,,,,27,,,,,,,,,,,
27075419,NLM,MEDLINE,20171127,20220321,1473-6535 (Electronic) 0957-9672 (Print) 0957-9672 (Linking),27,2016 Aug,Effects of melatonin on cardiovascular diseases: progress in the past year.,408-13,10.1097/MOL.0000000000000314 [doi],"['Sun, Hang', 'Gusdon, Aaron M', 'Qu, Shen']","['Sun H', 'Gusdon AM', 'Qu S']","[""aDepartment of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China bDepartment of Pathology, Division of Neuropathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Neurology, Weill Cornell Medical College, New York, USA.""]",['eng'],"['Journal Article', 'Review']",,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Animals', 'Cardiovascular Diseases/complications/*drug therapy/metabolism/pathology', 'Cell Hypoxia/drug effects', 'Humans', 'Lipid Metabolism/drug effects', 'Melatonin/*pharmacology/therapeutic use']",2016/04/15 06:00,2017/11/29 06:00,['2016/04/15 06:00'],"['2016/04/15 06:00 [entrez]', '2016/04/15 06:00 [pubmed]', '2017/11/29 06:00 [medline]']",['10.1097/MOL.0000000000000314 [doi]'],ppublish,Curr Opin Lipidol. 2016 Aug;27(4):408-13. doi: 10.1097/MOL.0000000000000314.,4,"PURPOSE OF REVIEW: Melatonin is a neuroendocrine hormone synthesized primarily by the pineal gland. Numerous studies have suggested that melatonin plays an important role in various cardiovascular diseases. In this article, recent progress regarding melatonin's effects on cardiovascular diseases is reviewed. RECENT FINDINGS: In the past year, studies have focused on the mechanism of protection of melatonin on cardiovascular diseases, including myocardial ischemia-reperfusion injury, myocardial hypoxia-reoxygenation injury, pulmonary hypertension, hypertension, atherosclerosis, valvular heart diseases, and other cardiovascular diseases. SUMMARY: Studies have demonstrated that melatonin has significant effects on ischemia-reperfusion injury, myocardial chronic intermittent hypoxia injury, pulmonary hypertension, hypertension, valvular heart diseases, vascular diseases, and lipid metabolism. As an inexpensive and well tolerated drug, melatonin may be a new therapeutic option for cardiovascular disease.",,PMC4947538,,,,,['JL5DK93RCL (Melatonin)'],,,,,,,,,,,,,
36306433,NLM,MEDLINE,20221215,20230109,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Dec 7,Lifestyle intervention for primary prevention of cardiovascular diseases.,2250-2251,10.1093/eurjpc/zwac245 [doi],"['Fukumoto, Yoshihiro']",['Fukumoto Y'],"['Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Primary Prevention', 'Primary Health Care', 'Hospitals']",2022/10/29 06:00,2022/12/15 06:00,['2022/10/28 15:02'],"['2022/10/29 06:00 [pubmed]', '2022/12/15 06:00 [medline]', '2022/10/28 15:02 [entrez]']","['6779619 [pii]', '10.1093/eurjpc/zwac245 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Dec 7;29(17):2250-2251. doi: 10.1093/eurjpc/zwac245.,17,,['ORCID: 0000-0002-8947-109X'],,['Conflict of interest: None declared.'],,,,,,,['Eur J Prev Cardiol. 2022 Dec 7;29(17):2252-2263. PMID: 36124709'],,,,,,,,,,
25529368,NLM,MEDLINE,20150520,20150318,1873-1740 (Electronic) 0033-0620 (Linking),57,2015 Mar-Apr,The vasculature in cardiovascular diseases: will the vasculature tell us what the future holds?,407-8,S0033-0620(14)00187-X [pii] 10.1016/j.pcad.2014.12.004 [doi],"['Phillips, Shane A', 'Guazzi, Marco']","['Phillips SA', 'Guazzi M']","['Department of Physical Therapy and Integrative Physiology Laboratory, College of Applied Health Sciences, University of Illinois, Chicago, IL. Electronic address: shanep@uic.edu.', 'Cardiology, I.R.C.C.S. Policlinico San Donato, University of Milano, San Donato Milanese, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",20141218,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Animals', '*Blood Vessels/metabolism/pathology/physiopathology', '*Cardiovascular Diseases/diagnosis/metabolism/mortality/pathology/physiopathology/therapy', 'Diagnostic Techniques, Cardiovascular', 'Humans', 'Patient Selection', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2014/12/23 06:00,2015/05/21 06:00,['2014/12/23 06:00'],"['2014/12/23 06:00 [entrez]', '2014/12/23 06:00 [pubmed]', '2015/05/21 06:00 [medline]']","['S0033-0620(14)00187-X [pii]', '10.1016/j.pcad.2014.12.004 [doi]']",ppublish,Prog Cardiovasc Dis. 2015 Mar-Apr;57(5):407-8. doi: 10.1016/j.pcad.2014.12.004. Epub 2014 Dec 18.,5,,,,,,,,,,,,,,,,,,,,,
21584714,NLM,MEDLINE,20120315,20211020,1615-6692 (Electronic) 0340-9937 (Linking),36,2011 Jun,Treatment of cardiovascular diseases in cancer patients.,340-5,10.1007/s00059-011-3452-5 [doi],"['Noutsias, M', 'Maisch, B']","['Noutsias M', 'Maisch B']","['Department of Internal Medicine-Cardiology, University Hospital of Marburg and Giessen / UKGM GmbH, Philipps-Universitat Marburg, Deutschland. michel.noutsias@staff.uni-marburg.de']",['eng'],"['Journal Article', 'Review']",,Germany,Herz,Herz,7801231,IM,"['Cardiovascular Diseases/diagnosis/*etiology/*therapy', 'Humans', 'Neoplasms/*complications/diagnosis/*therapy']",2011/05/18 06:00,2012/03/16 06:00,['2011/05/18 06:00'],"['2011/05/18 06:00 [entrez]', '2011/05/18 06:00 [pubmed]', '2012/03/16 06:00 [medline]']",['10.1007/s00059-011-3452-5 [doi]'],ppublish,Herz. 2011 Jun;36(4):340-5. doi: 10.1007/s00059-011-3452-5.,4,"Cardiovascular diseases and cancer are the leading causes of death in the Western world. Cancer treatment has been associated with cardiovascular complications, among others cardiotoxicity of mediastinal radiation and certain chemotherapeutics. Identification of patients at high risk, prevention, early diagnosis, and treatment of cardiovascular diseases are emerging fields in cancer patients. Close interdisciplinary work between oncologists and cardiologists is pertinent for the treatment of cardiovascular diseases and complications in cancer patients. Diagnostics and treatment applied to the individual case should be based on the available evidence in terms of patient-centered management. Further clinical research focused on the pathogenesis and treatment of cardiovascular diseases in cancer patients is warranted to pave the way to guidelines for this nonhomogeneous patient group.",,,,,,,,,,,,,,,,,,,,
29407123,NLM,MEDLINE,20180924,20180924,1874-1754 (Electronic) 0167-5273 (Linking),254,2018 Mar 1,The impact of migration on cardiovascular diseases.,356-361,S0167-5273(17)37192-9 [pii] 10.1016/j.ijcard.2017.11.084 [doi],"['Odone, Anna', 'McKee, Charlotte', 'McKee, Martin']","['Odone A', 'McKee C', 'McKee M']","['Department of Medicine and Surgery, University of Parma, Parma, Italy.', 'Department of War Studies, Kings College London, United Kingdom.', 'Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, United Kingdom. Electronic address: martin.mckee@lshtm.ac.uk.']",['eng'],['Editorial'],20180128,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['Cardiovascular Diseases/diagnosis/*economics/*epidemiology', 'Humans', 'Risk Factors', 'Socioeconomic Factors', '*Transients and Migrants/education']",2018/02/07 06:00,2018/09/25 06:00,['2018/02/07 06:00'],"['2017/11/18 00:00 [received]', '2017/11/22 00:00 [accepted]', '2018/02/07 06:00 [entrez]', '2018/02/07 06:00 [pubmed]', '2018/09/25 06:00 [medline]']","['S0167-5273(17)37192-9 [pii]', '10.1016/j.ijcard.2017.11.084 [doi]']",ppublish,Int J Cardiol. 2018 Mar 1;254:356-361. doi: 10.1016/j.ijcard.2017.11.084. Epub 2018 Jan 28.,,,,,,,,,,,,,,,,,,,,,,
36798660,NLM,MEDLINE,20230222,20230324,1664-2392 (Print) 1664-2392 (Electronic) 1664-2392 (Linking),14,2023,Editorial: Endocrine-related cardiovascular diseases: Recent advances in diagnosis and treatment.,1147752,10.3389/fendo.2023.1147752 [doi] 1147752,"['Bhat, Audesh', 'Dhar, Arti', 'Desai, Kaushik']","['Bhat A', 'Dhar A', 'Desai K']","['Center for Molecular Biology, Central University of Jammu, Jammu and Kashmir, India.', 'Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Telangana, India.', 'Department of Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada.']",['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",20230131,Switzerland,Front Endocrinol (Lausanne),Frontiers in endocrinology,101555782,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/etiology/therapy', '*Cardiovascular System', 'Heart', '*Endocrine System Diseases/diagnosis/therapy']",2023/02/18 06:00,2023/02/22 06:00,['2023/02/17 02:12'],"['2023/01/19 00:00 [received]', '2023/01/20 00:00 [accepted]', '2023/02/17 02:12 [entrez]', '2023/02/18 06:00 [pubmed]', '2023/02/22 06:00 [medline]']",['10.3389/fendo.2023.1147752 [doi]'],epublish,Front Endocrinol (Lausanne). 2023 Jan 31;14:1147752. doi: 10.3389/fendo.2023.1147752. eCollection 2023.,,,,PMC9927393,"['The authors declare that the research was conducted in the absence of any', 'commercial or financial relationships that could be construed as a potential', 'conflict of interest.']",['NOTNLM'],"['Alpha-adrenergic receptor', 'Chronic coronary syndrome (CCS)', 'calMR', 'cardiovascular disease', 'diffuse myocardial fibrosis', 'essential hypertension (HTN)', 'lipocalin-2 (LCN-2)', 'thyroid hormones and carotid plaque']",,,,,"['Editorial on the Research Topic Endocrine-related cardiovascular diseases: Recent', 'advances in diagnosis and treatment']",,,,,,,,,,
33667418,NLM,MEDLINE,20220110,20220802,1095-8584 (Electronic) 0022-2828 (Print) 0022-2828 (Linking),157,2021 Aug,Metabolism and Inflammation in Cardiovascular Health and Diseases: Mechanisms to Therapies.,113-114,S0022-2828(21)00045-6 [pii] 10.1016/j.yjmcc.2021.02.011 [doi],"['Schiattarella, Gabriele G', 'Wang, Yibin', 'Tian, Rong', 'Hill, Joseph A']","['Schiattarella GG', 'Wang Y', 'Tian R', 'Hill JA']","['Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy; Center for Cardiovascular Research (CCR), Department of Cardiology, Charite - Universitatsmedizin Berlin, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany; Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.', 'Department of Anesthesiology, Cardiovascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: yibinwang@mednet.ucla.edu.', 'Department of Anesthesiology & Pain Medicine, and Bioengineering, University of Washington School of Medicine, Seattle, WA, USA.', 'Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.']",['eng'],['Editorial'],20210302,England,J Mol Cell Cardiol,Journal of molecular and cellular cardiology,0262322,IM,"['Animals', 'Cardiovascular Diseases/diagnosis/*etiology/*metabolism/therapy', '*Cardiovascular Physiological Phenomena', 'Cardiovascular System/*metabolism', 'Disease Management', 'Disease Susceptibility', '*Energy Metabolism', 'Humans']",2021/03/06 06:00,2022/01/11 06:00,['2021/03/05 20:10'],"['2021/02/05 00:00 [received]', '2021/02/21 00:00 [accepted]', '2021/03/06 06:00 [pubmed]', '2022/01/11 06:00 [medline]', '2021/03/05 20:10 [entrez]']","['S0022-2828(21)00045-6 [pii]', '10.1016/j.yjmcc.2021.02.011 [doi]']",ppublish,J Mol Cell Cardiol. 2021 Aug;157:113-114. doi: 10.1016/j.yjmcc.2021.02.011. Epub 2021 Mar 2.,,,,PMC8319053,,,,"['R01 HL140116/HL/NHLBI NIH HHS/United States', 'R01 HL149695/HL/NHLBI NIH HHS/United States']",,,,,['NIHMS1702769'],,,,,,,,,
37474084,NLM,MEDLINE,20231102,20231114,1873-1740 (Electronic) 0033-0620 (Linking),79,2023 Jul-Aug,Cardiovascular statistics 2023.,112-113,S0033-0620(23)00071-3 [pii] 10.1016/j.pcad.2023.07.005 [doi],"['Lavie, Carl J']",['Lavie CJ'],"['Ochsner Heart and Vascular Institute, Ochsner Clinical School - The UQ School of Medicine, New Orleans, LA, USA. Electronic address: clavie@ochsner.org.']",['eng'],['Editorial'],20230718,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Humans', '*Cardiovascular System', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Heart']",2023/07/21 01:12,2023/07/21 01:13,['2023/07/20 19:28'],"['2023/07/21 01:13 [medline]', '2023/07/21 01:12 [pubmed]', '2023/07/20 19:28 [entrez]']","['S0033-0620(23)00071-3 [pii]', '10.1016/j.pcad.2023.07.005 [doi]']",ppublish,Prog Cardiovasc Dis. 2023 Jul-Aug;79:112-113. doi: 10.1016/j.pcad.2023.07.005. Epub 2023 Jul 18.,,,,,,,,,,,,,,,,,,,,,,
14535466,NLM,MEDLINE,20031112,20220318,0165-7380 (Print) 0165-7380 (Linking),27 Suppl 1,2003 Sep,Cardiovascular diseases in the ageing dog: diagnostic and therapeutic problems.,555-60,,"['Guglielmini, C']",['Guglielmini C'],"['Department of Veterinary Clinical Sciences, School of Veterinary Medicine, University of Teramo, Viale Crispi 212, I-64020 Cartecchio (TE), Italy. guglielmini@vet.unite.it']",['eng'],"['Journal Article', 'Review']",,Switzerland,Vet Res Commun,Veterinary research communications,8100520,IM,"['Aging/*physiology', 'Animals', 'Cardiomegaly/diagnosis/therapy/veterinary', 'Cardiomyopathy, Dilated/diagnosis/therapy/veterinary', 'Cardiovascular Diseases/classification/diagnosis/therapy/*veterinary', 'Dog Diseases/classification/*diagnosis/therapy', 'Dogs', 'Heart Neoplasms/diagnosis/therapy/veterinary', 'Sick Sinus Syndrome/diagnosis/therapy/veterinary']",2003/10/11 05:00,2003/11/13 05:00,['2003/10/11 05:00'],"['2003/10/11 05:00 [pubmed]', '2003/11/13 05:00 [medline]', '2003/10/11 05:00 [entrez]']",['10.1023/b:verc.0000014216.73396.f6 [doi]'],ppublish,Vet Res Commun. 2003 Sep;27 Suppl 1:555-60. doi: 10.1023/b:verc.0000014216.73396.f6.,,,,,,,,,,,23,,,,,,,,,,,
33085520,NLM,MEDLINE,20201214,20201214,1524-4636 (Electronic) 1079-5642 (Linking),40,2020 Nov,Lymphatics in Cardiovascular Disease.,e275-e283,10.1161/ATVBAHA.120.314735 [doi],"['Zhou, Yijiang', 'Huang, Chengchen', 'Hu, Yanhua', 'Xu, Qingbo', 'Hu, Xiaosheng']","['Zhou Y', 'Huang C', 'Hu Y', 'Xu Q', 'Hu X']","['From the Department of Cardiology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.', 'From the Department of Cardiology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.', 'From the Department of Cardiology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.', 'From the Department of Cardiology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.', 'From the Department of Cardiology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20201021,United States,Arterioscler Thromb Vasc Biol,"Arteriosclerosis, thrombosis, and vascular biology",9505803,IM,"['Animals', 'Biomarkers/metabolism', 'Cardiovascular Diseases/metabolism/pathology/*physiopathology/therapy', 'Humans', '*Lymphangiogenesis', 'Lymphatic System/metabolism/pathology/*physiopathology', 'Signal Transduction']",2020/10/22 06:00,2020/12/15 06:00,['2020/10/21 15:35'],"['2020/10/21 15:35 [entrez]', '2020/10/22 06:00 [pubmed]', '2020/12/15 06:00 [medline]']",['10.1161/ATVBAHA.120.314735 [doi]'],ppublish,Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):e275-e283. doi: 10.1161/ATVBAHA.120.314735. Epub 2020 Oct 21.,11,,,,,['NOTNLM'],"['arteriosclerosis', 'cardiovascular diseases', 'lymph nodes', 'myocardial infarction', 'thrombosis']",,['0 (Biomarkers)'],,,,,,,,,,,,,
2647107,NLM,MEDLINE,19890421,20190919,0785-3890 (Print) 0785-3890 (Linking),21,1989 Feb,Determinants of cardiovascular diseases in the elderly.,3-12,,"['Karvonen, M J']",['Karvonen MJ'],,['eng'],"['Journal Article', 'Review']",,England,Ann Med,Annals of medicine,8906388,IM,"['Aged', 'Cardiovascular Diseases/blood/*etiology/prevention & control', 'Humans', 'Risk Factors']",1989/02/01 00:00,1989/02/01 00:01,['1989/02/01 00:00'],"['1989/02/01 00:00 [pubmed]', '1989/02/01 00:01 [medline]', '1989/02/01 00:00 [entrez]']",['10.3109/07853898909149175 [doi]'],ppublish,Ann Med. 1989 Feb;21(1):3-12. doi: 10.3109/07853898909149175.,1,"The roles of age, gender, diet, plasma lipoproteins, blood pressure, smoking, physical activity, alcohol consumption and psychosocial factors as determinants of cardiovascular diseases have been studied mainly in the middle aged but little in the elderly. The risk factor status of glucose intolerance, body weight, and the physical and chemical environment has been less firmly established. This review examines the published evidence, emphasising the potential of extending the prevention of cardiovascular diseases beyond 60.",,,,,,,,,112,,,,,,,,,,,
31195420,NLM,MEDLINE,20200124,20200124,1098-9064 (Electronic) 0094-6176 (Linking),45,2019 Jul,Investigation of Possible Herb-Drug Interactions for the Treatment of Cardiovascular Diseases.,548-551,10.1055/s-0039-1692211 [doi],"['Zuo, Huali L', 'Yang, Fengqing Q', 'Hu, Yuanjia J']","['Zuo HL', 'Yang FQ', 'Hu YJ']","['State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau Special Administrative Region, China.', 'School of Chemistry and Chemical Engineering, Chongqing University, Chongqing, China.', 'State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau Special Administrative Region, China.']",['eng'],"['Letter', 'Review']",20190613,United States,Semin Thromb Hemost,Seminars in thrombosis and hemostasis,0431155,IM,"['*Cardiovascular Diseases/drug therapy/metabolism/pathology', '*Herb-Drug Interactions', 'Humans']",2019/06/14 06:00,2020/01/25 06:00,['2019/06/14 06:00'],"['2019/06/14 06:00 [pubmed]', '2020/01/25 06:00 [medline]', '2019/06/14 06:00 [entrez]']",['10.1055/s-0039-1692211 [doi]'],ppublish,Semin Thromb Hemost. 2019 Jul;45(5):548-551. doi: 10.1055/s-0039-1692211. Epub 2019 Jun 13.,5,,,,['The authors have no conflicts of interest to declare.'],,,,,,,,,['Semin Thromb Hemost. 2019 Jul;45(5):552-553. PMID: 31195418'],,,,,,,,
36729046,NLM,MEDLINE,20230216,20230325,2047-4881 (Electronic) 2047-4873 (Linking),30,2023 Feb 14,Editorial comments: focus on cardiovascular diseases.,203-205,10.1093/eurjpc/zwad016 [doi],"['Halasz, Geza', 'Bandera, Francesco', 'Piepoli, Massimo']","['Halasz G', 'Bandera F', 'Piepoli M']","['Azienda Ospedaliera San Camillo-Forlanini, Circonvallazione Gianicolense, Rome, Italy.', 'Clinical Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy.', 'Department of Biomedical Science for Health, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.', 'Clinical Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy.', 'Department of Biomedical Science for Health, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.']",['eng'],['Journal Article'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Editorial Policies']",2023/02/03 06:00,2023/02/17 06:00,['2023/02/02 10:54'],"['2023/02/03 06:00 [pubmed]', '2023/02/17 06:00 [medline]', '2023/02/02 10:54 [entrez]']","['7024692 [pii]', '10.1093/eurjpc/zwad016 [doi]']",ppublish,Eur J Prev Cardiol. 2023 Feb 14;30(3):203-205. doi: 10.1093/eurjpc/zwad016.,3,,"['ORCID: 0000-0001-7220-123X', 'ORCID: 0000-0002-5821-7371', 'ORCID: 0000-0003-1124-234X']",,['Conflict of interest: None declared.'],,,,,,,,,,,,,,,,,
37173185,NLM,MEDLINE,20231205,20231205,1989-4805 (Electronic) 1889-1837 (Linking),40,2023 Oct-Dec,"Oral health, hypertension and cardiovascular diseases.",167-170,S1889-1837(23)00023-5 [pii] 10.1016/j.hipert.2023.04.001 [doi],"['Carasol, M', 'Munoz Aguilera, E', 'Ruilope, L M']","['Carasol M', 'Munoz Aguilera E', 'Ruilope LM']","['Alianza por la Salud Periodontal y General, Sociedad Espanola de Periodoncia, Spain; Grupo de Investigacion ETEP (Etiologia y terapeutica de las Enfermedades Periodontales), Facultad de Odontologia, Universidad Complutense de Madrid, Spain. Electronic address: mcarasol@gmail.com.', 'Alianza por la Salud Periodontal y General, Sociedad Espanola de Periodoncia, Spain; Lecturer in Periodontology, London, United Kingdom.', 'Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain.']",['eng'],['Journal Article'],20230510,Spain,Hipertens Riesgo Vasc,Hipertension y riesgo vascular,101510649,IM,"['Humans', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Oral Health', '*Hypertension/epidemiology', 'Risk Factors']",2023/05/13 15:13,2023/12/05 12:42,['2023/05/12 21:59'],"['2023/03/23 00:00 [received]', '2023/04/11 00:00 [revised]', '2023/04/12 00:00 [accepted]', '2023/12/05 12:42 [medline]', '2023/05/13 15:13 [pubmed]', '2023/05/12 21:59 [entrez]']","['S1889-1837(23)00023-5 [pii]', '10.1016/j.hipert.2023.04.001 [doi]']",ppublish,Hipertens Riesgo Vasc. 2023 Oct-Dec;40(4):167-170. doi: 10.1016/j.hipert.2023.04.001. Epub 2023 May 10.,4,,,,,,,,,,,,,,,,,,,,,
32224111,NLM,MEDLINE,20200817,20210923,1873-1740 (Electronic) 0033-0620 (Print) 0033-0620 (Linking),63,2020 May-Jun,Special assorted cardiovascular topics.,193,S0033-0620(20)30070-0 [pii] 10.1016/j.pcad.2020.03.016 [doi],"['Lavie, Carl J']",['Lavie CJ'],"['John Ochsner Heart and Vascular Institute, Ochsner Clinical School -the University of Queensland School of Medicine, New Orleans, LA, United States of America.']",['eng'],"['Editorial', 'Introductory Journal Article']",20200326,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Humans', 'Prognosis', 'Risk Factors']",2020/04/01 06:00,2020/08/18 06:00,['2020/04/01 06:00'],"['2020/04/01 06:00 [pubmed]', '2020/08/18 06:00 [medline]', '2020/04/01 06:00 [entrez]']","['S0033-0620(20)30070-0 [pii]', '10.1016/j.pcad.2020.03.016 [doi]']",ppublish,Prog Cardiovasc Dis. 2020 May-Jun;63(3):193. doi: 10.1016/j.pcad.2020.03.016. Epub 2020 Mar 26.,3,,,PMC7118538,,,,,,,,,,"['Prog Cardiovasc Dis. 2021 Jul-Aug;67:1. PMID: 34412824', 'Prog Cardiovasc Dis. 2021 Jul-Aug;67:114-115. PMID: 34412825']",,,,,,,,
15180587,NLM,MEDLINE,20050202,20191108,1566-5232 (Print) 1566-5232 (Linking),4,2004 Jun,Gene therapy approaches for cardiovascular diseases.,207-23,,"['Quarck, Rozenn', 'Holvoet, Paul']","['Quarck R', 'Holvoet P']","['Cardiovascular Research Unit, Center for Experimental Surgery and Anesthesiology, Katholieke Universiteit Leuven, Belgium.']",['eng'],"['Journal Article', 'Review']",,United Arab Emirates,Curr Gene Ther,Current gene therapy,101125446,IM,"['Animals', 'Cardiovascular Diseases/blood/*genetics/pathology/*therapy', 'Drug Delivery Systems', 'Gene Silencing', 'Genetic Therapy/*methods', 'Humans', 'Tissue Engineering']",2004/06/08 05:00,2005/02/03 09:00,['2004/06/08 05:00'],"['2004/06/08 05:00 [pubmed]', '2005/02/03 09:00 [medline]', '2004/06/08 05:00 [entrez]']",['10.2174/1566523043346499 [doi]'],ppublish,Curr Gene Ther. 2004 Jun;4(2):207-23. doi: 10.2174/1566523043346499.,2,"Cardiovascular diseases are one of the main causes of mortality in Western countries. Gene therapy is emerging as a potential strategy for the treatment of cardiovascular diseases, such as peripheral arterial disease, ischemic heart disease, restenosis after angioplasty, vascular bypass graft occlusion and transplant-associated coronary artery disease. Since the initial experiments more than one decade ago, remarkable progress has been made in the field of gene transfer and human clinical trials are underway. In here we give an overview of available gene transfer strategies describing several delivery routes and currently used vectors in animal studies and clinical trials. Hereby we want to focus on new approaches including the potential combination of gene therapy with cell therapy and tissue engineering, gene silencing and recently developed techniques for targeting genes to the vascular wall and the myocardium.",,,,,,,,,208,,,,,,,,,,,
11759844,NLM,MEDLINE,20020220,20190513,0300-5771 (Print) 0300-5771 (Linking),30 Suppl 1,2001 Oct,"Cardiovascular diseases: causes, surveillance and prevention.",S1-4,,"['Beaglehole, R', 'Saracci, R', 'Panico, S']","['Beaglehole R', 'Saracci R', 'Panico S']",,['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",,England,Int J Epidemiol,International journal of epidemiology,7802871,IM,"['Cardiovascular Diseases/*epidemiology/etiology/prevention & control', 'Coronary Disease/epidemiology/etiology/prevention & control', '*Global Health', 'Humans', '*Population Surveillance', 'Risk Factors']",2002/01/05 10:00,2002/02/21 10:01,['2002/01/05 10:00'],"['2002/01/05 10:00 [pubmed]', '2002/02/21 10:01 [medline]', '2002/01/05 10:00 [entrez]']",['10.1093/ije/30.suppl_1.s1 [doi]'],ppublish,Int J Epidemiol. 2001 Oct;30 Suppl 1:S1-4. doi: 10.1093/ije/30.suppl_1.s1.,,,,,,,,,,,,,,,,,,,,,,
33559849,NLM,MEDLINE,20210818,20210818,1724-6059 (Electronic) 1121-8428 (Print) 1121-8428 (Linking),34,2021 Feb,"A brand new world: from cardiovascular diseases to aquaponics, focusing on challenges can bring new hope. An introduction to 2021 from Journal of Nephrology.",1-2,10.1007/s40620-021-00978-3 [doi],"['Piccoli, Giorgina Barbara']",['Piccoli GB'],"['Centre Hospitalier Le Mans, 72000, Le Mans, France. gbpiccoli@yahoo.it.']",['eng'],['Editorial'],,Italy,J Nephrol,Journal of nephrology,9012268,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans', '*Nephrology']",2021/02/10 06:00,2021/08/19 06:00,['2021/02/09 08:48'],"['2021/02/10 06:00 [pubmed]', '2021/08/19 06:00 [medline]', '2021/02/09 08:48 [entrez]']","['10.1007/s40620-021-00978-3 [pii]', '978 [pii]', '10.1007/s40620-021-00978-3 [doi]']",ppublish,J Nephrol. 2021 Feb;34(1):1-2. doi: 10.1007/s40620-021-00978-3.,1,,,PMC7871132,['The authors declare that they have no conflict of interest.'],,,,,,,,,,,,,,,,,
27324354,NLM,MEDLINE,20161213,20161230,1524-4539 (Electronic) 0009-7322 (Linking),133,2016 Jun 21,The Future of Cardiovascular Biomedicine.,2601-2,10.1161/CIRCULATIONAHA.115.020553 [doi],"['MacRae, Calum A', 'Loscalzo, Joseph']","['MacRae CA', 'Loscalzo J']","[""From Harvard Medical School/Brigham and Women's Hospital, Cardiovascular Medicine, Boston, MA. camacrae@bics.bwh.harvard.edu."", ""From Harvard Medical School/Brigham and Women's Hospital, Cardiovascular Medicine, Boston, MA.""]",['eng'],['Introductory Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Animals', 'Biomedical Research/*trends', 'Cardiology/*trends', '*Cardiovascular Diseases/diagnosis/genetics/physiopathology/therapy', 'Forecasting', 'Humans', 'Molecular Medicine/*trends']",2016/06/22 06:00,2016/12/15 06:00,['2016/06/22 06:00'],"['2016/06/22 06:00 [entrez]', '2016/06/22 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['CIRCULATIONAHA.115.020553 [pii]', '10.1161/CIRCULATIONAHA.115.020553 [doi]']",ppublish,Circulation. 2016 Jun 21;133(25):2601-2. doi: 10.1161/CIRCULATIONAHA.115.020553.,25,,,,,['NOTNLM'],"['cardiovascular diseases', 'genomics', 'patient outcome assessment', 'physiopathology', 'prevention & control']",,,,,,,,,,,,,,,
30799649,NLM,MEDLINE,20200803,20200803,2047-4881 (Electronic) 2047-4873 (Linking),26,2019 Mar,Editor's presentation.,339-341,10.1177/2047487319833263 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"[""Heart Failure Unit, Cardiology, G da Saliceto Hospital; Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Piacenza, Italy.""]",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiovascular Diseases/diagnostic imaging/mortality/physiopathology/*prevention & control', 'Humans', 'Predictive Value of Tests', '*Primary Prevention', 'Prognosis', 'Risk Factors', '*Secondary Prevention']",2019/02/26 06:00,2020/08/04 06:00,['2019/02/26 06:00'],"['2019/02/26 06:00 [entrez]', '2019/02/26 06:00 [pubmed]', '2020/08/04 06:00 [medline]']",['10.1177/2047487319833263 [doi]'],ppublish,Eur J Prev Cardiol. 2019 Mar;26(4):339-341. doi: 10.1177/2047487319833263.,4,,,,,,,,,,,,,,,,,,,,,
31806188,NLM,MEDLINE,20200831,20200831,1876-7591 (Electronic) 1876-7591 (Linking),12,2019 Dec,Progress in Cardiovascular Imaging.,2589-2610,S1936-878X(19)30963-5 [pii] 10.1016/j.jcmg.2019.11.002 [doi],"['Shaw, Leslee', 'Chandrashekhar, Y']","['Shaw L', 'Chandrashekhar Y']",,['eng'],"['Journal Article', 'Review']",,United States,JACC Cardiovasc Imaging,JACC. Cardiovascular imaging,101467978,IM,"['Cardiac Imaging Techniques/*trends', 'Cardiovascular Diseases/*diagnostic imaging/epidemiology/physiopathology/therapy', 'Diffusion of Innovation', 'Forecasting', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Assessment', 'Risk Factors']",2019/12/07 06:00,2020/09/01 06:00,['2019/12/07 06:00'],"['2019/12/07 06:00 [entrez]', '2019/12/07 06:00 [pubmed]', '2020/09/01 06:00 [medline]']","['S1936-878X(19)30963-5 [pii]', '10.1016/j.jcmg.2019.11.002 [doi]']",ppublish,JACC Cardiovasc Imaging. 2019 Dec;12(12):2589-2610. doi: 10.1016/j.jcmg.2019.11.002.,12,,,,,,,,,,,,,,['JACC: Cardiovascular Imaging Editors'],,,,,,,
21122644,NLM,MEDLINE,20110509,20101202,1933-2874 (Print) 1876-4789 (Linking),4,2010 May-Jun,Estimating risk and setting targets for treatment in the national effort to reduce cardiovascular diseases. Foreword.,139-41,10.1016/j.jacl.2010.03.074 [doi],"['Brown, W Virgil']",['Brown WV'],,['eng'],"['Editorial', 'Introductory Journal Article']",20100401,United States,J Clin Lipidol,Journal of clinical lipidology,101300157,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/*therapy', 'Humans', 'Practice Guidelines as Topic', 'Risk Factors']",2010/12/03 06:00,2011/05/10 06:00,['2010/12/03 06:00'],"['2010/03/25 00:00 [received]', '2010/03/25 00:00 [accepted]', '2010/12/03 06:00 [entrez]', '2010/12/03 06:00 [pubmed]', '2011/05/10 06:00 [medline]']","['S1933-2874(10)00173-X [pii]', '10.1016/j.jacl.2010.03.074 [doi]']",ppublish,J Clin Lipidol. 2010 May-Jun;4(3):139-41. doi: 10.1016/j.jacl.2010.03.074. Epub 2010 Apr 1.,3,,,,,,,,,,,,,,,,,,,,,
30789232,NLM,MEDLINE,20200330,20200330,1755-3245 (Electronic) 0008-6363 (Linking),115,2019 Mar 1,Recent Cardiovascular Research highlights from China.,e37-e38,10.1093/cvr/cvy245 [doi],"['Gao, Pingjin']",['Gao P'],"['Department of Hypertension, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Ruijin Hospital and Shanghai Institute of Hypertension, Shanghai Jiao Tong University School of Medicine, Shanghai, China.']",['eng'],['Editorial'],,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Animals', 'Bibliometrics', '*Biomedical Research', '*Cardiovascular Diseases/genetics/metabolism/pathology/physiopathology', '*Cardiovascular System/metabolism/pathology/physiopathology', 'China', 'Humans', '*Periodicals as Topic']",2019/02/23 06:00,2020/03/31 06:00,['2019/02/22 06:00'],"['2019/02/22 06:00 [entrez]', '2019/02/23 06:00 [pubmed]', '2020/03/31 06:00 [medline]']","['5346789 [pii]', '10.1093/cvr/cvy245 [doi]']",ppublish,Cardiovasc Res. 2019 Mar 1;115(3):e37-e38. doi: 10.1093/cvr/cvy245.,3,,,,,,,,,,,,,,,,,,,,,
19622927,NLM,MEDLINE,20090930,20090722,1473-5598 (Electronic) 0263-6352 (Linking),27,2009 Aug,Cardiovascular regulation and cardiovascular diseases: what can sleep teach us?,1533-5,10.1097/HJH.0b013e32832e66cf [doi],"['Castiglioni, Paolo', 'Lombardi, Carolina']","['Castiglioni P', 'Lombardi C']",,['eng'],"['Comment', 'Editorial']",,Netherlands,J Hypertens,Journal of hypertension,8306882,IM,"['Autonomic Nervous System/physiology', 'Cardiovascular Diseases/*etiology/mortality/physiopathology', '*Hemodynamics', 'Humans', 'Hypertension/physiopathology', 'Sleep/*physiology']",2009/07/23 09:00,2009/10/01 06:00,['2009/07/23 09:00'],"['2009/07/23 09:00 [entrez]', '2009/07/23 09:00 [pubmed]', '2009/10/01 06:00 [medline]']","['00004872-200908000-00005 [pii]', '10.1097/HJH.0b013e32832e66cf [doi]']",ppublish,J Hypertens. 2009 Aug;27(8):1533-5. doi: 10.1097/HJH.0b013e32832e66cf.,8,,,,,,,,,,,['J Hypertens. 2009 Aug;27(8):1655-63. PMID: 19451834'],,,,,,,,,,
34989671,NLM,MEDLINE,20220125,20220125,1646-0758 (Electronic) 0870-399X (Linking),34,2021 Dec 2,[Cardiovascular Diseases in People with Severe Mental Illness: The Importance of Diagnosis].,882,10.20344/amp.17103 [doi],"['Bernardo, Marta']",['Bernardo M'],['Unidade de Saude Familiar Andreas. Mafra. Portugal.'],['por'],"['Comment', 'Letter']",20211202,Portugal,Acta Med Port,Acta medica portuguesa,7906803,IM,"['*Cardiovascular Diseases/complications/diagnosis/epidemiology', 'Humans', '*Mental Disorders/complications/diagnosis', 'Risk Factors']",2022/01/07 06:00,2022/01/27 06:00,['2022/01/06 12:17'],"['2021/09/02 00:00 [received]', '2021/09/22 00:00 [accepted]', '2022/01/06 12:17 [entrez]', '2022/01/07 06:00 [pubmed]', '2022/01/27 06:00 [medline]']",['10.20344/amp.17103 [doi]'],ppublish,Acta Med Port. 2021 Dec 2;34(12):882. doi: 10.20344/amp.17103. Epub 2021 Dec 2.,12,,,,,['NOTNLM'],"['Cardiovascular Disease', 'Early Diagnosis', 'Mental Disorders', 'Risk Reduction Behavior']",,,,,['Acta Med Port. 2021 Aug 31;34(9):569-571. PMID: 34863323'],,,,Doencas Cardiovasculares nas Pessoas com Doenca Mental Grave: A Importancia do Diagnostico.,,,,,,
1488179,NLM,MEDLINE,19930219,20190214,0029-6643 (Print) 0029-6643 (Linking),50,1992 Dec,The effect of nutritional prevention of cardiovascular diseases on longevity.,407-12,,"['Gonzalez Biosca, D', 'Mizushima, S', 'Sawamura, M', 'Nara, Y', 'Yamori, Y']","['Gonzalez Biosca D', 'Mizushima S', 'Sawamura M', 'Nara Y', 'Yamori Y']","['WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases, Izumo, Japan.']",['eng'],"['Journal Article', 'Review']",,United States,Nutr Rev,Nutrition reviews,0376405,IM,"['Cardiovascular Diseases/etiology/mortality/*prevention & control', 'Diet', 'Female', 'Humans', '*Longevity', 'Male', '*Nutritional Physiological Phenomena']",1992/12/01 00:00,1992/12/01 00:01,['1992/12/01 00:00'],"['1992/12/01 00:00 [pubmed]', '1992/12/01 00:01 [medline]', '1992/12/01 00:00 [entrez]']",['10.1111/j.1753-4887.1992.tb02492.x [doi]'],ppublish,Nutr Rev. 1992 Dec;50(12):407-12. doi: 10.1111/j.1753-4887.1992.tb02492.x.,12,,,,,,,,,,33,,,,,,,,,,,
38038703,NLM,MEDLINE,20231204,20231204,0260-1060 (Print) 0260-1060 (Linking),29,2023 Dec,Dietary patterns and the risk of cardiovascular diseases.,609-610,10.1177/02601060231216523 [doi],"['Ahmad, Firdos']",['Ahmad F'],"['Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, UAE.', 'Cardiovascular Research Group, Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, UAE.']",['eng'],['Editorial'],,England,Nutr Health,Nutrition and health,8306569,IM,"['Humans', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Diet', 'Risk Factors']",2023/12/01 12:42,2023/12/04 12:42,['2023/12/01 10:33'],"['2023/12/04 12:42 [medline]', '2023/12/01 12:42 [pubmed]', '2023/12/01 10:33 [entrez]']",['10.1177/02601060231216523 [doi]'],ppublish,Nutr Health. 2023 Dec;29(4):609-610. doi: 10.1177/02601060231216523.,4,,,,,,,,,,,,,,,,,,,,,
31926995,NLM,MEDLINE,20200511,20200511,1873-1740 (Electronic) 0033-0620 (Linking),63,2020 Jan-Feb,PCVD 2020.,74-75,S0033-0620(20)30011-6 [pii] 10.1016/j.pcad.2020.01.001 [doi],"['Lavie, Carl J']",['Lavie CJ'],"['Cardiac Rehabilitation and Preventive Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, USA.']",['eng'],['Editorial'],20200109,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['*Biomedical Research', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Editorial Policies', 'Humans', 'Journal Impact Factor', '*Periodicals as Topic']",2020/01/14 06:00,2020/05/12 06:00,['2020/01/14 06:00'],"['2020/01/14 06:00 [pubmed]', '2020/05/12 06:00 [medline]', '2020/01/14 06:00 [entrez]']","['S0033-0620(20)30011-6 [pii]', '10.1016/j.pcad.2020.01.001 [doi]']",ppublish,Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):74-75. doi: 10.1016/j.pcad.2020.01.001. Epub 2020 Jan 9.,1,,,,,,,,,,,,,,,,,,,,,
9708571,NLM,MEDLINE,19980902,20191102,0022-2143 (Print) 0022-2143 (Linking),132,1998 Aug,Ten steps to gene therapy for cardiovascular diseases.,104-11,,"['Rios, C D', 'Chu, Y', 'Davidson, B L', 'Heistad, D D']","['Rios CD', 'Chu Y', 'Davidson BL', 'Heistad DD']","['Department of Internal Medicine, the Cardiovascular Center, University of Iowa College of Medicine, Iowa City, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",,United States,J Lab Clin Med,The Journal of laboratory and clinical medicine,0375375,IM,"['Animals', 'Cardiovascular Diseases/genetics/immunology/physiopathology/*therapy', 'Gene Transfer Techniques', '*Genetic Therapy', 'Genetic Vectors', 'Humans']",1998/08/26 00:00,1998/08/26 00:01,['1998/08/26 00:00'],"['1998/08/26 00:00 [pubmed]', '1998/08/26 00:01 [medline]', '1998/08/26 00:00 [entrez]']","['S0022-2143(98)90005-1 [pii]', '10.1016/s0022-2143(98)90005-1 [doi]']",ppublish,J Lab Clin Med. 1998 Aug;132(2):104-11. doi: 10.1016/s0022-2143(98)90005-1.,2,,,,,,,"['HL 14388/HL/NHLBI NIH HHS/United States', 'HL 16066/HL/NHLBI NIH HHS/United States', 'NS 24621/NS/NINDS NIH HHS/United States']",,,70,,,,,,,,,,,
35120976,NLM,MEDLINE,20220413,20220413,1873-1740 (Electronic) 0033-0620 (Linking),70,2022 Jan-Feb,Nine Years as Editor-in Chief of Progress in Cardiovascular Diseases.,195-196,S0033-0620(22)00018-4 [pii] 10.1016/j.pcad.2022.01.011 [doi],"['Lavie, Carl J']",['Lavie CJ'],"['John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States of America. Electronic address: clavie@ochsner.org.']",['eng'],['Journal Article'],20220201,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans']",2022/02/06 06:00,2022/04/14 06:00,['2022/02/05 05:37'],"['2022/02/06 06:00 [pubmed]', '2022/04/14 06:00 [medline]', '2022/02/05 05:37 [entrez]']","['S0033-0620(22)00018-4 [pii]', '10.1016/j.pcad.2022.01.011 [doi]']",ppublish,Prog Cardiovasc Dis. 2022 Jan-Feb;70:195-196. doi: 10.1016/j.pcad.2022.01.011. Epub 2022 Feb 1.,,,,,,,,,,,,,,,,,,,,,,
29956553,NLM,MEDLINE,20190911,20200511,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Jul,Editor's presentation.,1011-1013,10.1177/2047487318786200 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, G da Saliceto Hospital, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/epidemiology/physiopathology/psychology/therapy', 'Health Status', 'Humans', 'Mental Health', 'Prognosis', 'Risk Factors']",2018/06/30 06:00,2019/09/12 06:00,['2018/06/30 06:00'],"['2018/06/30 06:00 [entrez]', '2018/06/30 06:00 [pubmed]', '2019/09/12 06:00 [medline]']",['10.1177/2047487318786200 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Jul;25(10):1011-1013. doi: 10.1177/2047487318786200.,10,,,,,,,,,,,,,,,,,,,,,
36291738,NLM,MEDLINE,20221028,20221110,2218-273X (Electronic) 2218-273X (Linking),12,2022 Oct 21,Advances in Molecular Biomarkers in Cardiology.,,10.3390/biom12101530 [doi] 1530,"['Scicchitano, Pietro', 'Cameli, Matteo']","['Scicchitano P', 'Cameli M']","['Cardiology Section, Hospital ""F. Perinei"" ASL BA, 70022 Altamura, Bari, Italy.', 'Department of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy.']",['eng'],['Editorial'],20221021,Switzerland,Biomolecules,Biomolecules,101596414,IM,"['Humans', '*Cardiology', '*Cardiovascular Diseases/diagnosis/genetics/therapy', 'Biomarkers']",2022/10/28 06:00,2022/10/29 06:00,['2022/10/27 01:13'],"['2022/10/17 00:00 [received]', '2022/10/17 00:00 [accepted]', '2022/10/27 01:13 [entrez]', '2022/10/28 06:00 [pubmed]', '2022/10/29 06:00 [medline]']","['biom12101530 [pii]', 'biomolecules-12-01530 [pii]', '10.3390/biom12101530 [doi]']",epublish,Biomolecules. 2022 Oct 21;12(10):1530. doi: 10.3390/biom12101530.,10,Cardiovascular diseases (CVD) represent the leading cause of death in the world despite innovations in therapies and advances in the general management of patients [...].,"['ORCID: 0000-0003-0471-0053', 'ORCID: 0000-0003-3872-8964']",PMC9599388,['The authors declare no conflict of interest.'],,,,['0 (Biomarkers)'],,,,,,,,,,,,,
32150471,NLM,MEDLINE,20201102,20201102,1524-4539 (Electronic) 0009-7322 (Linking),141,2020 Mar 10,Reducing the Risk of Cardiovascular Disease: Brick by BRICS.,800-802,10.1161/CIRCULATIONAHA.119.044757 [doi],"['Reddy, K Srinath', 'Prabhakaran, Dorairaj']","['Reddy KS', 'Prabhakaran D']","['Public Health Foundation of India, New Delhi.', 'Public Health Foundation of India, New Delhi.']",['eng'],"['Comment', 'Editorial']",20200309,United States,Circulation,Circulation,0147763,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Cohort Studies', 'Global Burden of Disease', 'Global Health', 'Humans']",2020/03/10 06:00,2020/11/03 06:00,['2020/03/10 06:00'],"['2020/03/10 06:00 [entrez]', '2020/03/10 06:00 [pubmed]', '2020/11/03 06:00 [medline]']",['10.1161/CIRCULATIONAHA.119.044757 [doi]'],ppublish,Circulation. 2020 Mar 10;141(10):800-802. doi: 10.1161/CIRCULATIONAHA.119.044757. Epub 2020 Mar 9.,10,,,,,['NOTNLM'],"['Editorials', 'cardiovascular diseases', 'global burden of disease']",,,,,['Circulation. 2020 Mar 10;141(10):790-799. PMID: 31941371'],,,,,,,,,,
35422259,NLM,MEDLINE,20220418,20220418,1558-4232 (Electronic) 1094-9194 (Linking),25,2022 May,Heart Diseases in Reptiles: Diagnosis and Therapy.,383-407,S1094-9194(22)00003-2 [pii] 10.1016/j.cvex.2022.01.003 [doi],"['Schilliger, Lionel']",['Schilliger L'],"[""Clinique Veterinaire du Village d'Auteuil, 35 rue Leconte de Lisle, Paris 75016, France. Electronic address: Dr.L.Schilliger@club-internet.fr.""]",['eng'],"['Journal Article', 'Review']",,United States,Vet Clin North Am Exot Anim Pract,The veterinary clinics of North America. Exotic animal practice,9815628,IM,"['Animals', '*Cardiovascular Agents', '*Cardiovascular Diseases/diagnosis/therapy/veterinary', '*Heart Diseases/diagnosis/therapy/veterinary', 'Reptiles']",2022/04/16 06:00,2022/04/19 06:00,['2022/04/15 05:20'],"['2022/04/15 05:20 [entrez]', '2022/04/16 06:00 [pubmed]', '2022/04/19 06:00 [medline]']","['S1094-9194(22)00003-2 [pii]', '10.1016/j.cvex.2022.01.003 [doi]']",ppublish,Vet Clin North Am Exot Anim Pract. 2022 May;25(2):383-407. doi: 10.1016/j.cvex.2022.01.003.,2,"The notion that poikilotherms do not suffer from cardiovascular conditions is being increasingly challenged as diagnostic tools used in companion animal practice are applied to reptiles. However, the cause, diagnosis, and treatment of cardiac conditions in reptiles is difficult because of the scarcity of published literature. Auscultation, electrocardiography, radiography, and ultrasonography are helpful diagnostic techniques in herpetologic practice. Although the pharmacokinetics and pharmacodynamics of cardiovascular drugs are poorly understood in these animals, basic principles remain applicable; these include pharmacologic and nonpharmacologic interventions. Further research is needed to establish species-specific cardiac reference ranges and evidence-based treatment options.",,,['Disclosure The author has nothing to disclose.'],['NOTNLM'],"['Cardiology', 'Diagnosis', 'Electrocardiography', 'Radiography', 'Reptile', 'Therapy', 'Ultrasonography']",,['0 (Cardiovascular Agents)'],['Copyright (c) 2022 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,
20810751,NLM,MEDLINE,20100927,20181201,1535-5667 (Electronic) 0161-5505 (Linking),51,2010 Sep,Cardiovascular disease.,15N-19N,,"['Schwaiger, Markus']",['Schwaiger M'],,['eng'],"['Lecture', 'News']",,United States,J Nucl Med,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",0217410,IM,"['*Cardiovascular Diseases/diagnosis/metabolism/physiopathology/therapy', 'Congresses as Topic', 'Diagnostic Imaging', 'Humans', '*Nuclear Medicine/instrumentation/methods', 'Radiopharmaceuticals/therapeutic use']",2010/09/03 06:00,2010/09/29 06:00,['2010/09/03 06:00'],"['2010/09/03 06:00 [entrez]', '2010/09/03 06:00 [pubmed]', '2010/09/29 06:00 [medline]']",['51/9/15N [pii]'],ppublish,J Nucl Med. 2010 Sep;51(9):15N-19N.,9,,,,,,,,['0 (Radiopharmaceuticals)'],,,,,,,,,,,,,
37156319,NLM,MEDLINE,20230626,20231116,1873-1740 (Electronic) 0033-0620 (Linking),78,2023 May-Jun,Adipo-cardiology: The next frontier in cardiovascular disease.,1,S0033-0620(23)00049-X [pii] 10.1016/j.pcad.2023.05.001 [doi],"['Neeland, Ian J']",['Neeland IJ'],"['UH Center for Cardiovascular Prevention, Translational Science Unit, Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA), Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, 11100 Euclid Ave, Mailstop Lakeside 5038, Cleveland, OH 44106, USA. Electronic address: Ian.Neeland@UHhospitals.org.']",['eng'],['Editorial'],20230506,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Cardiology', '*Cardiovascular System']",2023/05/09 00:42,2023/06/26 06:42,['2023/05/08 19:20'],"['2023/06/26 06:42 [medline]', '2023/05/09 00:42 [pubmed]', '2023/05/08 19:20 [entrez]']","['S0033-0620(23)00049-X [pii]', '10.1016/j.pcad.2023.05.001 [doi]']",ppublish,Prog Cardiovasc Dis. 2023 May-Jun;78:1. doi: 10.1016/j.pcad.2023.05.001. Epub 2023 May 6.,,,,,,,,,,,,,,,,,,,,,,
4929953,NLM,MEDLINE,19710628,20131121,0002-8223 (Print) 0002-8223 (Linking),58,1971 May,Research in cardiovascular diseases.,401-5,,"['Cooper, T', 'Mitchell, S C']","['Cooper T', 'Mitchell SC']",,['eng'],"['Journal Article', 'Review']",,United States,J Am Diet Assoc,Journal of the American Dietetic Association,7503061,IM,"['Adult', 'Aged', 'Arteriosclerosis', 'Blood Protein Disorders', 'Cardiovascular Diseases/diagnosis/epidemiology/mortality/*prevention & control/therapy', 'Cholesterol/blood', 'Coronary Disease', 'Diet Therapy', 'Geography', 'Humans', 'Hypertension', 'Lipoproteins/blood', 'Lung Diseases', 'Male', 'Middle Aged', 'National Institutes of Health (U.S.)', 'Research', 'United States']",1971/05/01 00:00,1971/05/01 00:01,['1971/05/01 00:00'],"['1971/05/01 00:00 [pubmed]', '1971/05/01 00:01 [medline]', '1971/05/01 00:00 [entrez]']",,ppublish,J Am Diet Assoc. 1971 May;58(5):401-5.,5,,,,,,,,"['0 (Lipoproteins)', '97C5T2UQ7J (Cholesterol)']",,8,,,,,,,,,,,
22113984,NLM,MEDLINE,20120321,20211021,1757-4684 (Electronic) 1757-4676 (Print) 1757-4676 (Linking),3,2011 Dec,Cardiovascular disease review series.,697,10.1002/emmm.201100182 [doi],"['Dimmeler, Stefanie']",['Dimmeler S'],,['eng'],"['Editorial', 'Introductory Journal Article']",20111124,England,EMBO Mol Med,EMBO molecular medicine,101487380,IM,"['Biomedical Research/*trends', 'Cardiovascular Diseases/*pathology/*physiopathology/prevention & control/therapy', 'Chemokines/metabolism', 'Humans', 'MicroRNAs/metabolism', 'Regeneration']",2011/11/25 06:00,2012/03/22 06:00,['2011/11/25 06:00'],"['2011/11/25 06:00 [entrez]', '2011/11/25 06:00 [pubmed]', '2012/03/22 06:00 [medline]']",['10.1002/emmm.201100182 [doi]'],ppublish,EMBO Mol Med. 2011 Dec;3(12):697. doi: 10.1002/emmm.201100182. Epub 2011 Nov 24.,12,,,PMC3377116,,,,,"['0 (Chemokines)', '0 (MicroRNAs)']",,,,,,,,,,,,,
25515857,NLM,MEDLINE,20160601,20191027,1875-6212 (Electronic) 1570-1611 (Linking),13,2015,Editorial: Novel microRNAs as Putative Therapeutic Targets in Cardiovascular Diseases.,564-5,,"['Karapetsas, Athanasios', 'Tokamani, Maria', 'Kolettas, Evangelos', 'Sandaltzopoulos, Raphael']","['Karapetsas A', 'Tokamani M', 'Kolettas E', 'Sandaltzopoulos R']","['Department of Molecular Biology and Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece. rmsandal@mbg.duth.gr.']",['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",,United Arab Emirates,Curr Vasc Pharmacol,Current vascular pharmacology,101157208,IM,"['Atherosclerosis/*genetics/physiopathology/therapy', 'Cardiovascular Diseases/*genetics/physiopathology/therapy', 'Humans', 'MicroRNAs/*genetics', 'Molecular Targeted Therapy']",2014/12/18 06:00,2016/06/02 06:00,['2014/12/18 06:00'],"['2014/12/18 06:00 [entrez]', '2014/12/18 06:00 [pubmed]', '2016/06/02 06:00 [medline]']","['CVP-EPUB-64058 [pii]', '10.2174/1570161112666141217153158 [doi]']",ppublish,Curr Vasc Pharmacol. 2015;13(5):564-5. doi: 10.2174/1570161112666141217153158.,5,,,,,,,,['0 (MicroRNAs)'],,,,,,,,,,,,,
25432396,NLM,MEDLINE,20150803,20141129,1558-4410 (Electronic) 0889-8529 (Linking),43,2014 Dec,Lipids.,xiii-xiv,S0889-8529(14)00079-6 [pii] 10.1016/j.ecl.2014.09.001 [doi],"['Smith, Donald A']",['Smith DA'],"['Associate Professor of Medicine and Preventive Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, Box 1014, New York, NY 10029-6574, USA. Electronic address: donald.smith@mssm.edu.']",['eng'],['Editorial'],20141003,United States,Endocrinol Metab Clin North Am,Endocrinology and metabolism clinics of North America,8800104,IM,"['Cardiovascular Diseases/diagnosis/diet therapy/*drug therapy/prevention & control', 'Humans', 'Lipoproteins/*metabolism', '*Practice Guidelines as Topic']",2014/11/30 06:00,2015/08/04 06:00,['2014/11/30 06:00'],"['2014/11/30 06:00 [entrez]', '2014/11/30 06:00 [pubmed]', '2015/08/04 06:00 [medline]']","['S0889-8529(14)00079-6 [pii]', '10.1016/j.ecl.2014.09.001 [doi]']",ppublish,Endocrinol Metab Clin North Am. 2014 Dec;43(4):xiii-xiv. doi: 10.1016/j.ecl.2014.09.001. Epub 2014 Oct 3.,4,,,,,,,,['0 (Lipoproteins)'],,,,,,,,,,,,,
35658148,NLM,MEDLINE,20220608,20220609,2972-4066 (Electronic) 0304-4602 (Linking),51,2022 May,Sepsis and cardiovascular events: The story so far.,261-262,10.47102/annals-acadmedsg.2022135 [doi],"['Imran, Bin Mohamed Noor']",['Imran BMN'],"['Department of Respiratory & Critical Care Medicine, Changi General Hospital, Singapore.']",['eng'],['Editorial'],,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,IM,"['*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Humans', 'Risk Factors', '*Sepsis']",2022/06/04 06:00,2022/06/09 06:00,['2022/06/03 20:20'],"['2022/06/03 20:20 [entrez]', '2022/06/04 06:00 [pubmed]', '2022/06/09 06:00 [medline]']",['10.47102/annals-acadmedsg.2022135 [doi]'],ppublish,Ann Acad Med Singap. 2022 May;51(5):261-262. doi: 10.47102/annals-acadmedsg.2022135.,5,,,,,,,,,,,,,,,,,,,,,
33623992,NLM,MEDLINE,20210930,20210930,2047-4881 (Electronic) 2047-4873 (Linking),28,2021 Apr 23,Cardiovascular risk in lupus: looking beyond the score.,344-345,10.1093/eurjpc/zwaa009 [doi],"['Mankad, Rekha', 'Lopez-Jimenez, Francisco']","['Mankad R', 'Lopez-Jimenez F']","['Mayo Clinic Department of Cardiovascular Diseases Rochester, MN.', 'Mayo Clinic Department of Cardiovascular Diseases Rochester, MN.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/etiology', 'Heart Disease Risk Factors', 'Humans', 'Risk Factors']",2021/02/25 06:00,2021/10/01 06:00,['2021/02/24 05:45'],"['2021/02/25 06:00 [pubmed]', '2021/10/01 06:00 [medline]', '2021/02/24 05:45 [entrez]']","['5909829 [pii]', '10.1093/eurjpc/zwaa009 [doi]']",ppublish,Eur J Prev Cardiol. 2021 Apr 23;28(3):344-345. doi: 10.1093/eurjpc/zwaa009.,3,,,,,,,,,,,['Eur J Prev Cardiol. 2021 Apr 23;28(3):346-352. PMID: 33891687'],,,,,,,,,,
23953371,NLM,MEDLINE,20130830,20220408,1474-547X (Electronic) 0140-6736 (Linking),382,2013 Aug 17,Cardiovascular health for all.,572,S0140-6736(13)61730-4 [pii] 10.1016/S0140-6736(13)61730-4 [doi],,,,['eng'],['Editorial'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Cardiovascular Diseases/epidemiology/prevention & control/*therapy', 'Health Services Accessibility', 'Humans']",2013/08/21 06:00,2013/08/31 06:00,['2013/08/20 06:00'],"['2013/08/20 06:00 [entrez]', '2013/08/21 06:00 [pubmed]', '2013/08/31 06:00 [medline]']","['S0140-6736(13)61730-4 [pii]', '10.1016/S0140-6736(13)61730-4 [doi]']",ppublish,Lancet. 2013 Aug 17;382(9892):572. doi: 10.1016/S0140-6736(13)61730-4.,9892,,,,,,,,,,,,,,,,,,,,,
32828229,NLM,MEDLINE,20210621,20210621,1523-1755 (Electronic) 0085-2538 (Linking),98,2020 Sep,Cardiovascular complications of chronic kidney disease: pioneering studies.,522-526,S0085-2538(20)30807-3 [pii] 10.1016/j.kint.2020.07.001 [doi],"['Drueke, Tilman B', 'Floege, Jurgen']","['Drueke TB', 'Floege J']","['Inserm U-1018, CESP, Paris-Ile-de-France-Ouest University (UVSQ), Paris-Sud University (UPS), and Paris Saclay University, Villejuif, France. Electronic address: tilman.drueke@inserm.fr.', 'Department of Nephrology and Clinical Immunology, University Hospital, Rheinisch Westfalische Technische Hochschule Aachen, Aachen, Germany.']",['eng'],['Editorial'],,United States,Kidney Int,Kidney international,0323470,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/etiology', '*Heart Diseases', 'Humans', '*Kidney Failure, Chronic', 'Renal Dialysis']",2020/08/24 06:00,2021/06/22 06:00,['2020/08/24 06:00'],"['2020/06/08 00:00 [received]', '2020/07/02 00:00 [revised]', '2020/07/02 00:00 [accepted]', '2020/08/24 06:00 [entrez]', '2020/08/24 06:00 [pubmed]', '2021/06/22 06:00 [medline]']","['S0085-2538(20)30807-3 [pii]', '10.1016/j.kint.2020.07.001 [doi]']",ppublish,Kidney Int. 2020 Sep;98(3):522-526. doi: 10.1016/j.kint.2020.07.001.,3,,,,,['NOTNLM'],"['anemia', 'cardiac ischemia', 'cardiovascular disease', 'chronic kidney disease', 'dialysis', 'myocardial fibrosis', 'vascular calcification', 'vascular stiffness']",,,,,,,,,,,,,,,
33387251,NLM,MEDLINE,20211130,20211130,1559-0259 (Electronic) 1530-7905 (Linking),21,2021 Jan,Editorial: From the Editor-in-Chief.,1,10.1007/s12012-020-09628-9 [doi],"['Kang, Y James']",['Kang YJ'],"['Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, China. ykang7@uthsc.edu.', 'Memphis Institute of Regenerative Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. ykang7@uthsc.edu.']",['eng'],['Editorial'],20210102,United States,Cardiovasc Toxicol,Cardiovascular toxicology,101135818,IM,"['Animals', 'Cardiovascular Diseases/*chemically induced/metabolism/pathology/physiopathology', 'Cardiovascular System/*drug effects/metabolism/pathology/physiopathology', '*Editorial Policies', 'Humans', '*Periodicals as Topic', 'Risk Assessment', '*Toxicology']",2021/01/03 06:00,2021/12/01 06:00,['2021/01/02 12:10'],"['2020/12/21 00:00 [accepted]', '2021/01/03 06:00 [pubmed]', '2021/12/01 06:00 [medline]', '2021/01/02 12:10 [entrez]']","['10.1007/s12012-020-09628-9 [pii]', '10.1007/s12012-020-09628-9 [doi]']",ppublish,Cardiovasc Toxicol. 2021 Jan;21(1):1. doi: 10.1007/s12012-020-09628-9. Epub 2021 Jan 2.,1,,,,,,,,,,,,,,,,,,,,,
29695533,NLM,MEDLINE,20190708,20190708,1524-4636 (Electronic) 1079-5642 (Linking),38,2018 May,Recent Advances in the Development of Cardiovascular Biomarkers.,e61-e70,10.1161/ATVBAHA.118.310226 [doi],"['Satoh, Kimio', 'Shimokawa, Hiroaki']","['Satoh K', 'Shimokawa H']","['From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.', 'From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. shimo@cardio.med.tohoku.ac.jp.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Arterioscler Thromb Vasc Biol,"Arteriosclerosis, thrombosis, and vascular biology",9505803,IM,"['Animals', 'Biomarkers/*metabolism', 'Cardiovascular Diseases/diagnosis/*metabolism/mortality/therapy', 'Diagnosis, Differential', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Assessment', 'Risk Factors']",2018/04/27 06:00,2019/07/10 06:00,['2018/04/27 06:00'],"['2018/04/27 06:00 [entrez]', '2018/04/27 06:00 [pubmed]', '2019/07/10 06:00 [medline]']","['ATVBAHA.118.310226 [pii]', '10.1161/ATVBAHA.118.310226 [doi]']",ppublish,Arterioscler Thromb Vasc Biol. 2018 May;38(5):e61-e70. doi: 10.1161/ATVBAHA.118.310226.,5,,,,,['NOTNLM'],"['air pollution', 'biomarkers', 'cardiovascular diseases', 'cyclophilin A', 'reactive oxygen species']",,['0 (Biomarkers)'],,,,,,,,,,,,,
33076696,NLM,MEDLINE,20210315,20210315,1942-0080 (Electronic) 1941-9651 (Linking),13,2020 Oct,In This Issue of the Journal.,e011986,10.1161/CIRCIMAGING.120.011986 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",20201020,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['Animals', '*Biomedical Research', '*Cardiac Imaging Techniques', '*Cardiology', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans']",2020/10/21 06:00,2021/03/16 06:00,['2020/10/20 05:38'],"['2020/10/20 05:38 [entrez]', '2020/10/21 06:00 [pubmed]', '2021/03/16 06:00 [medline]']",['10.1161/CIRCIMAGING.120.011986 [doi]'],ppublish,Circ Cardiovasc Imaging. 2020 Oct;13(10):e011986. doi: 10.1161/CIRCIMAGING.120.011986. Epub 2020 Oct 20.,10,,,,,,,,,,,,,,,,,,,,,
33317333,NLM,MEDLINE,20210315,20210315,1942-0080 (Electronic) 1941-9651 (Linking),13,2020 Dec,In This Issue of the Journal.,e012204,10.1161/CIRCIMAGING.120.012204 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor in Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",20201215,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['Animals', '*Biomedical Research', '*Cardiac Imaging Techniques', '*Cardiology', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans']",2020/12/16 06:00,2021/03/16 06:00,['2020/12/15 05:38'],"['2020/12/15 05:38 [entrez]', '2020/12/16 06:00 [pubmed]', '2021/03/16 06:00 [medline]']",['10.1161/CIRCIMAGING.120.012204 [doi]'],ppublish,Circ Cardiovasc Imaging. 2020 Dec;13(12):e012204. doi: 10.1161/CIRCIMAGING.120.012204. Epub 2020 Dec 15.,12,,,,,,,,,,,,,,,,,,,,,
33569604,NLM,MEDLINE,20220404,20221110,2047-4881 (Electronic) 2047-4873 (Linking),28,2022 Feb 3,Underuse of cardiovascular preventive pharmacotherapy could be compensated by lifestyle-measures.,1903-1904,10.1093/eurjpc/zwab026 [doi],"['Hoffmann, Andreas']",['Hoffmann A'],"['Department of Cardiology, University of Basel, Socinstrasse 23, 4051 Basel, Switzerland.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Heart', 'Humans', 'Life Style']",2021/02/12 06:00,2022/04/05 06:00,['2021/02/11 05:56'],"['2021/02/12 06:00 [pubmed]', '2022/04/05 06:00 [medline]', '2021/02/11 05:56 [entrez]']","['6132796 [pii]', '10.1093/eurjpc/zwab026 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Feb 3;28(17):1903-1904. doi: 10.1093/eurjpc/zwab026.,17,,,,,,,,,,,['Eur J Prev Cardiol. 2022 Feb 3;28(17):1905-1913. PMID: 33580793'],,['Eur J Prev Cardiol. 2022 Sep 7;29(12):e312-e313. PMID: 35512449'],,,,,,,,
27922586,NLM,MEDLINE,20170807,20181023,0717-6384 (Electronic) 0717-6384 (Linking),16,2016 Nov 15,Hyperuricemia as a risk factor for cardiovascular disease: clinical review.,e6606,10.5867/medwave.2016.10.6606 [doi],"['Gudino Gomezjurado, Alvaro']",['Gudino Gomezjurado A'],"['Facultad de Medicina, Pontificia Universidad Catolica del Ecuador, Quito, Ecuador. Address: Calle Teodoro Sampaio 10-20, Pinheiros, Sao Paulo, Brasil. Email: alvaro1983@outlook.com.']","['spa', 'eng']","['Journal Article', 'Review']",20161115,Chile,Medwave,Medwave,101581949,IM,"['Atrial Fibrillation/epidemiology/etiology', 'Cardiovascular Diseases/epidemiology/*etiology/physiopathology', 'Coronary Disease/epidemiology/etiology', 'Heart Failure/epidemiology/etiology', 'Humans', 'Hypertension/epidemiology/etiology', 'Hyperuricemia/*complications/physiopathology', 'Risk Factors']",2016/12/07 06:00,2017/08/08 06:00,['2016/12/07 06:00'],"['2016/07/29 00:00 [received]', '2016/10/13 00:00 [accepted]', '2016/12/07 06:00 [entrez]', '2016/12/07 06:00 [pubmed]', '2017/08/08 06:00 [medline]']","['e6606 [pii]', '10.5867/medwave.2016.10.6606 [doi]']",epublish,Medwave. 2016 Nov 15;16(10):e6606. doi: 10.5867/medwave.2016.10.6606.,10,"Cardiovascular diseases are one of the most important causes of morbidity and mortality worldwide. Several risk factors have been associated with the development of these pathologies. However, there is controversy about whether hyperuricemia is an independent risk factor for developing cardiovascular disease. To answer this question, we performed a recent literature review of relevant published material to assess the association of hyperuricemia with four major cardiovascular diseases: hypertension, coronary heart disease, heart failure and atrial fibrillation.",,,,['NOTNLM'],"['atrial fibrillation', 'cardiovascular disease', 'coronary disease', 'heart failure', 'hypertension', 'hyperuricemia']",,,,,,,,,La hiperuricemia como factor de riesgo para el desarrollo de enfermedad cardiovascular: revision clinica.,,,,,,
36151314,NLM,MEDLINE,20220928,20221221,1435-1269 (Electronic) 0948-6704 (Linking),55,2022 Oct,[Cardiology in older adults].,453-454,10.1007/s00391-022-02108-5 [doi],"['Gosch, M', 'Simm, A']","['Gosch M', 'Simm A']","['Medizinische Klinik 2, Schwerpunkt Geriatrie, Klinikum Nurnberg, Paracelsus Medizinische Privatuniversitat Nurnberg, Prof. Ernst-Nathan-Str. 1, 90427, Nurnberg, Deutschland. markus.gosch@klinikum-nuernberg.de.', 'Klinik und Poliklinik fur Herzchirurgie, Universitatsklinikum Halle (Saale), Ernst-Grube Str. 40, 06120, Halle (Saale), Deutschland. andreas.simm@uk-halle.de.']",['ger'],['Editorial'],20220923,Germany,Z Gerontol Geriatr,Zeitschrift fur Gerontologie und Geriatrie,9506215,IM,"['Aged', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans']",2022/09/24 06:00,2022/09/28 06:00,['2022/09/23 23:31'],"['2022/08/18 00:00 [accepted]', '2022/09/23 23:31 [entrez]', '2022/09/24 06:00 [pubmed]', '2022/09/28 06:00 [medline]']","['10.1007/s00391-022-02108-5 [pii]', '10.1007/s00391-022-02108-5 [doi]']",ppublish,Z Gerontol Geriatr. 2022 Oct;55(6):453-454. doi: 10.1007/s00391-022-02108-5. Epub 2022 Sep 23.,6,,,,,,,,,,,,,,,Kardiologie im Alter.,,,,,,
24997750,NLM,MEDLINE,20150512,20181202,1768-3181 (Electronic) 0003-3928 (Linking),63,2014 Jun,[Editorial: Cardiovascular diseases in women].,119,S0003-3928(14)00091-2 [pii] 10.1016/j.ancard.2014.06.001 [doi],"['Halimi, J-M']",['Halimi JM'],"['Service de nephrologie-immunologie clinique, hopital Bretonneau, EA 4245, universite Francois-Rabelais, 2, boulevard Tonnelle, 37000 Tours, France. Electronic address: halimi@med.univ-tours.fr.']",['fre'],"['Congress', 'Editorial']",,France,Ann Cardiol Angeiol (Paris),Annales de cardiologie et d'angeiologie,0142167,IM,"['Africa, Northern', 'Cardiology', '*Cardiovascular Diseases/diagnosis/etiology/prevention & control', 'Humans', 'Paris', 'Publishing', ""*Women's Health""]",2014/07/07 06:00,2015/05/13 06:00,['2014/07/07 06:00'],"['2014/07/07 06:00 [entrez]', '2014/07/07 06:00 [pubmed]', '2015/05/13 06:00 [medline]']","['S0003-3928(14)00091-2 [pii]', '10.1016/j.ancard.2014.06.001 [doi]']",ppublish,Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):119. doi: 10.1016/j.ancard.2014.06.001.,3,,,,,,,,,,,,,,,Editorial.,,,,,,
30355160,NLM,MEDLINE,20191003,20191007,1524-4571 (Electronic) 0009-7330 (Linking),123,2018 Oct 12,Denisa Wagner.,1020-1023,10.1161/CIRCRESAHA.118.314091 [doi],"['Ince, Susan']",['Ince S'],,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait']",,United States,Circ Res,Circulation research,0047103,IM,"['Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/blood/*history/immunology/therapy', 'Career Choice', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Job Satisfaction', 'Mentors/history']",2018/10/26 06:00,2019/10/08 06:00,['2018/10/26 06:00'],"['2018/10/26 06:00 [entrez]', '2018/10/26 06:00 [pubmed]', '2019/10/08 06:00 [medline]']",['10.1161/CIRCRESAHA.118.314091 [doi]'],ppublish,Circ Res. 2018 Oct 12;123(9):1020-1023. doi: 10.1161/CIRCRESAHA.118.314091.,9,,,,,,,,,,,,,,,,['Wagner D'],"['Wagner, Denisa']",,,,
25653195,NLM,MEDLINE,20160104,20150303,2567-689X (Electronic) 0340-6245 (Linking),113,2015 Mar,Surfing on the cardiovascular frontier wave.,439-40,10.1160/TH15-01-0086 [doi],"['Preissner, Klaus T', 'Boisvert, William A', 'Hausenloy, Derek J']","['Preissner KT', 'Boisvert WA', 'Hausenloy DJ']","['Klaus T. Preissner, PhD, Department Biochemistry, Medical School, Justus-Liebig-University, Friedrichstrasse 24, 35392 Giessen, Germany, Tel.: +49 641 994 7500, Fax: +49 641 994 7509, E-mail: klaus.t.preissner@biochemie.med.uni-giessen.de.']",['eng'],"['Editorial', 'Introductory Journal Article']",20150205,Germany,Thromb Haemost,Thrombosis and haemostasis,7608063,IM,"['Animals', 'Cardiovascular Diseases/metabolism/pathology/*physiopathology/therapy', 'Energy Metabolism', 'Humans', 'Myocardium/metabolism/pathology', 'Oxidative Stress', '*Stress, Physiological']",2015/02/06 06:00,2016/01/05 06:00,['2015/02/06 06:00'],"['2015/01/29 00:00 [received]', '2015/01/29 00:00 [accepted]', '2015/02/06 06:00 [entrez]', '2015/02/06 06:00 [pubmed]', '2016/01/05 06:00 [medline]']","['15-01-0086 [pii]', '10.1160/TH15-01-0086 [doi]']",ppublish,Thromb Haemost. 2015 Mar;113(3):439-40. doi: 10.1160/TH15-01-0086. Epub 2015 Feb 5.,3,,,,,,,,,,,,,,,,,,,,,
31176388,NLM,MEDLINE,20191213,20191217,1444-2892 (Electronic) 1443-9506 (Linking),28,2019 Jul,Combatting the Global Crisis of Cardiovascular Disease.,981-983,S1443-9506(19)30362-2 [pii] 10.1016/j.hlc.2019.05.001 [doi],"['Palagyi, Anna', 'de Silva, H Asita', 'Praveen, Devarsetty', 'Patel, Anushka']","['Palagyi A', 'de Silva HA', 'Praveen D', 'Patel A']","['The George Institute for Global Health, University of New South Wales, Sydney, Australia. Electronic address: apalagyi@georgeinstitute.org.au.', 'Clinical Trials Unit, Department of Pharmacology, Faculty of Medicine, University of Kelaniya, Sri Lanka.', 'The George Institute for Global Health, University of New South Wales, Sydney, Australia; The George Institute for Global Health, University of New South Wales, Hyderabad, India.', 'The George Institute for Global Health, University of New South Wales, Sydney, Australia.']",['eng'],['Editorial'],,Australia,Heart Lung Circ,"Heart, lung & circulation",100963739,IM,"['*Cardiovascular Diseases/economics/epidemiology/therapy', 'Humans']",2019/06/10 06:00,2019/12/18 06:00,['2019/06/10 06:00'],"['2019/06/10 06:00 [entrez]', '2019/06/10 06:00 [pubmed]', '2019/12/18 06:00 [medline]']","['S1443-9506(19)30362-2 [pii]', '10.1016/j.hlc.2019.05.001 [doi]']",ppublish,Heart Lung Circ. 2019 Jul;28(7):981-983. doi: 10.1016/j.hlc.2019.05.001.,7,,,,,['NOTNLM'],"['Blood pressure', 'Health systems', 'Hypertension', 'Implementation', 'Low- and middle-income countries']",,,,,,,,,,,,,,,
27288021,NLM,MEDLINE,20180205,20180205,1468-201X (Electronic) 1355-6037 (Linking),102,2016 Jul 1,Heartbeat: Lonely Hearts.,985-6,10.1136/heartjnl-2016-310034 [doi],"['Otto, Catherine M']",['Otto CM'],,['eng'],"['Editorial', 'Introductory Journal Article']",,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/psychology/therapy', 'Coronary Disease/diagnosis/epidemiology/*psychology', 'Humans', '*Loneliness', 'Risk Factors', '*Social Isolation']",2016/06/12 06:00,2018/02/06 06:00,['2016/06/12 06:00'],"['2016/06/12 06:00 [entrez]', '2016/06/12 06:00 [pubmed]', '2018/02/06 06:00 [medline]']","['heartjnl-2016-310034 [pii]', '10.1136/heartjnl-2016-310034 [doi]']",ppublish,Heart. 2016 Jul 1;102(13):985-6. doi: 10.1136/heartjnl-2016-310034.,13,,['ORCID: 0000-0002-0527-9392'],,,['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
29977463,NLM,MEDLINE,20190314,20190314,1947-6108 (Electronic) 1947-6094 (Print) 1947-6108 (Linking),14,2018 Apr-Jun,The Urgency and Impact of Cardiovascular Critical Care.,75-76,10.14797/mdcj-14-2-75 [doi],"['Masud, Faisal']",['Masud F'],,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Methodist Debakey Cardiovasc J,Methodist DeBakey cardiovascular journal,101508600,IM,"['Cardiology/*methods', 'Cardiovascular Diseases/diagnosis/mortality/physiopathology/*therapy', 'Critical Care/*methods', 'Humans', 'Treatment Outcome']",2018/07/07 06:00,2019/03/15 06:00,['2018/07/07 06:00'],"['2018/07/07 06:00 [entrez]', '2018/07/07 06:00 [pubmed]', '2019/03/15 06:00 [medline]']",['10.14797/mdcj-14-2-75 [doi]'],ppublish,Methodist Debakey Cardiovasc J. 2018 Apr-Jun;14(2):75-76. doi: 10.14797/mdcj-14-2-75.,2,,,PMC6027716,,,,,,,,,,,,,,,,,,
31211364,NLM,MEDLINE,20200615,20200615,1755-3245 (Electronic) 0008-6363 (Linking),115,2019 Jul 1,New clinical classification of rare cardiovascular diseases and disorders: relevance for cardiovascular research.,e77-e79,10.1093/cvr/cvz142 [doi],"['Podolec, Piotr', 'Matusik, Pawel T']","['Podolec P', 'Matusik PT']","['Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, 80 Pradnicka Street, Krakow, Poland.', 'Centre for Rare Cardiovascular Diseases, The John Paul II Hospital, 80 Pradnicka Street, 31-202 Krakow, Poland.', 'Centre for Rare Cardiovascular Diseases, The John Paul II Hospital, 80 Pradnicka Street, 31-202 Krakow, Poland.', 'Department of Electrocardiology, Institute of Cardiology, Jagiellonian University Medical College, 80 Pradnicka Street, Krakow, Poland.']",['eng'],['Journal Article'],,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Animals', '*Biomedical Research', '*Cardiology', 'Cardiovascular Diseases/*classification/diagnosis/physiopathology/therapy', 'Humans', 'Rare Diseases/*classification/diagnosis/physiopathology/therapy', '*Terminology as Topic']",2019/06/19 06:00,2020/06/17 06:00,['2019/06/19 06:00'],"['2019/06/19 06:00 [pubmed]', '2020/06/17 06:00 [medline]', '2019/06/19 06:00 [entrez]']","['5519989 [pii]', '10.1093/cvr/cvz142 [doi]']",ppublish,Cardiovasc Res. 2019 Jul 1;115(8):e77-e79. doi: 10.1093/cvr/cvz142.,8,,,,,,,,,,,,,,,,,,,,,
28062604,NLM,MEDLINE,20190228,20200511,1530-8561 (Electronic) 0009-9147 (Linking),63,2017 Jan,"Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.",1-4,10.1373/clinchem.2016.263350 [doi],"['Apple, Fred S', 'Cullen, Louise', 'Felker, G Michael', 'Ginsburg, Geoffrey', 'Morrow, David']","['Apple FS', 'Cullen L', 'Felker GM', 'Ginsburg G', 'Morrow D']","['Hennepin County Medical Center, Minneapolis, MN; apple004@umn.edu.', ""Royal Brisbane and Women's Hospital, Herston, Brisbane, Queensland, Australia."", 'Duke University, Durham, NC.', 'Duke University Institute for Genome Sciences and Policy, Durham, NC.', ""Brigham and Women's Hospital, Boston, MA.""]",['eng'],['Editorial'],,England,Clin Chem,Clinical chemistry,9421549,IM,"['Biomarkers/*analysis', 'Cardiovascular Diseases/diagnosis/drug therapy/epidemiology/*physiopathology', 'Female', '*Genomics', 'Humans', 'Male', '*Proteomics']",2017/01/08 06:00,2019/03/01 06:00,['2017/01/08 06:00'],"['2016/10/28 00:00 [received]', '2016/10/31 00:00 [accepted]', '2017/01/08 06:00 [entrez]', '2017/01/08 06:00 [pubmed]', '2019/03/01 06:00 [medline]']","['63/1/1 [pii]', '10.1373/clinchem.2016.263350 [doi]']",ppublish,Clin Chem. 2017 Jan;63(1):1-4. doi: 10.1373/clinchem.2016.263350.,1,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
30615150,NLM,MEDLINE,20200713,20200713,1522-9645 (Electronic) 0195-668X (Linking),40,2019 Jan 7,Funding cardiovascular research in Europe.,80-82,10.1093/eurheartj/ehy817 [doi],"['Nicholls, Mark']",['Nicholls M'],,['eng'],['Journal Article'],,England,Eur Heart J,European heart journal,8006263,IM,"['Biomedical Research/*economics', 'Cardiology/*organization & administration', '*Cardiovascular Diseases/economics/prevention & control/therapy', 'Europe', 'Humans']",2019/01/08 06:00,2020/07/14 06:00,['2019/01/08 06:00'],"['2019/01/08 06:00 [entrez]', '2019/01/08 06:00 [pubmed]', '2020/07/14 06:00 [medline]']","['5273810 [pii]', '10.1093/eurheartj/ehy817 [doi]']",ppublish,Eur Heart J. 2019 Jan 7;40(2):80-82. doi: 10.1093/eurheartj/ehy817.,2,,,,,,,,,,,,,,,,,,,,,
28495921,NLM,MEDLINE,20180202,20180202,1468-201X (Electronic) 1355-6037 (Linking),103,2017 Jun,Heartbeat: Managing cardiovascular disease as a family of diseases in the community.,803-804,10.1136/heartjnl-2017-311713 [doi],"['Ribeiro, Antonio Luiz', 'Otto, Catherine M']","['Ribeiro AL', 'Otto CM']","['University Hospital and School of Medicine, Universidade Federal de Minas Gerais, Brazil.', 'University of Washington School of Medicine, Seattle, USA.']",['eng'],['Journal Article'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control', '*Community Health Services', 'Humans', '*Primary Prevention']",2017/05/13 06:00,2018/02/03 06:00,['2017/05/13 06:00'],"['2017/05/13 06:00 [entrez]', '2017/05/13 06:00 [pubmed]', '2018/02/03 06:00 [medline]']","['heartjnl-2017-311713 [pii]', '10.1136/heartjnl-2017-311713 [doi]']",ppublish,Heart. 2017 Jun;103(11):803-804. doi: 10.1136/heartjnl-2017-311713.,11,,,,['Competing interests: None declared.'],['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
35881657,NLM,MEDLINE,20221118,20230109,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Nov 15,Favourable lifestyle reduces cardiovascular disease risks in hypertensive patients.,2099-2100,10.1093/eurjpc/zwac154 [doi],"['Gao, Chuan']",['Gao C'],"['Department of Genetic and Genomics Sciences, Icahn School of Medicine at Mount Sinai, NY, USA.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Incidence', 'Genetic Predisposition to Disease', '*Hypertension/diagnosis/epidemiology/complications', 'Life Style', '*Coronary Disease/complications', '*Stroke', 'Healthy Lifestyle']",2022/07/27 06:00,2022/11/19 06:00,['2022/07/26 13:44'],"['2022/07/27 06:00 [pubmed]', '2022/11/19 06:00 [medline]', '2022/07/26 13:44 [entrez]']","['6650272 [pii]', '10.1093/eurjpc/zwac154 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Nov 15;29(16):2099-2100. doi: 10.1093/eurjpc/zwac154.,16,,,,"['Conflict of interest: The author declared no potential conflicts of interest with', 'respect to the research, authorship, and/or publication of this article.']",,,,,,,['Eur J Prev Cardiol. 2022 Nov 15;29(16):2101-2110. PMID: 35788660'],,,,,,,,,,
29745964,NLM,MEDLINE,20190204,20190215,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),29,2018 Mar/Apr,From the Editor's Desk.,67,,"['Commerford, P J']",['Commerford PJ'],['Editor-in-Chief.'],['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['Africa/epidemiology', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Humans', '*Peer Review, Research', '*Periodicals as Topic']",2018/05/11 06:00,2019/02/05 06:00,['2018/05/11 06:00'],"['2018/05/11 06:00 [entrez]', '2018/05/11 06:00 [pubmed]', '2019/02/05 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2018 Mar/Apr;29(2):67.,2,,,PMC6008898,,,,,,,,,,,,,,,,,,
37316170,NLM,MEDLINE,20230616,20230620,1468-201X (Electronic) 1355-6037 (Linking),109,2023 Jun 14,Heartbeat: cancer history and risk of cardiovascular disease.,967-969,10.1136/heartjnl-2023-323039 [doi],"['Otto, Catherine M']",['Otto CM'],"['Division of Cardiology, University of Washington, Seattle, Washington, USA cmotto@uw.edu.']",['eng'],['Editorial'],20230614,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Humans', 'Heart Rate', '*Cardiovascular Diseases/diagnosis/epidemiology/etiology', '*Neoplasms/diagnosis/epidemiology']",2023/06/15 01:08,2023/06/16 06:42,['2023/06/14 21:04'],"['2023/06/16 06:42 [medline]', '2023/06/15 01:08 [pubmed]', '2023/06/14 21:04 [entrez]']","['heartjnl-2023-323039 [pii]', '10.1136/heartjnl-2023-323039 [doi]']",epublish,Heart. 2023 Jun 14;109(13):967-969. doi: 10.1136/heartjnl-2023-323039.,13,,['ORCID: 0000-0002-0527-9392'],,['Competing interests: None declared.'],['NOTNLM'],['Aortic Diseases'],,,,,,,,,,,,,,,
20446877,NLM,MEDLINE,20110106,20151119,1651-1999 (Electronic) 0803-7051 (Linking),19,2010 Oct,The cardiovascular continuum refined: A hypothesis.,273-7,10.3109/08037051.2010.481072 [doi],"['Volpe, Massimo', 'Camm, John', 'Coca, Antonio', 'Unger, Thomas']","['Volpe M', 'Camm J', 'Coca A', 'Unger T']","['University of Roma ""La Sapienza"" Sant Andrea Hospital, Italy. volpema@uniroma1.it']",['eng'],"['Journal Article', 'Review']",,England,Blood Press,Blood pressure,9301454,IM,"['Biomarkers', '*Cardiovascular Diseases/complications/diagnosis/pathology/therapy', 'Disease Progression', 'Humans', 'Molecular Diagnostic Techniques', 'Risk']",2010/05/08 06:00,2011/01/07 06:00,['2010/05/08 06:00'],"['2010/05/08 06:00 [entrez]', '2010/05/08 06:00 [pubmed]', '2011/01/07 06:00 [medline]']",['10.3109/08037051.2010.481072 [doi]'],ppublish,Blood Press. 2010 Oct;19(5):273-7. doi: 10.3109/08037051.2010.481072.,5,"In the light of recent advances in the understanding of cardiovascular disease processes, this article presents an update on the cardiovascular continuum and early intervention targets to prevent disease manifestation and potentially reverse disease progression. It addresses markers of disease progression (urinary albumin excretion, high-sensitivity C-reactive protein, natriuretic peptides, estimated glomerular filtration rate), manifestations of cardiovascular disease such as atrial fibrillation and heart failure with preserved ejection fraction, and future directions for therapeutic strategies with cardiovascular progression prediction tools. The combination of proteomic biomarkers with clinical phenotypes and genetic haplotype information may also aid prognosis of individual cardiovascular risk in a near future.",,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
22527028,NLM,MEDLINE,20121030,20120511,1432-1963 (Electronic) 0172-8113 (Linking),33,2012 May,[Pathology of the cardiovascular system].,173-4,10.1007/s00292-011-1553-9 [doi],"['Wohlschlager, J', 'Baba, H A']","['Wohlschlager J', 'Baba HA']",,['ger'],"['Editorial', 'Introductory Journal Article']",,Germany,Pathologe,Der Pathologe,8006541,IM,"['Cardiovascular Diseases/epidemiology/*pathology/therapy', 'Cardiovascular System/pathology', 'Cross-Sectional Studies', 'Humans']",2012/04/25 06:00,2012/10/31 06:00,['2012/04/25 06:00'],"['2012/04/25 06:00 [entrez]', '2012/04/25 06:00 [pubmed]', '2012/10/31 06:00 [medline]']",['10.1007/s00292-011-1553-9 [doi]'],ppublish,Pathologe. 2012 May;33(3):173-4. doi: 10.1007/s00292-011-1553-9.,3,,,,,,,,,,,,,,,Pathologie des Herz-Kreislauf-Systems.,,,,,,
33094796,NLM,MEDLINE,20201109,20201109,1680-0745 (Electronic) 1015-9657 (Linking),31,2020 Mar/Apr,From the Editor's Desk.,57,,"['Commerford, Pat']",['Commerford P'],['Editor-in-Chief.'],['eng'],['Editorial'],,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['Africa/epidemiology', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Evidence-Based Medicine', 'Humans', 'Information Dissemination', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2020/10/24 06:00,2020/11/11 06:00,['2020/10/23 08:39'],"['2020/10/23 08:39 [entrez]', '2020/10/24 06:00 [pubmed]', '2020/11/11 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2020 Mar/Apr;31(2):57.,2,,,,,,,,,,,,,,,,,,,,,
27511613,NLM,MEDLINE,20170330,20181023,1756-1833 (Electronic) 0959-8138 (Linking),354,2016 Aug 10,Blood pressure variability and cardiovascular risk.,i4190,10.1136/bmj.i4190 [doi],"['Whittle, Jeff']",['Whittle J'],"['Primary Care, Clement J Zablocki VA Medical Center, Milwaukee, WI, 53295, USA Department of Medicine, Medical College of Wisconsin, Wauwatosa, WI, 53226, USA.']",['eng'],['Editorial'],20160810,England,BMJ,BMJ (Clinical research ed.),8900488,IM,"['Blood Pressure/*physiology', 'Cardiovascular Diseases/*epidemiology/*etiology/prevention & control', 'Humans', 'Hypertension/*complications/drug therapy', 'Risk Factors']",2016/08/12 06:00,2017/03/31 06:00,['2016/08/12 06:00'],"['2016/08/12 06:00 [entrez]', '2016/08/12 06:00 [pubmed]', '2017/03/31 06:00 [medline]']",['10.1136/bmj.i4190 [doi]'],epublish,BMJ. 2016 Aug 10;354:i4190. doi: 10.1136/bmj.i4190.,,,,,,,,,,,,,,,,,,,,,,
35422260,NLM,MEDLINE,20220418,20220418,1558-4232 (Electronic) 1094-9194 (Linking),25,2022 May,Heart Disease in Pet Birds - Diagnostic Options.,409-433,S1094-9194(22)00004-4 [pii] 10.1016/j.cvex.2022.01.004 [doi],"['Cornelia, Konicek', 'Krautwald-Junghanns, Maria-E']","['Cornelia K', 'Krautwald-Junghanns ME']","['Department of Small Animal Medicine, University of Veterinary Medicine Vienna, Veterinarplatz 1, Vienna 1210, Austria. Electronic address: cornelia.konicek@vetmeduni.ac.at.', 'Department for Birds and Reptiles, Veterinary Teaching Hospital, University of Leipzig, An den Tierkliniken 17, Leipzig 04103, Germany.']",['eng'],"['Journal Article', 'Review']",,United States,Vet Clin North Am Exot Anim Pract,The veterinary clinics of North America. Exotic animal practice,9815628,IM,"['Animals', 'Birds', '*Cardiovascular Diseases/diagnosis/veterinary', '*Heart Diseases/diagnosis/veterinary', 'Radiography']",2022/04/16 06:00,2022/04/19 06:00,['2022/04/15 05:20'],"['2022/04/15 05:20 [entrez]', '2022/04/16 06:00 [pubmed]', '2022/04/19 06:00 [medline]']","['S1094-9194(22)00004-4 [pii]', '10.1016/j.cvex.2022.01.004 [doi]']",ppublish,Vet Clin North Am Exot Anim Pract. 2022 May;25(2):409-433. doi: 10.1016/j.cvex.2022.01.004.,2,"Cardiovascular diseases are common in pet birds. Diagnosis is often made postmortem only. In any case, suspicious for cardiac disease, a full diagnostic work up should be applied. First indications are given by the anamnestic data. Relative predisposition to cardiovascular diseases is associated with the species, breed, age, gender, lifestyle, and diet. Clinical signs and examination can reveal further indications of cardiovascular diseases, but may be unspecific or even without any pathologic finding. Diagnostic imaging, at least radiography, and echocardiography are always recommended. Advanced imaging methods, especially angiocardiography, can be valuable but is also more invasive and expensive.",,,,['NOTNLM'],"['Atherosclerosis', 'Birds', 'Cardiovascular disease', 'Clinical examination', 'Diagnostic imaging', 'ECG', 'Echocardiography', 'Parrots']",,,['Copyright (c) 2022 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,
31984428,NLM,MEDLINE,20200911,20200911,1755-3245 (Electronic) 0008-6363 (Linking),116,2020 Feb 1,Leaders in Cardiovascular Research: Salim Yusuf.,e26-e28,10.1093/cvr/cvz299 [doi],"['Guzik, Tomasz J', 'Yusuf, Salim']","['Guzik TJ', 'Yusuf S']","['Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.', 'McMaster University, Hamilton, Canada.', 'Population Health Research institute, McMaster University, Hamilton, Canada.', 'Hamilton Health Sciences, Hamilton, Canada.']",['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait', 'Video-Audio Media']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/mortality/physiopathology/therapy', 'Diffusion of Innovation', 'History, 20th Century', 'History, 21st Century', 'Humans']",2020/01/28 06:00,2020/09/12 06:00,['2020/01/28 06:00'],"['2020/01/28 06:00 [entrez]', '2020/01/28 06:00 [pubmed]', '2020/09/12 06:00 [medline]']","['5716070 [pii]', '10.1093/cvr/cvz299 [doi]']",ppublish,Cardiovasc Res. 2020 Feb 1;116(2):e26-e28. doi: 10.1093/cvr/cvz299.,2,,,,,['NOTNLM'],"['Antiplatelet', 'Epidemiology', 'Frailty', 'Heart failure', 'Stroke']",,,,,,,,,,['Yusuf S'],"['Yusuf, Salim']",,,,
32665361,NLM,MEDLINE,20210621,20221207,1468-201X (Electronic) 1355-6037 (Linking),106,2020 Oct,Homelessness: a 'cause of the causes' of cardiovascular disease?,1456-1457,10.1136/heartjnl-2020-317224 [doi],"['Lane, Deirdre A']",['Lane DA'],"['Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK deirdre.lane@liverpool.ac.uk.']",['eng'],"['Comment', 'Editorial']",20200714,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/etiology', 'Causality', '*Ill-Housed Persons', 'Humans']",2020/07/16 06:00,2021/06/22 06:00,['2020/07/16 06:00'],"['2020/07/16 06:00 [pubmed]', '2021/06/22 06:00 [medline]', '2020/07/16 06:00 [entrez]']","['heartjnl-2020-317224 [pii]', '10.1136/heartjnl-2020-317224 [doi]']",ppublish,Heart. 2020 Oct;106(19):1456-1457. doi: 10.1136/heartjnl-2020-317224. Epub 2020 Jul 14.,19,,['ORCID: 0000-0002-5604-9378'],,['Competing interests: None declared.'],['NOTNLM'],"['cardiac risk factors and prevention', 'health care delivery']",,,,,['Heart. 2020 Oct;106(19):1483-1488. PMID: 32665359'],,,,,,,,,,
14692114,NLM,MEDLINE,20040525,20161020,0869-6047 (Print) 0869-6047 (Linking),,2003,[Current genetic technologies in the diagnosis and treatment of cardiovascular diseases].,38-43,,"['Bochkov, N P', 'Puzyrev, V P']","['Bochkov NP', 'Puzyrev VP']",,['rus'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Cardiovascular Diseases/diagnosis/*genetics/*therapy', '*Genetic Therapy', '*Genetic Variation', 'Heart Defects, Congenital/genetics', 'Heredity', 'Humans']",2003/12/25 05:00,2004/05/27 05:00,['2003/12/25 05:00'],"['2003/12/25 05:00 [pubmed]', '2004/05/27 05:00 [medline]', '2003/12/25 05:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 2003;(11):38-43.,11,,,,,,,,,,27,,,,,Sovremennye geneticheskie tekhnologii v diagnostike i lechenii serdechno-sosudistykh zabolevanii.,,,,,,
29932743,NLM,MEDLINE,20190325,20190325,1744-8298 (Electronic) 1479-6678 (Linking),14,2018 Jul,Advances in the management of cardiovascular disease during pregnancy.,269-272,10.2217/fca-2018-0033 [doi],"['Viaris de Lesegno, Benjamin', 'Nelson-Piercy, Catherine']","['Viaris de Lesegno B', 'Nelson-Piercy C']","[""Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London SE1 7EH, UK."", ""Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London SE1 7EH, UK.""]",['eng'],['Editorial'],20180622,England,Future Cardiol,Future cardiology,101239345,IM,"['Cardiovascular Diseases/*diagnosis/etiology/*therapy', 'Female', 'Humans', 'Pregnancy', 'Pregnancy Complications, Cardiovascular/*diagnosis/etiology/*therapy']",2018/06/23 06:00,2019/03/26 06:00,['2018/06/23 06:00'],"['2018/06/23 06:00 [pubmed]', '2019/03/26 06:00 [medline]', '2018/06/23 06:00 [entrez]']",['10.2217/fca-2018-0033 [doi]'],ppublish,Future Cardiol. 2018 Jul;14(4):269-272. doi: 10.2217/fca-2018-0033. Epub 2018 Jun 22.,4,,,,,['NOTNLM'],"['anticoagulation', 'cardiac disease', 'mitral stenosis', 'pregnancy', 'pulmonary hypertension']",,,,,,,,,,,,,,,
16415644,NLM,MEDLINE,20060914,20191109,1076-7460 (Print) 1076-7460 (Linking),15,2006 Jan-Feb,Lifestyle and prevention of cardiovascular disease in the elderly: an Italian perspective.,28-34,,"['Abete, Pasquale', 'Della Morte, David', 'Mazzella, Francesca', ""D'Ambrosio, Daniele"", 'Galizia, Gianluigi', 'Testa, Gianluca', 'Gargiulo, Gaetano', 'Cacciatore, Francesco', 'Rengo, Franco']","['Abete P', 'Della Morte D', 'Mazzella F', ""D'Ambrosio D"", 'Galizia G', 'Testa G', 'Gargiulo G', 'Cacciatore F', 'Rengo F']","['Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Cattedra di Geriatria, Universita degli Studi di Napoli Federico II, Naples, Italy. p.abete@unina.it']",['eng'],"['Journal Article', 'Review']",,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Aged', 'Aged, 80 and over', 'Body Mass Index', 'Caloric Restriction', 'Cardiovascular Diseases/epidemiology/genetics/physiopathology/*prevention & control/therapy', 'Clinical Trials as Topic', 'Genetic Predisposition to Disease', 'Humans', 'Ischemic Preconditioning, Myocardial', 'Italy/epidemiology', '*Life Style', 'Motor Activity']",2006/01/18 09:00,2006/09/15 09:00,['2006/01/18 09:00'],"['2006/01/18 09:00 [pubmed]', '2006/09/15 09:00 [medline]', '2006/01/18 09:00 [entrez]']",['10.1111/j.1076-7460.2006.05285.x [doi]'],ppublish,Am J Geriatr Cardiol. 2006 Jan-Feb;15(1):28-34. doi: 10.1111/j.1076-7460.2006.05285.x.,1,"The life span of human beings is partially influenced by genetic factors, but outcomes of aging are profoundly influenced by lifestyle and other environmental factors. Age-related modifications of the cardiovascular system are preserved by antiaging lifestyle interventions such as physical activity and caloric restriction. Accordingly, physical activity and low body mass index reduce mortality in older men with cardiovascular diseases. Several mechanisms have been proposed to explain the protective effect of lifestyle interventions against cardiovascular diseases in the elderly, including a reduction of vulnerability (i.e., the age-related reduction of endogenous mechanisms protective against pathologic insults). The age-related reduction of ischemic preconditioning, the most powerful endogenous protective mechanism against myocardial ischemia, is restored by both physical activity and caloric restriction. Thus, older persons can implement lifestyle practices that minimize their risk of death from cardiovascular diseases.",,,,,,,,,54,,,,,,,,,,,
30355164,NLM,MEDLINE,20191003,20191007,1524-4571 (Electronic) 0009-7330 (Linking),123,2018 Oct 12,Erin Reineke.,1017-1019,10.1161/CIRCRESAHA.118.314090 [doi],"['Goldberg-Smith, Pam']",['Goldberg-Smith P'],,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait']",,United States,Circ Res,Circulation research,0047103,IM,"['Awards and Prizes', 'Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/drug therapy/*history/pathology/physiopathology', 'Career Choice', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Job Satisfaction']",2018/10/26 06:00,2019/10/08 06:00,['2018/10/26 06:00'],"['2018/10/26 06:00 [entrez]', '2018/10/26 06:00 [pubmed]', '2019/10/08 06:00 [medline]']",['10.1161/CIRCRESAHA.118.314090 [doi]'],ppublish,Circ Res. 2018 Oct 12;123(9):1017-1019. doi: 10.1161/CIRCRESAHA.118.314090.,9,,,,,,,,,,,,,,,,['Reineke E'],"['Reineke, Erin']",,,,
31698950,NLM,MEDLINE,20210315,20210315,2047-4881 (Electronic) 2047-4873 (Linking),27,2020 Dec,Cognitive behavioural therapy for anxiety in cardiovascular diseases and implantable devices: A cautionary note.,2049,10.1177/2047487319888594 [doi],"['Tully, Phillip J']",['Tully PJ'],"[""Freemasons Foundation Centre for Men's Health School of Medicine, University of Adelaide, Australia.""]",['eng'],"['Comment', 'Letter']",20191107,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Anxiety/diagnosis/therapy', 'Anxiety Disorders', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Cognitive Behavioral Therapy', 'Defibrillators', 'Humans']",2019/11/09 06:00,2021/03/16 06:00,['2019/11/09 06:00'],"['2019/11/09 06:00 [pubmed]', '2021/03/16 06:00 [medline]', '2019/11/09 06:00 [entrez]']",['10.1177/2047487319888594 [doi]'],ppublish,Eur J Prev Cardiol. 2020 Dec;27(19):2049. doi: 10.1177/2047487319888594. Epub 2019 Nov 7.,19,,,,,,,,,,,['Eur J Prev Cardiol. 2020 Feb;27(3):258-268. PMID: 31575299'],,,,,,,,,,
33872077,NLM,MEDLINE,20211217,20211217,1524-4539 (Electronic) 0009-7322 (Linking),143,2021 Apr 20,"Sodium, Blood Pressure, and the Likely Massive Avoidable Burden of Cardiovascular Disease.",1568-1570,10.1161/CIRCULATIONAHA.120.052654 [doi],"['Neal, Bruce', 'Wu, Jason']","['Neal B', 'Wu J']","['The George Institute for Global Health, UNSW Sydney, New South Wales, Australia (B.N., J.W.).', 'Imperial College London, United Kingdom (B.N.).', 'The George Institute for Global Health, UNSW Sydney, New South Wales, Australia (B.N., J.W.).']",['eng'],"['Comment', 'Editorial']",20210419,United States,Circulation,Circulation,0147763,IM,"['Blood Pressure', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans', 'Risk Factors', '*Sodium']",2021/04/20 06:00,2021/12/18 06:00,['2021/04/19 17:14'],"['2021/04/19 17:14 [entrez]', '2021/04/20 06:00 [pubmed]', '2021/12/18 06:00 [medline]']",['10.1161/CIRCULATIONAHA.120.052654 [doi]'],ppublish,Circulation. 2021 Apr 20;143(16):1568-1570. doi: 10.1161/CIRCULATIONAHA.120.052654. Epub 2021 Apr 19.,16,,,,,['NOTNLM'],"['Editorials', 'blood pressure', 'cardiovascular diseases', 'sodium']",,['9NEZ333N27 (Sodium)'],,,['Circulation. 2021 Apr 20;143(16):1542-1567. PMID: 33586450'],,,,,,,,,,
2889835,NLM,MEDLINE,19871217,20161017,0098-7484 (Print) 0098-7484 (Linking),258,1987 Nov 27,Immunologic aspects of cardiovascular disease.,2974-82,,"['Ledford, D K', 'Espinoza, L R']","['Ledford DK', 'Espinoza LR']",,['eng'],"['Journal Article', 'Review']",,United States,JAMA,JAMA,7501160,IM,"['Cardiovascular Diseases/diagnosis/*immunology/therapy', 'Giant Cell Arteritis', 'Granulomatosis with Polyangiitis', 'Humans', 'Hypersensitivity', 'Myocarditis', 'Pericarditis', 'Polyarteritis Nodosa', 'Rheumatic Fever', 'Takayasu Arteritis', 'Vasculitis/immunology']",1987/11/27 00:00,1987/11/27 00:01,['1987/11/27 00:00'],"['1987/11/27 00:00 [pubmed]', '1987/11/27 00:01 [medline]', '1987/11/27 00:00 [entrez]']",,ppublish,JAMA. 1987 Nov 27;258(20):2974-82.,20,"The current classification scheme of the diverse inflammatory cardiovascular diseases permits a clinical staging and facilitates prognostic assessment and therapeutic decision making. Ultimately, improvement in the classification of and definitive therapy for these conditions awaits better definition of the interaction among specific etiologic agents, host factors, and the immune system responsible for these diseases.",,,,,,,,,36,,,,,,,,,,,
30466322,NLM,MEDLINE,20191125,20191125,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Dec,Editor's presentation.,1907-1909,10.1177/2047487318813775 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, Cardiology, G da Saliceto Hospital, Piacenza, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnostic imaging/epidemiology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2018/11/24 06:00,2019/11/26 06:00,['2018/11/24 06:00'],"['2018/11/24 06:00 [entrez]', '2018/11/24 06:00 [pubmed]', '2019/11/26 06:00 [medline]']",['10.1177/2047487318813775 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Dec;25(18):1907-1909. doi: 10.1177/2047487318813775.,18,,,,,,,,,,,,,,,,,,,,,
30409093,NLM,MEDLINE,20191125,20191125,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Nov,Editor's presentation.,1795-1797,10.1177/2047487318811005 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, Cardiology, G da Saliceto Hospital, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2018/11/10 06:00,2019/11/26 06:00,['2018/11/10 06:00'],"['2018/11/10 06:00 [entrez]', '2018/11/10 06:00 [pubmed]', '2019/11/26 06:00 [medline]']",['10.1177/2047487318811005 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Nov;25(17):1795-1797. doi: 10.1177/2047487318811005.,17,,,,,,,,,,,,,,,,,,,,,
29384418,NLM,MEDLINE,20190409,20190409,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Feb,Editor's presentation.,227-229,10.1177/2047487318756841 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, Cardiology, G da Saliceto Hospital, Piacenza, Emilia, Romagna, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Age Factors', '*Cardiovascular Diseases/mortality/physiopathology/psychology/therapy', 'Comorbidity', 'Exercise Tolerance', 'Health Status', 'Hemodynamics', 'Humans', 'Prognosis', 'Risk Assessment', 'Risk Factors']",2018/02/01 06:00,2019/04/10 06:00,['2018/02/01 06:00'],"['2018/02/01 06:00 [entrez]', '2018/02/01 06:00 [pubmed]', '2019/04/10 06:00 [medline]']",['10.1177/2047487318756841 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Feb;25(3):227-229. doi: 10.1177/2047487318756841.,3,,,,,,,,,,,,,,,,,,,,,
30334660,NLM,MEDLINE,20191125,20191125,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Nov,Editor's presentation.,1683-1685,10.1177/2047487318806722 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, Cardiology, G da Saliceto Hospital, Piacenza, Emilia, Romagna, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2018/10/20 06:00,2019/11/26 06:00,['2018/10/19 06:00'],"['2018/10/19 06:00 [entrez]', '2018/10/20 06:00 [pubmed]', '2019/11/26 06:00 [medline]']",['10.1177/2047487318806722 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Nov;25(16):1683-1685. doi: 10.1177/2047487318806722.,16,,,,,,,,,,,,,,,,,,,,,
30198782,NLM,MEDLINE,20191125,20191125,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Sep,Editor's presentation.,1459-1461,10.1177/2047487318799428 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, G da Saliceto Hospital, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Prognosis', 'Risk Factors']",2018/09/11 06:00,2019/11/26 06:00,['2018/09/11 06:00'],"['2018/09/11 06:00 [entrez]', '2018/09/11 06:00 [pubmed]', '2019/11/26 06:00 [medline]']",['10.1177/2047487318799428 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Sep;25(14):1459-1461. doi: 10.1177/2047487318799428.,14,,,,,,,,,,,,,,,,,,,,,
21418027,NLM,MEDLINE,20111212,20190728,1873-4286 (Electronic) 1381-6128 (Linking),17,2011,Cardiovascular disease: focus on dyslipidemia.,850-1,,"['Gouni-Berthold, I']",['Gouni-Berthold I'],,['eng'],['Editorial'],,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Aging', 'Cardiovascular Diseases/*drug therapy/epidemiology/physiopathology/*prevention & control', 'Dyslipidemias/*drug therapy', 'Humans']",2011/03/23 06:00,2011/12/14 06:00,['2011/03/23 06:00'],"['2011/03/09 00:00 [received]', '2011/03/16 00:00 [accepted]', '2011/03/23 06:00 [entrez]', '2011/03/23 06:00 [pubmed]', '2011/12/14 06:00 [medline]']","['BSP/CPD/E-Pub/000385 [pii]', '10.2174/138161211795428812 [doi]']",ppublish,Curr Pharm Des. 2011;17(9):850-1. doi: 10.2174/138161211795428812.,9,,,,,,,,,,,,,,,,,,,,,
8903751,NLM,MEDLINE,19970312,20051116,0885-114X (Print) 0885-114X (Linking),10,1995 Oct-Dec,Cardiovascular disease among firefighters.,821-7,,"['Melius, J M']",['Melius JM'],"[""Center to Protect Workers' Rights, Washington, DC, USA.""]",['eng'],"['Journal Article', 'Review']",,United States,Occup Med,"Occupational medicine (Philadelphia, Pa.)",8605629,IM,"['*Cardiovascular Diseases/epidemiology/etiology/physiopathology/prevention & control', '*Fires', 'Humans', 'Incidence', '*Occupational Diseases/epidemiology/etiology/physiopathology/prevention & control', 'Risk Factors', 'Survival Rate']",1995/10/01 00:00,1995/10/01 00:01,['1995/10/01 00:00'],"['1995/10/01 00:00 [pubmed]', '1995/10/01 00:01 [medline]', '1995/10/01 00:00 [entrez]']",,ppublish,Occup Med. 1995 Oct-Dec;10(4):821-7.,4,"The author reviews the literature of the past 20 years on heart disease among firefighters, covering the specific aspects of firefighting that may be related to potential cardiovascular disease. The author then outlines steps that can be taken to reduce the risks of developing cardiovascular disease.",,,,,,,,,45,,,,,,,,,,,
16189754,NLM,MEDLINE,20051121,20071115,0012-0472 (Print) 0012-0472 (Linking),130,2005 Sep 30,[Diagnosis and treatment of cardiovascular diseases according to the guidelines].,2187-8,,"['Strasser, R H']",['Strasser RH'],,['ger'],['Editorial'],,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Cardiology', 'Cardiovascular Diseases/*diagnosis/etiology/*therapy', 'Germany', 'Guideline Adherence', 'Humans', '*Practice Guidelines as Topic', 'Prognosis', 'Risk Factors', 'Societies, Medical']",2005/09/29 09:00,2005/12/13 09:00,['2005/09/29 09:00'],"['2005/09/29 09:00 [pubmed]', '2005/12/13 09:00 [medline]', '2005/09/29 09:00 [entrez]']",['10.1055/s-2005-916362 [doi]'],ppublish,Dtsch Med Wochenschr. 2005 Sep 30;130(39):2187-8. doi: 10.1055/s-2005-916362.,39,,,,,,,,,,,,,,,Leitliniengerechte Diagnostik und Therapie kardiologischer Erkrankungen.,,,,,,
28494712,NLM,MEDLINE,20180918,20180918,1477-0377 (Electronic) 1358-863X (Linking),22,2017 Jun,Membership spotlight.,275-277,10.1177/1358863X17701848 [doi],"['Mohler, Emile R', 'Campia, Umberto']","['Mohler ER', 'Campia U']",,['eng'],"['Biography', 'Historical Article', 'Interview']",,England,Vasc Med,"Vascular medicine (London, England)",9610930,IM,"['Biomedical Research/*history', 'Cardiovascular Diseases/diagnosis/*history/physiopathology/therapy', 'Career Choice', 'Education, Medical/history', 'History, 20th Century', 'History, 21st Century', 'Mentors/history', 'Societies, Medical/*history']",2017/05/13 06:00,2018/09/19 06:00,['2017/05/13 06:00'],"['2017/05/13 06:00 [entrez]', '2017/05/13 06:00 [pubmed]', '2018/09/19 06:00 [medline]']",['10.1177/1358863X17701848 [doi]'],ppublish,Vasc Med. 2017 Jun;22(3):275-277. doi: 10.1177/1358863X17701848.,3,,,,,,,,,,,,,,,,"['Mohler ER', 'Campia U']","['Mohler, Emile R', 'Campia, Umberto']",,,,
33589369,NLM,MEDLINE,20210913,20210913,1878-0938 (Electronic) 1878-0938 (Linking),26,2021 May,The Losing Battles in the Winning Campaign Against Cardiovascular Disease.,32-33,S1553-8389(21)00089-0 [pii] 10.1016/j.carrev.2021.02.005 [doi],"['Thomas, Joseph L', 'Velazquez, Ignacio D']","['Thomas JL', 'Velazquez ID']","['Division of Cardiology, Harbor-UCLA Medical Center, Torrance, CA, United States of America; The Lundquist Institute for Biomedical Research at Harbor-UCLA, Torrance, CA, United States of America. Electronic address: JTHOMAS@Lundquist.org.', 'Division of Cardiology, Harbor-UCLA Medical Center, Torrance, CA, United States of America; The Lundquist Institute for Biomedical Research at Harbor-UCLA, Torrance, CA, United States of America.']",['eng'],"['Comment', 'Editorial']",20210213,United States,Cardiovasc Revasc Med,Cardiovascular revascularization medicine : including molecular interventions,101238551,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans']",2021/02/17 06:00,2021/09/14 06:00,['2021/02/16 05:49'],"['2021/02/02 00:00 [received]', '2021/02/04 00:00 [accepted]', '2021/02/17 06:00 [pubmed]', '2021/09/14 06:00 [medline]', '2021/02/16 05:49 [entrez]']","['S1553-8389(21)00089-0 [pii]', '10.1016/j.carrev.2021.02.005 [doi]']",ppublish,Cardiovasc Revasc Med. 2021 May;26:32-33. doi: 10.1016/j.carrev.2021.02.005. Epub 2021 Feb 13.,,,,,,,,,,,,['Cardiovasc Revasc Med. 2021 May;26:26-31. PMID: 33229134'],,,,,,,,,,
24330975,NLM,MEDLINE,20150402,20131216,1578-1879 (Electronic) 0214-9168 (Linking),25,2013 Nov-Dec,[Cardiovascular diseases in Spain: conclusions and final comments].,231-2,S0214-9168(13)00120-4 [pii] 10.1016/j.arteri.2013.11.003 [doi],"['Civeira, Fernando']",['Civeira F'],"['Unidad de Lipidos. Servicio de Medicina Interna, Hospital Universitario Miguel Servet, Universidad de Zaragoza, Zaragoza, Espana. Electronic address: civeira@unizar.es.']",['spa'],['Journal Article'],,Spain,Clin Investig Arterioscler,Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis,9208512,IM,"['Aging', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Humans', 'Risk Factors', 'Spain/epidemiology']",2013/12/18 06:00,2015/04/04 06:00,['2013/12/17 06:00'],"['2013/11/07 00:00 [received]', '2013/11/11 00:00 [accepted]', '2013/12/17 06:00 [entrez]', '2013/12/18 06:00 [pubmed]', '2015/04/04 06:00 [medline]']","['S0214-9168(13)00120-4 [pii]', '10.1016/j.arteri.2013.11.003 [doi]']",ppublish,Clin Investig Arterioscler. 2013 Nov-Dec;25(5):231-2. doi: 10.1016/j.arteri.2013.11.003.,5,,,,,,,,,,,,,,,Enfermedad cardiovascular en Espana: conclusiones y comentarios finales.,,,,,,
34228329,NLM,MEDLINE,20220208,20220208,1532-6551 (Electronic) 1071-3581 (Linking),28,2021 Aug,Cardiovascular disease in the literature: A selection of recent original research papers.,1207-1209,10.1007/s12350-021-02720-9 [doi],"['Hage, Fadi G', 'AlJaroudi, Wael']","['Hage FG', 'AlJaroudi W']","['Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Lyons Harrison Research Building 306, 1900 University BLVD, Birmingham, AL, 35294, USA. fadihage@uab.edu.', 'Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA. fadihage@uab.edu.', 'Division of Cardiovascular Medicine, Augusta University, Augusta, Georgia.']",['eng'],"['Journal Article', 'Review']",20210706,United States,J Nucl Cardiol,Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,9423534,IM,"['Cardiovascular Diseases/complications/*diagnosis/*therapy', 'Humans']",2021/07/07 06:00,2021/07/07 06:01,['2021/07/06 13:25'],"['2021/06/23 00:00 [received]', '2021/06/24 00:00 [accepted]', '2021/07/07 06:00 [pubmed]', '2021/07/07 06:01 [medline]', '2021/07/06 13:25 [entrez]']","['10.1007/s12350-021-02720-9 [pii]', '10.1007/s12350-021-02720-9 [doi]']",ppublish,J Nucl Cardiol. 2021 Aug;28(4):1207-1209. doi: 10.1007/s12350-021-02720-9. Epub 2021 Jul 6.,4,,,,,,,,,,,,,,,,,,,,,
28906535,NLM,MEDLINE,20190128,20190128,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),28,2017 Jul/Aug,From the Editor's Desk.,207,,"['Commerford, Pat']",['Commerford P'],['Editor-in-Chief.'],['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Echocardiography', 'Electrocardiography', 'Humans', 'Prognosis', 'South Africa/epidemiology']",2017/09/15 06:00,2019/01/29 06:00,['2017/09/15 06:00'],"['2017/09/15 06:00 [entrez]', '2017/09/15 06:00 [pubmed]', '2019/01/29 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2017 Jul/Aug;28(4):207.,4,,,PMC5646187,,,,,,,,,,,,,,,,,,
23091846,NLM,MEDLINE,20121106,20130212,0040-3660 (Print) 0040-3660 (Linking),84,2012,[Experience in preventing cardiovascular diseases in our country].,4-10,,"['Boitsov, S A', 'Oganov, R G']","['Boitsov SA', 'Oganov RG']",,['rus'],"['Editorial', 'English Abstract']",,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Cardiovascular Diseases/etiology/physiopathology/*prevention & control', 'Humans', 'Risk Factors', 'Russia']",2012/10/24 06:00,2012/11/07 06:00,['2012/10/24 06:00'],"['2012/10/24 06:00 [entrez]', '2012/10/24 06:00 [pubmed]', '2012/11/07 06:00 [medline]']",,ppublish,Ter Arkh. 2012;84(9):4-10.,9,The paper gives concise historic information on the prevention of non-communicable diseases and characterizes the-state-of-the-art of cardiovascular disease prevention in Russia.,,,,,,,,,,,,,,,,,,,,
24814106,NLM,MEDLINE,20150915,20211021,2213-3763 (Electronic) 0019-4832 (Print) 0019-4832 (Linking),66,2014 Mar-Apr,Quo vadis cardiology?,151-2,S0019-4832(14)00099-6 [pii] 10.1016/j.ihj.2014.03.001 [doi],"['Mehrotra, Rahul', 'Sarat Chandra, K']","['Mehrotra R', 'Sarat Chandra K']","['Senior Consultant Cardiology, Medanta, The Medicity, Gurgaon, Haryana, India.', 'Honorary Editor, Indian Heart Journal, India; Chief Cardiologist, Indo US Superspeciality Hospital, Hyderabad, India. Electronic address: saratkoduganti@gmail.com.']",['eng'],['Editorial'],,India,Indian Heart J,Indian heart journal,0374675,IM,"['Cardiology/*trends', 'Cardiovascular Diseases/epidemiology/*prevention & control/therapy', 'Forecasting', 'Humans']",2014/05/13 06:00,2015/09/16 06:00,['2014/05/13 06:00'],"['2014/05/13 06:00 [entrez]', '2014/05/13 06:00 [pubmed]', '2015/09/16 06:00 [medline]']","['S0019-4832(14)00099-6 [pii]', '10.1016/j.ihj.2014.03.001 [doi]']",ppublish,Indian Heart J. 2014 Mar-Apr;66(2):151-2. doi: 10.1016/j.ihj.2014.03.001.,2,,,PMC4017379,,,,,,,,,,['Indian Heart J. 2014 Sep-Oct;66(5):560-1. PMID: 25443617'],,,,,,,,
23364763,NLM,MEDLINE,20130213,20130131,1476-4687 (Electronic) 0028-0836 (Linking),493,2013 Jan 31,Heart health.,S1,10.1038/493S1a [doi],"['May, Mike']",['May M'],,['eng'],['Introductory Journal Article'],,England,Nature,Nature,0410462,IM,"['Cardiovascular Diseases/drug therapy/*prevention & control/*therapy', 'Humans', 'Risk Assessment']",2013/02/01 06:00,2013/02/14 06:00,['2013/02/01 06:00'],"['2013/02/01 06:00 [entrez]', '2013/02/01 06:00 [pubmed]', '2013/02/14 06:00 [medline]']","['493S1a [pii]', '10.1038/493S1a [doi]']",ppublish,Nature. 2013 Jan 31;493(7434):S1. doi: 10.1038/493S1a.,7434,,,,,,,,,,,,,,,,,,,,,
23797424,NLM,MEDLINE,20131101,20171116,1897-4279 (Electronic) 0022-9032 (Linking),71,2013,[Editorial].,547,10.5603/KP.2013.0116 [doi],"['Filipiak, Krzysztof J']",['Filipiak KJ'],,['pol'],"['Editorial', 'Introductory Journal Article']",,Poland,Kardiol Pol,Kardiologia polska,0376352,IM,"['Cardiovascular Diseases/*complications/diagnosis/*physiopathology/therapy', 'Diabetes Complications', 'Humans', 'Hypercholesterolemia/complications', 'Metabolic Syndrome/complications', 'Periodontal Diseases/complications']",2013/06/26 06:00,2013/11/02 06:00,['2013/06/26 06:00'],"['2013/06/18 00:00 [received]', '2013/06/18 00:00 [accepted]', '2013/06/26 06:00 [entrez]', '2013/06/26 06:00 [pubmed]', '2013/11/02 06:00 [medline]']","['VM/OJS/KP/7971 [pii]', '10.5603/KP.2013.0116 [doi]']",ppublish,Kardiol Pol. 2013;71(6):547. doi: 10.5603/KP.2013.0116.,6,,,,,,,,,,,,,,,Slowo redakcyjne.,,,,,,
29542283,NLM,MEDLINE,20190314,20190314,1522-726X (Electronic) 1522-1946 (Linking),91,2018 Feb 15,Catheterization and Cardiovascular Interventions CIT Special Issue: Editor In Chief Editorial.,549,10.1002/ccd.27556 [doi],"['Bailey, Steven R']",['Bailey SR'],['Catheterization and Cardiovascular Interventions.'],['eng'],['Editorial'],,United States,Catheter Cardiovasc Interv,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,100884139,IM,"['Cardiac Catheterization/*trends', 'Cardiac Surgical Procedures/*trends', 'Cardiology/*trends', 'Cardiovascular Diseases/diagnosis/physiopathology/surgery/*therapy', 'China', 'Congresses as Topic', 'Diffusion of Innovation', 'Humans']",2018/03/16 06:00,2019/03/15 06:00,['2018/03/16 06:00'],"['2018/03/16 06:00 [entrez]', '2018/03/16 06:00 [pubmed]', '2019/03/15 06:00 [medline]']",['10.1002/ccd.27556 [doi]'],ppublish,Catheter Cardiovasc Interv. 2018 Feb 15;91(S1):549. doi: 10.1002/ccd.27556.,S1,,,,,,,,,,,,,,,,,,,,,
25399272,NLM,MEDLINE,20141208,20161017,1538-3598 (Electronic) 0098-7484 (Linking),312,2014 Nov 19,Progress against cardiovascular disease: putting the pieces together.,1979-80,10.1001/jama.2014.15554 [doi],"['Greenland, Philip', 'Peterson, Eric D', 'Gaziano, J Michael']","['Greenland P', 'Peterson ED', 'Gaziano JM']","['Department of Preventive Medicine, Northwestern University, Chicago, Illinois4Senior Editor, JAMA.', 'Duke University Medical Center, Durham, North Carolina5Associate Editor, JAMA.', ""VA Boston, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts5Associate Editor, JAMA.""]",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,JAMA,JAMA,7501160,IM,"['*Cardiovascular Diseases/complications/epidemiology/prevention & control/therapy', 'Humans']",2014/11/17 06:00,2014/12/15 06:00,['2014/11/17 06:00'],"['2014/11/17 06:00 [entrez]', '2014/11/17 06:00 [pubmed]', '2014/12/15 06:00 [medline]']","['1935105 [pii]', '10.1001/jama.2014.15554 [doi]']",ppublish,JAMA. 2014 Nov 19;312(19):1979-80. doi: 10.1001/jama.2014.15554.,19,,,,,,,,,,,,,,,,,,,,,
26908853,NLM,MEDLINE,20161213,20181113,1941-7705 (Electronic) 1941-7713 (Print) 1941-7713 (Linking),9,2016 Feb,Annual Women's Issue.,S1-2,10.1161/CIRCOUTCOMES.116.002673 [doi],"['Krumholz, Harlan M']",['Krumholz HM'],"['From the Section of Cardiovascular Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT; and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT. harlan.krumholz@yale.edu.']",['eng'],"['Editorial', 'Research Support, N.I.H., Extramural']",,United States,Circ Cardiovasc Qual Outcomes,Circulation. Cardiovascular quality and outcomes,101489148,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control/therapy', 'Female', 'Humans', 'Male', 'Sex Characteristics', ""*Women's Health""]",2016/02/26 06:00,2016/12/15 06:00,['2016/02/25 06:00'],"['2016/02/25 06:00 [entrez]', '2016/02/26 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['CIRCOUTCOMES.116.002673 [pii]', '10.1161/CIRCOUTCOMES.116.002673 [doi]']",ppublish,Circ Cardiovasc Qual Outcomes. 2016 Feb;9(2 Suppl 1):S1-2. doi: 10.1161/CIRCOUTCOMES.116.002673.,2 Suppl 1,,,PMC5360717,,['NOTNLM'],"['American Heart Association', 'awareness', 'return to work', 'sex characteristics', ""women's health""]","['U01 HL105270/HL/NHLBI NIH HHS/United States', 'U01 HL105270-05/HL/NHLBI NIH HHS/United States']",,,,,['NIHMS754243'],,,,,,,,,
35760622,NLM,MEDLINE,20230421,20230421,1578-1879 (Electronic) 0214-9168 (Linking),35,2023 Mar-Apr,"Nutrition, cardiovascular disease risk and climate change.",101-103,S0214-9168(22)00066-3 [pii] 10.1016/j.arteri.2022.06.001 [doi],"['Gonzalez Svatetz, Carlos A']",['Gonzalez Svatetz CA'],"['Investigador emerito, Unidad Nutricion y Cancer, Instituto Catalan de Oncologia (ICO-IDIBELL), Barcelona, Espana. Electronic address: cagonzalez@iconcologia.net.']","['eng', 'spa']",['Journal Article'],20220625,Spain,Clin Investig Arterioscler,Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis,9208512,IM,"['Humans', '*Climate Change', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control']",2022/06/28 06:00,2023/04/21 06:41,['2022/06/27 22:03'],"['2023/04/21 06:41 [medline]', '2022/06/28 06:00 [pubmed]', '2022/06/27 22:03 [entrez]']","['S0214-9168(22)00066-3 [pii]', '10.1016/j.arteri.2022.06.001 [doi]']",ppublish,Clin Investig Arterioscler. 2023 Mar-Apr;35(2):101-103. doi: 10.1016/j.arteri.2022.06.001. Epub 2022 Jun 25.,2,,,,,,,,,,,,,,,"Nutricion, riesgo de enfermedad cardiovascular y cambio climatico.",,,,,,
10341770,NLM,MEDLINE,19990604,20210518,0025-729X (Print) 0025-729X (Linking),170,1999 May 3,Cardiovascular disease at the turn of the century.,408-9,,"['Tonkin, A M', 'Bennett, S']","['Tonkin AM', 'Bennett S']",,['eng'],"['Editorial', 'Review']",,Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Australia/epidemiology', 'Cardiovascular Diseases/*epidemiology/ethnology/etiology/mortality', 'Humans', 'Mortality/trends', 'Prevalence']",1999/05/26 00:00,1999/05/26 00:01,['1999/05/26 00:00'],"['1999/05/26 00:00 [pubmed]', '1999/05/26 00:01 [medline]', '1999/05/26 00:00 [entrez]']",['10.5694/j.1326-5377.1999.tb127813.x [doi]'],ppublish,Med J Aust. 1999 May 3;170(9):408-9. doi: 10.5694/j.1326-5377.1999.tb127813.x.,9,,,,,,,,,,4,,,['Med J Aust. 1999 Sep 6;171(5):279-80. PMID: 10495768'],,,,,,,,
31154831,NLM,MEDLINE,20200907,20200907,2047-4881 (Electronic) 2047-4873 (Linking),26,2019 Jun,Editor's Presentation.,899-901,10.1177/2047487319853064 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['1 Heart Failure Unit, G. da Saliceto Hospital, AUSL Piacenza, Italy.', ""2 Institute of Life Sciences, Scuola Superiore Sant'Anna, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/prevention & control', 'Humans', 'Preventive Health Services', 'Risk Assessment', 'Risk Factors']",2019/06/04 06:00,2020/09/08 06:00,['2019/06/04 06:00'],"['2019/06/04 06:00 [entrez]', '2019/06/04 06:00 [pubmed]', '2020/09/08 06:00 [medline]']",['10.1177/2047487319853064 [doi]'],ppublish,Eur J Prev Cardiol. 2019 Jun;26(9):899-901. doi: 10.1177/2047487319853064.,9,,,,,,,,,,,,,,,,,,,,,
30317885,NLM,MEDLINE,20191125,20191125,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Oct,Editor's presentation.,1571-1573,10.1177/2047487318804454 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, Cardiology, G da Saliceto Hospital, Italy.']",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2018/10/16 06:00,2019/11/26 06:00,['2018/10/16 06:00'],"['2018/10/16 06:00 [entrez]', '2018/10/16 06:00 [pubmed]', '2019/11/26 06:00 [medline]']",['10.1177/2047487318804454 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Oct;25(15):1571-1573. doi: 10.1177/2047487318804454.,15,,,,,,,,,,,,,,,,,,,,,
20498452,NLM,MEDLINE,20100611,20161122,1524-4628 (Electronic) 0039-2499 (Linking),41,2010 Jun,Promoting cardiovascular and cerebrovascular health.,1079-83,10.1161/STROKEAHA.110.587709 [doi],"['Fuster, Valentin', 'Bansilal, Sameer']","['Fuster V', 'Bansilal S']","['Mount Sinai School of Medicine, The Zena and Michael A. Wiener Cardiovascular Institute, 1 Gustave L. Levy Place, Box 1030 New York, NY 10029, USA. valentin.fuster@mssm.edu']",['eng'],"['Journal Article', 'Review']",,United States,Stroke,Stroke,0235266,IM,"['Cardiovascular Diseases/economics/*mortality/*prevention & control', 'Humans', 'United States/epidemiology']",2010/05/26 06:00,2010/06/12 06:00,['2010/05/26 06:00'],"['2010/05/26 06:00 [entrez]', '2010/05/26 06:00 [pubmed]', '2010/06/12 06:00 [medline]']","['41/6/1079 [pii]', '10.1161/STROKEAHA.110.587709 [doi]']",ppublish,Stroke. 2010 Jun;41(6):1079-83. doi: 10.1161/STROKEAHA.110.587709.,6,,,,,,,,,,24,,,,,,,,,,,
27888900,NLM,MEDLINE,20170529,20170529,1578-1879 (Electronic) 0214-9168 (Linking),28 Suppl 2,2016 May,[Not Available].,1-2,S0214-9168(16)30163-2 [pii] 10.1016/S0214-9168(16)30163-2 [doi],"['Pedro-Botet, Juan', 'Millan Nunez-Cortes, Jesus']","['Pedro-Botet J', 'Millan Nunez-Cortes J']","['Unitat de Lipids i Risc Vascular, Hospital del Mar, Universitat Autonoma de Barcelona, Barcelona, Espana. Electronic address: jpedrobotet@parcdesalutmar.cat.', 'Unidad de Lipidos, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Espana.']",['spa'],['Journal Article'],,Spain,Clin Investig Arterioscler,Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis,9208512,IM,"['Atherosclerosis/epidemiology/etiology/*prevention & control', 'Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Humans', 'Risk Factors']",2016/11/28 06:00,2017/05/30 06:00,['2016/11/28 06:00'],"['2016/11/28 06:00 [entrez]', '2016/11/28 06:00 [pubmed]', '2017/05/30 06:00 [medline]']","['S0214-9168(16)30163-2 [pii]', '10.1016/S0214-9168(16)30163-2 [doi]']",ppublish,Clin Investig Arterioscler. 2016 May;28 Suppl 2:1-2. doi: 10.1016/S0214-9168(16)30163-2.,,,,,,,,,,,,,,,,Necesidades no cubiertas: una vision de futuro.,,,,,,
17478983,NLM,MEDLINE,20070703,20191110,1541-9215 (Print) 1541-9215 (Linking),5,2007 Spring,Fighting cardiovascular disease.,123-4,,"['Rivera, Juan Jose']",['Rivera JJ'],"['Division of Medicine, Department of Cardiology, John Hopkins University, Baltimore, MD 21287, USA. jriver16@jhmi.edu']",['eng'],['Journal Article'],,England,Am Heart Hosp J,The American heart hospital journal,101156064,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/etiology/*prevention & control', 'Humans', 'Risk Assessment/methods', 'United States/epidemiology']",2007/05/05 09:00,2007/07/04 09:00,['2007/05/05 09:00'],"['2007/05/05 09:00 [pubmed]', '2007/07/04 09:00 [medline]', '2007/05/05 09:00 [entrez]']",['10.1111/j.1541-9215.2007.06509.x [doi]'],ppublish,Am Heart Hosp J. 2007 Spring;5(2):123-4. doi: 10.1111/j.1541-9215.2007.06509.x.,2,,,,,,,,,,,,,,,,,,,,,
8759488,NLM,MEDLINE,19960930,20190512,1460-2725 (Print) 1460-2393 (Linking),89,1996 Jul,Smoking and cardiovascular disease.,493-8,,"['Yarnell, J W']",['Yarnell JW'],"[""Department of Epidemiology and Public Health, Queen's University, Belfast.""]",['eng'],"['Journal Article', 'Review']",,England,QJM,QJM : monthly journal of the Association of Physicians,9438285,IM,"['Adult', 'Arteriosclerosis/etiology', 'Cardiovascular Diseases/epidemiology/*etiology/prevention & control', 'Female', 'Humans', 'Male', 'Middle Aged', 'Smoking/*adverse effects']",1996/07/01 00:00,1996/07/01 00:01,['1996/07/01 00:00'],"['1996/07/01 00:00 [pubmed]', '1996/07/01 00:01 [medline]', '1996/07/01 00:00 [entrez]']",['10.1093/qjmed/89.7.493 [doi]'],ppublish,QJM. 1996 Jul;89(7):493-8. doi: 10.1093/qjmed/89.7.493.,7,,,,,,,,,,83,,,,,,,,,,,
32486963,NLM,MEDLINE,20210111,20210111,2047-4881 (Electronic) 2047-4873 (Linking),27,2020 Jun,Editor's presentation: Staying healthy and fighting cardiovascular disease at the time of COVID.,899-902,10.1177/2047487320928709 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, G da Saliceto Hospital, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Italy.""]",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*COVID-19', '*Cardiology', 'Cardiovascular Diseases/diagnosis/mortality/physiopathology/*therapy', '*Continuity of Patient Care', '*Delivery of Health Care, Integrated', 'Health Status', 'Humans', 'Prognosis']",2020/06/04 06:00,2021/01/12 06:00,['2020/06/04 06:00'],"['2020/06/04 06:00 [entrez]', '2020/06/04 06:00 [pubmed]', '2021/01/12 06:00 [medline]']",['10.1177/2047487320928709 [doi]'],ppublish,Eur J Prev Cardiol. 2020 Jun;27(9):899-902. doi: 10.1177/2047487320928709.,9,,,,,,,,,,,,,,,,,,,,,
33876240,NLM,MEDLINE,20211210,20211214,2047-4881 (Electronic) 2047-4873 (Linking),28,2021 May 8,Editors' Introduction: Focus on implementation of cardiovascular prevention in clinical practice.,353-355,10.1093/eurjpc/zwab062 [doi],"['Halasz, Geza', 'Piepoli, Massimo F']","['Halasz G', 'Piepoli MF']","['Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Parma, Italy.', 'Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Parma, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Editorial Policies', 'Humans']",2021/04/21 06:00,2021/12/15 06:00,['2021/04/20 06:40'],"['2021/04/01 00:00 [accepted]', '2021/04/21 06:00 [pubmed]', '2021/12/15 06:00 [medline]', '2021/04/20 06:40 [entrez]']","['6238567 [pii]', '10.1093/eurjpc/zwab062 [doi]']",ppublish,Eur J Prev Cardiol. 2021 May 8;28(4):353-355. doi: 10.1093/eurjpc/zwab062.,4,,['ORCID: 0000-0001-7220-123X'],,,,,,,,,,,,,,,,,,,
23173595,NLM,MEDLINE,20130916,20190728,1873-4286 (Electronic) 1381-6128 (Linking),19,2013,Modifying cardiovascular risk factors: new markers of cardiovascular damage.,2335-40,,"['Leone, Aurelio']",['Leone A'],,['eng'],"['Editorial', 'Introductory Journal Article']",,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Biomarkers/*metabolism', 'Cardiovascular Diseases/*diagnosis/epidemiology/metabolism', 'Humans', 'Risk Factors']",2012/11/24 06:00,2013/09/17 06:00,['2012/11/24 06:00'],"['2012/11/24 06:00 [entrez]', '2012/11/24 06:00 [pubmed]', '2013/09/17 06:00 [medline]']","['CPD-EPUB-20121119-14 [pii]', '10.2174/1381612811319130001 [doi]']",ppublish,Curr Pharm Des. 2013;19(13):2335-40. doi: 10.2174/1381612811319130001.,13,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
16010007,NLM,MEDLINE,20050804,20191026,1543-1894 (Print) 1543-1894 (Linking),112,2005,Introduction to methods in molecular cardiology.,3-12,,"['Sun, Zhongjie']",['Sun Z'],"['Department of Medicine, University of Florida, Gainesville, FL, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Methods Mol Med,Methods in molecular medicine,101123138,IM,"['Animals', 'Cardiology/*methods/trends', 'Cardiovascular Diseases/diagnosis/genetics/pathology/*prevention & control/*therapy', 'Gene Transfer Techniques', 'Genetic Therapy/methods', 'Humans', 'Molecular Biology/*methods']",2005/07/13 09:00,2005/08/05 09:00,['2005/07/13 09:00'],"['2005/07/13 09:00 [pubmed]', '2005/08/05 09:00 [medline]', '2005/07/13 09:00 [entrez]']","['1-59259-879-X:003 [pii]', '10.1385/1-59259-879-x:003 [doi]']",ppublish,Methods Mol Med. 2005;112:3-12. doi: 10.1385/1-59259-879-x:003.,,"Molecular cardiology is a new area of cardiovascular medicine that aims to apply molecular biological techniques for the mechanistic investigation, diagnosis, prevention, and treatment of cardiovascular disease. As an emerging discipline, it has changed our conceptual thinking of cardiovascular development, disease etiology, and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. With the rapid development and application of molecular biological techniques, scientists and clinicians are closer to curing heart diseases that were thought to be incurable 20 yr ago. There clearly is a need for a more thorough understanding of the molecular mechanisms of cardiovascular diseases to promote the advancement of cell and gene therapy for heart diseases. This chapter briefly reviews state-of-the-art techniques in the area of molecular cardiology.",,,,,,,,,22,,,,,,,,,,,
34273434,NLM,MEDLINE,20211020,20211020,1874-1754 (Electronic) 0167-5273 (Linking),339,2021 Sep 15,Screening for atrial fibrillation: Does cardiovascular disease reduce the probability of detection?,56-57,S0167-5273(21)01097-4 [pii] 10.1016/j.ijcard.2021.07.003 [doi],"['Nedios, Sotirios']",['Nedios S'],"['Department of Electrophysiology, Heart Center, University of Leipzig, Germany; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, the Netherlands. Electronic address: sotirios.nedios@helios-gesundheit.de.']",['eng'],"['Comment', 'Editorial']",20210715,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['*Atrial Fibrillation/diagnosis/epidemiology', '*Brain Ischemia', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans', 'Mass Screening', 'Probability', '*Stroke']",2021/07/18 06:00,2021/10/21 06:00,['2021/07/17 20:11'],"['2021/06/08 00:00 [received]', '2021/07/02 00:00 [accepted]', '2021/07/18 06:00 [pubmed]', '2021/10/21 06:00 [medline]', '2021/07/17 20:11 [entrez]']","['S0167-5273(21)01097-4 [pii]', '10.1016/j.ijcard.2021.07.003 [doi]']",ppublish,Int J Cardiol. 2021 Sep 15;339:56-57. doi: 10.1016/j.ijcard.2021.07.003. Epub 2021 Jul 15.,,,,,,['NOTNLM'],"['Atrial fibrillation', 'Electrocardiogram', 'Screening', 'Stroke']",,,,,['Int J Cardiol. 2021 Jul 1;334:55-57. PMID: 33932428'],,,,,,,,,,
25555280,NLM,MEDLINE,20160115,20150404,1874-1754 (Electronic) 0167-5273 (Linking),181,2015 Feb 15,Exercise as the master polypill of the 21st century for the prevention of cardiovascular disease.,360-1,S0167-5273(14)02470-X [pii] 10.1016/j.ijcard.2014.12.048 [doi],"['Sanchis-Gomar, Fabian', 'Fiuza-Luces, Carmen', 'Lucia, Alejandro']","['Sanchis-Gomar F', 'Fiuza-Luces C', 'Lucia A']","['Department of Physiology, Faculty of Medicine, University of Valencia, Fundacion Investigacion Hospital Clinico Universitario/INCLIVA, Spain. Electronic address: fabian.sanchis@uv.es.', ""Universidad Europea and Research Institute of Hospital 12 de Octubre ('i+12'), Spain."", ""Universidad Europea and Research Institute of Hospital 12 de Octubre ('i+12'), Spain.""]",['eng'],"['Letter', 'Review']",20141223,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['Cardiovascular Diseases/epidemiology/physiopathology/*prevention & control', '*Exercise/physiology', 'Humans', 'Primary Prevention/*methods']",2015/01/03 06:00,2016/01/16 06:00,['2015/01/03 06:00'],"['2014/12/18 00:00 [received]', '2014/12/20 00:00 [accepted]', '2015/01/03 06:00 [entrez]', '2015/01/03 06:00 [pubmed]', '2016/01/16 06:00 [medline]']","['S0167-5273(14)02470-X [pii]', '10.1016/j.ijcard.2014.12.048 [doi]']",ppublish,Int J Cardiol. 2015 Feb 15;181:360-1. doi: 10.1016/j.ijcard.2014.12.048. Epub 2014 Dec 23.,,,,,,['NOTNLM'],"['Cardiovascular diseases', 'Mortality', 'Myocardial infarction', 'Polypill']",,,,,,,,,,,,,,,
28895476,NLM,MEDLINE,20180827,20180827,2047-4881 (Electronic) 2047-4873 (Linking),24,2017 Sep,Editor's presentation.,1459-1461,10.1177/2047487317728438 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, G da Saliceto Hospital, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiac Rehabilitation', 'Cardiovascular Diseases/*epidemiology/mortality/physiopathology/prevention & control', 'Comorbidity', 'Humans', 'Primary Prevention', 'Prognosis', 'Risk Assessment', 'Risk Factors']",2017/09/13 06:00,2018/08/28 06:00,['2017/09/13 06:00'],"['2017/09/13 06:00 [entrez]', '2017/09/13 06:00 [pubmed]', '2018/08/28 06:00 [medline]']",['10.1177/2047487317728438 [doi]'],ppublish,Eur J Prev Cardiol. 2017 Sep;24(14):1459-1461. doi: 10.1177/2047487317728438.,14,,,,,,,,,,,,,,,,,,,,,
29115869,NLM,MEDLINE,20181029,20181029,2047-4881 (Electronic) 2047-4873 (Linking),24,2017 Nov,Editor's presentation.,1795-1797,10.1177/2047487317741702 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, G da Saliceto Hospital, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnostic imaging/epidemiology/physiopathology/therapy', 'Exercise Therapy', 'Humans', 'Hypolipidemic Agents/therapeutic use', 'Predictive Value of Tests', 'Risk Factors', 'Risk Reduction Behavior', 'Treatment Outcome']",2017/11/09 06:00,2018/10/30 06:00,['2017/11/09 06:00'],"['2017/11/09 06:00 [entrez]', '2017/11/09 06:00 [pubmed]', '2018/10/30 06:00 [medline]']",['10.1177/2047487317741702 [doi]'],ppublish,Eur J Prev Cardiol. 2017 Nov;24(17):1795-1797. doi: 10.1177/2047487317741702.,17,,,,,,,,['0 (Hypolipidemic Agents)'],,,,,,,,,,,,,
36321773,NLM,MEDLINE,20221216,20221221,1744-8298 (Electronic) 1479-6678 (Linking),18,2022 Dec,Lipid disorders in children: diagnosis and treatment.,915-920,10.2217/fca-2022-0062 [doi],"['Farzam, Khashayar']",['Farzam K'],"['Curex Medical Centre, 380 King St N Unit 5, Waterloo, Ontario, N2J 2Z3, Canada.']",['eng'],['Editorial'],20221102,England,Future Cardiol,Future cardiology,101239345,IM,"['Humans', 'Child', '*Cardiovascular Diseases/diagnosis/therapy/etiology', 'Lipids']",2022/11/03 06:00,2022/12/15 06:00,['2022/11/02 08:42'],"['2022/11/03 06:00 [pubmed]', '2022/12/15 06:00 [medline]', '2022/11/02 08:42 [entrez]']",['10.2217/fca-2022-0062 [doi]'],ppublish,Future Cardiol. 2022 Dec;18(12):915-920. doi: 10.2217/fca-2022-0062. Epub 2022 Nov 2.,12,Cardiovascular disease is a leading cause of death in western countries and pediatric lipid disorders create a lifelong continuous risk that starts from childhood. Increased knowledge and awareness on these disorders could prove to be life saving for many patients.,,,,['NOTNLM'],"['cardiology', 'dyslipidemia', 'familial hyperlipidemia', 'hyperlipidemia', 'lipid disorder', 'lipidology', 'pediatric heart disease', 'pediatric lipid disorders', 'pediatric obesity']",,['0 (Lipids)'],,,,,,,,,,,,,
33693640,NLM,MEDLINE,20220510,20220614,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 May 6,I can't see your heart from here.,903,10.1093/eurjpc/zwab039 [doi],"['Marques-Vidal, Pedro']",['Marques-Vidal P'],"['Department of Medicine, Internal Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Heart', 'Humans', 'Visual Acuity']",2021/03/12 06:00,2022/05/11 06:00,['2021/03/11 06:50'],"['2021/03/12 06:00 [pubmed]', '2022/05/11 06:00 [medline]', '2021/03/11 06:50 [entrez]']","['6162695 [pii]', '10.1093/eurjpc/zwab039 [doi]']",ppublish,Eur J Prev Cardiol. 2022 May 6;29(6):903. doi: 10.1093/eurjpc/zwab039.,6,,['ORCID: 0000-0002-4548-8500'],,,,,,,,,['Eur J Prev Cardiol. 2022 May 6;29(6):904-912. PMID: 33615358'],,,,,,,,,,
9263661,NLM,MEDLINE,19970929,20190920,1062-4821 (Print) 1062-4821 (Linking),6,1997 May,Epidemiology and prevention.,213-4,,"['Whelton, P K', 'Weber, M A']","['Whelton PK', 'Weber MA']",,['eng'],"['Editorial', 'Review']",,England,Curr Opin Nephrol Hypertens,Current opinion in nephrology and hypertension,9303753,IM,"['Antihypertensive Agents/therapeutic use', 'Cardiovascular Diseases/epidemiology/mortality/prevention & control', 'Humans', 'Hypertension/drug therapy/*epidemiology/*prevention & control']",1997/05/01 00:00,1997/05/01 00:01,['1997/05/01 00:00'],"['1997/05/01 00:00 [pubmed]', '1997/05/01 00:01 [medline]', '1997/05/01 00:00 [entrez]']",['10.1097/00041552-199705000-00002 [doi]'],ppublish,Curr Opin Nephrol Hypertens. 1997 May;6(3):213-4. doi: 10.1097/00041552-199705000-00002.,3,,,,,,,,['0 (Antihypertensive Agents)'],,10,,,,,,,,,,,
34058007,NLM,MEDLINE,20220405,20220405,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Mar 11,Secondary prevention after an acute cardiovascular event: far from targets and large room for improvement.,360-361,10.1093/eurjpc/zwab085 [doi],"['Aboyans, Victor', 'Boukhris, Marouane']","['Aboyans V', 'Boukhris M']","['Department of Cardiology, Dupuytren University Hospital, Limoges, France.', 'Inserm 1094 & IRD, Limoges University, 2, ave Gerard Mrcland, 87025, Limoges, France.', 'Department of Cardiology, Dupuytren University Hospital, Limoges, France.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans', 'Risk Factors', 'Secondary Prevention']",2021/06/01 06:00,2022/04/06 06:00,['2021/05/31 17:10'],"['2021/06/01 06:00 [pubmed]', '2022/04/06 06:00 [medline]', '2021/05/31 17:10 [entrez]']","['6289957 [pii]', '10.1093/eurjpc/zwab085 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Mar 11;29(2):360-361. doi: 10.1093/eurjpc/zwab085.,2,,,,,,,,,,,['Eur J Prev Cardiol. 2022 Mar 11;29(2):362-370. PMID: 33778888'],,,,,,,,,,
16672926,NLM,MEDLINE,20060718,20061115,1474-1776 (Print) 1474-1776 (Linking),5,2006 May,Therapeutic implications of the gender-specific aspects of cardiovascular disease.,425-38,,"['Regitz-Zagrosek, Vera']",['Regitz-Zagrosek V'],"['Centre for Gender in Medicine and Cardiovascular Disease in Women, Charite- Universitaetsmedizin Berlin and Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. vrz@dhzb.de']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Nat Rev Drug Discov,Nature reviews. Drug discovery,101124171,IM,"['Animals', 'Cardiovascular Agents/adverse effects/*therapeutic use', 'Cardiovascular Diseases/*drug therapy/epidemiology/genetics/physiopathology', 'Drug Evaluation, Preclinical', 'Female', 'Humans', 'Male', 'Sex Factors']",2006/05/05 09:00,2006/07/19 09:00,['2006/05/05 09:00'],"['2006/05/05 09:00 [pubmed]', '2006/07/19 09:00 [medline]', '2006/05/05 09:00 [entrez]']","['nrd2032 [pii]', '10.1038/nrd2032 [doi]']",ppublish,Nat Rev Drug Discov. 2006 May;5(5):425-38. doi: 10.1038/nrd2032.,5,"The manifestations of cardiovascular diseases differ between men and women, as do outcomes after therapeutic interventions. It is important that those involved in drug discovery and development, as well as disease treatment, are aware of these differences because such variations are likely to have an increasing role in therapeutic decisions in the future. Here, I review gender differences in the most frequent cardiovascular diseases and their underlying sex-dependent molecular pathophysiology, and discuss gender-specific effects of current cardiovascular drugs and the implications for novel strategies for drug development.",,,,,,,['0 (Cardiovascular Agents)'],,153,,,,,,,,,,,
37039627,NLM,MEDLINE,20230526,20230531,1784-973X (Electronic) 0001-5385 (Linking),78,2023 Jun,Occult malignancy in patients with pericarditis and concurrent cardiovascular diseases: a population-based cohort study.,505-508,10.1080/00015385.2023.2191387 [doi],"['Seto, Joel', 'Sehly, Amro', 'Ryan, Timothy', 'Jaltotage, Biyanka', 'Sanfilippo, Frank', 'Dwivedi, Girish']","['Seto J', 'Sehly A', 'Ryan T', 'Jaltotage B', 'Sanfilippo F', 'Dwivedi G']","['School of Medicine, University of Western Australia, Perth, Australia.', 'Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.', 'Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.', 'Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.', 'School of Population and Global Health, University of Western Australia, Perth, Australia.', 'School of Medicine, University of Western Australia, Perth, Australia.', 'Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.', 'Harry Perkins Institute of Medical Research, Perth, Australia.']",['eng'],['Journal Article'],20230411,England,Acta Cardiol,Acta cardiologica,0370570,IM,"['Humans', 'Cohort Studies', '*Cardiovascular Diseases/complications/diagnosis/epidemiology', '*Pericarditis/complications/diagnosis/epidemiology', '*Neoplasms/complications/diagnosis/epidemiology']",2023/04/12 06:00,2023/05/26 06:42,['2023/04/11 09:53'],"['2023/05/26 06:42 [medline]', '2023/04/12 06:00 [pubmed]', '2023/04/11 09:53 [entrez]']",['10.1080/00015385.2023.2191387 [doi]'],ppublish,Acta Cardiol. 2023 Jun;78(4):505-508. doi: 10.1080/00015385.2023.2191387. Epub 2023 Apr 11.,4,,['ORCID: 0000-0003-0717-740X'],,,,,,,,,,,,,,,,,,,
33190536,NLM,MEDLINE,20210315,20210315,1942-0080 (Electronic) 1941-9651 (Linking),13,2020 Nov,In This Issue of the Journal.,e012105,10.1161/CIRCIMAGING.120.012105 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",20201116,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Biomedical Research', '*Cardiac Imaging Techniques', '*Cardiology', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans']",2020/11/17 06:00,2021/03/16 06:00,['2020/11/16 05:25'],"['2020/11/16 05:25 [entrez]', '2020/11/17 06:00 [pubmed]', '2021/03/16 06:00 [medline]']",['10.1161/CIRCIMAGING.120.012105 [doi]'],ppublish,Circ Cardiovasc Imaging. 2020 Nov;13(11):e012105. doi: 10.1161/CIRCIMAGING.120.012105. Epub 2020 Nov 16.,11,,,,,,,,,,,,,,,,,,,,,
8316269,NLM,MEDLINE,19930729,20220408,0028-4793 (Print) 0028-4793 (Linking),329,1993 Jul 22,Cardiovascular health and disease in women.,247-56,,"['Wenger, N K', 'Speroff, L', 'Packard, B']","['Wenger NK', 'Speroff L', 'Packard B']","['Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303.']",['eng'],"['Journal Article', 'Review']",,United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Coronary Disease/diagnosis/prevention & control/therapy', 'Estrogen Replacement Therapy', 'Female', 'Humans', 'Pregnancy', 'Pregnancy Complications, Cardiovascular/therapy', 'Prognosis', ""*Women's Health""]",1993/07/22 00:00,1993/07/22 00:01,['1993/07/22 00:00'],"['1993/07/22 00:00 [pubmed]', '1993/07/22 00:01 [medline]', '1993/07/22 00:00 [entrez]']",['10.1056/NEJM199307223290406 [doi]'],ppublish,N Engl J Med. 1993 Jul 22;329(4):247-56. doi: 10.1056/NEJM199307223290406.,4,,,,,,,,,,138,,,['N Engl J Med. 1993 Jul 22;329(4):271-2. PMID: 8316272'],,,,,,,,
33122018,NLM,MEDLINE,20210527,20210527,1874-1754 (Electronic) 0167-5273 (Linking),322,2021 Jan 1,Tailoring risk prediction at the patient level: future perspectives in cardiovascular medicine.,51-52,S0167-5273(20)34049-3 [pii] 10.1016/j.ijcard.2020.10.062 [doi],"['Benenati, Stefano', 'Canepa, Marco']","['Benenati S', 'Canepa M']","['Cardiovascular Disease Unit, Ospedale Policlinico San Martino IRCCS, Genova, Italy; Department of Internal Medicine, University of Genoa, Genova, Italy.', 'Cardiovascular Disease Unit, Ospedale Policlinico San Martino IRCCS, Genova, Italy; Department of Internal Medicine, University of Genoa, Genova, Italy. Electronic address: marco.canepa@unige.it.']",['eng'],"['Comment', 'Editorial']",20201026,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['*Cardiovascular Agents', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Forecasting', 'Humans']",2020/10/31 06:00,2021/05/28 06:00,['2020/10/30 05:36'],"['2020/10/14 00:00 [received]', '2020/10/17 00:00 [revised]', '2020/10/20 00:00 [accepted]', '2020/10/31 06:00 [pubmed]', '2021/05/28 06:00 [medline]', '2020/10/30 05:36 [entrez]']","['S0167-5273(20)34049-3 [pii]', '10.1016/j.ijcard.2020.10.062 [doi]']",ppublish,Int J Cardiol. 2021 Jan 1;322:51-52. doi: 10.1016/j.ijcard.2020.10.062. Epub 2020 Oct 26.,,,,,"['Declaration of Competing Interest S.B. has nothing to disclose. M.C. reports', 'grants and personal fees from Pfizer, Novartis, Akcea Therapeutics, Sanofi', 'Genzyme, outside the submitted work.']",,,,['0 (Cardiovascular Agents)'],,,['Int J Cardiol. 2021 Feb 15;325:140-148. PMID: 32987048'],,,,,,,,,,
19773608,NLM,MEDLINE,20091217,20211020,1875-8630 (Electronic) 0278-0240 (Print) 0278-0240 (Linking),26,2009,Circulating biomarkers in cardiovascular disease.,197-8,10.3233/DMA-2009-0644 [doi],"['Ingelsson, Erik']",['Ingelsson E'],,['eng'],['Editorial'],,United States,Dis Markers,Disease markers,8604127,IM,"['Biomarkers/analysis/*blood', 'Cardiovascular Diseases/*blood/diagnosis/therapy', 'Humans']",2009/09/24 06:00,2009/12/18 06:00,['2009/09/24 06:00'],"['2009/09/24 06:00 [entrez]', '2009/09/24 06:00 [pubmed]', '2009/12/18 06:00 [medline]']","['3123J78204868867 [pii]', '10.3233/DMA-2009-0644 [doi]']",ppublish,Dis Markers. 2009;26(5-6):197-8. doi: 10.3233/DMA-2009-0644.,5-6,,,PMC3833610,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
15699948,NLM,MEDLINE,20060418,20170310,0022-9040 (Print) 0022-9040 (Linking),45,2005,[Specific features of cardiovascular diseases and their treatment in women].,98-104,,"['Tereshenko, S N', 'Uskach, T M', 'Kositzina, I V', 'Dzhaiani, N A']","['Tereshenko SN', 'Uskach TM', 'Kositzina IV', 'Dzhaiani NA']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Cardiovascular Agents/therapeutic use', 'Cardiovascular Diseases/*diagnosis/drug therapy/etiology/*therapy', 'Diabetes Complications/diagnosis/therapy', 'Dyslipidemias/diagnosis/therapy', 'Female', 'Heart Failure/diagnosis/therapy', 'Humans', 'Hypertension/diagnosis/therapy', 'Risk Factors', 'Smoking/adverse effects', ""*Women's Health""]",2005/02/09 09:00,2006/04/19 09:00,['2005/02/09 09:00'],"['2005/02/09 09:00 [pubmed]', '2006/04/19 09:00 [medline]', '2005/02/09 09:00 [entrez]']",,ppublish,Kardiologiia. 2005;45(1):98-104.,1,,,,,,,,['0 (Cardiovascular Agents)'],,79,,,,,,,,,,,
21448530,NLM,MEDLINE,20120827,20110330,2175-8239 (Electronic) 0101-2800 (Linking),32,2010 Mar,Assessment and management of cardiovascular disease in patients with chronic kidney disease.,118-25,S0101-28002010000100019 [pii],"['Bucharles, Sergio Gardano Elias', 'Varela, Alexandre M', 'Barberato, Silvio Henrique', 'Pecoits-Filho, Roberto']","['Bucharles SG', 'Varela AM', 'Barberato SH', 'Pecoits-Filho R']","['Instituto do Rim do Parana, PUC do Parana, Curitiba, Parana, Brasil.']","['eng', 'por']","['Journal Article', 'Review']",,Brazil,J Bras Nefrol,Jornal brasileiro de nefrologia,9426946,IM,"['Cardiovascular Diseases/*diagnosis/etiology/physiopathology/*therapy', 'Chronic Disease', 'Humans', 'Kidney Diseases/*complications', 'Risk Factors']",2011/03/31 06:00,2012/08/28 06:00,['2011/03/31 06:00'],"['2010/01/08 00:00 [received]', '2010/01/11 00:00 [accepted]', '2011/03/31 06:00 [entrez]', '2011/03/31 06:00 [pubmed]', '2012/08/28 06:00 [medline]']",['S0101-28002010000100019 [pii]'],ppublish,J Bras Nefrol. 2010 Mar;32(1):118-25.,1,"Cardiovascular disease is the leading cause of death in the set of chronic kidney disease (CKD) patients, whether on renal replacement therapy or conservative treatment. A better understanding of cardiovascular risk factors, diagnostic approach and management are central keys to develop strategies to reduce cardiovascular mortality among those patients. This review article discusses some aspects of pathophysiology, investigation methods and current treatment of cardiovascular disease in CKD patients.",,,,,,,,,,,,['J Bras Nefrol. 2011 Mar;33(1):113-4. PMID: 21541471'],,,,,,,,
22283771,NLM,MEDLINE,20120927,20220408,1873-4286 (Electronic) 1381-6128 (Linking),18,2012,Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis.,981-1004,,"['Durante, Alessandro', 'Peretto, Giovanni', 'Laricchia, Alessandra', 'Ancona, Francesco', 'Spartera, Marco', 'Mangieri, Antonio', 'Cianflone, Domenico']","['Durante A', 'Peretto G', 'Laricchia A', 'Ancona F', 'Spartera M', 'Mangieri A', 'Cianflone D']","['San Raffaele Scientific Institute and Universita Vita-Salute San Raffaele, Via Olgettina 60, Milan, Italy.']",['eng'],"['Journal Article', 'Review']",,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Animals', 'Atherosclerosis/drug therapy/*etiology/genetics/metabolism', 'Cardiovascular Diseases/drug therapy/etiology/genetics/metabolism', 'Humans', 'Renin-Angiotensin System/drug effects/*physiology']",2012/01/31 06:00,2012/09/28 06:00,['2012/01/31 06:00'],"['2011/10/28 00:00 [received]', '2011/12/13 00:00 [accepted]', '2012/01/31 06:00 [entrez]', '2012/01/31 06:00 [pubmed]', '2012/09/28 06:00 [medline]']","['CPD-EPUB-20120124-005 [pii]', '10.2174/138161212799436467 [doi]']",ppublish,Curr Pharm Des. 2012;18(7):981-1004. doi: 10.2174/138161212799436467.,7,"Renin-angiotensin-aldosterone (RAAS) is a hormone system which acts on multiple physiologic pathways primarily by regulating blood pressure and fluid balance, but also by local autocrine and paracrine actions. In pathophysiologic conditions RAAS also contributes to the development of atherosclerosis and its various manifestations, both directly and indirectly through the actions on other systems. RAAS mainly acts as a promoter of atherosclerosis by its action on vessels, and by promoting the development of hypertension, insulin resistance and diabetes, obesity, vascular and systemic inflammation. As RAAS plays a key role in the pathogenesis of cardiovascular diseases, RAAS genes have been extensively studied as candidate genes for atherosclerosis and coronary artery disease. Several polymorphisms of its genes have been found to be in relationship with atherosclerosis and cardiovascular diseases. In this review we will discuss these issues and present the most recent advances about this topic.",,,,,,,,,,,,,,,,,,,,
779276,NLM,MEDLINE,19760901,20091111,0506-2772 (Print) 0506-2772 (Linking),15,1976,[Climatoprophylaxis and climatotherapy of cardiovascular diseases].,9-14,,"['Doinov, M S']",['Doinov MS'],,['bul'],"['Journal Article', 'Review']",,Bulgaria,Vutr Boles,Vutreshni bolesti,0032666,IM,"['Adult', 'Altitude', 'Arteriosclerosis/therapy', 'Balneology', 'Bulgaria', 'Cardiovascular Diseases/physiopathology/*prevention & control/therapy', '*Climate', 'Environment, Controlled', 'Europe, Eastern', 'Health Resorts', 'Homeostasis', 'Humans', 'Hypertension/therapy', 'Meteorological Concepts', 'Temperature', 'USSR']",1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Vutr Boles. 1976;15(2):9-14.,2,,,,,,,,,,0,,,,,Klimatoprofilaktika i klimatolechenie na surdechno-sudovite zaboliavaniia.,,,,,,
24842600,NLM,MEDLINE,20151214,20160525,2213-8595 (Electronic) 2213-8587 (Linking),2,2014 Aug,The modifiable burden of worldwide mortality from cardiovascular diseases.,604-6,S2213-8587(14)70040-3 [pii] 10.1016/S2213-8587(14)70040-3 [doi],"['Huxley, Rachel R', 'Perkovic, Vlado']","['Huxley RR', 'Perkovic V']","['School of Population Health, University of Queensland, Herston, QLD 4006, Australia; The George Institute for Global Health, Sydney, NSW, Australia. Electronic address: r.huxley@uq.edu.au.', 'The George Institute for Global Health, Sydney, NSW, Australia.']",['eng'],['Journal Article'],20140516,England,Lancet Diabetes Endocrinol,The lancet. Diabetes & endocrinology,101618821,IM,"['Cardiovascular Diseases/complications/epidemiology/mortality/*prevention & control', '*Cost of Illness', '*Global Health', '*Health Promotion', '*Health Transition', 'Humans', 'Risk Factors']",2014/05/21 06:00,2015/12/15 06:00,['2014/05/21 06:00'],"['2014/05/21 06:00 [entrez]', '2014/05/21 06:00 [pubmed]', '2015/12/15 06:00 [medline]']","['S2213-8587(14)70040-3 [pii]', '10.1016/S2213-8587(14)70040-3 [doi]']",ppublish,Lancet Diabetes Endocrinol. 2014 Aug;2(8):604-6. doi: 10.1016/S2213-8587(14)70040-3. Epub 2014 May 16.,8,,,,,,,,,,,,,,,,,,,,,
35183064,NLM,MEDLINE,20220405,20220405,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Feb 19,Editorial comments: Focus issue Arterial Hypertension and the 2021 ESC Guidelines on Cardiovascular Prevention.,1-4,10.1093/eurjpc/zwac031 [doi],"['Parati, Gianfranco', 'Piepoli, Massimo F']","['Parati G', 'Piepoli MF']","['University of Milano-Bicocca and IRCCS, Istituto Auxologico Italiano, Milan, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Antihypertensive Agents/therapeutic use', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Heart', 'Humans', '*Hypertension/drug therapy/therapy']",2022/02/20 06:00,2022/04/06 06:00,['2022/02/19 20:16'],"['2022/02/19 20:16 [entrez]', '2022/02/20 06:00 [pubmed]', '2022/04/06 06:00 [medline]']","['6532498 [pii]', '10.1093/eurjpc/zwac031 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Feb 19;29(1):1-4. doi: 10.1093/eurjpc/zwac031.,1,,['ORCID: 0000-0001-9402-7439'],,,,,,['0 (Antihypertensive Agents)'],,,,,,,,,,,,,
19535296,NLM,MEDLINE,20100203,20100119,1521-7035 (Electronic) 1521-6616 (Linking),134,2010 Jan,Immunology of cardiovascular disease.,1-4,10.1016/j.clim.2009.05.013 [doi],"['Virella, Gabriel']",['Virella G'],"['Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.']",['eng'],['Introductory Journal Article'],20090616,United States,Clin Immunol,"Clinical immunology (Orlando, Fla.)",100883537,IM,"['Allergy and Immunology/*trends', 'Animals', 'Cardiovascular Diseases/*immunology/pathology/*therapy', 'Humans']",2009/06/19 09:00,2010/02/04 06:00,['2009/06/19 09:00'],"['2009/05/21 00:00 [received]', '2009/05/21 00:00 [accepted]', '2009/06/19 09:00 [entrez]', '2009/06/19 09:00 [pubmed]', '2010/02/04 06:00 [medline]']","['S1521-6616(09)00692-5 [pii]', '10.1016/j.clim.2009.05.013 [doi]']",ppublish,Clin Immunol. 2010 Jan;134(1):1-4. doi: 10.1016/j.clim.2009.05.013. Epub 2009 Jun 16.,1,,,,,,,,,,,,,,,,,,,,,
27679805,NLM,MEDLINE,20180205,20180205,1468-201X (Electronic) 1355-6037 (Linking),102,2016 Oct 15,Heartbeat: Do common genetic variants have a role in cardiovascular disease prediction?,1605-6,10.1136/heartjnl-2016-310515 [doi],"['Otto, Catherine M']",['Otto CM'],,['eng'],"['Editorial', 'Introductory Journal Article']",,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*Biomedical Research', '*Cardiology', 'Cardiovascular Diseases/diagnosis/epidemiology/*genetics/therapy', 'Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Single Nucleotide', 'Risk Factors']",2016/09/30 06:00,2018/02/06 06:00,['2016/09/29 06:00'],"['2016/09/29 06:00 [entrez]', '2016/09/30 06:00 [pubmed]', '2018/02/06 06:00 [medline]']","['heartjnl-2016-310515 [pii]', '10.1136/heartjnl-2016-310515 [doi]']",ppublish,Heart. 2016 Oct 15;102(20):1605-6. doi: 10.1136/heartjnl-2016-310515.,20,,['ORCID: 0000-0002-0527-9392'],,,['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
12377723,NLM,MEDLINE,20021127,20190901,1524-4636 (Electronic) 1079-5642 (Linking),22,2002 Oct 1,"Inflammation in cardiovascular disease: cart, horse or both--revisited.",1514-5,,"['Tracy, Russell P']",['Tracy RP'],,['eng'],"['Comment', 'Editorial', 'Review']",,United States,Arterioscler Thromb Vasc Biol,"Arteriosclerosis, thrombosis, and vascular biology",9505803,IM,"['Cardiovascular Diseases/complications/etiology/*pathology', 'Humans', 'Inflammation/complications/etiology/pathology']",2002/10/16 04:00,2002/11/28 04:00,['2002/10/16 04:00'],"['2002/10/16 04:00 [pubmed]', '2002/11/28 04:00 [medline]', '2002/10/16 04:00 [entrez]']",['10.1161/01.atv.0000035403.39442.db [doi]'],ppublish,Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1514-5. doi: 10.1161/01.atv.0000035403.39442.db.,10,,,,,,,,,,22,['Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1668-73. PMID: 12377747'],,,,,,,,,,
9295917,NLM,MEDLINE,19970925,20090213,0003-9683 (Print) 0003-9683 (Linking),90 Spec No 3,1997 Jun,[Genetics of cardiovascular diseases].,9-10,,"['Komajda, M']",['Komajda M'],,['fre'],['Editorial'],,France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,IM,"['Cardiovascular Diseases/*genetics/physiopathology/therapy', 'Chromosome Mapping', 'Genetic Techniques', 'Humans', 'Prognosis', 'Risk Factors']",1997/06/01 00:00,1997/09/20 00:01,['1997/06/01 00:00'],"['1997/06/01 00:00 [pubmed]', '1997/09/20 00:01 [medline]', '1997/06/01 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1997 Jun;90 Spec No 3:9-10.,,,,,,,,,,,,,,,,Genetique des maladies casdiovasculaires.,,,,,,
35459721,NLM,MEDLINE,20220426,20220517,1468-201X (Electronic) 1355-6037 (Linking),108,2022 May,"American College of Cardiology and British Cardiovascular Society at 100-learning, sharing and growing together: a letter from America.",751-752,10.1136/heartjnl-2021-320141 [doi],"['Itchhaporia, Dipti']",['Itchhaporia D'],"['Cardiology, University of California Irvine, Hoag Hospital Newport Beach, Newport Beach, California, USA drdipti@yahoo.com.']",['eng'],['Editorial'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['American Heart Association', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Cardiovascular System', 'Humans', 'Societies, Medical', 'United States']",2022/04/24 06:00,2022/04/27 06:00,['2022/04/23 05:21'],"['2022/04/23 05:21 [entrez]', '2022/04/24 06:00 [pubmed]', '2022/04/27 06:00 [medline]']","['heartjnl-2021-320141 [pii]', '10.1136/heartjnl-2021-320141 [doi]']",ppublish,Heart. 2022 May;108(10):751-752. doi: 10.1136/heartjnl-2021-320141.,10,,,,['Competing interests: None declared.'],['NOTNLM'],['aortic diseases'],,,,,,,,,,,,,,,
1304738,NLM,MEDLINE,19921217,20220311,0028-4793 (Print) 0028-4793 (Linking),327,1992 Dec 10,Age and the cardiovascular system.,1735-9,,"['Wei, J Y']",['Wei JY'],"['Division on Aging, Harvard Medical School, Brockton-West Roxbury Veterans Affairs Medical Center, MA.']",['eng'],"['Journal Article', 'Review']",,United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Cardiovascular Diseases/diagnosis/*physiopathology/therapy', 'Humans', 'Middle Aged']",1992/12/10 00:00,1992/12/10 00:01,['1992/12/10 00:00'],"['1992/12/10 00:00 [pubmed]', '1992/12/10 00:01 [medline]', '1992/12/10 00:00 [entrez]']",['10.1056/NEJM199212103272408 [doi]'],ppublish,N Engl J Med. 1992 Dec 10;327(24):1735-9. doi: 10.1056/NEJM199212103272408.,24,,,,,,,,,,53,,,['N Engl J Med. 1993 Apr 29;328(17):1279-80. PMID: 8464451'],,,,,,,,
33133353,NLM,MEDLINE,20210217,20210217,1947-6108 (Electronic) 1947-6094 (Print) 1947-6108 (Linking),16,2020 Jul-Sep,Quality and Patient Safety in an Atypical Year.,188-191,10.14797/mdcj-16-3-188 [doi],"['Phillips, Robert A', 'Nasir, Khurram']","['Phillips RA', 'Nasir K']",,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Methodist Debakey Cardiovasc J,Methodist DeBakey cardiovascular journal,101508600,IM,"['*COVID-19', '*Cardiology', 'Cardiovascular Diseases/diagnosis/mortality/*therapy', 'Humans', '*Patient Safety', '*Quality of Health Care']",2020/11/03 06:00,2021/02/18 06:00,['2020/11/02 06:16'],"['2020/11/02 06:16 [entrez]', '2020/11/03 06:00 [pubmed]', '2021/02/18 06:00 [medline]']",['10.14797/mdcj-16-3-188 [doi]'],ppublish,Methodist Debakey Cardiovasc J. 2020 Jul-Sep;16(3):188-191. doi: 10.14797/mdcj-16-3-188.,3,,,PMC7587326,,,,,,,,,,,,,,,,,,
29771896,NLM,MEDLINE,20190605,20190605,1175-8716 (Electronic) 0028-8446 (Linking),131,2018 May 18,How simple mistakes and short-term bias elevate cardiovascular risk.,7-9,,"['Stewart, Ralph Ah']",['Stewart RA'],"['Green Lane Cardiovascular Service, Auckland City Hospital, Auckland.']",['eng'],['Editorial'],20180518,New Zealand,N Z Med J,The New Zealand medical journal,0401067,IM,"['Bias', 'Cardiovascular Diseases/diagnosis/epidemiology/*etiology/prevention & control', 'Humans', '*Medical Errors', 'New Zealand/epidemiology', 'Risk Assessment', 'Risk Factors', 'Secondary Prevention']",2018/05/18 06:00,2019/06/06 06:00,['2018/05/18 06:00'],"['2018/05/18 06:00 [entrez]', '2018/05/18 06:00 [pubmed]', '2019/06/06 06:00 [medline]']",,epublish,N Z Med J. 2018 May 18;131(1475):7-9.,1475,,,,['Nil.'],,,,,,,,,,,,,,,,,
37788949,NLM,MEDLINE,20231127,20231127,1590-3729 (Electronic) 0939-4753 (Linking),33,2023 Dec,Effect of genetically determined BCAA levels on cardiovascular diseases and their risk factors: A Mendelian randomization study.,2406-2412,S0939-4753(23)00326-5 [pii] 10.1016/j.numecd.2023.08.003 [doi],"['Zuo, Zheng', 'Tong, Yi', 'Li, Minghua', 'Wang, Zhenggui', 'Wang, Xishu', 'Guo, Xiaoxue', 'Sun, Ying', 'Zhang, Zhiguo']","['Zuo Z', 'Tong Y', 'Li M', 'Wang Z', 'Wang X', 'Guo X', 'Sun Y', 'Zhang Z']","['Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China.', 'Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China.', 'Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China.', 'Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China.', 'Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China.', 'Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China.', 'Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China.', 'Cardiovascular Medicine Department, Cardiology Center, First Hospital of Jilin University, Changchun, Jilin Province, China. Electronic address: zhangzhig@jlu.edu.cn.']",['eng'],['Journal Article'],20230814,Netherlands,Nutr Metab Cardiovasc Dis,"Nutrition, metabolism, and cardiovascular diseases : NMCD",9111474,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/genetics', 'Mendelian Randomization Analysis', '*Hypertension', '*Heart Failure', '*Heart Valve Diseases', 'Genome-Wide Association Study']",2023/10/04 00:42,2023/11/27 12:44,['2023/10/03 21:52'],"['2023/04/16 00:00 [received]', '2023/07/20 00:00 [revised]', '2023/08/04 00:00 [accepted]', '2023/11/27 12:44 [medline]', '2023/10/04 00:42 [pubmed]', '2023/10/03 21:52 [entrez]']","['S0939-4753(23)00326-5 [pii]', '10.1016/j.numecd.2023.08.003 [doi]']",ppublish,Nutr Metab Cardiovasc Dis. 2023 Dec;33(12):2406-2412. doi: 10.1016/j.numecd.2023.08.003. Epub 2023 Aug 14.,12,"BACKGROUND AND AIMS: Observational studies have demonstrated that serum branched-chain amino acids (BCAAs) are associated with the risk of various cardiovascular diseases (CVDs) and their risk factors. However, the causal effect is unclear. The aim of this study was to investigate the effect of genetically determined BCAA levels on CVDs and their risk factors using Mendelian randomization (MR). METHODS AND RESULTS: We performed univariable and multivariable MR analyses using summary-level data from multiple GWASs and the FinnGen consortium to investigate the association between BCAA levels and the risk of CVDs (myocardial infarction, ischemic stroke, and intracerebral hemorrhage) and their risk factors (atrial fibrillation, hypertension, heart failure, and valvular heart disease). We used the random-effects IVW approach as the primary statistical method and incorporated MR estimates from different data sources using the fixed-effects model. We found genetically determined total and individual BCAA levels and a high risk of hypertension. However, there is no evidence of a causal relationship between BCAA levels and 3 cardiovascular diseases and other their risk factors. The odds of hypertension increased per 1-SD increase in BCAA levels (OR = 1.02 95% CI: 1.01, 1.04; P = 0.005), valine (OR = 1.02 95% CI: 1.01, 1.03; P<0.0001), leucine (OR = 1.02 95% CI: 1.01, 1.04; P0.01), and isoleucine (OR = 1.02 95% CI: 1.01, 1.03; P < 0.0001). This result was also significant in the multivariable MR. CONCLUSIONS: This MR study suggests that total and individual BCAA levels could be associated with a high risk of hypertension.",,,['Declaration of competing interest The authors declared no conflict of interest.'],['NOTNLM'],"['Branched-chain amino acids', 'Cardiovascular diseases', 'Isoleucine', 'Leucine', 'Mendelian randomization', 'Valine']",,,['Copyright (c) 2023 The Author(s). Published by Elsevier B.V. All rights reserved.'],,,,,,,,,,,,
16712750,NLM,MEDLINE,20060612,20071115,0300-8932 (Print) 0300-8932 (Linking),59,2006 Mar,[Cardiovascular disease in women. Why now?].,259-63,,"['Alfonso, Fernando', 'Bermejo, Javier', 'Segovia, Javier']","['Alfonso F', 'Bermejo J', 'Segovia J']","['Editor Jefe, Revista Espanola de Cardiologia. rec@revespcardiol.org']",['spa'],"['Comparative Study', 'Journal Article', 'Review']",,Spain,Rev Esp Cardiol,Revista espanola de cardiologia,0404277,IM,"['Aged', 'Arrhythmias, Cardiac/diagnosis/epidemiology/therapy', 'Cardiomyopathies/diagnosis/epidemiology/therapy', 'Cardiovascular Diseases/diagnosis/*epidemiology/mortality/prevention & control/therapy', 'Cerebrovascular Disorders/diagnosis/epidemiology/prevention & control', 'Clinical Trials as Topic', 'Death, Sudden, Cardiac/epidemiology', 'Electrocardiography', 'Female', 'Forecasting', 'Humans', 'Male', 'Myocardial Ischemia/diagnosis/epidemiology', 'Prevalence', 'Primary Prevention', 'Prognosis', 'Randomized Controlled Trials as Topic', 'Risk Factors', 'Sex Factors']",2006/05/23 09:00,2006/06/13 09:00,['2006/05/23 09:00'],"['2006/05/23 09:00 [pubmed]', '2006/06/13 09:00 [medline]', '2006/05/23 09:00 [entrez]']",['13086083 [pii]'],ppublish,Rev Esp Cardiol. 2006 Mar;59(3):259-63.,3,,,,,,,,,,35,,,,,Enfermedades cardiovasculares en la mujer: 'por que ahora?,,,,,,
30745400,NLM,MEDLINE,20191119,20200309,1488-2329 (Electronic) 0820-3946 (Print) 0820-3946 (Linking),191,2019 Feb 11,Identifying and managing younger women at high risk of cardiovascular disease.,E159-E163,10.1503/cmaj.180053 [doi],"['Srivaratharajah, Kajenny', 'Abramson, Beth L']","['Srivaratharajah K', 'Abramson BL']","['Division of General Internal Medicine (Srivaratharajah), Department of Medicine, McMaster University, Hamilton, Ont.; Division of Cardiology (Abramson), Department of Medicine, University of Toronto, Toronto, Ont.', 'Division of General Internal Medicine (Srivaratharajah), Department of Medicine, McMaster University, Hamilton, Ont.; Division of Cardiology (Abramson), Department of Medicine, University of Toronto, Toronto, Ont. abramsonb@smh.ca.']",['eng'],"['Journal Article', 'Review']",,Canada,CMAJ,CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,9711805,IM,"['Cardiovascular Diseases/blood/*diagnosis/epidemiology/*prevention & control', 'Female', 'Hormone Replacement Therapy', 'Humans', 'Risk Assessment', 'Sex Factors', ""*Women's Health""]",2019/02/13 06:00,2019/11/20 06:00,['2019/02/13 06:00'],"['2019/02/13 06:00 [entrez]', '2019/02/13 06:00 [pubmed]', '2019/11/20 06:00 [medline]']","['191/6/E159 [pii]', '191e159 [pii]', '10.1503/cmaj.180053 [doi]']",ppublish,CMAJ. 2019 Feb 11;191(6):E159-E163. doi: 10.1503/cmaj.180053.,6,,,PMC6370542,['Competing interests: None declared.'],,,,,,,,,,,,,,,,,
34582926,NLM,MEDLINE,20211229,20211229,1873-1740 (Electronic) 0033-0620 (Linking),68,2021 Sep-Oct,Introduction to assorted topics II 2021.,1,S0033-0620(21)00107-9 [pii] 10.1016/j.pcad.2021.09.011 [doi],"['Lavie, Carl J']",['Lavie CJ'],"['John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana, USA. Electronic address: clavie@ochsner.org.']",['eng'],"['Editorial', 'Introductory Journal Article']",20210925,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Animals', '*Biomedical Research', '*Cardiovascular Diseases/diagnostic imaging/mortality/physiopathology/therapy', 'Comorbidity', 'Heart Disease Risk Factors', 'Humans', 'Prognosis']",2021/09/29 06:00,2021/12/30 06:00,['2021/09/28 20:15'],"['2021/09/29 06:00 [pubmed]', '2021/12/30 06:00 [medline]', '2021/09/28 20:15 [entrez]']","['S0033-0620(21)00107-9 [pii]', '10.1016/j.pcad.2021.09.011 [doi]']",ppublish,Prog Cardiovasc Dis. 2021 Sep-Oct;68:1. doi: 10.1016/j.pcad.2021.09.011. Epub 2021 Sep 25.,,,,,,,,,,,,,,,,,,,,,,
19808599,NLM,MEDLINE,20091026,20091007,1942-0080 (Electronic) 1941-9651 (Linking),2,2009 May,The prognostic implications of cardiovascular magnetic resonance.,243-50,10.1161/CIRCIMAGING.108.840975 [doi],"['Flett, Andrew S', 'Westwood, Mark A', 'Davies, L Ceri', 'Mathur, Anthony', 'Moon, James C']","['Flett AS', 'Westwood MA', 'Davies LC', 'Mathur A', 'Moon JC']","['Department of Cardiology, The Heart Hospital, Part of University College London Hospitals NHS Trust, London, United Kingdom.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['Cardiovascular Diseases/complications/*diagnosis/mortality/therapy', 'Humans', '*Magnetic Resonance Imaging', 'Predictive Value of Tests', 'Prognosis', 'Severity of Illness Index', 'Time Factors']",2009/10/08 06:00,2009/10/27 06:00,['2009/10/08 06:00'],"['2009/10/08 06:00 [entrez]', '2009/10/08 06:00 [pubmed]', '2009/10/27 06:00 [medline]']","['2/3/243 [pii]', '10.1161/CIRCIMAGING.108.840975 [doi]']",ppublish,Circ Cardiovasc Imaging. 2009 May;2(3):243-50. doi: 10.1161/CIRCIMAGING.108.840975.,3,,,,,,,['Department of Health/United Kingdom'],,,71,,,,,,,,,,,
30395139,NLM,MEDLINE,20190610,20220409,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),29,2018 Sep/Oct,From the Editor's Desk.,267,,"['Commerford, Pat']",['Commerford P'],['Editor-in-Chief.'],['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Humans', 'Prognosis']",2018/11/06 06:00,2019/06/14 06:00,['2018/11/06 06:00'],"['2018/11/06 06:00 [entrez]', '2018/11/06 06:00 [pubmed]', '2019/06/14 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2018 Sep/Oct;29(5):267.,5,,,PMC8962705,,,,,,,,,,,,,,,,,,
34380323,NLM,MEDLINE,20211129,20211129,1942-0080 (Electronic) 1941-9651 (Linking),14,2021 Aug,In This Issue of the Journal.,e013336,10.1161/CIRCIMAGING.121.013336 [doi],"['Gropler, Robert J']",['Gropler RJ'],,['eng'],"['Editorial', 'Introductory Journal Article']",20210812,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis']",2021/08/13 06:00,2021/11/30 06:00,['2021/08/12 05:26'],"['2021/08/13 06:00 [pubmed]', '2021/11/30 06:00 [medline]', '2021/08/12 05:26 [entrez]']",['10.1161/CIRCIMAGING.121.013336 [doi]'],ppublish,Circ Cardiovasc Imaging. 2021 Aug;14(8):e013336. doi: 10.1161/CIRCIMAGING.121.013336. Epub 2021 Aug 12.,8,,,,,,,,,,,,,,,,,,,,,
10804812,NLM,MEDLINE,20000706,20111117,0047-1860 (Print) 0047-1860 (Linking),48,2000 Feb,[Progress in biochemical and genetic examinations in clinical laboratory of cardiovascular diseases].,101-4,,"['Murakami, T', 'Ozaki, T', 'Iizuka, K', 'Kawaguchi, H']","['Murakami T', 'Ozaki T', 'Iizuka K', 'Kawaguchi H']","['Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo.']",['jpn'],"['English Abstract', 'Journal Article', 'Review']",,Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,IM,"['Cardiovascular Diseases/*diagnosis/genetics/metabolism', '*Clinical Laboratory Techniques', '*Cytogenetic Analysis', 'Humans']",2000/05/11 09:00,2000/07/08 11:00,['2000/05/11 09:00'],"['2000/05/11 09:00 [pubmed]', '2000/07/08 11:00 [medline]', '2000/05/11 09:00 [entrez]']",,ppublish,Rinsho Byori. 2000 Feb;48(2):101-4.,2,"For diagnosing cardiovascular emergencies, cardiologists mainly rely on physiological examinations. Biochemical laboratory examinations can facilitate emergency diagnosis and genetic diagnosis can facilitate a fundamental understanding of cardiovascular diseases. Recent progress in biochemical examinations for cardiovascular diseases includes measurement of troponin T, heart type fatty acid-binding protein, and LDL-cholesterol. Recent progress in genetic examinations includes analysis of mitochondrial DNA, obesity-related genes and single nucleotide polymorphisms. A safe and convenient system of collecting, transporting, and storing blood and other biological specimens, and the subsequent purification of genomic DNA from the stored specimens is available. Therefore, busy doctors and staff of clinical laboratory can plan subsequent DNA examinations without causing concern and pain. A recently reported human mutation of heterotrimeric G protein beta 3 subunit produces a gain-of-function G protein signaling abnormality. A common polymorphic base substitution, C825T, in the GNB3 gene is associated with an aberrantly spliced transcript lacking 123 nucleotides. A significant association of the T allele with essential hypertension or obesity has been suggested.",,,,,,,,,8,,,,,,,,,,,
19355954,NLM,MEDLINE,20090616,20190728,1873-4286 (Electronic) 1381-6128 (Linking),15,2009,Imaging and laboratory biomarkers in cardiovascular disease.,1131-41,,"['Andreassi, Maria Grazia', 'Gastaldelli, Amalia', 'Clerico, Aldo', 'Salvadori, Piero A', 'Sicari, Rosa', 'Picano, Eugenio']","['Andreassi MG', 'Gastaldelli A', 'Clerico A', 'Salvadori PA', 'Sicari R', 'Picano E']","['CNR, Institute of Clinical Physiology, Pisa, Italy.']",['eng'],"['Journal Article', 'Review']",,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Animals', 'Atherosclerosis/genetics/pathology', 'Biomarkers', 'Cardiovascular Diseases/*diagnosis/genetics/metabolism/*pathology', 'Clinical Laboratory Techniques', 'Heart Failure/genetics/pathology', 'Humans']",2009/04/10 09:00,2009/06/17 09:00,['2009/04/10 09:00'],"['2009/04/10 09:00 [entrez]', '2009/04/10 09:00 [pubmed]', '2009/06/17 09:00 [medline]']",['10.2174/138161209787846937 [doi]'],ppublish,Curr Pharm Des. 2009;15(10):1131-41. doi: 10.2174/138161209787846937.,10,"Imaging and laboratory biomarkers are an essential support to modern practice of medicine, allowing a better identification, severity titration, staging and follow-up of atherosclerosis and heart failure disease. This review provides an overview of imaging, biochemical and genetic biomarkers used in clinical practice and for research purposes in order to evaluate the 4 different aspect of patient vulnerability to cardiovascular disease: arterial; blood; myocardial; metabolic vulnerability. Yet, no single perfect biomarker exists and there is wide room for optimization and integration between clinical evaluation and biomarker evaluation. In general, a targeted approach tailored on the individual patient should be preferred to a carpet diagnostic bombing, which will lead to an exorbitant multiplier of costs, risks and inappropriate testing.",,,,,,,['0 (Biomarkers)'],,77,,,['Curr Pharm Des. 2009;15(10):1034-7. PMID: 19355945'],,,,,,,,
32912032,NLM,MEDLINE,20210315,20210315,1942-0080 (Electronic) 1941-9651 (Linking),13,2020 Sep,In This Issue of the Journal.,e011784,10.1161/CIRCIMAGING.120.011784 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor in Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",20200911,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Biomedical Research', '*Cardiac Imaging Techniques', '*Cardiology', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans']",2020/09/12 06:00,2021/03/16 06:00,['2020/09/11 05:29'],"['2020/09/11 05:29 [entrez]', '2020/09/12 06:00 [pubmed]', '2021/03/16 06:00 [medline]']",['10.1161/CIRCIMAGING.120.011784 [doi]'],ppublish,Circ Cardiovasc Imaging. 2020 Sep;13(9):e011784. doi: 10.1161/CIRCIMAGING.120.011784. Epub 2020 Sep 11.,9,,,,,,,,,,,,,,,,,,,,,
32408827,NLM,MEDLINE,20201109,20201109,1942-0080 (Electronic) 1941-9651 (Linking),13,2020 May,In This Issue of the Journal.,e011018,10.1161/CIRCIMAGING.120.011018 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor in Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",20200515,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['Cardiovascular Diseases/*diagnostic imaging/epidemiology/physiopathology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2020/05/16 06:00,2020/11/11 06:00,['2020/05/16 06:00'],"['2020/05/16 06:00 [entrez]', '2020/05/16 06:00 [pubmed]', '2020/11/11 06:00 [medline]']",['10.1161/CIRCIMAGING.120.011018 [doi]'],ppublish,Circ Cardiovasc Imaging. 2020 May;13(5):e011018. doi: 10.1161/CIRCIMAGING.120.011018. Epub 2020 May 15.,5,,,,,,,,,,,,,,,,,,,,,
31313635,NLM,MEDLINE,20200402,20200402,1746-076X (Electronic) 1746-0751 (Linking),14,2019 Jul,Potential for stem cell-derived biologic pumps for cardiovascular and other medical therapies.,617-619,10.2217/rme-2019-0056 [doi],"['Kloner, Robert A', 'Hale, Sharon L', 'Dai, Wangde']","['Kloner RA', 'Hale SL', 'Dai W']","['Huntington Medical Research Institutes, Pasadena, CA 91105, USA.', 'Keck School of Medicine of University of Southern California, Division of Cardiovascular Medicine and Department of Medicine, University of Southern California, Los Angeles, CA 90033, USA.', 'Huntington Medical Research Institutes, Pasadena, CA 91105, USA.', 'Huntington Medical Research Institutes, Pasadena, CA 91105, USA.', 'Keck School of Medicine of University of Southern California, Division of Cardiovascular Medicine and Department of Medicine, University of Southern California, Los Angeles, CA 90033, USA.']",['eng'],['Editorial'],20190717,England,Regen Med,Regenerative medicine,101278116,IM,"['*Cardiovascular Diseases/metabolism/pathology/therapy', '*Cell- and Tissue-Based Therapy', 'Humans', '*Stem Cells']",2019/07/18 06:00,2020/04/03 06:00,['2019/07/18 06:00'],"['2019/07/18 06:00 [pubmed]', '2020/04/03 06:00 [medline]', '2019/07/18 06:00 [entrez]']",['10.2217/rme-2019-0056 [doi]'],ppublish,Regen Med. 2019 Jul;14(7):617-619. doi: 10.2217/rme-2019-0056. Epub 2019 Jul 17.,7,,,,,['NOTNLM'],"['aorta', 'biologic pumps', 'neonatal cardiomyocytes', 'stem cells', 'vena cava', 'ventricular assist']",,,,,,,,,,,,,,,
22659859,NLM,MEDLINE,20121009,20120604,1873-1953 (Electronic) 1474-5151 (Linking),11,2012 Jun,"Cardiovascular disease: is it time to finally recognise it as a complex, chronic life-span illness?",135-7,10.1177/1474515111429664 [doi],"['Rolley, John X', 'Thompson, David R']","['Rolley JX', 'Thompson DR']",,['eng'],['Editorial'],,England,Eur J Cardiovasc Nurs,European journal of cardiovascular nursing,101128793,IM,"['Cardiovascular Diseases/epidemiology/*nursing/*physiopathology', 'Chronic Disease', '*Health Behavior', 'Humans', 'Prevalence']",2012/06/05 06:00,2012/10/10 06:00,['2012/06/05 06:00'],"['2012/06/05 06:00 [entrez]', '2012/06/05 06:00 [pubmed]', '2012/10/10 06:00 [medline]']","['11/2/135 [pii]', '10.1177/1474515111429664 [doi]']",ppublish,Eur J Cardiovasc Nurs. 2012 Jun;11(2):135-7. doi: 10.1177/1474515111429664.,2,,,,,,,,,,,,,,,,,,,,,
1670127,NLM,MEDLINE,19940623,20051116,1220-5818 (Print) 1220-5818 (Linking),43,1991,"[An update on cardiovascular diseases in the elderly--the prophylactic, diagnostic and treatment aspects].",7-19,,"['Popescu, P', 'Iliesiu, A']","['Popescu P', 'Iliesiu A']","['Clinica Medicala, Spitalul Clinic Panduri, Bucurest.']",['rum'],"['Journal Article', 'Review']",,Romania,Med Interna,"Medicina interna (Bucharest, Romania : 1991)",9431273,IM,"['Aged', 'Aging/physiology', 'Arteriosclerosis/diagnosis/prevention & control/therapy', 'Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Humans', 'Hypercholesterolemia/diagnosis/prevention & control/therapy', 'Hypertension/diagnosis/prevention & control/therapy']",1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",,ppublish,Med Interna. 1991;43(1-2):7-19.,1-2,,,,,,,,,,38,,,,,"Actualitati privind bolile cardiovasculare la virstnici--aspecte de profilaxie, diagnostic si tratament.",,,,,,
31109182,NLM,MEDLINE,20200316,20200316,1942-0080 (Electronic) 1941-9651 (Linking),12,2019 May,In This Issue of the Journal.,e009316,10.1161/CIRCIMAGING.119.009316 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis']",2019/05/22 06:00,2020/03/17 06:00,['2019/05/22 06:00'],"['2019/05/22 06:00 [entrez]', '2019/05/22 06:00 [pubmed]', '2020/03/17 06:00 [medline]']",['10.1161/CIRCIMAGING.119.009316 [doi]'],ppublish,Circ Cardiovasc Imaging. 2019 May;12(5):e009316. doi: 10.1161/CIRCIMAGING.119.009316.,5,,,,,,,,,,,,,,,,,,,,,
30636435,NLM,MEDLINE,20191028,20191028,1942-0080 (Electronic) 1941-9651 (Linking),12,2019 Dec,In This Issue of the Journal.,e008821,10.1161/CIRCIMAGING.118.008821 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnostic imaging/mortality/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis']",2019/01/15 06:00,2019/10/29 06:00,['2019/01/15 06:00'],"['2019/01/15 06:00 [entrez]', '2019/01/15 06:00 [pubmed]', '2019/10/29 06:00 [medline]']",['10.1161/CIRCIMAGING.118.008821 [doi]'],ppublish,Circ Cardiovasc Imaging. 2019 Dec;12(1):e008821. doi: 10.1161/CIRCIMAGING.118.008821.,1,,,,,,,,,,,,,,,,,,,,,
30871336,NLM,MEDLINE,20200203,20200203,1942-0080 (Electronic) 1941-9651 (Linking),12,2019 Mar,In This Issue of the Journal.,e009041,10.1161/CIRCIMAGING.119.009041 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['Cardiovascular Diseases/*diagnostic imaging/epidemiology/physiopathology/therapy', 'Editorial Policies', 'Humans', 'Periodicals as Topic', 'Social Media']",2019/03/16 06:00,2020/02/06 06:00,['2019/03/16 06:00'],"['2019/03/16 06:00 [entrez]', '2019/03/16 06:00 [pubmed]', '2020/02/06 06:00 [medline]']",['10.1161/CIRCIMAGING.119.009041 [doi]'],ppublish,Circ Cardiovasc Imaging. 2019 Mar;12(3):e009041. doi: 10.1161/CIRCIMAGING.119.009041.,3,,,,,,,,,,,,,,,,,,,,,
31001989,NLM,MEDLINE,20200302,20200302,1942-0080 (Electronic) 1941-9651 (Linking),12,2019 Apr,In This Issue of the Journal.,e009162,10.1161/CIRCIMAGING.119.009162 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis']",2019/04/20 06:00,2020/03/03 06:00,['2019/04/20 06:00'],"['2019/04/20 06:00 [entrez]', '2019/04/20 06:00 [pubmed]', '2020/03/03 06:00 [medline]']",['10.1161/CIRCIMAGING.119.009162 [doi]'],ppublish,Circ Cardiovasc Imaging. 2019 Apr;12(4):e009162. doi: 10.1161/CIRCIMAGING.119.009162.,4,,,,,,,,,,,,,,,,,,,,,
17965400,NLM,MEDLINE,20080129,20071029,1524-4539 (Electronic) 0009-7322 (Linking),116,2007 Oct 23,Poverty and human development: the global implications of cardiovascular disease.,1871-3,,"['Beaglehole, Robert', 'Reddy, Srinath', 'Leeder, Stephen R']","['Beaglehole R', 'Reddy S', 'Leeder SR']",,['eng'],"['Editorial', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['*Cardiovascular Diseases/economics/epidemiology/etiology/prevention & control', 'Humans', '*Poverty Areas', 'World Health Organization']",2007/10/30 09:00,2008/01/30 09:00,['2007/10/30 09:00'],"['2007/10/30 09:00 [pubmed]', '2008/01/30 09:00 [medline]', '2007/10/30 09:00 [entrez]']","['116/17/1871 [pii]', '10.1161/CIRCULATIONAHA.107.736926 [doi]']",ppublish,Circulation. 2007 Oct 23;116(17):1871-3. doi: 10.1161/CIRCULATIONAHA.107.736926.,17,,,,,,,,,,17,,,,,,,,,,,
26498907,NLM,MEDLINE,20180302,20211204,1873-1953 (Electronic) 1474-5151 (Linking),15,2016 Apr,Cardiovascular care research for immigrant or ethnic groups.,e1,10.1177/1474515115613889 [doi],"['King-Shier, Kathryn M']",['King-Shier KM'],"['University of Calgary, Canada kingk@ucalgary.ca.']",['eng'],['Editorial'],20151023,England,Eur J Cardiovasc Nurs,European journal of cardiovascular nursing,101128793,IM,"['Biomedical Research/*organization & administration', 'Cardiovascular Diseases/diagnosis/*ethnology/therapy', '*Emigrants and Immigrants', '*Ethnicity', 'Humans']",2015/10/27 06:00,2018/03/03 06:00,['2015/10/27 06:00'],"['2015/10/01 00:00 [received]', '2015/10/05 00:00 [accepted]', '2015/10/27 06:00 [entrez]', '2015/10/27 06:00 [pubmed]', '2018/03/03 06:00 [medline]']","['1474515115613889 [pii]', '10.1177/1474515115613889 [doi]']",ppublish,Eur J Cardiovasc Nurs. 2016 Apr;15(3):e1. doi: 10.1177/1474515115613889. Epub 2015 Oct 23.,3,,,,,,,,,,,,,,,,,,,,,
33891679,NLM,MEDLINE,20220103,20220323,1755-3245 (Electronic) 0008-6363 (Linking),117,2021 Apr 23,A titan of Cardiovascular Research: Professor Peter Sleight (1929-2020).,e64-e66,10.1093/cvr/cvab119 [doi],"['Channon, Keith M', 'Watkins, Hugh']","['Channon KM', 'Watkins H']","['Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.', 'Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.']",['eng'],"['Biography', 'Historical Article', 'Journal Article', 'Portrait']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/diagnosis/*history/physiopathology/therapy', 'History, 20th Century', 'History, 21st Century', 'Humans']",2021/04/24 06:00,2022/01/04 06:00,['2021/04/23 17:20'],"['2021/04/23 17:20 [entrez]', '2021/04/24 06:00 [pubmed]', '2022/01/04 06:00 [medline]']","['6247999 [pii]', '10.1093/cvr/cvab119 [doi]']",ppublish,Cardiovasc Res. 2021 Apr 23;117(5):e64-e66. doi: 10.1093/cvr/cvab119.,5,,,,,['NOTNLM'],"['Aspirin', 'Cardiology', 'Cardiovascular research', 'Memorial', 'Thrombolysis']","['CH/16/1/32013/BHF_/British Heart Foundation/United Kingdom', 'CH/1992001/6764/BHF_/British Heart Foundation/United Kingdom']",,,,,,,,,['Sleight P'],"['Sleight, Peter']",,,,
32692036,NLM,MEDLINE,20210802,20210802,1473-6535 (Electronic) 0957-9672 (Linking),31,2020 Aug,The potential role of the lipid phosphate phosphatase 3 (Plpp3) gene in cardiovascular disease.,258-259,10.1097/MOL.0000000000000695 [doi],"['Davidson, Jillian', 'Rotondo, Dino']","['Davidson J', 'Rotondo D']","['Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.']",['eng'],"['Journal Article', 'Review']",,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Animals', 'Cardiovascular Diseases/drug therapy/enzymology/*genetics/metabolism', 'Humans', 'Molecular Targeted Therapy', 'Phosphatidate Phosphatase/*genetics']",2020/07/22 06:00,2021/08/03 06:00,['2020/07/22 06:00'],"['2020/07/22 06:00 [entrez]', '2020/07/22 06:00 [pubmed]', '2021/08/03 06:00 [medline]']","['00041433-202008000-00012 [pii]', '10.1097/MOL.0000000000000695 [doi]']",ppublish,Curr Opin Lipidol. 2020 Aug;31(4):258-259. doi: 10.1097/MOL.0000000000000695.,4,,,,,,,,"['EC 3.1.3.- (lipid phosphate phosphatase)', 'EC 3.1.3.4 (Phosphatidate Phosphatase)']",,,,,,,,,,,,,
23364768,NLM,MEDLINE,20130213,20130131,1476-4687 (Electronic) 0028-0836 (Linking),493,2013 Jan 31,Cardiovascular disease: Biochemistry to behaviour.,S2-3,10.1038/493S2a [doi],"['Cannon, Bill']",['Cannon B'],,['eng'],['Journal Article'],,England,Nature,Nature,0410462,IM,"['Behavior', 'Biochemistry', 'Cardiovascular Diseases/*epidemiology/mortality/pathology/*prevention & control', 'Female', 'Humans', 'Male', 'Risk Factors', 'Socioeconomic Factors']",2013/02/01 06:00,2013/02/14 06:00,['2013/02/01 06:00'],"['2013/02/01 06:00 [entrez]', '2013/02/01 06:00 [pubmed]', '2013/02/14 06:00 [medline]']","['493S2a [pii]', '10.1038/493S2a [doi]']",ppublish,Nature. 2013 Jan 31;493(7434):S2-3. doi: 10.1038/493S2a.,7434,,,,,,,,,,,,,,,,,,,,,
34160053,NLM,MEDLINE,20220401,20220513,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Mar 30,Treat young and expect to live or treat when expecting to leave? Moving towards lifetime-guided benefit strategies in cardiovascular prevention.,632-634,10.1093/eurjpc/zwab041 [doi],"['Karagiannidis, Efstratios', 'Papazoglou, Andreas S']","['Karagiannidis E', 'Papazoglou AS']","['First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636 Thessaloniki, Greece.', 'First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636 Thessaloniki, Greece.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Employment', 'Humans']",2021/06/24 06:00,2022/04/02 06:00,['2021/06/23 09:17'],"['2021/06/24 06:00 [pubmed]', '2022/04/02 06:00 [medline]', '2021/06/23 09:17 [entrez]']","['6308227 [pii]', '10.1093/eurjpc/zwab041 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Mar 30;29(4):632-634. doi: 10.1093/eurjpc/zwab041.,4,,"['ORCID: 0000-0001-8328-5942', 'ORCID: 0000-0003-4981-8121']",,,,,,,,,['Eur J Prev Cardiol. 2021 May 02;:. PMID: 34009323'],,,,,,,,,,
27173371,NLM,MEDLINE,20180205,20180205,1468-201X (Electronic) 1355-6037 (Linking),102,2016 Jun 1,Heartbeat: The gut microbiota and heart failure.,811-2,10.1136/heartjnl-2016-309848 [doi],"['Otto, Catherine M', 'Rahimi, Kazem']","['Otto CM', 'Rahimi K']",,['eng'],"['Editorial', 'Introductory Journal Article']",,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnostic imaging/microbiology/mortality/therapy', '*Gastrointestinal Microbiome', 'Gastrointestinal Tract/*microbiology', 'Heart Failure/*microbiology', 'Humans', 'Risk Factors']",2016/05/14 06:00,2018/02/06 06:00,['2016/05/14 06:00'],"['2016/05/14 06:00 [entrez]', '2016/05/14 06:00 [pubmed]', '2018/02/06 06:00 [medline]']","['heartjnl-2016-309848 [pii]', '10.1136/heartjnl-2016-309848 [doi]']",ppublish,Heart. 2016 Jun 1;102(11):811-2. doi: 10.1136/heartjnl-2016-309848.,11,,['ORCID: 0000-0002-0527-9392'],,,['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
23872638,NLM,MEDLINE,20140325,20130906,1473-6535 (Electronic) 0957-9672 (Linking),24,2013 Oct,Epigenetic regulation in vascular cells.,438-43,10.1097/MOL.0b013e328364292d [doi],"['Turunen, Mikko P', 'Aavik, Einari', 'Yla-Herttuala, Seppo']","['Turunen MP', 'Aavik E', 'Yla-Herttuala S']","['Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute, University of Eastern Finland, Kuopio, Finland.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Animals', '*Cardiovascular Diseases/genetics/metabolism/pathology', '*Epigenesis, Genetic', 'Humans']",2013/07/23 06:00,2014/03/26 06:00,['2013/07/23 06:00'],"['2013/07/23 06:00 [entrez]', '2013/07/23 06:00 [pubmed]', '2014/03/26 06:00 [medline]']",['10.1097/MOL.0b013e328364292d [doi]'],ppublish,Curr Opin Lipidol. 2013 Oct;24(5):438-43. doi: 10.1097/MOL.0b013e328364292d.,5,"PURPOSE OF REVIEW: This review summarizes recent findings in the epigenetics of vascular cells and discusses the new challenges for therapeutic strategies of cardiovascular diseases. RECENT FINDINGS: There is emerging optimism that epigenetic mechanisms can provide the missing link to connect (epi)genomes with the cause of complex diseases. Environmental factors like intrauterine conditions during fetal development appear to preprogram humans for complex diseases. The purpose of this review is to summarize the newest results about the inheritable epigenetic features of cardiovascular diseases. Also, the recently discovered role of small RNAs in epigenetic gene regulation is discussed. SUMMARY: Epigenetic mechanisms of gene regulation will likely become major determinants in the pathogenesis of complex diseases and may offer new opportunities for the treatment of these diseases.",,,,,,,,,,,,,,,,,,,,
2688107,NLM,MEDLINE,19900125,20180524,0093-7754 (Print) 0093-7754 (Linking),16,1989 Dec,Cardiovascular emergencies.,463-70,,"['Helms, S R', 'Carlson, M D']","['Helms SR', 'Carlson MD']","['Department of Medicine, Case Western Reserve University, Cleveland, OH, 44106.']",['eng'],"['Journal Article', 'Review']",,United States,Semin Oncol,Seminars in oncology,0420432,IM,"['Cardiac Tamponade/diagnosis/etiology/therapy', 'Cardiovascular Diseases/diagnosis/*etiology/therapy', 'Emergencies', 'Humans', 'Neoplasm Metastasis', 'Neoplasms/*complications/pathology/therapy', 'Superior Vena Cava Syndrome/etiology/physiopathology/therapy']",1989/12/01 00:00,1989/12/01 00:01,['1989/12/01 00:00'],"['1989/12/01 00:00 [pubmed]', '1989/12/01 00:01 [medline]', '1989/12/01 00:00 [entrez]']",['0093-7754(89)90025-0 [pii]'],ppublish,Semin Oncol. 1989 Dec;16(6):463-70.,6,,,,,,,,,,33,,,,,,,,,,,
19153281,NLM,MEDLINE,20090213,20090120,1524-4539 (Electronic) 0009-7322 (Linking),119,2009 Jan 20,Assessing cardiovascular risk: should we discard diastolic blood pressure?,210-2,10.1161/CIRCULATIONAHA.108.827931 [doi],"['Schillaci, Giuseppe', 'Pirro, Matteo', 'Mannarino, Elmo']","['Schillaci G', 'Pirro M', 'Mannarino E']",,['eng'],"['Comment', 'Editorial']",,United States,Circulation,Circulation,0147763,IM,"['Blood Pressure/*physiology', 'Cardiovascular Diseases/diagnosis/etiology/*physiopathology', 'Diastole/physiology', 'Humans', 'Hypertension/complications/diagnosis/physiopathology', 'Risk Factors']",2009/01/21 09:00,2009/02/14 09:00,['2009/01/21 09:00'],"['2009/01/21 09:00 [entrez]', '2009/01/21 09:00 [pubmed]', '2009/02/14 09:00 [medline]']","['119/2/210 [pii]', '10.1161/CIRCULATIONAHA.108.827931 [doi]']",ppublish,Circulation. 2009 Jan 20;119(2):210-2. doi: 10.1161/CIRCULATIONAHA.108.827931.,2,,,,,,,,,,,['Circulation. 2009 Jan 20;119(2):243-50. PMID: 19118251'],,,,,,,,,,
29257734,NLM,MEDLINE,20180917,20180917,1939-2869 (Electronic) 0891-1150 (Linking),84,2017 Dec,Introduction: Challenges and advances in cardiovascular disease.,11,10.3949/ccjm.84.s3.01 [doi],"['Fares, Maan A']",['Fares MA'],"['Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA. FARESM@ccf.org.']",['eng'],['Journal Article'],,United States,Cleve Clin J Med,Cleveland Clinic journal of medicine,8703441,IM,"['*Cardiovascular Diseases/complications/epidemiology/therapy', 'Humans']",2017/12/20 06:00,2018/09/18 06:00,['2017/12/20 06:00'],"['2017/12/20 06:00 [entrez]', '2017/12/20 06:00 [pubmed]', '2018/09/18 06:00 [medline]']",['10.3949/ccjm.84.s3.01 [doi]'],ppublish,Cleve Clin J Med. 2017 Dec;84(12 Suppl 3):11. doi: 10.3949/ccjm.84.s3.01.,12 Suppl 3,,,,,,,,,,,,,,,,,,,,,
20609571,NLM,MEDLINE,20101116,20100723,1590-3729 (Electronic) 0939-4753 (Linking),20,2010 Jul,CVD in women.,377-8,10.1016/j.numecd.2010.02.011 [doi],"['Howard, Barbara V', 'Taskinen, Marja-Riitta']","['Howard BV', 'Taskinen MR']","['MedStar Health Research Institute, Georgetown University, Washington, DC, USA. barbara.v.howard@medstar.net']",['eng'],"['Historical Article', 'Introductory Journal Article']",20100706,Netherlands,Nutr Metab Cardiovasc Dis,"Nutrition, metabolism, and cardiovascular diseases : NMCD",9111474,IM,"['*Cardiovascular Diseases/complications/drug therapy/epidemiology/prevention & control', 'Female', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Risk Factors', ""Women's Health/*history""]",2010/07/09 06:00,2010/11/17 06:00,['2010/07/09 06:00'],"['2010/02/05 00:00 [received]', '2010/02/12 00:00 [accepted]', '2010/07/09 06:00 [entrez]', '2010/07/09 06:00 [pubmed]', '2010/11/17 06:00 [medline]']","['S0939-4753(10)00046-3 [pii]', '10.1016/j.numecd.2010.02.011 [doi]']",ppublish,Nutr Metab Cardiovasc Dis. 2010 Jul;20(6):377-8. doi: 10.1016/j.numecd.2010.02.011. Epub 2010 Jul 6.,6,,,,,,,,,,,,,,,,,,,,,
2079179,NLM,MEDLINE,19910502,20041117,0046-5968 (Print) 0046-5968 (Linking),20,1990 Sep,"[Arterial hypertension, insulin resistance, and cardiovascular diseases].",791-4,,"['Ferrannini, E']",['Ferrannini E'],,['ita'],['Editorial'],,Italy,G Ital Cardiol,Giornale italiano di cardiologia,1270331,IM,"['Cardiovascular Diseases/*etiology/physiopathology', 'Humans', 'Hypertension/*complications/physiopathology', '*Insulin Resistance']",1990/09/01 00:00,1990/09/01 00:01,['1990/09/01 00:00'],"['1990/09/01 00:00 [pubmed]', '1990/09/01 00:01 [medline]', '1990/09/01 00:00 [entrez]']",,ppublish,G Ital Cardiol. 1990 Sep;20(9):791-4.,9,,,,,,,,,,,,,,,"Ipertensione arteriosa, resistenza insulinica e malattie cardiovascolari.",,,,,,
12793043,NLM,MEDLINE,20030626,20081121,0042-773X (Print) 0042-773X (Linking),49,2003 Apr,[Biorhythms].,253,,"['Siegelova, J']",['Siegelova J'],,['cze'],"['Comment', 'Editorial']",,Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Cardiovascular Diseases/epidemiology/*physiopathology/therapy', 'Chronobiology Phenomena', 'Chronotherapy', '*Circadian Rhythm', 'Hemodynamics', 'Humans']",2003/06/10 05:00,2003/06/27 05:00,['2003/06/10 05:00'],"['2003/06/10 05:00 [pubmed]', '2003/06/27 05:00 [medline]', '2003/06/10 05:00 [entrez]']",,ppublish,Vnitr Lek. 2003 Apr;49(4):253.,4,,,,,,,,,,,"['Vnitr Lek. 2003 Apr;49(4):297-301. PMID: 12793053', 'Vnitr Lek. 2003 Apr;49(4):302-7. PMID: 12793054', 'Vnitr Lek. 2003 Apr;49(4):308-13. PMID: 12793055']",,,,Biorytmy.,,,,,,
27938835,NLM,MEDLINE,20180124,20180124,2211-8179 (Electronic) 2211-8160 (Linking),11,2016 Dec,The Need for Brazil to Focus on CVD.,439-440,S2211-8160(16)30734-7 [pii] 10.1016/j.gheart.2016.10.001 [doi],"['Mota, Diandro', 'Mattos, Antonio Cordeiro', 'Oliveira, Gustavo', 'Avezum, Alvaro']","['Mota D', 'Mattos AC', 'Oliveira G', 'Avezum A']","['Research Division at Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil.', 'Research Division at Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil.', 'Research Division at Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil.', 'Research Division at Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil. Electronic address: avezum@yahoo.com.']",['eng'],['Editorial'],,England,Glob Heart,Global heart,101584391,IM,"['Brazil/epidemiology', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control/therapy', 'Cause of Death', '*Government', 'Humans', '*Public-Private Sector Partnerships', '*Societies, Medical']",2016/12/13 06:00,2018/01/25 06:00,['2016/12/13 06:00'],"['2016/09/29 00:00 [received]', '2016/10/03 00:00 [accepted]', '2016/12/13 06:00 [entrez]', '2016/12/13 06:00 [pubmed]', '2018/01/25 06:00 [medline]']","['S2211-8160(16)30734-7 [pii]', '10.1016/j.gheart.2016.10.001 [doi]']",ppublish,Glob Heart. 2016 Dec;11(4):439-440. doi: 10.1016/j.gheart.2016.10.001.,4,,,,,,,,,,,,,,,,,,,,,
30865479,NLM,MEDLINE,20191219,20191219,1524-4539 (Electronic) 0009-7322 (Linking),139,2019 Mar 5,AHA Scientific Sessions 2018 Highlights.,1335-1337,10.1161/CIRCULATIONAHA.119.039755 [doi],"['Peterson, Eric D', 'Lloyd-Jones, Donald']","['Peterson ED', 'Lloyd-Jones D']","['Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC (E.D.P).', 'Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (D.L-J.).']",['eng'],"['Congress', 'News']",,United States,Circulation,Circulation,0147763,IM,"['Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Humans']",2019/03/14 06:00,2019/12/20 06:00,['2019/03/14 06:00'],"['2019/03/14 06:00 [entrez]', '2019/03/14 06:00 [pubmed]', '2019/12/20 06:00 [medline]']",['10.1161/CIRCULATIONAHA.119.039755 [doi]'],ppublish,Circulation. 2019 Mar 5;139(10):1335-1337. doi: 10.1161/CIRCULATIONAHA.119.039755.,10,,,,,,,,,,,,,,,,,,,,,
32544476,NLM,MEDLINE,20210114,20210114,1874-1754 (Electronic) 0167-5273 (Linking),317,2020 Oct 15,Cardio-oncology - More than just cardiac complications of cancer treatment.,174-175,S0167-5273(20)32399-8 [pii] 10.1016/j.ijcard.2020.06.003 [doi],"['Ghosh, Arjun K']",['Ghosh AK'],"[""Cardio-Oncology Services, Barts Heart Centre, St Bartholomew's Hospital, London, UK; University College London Hospital London, London, UK. Electronic address: arjun.ghosh@nhs.net.""]",['eng'],"['Comment', 'Editorial']",20200613,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['Adult', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Cohort Studies', '*Heart Diseases/diagnosis/epidemiology/etiology', 'Humans', 'Medical Oncology', '*Neoplasms/therapy']",2020/06/17 06:00,2021/01/15 06:00,['2020/06/17 06:00'],"['2020/05/25 00:00 [received]', '2020/06/01 00:00 [accepted]', '2020/06/17 06:00 [pubmed]', '2021/01/15 06:00 [medline]', '2020/06/17 06:00 [entrez]']","['S0167-5273(20)32399-8 [pii]', '10.1016/j.ijcard.2020.06.003 [doi]']",ppublish,Int J Cardiol. 2020 Oct 15;317:174-175. doi: 10.1016/j.ijcard.2020.06.003. Epub 2020 Jun 13.,,,,,,,,,,,,['Int J Cardiol. 2020 Oct 15;317:167-173. PMID: 32360647'],,,,,,,,,,
29254880,NLM,MEDLINE,20180924,20180924,1874-1754 (Electronic) 0167-5273 (Linking),254,2018 Mar 1,"Foreword by the Guest Editors of the new section of the IJC, ""Migration and cardiovascular disease"".",353-355,S0167-5273(17)36795-5 [pii] 10.1016/j.ijcard.2017.12.017 [doi],"['De Backer, G G', 'Maggioni, A P']","['De Backer GG', 'Maggioni AP']","['Dept. Public Health, Ghent University, Ghent, Belgium. Electronic address: guy.debacker@ugent.be.', 'Centro Studi ANMCO, Fondazione ""per il Tuo cuore"" HCF ONLUS, Firenze, Italy.']",['eng'],['Editorial'],20171214,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['Cardiovascular Diseases/*diagnosis/*epidemiology/physiopathology', '*Editorial Policies', 'Humans', 'Refugees', '*Transients and Migrants']",2017/12/20 06:00,2018/09/25 06:00,['2017/12/20 06:00'],"['2017/11/01 00:00 [received]', '2017/12/06 00:00 [accepted]', '2017/12/20 06:00 [pubmed]', '2018/09/25 06:00 [medline]', '2017/12/20 06:00 [entrez]']","['S0167-5273(17)36795-5 [pii]', '10.1016/j.ijcard.2017.12.017 [doi]']",ppublish,Int J Cardiol. 2018 Mar 1;254:353-355. doi: 10.1016/j.ijcard.2017.12.017. Epub 2017 Dec 14.,,,,,,,,,,,,,,,,,,,,,,
30625335,NLM,MEDLINE,20190314,20190314,1873-1740 (Electronic) 0033-0620 (Linking),62,2019 Jan-Feb,Five Years as Editor-in-Chief.,83-84,S0033-0620(19)30001-5 [pii] 10.1016/j.pcad.2019.01.001 [doi],"['Lavie, Carl J']",['Lavie CJ'],"['John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA. Electronic address: clavie@ochsner.org.']",['eng'],['Editorial'],20190106,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control/therapy', '*Editorial Policies', 'Humans', '*Periodicals as Topic']",2019/01/10 06:00,2019/03/15 06:00,['2019/01/10 06:00'],"['2019/01/10 06:00 [pubmed]', '2019/03/15 06:00 [medline]', '2019/01/10 06:00 [entrez]']","['S0033-0620(19)30001-5 [pii]', '10.1016/j.pcad.2019.01.001 [doi]']",ppublish,Prog Cardiovasc Dis. 2019 Jan-Feb;62(1):83-84. doi: 10.1016/j.pcad.2019.01.001. Epub 2019 Jan 6.,1,,,,,,,,,,,,,,,,,,,,,
29564600,NLM,MEDLINE,20181123,20181123,1869-1889 (Electronic) 1674-7305 (Linking),61,2018 May,Profile of Dr. Dongfeng Gu.,501-503,10.1007/s11427-018-9282-9 [doi],,,,['eng'],"['Biography', 'Historical Article', 'Journal Article']",,China,Sci China Life Sci,Science China. Life sciences,101529880,IM,"['*Cardiovascular Diseases/epidemiology/genetics/prevention & control', 'China', '*Genetics, Medical', 'History, 20th Century', 'History, 21st Century', 'Hypertension/diagnosis/drug therapy']",2018/03/23 06:00,2018/11/24 06:00,['2018/03/23 06:00'],"['2018/03/23 06:00 [pubmed]', '2018/11/24 06:00 [medline]', '2018/03/23 06:00 [entrez]']","['10.1007/s11427-018-9282-9 [pii]', '10.1007/s11427-018-9282-9 [doi]']",ppublish,Sci China Life Sci. 2018 May;61(5):501-503. doi: 10.1007/s11427-018-9282-9.,5,,,,,,,,,,,,,,,,['Gu D'],"['Gu, Dongfeng']",,,,
37054861,NLM,MEDLINE,20230626,20231116,1873-1740 (Electronic) 0033-0620 (Linking),78,2023 May-Jun,Leisure time versus occupational physical activity for cardiometabolic risk.,83-84,S0033-0620(23)00033-6 [pii] 10.1016/j.pcad.2023.04.003 [doi],"['Neeland, Ian J', 'Lavie, Carl J']","['Neeland IJ', 'Lavie CJ']","['Harrington Heart and Vascular Institute, University Hospital Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: Ian.Neeland@UHhospitals.org.', 'Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, USA.']",['eng'],['Editorial'],20230411,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Humans', '*Leisure Activities', 'Exercise', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control']",2023/04/14 06:00,2023/06/26 06:41,['2023/04/13 19:23'],"['2023/06/26 06:41 [medline]', '2023/04/14 06:00 [pubmed]', '2023/04/13 19:23 [entrez]']","['S0033-0620(23)00033-6 [pii]', '10.1016/j.pcad.2023.04.003 [doi]']",ppublish,Prog Cardiovasc Dis. 2023 May-Jun;78:83-84. doi: 10.1016/j.pcad.2023.04.003. Epub 2023 Apr 11.,,,,,,,,,,,,,,,,,,,,,,
7638466,NLM,MEDLINE,19950913,20041117,0271-8235 (Print) 0271-8235 (Linking),15,1995 Mar,Cardiovascular considerations in the management of neuromuscular disease.,93-108,,"['Ishikawa, Y', 'Bach, J R', 'Sarma, R J', 'Tamura, T', 'Song, J', 'Marra, S W', 'Ishikawa, Y', 'Minami, R']","['Ishikawa Y', 'Bach JR', 'Sarma RJ', 'Tamura T', 'Song J', 'Marra SW', 'Ishikawa Y', 'Minami R']","['Yakumo Byoin National Sanatorium, Hokkaido, Japan.']",['eng'],"['Journal Article', 'Review']",,United States,Semin Neurol,Seminars in neurology,8111343,IM,"['Cardiomyopathies/diagnosis/etiology/therapy', 'Cardiovascular Diseases/diagnosis/*etiology/*therapy', 'Heart Diseases/diagnosis/etiology/therapy', 'Humans', 'Neuromuscular Diseases/*complications/*therapy']",1995/03/01 00:00,1995/03/01 00:01,['1995/03/01 00:00'],"['1995/03/01 00:00 [pubmed]', '1995/03/01 00:01 [medline]', '1995/03/01 00:00 [entrez]']",['10.1055/s-2008-1041013 [doi]'],ppublish,Semin Neurol. 1995 Mar;15(1):93-108. doi: 10.1055/s-2008-1041013.,1,,,,,,,,,,153,,,,,,,,,,,
24305592,NLM,MEDLINE,20140902,20180815,2241-5955 (Electronic) 1109-9666 (Linking),54,2013 Nov-Dec,Cardiovascular medicine: at the crossroads.,493,,"['Vardas, Panos E']",['Vardas PE'],"['Department of Cardiology, Heraklion University Hospital, Crete, Greece.']",['eng'],['Editorial'],,Netherlands,Hellenic J Cardiol,Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,101257381,IM,"['Cardiology/*trends', '*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Humans']",2013/12/07 06:00,2014/09/03 06:00,['2013/12/06 06:00'],"['2013/12/06 06:00 [entrez]', '2013/12/07 06:00 [pubmed]', '2014/09/03 06:00 [medline]']",,ppublish,Hellenic J Cardiol. 2013 Nov-Dec;54(6):493.,6,,,,,,,,,,,,,,,,,,,,,
31077587,NLM,MEDLINE,20200518,20200518,1755-3245 (Electronic) 0008-6363 (Print) 0008-6363 (Linking),115,2019 May 1,Cardiovascular Research at the American College of Cardiology Scientific Sessions 2019: the meeting's highlights.,e66-e68,10.1093/cvr/cvz098 [doi],"['Dey, Amit K']",['Dey AK'],"['Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, NIH, Building 10-CRC Room 5-5232, Bethesda, MD, USA.']",['eng'],"['Congress', 'Research Support, N.I.H., Extramural', 'Research Support, N.I.H., Intramural']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Humans']",2019/05/12 06:00,2020/05/19 06:00,['2019/05/12 06:00'],"['2019/05/12 06:00 [entrez]', '2019/05/12 06:00 [pubmed]', '2020/05/19 06:00 [medline]']","['5476346 [pii]', 'cvz098 [pii]', '10.1093/cvr/cvz098 [doi]']",ppublish,Cardiovasc Res. 2019 May 1;115(6):e66-e68. doi: 10.1093/cvr/cvz098.,6,,,PMC6477641,,,,,,,,,,,,,,,,,,
3844705,NLM,MEDLINE,19850405,20041117,0031-4617 (Print) 0031-4617 (Linking),40,1985 Feb,Cardiovascular update.,6-7,,"['Longenecker, V']",['Longenecker V'],,['eng'],['Journal Article'],,United States,Pa Nurse,The Pennsylvania nurse,19540010R,,"['Cardiovascular Diseases/diagnosis/nursing/*prevention & control', 'Humans']",1985/02/01 00:00,1985/02/01 00:01,['1985/02/01 00:00'],"['1985/02/01 00:00 [pubmed]', '1985/02/01 00:01 [medline]', '1985/02/01 00:00 [entrez]']",,ppublish,Pa Nurse. 1985 Feb;40(2):6-7.,2,,,,,,,,,,,,,,,,,,,,,
2950892,NLM,MEDLINE,19870520,20041117,0891-0162 (Print) 0891-0162 (Linking),35,1987 Apr,Cardiovascular disease.,186-9,,,,,['eng'],['Journal Article'],,United States,AAOHN J,AAOHN journal : official journal of the American Association of Occupational Health Nurses,8608669,,"['Aged', 'Cardiovascular Diseases/diagnosis/prevention & control/*therapy', 'Humans']",1987/04/01 00:00,1987/04/01 00:01,['1987/04/01 00:00'],"['1987/04/01 00:00 [pubmed]', '1987/04/01 00:01 [medline]', '1987/04/01 00:00 [entrez]']",,ppublish,AAOHN J. 1987 Apr;35(4):186-9.,4,,,,,,,,,,,,,,,,,,,,,
18381029,NLM,MEDLINE,20081003,20190823,0025-7753 (Print) 0025-7753 (Linking),130,2008 Mar 22,[Pulse pressure and cardiovascular risk: from epidemiology to pathophysiology].,374-5,,"['de la Sierra, Alejandro']",['de la Sierra A'],,['spa'],['Editorial'],,Spain,Med Clin (Barc),Medicina clinica,0376377,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/*physiopathology', 'Humans', '*Pulse', 'Risk Factors']",2008/04/03 09:00,2008/10/04 09:00,['2008/04/03 09:00'],"['2008/04/03 09:00 [pubmed]', '2008/10/04 09:00 [medline]', '2008/04/03 09:00 [entrez]']","['S0025-7753(08)71452-0 [pii]', '10.1157/13117467 [doi]']",ppublish,Med Clin (Barc). 2008 Mar 22;130(10):374-5. doi: 10.1157/13117467.,10,,,,,,,,,,,,,,,Presion de pulso y riesgo cardiovascular: de la epidemiologia a la fisiopatologia.,,,,,,
22717845,NLM,MEDLINE,20121122,20220409,0807-7096 (Electronic) 0029-2001 (Linking),132,2012 Jun 12,Why measure resting heart rate?,1314,10.4045/tidsskr.12.0553 [doi],"['Nauman, Javaid']",['Nauman J'],,"['eng', 'nor']",['Editorial'],,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Cardiovascular Diseases/*diagnosis/mortality/prevention & control', '*Heart Rate', 'Humans', 'Rest']",2012/06/22 06:00,2012/12/10 06:00,['2012/06/22 06:00'],"['2012/06/22 06:00 [entrez]', '2012/06/22 06:00 [pubmed]', '2012/12/10 06:00 [medline]']","['2274874 [pii]', '10.4045/tidsskr.12.0553 [doi]']",ppublish,Tidsskr Nor Laegeforen. 2012 Jun 12;132(11):1314. doi: 10.4045/tidsskr.12.0553.,11,,,,,,,,,,,,,,,,,,,,,
30087515,NLM,MEDLINE,20191002,20191002,1827-6806 (Print) 1827-6806 (Linking),19,2018 Sep,[Prof. Fausto Rovelli].,530-531,10.1714/2951.29673 [doi],"['Pirelli, Salvatore', 'Ferratini, Maurizio']","['Pirelli S', 'Ferratini M']","['U.O. Cardiologia, Clinica San Carlo, Paderno Dugnano (MI) e-mail: pirelli.s@libero.it.', 'U.O. Cardiologia Riabilitativa S. Maria Nascente-Fondazione Don Gnocchi, Milano.']",['ita'],"['Biography', 'Historical Article', 'Journal Article']",,Italy,G Ital Cardiol (Rome),Giornale italiano di cardiologia (2006),101263411,IM,"['Cardiology/*history', 'Cardiovascular Diseases/diagnosis/*history/therapy', 'History, 20th Century', 'Humans']",2018/08/09 06:00,2019/10/03 06:00,['2018/08/09 06:00'],"['2018/08/09 06:00 [entrez]', '2018/08/09 06:00 [pubmed]', '2019/10/03 06:00 [medline]']",['10.1714/2951.29673 [doi]'],ppublish,G Ital Cardiol (Rome). 2018 Sep;19(9):530-531. doi: 10.1714/2951.29673.,9,,,,,,,,,,,,,,,Prof. Fausto Rovelli.,['Rovelli F'],"['Rovelli, Fausto']",,,,
21525448,NLM,MEDLINE,20110701,20211020,1935-5548 (Electronic) 0149-5992 (Print) 0149-5992 (Linking),34 Suppl 2,2011 May,Should C-reactive protein be a target of therapy?,S155-60,10.2337/dc11-s211 [doi],"['Oh, Jisun', 'Teoh, Hwee', 'Leiter, Lawrence A']","['Oh J', 'Teoh H', 'Leiter LA']","[""Division of Endocrinology and Metabolism, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.""]",['eng'],"['Journal Article', 'Review']",,United States,Diabetes Care,Diabetes care,7805975,IM,"['C-Reactive Protein/*metabolism', 'Cardiovascular Diseases/diagnosis/*metabolism/*prevention & control']",2011/05/06 06:00,2011/07/02 06:00,['2011/04/29 06:00'],"['2011/04/29 06:00 [entrez]', '2011/05/06 06:00 [pubmed]', '2011/07/02 06:00 [medline]']","['34/Supplement_2/S155 [pii]', 's211 [pii]', '10.2337/dc11-s211 [doi]']",ppublish,Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S155-60. doi: 10.2337/dc11-s211.,Suppl 2,,,PMC3632154,,,,,['9007-41-4 (C-Reactive Protein)'],,,,,,,,,,,,,
16754268,NLM,MEDLINE,20060816,20060606,0803-7051 (Print) 0803-7051 (Linking),15,2006,Hypertension and cardiovascular disease in women: progress towards better understanding of gender-specific differences?,68-70,,"['Narkiewicz, Krzysztof', 'Kjeldsen, Sverre E', 'Hedner, Thomas']","['Narkiewicz K', 'Kjeldsen SE', 'Hedner T']",,['eng'],['Editorial'],,England,Blood Press,Blood pressure,9301454,IM,"['Age Factors', '*Cardiovascular Diseases/diagnosis/etiology/prevention & control', 'Female', 'Humans', '*Hypertension/diagnosis/etiology/prevention & control', 'Male', 'Prognosis', 'Risk Factors', 'Sex Factors']",2006/06/07 09:00,2006/08/17 09:00,['2006/06/07 09:00'],"['2006/06/07 09:00 [pubmed]', '2006/08/17 09:00 [medline]', '2006/06/07 09:00 [entrez]']","['V864TU7628325U86 [pii]', '10.1080/08037050600750165 [doi]']",ppublish,Blood Press. 2006;15(2):68-70. doi: 10.1080/08037050600750165.,2,,,,,,,,,,,,,,,,,,,,,
24337210,NLM,MEDLINE,20140811,20211021,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),24,2013 Oct-Nov,Reflections on a range of cardiovascular issues.,343,,"['Brink, Paul A']",['Brink PA'],"['Department of Internal Medicine, Faculty of Health Sciences, University of Stellenbosch and Tygerberg Hospital, Tygerberg.']",['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Humans', 'Prognosis', 'Risk Factors']",2013/12/18 06:00,2014/08/12 06:00,['2013/12/17 06:00'],"['2013/12/17 06:00 [entrez]', '2013/12/18 06:00 [pubmed]', '2014/08/12 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2013 Oct-Nov;24(9-10):343.,9-10,,,PMC3896101,,,,,,,,,,,,,,,,,,
18786087,NLM,MEDLINE,20081222,20080912,1755-5914 (Print) 1755-5914 (Linking),26,2008 Fall,Transcriptomics: new targets for diagnosing and treating cardiovascular disease.,179-81,10.1111/j.1755-5922.2008.00055.x [doi],"['Freedman, Jane E']",['Freedman JE'],,['eng'],['Editorial'],,England,Cardiovasc Ther,Cardiovascular therapeutics,101319630,IM,"['Cardiovascular Diseases/*diagnosis/genetics/*therapy', 'Gene Expression Profiling/*methods/trends', 'Humans']",2008/09/13 09:00,2008/12/23 09:00,['2008/09/13 09:00'],"['2008/09/13 09:00 [pubmed]', '2008/12/23 09:00 [medline]', '2008/09/13 09:00 [entrez]']","['CDR055 [pii]', '10.1111/j.1755-5922.2008.00055.x [doi]']",ppublish,Cardiovasc Ther. 2008 Fall;26(3):179-81. doi: 10.1111/j.1755-5922.2008.00055.x.,3,,,,,,,,,,,,,,,,,,,,,
28808142,NLM,MEDLINE,20190128,20190128,1524-4539 (Electronic) 0009-7322 (Linking),136,2017 Aug 15,Reflections of the Editor-in-Chief.,613-614,10.1161/CIRCULATIONAHA.117.030459 [doi],"['Hill, Joseph A']",['Hill JA'],"['From Departments of Internal Medicine and Molecular Biology, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas. joseph.hill@utsouthwestern.edu.']",['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['*Biomedical Research', 'Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', '*Editorial Policies', '*Global Health', 'Humans', '*Periodicals as Topic', 'Prognosis', 'Risk Factors']",2017/08/16 06:00,2019/01/29 06:00,['2017/08/16 06:00'],"['2017/08/16 06:00 [entrez]', '2017/08/16 06:00 [pubmed]', '2019/01/29 06:00 [medline]']","['CIRCULATIONAHA.117.030459 [pii]', '10.1161/CIRCULATIONAHA.117.030459 [doi]']",ppublish,Circulation. 2017 Aug 15;136(7):613-614. doi: 10.1161/CIRCULATIONAHA.117.030459.,7,,,,,,,,,,,,,,,,,,,,,
10884152,NLM,MEDLINE,20000731,20190910,0355-3140 (Print) 0355-3140 (Linking),25,1999 Dec,Challenges for research and prevention in relation to work and cardiovascular diseases.,550-7,,"['Kristensen, T S']",['Kristensen TS'],"['National Institute of Occupational Health, Copenhagen, Denmark. tsk@ami.dk']",['eng'],"['Historical Article', 'Journal Article']",,Finland,Scand J Work Environ Health,"Scandinavian journal of work, environment & health",7511540,IM,"['Cardiovascular Diseases/epidemiology/history/*prevention & control/psychology', 'History, 20th Century', 'Humans', 'Occupational Diseases/epidemiology/history/*prevention & control/psychology']",2000/07/07 11:00,2000/08/06 11:00,['2000/07/07 11:00'],"['2000/07/07 11:00 [pubmed]', '2000/08/06 11:00 [medline]', '2000/07/07 11:00 [entrez]']","['479 [pii]', '10.5271/sjweh.479 [doi]']",ppublish,Scand J Work Environ Health. 1999 Dec;25(6):550-7. doi: 10.5271/sjweh.479.,6,"The purpose of this paper is to discuss future challenges for research and prevention in the field of work environment and cardiovascular diseases (CVD). First, research on CVD and work during the last half of the 20th century is discussed. Second, the theories dominating the last 20 years are presented. Third, cardiovascular and occupational epidemiology are compared, and it is stressed that occupational epidemiology should avoid the individualistic bias of mainstream cardiovascular epidemiology. Finally, future challenges are discussed, and improvements are recommended concerning the use of intermediate end points, intervention research, theories about chemical and physical risk factors, the use of a unifying model for society, stress, and health, and the application of integrated prevention. It is concluded that research on CVD and work can play an important part in the development of integrated prevention strategies for the next century.",,,,,,,,,,,,,,,,,,,,
21475567,NLM,MEDLINE,20110830,20211020,1866-0452 (Electronic) 1866-0452 (Linking),108,2011 Mar,Not very meaningful.,187; author reply 187-8,10.3238/arztebl.2011.0187a [doi],"['Schneider, Thomas']",['Schneider T'],,['eng'],"['Comment', 'Letter']",20110318,Germany,Dtsch Arztebl Int,Deutsches Arzteblatt international,101475967,IM,"['Cardiovascular Diseases/*diagnosis/*epidemiology/therapy', 'Cerebrovascular Disorders/*diagnosis/*epidemiology/therapy', 'Comorbidity', 'Humans', 'Hypertension/*diagnosis/*epidemiology/therapy', 'Prevalence']",2011/04/09 06:00,2011/08/31 06:00,['2011/04/09 06:00'],"['2011/04/09 06:00 [entrez]', '2011/04/09 06:00 [pubmed]', '2011/08/31 06:00 [medline]']",['10.3238/arztebl.2011.0187a [doi]'],ppublish,Dtsch Arztebl Int. 2011 Mar;108(11):187; author reply 187-8. doi: 10.3238/arztebl.2011.0187a. Epub 2011 Mar 18.,11,,,PMC3071955,,,,,,,,['Dtsch Arztebl Int. 2010 Dec;107(49):866-73. PMID: 21191547'],,,,,,,,,,
12641912,NLM,MEDLINE,20030814,20041117,0376-2491 (Print) 0376-2491 (Linking),82,2002 Dec 25,[Cardiology].,1657-9,,"['Qi, Wenhang', 'Xie, Yucai', 'Lu, Guoping']","['Qi W', 'Xie Y', 'Lu G']",,['chi'],['Journal Article'],,China,Zhonghua Yi Xue Za Zhi,Zhonghua yi xue za zhi,7511141,IM,"['Biomedical Research', 'Cardiology/*trends', 'Cardiovascular Diseases/epidemiology/prevention & control/therapy', 'China', 'Humans', 'Hypertension/epidemiology/therapy']",2003/03/19 04:00,2003/08/15 05:00,['2003/03/19 04:00'],"['2003/03/19 04:00 [pubmed]', '2003/08/15 05:00 [medline]', '2003/03/19 04:00 [entrez]']",,ppublish,Zhonghua Yi Xue Za Zhi. 2002 Dec 25;82(24):1657-9.,24,,,,,,,,,,,,,,,,,,,,,
16461830,NLM,MEDLINE,20060310,20060207,1524-4539 (Electronic) 0009-7322 (Linking),113,2006 Feb 7,"Arterial stiffness, vascular disease, and risk of cardiovascular events.",601-3,,"['Cohn, Jay N']",['Cohn JN'],,['eng'],"['Comment', 'Editorial']",,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Carotid Artery Diseases', 'Humans', 'Mass Screening', 'Vascular Diseases/diagnosis', 'Vascular Resistance']",2006/02/08 09:00,2006/03/11 09:00,['2006/02/08 09:00'],"['2006/02/08 09:00 [pubmed]', '2006/03/11 09:00 [medline]', '2006/02/08 09:00 [entrez]']","['113/5/601 [pii]', '10.1161/CIRCULATIONAHA.105.600866 [doi]']",ppublish,Circulation. 2006 Feb 7;113(5):601-3. doi: 10.1161/CIRCULATIONAHA.105.600866.,5,,,,,,,,,,,"['Circulation. 2006 Feb 7;113(5):657-63. PMID: 16461838', 'Circulation. 2006 Feb 7;113(5):664-70. PMID: 16461839']",,,,,,,,,,
20620418,NLM,MEDLINE,20100809,20141120,1873-1740 (Electronic) 0033-0620 (Linking),53,2010 Jul-Aug,Preface-Global impact of the Framingham Heart Study.,3,10.1016/j.pcad.2010.03.006 [doi],"['Wilson, Peter W F']",['Wilson PW'],,['eng'],"['Editorial', 'Historical Article', 'Introductory Journal Article']",,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Cardiovascular Diseases/*epidemiology/etiology/history/mortality/prevention & control', 'Evidence-Based Medicine', '*Global Health', 'History, 20th Century', 'History, 21st Century', 'Humans', 'International Cooperation', 'National Institutes of Health (U.S.)', '*Population Surveillance', 'Risk Assessment', 'Risk Factors', 'Time Factors', 'United States/epidemiology']",2010/07/14 06:00,2010/08/10 06:00,['2010/07/13 06:00'],"['2010/07/13 06:00 [entrez]', '2010/07/14 06:00 [pubmed]', '2010/08/10 06:00 [medline]']","['S0033-0620(10)00058-7 [pii]', '10.1016/j.pcad.2010.03.006 [doi]']",ppublish,Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):3. doi: 10.1016/j.pcad.2010.03.006.,1,,,,,,,,,,,,,,,,,,,,,
31982286,NLM,MEDLINE,20210215,20210215,1873-2615 (Electronic) 1050-1738 (Linking),31,2021 Jan,Editorial commentary: Balancing progress and practice: Preventive cardiology in the 2020s.,57-58,S1050-1738(19)30177-X [pii] 10.1016/j.tcm.2019.12.007 [doi],"['Ahsan, Lusana', 'Schulman-Marcus, Joshua']","['Ahsan L', 'Schulman-Marcus J']","['Division of Cardiology, Albany Medical Center, Albany, NY, USA.', 'Division of Cardiology, Albany Medical Center, Albany, NY, USA. Electronic address: schulmj1@amc.edu.']",['eng'],"['Comment', 'Editorial']",20191231,United States,Trends Cardiovasc Med,Trends in cardiovascular medicine,9108337,IM,"['*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans', 'United States']",2020/01/27 06:00,2021/02/16 06:00,['2020/01/27 06:00'],"['2019/12/17 00:00 [received]', '2019/12/21 00:00 [accepted]', '2020/01/27 06:00 [pubmed]', '2021/02/16 06:00 [medline]', '2020/01/27 06:00 [entrez]']","['S1050-1738(19)30177-X [pii]', '10.1016/j.tcm.2019.12.007 [doi]']",ppublish,Trends Cardiovasc Med. 2021 Jan;31(1):57-58. doi: 10.1016/j.tcm.2019.12.007. Epub 2019 Dec 31.,1,,,,,,,,,,,['Trends Cardiovasc Med. 2021 Jan;31(1):49-56. PMID: 31882264'],,,,,,,,,,
15687121,NLM,MEDLINE,20050711,20050202,1524-4539 (Electronic) 0009-7322 (Linking),111,2005 Feb 1,Evaluating and managing cardiovascular disease in women: understanding a woman's heart.,383-4,,"['Jacobs, Alice K', 'Eckel, Robert H']","['Jacobs AK', 'Eckel RH']",,['eng'],['Editorial'],,United States,Circulation,Circulation,0147763,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Cardiovascular Diseases/diagnosis/*epidemiology/prevention & control/therapy', 'Child', 'Female', 'Health Promotion', 'Humans', 'Middle Aged', 'Risk Factors', 'Sex Factors', ""*Women's Health""]",2005/02/03 09:00,2005/07/12 09:00,['2005/02/03 09:00'],"['2005/02/03 09:00 [pubmed]', '2005/07/12 09:00 [medline]', '2005/02/03 09:00 [entrez]']","['111/4/383 [pii]', '10.1161/01.CIR.0000155289.62829.0F [doi]']",ppublish,Circulation. 2005 Feb 1;111(4):383-4. doi: 10.1161/01.CIR.0000155289.62829.0F.,4,,,,,,,,,,,,,,,,,,['Circulation. 2005 Feb 1;111(4):e28-33. PMID: 15687115'],,,
15696904,NLM,MEDLINE,20050719,20051116,0211-6995 (Print) 0211-6995 (Linking),24 Suppl,2004,[Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis].,"142-60, 187-235",,"['Goicoechea, M A']",['Goicoechea MA'],"['Hospital General Gregorio Maranon, Madrid.']",['spa'],"['Journal Article', 'Review']",,Spain,Nefrologia,Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,8301215,IM,"['Calcinosis/etiology', 'Cardiovascular Diseases/diagnosis/epidemiology/*etiology/therapy', 'Cerebrovascular Disorders/etiology', 'Chronic Disease', 'Coronary Angiography', 'Decision Trees', 'Disease Progression', 'Heart Valve Diseases/etiology/surgery', 'Humans', 'Kidney Diseases/*complications/*therapy', 'Myocardial Ischemia/diagnosis/etiology/therapy', 'Myocardial Revascularization', 'Peripheral Vascular Diseases/diagnosis/etiology', '*Renal Dialysis', 'Risk Factors', 'Severity of Illness Index', 'Vascular Diseases/etiology']",2005/02/09 09:00,2005/07/20 09:00,['2005/02/09 09:00'],"['2005/02/09 09:00 [pubmed]', '2005/07/20 09:00 [medline]', '2005/02/09 09:00 [entrez]']",,ppublish,"Nefrologia. 2004;24 Suppl(6):142-60, 187-235.",6,,,,,,,,,,1583,,,,,Enfermedad cardiovascular en pacientes con estadios 4 y 5 de enfermedad renal cronica. Pacientes en dialisis cronica.,,,,,,
18228669,NLM,MEDLINE,20080701,20080129,0211-6995 (Print) 0211-6995 (Linking),27 Suppl 6,2007,[Inflammation and morbidity-mortality: for and against].,1-6,,"['Fernandez-Andrade, C']",['Fernandez-Andrade C'],"['Servicio de Nefrologia, Hospital Virgen del Rocio, Sevilla, Espana. Atecsa@terra.es']",['spa'],"['Journal Article', 'Review']",,Spain,Nefrologia,Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,8301215,IM,"['C-Reactive Protein/analysis/physiology', 'Cardiovascular Diseases/blood/complications/*immunology/mortality', 'Humans', 'Inflammation']",2008/01/30 09:00,2008/07/02 09:00,['2008/01/30 09:00'],"['2008/01/30 09:00 [pubmed]', '2008/07/02 09:00 [medline]', '2008/01/30 09:00 [entrez]']",,ppublish,Nefrologia. 2007;27 Suppl 6:1-6.,,,,,,,,,['9007-41-4 (C-Reactive Protein)'],,74,,,,,Inflamacion y morbimortalidad: turno a favor y en contra.,,,,,,
4236304,NLM,MEDLINE,19690222,20091111,0029-8573 (Print) 0029-8573 (Linking),29,1967 Nov,[Cardiovascular damage].,504-11,,"['Kleinschmidt, A']",['Kleinschmidt A'],,['ger'],['Journal Article'],,Germany,Offentl Gesundheitswes,Das Offentliche Gesundheitswesen,0107170,IM,"['Adolescent', 'Adult', 'Aged', 'Arteriosclerosis Obliterans/epidemiology', 'Cardiovascular Diseases/diagnosis/*epidemiology/etiology/prevention & control', 'Coronary Disease/epidemiology', 'Disability Evaluation', 'Female', 'Germany, West', 'Humans', 'Hypertension/epidemiology', 'Male', 'Middle Aged', 'Myocardial Infarction/epidemiology', 'Stress, Physiological', 'Switzerland', 'United States']",1967/11/01 00:00,1967/11/01 00:01,['1967/11/01 00:00'],"['1967/11/01 00:00 [pubmed]', '1967/11/01 00:01 [medline]', '1967/11/01 00:00 [entrez]']",,ppublish,Offentl Gesundheitswes. 1967 Nov;29(11):504-11.,11,,,,,,,,,,,,,,,Herz- und Kreislaufschaden.,,,,,,
18386601,NLM,MEDLINE,20080507,20080404,1220-4749 (Print) 1220-4749 (Linking),44,2006,Therapeutical perspectives for apoptosis modulation in cardiovascular disease.,213-22,,"['Ginghina, Carmen', 'Craciunescu, Ileana', 'Iorga, V']","['Ginghina C', 'Craciunescu I', 'Iorga V']","['C.C. Iliescu Institute of Cardiovascular Diseases, Bucharest, Romania. ginghina@astral.ro']",['eng'],"['Journal Article', 'Review']",,Germany,Rom J Intern Med,Romanian journal of internal medicine = Revue roumaine de medecine interne,9304507,IM,"['Apoptosis/*drug effects', 'Cardiovascular Agents/*pharmacology/therapeutic use', 'Cardiovascular Diseases/*drug therapy/etiology/pathology', 'Humans']",2008/04/05 09:00,2008/05/08 09:00,['2008/04/05 09:00'],"['2008/04/05 09:00 [pubmed]', '2008/05/08 09:00 [medline]', '2008/04/05 09:00 [entrez]']",,ppublish,Rom J Intern Med. 2006;44(3):213-22.,3,"Apoptosis, or programmed cell death, is an active form of cell death, distinct from necrosis, through which multicellular organisms dispose of cells efficiently. Implication of apoptosis in the initiation and progression of many cardiovascular diseases, such as heart failure, systemic hypertension, coronary artery disease, has raised the possibility to elaborate new classes of medication to modulate this process. We review the most important drugs used in cardiovascular diseases and their interference with apoptosis, demonstrated by clinical studies as well as the involved mechanisms. We also analyze new molecules which protect cells from apoptosis and may therefore be clinically useful, as a new class of medication.",,,,,,,['0 (Cardiovascular Agents)'],,23,,,,,,,,,,,
12015933,NLM,MEDLINE,20020911,20190916,0300-8932 (Print) 0300-8932 (Linking),55,2002 May,[Diabetes and cardiovascular disease. A comprehensive insight to the new epidemic of the 21st century].,525-7,,"['Bosch, Xavier', 'Alfonso, Fernando', 'Bermejo, Javier']","['Bosch X', 'Alfonso F', 'Bermejo J']","['Revista Espanola de Cardiologia, Spain.']",['spa'],"['Journal Article', 'Review']",,Spain,Rev Esp Cardiol,Revista espanola de cardiologia,0404277,IM,"['Cardiovascular Diseases/epidemiology/*etiology/pathology/prevention & control', '*Diabetes Complications', 'Diabetes Mellitus/epidemiology/pathology', 'Diabetic Angiopathies/pathology', 'Humans']",2002/05/23 10:00,2002/09/12 10:01,['2002/05/23 10:00'],"['2002/05/23 10:00 [pubmed]', '2002/09/12 10:01 [medline]', '2002/05/23 10:00 [entrez]']","['13031153 [pii]', '10.1016/s0300-8932(02)76645-1 [doi]']",ppublish,Rev Esp Cardiol. 2002 May;55(5):525-7. doi: 10.1016/s0300-8932(02)76645-1.,5,,,,,,,,,,15,,,,,Diabetes y enfermedad cardiovascular. Una mirada hacia la nueva epidemia del siglo XXI.,,,,,,
19851344,NLM,MEDLINE,20100107,20211020,1759-5010 (Electronic) 1759-5002 (Linking),6,2009 Nov,The CVD paradox: mortality vs prevalence.,669,10.1038/nrcardio.2009.187 [doi],"['Fuster, Valentin', 'Mearns, Bryony M']","['Fuster V', 'Mearns BM']",,['eng'],['Editorial'],,England,Nat Rev Cardiol,Nature reviews. Cardiology,101500075,IM,"['Cardiovascular Diseases/economics/*epidemiology/mortality/prevention & control', 'Health Care Costs', 'Humans', 'Prevalence', 'Preventive Health Services', 'Risk Assessment', 'Risk Factors', 'Risk Reduction Behavior', 'Time Factors']",2009/10/24 06:00,2010/01/08 06:00,['2009/10/24 06:00'],"['2009/10/24 06:00 [entrez]', '2009/10/24 06:00 [pubmed]', '2010/01/08 06:00 [medline]']","['nrcardio.2009.187 [pii]', '10.1038/nrcardio.2009.187 [doi]']",ppublish,Nat Rev Cardiol. 2009 Nov;6(11):669. doi: 10.1038/nrcardio.2009.187.,11,,,,,,,,,,,,,,,,,,,,,
15802327,NLM,MEDLINE,20051222,20130523,0903-1936 (Print) 0903-1936 (Linking),25,2005 Apr,Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?,587-8,,"['Sunyer, J', 'Ulrik, C S']","['Sunyer J', 'Ulrik CS']",,['eng'],"['Comment', 'Editorial']",,England,Eur Respir J,The European respiratory journal,8803460,IM,"['Cardiovascular Diseases/etiology/*mortality/physiopathology/prevention & control', 'Cause of Death', '*Forced Expiratory Volume', 'Humans', 'Physical Fitness', 'Predictive Value of Tests', 'Smoking/adverse effects']",2005/04/02 09:00,2005/12/24 09:00,['2005/04/02 09:00'],"['2005/04/02 09:00 [pubmed]', '2005/12/24 09:00 [medline]', '2005/04/02 09:00 [entrez]']","['25/4/587 [pii]', '10.1183/09031936.05.00011105 [doi]']",ppublish,Eur Respir J. 2005 Apr;25(4):587-8. doi: 10.1183/09031936.05.00011105.,4,,,,,,,,,,,['Eur Respir J. 2005 Apr;25(4):618-25. PMID: 15802334'],,,,,,,,,,
20862484,NLM,MEDLINE,20110222,20101004,1435-1250 (Electronic) 0340-1855 (Linking),69,2010 Oct,[Cardiovascular complications and therapeutic strategy].,678-9,10.1007/s00393-009-0581-9 [doi],"['Schneider, M', 'Muller-Ladner, U']","['Schneider M', 'Muller-Ladner U']","['Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Heinrich-Heine-Universitat Dusseldorf, Deutschland. schneiderm@med.uni-duesseldorf.de']",['ger'],['Introductory Journal Article'],,Germany,Z Rheumatol,Zeitschrift fur Rheumatologie,0414162,IM,"['Cardiovascular Diseases/*complications/diagnosis/*therapy', 'Humans', 'Rheumatic Diseases/*complications/diagnosis/*therapy']",2010/09/24 06:00,2011/02/23 06:00,['2010/09/24 06:00'],"['2010/09/24 06:00 [entrez]', '2010/09/24 06:00 [pubmed]', '2011/02/23 06:00 [medline]']",['10.1007/s00393-009-0581-9 [doi]'],ppublish,Z Rheumatol. 2010 Oct;69(8):678-9. doi: 10.1007/s00393-009-0581-9.,8,,,,,,,,,,,,,,,Kardiovaskulare Komplikationen und Therapiestrategien.,,,,,,
7829816,NLM,MEDLINE,19950217,20170202,0098-8421 (Print) 0098-8421 (Linking),49,1994 Nov-Dec,Cardiovascular disease in women.,180,,"['Judelson, D R']",['Judelson DR'],,['eng'],['Editorial'],,United States,J Am Med Womens Assoc (1972),Journal of the American Medical Women's Association (1972),7503064,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Counseling', 'Female', 'Humans', 'Risk Factors', 'Sex Factors', ""*Women's Health""]",1994/11/01 00:00,1994/11/01 00:01,['1994/11/01 00:00'],"['1994/11/01 00:00 [pubmed]', '1994/11/01 00:01 [medline]', '1994/11/01 00:00 [entrez]']",,ppublish,J Am Med Womens Assoc (1972). 1994 Nov-Dec;49(6):180.,6,,,,,,,,,,,,,,,,,,,,,
16386685,NLM,MEDLINE,20060327,20061220,1558-3597 (Electronic) 0735-1097 (Linking),47,2006 Jan 3,Highlights of the Year in JACC 2005.,184-202,,"['Demaria, Anthony N', 'Ben-Yehuda, Ori', 'Berman, Daniel', 'Feld, Gregory K', 'Ginsberg, Jeffrey', 'Greenberg, Barry H', 'Lew, Wilbur Y W', 'Sahn, David', 'Tsimikas, Sotirios']","['Demaria AN', 'Ben-Yehuda O', 'Berman D', 'Feld GK', 'Ginsberg J', 'Greenberg BH', 'Lew WY', 'Sahn D', 'Tsimikas S']","['Cardiology Division, University of California-San Diego, San Diego, California.']",['eng'],"['Journal Article', 'Review']",20051215,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Animals', 'Cardiology/*trends', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Humans']",2006/01/03 09:00,2006/12/21 09:00,['2006/01/03 09:00'],"['2005/11/11 00:00 [received]', '2005/11/11 00:00 [accepted]', '2006/01/03 09:00 [pubmed]', '2006/12/21 09:00 [medline]', '2006/01/03 09:00 [entrez]']","['S0735-1097(05)02722-1 [pii]', '10.1016/j.jacc.2005.11.020 [doi]']",ppublish,J Am Coll Cardiol. 2006 Jan 3;47(1):184-202. doi: 10.1016/j.jacc.2005.11.020. Epub 2005 Dec 15.,1,,,,,,,,,,124,,,,,,,,,,,
22386287,NLM,MEDLINE,20120423,20130502,1873-1740 (Electronic) 0033-0620 (Linking),54,2012 Mar-Apr,Introduction. Cardiovascular care of the athletic patient.,379,10.1016/j.pcad.2012.02.002 [doi],"['Baggish, Aaron L', 'Thompson, Paul D']","['Baggish AL', 'Thompson PD']",,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Adaptation, Physiological', '*Athletes', 'Cardiovascular Diseases/diagnosis/etiology/physiopathology/*therapy', '*Exercise', 'Humans', 'Physical Endurance', 'Ventricular Remodeling']",2012/03/06 06:00,2012/04/24 06:00,['2012/03/06 06:00'],"['2012/03/06 06:00 [entrez]', '2012/03/06 06:00 [pubmed]', '2012/04/24 06:00 [medline]']","['S0033-0620(12)00011-4 [pii]', '10.1016/j.pcad.2012.02.002 [doi]']",ppublish,Prog Cardiovasc Dis. 2012 Mar-Apr;54(5):379. doi: 10.1016/j.pcad.2012.02.002.,5,,,,,,,,,,,,,,,,,,,,,
22296190,NLM,MEDLINE,20120525,20151119,1752-0371 (Electronic) 1752-0363 (Linking),6,2012 Feb,Inflammation and related biomarkers in cardiovascular disease.,1-3,10.2217/bmm.12.3 [doi],"['Bartunek, Jozef', 'Vanderheyden, Marc']","['Bartunek J', 'Vanderheyden M']","['Cardiovascular Center, OLV Ziekenhuis, Aalst, Belgium. jozef.bartunek@olvz-aalst.be']",['eng'],['Introductory Journal Article'],,England,Biomark Med,Biomarkers in medicine,101312535,IM,"['Biomarkers/metabolism', 'Cardiovascular Diseases/*complications/*metabolism/pathology/therapy', 'Humans', 'Inflammation/complications/metabolism/pathology', 'Risk Factors']",2012/02/03 06:00,2012/05/26 06:00,['2012/02/03 06:00'],"['2012/02/03 06:00 [entrez]', '2012/02/03 06:00 [pubmed]', '2012/05/26 06:00 [medline]']",['10.2217/bmm.12.3 [doi]'],ppublish,Biomark Med. 2012 Feb;6(1):1-3. doi: 10.2217/bmm.12.3.,1,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
12402410,NLM,MEDLINE,20030221,20181113,1080-0549 (Print) 1080-0549 (Linking),23,2002 Dec,Are cardiovascular diseases a subspeciality of clinical immunology?,243-5,,"['Meroni, Pier Luigi', 'Riboldi, Piersandro']","['Meroni PL', 'Riboldi P']","['Allergy & Clinical Immunology Unit, Department of Internal Medicine, University of Milan, IRCCS Istituto Auxologico Italiano, Milan, Italy.']",['eng'],['Journal Article'],,United States,Clin Rev Allergy Immunol,Clinical reviews in allergy & immunology,9504368,IM,"['*Allergy and Immunology', 'Cardiovascular Diseases/epidemiology/*immunology/therapy', '*Clinical Medicine', 'Humans', '*Medicine/classification', '*Specialization']",2002/10/31 04:00,2003/02/22 04:00,['2002/10/31 04:00'],"['2002/10/31 04:00 [pubmed]', '2003/02/22 04:00 [medline]', '2002/10/31 04:00 [entrez]']","['CRIAI:23:3:243 [pii]', '10.1385/CRIAI:23:3:243 [doi]']",ppublish,Clin Rev Allergy Immunol. 2002 Dec;23(3):243-5. doi: 10.1385/CRIAI:23:3:243.,3,,,,,,,,,,,,,,,,,,,,,
27841906,NLM,MEDLINE,20170227,20170817,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),27,2016 Jul/Aug,From the Editor's Desk.,207,,"['Commerford, P J']",['Commerford PJ'],['Editor-in-Chief.'],['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Humans']",2016/11/15 06:00,2017/02/28 06:00,['2016/11/15 06:00'],"['2016/11/15 06:00 [entrez]', '2016/11/15 06:00 [pubmed]', '2017/02/28 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2016 Jul/Aug;27(4):207.,4,,,PMC5340895,,,,,,,,,,,,,,,,,,
27841897,NLM,MEDLINE,20170227,20170817,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),27,2016 May/Jun,From the Editor's Desk.,127,,"['Commerford, P J']",['Commerford PJ'],['Editor-in-Chief.'],['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/genetics/physiopathology/therapy', 'Humans']",2016/11/15 06:00,2017/02/28 06:00,['2016/11/15 06:00'],"['2016/11/15 06:00 [entrez]', '2016/11/15 06:00 [pubmed]', '2017/02/28 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2016 May/Jun;27(3):127.,3,,,PMC5101429,,,,,,,,,,,,,,,,,,
22153579,NLM,MEDLINE,20120412,20111213,1879-1336 (Electronic) 1054-8807 (Linking),21,2012 Jan-Feb,Looking forward for Cardiovascular Pathology.,1,10.1016/j.carpath.2011.11.006 [doi],"['Buja, L Maximilian']",['Buja LM'],,['eng'],['Editorial'],,United States,Cardiovasc Pathol,Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology,9212060,IM,"['Cardiovascular Diseases/etiology/*pathology/therapy', 'Humans', '*Periodicals as Topic', 'Publishing/*organization & administration', 'Societies, Medical']",2011/12/14 06:00,2012/04/13 06:00,['2011/12/14 06:00'],"['2011/11/04 00:00 [received]', '2011/11/07 00:00 [revised]', '2011/11/07 00:00 [accepted]', '2011/12/14 06:00 [entrez]', '2011/12/14 06:00 [pubmed]', '2012/04/13 06:00 [medline]']","['S1054-8807(11)00138-4 [pii]', '10.1016/j.carpath.2011.11.006 [doi]']",ppublish,Cardiovasc Pathol. 2012 Jan-Feb;21(1):1. doi: 10.1016/j.carpath.2011.11.006.,1,,,,,,,,,,,,,,,,,,,,,
29860927,NLM,MEDLINE,20181126,20181202,1753-9455 (Electronic) 1753-9447 (Print) 1753-9447 (Linking),12,2018 Aug,Conference report: the 67th American College of Cardiology conference.,203-206,10.1177/1753944718778464 [doi],"['Conroy, Elena']",['Conroy E'],"[""SAGE Publishing, 1 Oliver's Yard, 55 City Road, London, EC1Y 1SP, UK.""]",['eng'],"['Congress', 'Editorial']",20180604,England,Ther Adv Cardiovasc Dis,Therapeutic advances in cardiovascular disease,101316343,IM,"['*Biomedical Research', '*Cardiology', 'Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/*therapy', 'Humans', 'Treatment Outcome']",2018/06/05 06:00,2018/11/27 06:00,['2018/06/05 06:00'],"['2018/06/05 06:00 [pubmed]', '2018/11/27 06:00 [medline]', '2018/06/05 06:00 [entrez]']","['10.1177_1753944718778464 [pii]', '10.1177/1753944718778464 [doi]']",ppublish,Ther Adv Cardiovasc Dis. 2018 Aug;12(8):203-206. doi: 10.1177/1753944718778464. Epub 2018 Jun 4.,8,,['ORCID: 0000-0001-9606-8883'],PMC6041875,,,,,,,,,,,,,,,,,,
29952182,NLM,MEDLINE,20180816,20180816,0342-9601 (Print) 0342-9601 (Linking),40,2017 Apr,[In process].,178-80,,"['Verspohl, Eugen J']",['Verspohl EJ'],,['ger'],['Journal Article'],,Germany,Med Monatsschr Pharm,Medizinische Monatsschrift fur Pharmazeuten,7802665,IM,"['Cardiovascular Diseases/complications/epidemiology/prevention & control/*therapy', 'Humans', 'Migraine Disorders/complications/epidemiology/*therapy']",2017/04/01 00:00,2018/08/17 06:00,['2018/06/29 06:00'],"['2018/06/29 06:00 [entrez]', '2017/04/01 00:00 [pubmed]', '2018/08/17 06:00 [medline]']",,ppublish,Med Monatsschr Pharm. 2017 Apr;40(4):178-80.,4,,,,,,,,,,,,,,,Migranepatienten sind verstarkt Herz-Kreislauf-Erkrankungen ausgesetzt.,,,,,,
4658657,NLM,MEDLINE,19730608,20071115,0010-0978 (Print) 0010-0978 (Linking),13,1972 Dec 30,[Cardiothyrosis].,1227-33,,"['Pernod, J', 'Fromantin, M']","['Pernod J', 'Fromantin M']",,['fre'],['Journal Article'],,France,Cah Med,Les Cahiers de medecine,0242654,IM,"['Arrhythmias, Cardiac/etiology', 'Cardiac Output', 'Cardiovascular Diseases/*etiology/physiopathology/therapy', 'Coronary Disease/etiology', 'Heart Failure/etiology', 'Heart Function Tests', 'Hemodynamics', 'Humans', 'Hyperthyroidism/*complications/physiopathology/therapy']",1972/12/30 00:00,1972/12/30 00:01,['1972/12/30 00:00'],"['1972/12/30 00:00 [pubmed]', '1972/12/30 00:01 [medline]', '1972/12/30 00:00 [entrez]']",,ppublish,Cah Med. 1972 Dec 30;13(17):1227-33.,17,,,,,,,,,,,,,,,Les cardiothyreoses.,,,,,,
34179949,NLM,MEDLINE,20211115,20220103,1755-3245 (Electronic) 0008-6363 (Linking),117,2021 Jul 7,Fish and cardiovascular disease prevention: time for a closer collaboration between basic science and clinical research.,e94-e96,10.1093/cvr/cvab186 [doi],"['Panagiotakos, Demosthenes B', 'Kouvari, Matina']","['Panagiotakos DB', 'Kouvari M']","['Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.', 'Discipline of Nutrition and Dietetics, Faculty of Health, University of Canberra, Canberra, Australia.', 'Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.', 'Discipline of Nutrition and Dietetics, Faculty of Health, University of Canberra, Canberra, Australia.']",['eng'],"['Comment', 'Journal Article']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Animals', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Research']",2021/06/29 06:00,2021/11/16 06:00,['2021/06/28 06:17'],"['2021/06/29 06:00 [pubmed]', '2021/11/16 06:00 [medline]', '2021/06/28 06:17 [entrez]']","['6310338 [pii]', '10.1093/cvr/cvab186 [doi]']",ppublish,Cardiovasc Res. 2021 Jul 7;117(8):e94-e96. doi: 10.1093/cvr/cvab186.,8,,['ORCID: 0000-0002-1558-194X'],,,,,,,,,['JAMA Intern Med. 2021 May 1;181(5):631-649. PMID: 33683310'],,,,,,,,,,
20863999,NLM,MEDLINE,20110215,20151119,1879-1972 (Electronic) 1054-139X (Linking),47,2010 Oct,Are we there yet? Pediatric screening for inflammatory biomarkers and low cardiorespiratory fitness to identify youth at increased risk of cardiovascular disease.,319-21,10.1016/j.jadohealth.2010.07.026 [doi],"['Magnussen, Costan G', 'Raitakari, Olli T']","['Magnussen CG', 'Raitakari OT']",,['eng'],"['Comment', 'Editorial']",,United States,J Adolesc Health,The Journal of adolescent health : official publication of the Society for Adolescent Medicine,9102136,IM,"['Adolescent', 'Biomarkers/analysis/metabolism', 'Cardiovascular Diseases/diagnosis/etiology/metabolism/*prevention & control', 'Child', 'Humans', 'Inflammation/*metabolism', 'Mass Screening', 'Risk Factors']",2010/09/25 06:00,2011/02/16 06:00,['2010/09/25 06:00'],"['2010/07/30 00:00 [received]', '2010/07/30 00:00 [accepted]', '2010/09/25 06:00 [entrez]', '2010/09/25 06:00 [pubmed]', '2011/02/16 06:00 [medline]']","['S1054-139X(10)00383-6 [pii]', '10.1016/j.jadohealth.2010.07.026 [doi]']",ppublish,J Adolesc Health. 2010 Oct;47(4):319-21. doi: 10.1016/j.jadohealth.2010.07.026.,4,,,,,,,,['0 (Biomarkers)'],,,"['J Adolesc Health. 2010 Oct;47(4):346-51. PMID: 20864003', 'J Adolesc Health. 2010 Oct;47(4):352-9. PMID: 20864004']",,,,,,,,,,
8417409,NLM,MEDLINE,19930126,20190830,0031-3955 (Print) 0031-3955 (Linking),40,1993 Feb,Cardiovascular manifestations of hypertension in children.,51-9,,"['Finta, K M']",['Finta KM'],"['Department of Pediatric Cardiology, University of Michigan, Ann Arbor.']",['eng'],"['Journal Article', 'Review']",,United States,Pediatr Clin North Am,Pediatric clinics of North America,0401126,IM,"['Cardiovascular Diseases/*etiology/pathology/physiopathology', 'Child', 'Electrocardiography', 'Exercise Test', 'Humans', 'Hypertension/*complications/pathology/physiopathology']",1993/02/01 00:00,1993/02/01 00:01,['1993/02/01 00:00'],"['1993/02/01 00:00 [pubmed]', '1993/02/01 00:01 [medline]', '1993/02/01 00:00 [entrez]']","['S0031-3955(16)38480-2 [pii]', '10.1016/s0031-3955(16)38480-2 [doi]']",ppublish,Pediatr Clin North Am. 1993 Feb;40(1):51-9. doi: 10.1016/s0031-3955(16)38480-2.,1,"Hypertension has its roots in childhood. Electrocardiographic, echocardiographic, and exercise testing in young patients point to early abnormalities of cardiovascular status in children with early hypertensive disease. Altered morphology of the cardiovascular system and vascular reactivity is also seen in the hypertensive or prehypertensive child. Perhaps investigation and preventive tactics may be best applied to the pediatric population.",,,,,,,,,36,,,,,,,,,,,
26659433,NLM,MEDLINE,20160919,20160322,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),26,2015 Nov-Dec,From the Editor's Desk.,203,,"['Commerford, P J']",['Commerford PJ'],"['Professor Emeritus, Senior Scholar, Cardiac Clinic, Department of Medicine, University of Cape Town. editor@clinicscardive.com.']",['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['Africa', 'Animals', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans']",2015/12/15 06:00,2016/09/20 06:00,['2015/12/15 06:00'],"['2015/12/15 06:00 [entrez]', '2015/12/15 06:00 [pubmed]', '2016/09/20 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2015 Nov-Dec;26(6):203.,6,,,PMC4779935,,,,,,,,,,,,,,,,,,
11973236,NLM,MEDLINE,20020516,20190704,0003-2999 (Print) 0003-2999 (Linking),94,2002 May,Guidelines on perioperative cardiovascular evaluation: what have we learned over the past 6 years to warrant an update?,1378-9,,"['Fleisher, Lee A', 'Eagle, Kim A']","['Fleisher LA', 'Eagle KA']",,['eng'],"['Comment', 'Editorial']",,United States,Anesth Analg,Anesthesia and analgesia,1310650,IM,"['Cardiovascular Diseases/complications/*physiopathology/therapy', 'Coronary Disease/*prevention & control', '*Heart Function Tests', 'Humans', '*Perioperative Care', '*Practice Guidelines as Topic']",2002/04/26 10:00,2002/05/17 10:01,['2002/04/26 10:00'],"['2002/04/26 10:00 [pubmed]', '2002/05/17 10:01 [medline]', '2002/04/26 10:00 [entrez]']",['10.1097/00000539-200205000-00087 [doi]'],ppublish,Anesth Analg. 2002 May;94(5):1378-9. doi: 10.1097/00000539-200205000-00087.,5,,,,,,,,,,,['Anesth Analg. 2002 May;94(5):1052-64. PMID: 11973163'],,,,,,,,,,
23303765,NLM,MEDLINE,20140109,20130513,1873-1953 (Electronic) 1474-5151 (Linking),12,2013 Jun,Motivational interviewing as a brief intervention to improve cardiovascular health.,226-9,10.1177/1474515112472271 [doi],"['Ski, Chantal F', 'Thompson, David R']","['Ski CF', 'Thompson DR']",,['eng'],['Editorial'],20130109,England,Eur J Cardiovasc Nurs,European journal of cardiovascular nursing,101128793,IM,"['Cardiovascular Diseases/mortality/psychology/*therapy', 'Humans', '*Motivational Interviewing']",2013/01/11 06:00,2014/01/10 06:00,['2013/01/11 06:00'],"['2013/01/11 06:00 [entrez]', '2013/01/11 06:00 [pubmed]', '2014/01/10 06:00 [medline]']","['1474515112472271 [pii]', '10.1177/1474515112472271 [doi]']",ppublish,Eur J Cardiovasc Nurs. 2013 Jun;12(3):226-9. doi: 10.1177/1474515112472271. Epub 2013 Jan 9.,3,,,,,,,,,,,,,,,,,,,,,
33574131,NLM,MEDLINE,20210217,20210825,1468-201X (Electronic) 1355-6037 (Linking),107,2021 Mar,Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular disease.,345-347,10.1136/heartjnl-2021-319052 [doi],"['Otto, Catherine M']",['Otto CM'],"['Division of Cardiology, University of Washington, Seattle, WA 98195, USA cmotto@uw.edu.']",['eng'],"['Comment', 'Journal Article']",,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*COVID-19', '*Cardiovascular Diseases/diagnosis/epidemiology/etiology', 'Heart Rate', 'Humans', 'SARS-CoV-2', '*Tricuspid Valve Insufficiency']",2021/02/13 06:00,2021/02/18 06:00,['2021/02/12 05:53'],"['2021/02/12 05:53 [entrez]', '2021/02/13 06:00 [pubmed]', '2021/02/18 06:00 [medline]']","['heartjnl-2021-319052 [pii]', '10.1136/heartjnl-2021-319052 [doi]']",ppublish,Heart. 2021 Mar;107(5):345-347. doi: 10.1136/heartjnl-2021-319052.,5,,['ORCID: 0000-0002-0527-9392'],,['Competing interests: None declared.'],['NOTNLM'],['COVID-19'],,,,,"['Heart. 2021 Mar;107(5):403-410. PMID: 33139325', 'Heart. 2021 Mar;107(5):358-365. 1 Mar;107(5):358-365. PMID: 33452116']",,,,,,,,,,
9396200,NLM,MEDLINE,19980108,20080215,0023-9852 (Print) 0023-9852 (Linking),45,1997,Cardiovascular disease in the elderly.,148-54,,"['Alam, S', 'Abou-Khamis, A']","['Alam S', 'Abou-Khamis A']","['Department of Medicine, American University Hospital, Beirut.']",['eng'],"['Journal Article', 'Review']",,Lebanon,J Med Liban,Le Journal medical libanais. The Lebanese medical journal,0375352,IM,"['Age Distribution', 'Age Factors', 'Aged', 'Cardiovascular Diseases/*diagnosis/epidemiology/etiology/*therapy', 'Cause of Death', 'Humans', 'Risk Factors']",1997/01/01 00:00,1997/12/13 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/12/13 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,J Med Liban. 1997;45(3):148-54.,3,,,,,,,,,,44,,,,,,,,,,,
29800378,NLM,MEDLINE,20190813,20190813,1755-3245 (Electronic) 0008-6363 (Linking),114,2018 Jun 1,Recognizing young investigators at Frontiers in Cardiovascular Biology 2018.,e53-e55,10.1093/cvr/cvy102 [doi],"['Small, Heather Y']",['Small HY'],"['BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.']",['eng'],"['Comparative Study', 'Journal Article']",,England,Cardiovasc Res,Cardiovascular research,0077427,,"['Animals', '*Awards and Prizes', '*Biomedical Research', 'Cardiology/*methods', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Humans', '*Research Personnel']",2018/05/26 06:00,2019/08/14 06:00,['2018/05/26 06:00'],"['2018/05/26 06:00 [entrez]', '2018/05/26 06:00 [pubmed]', '2019/08/14 06:00 [medline]']","['5001819 [pii]', '10.1093/cvr/cvy102 [doi]']",ppublish,Cardiovasc Res. 2018 Jun 1;114(7):e53-e55. doi: 10.1093/cvr/cvy102.,7,,,,,,,,,,,,,,['FCVB Young Investigators'],,,,,,,
28808147,NLM,MEDLINE,20190128,20190128,1524-4539 (Electronic) 0009-7322 (Linking),136,2017 Aug 15,Eleventh Oriental Congress of Cardiology.,687-688,10.1161/CIRCULATIONAHA.117.030018 [doi],"['Ge, Junbo']",['Ge J'],"['From Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China. ge.junbo@zs-hospital.sh.cn.']",['eng'],['Congress'],,United States,Circulation,Circulation,0147763,IM,"['Animals', 'Biomedical Research/*methods', 'Cardiology/*methods', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Humans']",2017/08/16 06:00,2019/01/29 06:00,['2017/08/16 06:00'],"['2017/08/16 06:00 [entrez]', '2017/08/16 06:00 [pubmed]', '2019/01/29 06:00 [medline]']","['CIRCULATIONAHA.117.030018 [pii]', '10.1161/CIRCULATIONAHA.117.030018 [doi]']",ppublish,Circulation. 2017 Aug 15;136(7):687-688. doi: 10.1161/CIRCULATIONAHA.117.030018.,7,,,,,,,,,,,,,,,,,,,,,
15356942,NLM,MEDLINE,20041102,20141120,0042-9686 (Print) 0042-9686 (Linking),82,2004 Jun,Cardiovascular disease--a global health time bomb.,470-1,,"['Fleck, Fiona']",['Fleck F'],,['eng'],['News'],,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,IM,"['Cardiovascular Diseases/*epidemiology/mortality/prevention & control', '*Global Health', 'Humans', 'Time Factors']",2004/09/11 05:00,2004/11/04 09:00,['2004/09/11 05:00'],"['2004/09/11 05:00 [pubmed]', '2004/11/04 09:00 [medline]', '2004/09/11 05:00 [entrez]']",,ppublish,Bull World Health Organ. 2004 Jun;82(6):470-1.,6,,,PMC2622865,,,,,,,,,,,,,,,,,,
1286896,NLM,MEDLINE,19930317,20051116,0019-6061 (Print) 0019-6061 (Linking),29,1992 Oct,Cardiovascular complications of enteric fever.,1319-22,,"['Singh, S', 'Singhi, S']","['Singh S', 'Singhi S']","['Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh.']",['eng'],"['Journal Article', 'Review']",,India,Indian Pediatr,Indian pediatrics,2985062R,IM,"['Cardiovascular Diseases/diagnosis/*etiology/therapy', 'Child', 'Humans', 'Typhoid Fever/*complications']",1992/10/01 00:00,1992/10/01 00:01,['1992/10/01 00:00'],"['1992/10/01 00:00 [pubmed]', '1992/10/01 00:01 [medline]', '1992/10/01 00:00 [entrez]']",,ppublish,Indian Pediatr. 1992 Oct;29(10):1319-22.,10,,,,,,,,,,20,,,,,,,,,,,
31530192,NLM,MEDLINE,20200921,20200921,2047-4881 (Electronic) 2047-4873 (Linking),26,2019 Oct,"Editor's presentation: 'You say you love your children above all else, and yet you are stealing their future in front of their very eyes'.",1575-1577,10.1177/2047487319873844 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, G da Saliceto Hospital, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/*prevention & control', 'Exercise Test', '*Health Behavior', 'Health Status', '*Healthy Lifestyle', 'Humans', 'Resistance Training', 'Risk Factors', '*Risk Reduction Behavior']",2019/09/19 06:00,2020/09/22 06:00,['2019/09/19 06:00'],"['2019/09/19 06:00 [entrez]', '2019/09/19 06:00 [pubmed]', '2020/09/22 06:00 [medline]']",['10.1177/2047487319873844 [doi]'],ppublish,Eur J Prev Cardiol. 2019 Oct;26(15):1575-1577. doi: 10.1177/2047487319873844.,15,,,,,,,,,,,,,,,,,,,,,
26413011,NLM,MEDLINE,20160711,20161018,1526-6702 (Electronic) 0730-2347 (Print) 0730-2347 (Linking),42,2015 Aug,Mother and the Bicycle.,308,10.14503/THIJ-15-5140 [doi],"['Korompai, Ferenc L']",['Korompai FL'],,['eng'],['Journal Article'],20150801,United States,Tex Heart Inst J,Texas Heart Institute journal,8214622,IM,"['*Attitude of Health Personnel', '*Bicycling', 'Cardiovascular Diseases/diagnosis/physiopathology/*psychology/therapy', 'Emotions', '*Health Knowledge, Attitudes, Practice', 'Humans', '*Mother-Child Relations', 'Physicians/*psychology', 'Quality of Life']",2015/09/29 06:00,2016/07/12 06:00,['2015/09/29 06:00'],"['2015/09/29 06:00 [entrez]', '2015/09/29 06:00 [pubmed]', '2016/07/12 06:00 [medline]']",['10.14503/THIJ-15-5140 [doi]'],epublish,Tex Heart Inst J. 2015 Aug 1;42(4):308. doi: 10.14503/THIJ-15-5140. eCollection 2015 Aug.,4,,,PMC4567108,,,,,,,,,,,,,,,,,,
11071796,NLM,MEDLINE,20010308,20181130,0195-668X (Print) 0195-668X (Linking),21,2000 Dec,Clinical and research challenges in risk factors for cardiovascular diseases.,1917-21,,"['Hennekens, C H']",['Hennekens CH'],"['University of Miami School of Medicine, Miami, Florida, USA.']",['eng'],['Lecture'],,England,Eur Heart J,European heart journal,8006263,IM,"['Biomarkers', 'Cardiovascular Diseases/diagnosis/*mortality/*prevention & control', 'Developed Countries', 'Humans', '*Primary Prevention', 'Risk Factors']",2000/11/10 11:00,2001/03/10 10:01,['2000/11/10 11:00'],"['2000/11/10 11:00 [pubmed]', '2001/03/10 10:01 [medline]', '2000/11/10 11:00 [entrez]']","['S0195668X99922212 [pii]', '10.1053/euhj.1999.2221 [doi]']",ppublish,Eur Heart J. 2000 Dec;21(23):1917-21. doi: 10.1053/euhj.1999.2221.,23,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
18577879,NLM,MEDLINE,20090311,20081202,1421-9751 (Electronic) 0008-6312 (Linking),112,2009,Pleiotropic effects of statins and beyond.,1-3,10.1159/000137691 [doi],"['Lansberg, Peter']",['Lansberg P'],,['eng'],"['Comment', 'Editorial']",20080625,Switzerland,Cardiology,Cardiology,1266406,IM,"['Cardiovascular Diseases/*drug therapy/immunology/metabolism', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use']",2008/06/26 09:00,2009/03/12 09:00,['2008/06/26 09:00'],"['2008/04/22 00:00 [received]', '2008/04/22 00:00 [accepted]', '2008/06/26 09:00 [pubmed]', '2009/03/12 09:00 [medline]', '2008/06/26 09:00 [entrez]']","['000137691 [pii]', '10.1159/000137691 [doi]']",ppublish,Cardiology. 2009;112(1):1-3. doi: 10.1159/000137691. Epub 2008 Jun 25.,1,,,,,,,,['0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors)'],,,['Cardiology. 2009;112(1):4-12. PMID: 18577880'],,,,,,,,,,
16287795,NLM,MEDLINE,20051128,20190619,1539-3704 (Electronic) 0003-4819 (Linking),143,2005 Nov 15,Update in cardiology.,737-43,,"['Stone, Peter H']",['Stone PH'],"[""Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. pstone@partners.org""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Cardiovascular Diseases/complications/prevention & control/*therapy', 'Humans', 'Risk Factors']",2005/11/17 09:00,2005/12/13 09:00,['2005/11/17 09:00'],"['2005/11/17 09:00 [pubmed]', '2005/12/13 09:00 [medline]', '2005/11/17 09:00 [entrez]']","['143/10/737 [pii]', '10.7326/0003-4819-143-10-200511150-00011 [doi]']",ppublish,Ann Intern Med. 2005 Nov 15;143(10):737-43. doi: 10.7326/0003-4819-143-10-200511150-00011.,10,,,,,,,,,,15,,,['Ann Intern Med. 2006 Feb 7;144(3):225; author reply 225-6. PMID: 16461978'],,,,,,['Ann Intern Med. 2006 Feb 7;144(3):227'],,
26867184,NLM,MEDLINE,20161026,20181202,1473-5598 (Electronic) 0263-6352 (Linking),34,2016 Apr,Prediction and prevention of hypertension-related events.,591-2,10.1097/HJH.0000000000000885 [doi],"['Zanchetti, Alberto']",['Zanchetti A'],"['aIstituto Auxologico Italiano bCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universita degli Studi di Milano, Milan, Italy.']",['eng'],['Introductory Journal Article'],,Netherlands,J Hypertens,Journal of hypertension,8306882,IM,"['*Cardiovascular Diseases/complications/epidemiology/prevention & control', 'Humans', '*Hypertension/complications/epidemiology']",2016/02/13 06:00,2016/10/27 06:00,['2016/02/12 06:00'],"['2016/02/12 06:00 [entrez]', '2016/02/13 06:00 [pubmed]', '2016/10/27 06:00 [medline]']",['10.1097/HJH.0000000000000885 [doi]'],ppublish,J Hypertens. 2016 Apr;34(4):591-2. doi: 10.1097/HJH.0000000000000885.,4,,,,,,,,,,,,,,,,,,,,,
24224165,NLM,MEDLINE,20140616,20211021,2314-6141 (Electronic) 2314-6133 (Print),2013,2013,Cardiometabolic diseases and related complications: current status and future perspective.,467682,10.1155/2013/467682 [doi] 467682,"['Ndisang, Joseph Fomusi', 'Rastogi, Sharad']","['Ndisang JF', 'Rastogi S']","['Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5.']",['eng'],['Journal Article'],20131009,United States,Biomed Res Int,BioMed research international,101600173,IM,"['Cardiovascular Diseases/complications/*mortality/pathology', 'Humans', 'Metabolic Diseases/complications/*pathology']",2013/11/14 06:00,2014/06/17 06:00,['2013/11/14 06:00'],"['2013/06/10 00:00 [received]', '2013/06/10 00:00 [accepted]', '2013/11/14 06:00 [entrez]', '2013/11/14 06:00 [pubmed]', '2014/06/17 06:00 [medline]']",['10.1155/2013/467682 [doi]'],ppublish,Biomed Res Int. 2013;2013:467682. doi: 10.1155/2013/467682. Epub 2013 Oct 9.,,,,PMC3809929,,,,,,,,,,,,,,,,,,
29293916,NLM,MEDLINE,20190520,20190520,1755-3245 (Electronic) 0008-6363 (Linking),114,2018 Jan 1,"Professor Charalambos Antoniades interviews Professor Tomasz Guzik, incoming Editor-in-Chief of Cardiovascular Research.",e10,10.1093/cvr/cvx232 [doi],"['Guzik, Tomasz']",['Guzik T'],,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait', 'Video-Audio Media']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/*history/immunology/metabolism/physiopathology', 'Editorial Policies', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Periodicals as Topic']",2018/01/03 06:00,2019/05/21 06:00,['2018/01/03 06:00'],"['2018/01/03 06:00 [entrez]', '2018/01/03 06:00 [pubmed]', '2019/05/21 06:00 [medline]']","['4775049 [pii]', '10.1093/cvr/cvx232 [doi]']",ppublish,Cardiovasc Res. 2018 Jan 1;114(1):e10. doi: 10.1093/cvr/cvx232.,1,,,,,,,,,,,,,,,,['Guzik T'],"['Guzik, Tomasz']",,,,
22089722,NLM,MEDLINE,20111207,20161017,1538-3598 (Electronic) 0098-7484 (Linking),306,2011 Nov 16,Cardiovascular science in the service of national strength.,2145-6,10.1001/jama.2011.1669 [doi],"['Lauer, Michael S']",['Lauer MS'],"['Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, 6701 Rockledge Dr, Room 8128, Bethesda, MD 20892, USA. lauerm@nhlbi.nih.gov']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",,United States,JAMA,JAMA,7501160,IM,"['*Biomedical Research', 'Cardiovascular Diseases/diagnosis/*epidemiology/physiopathology/*prevention & control/therapy', 'Cause of Death', '*Comparative Effectiveness Research', 'Financing, Government', 'Health Policy', 'Health Status', 'Humans', 'Life Expectancy', 'Public Health', 'United States/epidemiology']",2011/11/18 06:00,2011/12/13 00:00,['2011/11/18 06:00'],"['2011/11/18 06:00 [entrez]', '2011/11/18 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['306/19/2145 [pii]', '10.1001/jama.2011.1669 [doi]']",ppublish,JAMA. 2011 Nov 16;306(19):2145-6. doi: 10.1001/jama.2011.1669.,19,,,,,,,,,,,,,,,,,,,,,
15340729,NLM,MEDLINE,20090326,20040901,1615-6692 (Electronic) 0340-9937 (Linking),29,2004 Aug,Diabetes and the heart.,455,,"['Luscher, Thomas F', 'Ryden, Lars', 'Tschope, Diethelm']","['Luscher TF', 'Ryden L', 'Tschope D']",,['eng'],"['Editorial', 'Introductory Journal Article']",,Germany,Herz,Herz,7801231,IM,"['Cardiovascular Diseases/*diagnosis/etiology/*therapy', 'Diabetes Complications/*diagnosis/*therapy', 'Humans']",2004/09/02 05:00,2009/03/27 09:00,['2004/09/02 05:00'],"['2004/09/02 05:00 [pubmed]', '2009/03/27 09:00 [medline]', '2004/09/02 05:00 [entrez]']",['10.1007/s00059-004-2604-2 [doi]'],ppublish,Herz. 2004 Aug;29(5):455. doi: 10.1007/s00059-004-2604-2.,5,,,,,,,,,,,,,,,,,,,,,
18451896,NLM,MEDLINE,20080616,20080716,0807-7096 (Electronic) 0029-2001 (Linking),128,2008 May 1,[Transcendental meditation and cardiovascular disease].,1073,,"['Rasmussen, Lars Bjorn']",['Rasmussen LB'],,['nor'],['Letter'],,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Cardiovascular Diseases/mortality/*prevention & control/psychology', 'Humans', '*Meditation']",2008/05/03 09:00,2008/06/17 09:00,['2008/05/03 09:00'],"['2008/05/03 09:00 [pubmed]', '2008/06/17 09:00 [medline]', '2008/05/03 09:00 [entrez]']",['1686050 [pii]'],ppublish,Tidsskr Nor Laegeforen. 2008 May 1;128(9):1073.,9,,,,,,,,,,,,,,,Transcendental meditasjon og hjerte- og karsykdom.,,,,,,
7776737,NLM,MEDLINE,19950713,20081121,0025-7753 (Print) 0025-7753 (Linking),104,1995 Apr 15,[Stress and cardiovascular problems].,551-5,,"['Alonso, S J', 'Navarro, E']","['Alonso SJ', 'Navarro E']","['Departamento de Farmacologia, Facultad de Medicina, Universidad de La Laguna, Santa Cruz de Tenerife.']",['spa'],"['Journal Article', 'Review']",,Spain,Med Clin (Barc),Medicina clinica,0376377,IM,"['Animals', 'Cardiovascular Diseases/epidemiology/*etiology/physiopathology/psychology', 'Cardiovascular System/physiopathology', 'Humans', 'Psychophysiology', 'Risk Factors', 'Stress, Physiological/*complications/epidemiology/physiopathology/psychology']",1995/04/15 00:00,1995/04/15 00:01,['1995/04/15 00:00'],"['1995/04/15 00:00 [pubmed]', '1995/04/15 00:01 [medline]', '1995/04/15 00:00 [entrez]']",,ppublish,Med Clin (Barc). 1995 Apr 15;104(14):551-5.,14,,,,,,,,,,56,,,,,Estres y problemas cardiovasculares.,,,,,,
11705840,NLM,MEDLINE,20011207,20190623,1524-4539 (Electronic) 0009-7322 (Linking),104,2001 Nov 13,Cardiovascular disease rates in women with diabetes.,E9044-5,,"['SoRelle, R']",['SoRelle R'],,['eng'],['News'],,United States,Circulation,Circulation,0147763,IM,"['Adolescent', 'Adult', 'Aged', 'Cardiovascular Diseases/complications/diagnosis/*epidemiology', '*Diabetes Complications', 'Female', 'Hospitalization', 'Humans']",2001/11/14 10:00,2002/01/05 10:01,['2001/11/14 10:00'],"['2001/11/14 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/11/14 10:00 [entrez]']",['10.1161/hc4501.101952 [doi]'],ppublish,Circulation. 2001 Nov 13;104(20):E9044-5. doi: 10.1161/hc4501.101952.,20,,,,,,,,,,,,,,,,,,,,,
1412302,NLM,MEDLINE,19921120,20080716,0029-2001 (Print) 0029-2001 (Linking),112,1992 Sep 10,[Strategies for cardiovascular diseases].,2738-9,,"['Hjermann, I']",['Hjermann I'],"['Medisinsk klinikk, Ulleval sykehus, Oslo.']",['nor'],['Journal Article'],,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['*Cardiovascular Diseases/etiology/mortality/prevention & control', 'Humans', 'Prognosis', 'Risk Factors']",1992/09/10 00:00,1992/09/10 00:01,['1992/09/10 00:00'],"['1992/09/10 00:00 [pubmed]', '1992/09/10 00:01 [medline]', '1992/09/10 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1992 Sep 10;112(21):2738-9.,21,,,,,,,,,,,,,,,Strategier overfor hjerte- og karsykdommene.,,,,,,
17043343,NLM,MEDLINE,20061108,20190619,1539-3704 (Electronic) 0003-4819 (Linking),145,2006 Oct 17,Update in cardiology.,618-25,,"['Rapaport, Elliot']",['Rapaport E'],"['Cardiology Division, San Francisco General Hospital and University of California, San Francisco, San Francisco, California 94110, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['*Cardiovascular Diseases/complications/drug therapy/mortality', 'Diabetes Complications', 'Humans', 'Secondary Prevention']",2006/10/18 09:00,2006/11/10 09:00,['2006/10/18 09:00'],"['2006/10/18 09:00 [pubmed]', '2006/11/10 09:00 [medline]', '2006/10/18 09:00 [entrez]']","['145/8/618 [pii]', '10.7326/0003-4819-145-8-200610170-00011 [doi]']",ppublish,Ann Intern Med. 2006 Oct 17;145(8):618-25. doi: 10.7326/0003-4819-145-8-200610170-00011.,8,,,,,,,,,,4,,,['Ann Intern Med. 2007 Apr 17;146(8):615. PMID: 17438328'],,,,,,,,
19355945,NLM,MEDLINE,20090616,20180605,1873-4286 (Electronic) 1381-6128 (Linking),15,2009,Modifying cardiovascular risk factors: newer insights and preventive measures.,1034-7,,"['Landini, Luigi', 'Leone, Aurelio', 'Mikhailidis, Dimitri P']","['Landini L', 'Leone A', 'Mikhailidis DP']",,['eng'],"['Comment', 'Editorial', 'Introductory Journal Article']",,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Cardiovascular Diseases/*epidemiology/pathology/*prevention & control', 'Humans', 'Risk Factors']",2009/04/10 09:00,2009/06/17 09:00,['2009/04/10 09:00'],"['2009/04/10 09:00 [entrez]', '2009/04/10 09:00 [pubmed]', '2009/06/17 09:00 [medline]']",,ppublish,Curr Pharm Des. 2009;15(10):1034-7.,10,,,,,,,,,,,"['Curr Pharm Des. 2009;15(10):1038-53. PMID: 19355946', 'Curr Pharm Des. 2009;15(10):1054-62. PMID: 19355947', 'Curr Pharm Des. 2009;15(10):1063-71. PMID: 19355948', 'Curr Pharm Des. 2009;15(10):1072-84. PMID: 19355949', 'Curr Pharm Des. 2009;15(10):1085-94. PMID: 19355950', 'Curr Pharm Des. 2009;15(10):1095-106. PMID: 19355951', 'Curr Pharm Des. 2009;15(10):1107-22. PMID: 19355952', 'Curr Pharm Des. 2009;15(10):1123-30. PMID: 19355953', 'Curr Pharm Des. 2009;15(10):1131-41. PMID: 19355954', 'Curr Pharm Des. 2009;15(10):1142-56. PMID: 19355955']",,,,,,,,,,
1590644,NLM,MEDLINE,19920623,20200825,0304-4602 (Print) 0304-4602 (Linking),21,1992 Jan,Cardiovascular risk reduction through lifestyle change in clinical settings.,114-20,,"['Oldenburg, B', 'Gomel, M', 'Graham-Clarke, P']","['Oldenburg B', 'Gomel M', 'Graham-Clarke P']","['Department of Public Health, University of Sydney, Australia.']",['eng'],"['Journal Article', 'Review']",,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,IM,"['Cardiovascular Diseases/epidemiology/etiology/mortality/*prevention & control', 'Health Knowledge, Attitudes, Practice', 'Humans', '*Life Style', 'Primary Prevention', 'Risk Factors']",1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",,ppublish,Ann Acad Med Singap. 1992 Jan;21(1):114-20.,1,"A large amount of observational and experimental research has demonstrated that lifestyle factors are important determinants of cardiovascular disease. In particular, epidemiological evidence from large, controlled multiple risk factor intervention trials and research examining the effects of secular changes in lifestyle on changing morbidity and mortality rates indicate that changes in lifestyle can reduce the risk of coronary heart disease (CHD). This paper provides an overview of the lifestyle change process and provides guidelines for increasing the efficacy of lifestyle change interventions in clinical settings.",,,,,,,,,72,,,,,,,,,,,
11560457,NLM,MEDLINE,20011004,20190619,0003-4819 (Print) 0003-4819 (Linking),135,2001 Sep 18,Update in cardiology.,439-46,,"['Frishman, W H']",['Frishman WH'],"['New York Medical College/Westchester Medical Center,Valhalla, New York, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['*Cardiovascular Diseases/complications/prevention & control/therapy', 'Humans', 'Risk Factors']",2001/09/19 10:00,2001/10/05 10:01,['2001/09/19 10:00'],"['2001/09/19 10:00 [pubmed]', '2001/10/05 10:01 [medline]', '2001/09/19 10:00 [entrez]']","['200109180-00013 [pii]', '10.7326/0003-4819-135-6-200109180-00013 [doi]']",ppublish,Ann Intern Med. 2001 Sep 18;135(6):439-46. doi: 10.7326/0003-4819-135-6-200109180-00013.,6,,,,,,,,,,8,,,,,,,,,,,
2629146,NLM,MEDLINE,19900425,20071115,0040-3660 (Print) 0040-3660 (Linking),61,1989,[Standardization of the pathologicoanatomic diagnosis of the causes of death from the most prevalent diseases of the cardiovascular system].,50-2,,"['Avtandilov, G G', 'Rainova, L V']","['Avtandilov GG', 'Rainova LV']",,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Arteriosclerosis/classification/diagnosis/mortality/pathology', 'Cardiovascular Diseases/classification/diagnosis/*mortality/pathology', 'Cause of Death', 'Coronary Disease/classification/diagnosis/mortality/pathology', 'Humans', 'Hypertension/classification/diagnosis/mortality/pathology', 'Terminology as Topic', 'USSR']",1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1989;61(12):50-2.,12,,,,,,,,,,,,,,,K voprosu unifikatsii patologoanatomicheskoi diagnostiki prichin smerti ot naibolee rasprostranennykh zabolevanii serdechno-sosudistoi sistemy.,,,,,,
21272755,NLM,MEDLINE,20110307,20141120,1558-3597 (Electronic) 0735-1097 (Linking),57,2011 Feb 1,Family history of heart disease: the re-emergence of a traditional risk factor.,628-9,10.1016/j.jacc.2010.09.036 [doi],"['Assimes, Themistocles L']",['Assimes TL'],,['eng'],"['Comment', 'Editorial']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/*genetics', 'Family', 'Global Health', 'Humans', 'Risk Factors']",2011/01/29 06:00,2011/03/08 06:00,['2011/01/29 06:00'],"['2010/08/27 00:00 [received]', '2010/09/06 00:00 [accepted]', '2011/01/29 06:00 [entrez]', '2011/01/29 06:00 [pubmed]', '2011/03/08 06:00 [medline]']","['S0735-1097(10)04596-1 [pii]', '10.1016/j.jacc.2010.09.036 [doi]']",ppublish,J Am Coll Cardiol. 2011 Feb 1;57(5):628-9. doi: 10.1016/j.jacc.2010.09.036.,5,,,,,,,,,,,['J Am Coll Cardiol. 2011 Feb 1;57(5):619-27. PMID: 21272754'],,,,,,,,,,
18582768,NLM,MEDLINE,20080916,20080627,0929-693X (Print) 0929-693X (Linking),15,2008 Jun,[Cardiovascular complications in Kawasaki syndrome].,829-31,10.1016/S0929-693X(08)71929-8 [doi],"['Lambert, V']",['Lambert V'],"['Service de Cardiologie et Chirurgie Cardiaque Pediatrique, Centre Chirurgical Marie-Lannelongue, 133, avenue de la Resistance, 92350 Le Plessis-Robinson. v.lambert@ccml.fr <v.lambert@ccml.fr>']",['fre'],['Journal Article'],,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,IM,"['Angiography', 'Cardiovascular Diseases/diagnosis/epidemiology/*etiology/prevention & control', 'Child', 'Echocardiography', 'Electrocardiography', 'Humans', 'Mucocutaneous Lymph Node Syndrome/*complications/physiopathology', 'Myocardial Ischemia/etiology/physiopathology']",2008/06/28 09:00,2008/09/17 09:00,['2008/06/28 09:00'],"['2008/06/28 09:00 [pubmed]', '2008/09/17 09:00 [medline]', '2008/06/28 09:00 [entrez]']","['S0929-693X(08)71929-8 [pii]', '10.1016/S0929-693X(08)71929-8 [doi]']",ppublish,Arch Pediatr. 2008 Jun;15(5):829-31. doi: 10.1016/S0929-693X(08)71929-8.,5,,,,,,,,,,,,,,,Les complications cardiovasculaires du syndrome de Kawasaki.,,,,,,
7500687,NLM,MEDLINE,19960117,20041117,0025-7753 (Print) 0025-7753 (Linking),105,1995 Sep 23,[Life style and cardiovascular risk factors].,338-40,,"['Barriales Alvarez, V', 'Rodriguez Blanco, V M']","['Barriales Alvarez V', 'Rodriguez Blanco VM']",,['spa'],"['Comment', 'Editorial']",,Spain,Med Clin (Barc),Medicina clinica,0376377,IM,"['Cardiovascular Diseases/epidemiology/*etiology/prevention & control', 'Humans', '*Life Style', 'Risk Factors']",1995/09/23 00:00,1995/09/23 00:01,['1995/09/23 00:00'],"['1995/09/23 00:00 [pubmed]', '1995/09/23 00:01 [medline]', '1995/09/23 00:00 [entrez]']",,ppublish,Med Clin (Barc). 1995 Sep 23;105(9):338-40.,9,,,,,,,,,,,['Med Clin (Barc). 1995 Sep 23;105(9):327-33. PMID: 7500685'],,,,Estilo de vida y factores de riesgo cardiovascular.,,,,,,
1614660,NLM,MEDLINE,19920730,20041117,0360-4039 (Print) 0360-4039 (Linking),22,1992 Jun,Managing cardiovascular conditions.,"76-8, 80",,"['Ahrens, T']",['Ahrens T'],,['eng'],['Journal Article'],,United States,Nursing,Nursing,7600137,,"['Cardiovascular Diseases/*nursing/physiopathology/therapy', '*Education, Nursing, Continuing', '*Educational Measurement', 'Humans']",1992/06/01 00:00,1992/06/01 00:01,['1992/06/01 00:00'],"['1992/06/01 00:00 [pubmed]', '1992/06/01 00:01 [medline]', '1992/06/01 00:00 [entrez]']",,ppublish,"Nursing. 1992 Jun;22(6):76-8, 80.",6,,,,,,,,,,,,,,,,,,,,,
18422211,NLM,MEDLINE,20080710,20170214,0036-9330 (Print) 0036-9330 (Linking),53,2008 Feb,Coventina's column.,59,,"['Sanai, Leyla']",['Sanai L'],,['eng'],"['Journal Article', 'Review']",,Scotland,Scott Med J,Scottish medical journal,2983335R,IM,"['Cardiovascular Diseases/etiology/*prevention & control/psychology', '*Health Behavior', 'Humans', '*Public Health', 'Scotland']",2008/04/22 09:00,2008/07/11 09:00,['2008/04/22 09:00'],"['2008/04/22 09:00 [pubmed]', '2008/07/11 09:00 [medline]', '2008/04/22 09:00 [entrez]']",['10.1258/RSMSMJ.53.1.59 [doi]'],ppublish,Scott Med J. 2008 Feb;53(1):59. doi: 10.1258/RSMSMJ.53.1.59.,1,,,,,,,,,,0,,,,,,,,,,,
21452261,NLM,MEDLINE,20110526,20111209,2151-4658 (Electronic) 2151-464X (Linking),63,2011 Apr,Introduction to special theme: vascular comorbidity in the rheumatic diseases.,483,10.1002/acr.20461 [doi],"['Yelin, Edward', 'Katz, Patricia']","['Yelin E', 'Katz P']",['Arthritis Care & Research.'],['eng'],['Introductory Journal Article'],,United States,Arthritis Care Res (Hoboken),Arthritis care & research,101518086,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Comorbidity', 'Humans', 'Rheumatic Diseases/diagnosis/*epidemiology/therapy', 'Vascular Diseases/diagnosis/epidemiology/therapy']",2011/04/01 06:00,2011/05/27 06:00,['2011/04/01 06:00'],"['2011/04/01 06:00 [entrez]', '2011/04/01 06:00 [pubmed]', '2011/05/27 06:00 [medline]']",['10.1002/acr.20461 [doi]'],ppublish,Arthritis Care Res (Hoboken). 2011 Apr;63(4):483. doi: 10.1002/acr.20461.,4,,,,,,,,,,,,,,,,,,,,,
9090161,NLM,MEDLINE,19970506,20041117,0393-1978 (Print) 0393-1978 (Linking),42,1997 Feb,Endothelial dysfunction and cardiovascular disease.,177-87,,"['Sherman, D L', 'Loscalzo, J']","['Sherman DL', 'Loscalzo J']","['Whituker Cardiovascular Institute, Boston University School of Medicine, MA 02118, USA.']",['eng'],"['Journal Article', 'Review']",,Italy,Cardiologia,"Cardiologia (Rome, Italy)",8506637,IM,"['Animals', 'Arteriosclerosis/etiology/physiopathology', 'Cardiovascular Diseases/drug therapy/etiology/*physiopathology', 'Endothelium, Vascular/*physiopathology', 'Humans', 'Hypertension/etiology/physiopathology', 'Reference Values', 'Risk Factors']",1997/02/01 00:00,1997/02/01 00:01,['1997/02/01 00:00'],"['1997/02/01 00:00 [pubmed]', '1997/02/01 00:01 [medline]', '1997/02/01 00:00 [entrez]']",,ppublish,Cardiologia. 1997 Feb;42(2):177-87.,2,,,,,,,,,,102,,,,,,,,,,,
23475314,NLM,MEDLINE,20130321,20161017,1538-3598 (Electronic) 0098-7484 (Linking),309,2013 Mar 20,Improving cardiovascular health: a balance between discovery and delivery.,1117-8,10.1001/jama.2013.2416 [doi],"['Zoghbi, William A', 'Holmes, David R Jr']","['Zoghbi WA', 'Holmes DR Jr']","['American College of Cardiology Foundation, Washington, DC, USA. wzoghbi@tmhs.org']",['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,IM,"['Biomedical Research/trends', 'Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control/*therapy', '*Diffusion of Innovation', 'Humans', 'United States/epidemiology']",2013/03/12 06:00,2013/03/22 06:00,['2013/03/12 06:00'],"['2013/03/12 06:00 [entrez]', '2013/03/12 06:00 [pubmed]', '2013/03/22 06:00 [medline]']","['1662113 [pii]', '10.1001/jama.2013.2416 [doi]']",ppublish,JAMA. 2013 Mar 20;309(11):1117-8. doi: 10.1001/jama.2013.2416.,11,,,,,,,,,,,,,,,,,,,,,
28525919,NLM,MEDLINE,20180604,20181202,1755-3245 (Electronic) 0008-6363 (Linking),113,2017 Jun 1,A virtual issue for the CBCS Summer School 2017: focus on hot topics.,708-710,10.1093/cvr/cvx083 [doi],"['Sipido, Karin R', 'Vandevelde, Wouter']","['Sipido KR', 'Vandevelde W']","['Department of Cardiovascular Sciences, Experimental Cardiology, KU Leuven, University of Leuven, Campus Gasthuisberg O/N1?704, Herestraat 49, B-3000 Leuven, Belgium.', 'Department of Cardiovascular Sciences, Experimental Cardiology, KU Leuven, University of Leuven, Campus Gasthuisberg O/N1?704, Herestraat 49, B-3000 Leuven, Belgium.']",['eng'],"['Congress', 'Editorial']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Animals', 'Biomedical Research/*methods', 'Cardiology/*methods', '*Cardiovascular Diseases/genetics/metabolism/physiopathology/therapy', 'Humans']",2017/05/20 06:00,2018/06/05 06:00,['2017/05/20 06:00'],"['2017/05/20 06:00 [entrez]', '2017/05/20 06:00 [pubmed]', '2018/06/05 06:00 [medline]']","['3829665 [pii]', '10.1093/cvr/cvx083 [doi]']",ppublish,Cardiovasc Res. 2017 Jun 1;113(7):708-710. doi: 10.1093/cvr/cvx083.,7,,,,,,,,,,,,,,,,,,,,,
27938838,NLM,MEDLINE,20180124,20180124,2211-8179 (Electronic) 2211-8160 (Linking),11,2016 Dec,The Fight Against CVD in a Region of the Russian Federation.,445-446,S2211-8160(16)30761-X [pii] 10.1016/j.gheart.2016.10.025 [doi],"['Galyavich, Albert S', 'Vafin, Adel Yu', 'Ziganshina, Liliya E']","['Galyavich AS', 'Vafin AY', 'Ziganshina LE']","['Department of Cardiology, Kazan State Medical University, Kazan, Russia.', 'Department of Healthcare Management, Kazan State Medical University, Kazan, Russia.', 'Department of Basic and Clinical Pharmacology, Kazan Federal University, Kazan, Russia. Electronic address: leziign@gmail.com.']",['eng'],['Editorial'],,England,Glob Heart,Global heart,101584391,IM,"['Cardiovascular Diseases/epidemiology/mortality/*prevention & control/therapy', 'Humans', 'Myocardial Infarction/therapy', 'Public Health', 'Russia/epidemiology', 'Tatarstan/epidemiology']",2016/12/13 06:00,2018/01/25 06:00,['2016/12/13 06:00'],"['2016/10/19 00:00 [received]', '2016/10/19 00:00 [accepted]', '2016/12/13 06:00 [entrez]', '2016/12/13 06:00 [pubmed]', '2018/01/25 06:00 [medline]']","['S2211-8160(16)30761-X [pii]', '10.1016/j.gheart.2016.10.025 [doi]']",ppublish,Glob Heart. 2016 Dec;11(4):445-446. doi: 10.1016/j.gheart.2016.10.025.,4,,,,,,,,,,,,,,,,,,,,,
19519457,NLM,MEDLINE,20090813,20190907,1873-4294 (Electronic) 1568-0266 (Linking),9,2009,New medicinal chemistry approaches for the treatment of cardiovascular disease.,418,,"['Lee, Dennis']",['Lee D'],,['eng'],"['Editorial', 'Introductory Journal Article']",,United Arab Emirates,Curr Top Med Chem,Current topics in medicinal chemistry,101119673,IM,"['Cardiovascular Diseases/*drug therapy/metabolism/prevention & control', '*Chemistry, Pharmaceutical', 'Humans']",2009/06/13 09:00,2009/08/14 09:00,['2009/06/13 09:00'],"['2009/06/13 09:00 [entrez]', '2009/06/13 09:00 [pubmed]', '2009/08/14 09:00 [medline]']",['10.2174/156802609788340841 [doi]'],ppublish,Curr Top Med Chem. 2009;9(5):418. doi: 10.2174/156802609788340841.,5,,,,,,,,,,,,,,,,,,,,,
8152891,NLM,MEDLINE,19940506,20200910,,,1993 Dec,Women's cardiovascular health.,289-310,,"['Holm, K', 'Penckofer, S M']","['Holm K', 'Penckofer SM']",,['eng'],"['Bibliography', 'Journal Article']",,United States,NLN Publ,NLN publications,101770511,,"['*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Female', 'Humans', 'Risk Factors', ""*Women's Health""]",1993/12/01 00:00,1993/12/01 00:01,['1993/12/01 00:00'],"['1993/12/01 00:00 [pubmed]', '1993/12/01 00:01 [medline]', '1993/12/01 00:00 [entrez]']",,ppublish,NLN Publ. 1993 Dec;(19-2546):289-310.,19-2546,,,,,,,,,,,,,,,,,,,,,
21781608,NLM,MEDLINE,20120702,20110725,0253-3758 (Print) 0253-3758 (Linking),39,2011 May,[Cardiovascular protective effects and related mechanisms of n-3 polyunsaturated fatty acids].,474-6,,"['Li, Pei', 'Liu, Mei-lin', 'Xie, Ming-bin']","['Li P', 'Liu ML', 'Xie MB']",,['chi'],"['Journal Article', 'Review']",,China,Zhonghua Xin Xue Guan Bing Za Zhi,Zhonghua xin xue guan bing za zhi,7910682,IM,"['*Cardiovascular Diseases/epidemiology/metabolism/pathology', '*Fatty Acids, Omega-3', 'Humans']",2011/07/26 06:00,2012/07/03 06:00,['2011/07/26 06:00'],"['2011/07/26 06:00 [entrez]', '2011/07/26 06:00 [pubmed]', '2012/07/03 06:00 [medline]']",,ppublish,Zhonghua Xin Xue Guan Bing Za Zhi. 2011 May;39(5):474-6.,5,,,,,,,,"['0 (Fatty Acids, Omega-3)']",,,,,,,,,,,,,
8029585,NLM,MEDLINE,19940811,20041117,0249-6429 (Print) 0249-6429 (Linking),,1994 May,[Cardiovascular diseases in the elderly. Examinations and therapeutic strategies].,7-18,,"['Villard, J']",['Villard J'],,['fre'],['Journal Article'],,France,Soins Chir,"Soins. Chirurgie (Paris, France : 1982)",8406864,,"['Aged', 'Cardiovascular Diseases/*diagnosis/surgery/therapy', 'Echocardiography, Doppler', 'Humans']",1994/05/01 00:00,1994/05/01 00:01,['1994/05/01 00:00'],"['1994/05/01 00:00 [pubmed]', '1994/05/01 00:01 [medline]', '1994/05/01 00:00 [entrez]']",,ppublish,Soins Chir. 1994 May;(159):7-18.,159,,,,,,,,,,,,,,,Maladies cardio-vasculaires et sujet age examens et strategies therapeutiques.,,,,,,
5202466,NLM,MEDLINE,19701209,20001218,0098-6151 (Print) 0098-6151 (Linking),69,1970 Jul,The prevention of cardiovascular diseases. Introduction.,1119-21,,"['Wright, I S']",['Wright IS'],,['eng'],['Journal Article'],,United States,J Am Osteopath Assoc,The Journal of the American Osteopathic Association,7503065,IM,['Cardiovascular Diseases/*prevention & control/therapy'],1970/07/01 00:00,1970/07/01 00:01,['1970/07/01 00:00'],"['1970/07/01 00:00 [pubmed]', '1970/07/01 00:01 [medline]', '1970/07/01 00:00 [entrez]']",,ppublish,J Am Osteopath Assoc. 1970 Jul;69(11):1119-21.,11,,,,,,,,,,,,,,,,,,,,,
20104031,NLM,MEDLINE,20100419,20191210,1710-2774 (Print) 1710-2774 (Linking),13,2010,National trends in cardiovascular care and outcomes.,22-5,,"['Tu, Jack V', 'Jackevicius, Cynthia A', 'Lee, Douglas S', 'Donovan, Linda R']","['Tu JV', 'Jackevicius CA', 'Lee DS', 'Donovan LR']",['Institute for Clinical Evaluative Sciences.'],['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Canada,Healthc Q,"Healthcare quarterly (Toronto, Ont.)",101208192,,"['Adolescent', 'Adult', 'Canada/epidemiology', '*Cardiovascular Diseases/drug therapy/economics/epidemiology/etiology/mortality', 'Databases as Topic', 'Female', 'Heart Failure/mortality', 'Hospitalization/trends', 'Humans', 'Male', 'Middle Aged', '*Outcome Assessment, Health Care', 'Research', 'Risk Factors', 'Stroke/mortality', 'Young Adult']",2010/01/28 06:00,2010/04/20 06:00,['2010/01/28 06:00'],"['2010/01/28 06:00 [entrez]', '2010/01/28 06:00 [pubmed]', '2010/04/20 06:00 [medline]']",['10.12927/hcq.2013.21628 [doi]'],ppublish,Healthc Q. 2010;13(1):22-5. doi: 10.12927/hcq.2013.21628.,1,,,,,,,,,,,,,,['Canadian Cardiovascular Outcomes Research Team'],,,,,,,
3697042,NLM,MEDLINE,19880202,20041117,0029-1420 (Print) 0029-1420 (Linking),102,1987,[Cardiovascular diseases: we start with children].,265-6,,"['Ose, L']",['Ose L'],,['nor'],['Journal Article'],,Sweden,Nord Med,Nordisk medicin,0401001,IM,"['Adult', 'Arteriosclerosis/diet therapy/epidemiology/genetics', 'Cardiovascular Diseases/*epidemiology/etiology/prevention & control', 'Child', 'Humans', 'Middle Aged', 'Norway', 'Risk Factors']",1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",,ppublish,Nord Med. 1987;102(10):265-6.,10,,,,,,,,,,,,,,,Hjerte-karsykdommer: vi begynner med barna!,,,,,,
18177577,NLM,MEDLINE,20080205,20191027,1522-6417 (Print) 1522-6417 (Linking),9,2007 Nov,Worksite treatment for cardiovascular disease prevention.,342-3,,"['Alderman, Michael H']",['Alderman MH'],"['Albert Einstein College of Medicine, Department of Epidemiology and Population Health, 1300 Morris Park Avenue, Room 1315A, Belfer Building, Bronx, New York 10461, USA. alderman@aecom.yu.edu']",['eng'],['Editorial'],,United States,Curr Hypertens Rep,Current hypertension reports,100888982,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', '*Delivery of Health Care', 'Humans', '*Occupational Health Services', 'Workplace']",2008/01/08 09:00,2008/02/06 09:00,['2008/01/08 09:00'],"['2008/01/08 09:00 [pubmed]', '2008/02/06 09:00 [medline]', '2008/01/08 09:00 [entrez]']",['10.1007/s11906-007-0062-y [doi]'],ppublish,Curr Hypertens Rep. 2007 Nov;9(5):342-3. doi: 10.1007/s11906-007-0062-y.,5,,,,,,,,,,,,,,,,,,,,,
19371200,NLM,MEDLINE,20090730,20090417,1744-8298 (Electronic) 1479-6678 (Linking),5,2009 Jan,"Highlights of the 13th Annual Meeting of the European Council for Cardiovascular Research. 13th Annual Meeting of the European Council for Cardiovascular Research (ECCR). Nice, France, 10-12 October, 2008.",23-5,10.2217/14796678.5.1.23 [doi],"['Bader, Michael']",['Bader M'],"['Max-Delbruck-Center for Molecular Medicine (MDC), Berlin-Buch, Germany. mbader@mdc-berlin.de']",['eng'],['Journal Article'],,England,Future Cardiol,Future cardiology,101239345,IM,"['*Cardiovascular Diseases/complications/etiology/physiopathology/therapy', 'Cardiovascular System/growth & development', 'Humans', 'Kidney Diseases/complications', 'Research']",2009/04/18 09:00,2009/07/31 09:00,['2009/04/18 09:00'],"['2009/04/18 09:00 [entrez]', '2009/04/18 09:00 [pubmed]', '2009/07/31 09:00 [medline]']",['10.2217/14796678.5.1.23 [doi]'],ppublish,Future Cardiol. 2009 Jan;5(1):23-5. doi: 10.2217/14796678.5.1.23.,1,"The 13th Annual Meeting of the European Council for Cardiovascular Research (ECCR) gathered leading European groups in basic and clinical cardiovascular research in Nice, France, 10-12 October 2008. With 160 participants and approximately the same amount of oral and poster presentations, it was a small but very comprehensive meeting covering the most important and timely issues in research on cardiovascular diseases and their treatment. Highlights of this year's meeting were joint sessions with the European Society for Microcirculation about Vascular Disease and the European Society for Cardiology about the cardiorenal syndrome, along with the Danish Cardiovascular Research Academy (DACRA) about exercise hyperemia. The content of these sessions, as well as other important contributions to the conference, are summarized in this article.",,,,,,,,,,,,,,,,,,,,
18793888,NLM,MEDLINE,20101216,20130318,0072-9752 (Print) 0072-9752 (Linking),94,2009,The interactions between cardiovascular and cerebrovascular disease.,1039-57,10.1016/S0072-9752(08)94051-3 [doi],"['Di Pasquale, Giuseppe', 'Urbinati, Stefano']","['Di Pasquale G', 'Urbinati S']","['Unita Operativa di Cardiologia, Maggiore Hospital, Bologna, Italy. giuseppe.dipasquale@ausl.bologna.it']",['eng'],['Journal Article'],,Netherlands,Handb Clin Neurol,Handbook of clinical neurology,0166161,IM,"['*Cardiovascular Diseases/complications/epidemiology/therapy', '*Cerebrovascular Disorders/complications/epidemiology/therapy', 'Humans']",2008/09/17 09:00,2010/12/17 06:00,['2008/09/17 09:00'],"['2008/09/17 09:00 [pubmed]', '2010/12/17 06:00 [medline]', '2008/09/17 09:00 [entrez]']","['S0072-9752(08)94051-3 [pii]', '10.1016/S0072-9752(08)94051-3 [doi]']",ppublish,Handb Clin Neurol. 2009;94:1039-57. doi: 10.1016/S0072-9752(08)94051-3.,,,,,,,,,,,,,,,,,,,,,,
34279990,NLM,MEDLINE,20220103,20220103,1524-4539 (Electronic) 0009-7322 (Linking),144,2021 Jul 20,"Transgender People May Face Elevated, Often Untreated Heart Risks.",243-245,10.1161/CIRCULATIONAHA.121.055711 [doi],"['Kuehn, Bridget M']",['Kuehn BM'],,['eng'],['News'],20210719,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*etiology/therapy', '*Cardiovascular Physiological Phenomena', 'Cardiovascular System/*metabolism', 'Delivery of Health Care', '*Disease Susceptibility', 'Humans', 'Risk Assessment', 'Risk Factors', '*Transgender Persons']",2021/07/20 06:00,2022/01/04 06:00,['2021/07/19 17:11'],"['2021/07/19 17:11 [entrez]', '2021/07/20 06:00 [pubmed]', '2022/01/04 06:00 [medline]']",['10.1161/CIRCULATIONAHA.121.055711 [doi]'],ppublish,Circulation. 2021 Jul 20;144(3):243-245. doi: 10.1161/CIRCULATIONAHA.121.055711. Epub 2021 Jul 19.,3,,,,,,,,,,,,,,,,,,,,,
18319101,NLM,MEDLINE,20080529,20080305,0146-2806 (Print) 0146-2806 (Linking),33,2008 Apr,The diagnosis and management of cardiovascular disease in cancer patients. Foreword.,159,10.1016/j.cpcardiol.2008.01.003 [doi],"['Rahimtoola, Shahbudin H']",['Rahimtoola SH'],,['eng'],['Introductory Journal Article'],,Netherlands,Curr Probl Cardiol,Current problems in cardiology,7701802,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Comorbidity', 'Humans', 'Neoplasms/*epidemiology']",2008/03/06 09:00,2008/05/30 09:00,['2008/03/06 09:00'],"['2008/03/06 09:00 [pubmed]', '2008/05/30 09:00 [medline]', '2008/03/06 09:00 [entrez]']","['S0146-2806(08)00003-0 [pii]', '10.1016/j.cpcardiol.2008.01.003 [doi]']",ppublish,Curr Probl Cardiol. 2008 Apr;33(4):159. doi: 10.1016/j.cpcardiol.2008.01.003.,4,,,,,,,,,,,,,,,,,,,,,
12894953,NLM,MEDLINE,20031112,20041117,1049-510X (Print) 1049-510X (Linking),13,2003 Summer,Integrated health care must consider mental health to reduce rates of cardiovascular disease.,309,,"['Maass-Robinson, Saundra']",['Maass-Robinson S'],,['eng'],['Editorial'],,United States,Ethn Dis,Ethnicity & disease,9109034,IM,"['Cardiovascular Diseases/complications/ethnology/*prevention & control/psychology', 'Depression/complications', 'Humans', '*Mental Health', 'United States/epidemiology']",2003/08/05 05:00,2003/11/13 05:00,['2003/08/05 05:00'],"['2003/08/05 05:00 [pubmed]', '2003/11/13 05:00 [medline]', '2003/08/05 05:00 [entrez]']",,ppublish,Ethn Dis. 2003 Summer;13(3):309.,3,,,,,,,,,,,,,,,,,,,,,
12841483,NLM,MEDLINE,20030805,20041117,0019-5847 (Print) 0019-5847 (Linking),101,2003 Feb,The present scenario of cardiovascular disease.,60-1,,"['Thanikachalam, S']",['Thanikachalam S'],,['eng'],['Editorial'],,India,J Indian Med Assoc,Journal of the Indian Medical Association,7505608,IM,"['Cardiovascular Diseases/diagnosis/etiology/physiopathology/*prevention & control', 'Humans', 'Risk Factors']",2003/07/05 05:00,2003/08/06 05:00,['2003/07/05 05:00'],"['2003/07/05 05:00 [pubmed]', '2003/08/06 05:00 [medline]', '2003/07/05 05:00 [entrez]']",,ppublish,J Indian Med Assoc. 2003 Feb;101(2):60-1.,2,,,,,,,,,,,,,,,,,,,,,
24751559,NLM,MEDLINE,20151015,20181202,2214-9996 (Electronic) 2214-9996 (Linking),80,2014 Jan-Feb,Best of Mount Sinai Heart fellows symposia.,3-4,S2214-9996(13)00011-8 [pii] 10.1016/j.aogh.2013.12.010 [doi],"['Goldman, Martin E', 'Gandhi, Parul U']","['Goldman ME', 'Gandhi PU']",,['eng'],"['Congress', 'Introductory Journal Article']",20131227,United States,Ann Glob Health,Annals of global health,101620864,IM,"['*Cardiology', 'Cardiovascular Diseases/diagnosis/physiopathology/*therapy', 'Fellowships and Scholarships', 'Humans']",2014/04/23 06:00,2015/10/16 06:00,['2014/04/23 06:00'],"['2014/04/23 06:00 [entrez]', '2014/04/23 06:00 [pubmed]', '2015/10/16 06:00 [medline]']","['S2214-9996(13)00011-8 [pii]', '10.1016/j.aogh.2013.12.010 [doi]']",ppublish,Ann Glob Health. 2014 Jan-Feb;80(1):3-4. doi: 10.1016/j.aogh.2013.12.010. Epub 2013 Dec 27.,1,,,,,,,,,,,,,,,,,,,,,
4553776,NLM,MEDLINE,19720630,20071115,0020-9554 (Print) 0020-9554 (Linking),13,1972 Jan,[Functional cardiovascular disorders].,1-6,,"['Delius, L']",['Delius L'],,['ger'],['Journal Article'],,Germany,Internist (Berl),Der Internist,0264620,IM,"['Arrhythmias, Cardiac/diagnosis', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Electrocardiography', 'Emotions', 'Humans', 'Prognosis', 'Psychophysiologic Disorders/complications', 'Stress, Psychological', 'Sympathetic Nervous System']",1972/01/01 00:00,1972/01/01 00:01,['1972/01/01 00:00'],"['1972/01/01 00:00 [pubmed]', '1972/01/01 00:01 [medline]', '1972/01/01 00:00 [entrez]']",,ppublish,Internist (Berl). 1972 Jan;13(1):1-6.,1,,,,,,,,,,,,,,,Funktionelle kardiovasculare Storungen.,,,,,,
21475569,NLM,MEDLINE,20110830,20211020,1866-0452 (Electronic) 1866-0452 (Linking),108,2011 Mar,Retinopathy as a differential diagnosis.,187; author reply 187-8,10.3238/arztebl.2011.0187b [doi],"['Schmidt, Dieter']",['Schmidt D'],,['eng'],"['Comment', 'Letter']",20110318,Germany,Dtsch Arztebl Int,Deutsches Arzteblatt international,101475967,IM,"['Cardiovascular Diseases/*diagnosis/*epidemiology/therapy', 'Cerebrovascular Disorders/*diagnosis/*epidemiology/therapy', 'Comorbidity', 'Diagnosis, Differential', 'Humans', 'Hypertensive Retinopathy/*diagnosis/*epidemiology/therapy']",2011/04/09 06:00,2011/08/31 06:00,['2011/04/09 06:00'],"['2011/04/09 06:00 [entrez]', '2011/04/09 06:00 [pubmed]', '2011/08/31 06:00 [medline]']",['10.3238/arztebl.2011.0187b [doi]'],ppublish,Dtsch Arztebl Int. 2011 Mar;108(11):187; author reply 187-8. doi: 10.3238/arztebl.2011.0187b. Epub 2011 Mar 18.,11,,,PMC3071956,,,,,,,,['Dtsch Arztebl Int. 2010 Dec;107(49):866-73. PMID: 21191547'],,,,,,,,,,
19959781,NLM,MEDLINE,20091217,20181201,1524-4571 (Electronic) 0009-7330 (Linking),105,2009 Dec 4,Basic Cardiovascular Sciences Conference 2009: molecular mechanisms of cardiovascular disease.,1162-3,10.1161/CIRCRESAHA.109.211854 [doi],"['Baines, Christopher P', 'Pritchard, Tracy J']","['Baines CP', 'Pritchard TJ']",,['eng'],"['Congress', 'News']",,United States,Circ Res,Circulation research,0047103,IM,"['Animals', '*Biomedical Research', '*Cardiovascular Diseases/metabolism/pathology/physiopathology/therapy', 'Humans']",2009/12/05 06:00,2009/12/18 06:00,['2009/12/05 06:00'],"['2009/12/05 06:00 [entrez]', '2009/12/05 06:00 [pubmed]', '2009/12/18 06:00 [medline]']","['105/12/1162 [pii]', '10.1161/CIRCRESAHA.109.211854 [doi]']",ppublish,Circ Res. 2009 Dec 4;105(12):1162-3. doi: 10.1161/CIRCRESAHA.109.211854.,12,,,,,,,,,,,,,,,,,,,,,
30052923,NLM,MEDLINE,20190813,20190813,1755-3245 (Electronic) 0008-6363 (Linking),114,2018 Aug 1,"Scientists on the Spot: The past, present, and future of the Council on Basic Cardiovascular Science.",e74-e75,10.1093/cvr/cvy178 [doi],"['Waltenberger, Johannes', 'Pearson, Jeremy']","['Waltenberger J', 'Pearson J']","['Medical Faculty, University of Munster, Munster, Germany.', ""School of Cardiovascular Medicine & Sciences, King's College London, London, UK.""]",['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait']",,England,Cardiovasc Res,Cardiovascular research,0077427,,"['Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/diagnosis/*history/physiopathology/therapy', 'History, 21st Century', 'Humans']",2018/07/28 06:00,2019/08/14 06:00,['2018/07/28 06:00'],"['2018/07/28 06:00 [entrez]', '2018/07/28 06:00 [pubmed]', '2019/08/14 06:00 [medline]']","['5056800 [pii]', '10.1093/cvr/cvy178 [doi]']",ppublish,Cardiovasc Res. 2018 Aug 1;114(10):e74-e75. doi: 10.1093/cvr/cvy178.,10,,,,,,,,,,,,,,,,"['Pearson J', 'Waltenberger J']","['Pearson, Jeremy', 'Waltenberger, Johannes']",,,,
14109303,NLM,MEDLINE,19961201,20181201,0484-8632 (Print) 0484-8632 (Linking),8,1963,A STUDY CONCERNING THE RICKETTSIAL OR PARARICKETTSIAL ETIOLOGY OF SOME CARDIOVASCULAR DISEASES.,151-8,,"['NICOLAU, S S', 'SURDAN, C', 'SARATEANU, D', 'ATHANASIU, P', 'SORODOC, G', 'POPESCU-DANESCU, G', 'BABES, V', 'STEFANESCU, I', 'ILIESCU, C', 'RADESCU, R', 'MALITCHI, E', 'CADERE, T', 'FLORIAN, I', 'PARASCHIVESCU, N', 'SETLACEK, D', 'DUMITRESCU, S', 'SILVIUDAN, S']","['NICOLAU SS', 'SURDAN C', 'SARATEANU D', 'ATHANASIU P', 'SORODOC G', 'POPESCU-DANESCU G', 'BABES V', 'STEFANESCU I', 'ILIESCU C', 'RADESCU R', 'MALITCHI E', 'CADERE T', 'FLORIAN I', 'PARASCHIVESCU N', 'SETLACEK D', 'DUMITRESCU S', 'SILVIUDAN S']",,['eng'],['Journal Article'],,Romania,Rev Sci Med,Revue des sciences medicales,0204314,OM,"['*Antibodies', '*Arteritis', '*Cardiovascular Diseases', '*Cerebrovascular Disorders', '*Coronary Disease', '*Endocarditis', '*Heart Block', '*Myocardial Infarction', '*Myocarditis', '*Pericarditis', '*Phlebitis', '*Raynaud Disease', '*Rickettsia Infections', '*Thromboangiitis Obliterans', '*Thrombophlebitis']",1963/01/01 00:00,1963/01/01 00:01,['1963/01/01 00:00'],"['1963/01/01 00:00 [pubmed]', '1963/01/01 00:01 [medline]', '1963/01/01 00:00 [entrez]']",,ppublish,Rev Sci Med. 1963;8:151-8.,,,,,,['NLM'],"['*ANTIBODIES', '*ARTERITIS', '*CARDIOVASCULAR DISEASES', '*CEREBROVASCULAR DISORDERS', '*CORONARY DISEASE', '*ENDOCARDITIS', '*HEART BLOCK', '*MYOCARDIAL INFARCT', '*MYOCARDITIS', '*PERICARDITIS', '*PHLEBITIS', ""*RAYNAUD'S DISEASE"", '*RICKETTSIAL DISEASES', '*THROMBOANGIITIS OBLITERANS', '*THROMBOPHLEBITIS']",,['0 (Antibodies)'],,,,,,,,,,,,,
16293783,NLM,MEDLINE,20051222,20161122,1524-4628 (Electronic) 0039-2499 (Linking),36,2005 Dec,"Stroke by cause: some common, some exotic, some controversial.",2523-5,,"['Barnett, Henry J M']",['Barnett HJ'],,['eng'],"['Comment', 'Editorial']",20051117,United States,Stroke,Stroke,0235266,IM,"['Aged', 'Cardiovascular Diseases/classification/complications/diagnosis', 'Humans', 'Risk Factors', 'Stroke/classification/*etiology/*prevention & control']",2005/11/19 09:00,2005/12/24 09:00,['2005/11/19 09:00'],"['2005/11/19 09:00 [pubmed]', '2005/12/24 09:00 [medline]', '2005/11/19 09:00 [entrez]']","['01.STR.0000194560.65809.47 [pii]', '10.1161/01.STR.0000194560.65809.47 [doi]']",ppublish,Stroke. 2005 Dec;36(12):2523-5. doi: 10.1161/01.STR.0000194560.65809.47. Epub 2005 Nov 17.,12,,,,,,,,,,,['Stroke. 2005 Dec;36(12):2533-7. PMID: 16254219'],,,,,,,,,,
29925542,NLM,MEDLINE,20190226,20210109,1468-201X (Electronic) 1355-6037 (Linking),104,2018 Aug,Bernard and Joan Marshall Awards at the autumn meeting of the British Society for Cardiovascular Research 2017.,1383-1384,10.1136/heartjnl-2018-313271 [doi],"['Carr, Carolyn A', 'Dodd, Michael S', 'Heather, Lisa C']","['Carr CA', 'Dodd MS', 'Heather LC']","['Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.', 'Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.', 'Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.']",['eng'],"['Congress', 'Portrait']",20180620,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Animals', '*Awards and Prizes', '*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/genetics/metabolism/physiopathology/surgery', 'Humans']",2018/06/22 06:00,2019/02/27 06:00,['2018/06/22 06:00'],"['2018/06/22 06:00 [pubmed]', '2019/02/27 06:00 [medline]', '2018/06/22 06:00 [entrez]']","['heartjnl-2018-313271 [pii]', '10.1136/heartjnl-2018-313271 [doi]']",ppublish,Heart. 2018 Aug;104(16):1383-1384. doi: 10.1136/heartjnl-2018-313271. Epub 2018 Jun 20.,16,,,,['Competing interests: None declared.'],,,['FS/17/58/33072/BHF_/British Heart Foundation/United Kingdom'],,,,,,,,,,,,,,
20647574,NLM,MEDLINE,20110225,20161125,1941-7705 (Electronic) 1941-7713 (Linking),3,2010 Jul,Outcomes research: the next generation.,335-6,10.1161/CIRCOUTCOMES.110.957662 [doi],"['Kosiborod, Mikhail']",['Kosiborod M'],,['eng'],"['Comment', 'Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Qual Outcomes,Circulation. Cardiovascular quality and outcomes,101489148,IM,"['Biomarkers/*metabolism', 'Biomedical Research', '*Blood Pressure Determination', 'Cardiovascular Diseases/*diagnosis/*drug therapy/economics/mortality/physiopathology', 'Cost-Benefit Analysis', 'Education, Medical, Graduate', 'Hemoglobins/*metabolism', 'Hirudins', 'Humans', 'Peptide Fragments/therapeutic use', 'Prognosis', 'Recombinant Proteins/therapeutic use', 'Survival Analysis', 'Treatment Outcome']",2010/07/22 06:00,2011/02/26 06:00,['2010/07/22 06:00'],"['2010/07/22 06:00 [entrez]', '2010/07/22 06:00 [pubmed]', '2011/02/26 06:00 [medline]']","['3/4/335 [pii]', '10.1161/CIRCOUTCOMES.110.957662 [doi]']",ppublish,Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):335-6. doi: 10.1161/CIRCOUTCOMES.110.957662.,4,,,,,,,,"['0 (Biomarkers)', '0 (Hemoglobins)', '0 (Hirudins)', '0 (Peptide Fragments)', '0 (Recombinant Proteins)', 'TN9BEX005G (bivalirudin)']",,,"['Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):358-65. PMID: 20488917', 'Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):347-57. PMID: 20488918', 'Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):337-46. PMID: 20488919']",,,,,,,,,,
12457817,NLM,MEDLINE,20021210,20190611,0140-6736 (Print) 0140-6736 (Linking),360,2002 Nov 23,Interventional cardiology in Germany.,1694; author reply 1695-6,,"['Baldeweg, S E']",['Baldeweg SE'],,['eng'],"['Comment', 'Letter']",,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Cardiology/*statistics & numerical data', 'Cardiovascular Diseases/epidemiology/mortality/*therapy', 'Germany/epidemiology', 'Humans']",2002/11/30 04:00,2002/12/11 04:00,['2002/11/30 04:00'],"['2002/11/30 04:00 [pubmed]', '2002/12/11 04:00 [medline]', '2002/11/30 04:00 [entrez]']","['S0140673602116497 [pii]', '10.1016/s0140-6736(02)11649-7 [doi]']",ppublish,Lancet. 2002 Nov 23;360(9346):1694; author reply 1695-6. doi: 10.1016/s0140-6736(02)11649-7.,9346,,,,,,,,,,,['Lancet. 2002 Jun 8;359(9322):2027-9. PMID: 12076573'],,,,,,,,,,
7848742,NLM,MEDLINE,19950316,20191023,1041-2972 (Print) 1041-2972 (Linking),6,1994 Nov,Hypertension: complications and problems.,540-8; quiz 549-51,,"['Noel, H']",['Noel H'],,['eng'],['Journal Article'],,United States,J Am Acad Nurse Pract,Journal of the American Academy of Nurse Practitioners,8916634,,"['Cardiovascular Diseases/epidemiology/*etiology/prevention & control', 'Humans', 'Hypertension/*complications/drug therapy/genetics/physiopathology', 'Primary Prevention', 'Risk Factors']",1994/11/01 00:00,1994/11/01 00:01,['1994/11/01 00:00'],"['1994/11/01 00:00 [pubmed]', '1994/11/01 00:01 [medline]', '1994/11/01 00:00 [entrez]']",['10.1111/j.1745-7599.1994.tb00908.x [doi]'],ppublish,J Am Acad Nurse Pract. 1994 Nov;6(11):540-8; quiz 549-51. doi: 10.1111/j.1745-7599.1994.tb00908.x.,11,,,,,,,,,,,,,,,,,,,,,
7348559,NLM,MEDLINE,19830214,20041117,0163-7525 (Print) 0163-7525 (Linking),2,1981,The decline in cardiovascular disease mortality.,49-70,,"['Levy, R I']",['Levy RI'],,['eng'],['Journal Article'],,United States,Annu Rev Public Health,Annual review of public health,8006431,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/*mortality/prevention & control/therapy', 'Coronary Disease/mortality', 'Female', 'Humans', 'Hypertension/diagnosis/therapy', 'Male', 'Middle Aged', 'Risk', 'United States']",1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",['10.1146/annurev.pu.02.050181.000405 [doi]'],ppublish,Annu Rev Public Health. 1981;2:49-70. doi: 10.1146/annurev.pu.02.050181.000405.,,,,,,,,,,,,,,,,,,,,,,
7796491,NLM,MEDLINE,19950731,20190623,0009-7322 (Print) 0009-7322 (Linking),91,1995 Jun 15,Meeting highlights.,2857-61,,"['Ferguson, J J']",['Ferguson JJ'],,['eng'],['News'],,United States,Circulation,Circulation,0147763,IM,"['American Heart Association', 'Cardiovascular Diseases/*diagnosis/*physiopathology/*therapy', 'Drug Delivery Systems', 'Humans']",1995/06/15 00:00,1995/06/15 00:01,['1995/06/15 00:00'],"['1995/06/15 00:00 [pubmed]', '1995/06/15 00:01 [medline]', '1995/06/15 00:00 [entrez]']",['10.1161/01.cir.91.12.2857 [doi]'],ppublish,Circulation. 1995 Jun 15;91(12):2857-61. doi: 10.1161/01.cir.91.12.2857.,12,,,,,,,,,,,,,,,,,,,,,
26634020,NLM,MEDLINE,20160913,20151205,1947-6108 (Electronic) 1947-6094 (Print) 1947-6108 (Linking),11,2015 Jul-Sep,Guest Editor John Cooke Lends Expertise on Special Cardiovascular Regeneration Issue.,153,10.14797/mdcj-11-3-153 [doi],"['Cooke, J P']",['Cooke JP'],,['eng'],"['Biography', 'Historical Article']",,United States,Methodist Debakey Cardiovasc J,Methodist DeBakey cardiovascular journal,101508600,IM,"['Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/*history/pathology/physiopathology/surgery', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Regeneration', 'Regenerative Medicine/*history', 'Stem Cell Transplantation/*history']",2015/12/04 06:00,2016/09/14 06:00,['2015/12/04 06:00'],"['2015/12/04 06:00 [entrez]', '2015/12/04 06:00 [pubmed]', '2016/09/14 06:00 [medline]']",['10.14797/mdcj-11-3-153 [doi]'],ppublish,Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):153. doi: 10.14797/mdcj-11-3-153.,3,,,PMC4666419,,,,,,,,,,,,,['Cooke JP'],"['Cooke, John P']",,,,
20689349,NLM,MEDLINE,20101203,20100817,1423-0348 (Electronic) 0033-3190 (Linking),79,2010,Interview-based ratings of somatic and cognitive symptoms of depression and their impact on cardiovascular prognosis.,319-20,10.1159/000319528 [doi],"['Hoen, Petra W', 'Conradi, Henk Jan', 'Denollet, Johan', 'Martens, Elisabeth J', 'de Jonge, Peter']","['Hoen PW', 'Conradi HJ', 'Denollet J', 'Martens EJ', 'de Jonge P']",,['eng'],"['Letter', ""Research Support, Non-U.S. Gov't""]",20100802,Switzerland,Psychother Psychosom,Psychotherapy and psychosomatics,0024046,IM,"['Cardiovascular Diseases/complications/diagnosis/physiopathology/*psychology', 'Cognition', 'Depressive Disorder/*complications/physiopathology/psychology', 'Humans', 'Interviews as Topic', 'Prognosis', 'Psychiatric Status Rating Scales']",2010/08/07 06:00,2010/12/14 06:00,['2010/08/07 06:00'],"['2010/08/07 06:00 [entrez]', '2010/08/07 06:00 [pubmed]', '2010/12/14 06:00 [medline]']","['000319528 [pii]', '10.1159/000319528 [doi]']",ppublish,Psychother Psychosom. 2010;79(5):319-20. doi: 10.1159/000319528. Epub 2010 Aug 2.,5,,,,,,,,,,,,,,,,,,,,,
23364770,NLM,MEDLINE,20130213,20211021,1476-4687 (Electronic) 0028-0836 (Linking),493,2013 Jan 31,Perspective: The power of disease prevention.,S6,10.1038/493S6a [doi],"['Perk, Joep']",['Perk J'],"['Linnaeus University in Kalmar, Sweden. joep.perk@lnu.se']",['eng'],['Journal Article'],,England,Nature,Nature,0410462,IM,"['Advisory Committees', 'Behavior', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Humans', 'Risk Factors']",2013/02/01 06:00,2013/02/14 06:00,['2013/02/01 06:00'],"['2013/02/01 06:00 [entrez]', '2013/02/01 06:00 [pubmed]', '2013/02/14 06:00 [medline]']","['493S6a [pii]', '10.1038/493S6a [doi]']",ppublish,Nature. 2013 Jan 31;493(7434):S6. doi: 10.1038/493S6a.,7434,,,,,,,,,,,,,,,,,,,,,
23453922,NLM,MEDLINE,20150115,20151119,1665-1731 (Electronic) 1665-1731 (Linking),83,2013 Jan-Mar,Almanac 2012: Cardiovascular risk scores.,72-8,S1405-9940(13)00011-6 [pii] 10.1016/j.acmx.2013.01.006 [doi],"['Pell, Jill P']",['Pell JP'],"['Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, UK. Electronic address: jill.pell@glasgow.ac.uk.']",['eng'],['Journal Article'],,Mexico,Arch Cardiol Mex,Archivos de cardiologia de Mexico,101126728,IM,"['Biomarkers/blood', 'Cardiovascular Diseases/blood/diagnosis/*epidemiology/prevention & control', 'Genetic Markers', 'Humans', 'Risk Assessment']",2013/03/05 06:00,2015/01/16 06:00,['2013/03/05 06:00'],"['2013/01/09 00:00 [received]', '2013/01/15 00:00 [accepted]', '2013/03/05 06:00 [entrez]', '2013/03/05 06:00 [pubmed]', '2015/01/16 06:00 [medline]']","['S1405-9940(13)00011-6 [pii]', '10.1016/j.acmx.2013.01.006 [doi]']",ppublish,Arch Cardiol Mex. 2013 Jan-Mar;83(1):72-8. doi: 10.1016/j.acmx.2013.01.006.,1,,,,,,,,"['0 (Biomarkers)', '0 (Genetic Markers)']",,,,,,,,,,,['Arch Cardiol Mex. 2013 Apr-Jun;83(2):149'],,
12995012,NLM,MEDLINE,20030501,20181201,0370-9590 (Print) 0370-9590 (Linking),28,1952 May 10,[Cardiovascular diseases as an essential factor in mortality statistics].,366-71,,"['DAILHEU-GEOFFROY, P']",['DAILHEU-GEOFFROY P'],,['und'],['Journal Article'],,Argentina,Sem Med,La Semana medica,0404403,OM,"['*Biometry', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data']",1952/05/10 00:00,1952/05/10 00:01,['1952/05/10 00:00'],"['1952/05/10 00:00 [pubmed]', '1952/05/10 00:01 [medline]', '1952/05/10 00:00 [entrez]']",,ppublish,Sem Med. 1952 May 10;28(18):366-71.,18,,,,,['NLM'],['*CARDIOVASCULAR DISEASES/epidemiology and statistics'],,,,,,,,,"Les maladies cardio-vasculaires, facteur essentiel de mortalite.",,,,,['CLML: 5323:19425:105'],
14931781,NLM,MEDLINE,20040215,20181201,0566-0777 (Print) 0566-0777 (Linking),3,1952 Jun,Cardiovascular problems of ambulatory servicemen.,861-8,,"['WEHRMACHER, W H']",['WEHRMACHER WH'],,['eng'],['Journal Article'],,United States,U S Armed Forces Med J,United States Armed Forces medical journal,21410750R,OM,"['*Biometry', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data']",1952/06/01 00:00,1952/06/01 00:01,['1952/06/01 00:00'],"['1952/06/01 00:00 [pubmed]', '1952/06/01 00:01 [medline]', '1952/06/01 00:00 [entrez]']",,ppublish,U S Armed Forces Med J. 1952 Jun;3(6):861-8.,6,,,,,['NLM'],['*CARDIOVASCULAR DISEASES/epidemiology and statistics'],,,,,,,,,,,,,,['CLML: 5222:17839:90'],
16677348,NLM,MEDLINE,20070117,20060508,1397-3142 (Print) 1397-3142 (Linking),10,2006 May,Hypertension and future cardiovascular disease in pediatric renal transplant recipients.,276-8,,"['Flynn, Joseph T']",['Flynn JT'],,['eng'],"['Comment', 'Editorial']",,Denmark,Pediatr Transplant,Pediatric transplantation,9802574,IM,"['Cardiovascular Diseases/*complications/etiology/therapy', 'Child', 'Humans', 'Hypertension/*complications/etiology/therapy', 'Kidney Diseases/*complications/*therapy', 'Kidney Transplantation/*methods']",2006/05/09 09:00,2007/01/18 09:00,['2006/05/09 09:00'],"['2006/05/09 09:00 [pubmed]', '2007/01/18 09:00 [medline]', '2006/05/09 09:00 [entrez]']","['PTR008 [pii]', '10.1111/j.1399-3046.2006.00008.x [doi]']",ppublish,Pediatr Transplant. 2006 May;10(3):276-8. doi: 10.1111/j.1399-3046.2006.00008.x.,3,,,,,,,,,,,"['Pediatr Transplant. 2006 May;10(3):316-22. wrong citation in text; correct', 'pagination 316-22. PMID: 16677355']",,,,,,,,,,
1736463,NLM,MEDLINE,19920312,20060328,0041-5782 (Print) 0041-5782 (Linking),154,1992 Jan 27,"[Cardiovascular diseases in Denmark in the year 2000. Occurrence, treatment and technology, developmental trends].",282-3,,"['Haghfelt, T']",['Haghfelt T'],"['Odense Sygehus, Kardiologisk afdeling B.']",['dan'],['Journal Article'],,Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,IM,"['Cardiology/*trends', 'Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Denmark/epidemiology', 'Forecasting', 'Humans']",1992/01/27 00:00,1992/01/27 00:01,['1992/01/27 00:00'],"['1992/01/27 00:00 [pubmed]', '1992/01/27 00:01 [medline]', '1992/01/27 00:00 [entrez]']",,ppublish,Ugeskr Laeger. 1992 Jan 27;154(5):282-3.,5,,,,,,,,,,,,,,,"Hjerte-kar-sygdomme i Danmark ar 2000. Forekomst, behandling og teknologi, udviklingstendenser.",,,,,,
8611221,NLM,MEDLINE,19960603,20061115,1120-9135 (Print) 1120-9135 (Linking),6,1994 Jul-Dec,[The cardiovascular risk of essential arterial hypertension: general concepts].,501-9,,"['Gallo, P']",['Gallo P'],['Universita degli Studi di Roma La Sapienza.'],['ita'],"['English Abstract', 'Journal Article', 'Review']",,Italy,Ann Ig,Annali di igiene : medicina preventiva e di comunita,9002865,IM,"['Adult', 'Cardiovascular Diseases/diagnosis/epidemiology/*etiology', 'Female', 'Humans', 'Hypertension/*complications/diagnosis/epidemiology', 'Male', 'Middle Aged', 'Risk Factors']",1994/07/01 00:00,1994/07/01 00:01,['1994/07/01 00:00'],"['1994/07/01 00:00 [pubmed]', '1994/07/01 00:01 [medline]', '1994/07/01 00:00 [entrez]']",,ppublish,Ann Ig. 1994 Jul-Dec;6(4-6):501-9.,4-6,,,,,,,,,,43,,,,,Il rischio cardiovascolare dell'ipertensione arteriosa essenziale: concetti generali.,,,,,,
5509403,NLM,MEDLINE,19710601,20081121,0012-0219 (Print) 0012-0219 (Linking),25,1970 Dec 3,[Cardiovascular diseases--current status of their control and prospective tasks].,2303-8,,"['Heine, H', 'Schmidt, H', 'Anders, G']","['Heine H', 'Schmidt H', 'Anders G']",,['ger'],['Journal Article'],,Germany,Dtsch Gesundheitsw,Das Deutsche Gesundheitswesen,0433572,IM,"['Cardiovascular Diseases/epidemiology/etiology/mortality/*prevention & control', 'Germany, East', 'Humans', 'Obesity/complications', 'Smoking/complications', 'Stress, Physiological/complications']",1970/12/03 00:00,1970/12/03 00:01,['1970/12/03 00:00'],"['1970/12/03 00:00 [pubmed]', '1970/12/03 00:01 [medline]', '1970/12/03 00:00 [entrez]']",,ppublish,Dtsch Gesundheitsw. 1970 Dec 3;25(49):2303-8.,49,,,,,,,,,,,,,,,Herz-Kreislauf-Erkrankungen--gegenwartiger Stand ihrer Bekampfung und Aufgaben im Perspektivzeitraum.,,,,,,
6950499,NLM,MEDLINE,19820512,20091111,0080-6722 (Print) 0080-6722 (Linking),38,1981,Arterial thromboembolism in cardiovascular diseases: the therapeutics of today.,1-141,,,,,['eng'],['Journal Article'],,Denmark,Scand J Haematol Suppl,Scandinavian journal of haematology. Supplementum,0104315,IM,"['Cardiovascular Diseases/complications/*therapy', 'Humans', 'Thromboembolism/etiology/*therapy']",1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Scand J Haematol Suppl. 1981;38:1-141.,,,,,,,,,,,,,,,,,,,,,,
3774717,NLM,MEDLINE,19861208,20190501,0032-5473 (Print) 1469-0756 (Electronic) 0032-5473 (Linking),62,1986 Aug,Can we detect an effect of unemployment on cardiovascular morbidity or mortality?,801-4,,"['Cook, D G']",['Cook DG'],,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['Adult', 'Cardiovascular Diseases/etiology/mortality/*psychology', 'Humans', 'Male', 'Michigan', 'Middle Aged', '*Unemployment', 'United Kingdom']",1986/08/01 00:00,1986/08/01 00:01,['1986/08/01 00:00'],"['1986/08/01 00:00 [pubmed]', '1986/08/01 00:01 [medline]', '1986/08/01 00:00 [entrez]']",['10.1136/pgmj.62.730.801 [doi]'],ppublish,Postgrad Med J. 1986 Aug;62(730):801-4. doi: 10.1136/pgmj.62.730.801.,730,,,PMC2418831,,,,,,,,,,,,,,,,,,
24107723,NLM,MEDLINE,20140529,20131010,1473-5598 (Electronic) 0263-6352 (Linking),31,2013 Oct,"Guidelines, organ damage, diagnostic procedures and treatment.",1923-4,10.1097/HJH.0b013e328364dd74 [doi],"['Zanchetti, Alberto']",['Zanchetti A'],"['Istituto Auxologico Italiano and Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Universita di Milano, Milan, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,Netherlands,J Hypertens,Journal of hypertension,8306882,IM,"['Cardiology/*standards', 'Cardiovascular Diseases/*diagnosis/epidemiology/*therapy', 'Europe', 'Humans', 'Hypertension/*diagnosis/epidemiology/*therapy', 'Practice Guidelines as Topic', 'Societies, Medical']",2013/10/11 06:00,2014/05/30 06:00,['2013/10/11 06:00'],"['2013/10/11 06:00 [entrez]', '2013/10/11 06:00 [pubmed]', '2014/05/30 06:00 [medline]']","['00004872-201310000-00001 [pii]', '10.1097/HJH.0b013e328364dd74 [doi]']",ppublish,J Hypertens. 2013 Oct;31(10):1923-4. doi: 10.1097/HJH.0b013e328364dd74.,10,,,,,,,,,,,,,,,,,,,,,
3825468,NLM,MEDLINE,19870409,20070906,0001-7604 (Print) 0001-7604 (Linking),28,1986 Dec,"Psychophysiological reactivity testing for the investigation of cardiovascular diseases. Report of a CIANS Working Group concerning standardisation of procedures, and the need for collaborative studies on transcultural validation.",281-91,,,,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Czech Republic,Act Nerv Super (Praha),Activitas nervosa superior,0400662,IM,"['Cardiovascular Diseases/metabolism/physiopathology/*psychology', 'Humans', '*Personality']",1986/12/01 00:00,1986/12/01 00:01,['1986/12/01 00:00'],"['1986/12/01 00:00 [pubmed]', '1986/12/01 00:01 [medline]', '1986/12/01 00:00 [entrez]']",,ppublish,Act Nerv Super (Praha). 1986 Dec;28(4):281-91.,4,,,,,,,,,,,,,,,,,,,,,
24003504,NLM,MEDLINE,20130924,20191210,0025-8075 (Print) 0025-8075 (Linking),,2013 May-Jun,[Diagnosis and prognosis of cardiovascular diseases on the basis of neural networks].,42-4,,"['Iasnitskii, L N', 'Dumler, A A', 'Bogdanov, K V', 'Poleshchuk, A N', 'Cherepanov, F M', 'Makurina, T V', 'Chugainov, S V']","['Iasnitskii LN', 'Dumler AA', 'Bogdanov KV', 'Poleshchuk AN', 'Cherepanov FM', 'Makurina TV', 'Chugainov SV']",,['rus'],['Journal Article'],,Russia (Federation),Med Tekh,Meditsinskaia tekhnika,1305457,IM,"['Cardiovascular Diseases/*diagnosis/*physiopathology/therapy', 'Humans', '*Neural Networks, Computer', 'Prognosis']",2013/09/06 06:00,2013/09/26 06:00,['2013/09/06 06:00'],"['2013/09/06 06:00 [entrez]', '2013/09/06 06:00 [pubmed]', '2013/09/26 06:00 [medline]']",,ppublish,Med Tekh. 2013 May-Jun;(3):42-4.,3,,,,,,,,,,,,,,,,,,,,,
21464339,NLM,MEDLINE,20110621,20130625,1539-3704 (Electronic) 0003-4819 (Linking),154,2011 Apr 19,Update in cardiology: evidence published in 2010.,549-53,10.7326/0003-4819-154-8-201104190-00338 [doi],"['Redberg, Rita F']",['Redberg RF'],"['University of California, San Francisco, CA, USA. redberg@medicine.ucsf.edu']",['eng'],"['Journal Article', 'Review']",20110404,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Cardiovascular Diseases/*diagnosis/genetics/prevention & control/*therapy', 'Diabetic Angiopathies/therapy', 'Diagnostic Imaging', 'Humans']",2011/04/06 06:00,2011/06/22 06:00,['2011/04/06 06:00'],"['2011/04/06 06:00 [entrez]', '2011/04/06 06:00 [pubmed]', '2011/06/22 06:00 [medline]']","['0003-4819-154-8-201104190-00338 [pii]', '10.7326/0003-4819-154-8-201104190-00338 [doi]']",ppublish,Ann Intern Med. 2011 Apr 19;154(8):549-53. doi: 10.7326/0003-4819-154-8-201104190-00338. Epub 2011 Apr 4.,8,,,,,,,,,,,,,,,,,,,,,
7373817,NLM,MEDLINE,19800722,20190630,0098-7484 (Print) 0098-7484 (Linking),243,1980 Jun 20,Water hardness and cardiovascular mortality. An idea that has served its purpose.,2399-400,,"['Hammer, D I', 'Heyden, S']","['Hammer DI', 'Heyden S']",,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,IM,"['Cardiovascular Diseases/epidemiology/etiology/*mortality/prevention & control', 'Hardness', 'Humans', 'Risk', 'United States', 'Water Softening', '*Water Supply']",1980/06/20 00:00,1980/06/20 00:01,['1980/06/20 00:00'],"['1980/06/20 00:00 [pubmed]', '1980/06/20 00:01 [medline]', '1980/06/20 00:00 [entrez]']",['10.1001/jama.1980.03300490017018 [doi]'],ppublish,JAMA. 1980 Jun 20;243(23):2399-400. doi: 10.1001/jama.1980.03300490017018.,23,,,,,,,,,,,,,,,,,,,,,
18551001,NLM,MEDLINE,20081023,20080613,0263-6352 (Print) 0263-6352 (Linking),26,2008 Jul,Impaired baroreflex sensitivity as a potential marker of cardiovascular risk in hypertension.,1303-4,10.1097/HJH.0b013e328305e1a5 [doi],"['Narkiewicz, Krzysztof', 'Grassi, Guido']","['Narkiewicz K', 'Grassi G']","['Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland. knark@amg.gda.pl']",['eng'],"['Comment', 'Journal Article']",,Netherlands,J Hypertens,Journal of hypertension,8306882,IM,"['Baroreflex/*physiology', 'Cardiovascular Diseases/epidemiology/etiology/physiopathology', 'Humans', 'Hypertension/complications/*physiopathology', 'Predictive Value of Tests']",2008/06/14 09:00,2008/10/24 09:00,['2008/06/14 09:00'],"['2008/06/14 09:00 [pubmed]', '2008/10/24 09:00 [medline]', '2008/06/14 09:00 [entrez]']","['00004872-200807000-00006 [pii]', '10.1097/HJH.0b013e328305e1a5 [doi]']",ppublish,J Hypertens. 2008 Jul;26(7):1303-4. doi: 10.1097/HJH.0b013e328305e1a5.,7,,,,,,,,,,,['J Hypertens. 2008 Jul;26(7):1373-8. PMID: 18551013'],,,,,,,,,,
31180744,NLM,MEDLINE,20200316,20200316,1524-4539 (Electronic) 0009-7322 (Linking),139,2019 Jun 11,Highlights of the American College of Cardiology Annual Scientific Sessions 2019.,2793-2795,10.1161/CIRCULATIONAHA.119.041572 [doi],"['Kates, Andrew M', 'Morris, Pamela B']","['Kates AM', 'Morris PB']","['Washington University School of Medicine, St. Louis, MO (A.M.K.).', 'Medical University of South Carolina, Charleston (P.B.M.).']",['eng'],['Congress'],20190610,United States,Circulation,Circulation,0147763,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Diffusion of Innovation', 'Humans']",2019/06/11 06:00,2020/03/17 06:00,['2019/06/11 06:00'],"['2019/06/11 06:00 [entrez]', '2019/06/11 06:00 [pubmed]', '2020/03/17 06:00 [medline]']",['10.1161/CIRCULATIONAHA.119.041572 [doi]'],ppublish,Circulation. 2019 Jun 11;139(24):2793-2795. doi: 10.1161/CIRCULATIONAHA.119.041572. Epub 2019 Jun 10.,24,,,,,,,,,,,,,,,,,,,,,
9270322,NLM,MEDLINE,19971001,20191102,0084-2230 (Print) 0084-2230 (Linking),82,1997,Physical activity in the prevention and management of cardiovascular disease.,191-209,,"['Birrer, R B']",['Birrer RB'],"['Catholic Medical Center of Brooklyn and Queens, Jamaica, N.Y., USA.']",['eng'],"['Journal Article', 'Review']",,Switzerland,World Rev Nutr Diet,World review of nutrition and dietetics,0117263,IM,"['Aging', 'Cardiovascular Diseases/epidemiology/*prevention & control/*therapy', '*Exercise', 'Humans']",1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",['10.1159/000059637 [doi]'],ppublish,World Rev Nutr Diet. 1997;82:191-209. doi: 10.1159/000059637.,,,,,,,,,,,45,,,,,,,,,,,
28446471,NLM,MEDLINE,20190610,20190613,1524-4636 (Electronic) 1079-5642 (Linking),37,2017 May,ATVB Named Lecture Review-Insight Into Author: Hiroaki Shimokawa.,780,10.1161/ATV.0000000000000053 [doi],,,,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait']",,United States,Arterioscler Thromb Vasc Biol,"Arteriosclerosis, thrombosis, and vascular biology",9505803,IM,"['Biomedical Research/*history', 'Cardiovascular Diseases/*history/pathology/physiopathology/therapy', 'Career Choice', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Mentors/history']",2017/04/28 06:00,2019/06/14 06:00,['2017/04/28 06:00'],"['2017/04/28 06:00 [entrez]', '2017/04/28 06:00 [pubmed]', '2019/06/14 06:00 [medline]']","['ATV.0000000000000053 [pii]', '10.1161/ATV.0000000000000053 [doi]']",ppublish,Arterioscler Thromb Vasc Biol. 2017 May;37(5):780. doi: 10.1161/ATV.0000000000000053.,5,,,,,,,,,,,,,,,,['Shimokawa H'],"['Shimokawa, Hiroaki']",,,,
16354233,NLM,MEDLINE,20060228,20160511,1328-8067 (Print) 1328-8067 (Linking),47,2005 Dec,Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease.,711-32,,,,,['eng'],"['Journal Article', 'Practice Guideline']",,Australia,Pediatr Int,Pediatrics international : official journal of the Japan Pediatric Society,100886002,IM,"['Cardiovascular Diseases/*diagnosis/etiology/*therapy', 'Humans', 'Mucocutaneous Lymph Node Syndrome/*complications']",2005/12/16 09:00,2006/03/01 09:00,['2005/12/16 09:00'],"['2005/12/16 09:00 [pubmed]', '2006/03/01 09:00 [medline]', '2005/12/16 09:00 [entrez]']","['PED2149 [pii]', '10.1111/j.1442-200x.2005.02149.x [doi]']",ppublish,Pediatr Int. 2005 Dec;47(6):711-32. doi: 10.1111/j.1442-200x.2005.02149.x.,6,,,,,,,,,,,,,,['Japanese Circulation Society Joint Research Group'],,,,,,,
4555352,NLM,MEDLINE,19720801,20151119,0026-3745 (Print) 0026-3745 (Linking),50,1972 Jan,The relation of thromboembolic disease to cardiovascular disease.,Suppl 2:89-104,,"['Kuller, L']",['Kuller L'],,['eng'],"['Journal Article', 'Review']",,United States,Milbank Mem Fund Q,The Milbank Memorial Fund quarterly,0377263,IM,"['Autopsy', 'Blood Group Antigens', 'Cardiovascular Diseases/*complications/diagnosis/epidemiology/etiology/pathology', 'Environment', 'Fibrinogen', 'Humans', 'Iodine Radioisotopes', 'Myocardial Infarction/complications', 'Obesity/complications', 'Posture', 'Pulmonary Embolism/complications', 'Stress, Physiological/complications', 'Thromboembolism/*complications/diagnosis/epidemiology/etiology/pathology', 'Thrombophlebitis/complications']",1972/01/01 00:00,1972/01/01 00:01,['1972/01/01 00:00'],"['1972/01/01 00:00 [pubmed]', '1972/01/01 00:01 [medline]', '1972/01/01 00:00 [entrez]']",,ppublish,Milbank Mem Fund Q. 1972 Jan;50(1):Suppl 2:89-104.,1,,,,,,,,"['0 (Blood Group Antigens)', '0 (Iodine Radioisotopes)', '9001-32-5 (Fibrinogen)']",,28,,,,,,,,,,,
23534107,NLM,MEDLINE,20130502,20130328,1660-9379 (Print) 1660-9379 (Linking),9,2013 Mar 6,[All men are equal...but there are some more equal than others].,491,,"['Zimmermann, M', 'Urban, P']","['Zimmermann M', 'Urban P']",,['fre'],['Editorial'],,Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,IM,"['Cardiovascular Diseases/epidemiology/genetics/*physiopathology', 'Female', 'Humans', 'Male', 'Prognosis', 'Sex Factors']",2013/03/29 06:00,2013/05/03 06:00,['2013/03/29 06:00'],"['2013/03/29 06:00 [entrez]', '2013/03/29 06:00 [pubmed]', '2013/05/03 06:00 [medline]']",,ppublish,Rev Med Suisse. 2013 Mar 6;9(376):491.,376,,,,,,,,,,,,,,,Tous les hommes sont egaux...mais it y en a qui sont plus egaux que d'autres..,,,,,,
9444296,NLM,MEDLINE,19980204,20091119,0828-282X (Print) 0828-282X (Linking),13,1997 Dec,When knowing enough is not enough.,1160-1,,"['Hux, J E', 'Naylor, C D']","['Hux JE', 'Naylor CD']",,['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",,England,Can J Cardiol,The Canadian journal of cardiology,8510280,IM,"['Canada', 'Cardiovascular Diseases/*diagnosis/surgery/therapy', 'Humans', 'Medicine', 'Specialization', '*Thoracic Surgery']",1998/01/28 00:00,1998/01/28 00:01,['1998/01/28 00:00'],"['1998/01/28 00:00 [pubmed]', '1998/01/28 00:01 [medline]', '1998/01/28 00:00 [entrez]']",,ppublish,Can J Cardiol. 1997 Dec;13(12):1160-1.,12,,,,,,,,,,,,,,,,,,,,,
31638159,NLM,MEDLINE,20200728,20200728,1755-3245 (Electronic) 0008-6363 (Linking),115,2019 Nov 1,Highlights of ESC Congress 2019: a report from the ESC Scientists of Tomorrow.,e151-e154,10.1093/cvr/cvz266 [doi],"['Abdellatif, Mahmoud', 'Patel, Jyoti', 'Smits, Anke M']","['Abdellatif M', 'Patel J', 'Smits AM']","['Department of Cardiology, Medical University of Graz, Graz, Austria.', 'Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Cardiovascular Cell Biology, Department of Cell and Chemical Biology, Postzone S-1-P, Leiden University Medical Center, RC, Leiden, The Netherlands.']",['eng'],['Congress'],,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Animals', 'Biomedical Research/*trends', 'Cardiology/*trends', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Diffusion of Innovation', 'Humans']",2019/10/23 06:00,2020/07/29 06:00,['2019/10/23 06:00'],"['2019/10/23 06:00 [entrez]', '2019/10/23 06:00 [pubmed]', '2020/07/29 06:00 [medline]']","['5602244 [pii]', '10.1093/cvr/cvz266 [doi]']",ppublish,Cardiovasc Res. 2019 Nov 1;115(13):e151-e154. doi: 10.1093/cvr/cvz266.,13,,,,,,,,,,,,,,,,,,,,,
12556666,NLM,MEDLINE,20030508,20221207,1524-6175 (Print) 1751-7176 (Electronic) 1524-6175 (Linking),5,2003 Jan-Feb,Introduction: management of hypertension and cardiovascular risk factors in African Americans.,3-4,,"['Ferdinand, Keith C']",['Ferdinand KC'],"['Heartbeats Life Center, New Orleans, LA 70117, USA.']",['eng'],['Journal Article'],,United States,J Clin Hypertens (Greenwich),"Journal of clinical hypertension (Greenwich, Conn.)",100888554,IM,"['*Black or African American', 'Cardiovascular Diseases/epidemiology/*ethnology/therapy', 'Humans', 'Hypertension/epidemiology/*ethnology/therapy', 'Risk Factors']",2003/01/31 04:00,2003/05/09 05:00,['2003/01/31 04:00'],"['2003/01/31 04:00 [pubmed]', '2003/05/09 05:00 [medline]', '2003/01/31 04:00 [entrez]']","['JCH2016 [pii]', '10.1111/j.1524-6175.2003.02016.x [doi]']",ppublish,J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1 Suppl 1):3-4. doi: 10.1111/j.1524-6175.2003.02016.x.,1 Suppl 1,,,PMC8099259,,,,,,,,,,,,,,,,,,
15226247,NLM,MEDLINE,20040728,20151119,1524-4539 (Electronic) 0009-7322 (Linking),109,2004 Jun 29,Introduction to surrogate markers.,IV20-1,,"['Cohn, Jay N']",['Cohn JN'],"['Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.']",['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Arteriosclerosis/complications', 'Biomarkers/analysis', 'Cardiovascular Diseases/*diagnosis/etiology/therapy', 'Disease Progression', 'Humans', 'Thrombosis/complications']",2004/07/01 05:00,2004/07/29 05:00,['2004/07/01 05:00'],"['2004/07/01 05:00 [pubmed]', '2004/07/29 05:00 [medline]', '2004/07/01 05:00 [entrez]']","['109/25_suppl_1/IV-20 [pii]', '10.1161/01.CIR.0000133441.05780.1d [doi]']",ppublish,Circulation. 2004 Jun 29;109(25 Suppl 1):IV20-1. doi: 10.1161/01.CIR.0000133441.05780.1d.,25 Suppl 1,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
10345256,NLM,MEDLINE,19990316,20041117,1099-8128 (Print) 1099-8128 (Linking),1,1998 Aug-Sep,Blood pressure control to reduce cardiovascular morbidity and mortality: today and tomorrow.,23-5,,"['Alderman, M H']",['Alderman MH'],"['Albert Einstein College of Medicine, Bronx, NY, USA.']",['eng'],['Journal Article'],,United States,Eff Clin Pract,Effective clinical practice : ECP,9815774,,"['Cardiovascular Diseases/etiology/mortality/*physiopathology', 'Community Health Planning', '*Disease Management', 'Humans', 'Hypertension/complications/diagnosis/*therapy', 'Risk Factors', 'United States']",1999/05/27 00:00,1999/05/27 00:01,['1999/05/27 00:00'],"['1999/05/27 00:00 [pubmed]', '1999/05/27 00:01 [medline]', '1999/05/27 00:00 [entrez]']",,ppublish,Eff Clin Pract. 1998 Aug-Sep;1(1):23-5.,1,,,,,,,,,,,,,,,,,,,,,
19635253,NLM,MEDLINE,20091116,20090728,0014-2565 (Print) 0014-2565 (Linking),209,2009 Jun,[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation].,279-302,,"['Lobos, J M', 'Royo-Bordonada, M A', 'Brotons, C', 'Alvarez-Sala, L', 'Armario, P', 'Maiques, A', 'Mauricio, D', 'Sans, S', 'Villar, F', 'Lizcano, A', 'Gil-Nunez, A', 'de Alvaro, F', 'Conthe, P', 'Luengo, E', 'Del Rio, A', 'Cortes, O', 'de Santiago, A', 'Varga, M A', 'Martinez, M', 'Lizarbe, V']","['Lobos JM', 'Royo-Bordonada MA', 'Brotons C', 'Alvarez-Sala L', 'Armario P', 'Maiques A', 'Mauricio D', 'Sans S', 'Villar F', 'Lizcano A', 'Gil-Nunez A', 'de Alvaro F', 'Conthe P', 'Luengo E', 'Del Rio A', 'Cortes O', 'de Santiago A', 'Varga MA', 'Martinez M', 'Lizarbe V']","['Sociedad Espanola de Medicina de Familia y Comunitaria, Espana. jmlobos@telefonica.net']",['spa'],"['English Abstract', 'Journal Article', 'Practice Guideline']",,Spain,Rev Clin Esp,Revista clinica espanola,8608576,IM,"['Behavior', 'Cardiovascular Diseases/blood/diagnosis/etiology/*prevention & control/psychology/therapy', 'Humans', 'Hypertension/complications/therapy', 'Risk Factors', 'Socioeconomic Factors', 'Spain']",2009/07/29 09:00,2009/11/17 06:00,['2009/07/29 09:00'],"['2009/07/29 09:00 [entrez]', '2009/07/29 09:00 [pubmed]', '2009/11/17 06:00 [medline]']",['S0014-2565(09)71477-8 [pii]'],ppublish,Rev Clin Esp. 2009 Jun;209(6):279-302.,6,"The present CEIPC Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to prevent premature mortality and morbidity due to CVD by means of dealing with its related risk factors in clinical practice. The guide focuses on primary prevention and emphasizes the role of the nurses and primary care doctors in promoting a healthy life style, based on increasing physical activity, changing dietary habits, and not smoking. The therapeutic goal is to achieve a Blood Pressure < 140/90 mmHg, but in patients with diabetes, chronic kidney disease, or definite CVD, the objective is < 130/80 mmHg. Serum cholesterol should be < 200 mg/dl and cLDL < 130 mg/dl, although in patients with CVD or diabetes, the objective is < 100 mg/dl (80 mg/dl if feasible in very high-risk patients). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, and drugs must be administered whenever applicable, with the objective guided by body mass index and waist circumference. In diabetic type 2 patients, the objective is glycated haemoglobin < 7%. Allowing people to know the guides and developing implementation programs, identifying barriers and seeking solutions for them, are priorities for the CEIPC in order to put the recommendations into practice.",,,,,,,,,,,,,['Comite Espanol Interdisciplinario para la Prevencion Cardiovascular'],Guia Europea de Prevencion Cardiovascular en la Practica Clinica. Adaptacion espanola del CEIPC 2008.,,,,,,
29101265,NLM,MEDLINE,20190114,20190114,1468-201X (Electronic) 1355-6037 (Linking),104,2018 Jun,ECG screening in athletes: differing views from two sides of the Atlantic.,1037-1043,10.1136/heartjnl-2016-309448 [doi],"['Lampert, Rachel']",['Lampert R'],,['eng'],['Journal Article'],20171103,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*Athletes', 'Cardiovascular Diseases/complications/*diagnosis/mortality/physiopathology', 'Clinical Decision-Making', 'Death, Sudden, Cardiac/*etiology', '*Electrocardiography', 'Humans', 'Patient Selection', 'Predictive Value of Tests', 'Prognosis', 'Risk Assessment', 'Risk Factors']",2017/11/05 06:00,2019/01/15 06:00,['2017/11/05 06:00'],"['2017/03/23 00:00 [received]', '2017/07/27 00:00 [revised]', '2017/09/17 00:00 [accepted]', '2017/11/05 06:00 [pubmed]', '2019/01/15 06:00 [medline]', '2017/11/05 06:00 [entrez]']","['heartjnl-2016-309448 [pii]', '10.1136/heartjnl-2016-309448 [doi]']",ppublish,Heart. 2018 Jun;104(12):1037-1043. doi: 10.1136/heartjnl-2016-309448. Epub 2017 Nov 3.,12,,,,['Competing interests: None declared.'],['NOTNLM'],"['ecg/electrocardiogram', 'electrocardiography']",,,,,,,,,,,,,,,
23160402,NLM,MEDLINE,20130417,20121119,1473-6535 (Electronic) 0957-9672 (Linking),23,2012 Dec,Current world literature.,576-9,10.1097/MOL.0b013e32835b899e [doi],,,,['eng'],['Bibliography'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['*Cardiovascular Diseases/blood/drug therapy/epidemiology', 'Clinical Trials as Topic', 'Humans']",2012/11/20 06:00,2013/04/18 06:00,['2012/11/20 06:00'],"['2012/11/20 06:00 [entrez]', '2012/11/20 06:00 [pubmed]', '2013/04/18 06:00 [medline]']","['00041433-201212000-00011 [pii]', '10.1097/MOL.0b013e32835b899e [doi]']",ppublish,Curr Opin Lipidol. 2012 Dec;23(6):576-9. doi: 10.1097/MOL.0b013e32835b899e.,6,,,,,,,,,,,,,,,,,,,,,
32406489,NLM,MEDLINE,20210208,20210208,1755-3245 (Electronic) 0008-6363 (Linking),116,2020 Jun 1,Highlights from the first ever virtual American College of Cardiology World Congress of Cardiology 2020 (ACC.20/WCC).,e75-e77,10.1093/cvr/cvaa099 [doi],"['Leucker, Thorsten M']",['Leucker TM'],"['Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Blalock 547 600 N. Wolfe Street, Baltimore, MD 21287, USA.']",['eng'],['Congress'],,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['*Biomedical Research', '*Cardiology', 'Cardiovascular Diseases/diagnosis/physiopathology/*therapy', 'Humans', '*Telecommunications']",2020/05/15 06:00,2021/02/09 06:00,['2020/05/15 06:00'],"['2020/05/15 06:00 [pubmed]', '2021/02/09 06:00 [medline]', '2020/05/15 06:00 [entrez]']","['5836933 [pii]', '10.1093/cvr/cvaa099 [doi]']",ppublish,Cardiovasc Res. 2020 Jun 1;116(7):e75-e77. doi: 10.1093/cvr/cvaa099.,7,,,,,['NOTNLM'],"['American College of Cardiology', 'Cardiology', 'Cardiovascular medicine', 'Cardiovascular research', 'Clinical trials']",,,,,,,,,,,,,,,
14132687,NLM,MEDLINE,19961201,20181201,0025-7869 (Print) 0025-7869 (Linking),16,1964 Jan,[HEPARIN IN CARDIOVASCULAR THERAPEUTICS].,1-12,,"['D OCZY, P', 'SZIGETI, I']","['D OCZY P', 'SZIGETI I']",,['rum'],['Journal Article'],,Romania,Med Interna (Bucur),Medicina interna,7503144,OM,"['*Angina Pectoris', '*Arteriosclerosis', '*Cardiovascular Diseases', '*Embolism', '*Heparin', 'Humans', '*Myocardial Infarction', '*Phlebitis', '*Thromboembolism', '*Thrombophlebitis', '*Varicose Veins']",1964/01/01 00:00,1964/01/01 00:01,['1964/01/01 00:00'],"['1964/01/01 00:00 [pubmed]', '1964/01/01 00:01 [medline]', '1964/01/01 00:00 [entrez]']",,ppublish,Med Interna (Bucur). 1964 Jan;16:1-12.,,,,,,['NLM'],"['*ANGINA PECTORIS', '*ARTERIOSCLEROSIS', '*CARDIOVASCULAR DISEASES', '*EMBOLISM', '*HEPARIN', '*MYOCARDIAL INFARCT', '*PHLEBITIS', '*THROMBOEMBOLISM', '*THROMBOPHLEBITIS', '*VARICOSE VEINS']",,['9005-49-6 (Heparin)'],,,,,,,HEPARINA IN TERAPEUTICA CARDIOVASCULAR A.,,,,,,
16717160,NLM,MEDLINE,20060602,20060523,1524-4539 (Electronic) 0009-7322 (Linking),113,2006 May 23,Cardiovascular disease management in Ireland.,f77-8,,"['Power, Sean', 'Shelley, Emer']","['Power S', 'Shelley E']","['Department of Health and Children, Dublin.']",['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/economics/epidemiology/prevention & control/*therapy', 'Humans', 'Ireland', 'Smoking Cessation/legislation & jurisprudence']",2006/05/24 09:00,2006/06/03 09:00,['2006/05/24 09:00'],"['2006/05/24 09:00 [pubmed]', '2006/06/03 09:00 [medline]', '2006/05/24 09:00 [entrez]']",['113/20/f77 [pii]'],ppublish,Circulation. 2006 May 23;113(20):f77-8.,20,,,,,,,,,,,,,,,,,,,,,
10069778,NLM,MEDLINE,19990413,20190623,0009-7322 (Print) 0009-7322 (Linking),99,1999 Mar 9,"Epidemic of cardiovascular disease and stroke: the three main challenges. Presented at the 71st scientific sessions of the American Heart Association. Dallas, Texas.",1132-7,,"['Fuster, V']",['Fuster V'],,['eng'],['Address'],,United States,Circulation,Circulation,0147763,IM,"['Asia', 'Canada', 'Cardiovascular Diseases/economics/*epidemiology/prevention & control/therapy', 'Cerebrovascular Disorders/economics/*epidemiology/prevention & control/therapy', '*Disease Outbreaks/economics/prevention & control', 'Europe', 'Female', 'Humans', 'Male', 'Research Design', 'United States']",1999/03/09 00:00,1999/03/09 00:01,['1999/03/09 00:00'],"['1999/03/09 00:00 [pubmed]', '1999/03/09 00:01 [medline]', '1999/03/09 00:00 [entrez]']",['10.1161/01.cir.99.9.1132 [doi]'],ppublish,Circulation. 1999 Mar 9;99(9):1132-7. doi: 10.1161/01.cir.99.9.1132.,9,,,,,,,,,,,,,,,,,,,,,
31092677,NLM,MEDLINE,20200525,20200525,1468-201X (Electronic) 1355-6037 (Linking),105,2019 Jun,"The British Cardiovascular Society Annual Conference Manchester, 3-5 June 2019: the vice president's message.",807-808,10.1136/heartjnl-2019-315334 [doi],"['Greenwood, John P']",['Greenwood JP'],"['Department of Cardiology, Leeds General Infirmary, Leeds, UK.', 'Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.']",['eng'],['Journal Article'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Animals', '*Biomedical Research', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', '*Congresses as Topic', 'Humans', 'Societies, Medical']",2019/05/17 06:00,2020/05/26 06:00,['2019/05/17 06:00'],"['2019/05/17 06:00 [entrez]', '2019/05/17 06:00 [pubmed]', '2020/05/26 06:00 [medline]']","['heartjnl-2019-315334 [pii]', '10.1136/heartjnl-2019-315334 [doi]']",ppublish,Heart. 2019 Jun;105(11):807-808. doi: 10.1136/heartjnl-2019-315334.,11,,,,['Competing interests: None declared.'],['NOTNLM'],['heart disease'],,,,,,,,,,,,,,,
20625258,NLM,MEDLINE,20101008,20100713,1473-6535 (Electronic) 0957-9672 (Linking),21,2010 Aug,Current Opinion in Lipidology. Current world literature.,378-85,10.1097/MOL.0b013e32833ccff4 [doi],,,,['eng'],['Bibliography'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Animals', '*Cardiovascular Diseases/drug therapy/metabolism/pathology/physiopathology', 'Humans', '*Lipid Metabolism']",2010/07/14 06:00,2010/10/12 06:00,['2010/07/14 06:00'],"['2010/07/14 06:00 [entrez]', '2010/07/14 06:00 [pubmed]', '2010/10/12 06:00 [medline]']","['00041433-201008000-00015 [pii]', '10.1097/MOL.0b013e32833ccff4 [doi]']",ppublish,Curr Opin Lipidol. 2010 Aug;21(4):378-85. doi: 10.1097/MOL.0b013e32833ccff4.,4,,,,,,,,,,,,,,,,,,,,,
10554708,NLM,MEDLINE,19991124,20061115,0957-9672 (Print) 0957-9672 (Linking),10,1999 Oct,Bibliography. Current world literature. Hyperlipidaemia and cardiovascular disease.,449-63,,,,,['eng'],['Bibliography'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Cardiovascular Diseases/*complications/physiopathology/prevention & control', 'Humans', 'Hyperlipidemias/*complications']",1999/11/11 00:00,1999/11/11 00:01,['1999/11/11 00:00'],"['1999/11/11 00:00 [pubmed]', '1999/11/11 00:01 [medline]', '1999/11/11 00:00 [entrez]']",,ppublish,Curr Opin Lipidol. 1999 Oct;10(5):449-63.,5,,,,,,,,,,,,,,,,,,,,,
2284725,NLM,MEDLINE,19910320,20090225,0026-9050 (Print) 0026-9050 (Linking),,1990 Oct,[The effect of earthquakes on the cardiovascular system].,20-2,,"['Chikovani, S I']",['Chikovani SI'],,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Voen Med Zh,Voenno-meditsinskii zhurnal,2984871R,IM,"['Cardiovascular Diseases/epidemiology/etiology/physiopathology', 'Cardiovascular System/*physiopathology', 'Cerebrovascular Disorders/epidemiology/etiology/physiopathology', '*Disasters', 'Humans', 'Incidence']",1990/10/01 00:00,1990/10/01 00:01,['1990/10/01 00:00'],"['1990/10/01 00:00 [pubmed]', '1990/10/01 00:01 [medline]', '1990/10/01 00:00 [entrez]']",,ppublish,Voen Med Zh. 1990 Oct;(10):20-2.,10,,,,,,,,,,18,,,,,Vliianie zemletriasenii na serdechno-sosudistuiu sistemu.,,,,,,
15633911,NLM,MEDLINE,20050929,20161020,1122-0643 (Print) 1122-0643 (Linking),62,2004 Sep,[Consensus document: secondary prevention].,191-5,,"['Griffo, Raffaele', 'Temporelli, Pier Luigi', 'Abrignani, Maurizio G', 'Colivicchi, Furio']","['Griffo R', 'Temporelli PL', 'Abrignani MG', 'Colivicchi F']","['UOC Cardiologia Riabilitativa, Ospedale La Colletta, Via del Giappone, 16011 Arenzano, GE. raffagriffo@tiscali.it']",['ita'],"['Consensus Development Conference', 'Journal Article', 'Review']",,Italy,Monaldi Arch Chest Dis,Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,9307314,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Humans']",2005/01/07 09:00,2005/09/30 09:00,['2005/01/07 09:00'],"['2005/01/07 09:00 [pubmed]', '2005/09/30 09:00 [medline]', '2005/01/07 09:00 [entrez]']",['10.4081/monaldi.2004.667 [doi]'],ppublish,Monaldi Arch Chest Dis. 2004 Sep;62(3):191-5. doi: 10.4081/monaldi.2004.667.,3,,,,,,,,,,24,,,,"['Gruppo Italiano di Cardiologia Riabilitativa e Preventiva', 'Area Prevenzione Cardiovascolare A.N.M.C.O']",Documento di consenso: la prevenzione secondaria.,,,,,,
14102526,NLM,MEDLINE,19961201,20181201,0039-3924 (Print) 0039-3924 (Linking),14,1963,[RICKETTSIAL OR PARARICKETTSIAL ETIOLOGY OF CARDIOVASCULAR DISEASES].,437-56,,"['NICOLAU, S S', 'SURDAN, C', 'SARATEANU, D', 'ATHANASIU, P', 'SORODOC, G', 'POPESCU-DANESCU, G']","['NICOLAU SS', 'SURDAN C', 'SARATEANU D', 'ATHANASIU P', 'SORODOC G', 'POPESCU-DANESCU G']",,['rum'],['Journal Article'],,Romania,Stud Cercet Endocrinol,Studii si cercetari de endocrinologie,7908548,OM,"['*Arrhythmias, Cardiac', '*Arteriosclerosis', '*Arteritis', '*Bundle-Branch Block', '*Cardiovascular Diseases', '*Coronary Disease', '*Endocarditis', '*Heart Defects, Congenital', '*Heart Failure', 'Humans', '*Myocardial Infarction', '*Myocarditis', '*Pericarditis', '*Raynaud Disease', '*Rickettsia Infections', '*Thrombophlebitis']",1963/01/01 00:00,1963/01/01 00:01,['1963/01/01 00:00'],"['1963/01/01 00:00 [pubmed]', '1963/01/01 00:01 [medline]', '1963/01/01 00:00 [entrez]']",,ppublish,Stud Cercet Endocrinol. 1963;14:437-56.,,,,,,['NLM'],"['*ARRHYTHMIA', '*ARTERIOSCLEROSIS', '*ARTERITIS', '*BUNDLE-BRANCH BLOCK', '*CARDIOVASCULAR DISEASES', '*CORONARY DISEASE', '*ENDOCARDITIS', '*HEART DEFECTS, CONGENITAL', '*HEART FAILURE, CONGESTIVE', '*MYOCARDIAL INFARCT', '*MYOCARDITIS', '*PERICARDITIS', ""*RAYNAUD'S DISEASE"", '*RICKETTSIAL DISEASES', '*THROMBOPHLEBITIS']",,,,,,,,,ETIOLOGIE RICKETTSIAN A SAU PARARICKETTSIAN A 'IN AFEC TIUNI CARDIOVASCULARE.,,,,,,
2925417,NLM,MEDLINE,19890427,20061115,0147-9563 (Print) 0147-9563 (Linking),18,1989 Mar,The senescent heart.,206-11,,"['Valle, B K', 'Lemberg, L']","['Valle BK', 'Lemberg L']","['Department of Medicine, University of Miami School of Medicine, FL 33101.']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Heart Lung,Heart & lung : the journal of critical care,0330057,IM,"['Aged', 'Aged, 80 and over', 'Aging/*physiology', 'Cardiovascular Diseases/epidemiology/*etiology/physiopathology/therapy', 'Female', 'Humans', 'Male', 'Prognosis', 'Risk Factors']",1989/03/01 00:00,1989/03/01 00:01,['1989/03/01 00:00'],"['1989/03/01 00:00 [pubmed]', '1989/03/01 00:01 [medline]', '1989/03/01 00:00 [entrez]']",,ppublish,Heart Lung. 1989 Mar;18(2):206-11.,2,"There are changes in the elderly population that make them more vulnerable to disease, react differently to disease, and respond differently to drugs. The changes that occur in the geriatric population are (1) general physical deconditioning, (2) blunted physiologic response to change, (3) decreased resilience, and (4) degenerative changes common to aging. Appreciation of these changes helps in the diagnoses, management, and evaluation of prognosis in the senescent patient.",,,,,,,,,,,,,,,,,,,,
6015214,NLM,MEDLINE,19701211,20041117,0070-4075 (Print) 0070-4075 (Linking),32,1966,[Epidemiologic methods in cardiovascular diseases].,67-73,,"['Holland, W W']",['Holland WW'],,['ger'],['Journal Article'],,Germany,Verh Dtsch Ges Kreislaufforsch,Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,7503703,IM,"['Analysis of Variance', 'Cardiovascular Diseases/diagnosis/*epidemiology/etiology', 'Epidemiologic Methods/*standards', 'Humans']",1966/01/01 00:00,1966/01/01 00:01,['1966/01/01 00:00'],"['1966/01/01 00:00 [pubmed]', '1966/01/01 00:01 [medline]', '1966/01/01 00:00 [entrez]']",,ppublish,Verh Dtsch Ges Kreislaufforsch. 1966;32:67-73.,,,,,,,,,,,,,,,,Epidemiologische Methoden bei Kreislauferkrankungen.,,,,,,
4727655,NLM,MEDLINE,19731101,20110113,0048-7848 (Print) 0048-7848 (Linking),77,1973 Apr-Jun,[Prevention of degenerative cardiovascular diseases].,209-14,,"['Creteanu, G', 'Lacatis, D']","['Creteanu G', 'Lacatis D']",,['rum'],['Journal Article'],,Romania,Rev Med Chir Soc Med Nat Iasi,Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,0413735,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Humans']",1973/04/01 00:00,1973/04/01 00:01,['1973/04/01 00:00'],"['1973/04/01 00:00 [pubmed]', '1973/04/01 00:01 [medline]', '1973/04/01 00:00 [entrez]']",,ppublish,Rev Med Chir Soc Med Nat Iasi. 1973 Apr-Jun;77(2):209-14.,2,,,,,,,,,,,,,,,Prevenirea bolilor degenerative cardiovasculare.,,,,,,
10691483,NLM,MEDLINE,20000224,20190611,0140-6736 (Print) 0140-6736 (Linking),354 Suppl,1999 Dec,Cardiology: where to go from here?,SIV8,,"['Wellens, H J']",['Wellens HJ'],"['Academisch Ziekenhuis, Maastricht, The Netherlands.']",['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Cardiology/*trends', 'Cardiovascular Diseases/diagnosis/prevention & control/*therapy', 'Humans']",2000/02/26 00:00,2000/02/26 00:01,['2000/02/26 00:00'],"['2000/02/26 00:00 [pubmed]', '2000/02/26 00:01 [medline]', '2000/02/26 00:00 [entrez]']","['S0140-6736(99)90351-3 [pii]', '10.1016/s0140-6736(99)90351-3 [doi]']",ppublish,Lancet. 1999 Dec;354 Suppl:SIV8. doi: 10.1016/s0140-6736(99)90351-3.,,,,,,,,,,,,,,,,,,,,,,
10801135,NLM,MEDLINE,20000712,20190516,0918-2918 (Print) 0918-2918 (Linking),39,2000 Apr,From bench to bedside in cardiovascular research a reflection on my research career.,271,,"['Yazaki, Y']",['Yazaki Y'],"['The Hospital, International Medical Center of Japan, Tokyo.']",['eng'],['Address'],,Japan,Intern Med,"Internal medicine (Tokyo, Japan)",9204241,IM,"['*Cardiovascular Diseases/etiology/physiopathology/therapy', '*Career Choice', 'Humans', '*Research']",2000/05/09 09:00,2000/07/15 11:00,['2000/05/09 09:00'],"['2000/05/09 09:00 [pubmed]', '2000/07/15 11:00 [medline]', '2000/05/09 09:00 [entrez]']",['10.2169/internalmedicine.39.271 [doi]'],ppublish,Intern Med. 2000 Apr;39(4):271. doi: 10.2169/internalmedicine.39.271.,4,,,,,,,,,,,,,,,,,,,,,
24344661,NLM,MEDLINE,20140901,20131218,1744-8298 (Electronic) 1479-6678 (Linking),10,2014 Jan,"Insights from major themes at EuroPRevent 2013, Rome, Italy.",39-41,10.2217/fca.13.46 [doi],"['Niebauer, Josef', 'Humphrey, Reed']","['Niebauer J', 'Humphrey R']","['University Institute of Sports Medicine, Prevention & Rehabilitation, Salzburg, Austria.']",['eng'],['Journal Article'],,England,Future Cardiol,Future cardiology,101239345,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control', 'Europe', 'Exercise', 'Humans']",2013/12/19 06:00,2014/09/02 06:00,['2013/12/19 06:00'],"['2013/12/19 06:00 [entrez]', '2013/12/19 06:00 [pubmed]', '2014/09/02 06:00 [medline]']",['10.2217/fca.13.46 [doi]'],ppublish,Future Cardiol. 2014 Jan;10(1):39-41. doi: 10.2217/fca.13.46.,1,,,,,,,,,,,,,,,,,,,,,
33367726,NLM,MEDLINE,20220330,20220401,2055-6845 (Electronic),7,2021 May 23,New evidence from the scientific sessions 2020 of the American Heart Association.,e1,10.1093/ehjcvp/pvaa143 [doi],"['Savarese, Gianluigi']",['Savarese G'],"['Division of Cardiology, Department of Medicine, Karolinska Institutet, Karolinska Univerisity Hospital, Norrbacka S1:02, 17176 Stockholm, Sweden.', 'Heart and Vascular Theme, Karolinska University Hospital, 17176 Stockholm, Sweden.']",['eng'],['Journal Article'],,England,Eur Heart J Cardiovasc Pharmacother,European heart journal. Cardiovascular pharmacotherapy,101669491,IM,"['*American Heart Association', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', 'United States']",2020/12/29 06:00,2022/03/31 06:00,['2020/12/28 12:16'],"['2020/12/14 00:00 [received]', '2020/12/16 00:00 [accepted]', '2020/12/29 06:00 [pubmed]', '2022/03/31 06:00 [medline]', '2020/12/28 12:16 [entrez]']","['6050094 [pii]', '10.1093/ehjcvp/pvaa143 [doi]']",ppublish,Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e1. doi: 10.1093/ehjcvp/pvaa143.,3,,['ORCID: 0000-0001-7732-0887'],,,,,,,,,,,,,,,,,,,
14925292,NLM,MEDLINE,20040215,20190503,0007-1072 (Print) 0007-1072 (Linking),9,1952 Apr,Cardiovascular disease in cotton workers. II. A clinical study with special reference to hypertension.,146-66,,"['SCHILLING, R S F', 'GOODMAN, N', ""O'SULLIVAN, J G""]","['SCHILLING RS', 'GOODMAN N', ""O'SULLIVAN JG""]",,['eng'],['Journal Article'],,England,Br J Ind Med,British journal of industrial medicine,0370637,OM,"['*Biomedical Research', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Cotton Fiber', 'Humans', 'Hypertension/*epidemiology/*statistics & numerical data', '*Occupational Diseases']",1952/04/01 00:00,1952/04/01 00:01,['1952/04/01 00:00'],"['1952/04/01 00:00 [pubmed]', '1952/04/01 00:01 [medline]', '1952/04/01 00:00 [entrez]']",['10.1136/oem.9.2.146 [doi]'],ppublish,Br J Ind Med. 1952 Apr;9(2):146-66. doi: 10.1136/oem.9.2.146.,2,,,PMC1037388,,['NLM'],"['*CARDIOVASCULAR DISEASES/epidemiology and statistics', '*COTTON', '*HYPERTENSION/epidemiology and statistics', '*OCCUPATIONAL DISEASES']",,,,,,,,,,,,,,['CLML: 5222:11280:90:121:218:317'],
23173223,NLM,MEDLINE,20130107,20161021,1523-9004 (Print) 1523-9004 (Linking),13,2010 Dec,"Exercise plays a key role in treating heart disease. Studies show that regular physical activity can improve cardiovascular risk factors such as weight, arterial health, blood pressure and cholesterol.",5,,,,,['eng'],['Journal Article'],,United States,Heart Advis,Heart advisor,9892190,,"['Cardiovascular Diseases/etiology/physiopathology/*therapy', '*Exercise', 'Humans', 'Life Style', 'Risk Factors']",2010/12/01 00:00,2013/01/08 06:00,['2012/11/24 06:00'],"['2012/11/24 06:00 [entrez]', '2010/12/01 00:00 [pubmed]', '2013/01/08 06:00 [medline]']",,ppublish,Heart Advis. 2010 Dec;13(12):5.,12,,,,,,,,,,,,,,,,,,,,,
8901646,NLM,MEDLINE,19961206,20190623,0009-7322 (Print) 0009-7322 (Linking),94,1996 Nov 1,Conference on Socioeconomic Status and Cardiovascular Health and disease.,2041-4,,"['Lenfant, C']",['Lenfant C'],,['eng'],"['Congress', 'News']",,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/*economics/prevention & control/psychology', '*Health Status', 'Humans', '*Social Class']",1996/11/01 00:00,1996/11/01 00:01,['1996/11/01 00:00'],"['1996/11/01 00:00 [pubmed]', '1996/11/01 00:01 [medline]', '1996/11/01 00:00 [entrez]']",['10.1161/01.cir.94.9.2041 [doi]'],ppublish,Circulation. 1996 Nov 1;94(9):2041-4. doi: 10.1161/01.cir.94.9.2041.,9,,,,,,,,,,,,,,,,,,,,,
21414659,NLM,MEDLINE,20110915,20220316,1474-547X (Electronic) 0140-6736 (Linking),378,2011 Aug 27,Rapid mortality falls after risk-factor changes in populations.,752-3,10.1016/S0140-6736(10)62302-1 [doi],"['Capewell, Simon', ""O'Flaherty, Martin""]","['Capewell S', ""O'Flaherty M""]","['Division of Public Health, University of Liverpool, Liverpool L69 3GB, UK. capewell@liverpool.ac.uk']",['eng'],['Journal Article'],20110315,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Cardiovascular Diseases/etiology/mortality/*prevention & control', '*Feeding Behavior', 'Humans', '*Risk Reduction Behavior', '*Smoking Cessation']",2011/03/19 06:00,2011/09/16 06:00,['2011/03/19 06:00'],"['2011/03/19 06:00 [entrez]', '2011/03/19 06:00 [pubmed]', '2011/09/16 06:00 [medline]']","['S0140-6736(10)62302-1 [pii]', '10.1016/S0140-6736(10)62302-1 [doi]']",ppublish,Lancet. 2011 Aug 27;378(9793):752-3. doi: 10.1016/S0140-6736(10)62302-1. Epub 2011 Mar 15.,9793,,,,,,,,,,,,,,,,,,,,,
5555737,NLM,MEDLINE,19710823,20041117,1013-2058 (Print) 1013-2058 (Linking),60,1971 Mar 9,[Relationship between mortality in cardiovascular diseases and sugar consumption in Switzerland].,298-303,,"['Ziegler, E']",['Ziegler E'],,['ger'],['Journal Article'],,Switzerland,Schweiz Rundsch Med Prax,Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,8403202,IM,"['Adult', 'Age Factors', 'Aged', 'Cardiovascular Diseases/epidemiology/*etiology/mortality', 'Coronary Disease/etiology', '*Dietary Carbohydrates', 'Dietary Fats', 'Humans', 'Intracranial Arteriosclerosis/etiology', 'Middle Aged', 'Switzerland']",1971/03/09 00:00,1971/03/09 00:01,['1971/03/09 00:00'],"['1971/03/09 00:00 [pubmed]', '1971/03/09 00:01 [medline]', '1971/03/09 00:00 [entrez]']",,ppublish,Schweiz Rundsch Med Prax. 1971 Mar 9;60(10):298-303.,10,,,,,,,,"['0 (Dietary Carbohydrates)', '0 (Dietary Fats)']",,,,,,,Die Beziehungen zwischen kardiovaskularer Sterblichkeit und Zuckerkonsum in der Schweiz.,,,,,,
18607189,NLM,MEDLINE,20081006,20080708,0957-9672 (Print) 0957-9672 (Linking),19,2008 Aug,Current world literature.,409-24,10.1097/MOL.0b013e32830b0d5b [doi],,,,['eng'],['Bibliography'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Animals', 'Cardiovascular Diseases/*complications/drug therapy/*metabolism/pathology', 'Humans', 'Hyperlipidemias/*complications/drug therapy/*metabolism/pathology']",2008/07/09 09:00,2008/10/07 09:00,['2008/07/09 09:00'],"['2008/07/09 09:00 [pubmed]', '2008/10/07 09:00 [medline]', '2008/07/09 09:00 [entrez]']","['00041433-200808000-00013 [pii]', '10.1097/MOL.0b013e32830b0d5b [doi]']",ppublish,Curr Opin Lipidol. 2008 Aug;19(4):409-24. doi: 10.1097/MOL.0b013e32830b0d5b.,4,,,,,,,,,,,,,,,,,,,,,
13122593,NLM,MEDLINE,20030501,20181201,0040-3660 (Print) 0040-3660 (Linking),25,1953 Sep-Oct,[Thrombosis and embolism in cardiovascular diseases].,19-23,,"['NOVITSKAIA, Z V']",['NOVITSKAIA ZV'],,['und'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,OM,"['Cardiovascular Diseases/*complications', '*Embolism', 'Humans', '*Thromboembolism', 'Thrombosis/*complications']",1953/09/01 00:00,1953/09/01 00:01,['1953/09/01 00:00'],"['1953/09/01 00:00 [pubmed]', '1953/09/01 00:01 [medline]', '1953/09/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1953 Sep-Oct;25(5):19-23.,5,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/complications', '*THROMBOEMBOLISM', '*THROMBOSIS/complications']",,,,,,,,,Trombozy i embolii pri perdschno-sosudistykh zabolevaniiakh.,,,,,['CLML: 5425:43850:93:461:462'],
20185090,NLM,MEDLINE,20100323,20140815,1474-4457 (Electronic) 1473-3099 (Linking),10,2010 Mar,Inflammation as the cause of coronary heart disease.,142-3,10.1016/S1473-3099(10)70029-3 [doi],"['Azambuja, Maria Ines Reinert']",['Azambuja MI'],,['eng'],"['Comment', 'Letter']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,IM,"['Cardiovascular Diseases/epidemiology/etiology/mortality/virology', 'Coronary Disease/epidemiology/*etiology/virology', 'Humans', 'Inflammation/*complications', 'Myocardial Infarction/epidemiology/etiology/virology', 'Virus Diseases/complications']",2010/02/27 06:00,2010/03/24 06:00,['2010/02/27 06:00'],"['2010/02/27 06:00 [entrez]', '2010/02/27 06:00 [pubmed]', '2010/03/24 06:00 [medline]']","['S1473-3099(10)70029-3 [pii]', '10.1016/S1473-3099(10)70029-3 [doi]']",ppublish,Lancet Infect Dis. 2010 Mar;10(3):142-3. doi: 10.1016/S1473-3099(10)70029-3.,3,,,,,,,,,,,['Lancet Infect Dis. 2009 Oct;9(10):601-10. PMID: 19778762'],,,,,,,,,,
10208782,NLM,MEDLINE,19990721,20190513,0195-668X (Print) 0195-668X (Linking),20,1999 May,'There is a voice that I enshrine in my heart...'.,631-40,,"['Ferrari, R', 'Marber, M', 'Cinca, J']","['Ferrari R', 'Marber M', 'Cinca J']",,['eng'],['Editorial'],,England,Eur Heart J,European heart journal,8006263,IM,"['Cardiovascular Diseases/blood/drug therapy/*etiology', 'Humans', '*Platelet Activation']",1999/04/20 00:00,1999/04/20 00:01,['1999/04/20 00:00'],"['1999/04/20 00:00 [pubmed]', '1999/04/20 00:01 [medline]', '1999/04/20 00:00 [entrez]']","['S0195668X9891555X [pii]', '10.1053/euhj.1998.1555 [doi]']",ppublish,Eur Heart J. 1999 May;20(9):631-40. doi: 10.1053/euhj.1998.1555.,9,,,,,,,,,,,,,,,,,,,,,
18290965,NLM,MEDLINE,20080325,20160831,1442-9071 (Electronic) 1442-6404 (Linking),36,2008 Jan-Feb,A 'reluctance to dispense with the anaesthetist': for valid reasons.,98-9; author reply 99-100,10.1111/j.1442-9071.2007.01662.x [doi],"['Fredrickson, Michael J', 'Mantell, Nick M']","['Fredrickson MJ', 'Mantell NM']",,['eng'],"['Comment', 'Letter']",,Australia,Clin Exp Ophthalmol,Clinical & experimental ophthalmology,100896531,IM,"['*Anesthesia', 'Cardiovascular Diseases/diagnosis/etiology/therapy', '*Cataract Extraction/adverse effects', 'Humans', 'Intraoperative Complications', 'Time Factors']",2008/02/23 09:00,2008/03/26 09:00,['2008/02/23 09:00'],"['2008/02/23 09:00 [pubmed]', '2008/03/26 09:00 [medline]', '2008/02/23 09:00 [entrez]']","['CEO1662 [pii]', '10.1111/j.1442-9071.2007.01662.x [doi]']",ppublish,Clin Exp Ophthalmol. 2008 Jan-Feb;36(1):98-9; author reply 99-100. doi: 10.1111/j.1442-9071.2007.01662.x.,1,,,,,,,,,,,['Clin Exp Ophthalmol. 2007 Mar;35(2):195-6. PMID: 17362468'],,,,,,,,,,
12239656,NLM,MEDLINE,20021022,20051116,0012-0472 (Print) 0012-0472 (Linking),127,2002 Sep 20,[Cardiological diagnosis in patients with obstructive sleep apnea].,1958-62,,"['Steiner, St', 'Schwalen, A', 'Strauer, B E']","['Steiner S', 'Schwalen A', 'Strauer BE']","['Klinik fur Kardiologie, Pneumologie und Angiologie, Universitatsklinikum Dusseldorf. steinest@uni-duesseldorf.de']",['ger'],"['Journal Article', 'Review']",,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Blood Pressure Monitoring, Ambulatory', 'Cardiovascular Diseases/*diagnosis/epidemiology/etiology/mortality', 'Coronary Angiography', 'Diagnosis, Differential', 'Echocardiography', 'Electrocardiography', 'Humans', 'Hypertension/diagnosis/epidemiology/etiology', 'Incidence', 'Risk Factors', 'Sleep Apnea, Obstructive/*complications']",2002/09/20 10:00,2002/10/31 04:00,['2002/09/20 10:00'],"['2002/09/20 10:00 [pubmed]', '2002/10/31 04:00 [medline]', '2002/09/20 10:00 [entrez]']",['10.1055/s-2002-34208 [doi]'],ppublish,Dtsch Med Wochenschr. 2002 Sep 20;127(38):1958-62. doi: 10.1055/s-2002-34208.,38,,,,,,,,,,52,,,,,Kardiologische Diagnostik bei Patienten mit obstruktiver Schlafapnoe.,,,,,,
9377340,NLM,MEDLINE,19971106,20161018,1019-5297 (Print) 1019-5297 (Linking),,1997 May-Jun,[Improvement in the prevention of cardiovascular diseases].,141-4,,"['Nazarenko, V R']",['Nazarenko VR'],,['rus'],['Journal Article'],,Ukraine,Lik Sprava,Likars'ka sprava,9601540,IM,"['Adult', 'Cardiovascular Diseases/complications/mortality/*prevention & control', 'Humans', 'Middle Aged', 'Ukraine/epidemiology']",1997/05/01 00:00,1998/02/12 00:01,['1997/05/01 00:00'],"['1997/05/01 00:00 [pubmed]', '1998/02/12 00:01 [medline]', '1997/05/01 00:00 [entrez]']",,ppublish,Lik Sprava. 1997 May-Jun;(3):141-4.,3,,,,,,,,,,,,,,,Nekotorye aspekty sovershenstvovaniia profilaktiki serdechno-sosudistykh zabolevanii.,,,,,,
10958027,NLM,MEDLINE,20000919,20041117,0300-8495 (Print) 0300-8495 (Linking),29,2000 Aug,Heart and soul.,789-90,,"['Hassed, C']",['Hassed C'],,['eng'],['News'],,Australia,Aust Fam Physician,Australian family physician,0326701,IM,"['Anxiety/etiology', 'Cardiovascular Diseases/complications/physiopathology/*psychology', 'Emotions', 'Humans', '*Psychophysiology', 'Quality of Life']",2000/08/25 11:00,2000/09/23 11:01,['2000/08/25 11:00'],"['2000/08/25 11:00 [pubmed]', '2000/09/23 11:01 [medline]', '2000/08/25 11:00 [entrez]']",,ppublish,Aust Fam Physician. 2000 Aug;29(8):789-90.,8,,,,,,,,,,,,,,,,,,,,,
7019145,NLM,MEDLINE,19810925,20041117,0020-9554 (Print) 0020-9554 (Linking),22,1981 Jun,[Vertigo and syncope in cardiovascular diseases].,340-7,,"['Sterz, H']",['Sterz H'],,['ger'],['Journal Article'],,Germany,Internist (Berl),Der Internist,0264620,IM,"['Brain Ischemia/etiology', 'Cardiovascular Diseases/*complications/diagnosis/therapy', 'Diagnosis, Differential', 'Humans', 'Syncope/*etiology', 'Vertigo/*etiology']",1981/06/01 00:00,1981/06/01 00:01,['1981/06/01 00:00'],"['1981/06/01 00:00 [pubmed]', '1981/06/01 00:01 [medline]', '1981/06/01 00:00 [entrez]']",,ppublish,Internist (Berl). 1981 Jun;22(6):340-7.,6,,,,,,,,,,,,,,,Schwindel und Synkopen durch kardiovaskulare Erkrankungen.,,,,,,
21060081,NLM,MEDLINE,20101223,20101109,1524-4539 (Electronic) 0009-7322 (Linking),122,2010 Nov 9,"Letter by O'Rourke et al regarding article, ""Arterial stiffness and cardiovascular events: the Framingham Heart Study"".",e512; author reply e515,10.1161/CIRCULATIONAHA.110.945089 [doi],"[""O'Rourke, Michael F"", 'Safar, Michel E', 'Roman, Mary J']","[""O'Rourke MF"", 'Safar ME', 'Roman MJ']",,['eng'],"['Comment', 'Letter']",,United States,Circulation,Circulation,0147763,IM,"['Arterial Occlusive Diseases/complications', 'Cardiovascular Diseases/epidemiology/*etiology/physiopathology', 'Cohort Studies', 'Humans', 'Pulse']",2010/11/10 06:00,2010/12/25 06:00,['2010/11/10 06:00'],"['2010/11/10 06:00 [entrez]', '2010/11/10 06:00 [pubmed]', '2010/12/25 06:00 [medline]']","['122/19/e512 [pii]', '10.1161/CIRCULATIONAHA.110.945089 [doi]']",ppublish,Circulation. 2010 Nov 9;122(19):e512; author reply e515. doi: 10.1161/CIRCULATIONAHA.110.945089.,19,,,,,,,,,,,['Circulation. 2010 Feb 2;121(4):505-11. PMID: 20083680'],,,,,,,,,,
21286678,NLM,MEDLINE,20110711,20211020,1433-0407 (Electronic) 0028-2804 (Linking),82,2011 Feb,[Interface between heart and brain: challenges and opportunities].,143-4,10.1007/s00115-010-3109-2 [doi],"['Rother, J', 'Laufs, U']","['Rother J', 'Laufs U']","['Asklepios Klinik Altona, Hamburg, Deutschland. j.roether@asklepios.com']",['ger'],['Introductory Journal Article'],,Germany,Nervenarzt,Der Nervenarzt,0400773,IM,"['Cardiovascular Diseases/*complications/diagnosis/*therapy', 'Cerebrovascular Disorders/*complications/diagnosis/*therapy', 'Humans']",2011/02/03 06:00,2011/07/12 06:00,['2011/02/03 06:00'],"['2011/02/03 06:00 [entrez]', '2011/02/03 06:00 [pubmed]', '2011/07/12 06:00 [medline]']",['10.1007/s00115-010-3109-2 [doi]'],ppublish,Nervenarzt. 2011 Feb;82(2):143-4. doi: 10.1007/s00115-010-3109-2.,2,,,,,,,,,,,,,,,Schnittstelle Herz und Hirn : Herausforderungen und Chancen.,,,,,,
20037942,NLM,MEDLINE,20100301,20091228,1205-7541 (Electronic) 0008-4212 (Linking),87,2009 Dec,"Advances in cardiovascular research: from genes and molecules to clinical applications. International symposium. Devin-Bratislava, Slovak Republic, 2008 September 27-29. Introduction.",v-vi,10.1139/y09-903 [doi],"['Ravingerova, Tana', 'Dhalla, Naranjan S']","['Ravingerova T', 'Dhalla NS']","['Slovak Academy of Sciences, Bratislava, Slovakia.']","['eng', 'fre']",['Introductory Journal Article'],,Canada,Can J Physiol Pharmacol,Canadian journal of physiology and pharmacology,0372712,IM,"['Cardiovascular Diseases/genetics/*metabolism/physiopathology', 'Cardiovascular System/metabolism/physiopathology', 'Humans']",2009/12/30 06:00,2010/03/02 06:00,['2009/12/30 06:00'],"['2009/12/30 06:00 [entrez]', '2009/12/30 06:00 [pubmed]', '2010/03/02 06:00 [medline]']",['10.1139/y09-903 [doi]'],ppublish,Can J Physiol Pharmacol. 2009 Dec;87(12):v-vi. doi: 10.1139/y09-903.,12,,,,,,,,,,,,,,,,,,,,,
12497816,NLM,MEDLINE,20030312,20071115,0393-1978 (Print) 0393-1978 (Linking),44 Suppl 1,1999 Dec,[From large trials and the GISSI Prevenzione study to field secondary prevention].,747-50,,"['Novo, S', 'Mansueto, P', 'Caruso, R', 'Tantillo, R', 'Evola, G', 'Evola, S', 'Strano, A', 'Mansueto, S']","['Novo S', 'Mansueto P', 'Caruso R', 'Tantillo R', 'Evola G', 'Evola S', 'Strano A', 'Mansueto S']","['Cattedra di Fisiopatologia Medica, Istituto di Medicina Interna e Geriatria, Universita degli Studi, Via del Vespro, 141, 90127 Palermo.']",['ita'],"['Journal Article', 'Review']",,Italy,Cardiologia,"Cardiologia (Rome, Italy)",8506637,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Clinical Trials as Topic', 'Humans']",2002/12/25 04:00,2003/03/13 04:00,['2002/12/25 04:00'],"['2002/12/25 04:00 [pubmed]', '2003/03/13 04:00 [medline]', '2002/12/25 04:00 [entrez]']",,ppublish,Cardiologia. 1999 Dec;44 Suppl 1(Pt 2):747-50.,Pt 2,,,,,,,,,,31,,,,,Dai grandi trial e dallo studio GISSI Prevenzione alla prevenzione secondaria nel territorio.,,,,,,
11686671,NLM,MEDLINE,20020118,20041117,0195-668X (Print) 0195-668X (Linking),22,2001 Nov,Relation between blood pressure and mortality: is there a threshold?,2132-3,,"['Van den Hoogen, P', 'Seidell, J', 'Nagelkerke, N', 'Menotti, A', 'Kromhout, D']","['Van den Hoogen P', 'Seidell J', 'Nagelkerke N', 'Menotti A', 'Kromhout D']",,['eng'],['Letter'],,England,Eur Heart J,European heart journal,8006263,IM,"['Age Factors', 'Blood Pressure/*physiology', 'Cardiovascular Diseases/etiology/mortality/physiopathology', 'Humans', 'Hypertension/complications/*mortality/physiopathology', 'Sensory Thresholds/physiology']",2001/11/01 10:00,2002/01/19 10:01,['2001/11/01 10:00'],"['2001/11/01 10:00 [pubmed]', '2002/01/19 10:01 [medline]', '2001/11/01 10:00 [entrez]']","['S0195668X0192915X [pii]', '10.1053/euhj.2001.2915 [doi]']",ppublish,Eur Heart J. 2001 Nov;22(22):2132-3. doi: 10.1053/euhj.2001.2915.,22,,,,,,,,,,,,,,,,,,,,,
22298807,NLM,MEDLINE,20120409,20211021,1524-4571 (Electronic) 0009-7330 (Linking),110,2012 Feb 17,The ten most read articles published in Circulation Research in 2011.,e24-8,10.1161/RES.0b013e31824c38b7 [doi],"['Bolli, Roberto']",['Bolli R'],,['eng'],['News'],20120131,United States,Circ Res,Circulation research,0047103,IM,"['Animals', 'Bibliometrics', '*Biomedical Research', '*Cardiovascular Diseases/genetics/metabolism/pathology/surgery', 'Gene Expression Regulation', 'Humans', '*Periodicals as Topic', 'Signal Transduction', 'Stem Cell Transplantation']",2012/02/03 06:00,2012/04/10 06:00,['2012/02/03 06:00'],"['2012/02/03 06:00 [entrez]', '2012/02/03 06:00 [pubmed]', '2012/04/10 06:00 [medline]']","['RES.0b013e31824c38b7 [pii]', '10.1161/RES.0b013e31824c38b7 [doi]']",ppublish,Circ Res. 2012 Feb 17;110(4):e24-8. doi: 10.1161/RES.0b013e31824c38b7. Epub 2012 Jan 31.,4,,,,,,,['P01 HL078825/HL/NHLBI NIH HHS/United States'],,,,,,,['Editors'],,,,,,,
24941637,NLM,MEDLINE,20140703,20161125,0076-6011 (Print) 0076-6011 (Linking),127,2010-2011,How to live forever.,29-35,,"['Sharma, Pankaj']",['Sharma P'],,['eng'],['Journal Article'],,England,Trans Med Soc Lond,Transactions of the Medical Society of London,7506118,IM,"['Aging', 'Cardiovascular Diseases/etiology/genetics/*mortality', 'Cell Survival', 'Humans', '*Longevity', '*Telomere Shortening', 'United Kingdom']",2010/01/01 00:00,2014/07/06 06:00,['2014/06/20 06:00'],"['2014/06/20 06:00 [entrez]', '2010/01/01 00:00 [pubmed]', '2014/07/06 06:00 [medline]']",,ppublish,Trans Med Soc Lond. 2010-2011;127:29-35.,,,,,,,,,,,,,,,,,,,,,,
12510417,NLM,MEDLINE,20030318,20041117,0009-9074 (Print) 0009-9074 (Linking),153,2002 Sep-Oct,[New risk factors of cardiovascular diseases].,327-8,,"['Navazio, F']",['Navazio F'],"['Department of Integrative Biology, 5101 VLSB, University of California at Berkeley, CA 94720-3140, USA. romanus@socrates.berkeley.edu']",['ita'],['Journal Article'],,Italy,Clin Ter,La Clinica terapeutica,0372604,IM,"['Cardiovascular Diseases/*etiology/metabolism/pathology/physiopathology', 'Humans', 'Inflammation', 'Lipoproteins/blood', 'Oxidative Stress', 'Risk Factors', 'Thrombophilia']",2003/01/04 04:00,2003/03/19 04:00,['2003/01/04 04:00'],"['2003/01/04 04:00 [pubmed]', '2003/03/19 04:00 [medline]', '2003/01/04 04:00 [entrez]']",,ppublish,Clin Ter. 2002 Sep-Oct;153(5):327-8.,5,,,,,,,,['0 (Lipoproteins)'],,,,,,,Nuovi fattori di rischio delle malattie cardiovascolari.,,,,,,
11484713,NLM,MEDLINE,20010920,20061030,0040-5957 (Print) 0040-5957 (Linking),56,2001 Mar-Apr,[Prevention of cardiovascular diseases:a medical-economic approach].,125-30,,,,,['fre'],['Journal Article'],,France,Therapie,Therapie,0420544,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/*economics/epidemiology/mortality/*prevention & control', 'Cost-Benefit Analysis', 'France', 'Humans', 'Hypercholesterolemia/prevention & control', 'Hypertension/prevention & control', 'Middle Aged', 'United States']",2001/08/04 10:00,2001/09/21 10:01,['2001/08/04 10:00'],"['2001/08/04 10:00 [pubmed]', '2001/09/21 10:01 [medline]', '2001/08/04 10:00 [entrez]']",,ppublish,Therapie. 2001 Mar-Apr;56(2):125-30.,2,,,,,,,,,,,,,,,La prevention des maladies cardiovasculaires: une approche medico-economique.,,,,,,
24364152,NLM,MEDLINE,20140117,20191210,0025-8075 (Print) 0025-8075 (Linking),,2013 Jul-Aug,[Probabilistic neural networks with macrolayers in systems for support of decision-making used for differential diagnosis of cardiovascular diseases].,18-20,,"['Burmaka, A A', 'Volkov, I I', 'Ivanov, V A', 'Serebrovskii, V I']","['Burmaka AA', 'Volkov II', 'Ivanov VA', 'Serebrovskii VI']",,['rus'],['Journal Article'],,Russia (Federation),Med Tekh,Meditsinskaia tekhnika,1305457,IM,"['Atherosclerosis/*diagnosis/pathology', 'Cardiovascular Diseases/classification/*diagnosis/physiopathology', 'Decision Making', 'Diagnosis, Differential', 'Humans', 'Myocardial Infarction/*diagnosis/pathology', '*Neural Networks, Computer']",2013/12/25 06:00,2014/01/18 06:00,['2013/12/25 06:00'],"['2013/12/25 06:00 [entrez]', '2013/12/25 06:00 [pubmed]', '2014/01/18 06:00 [medline]']",,ppublish,Med Tekh. 2013 Jul-Aug;(4):18-20.,4,,,,,,,,,,,,,,,,,,,,,
19777411,NLM,MEDLINE,20091005,20090924,1439-4413 (Electronic) 0012-0472 (Linking),134,2009 Oct,[Preventive cardiology: from prevention to optimal patient care].,1983,10.1055/s-0029-1237542 [doi],"['Erbel, R', 'Erdmann, E']","['Erbel R', 'Erdmann E']",,['ger'],['Editorial'],20090923,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Humans', 'Risk Factors']",2009/09/25 06:00,2009/10/06 06:00,['2009/09/25 06:00'],"['2009/09/25 06:00 [entrez]', '2009/09/25 06:00 [pubmed]', '2009/10/06 06:00 [medline]']",['10.1055/s-0029-1237542 [doi]'],ppublish,Dtsch Med Wochenschr. 2009 Oct;134(40):1983. doi: 10.1055/s-0029-1237542. Epub 2009 Sep 23.,40,,,,,,,,,,,,,,,Praventive Kardiologie: Von der Pravention zur optimierten Patientenversorgung.,,,,,,
14941401,NLM,MEDLINE,20040215,20181201,0029-1420 (Print) 0029-1420 (Linking),47,1952 Mar 21,[Mortality from cardiovascular diseases in various countries 1938-47].,396-400,,"['STROM, A', 'RYGH, A']","['STROM A', 'RYGH A']",,['und'],['Journal Article'],,Sweden,Nord Med,Nordisk medicin,0401001,OM,"['*Biometry', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data']",1952/03/21 00:00,1952/03/21 00:01,['1952/03/21 00:00'],"['1952/03/21 00:00 [pubmed]', '1952/03/21 00:01 [medline]', '1952/03/21 00:00 [entrez]']",,ppublish,Nord Med. 1952 Mar 21;47(12):396-400.,12,,,,,['NLM'],['*CARDIOVASCULAR DISEASES/epidemiology and statistics'],,,,,,,,,Dodeligheten av kretslossykdommer i forskjellige land 1938-47.,,,,,['CLML: 5222:27549:90'],
14724971,NLM,MEDLINE,20040527,20161020,0869-6047 (Print) 0869-6047 (Linking),,2003,[The occupational conditions as a risk factor in the development of cardiovascular diseases].,38-41,,"['Izmerov, N F']",['Izmerov NF'],,['rus'],"['Comparative Study', 'Journal Article']",,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Adult', 'Age Factors', 'Cardiovascular Diseases/*etiology/metabolism/mortality/prevention & control/psychology', 'Female', 'Humans', 'Hypertension/etiology/metabolism/prevention & control/psychology', 'Lipid Peroxidation', 'Male', 'Middle Aged', 'Myocardial Infarction/etiology/mortality/prevention & control', 'Myocardial Ischemia/etiology/metabolism/mortality/prevention & control/psychology', 'Occupational Diseases/*etiology/prevention & control/psychology', 'Occupations', 'Risk Factors', 'Sex Factors']",2004/01/17 05:00,2004/05/28 05:00,['2004/01/17 05:00'],"['2004/01/17 05:00 [pubmed]', '2004/05/28 05:00 [medline]', '2004/01/17 05:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 2003;(12):38-41.,12,,,,,,,,,,,,,,,Usloviia truda kak faktor riska razvitiia zabolevanii serdechno-sosudistoi sistemy.,,,,,,
4005632,NLM,MEDLINE,19850819,20161026,0006-9248 (Print) 0006-9248 (Linking),83,1985 Apr,[Theoretical basis of the origin and course of cardiovascular diseases--partial prognosis of basic research].,457-65,,"['Ruttkay-Nedecky, I', 'Smiesko, V', 'Antal, J', 'Barta, E', 'Balazovjech, I', 'Fiser, B', 'Egnerova, A', 'Gerova, M', 'Gero, J', 'Ginter, E']","['Ruttkay-Nedecky I', 'Smiesko V', 'Antal J', 'Barta E', 'Balazovjech I', 'Fiser B', 'Egnerova A', 'Gerova M', 'Gero J', 'Ginter E', 'et al.']",,['slo'],['Journal Article'],,Slovakia,Bratisl Lek Listy,Bratislavske lekarske listy,0065324,IM,"['*Cardiovascular Diseases/mortality/prevention & control/therapy', 'Czechoslovakia', 'Humans', 'Research']",1985/04/01 00:00,1985/04/01 00:01,['1985/04/01 00:00'],"['1985/04/01 00:00 [pubmed]', '1985/04/01 00:01 [medline]', '1985/04/01 00:00 [entrez]']",,ppublish,Bratisl Lek Listy. 1985 Apr;83(4):457-65.,4,,,,,,,,,,,,,,,Teoreticke zaklady vzniku a priebehu kardiovaskularnych ochoreni--ciastkova prognoza zakladneho vyskumu.,,,,,,
7101011,NLM,MEDLINE,19820924,20161018,0038-5239 (Print) 0038-5239 (Linking),,1982,[Epidemiological studies of cardiovascular diseases and their prevention].,20-4,,"['Akhmeteli, M A']",['Akhmeteli MA'],,['rus'],['Journal Article'],,Russia (Federation),Sov Zdravookhr,Sovetskoe zdravookhranenie,0404526,IM,"['Aged', 'Cardiovascular Diseases/*epidemiology/mortality/prevention & control', 'Humans', 'Male', 'Middle Aged', 'National Health Programs', 'Risk', 'USSR']",1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,Sov Zdravookhr. 1982;(5):20-4.,5,,,,,,,,,,,,,,,Epidemiologicheskie issledovaniia serdechno-sosudistykh zabolevanii i ikh profilaktika.,,,,,,
9749202,NLM,MEDLINE,19981001,20090213,0003-9683 (Print) 0003-9683 (Linking),91,1998 May,[Pediatric cardiology is a form of preventive medicine].,541-2,,"['Kachaner, J']",['Kachaner J'],,['fre'],['Editorial'],,France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Child', 'France', 'Humans', 'Pediatrics/trends', 'Preventive Medicine']",1998/09/28 00:00,1998/09/28 00:01,['1998/09/28 00:00'],"['1998/09/28 00:00 [pubmed]', '1998/09/28 00:01 [medline]', '1998/09/28 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1998 May;91(5):541-2.,5,,,,,,,,,,,,,,,La cardiologie pediatrique est une forme de medecine preventive.,,,,,,
27966002,NLM,MEDLINE,20170227,20181202,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),27,2016 Nov/Dec,"European Society of Cardiology congress update, Rome, 27-31 August 2016.",392-397,,"['Dalby, Anthony J']",['Dalby AJ'],,['eng'],['Congress'],,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Preventive Health Services', 'Risk Factors']",2016/12/15 06:00,2017/02/28 06:00,['2016/12/15 06:00'],"['2016/12/15 06:00 [entrez]', '2016/12/15 06:00 [pubmed]', '2017/02/28 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2016 Nov/Dec;27(6):392-397.,6,,,PMC5409223,,,,,,,,,,,,,,,,,,
19249900,NLM,MEDLINE,20090707,20181201,1029-2977 (Print) 1029-2977 (Linking),12,2009 Mar,Recent advances in cardiovascular medicine: the tenth Iranian congress on cardiovascular update.,213-6,,"['Gasparyan, Armen Yuri', 'Mohammad-Hasani, Mohammad-Reza', 'Hassoun, Heitham', 'Darban, Hamid']","['Gasparyan AY', 'Mohammad-Hasani MR', 'Hassoun H', 'Darban H']","['Hemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK. a.gasparyan@gmail.com <a.gasparyan@gmail.com>']",['eng'],"['Congress', 'Overall']",,Iran,Arch Iran Med,Archives of Iranian medicine,100889644,IM,"['Cardiovascular Diseases/*diagnosis/physiopathology/*therapy', 'Humans', 'Iran', 'Societies, Medical']",2009/03/03 09:00,2009/07/08 09:00,['2009/03/03 09:00'],"['2009/03/03 09:00 [entrez]', '2009/03/03 09:00 [pubmed]', '2009/07/08 09:00 [medline]']",['0025 [pii]'],ppublish,Arch Iran Med. 2009 Mar;12(2):213-6.,2,,,,,,,,,,,,,,,,,,,,,
1451650,NLM,MEDLINE,19930106,20051116,0012-0472 (Print) 0012-0472 (Linking),117,1992 Nov 27,[The diagnostic significance of lipoprotein(a)].,1845-8,,"['Mayer, J', 'Brauer, P', 'Solleder, E M']","['Mayer J', 'Brauer P', 'Solleder EM']","['Zentrallabor, Medizinische Universitatsklinik, Wurzburg.']",['ger'],"['Journal Article', 'Review']",,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Cardiovascular Diseases/blood/*diagnosis/epidemiology/therapy', 'Humans', 'Lipoprotein(a)/*blood', 'Risk Factors']",1992/11/27 00:00,1992/11/27 00:01,['1992/11/27 00:00'],"['1992/11/27 00:00 [pubmed]', '1992/11/27 00:01 [medline]', '1992/11/27 00:00 [entrez]']",['10.1055/s-2008-1062519 [doi]'],ppublish,Dtsch Med Wochenschr. 1992 Nov 27;117(48):1845-8. doi: 10.1055/s-2008-1062519.,48,,,,,,,,['0 (Lipoprotein(a))'],,17,,,,,Diagnostische Bedeutung von Lipoprotein(a).,,,,,,
5148654,NLM,MEDLINE,19720721,20041117,0012-0219 (Print) 0012-0219 (Linking),26,1971 Dec 2,[Analysis of the control status of cardiovascular diseases in the GDR].,2297-301,,"['Heine, H', 'Anders, G', 'Schmidt, H']","['Heine H', 'Anders G', 'Schmidt H']",,['ger'],['Journal Article'],,Germany,Dtsch Gesundheitsw,Das Deutsche Gesundheitswesen,0433572,IM,"['Age Factors', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Germany, East', 'Humans', 'State Medicine']",1971/12/02 00:00,1971/12/02 00:01,['1971/12/02 00:00'],"['1971/12/02 00:00 [pubmed]', '1971/12/02 00:01 [medline]', '1971/12/02 00:00 [entrez]']",,ppublish,Dtsch Gesundheitsw. 1971 Dec 2;26(49):2297-301.,49,,,,,,,,,,,,,,,Analyse des Standes der Bekampfung der Herz-Krankheiten in der DD.,,,,,,
12525776,NLM,MEDLINE,20030226,20160803,0398-0499 (Print) 0398-0499 (Linking),27,2002 Dec,[V. Management of diabetic heart disease].,276-7,,"['Passa, P']",['Passa P'],"['Service de Diabetologie, Hopital Saint-Louis, 1 avenue Claude-Vellefaux, 75475 Paris Cedex 10.']",['fre'],"['Journal Article', 'Review']",,France,J Mal Vasc,Journal des maladies vasculaires,7707965,IM,"['Cardiovascular Diseases/diagnosis/etiology/prevention & control/*therapy', '*Diabetes Complications', 'Diabetes Mellitus, Type 1/complications', 'Diabetes Mellitus, Type 2/complications', 'Humans']",2003/01/15 04:00,2003/02/27 04:00,['2003/01/15 04:00'],"['2003/01/15 04:00 [pubmed]', '2003/02/27 04:00 [medline]', '2003/01/15 04:00 [entrez]']",['MDOI-JMV-12-2002-27-5-0398-0499-101019-ART7 [pii]'],ppublish,J Mal Vasc. 2002 Dec;27(5):276-7.,5,,,,,,,,,,7,,,,,V. Prise en charge des cardiopathies diabetiques.,,,,,,
2126866,NLM,MEDLINE,19910326,20081121,0375-9393 (Print) 0375-9393 (Linking),56,1990 Jul-Aug,"[Nutritional, metabolic strategy in cardiocirculatory insufficiency].",491-2,,"['Simini, G', 'Paccagnella, A', 'Calo, M', 'Rosi, P', 'Cipolotti, G', 'Zanardo, G', 'Antonich, A', 'Da Ros, A', 'Salandin, V', 'Michielon, P']","['Simini G', 'Paccagnella A', 'Calo M', 'Rosi P', 'Cipolotti G', 'Zanardo G', 'Antonich A', 'Da Ros A', 'Salandin V', 'Michielon P', 'et al.']","['2. Servizio Anestesia e Rianimazione, Ospedale S. Maria dei Battuti, Treviso.']",['ita'],"['Journal Article', 'Review']",,Italy,Minerva Anestesiol,Minerva anestesiologica,0375272,IM,"['Cardiovascular Diseases/metabolism/surgery/*therapy', 'Humans', 'Nutritional Physiological Phenomena', 'Parenteral Nutrition, Total']",1990/07/01 00:00,1990/07/01 00:01,['1990/07/01 00:00'],"['1990/07/01 00:00 [pubmed]', '1990/07/01 00:01 [medline]', '1990/07/01 00:00 [entrez]']",,ppublish,Minerva Anestesiol. 1990 Jul-Aug;56(7-8):491-2.,7-8,,,,,,,,,,4,,,,,Strategie metabolico nutrizionali nell'insufficienza cardio-circolatoria.,,,,,,
3616041,NLM,MEDLINE,19870918,20041117,0014-2565 (Print) 0014-2565 (Linking),180,1987 May,[Control of cardiovascular diseases: trends and expectations].,504-6,,"['Robinson, D', 'Lenfant, C']","['Robinson D', 'Lenfant C']",,['spa'],['Journal Article'],,Spain,Rev Clin Esp,Revista clinica espanola,8608576,IM,"['Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Humans']",1987/05/01 00:00,1987/05/01 00:01,['1987/05/01 00:00'],"['1987/05/01 00:00 [pubmed]', '1987/05/01 00:01 [medline]', '1987/05/01 00:00 [entrez]']",,ppublish,Rev Clin Esp. 1987 May;180(9):504-6.,9,,,,,,,,,,,,,,,Control de las enfermedades cardiovasculares: tendencias y expectativas.,,,,,,
10335851,NLM,MEDLINE,19990701,20191103,0950-9240 (Print) 0950-9240 (Linking),13 Suppl 2,1999 Apr,The unique vulnerability of diabetic subjects to hypertensive injury.,S3-8; discussion S25-8,,"['Williams, B']",['Williams B'],"['Cardiovascular Research Institute, Leicester Royal Infirmary, UK.']",['eng'],"['Journal Article', 'Review']",,England,J Hum Hypertens,Journal of human hypertension,8811625,IM,"['Aging', 'Cardiovascular Diseases/epidemiology/*etiology/therapy', '*Diabetes Complications', 'Diabetic Angiopathies/epidemiology/etiology/therapy', 'Female', 'Humans', 'Hypertension/epidemiology/etiology/therapy', 'Male', 'Prognosis', 'Risk Assessment', 'Risk Factors']",1999/05/21 00:00,1999/05/21 00:01,['1999/05/21 00:00'],"['1999/05/21 00:00 [pubmed]', '1999/05/21 00:01 [medline]', '1999/05/21 00:00 [entrez]']",['10.1038/sj.jhh.1000828 [doi]'],ppublish,J Hum Hypertens. 1999 Apr;13 Suppl 2:S3-8; discussion S25-8. doi: 10.1038/sj.jhh.1000828.,,,,,,,,,,,33,,,,,,,,,,,
13050914,NLM,MEDLINE,20030501,20181201,,4,1953 May,Emotional states with special reference to the cardiovascular system.,321-4,,"['BERNSTEIN, A']",['BERNSTEIN A'],,['eng'],['Journal Article'],,United States,Am Pract Dig Treat,American practitioner and digest of treatment,14840350R,OM,"['Cardiovascular Diseases/*etiology/*surgery', '*Cardiovascular System', '*Emotions', 'Humans', '*Psychotherapy']",1953/05/01 00:00,1953/05/01 00:01,['1953/05/01 00:00'],"['1953/05/01 00:00 [pubmed]', '1953/05/01 00:01 [medline]', '1953/05/01 00:00 [entrez]']",,ppublish,Am Pract Dig Treat. 1953 May;4(5):321-4.,5,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/etiology and pathogenesis', '*CARDIOVASCULAR DISEASES/surgery', '*PSYCHOTHERAPY']",,,,,,,,,,,,,,['CLML: 5324:21444:129:130:541'],
3624163,NLM,MEDLINE,19870925,20191029,0910-8327 (Print) 0910-8327 (Linking),3,1987,"Guidelines for treatment and management of cardiovascular sequelae in Kawasaki disease. Subcommittee of Cardiovascular Sequelae, Subcommittee of Surgical Treatment, Kawasaki Disease Research Committee.",50-4,,,,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Japan,Heart Vessels,Heart and vessels,8511258,IM,"['Aneurysm/etiology/therapy', 'Cardiovascular Diseases/*etiology/surgery/therapy', 'Coronary Aneurysm/etiology/therapy', 'Coronary Disease/etiology/therapy', 'Heart Valve Diseases/etiology/therapy', 'Humans', 'Mucocutaneous Lymph Node Syndrome/*complications', 'Myocardial Infarction/etiology/therapy', 'Myocarditis/etiology/therapy', 'Pericarditis/etiology/therapy']",1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",['10.1007/BF02073648 [doi]'],ppublish,Heart Vessels. 1987;3(1):50-4. doi: 10.1007/BF02073648.,1,,,,,,,,,,,,,,,,,,,,,
9392999,NLM,MEDLINE,19980113,20141120,0251-2432 (Print) 0251-2432 (Linking),18,1997,Cardiovascular disease stoppable in developing countries?,163-5,,"['Bertrand, E']",['Bertrand E'],"['Hopital Nord, Marseille, France.']",['eng'],['Journal Article'],,Switzerland,World Health Forum,World health forum,8010746,IM,"['Cardiovascular Diseases/epidemiology/mortality/*prevention & control', '*Developing Countries', 'Global Health', 'Humans']",1997/01/01 00:00,1997/12/11 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/12/11 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,World Health Forum. 1997;18(2):163-5.,2,"The author discusses factors with a bearing on cardiovascular disease which are shared by many developing countries, and outlines the difficulties that have to be overcome if significant prevention is to be achieved.",,,,,,,,,,,,,,,,,,,,
28228440,NLM,MEDLINE,20190610,20190613,1524-4636 (Electronic) 1079-5642 (Linking),37,2017 Mar,ATVB Named Lecture Review-Insight Into Author.,381-382,10.1161/ATV.0000000000000046 [doi],,,,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait']",,United States,Arterioscler Thromb Vasc Biol,"Arteriosclerosis, thrombosis, and vascular biology",9505803,IM,"['Biomedical Research/*history', 'Cardiovascular Diseases/*history/pathology/physiopathology/therapy', 'Career Choice', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Mentors/history']",2017/02/24 06:00,2019/06/14 06:00,['2017/02/24 06:00'],"['2017/02/24 06:00 [entrez]', '2017/02/24 06:00 [pubmed]', '2019/06/14 06:00 [medline]']","['ATV.0000000000000046 [pii]', '10.1161/ATV.0000000000000046 [doi]']",ppublish,Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):381-382. doi: 10.1161/ATV.0000000000000046.,3,,,,,,,,,,,,,,,,['Ross R'],"['Ross, Russell']",,,,
5385365,NLM,MEDLINE,19701007,20041117,0012-0219 (Print) 0012-0219 (Linking),24,1969 Sep 25,[Control of cardiovascular diseases in German Democratic Republic].,1834-42,,"['Heine, H']",['Heine H'],,['ger'],['Journal Article'],,Germany,Dtsch Gesundheitsw,Das Deutsche Gesundheitswesen,0433572,IM,"['Adolescent', 'Adult', 'Aged', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Female', 'Germany, East', 'Humans', 'Male', 'Middle Aged']",1969/09/25 00:00,1969/09/25 00:01,['1969/09/25 00:00'],"['1969/09/25 00:00 [pubmed]', '1969/09/25 00:01 [medline]', '1969/09/25 00:00 [entrez]']",,ppublish,Dtsch Gesundheitsw. 1969 Sep 25;24(39):1834-42.,39,,,,,,,,,,,,,,,Die Bekampfung der Herz-Kreislauf-Krankheiten in der Deutschen Demokratischen Republik.,,,,,,
7967335,NLM,MEDLINE,19941201,20170310,0022-9040 (Print) 0022-9040 (Linking),33,1993,[Quality of life in patients with cardiovascular diseases].,"66-71, quiz 71-2",,"['Kots, Ia I', 'Libis, R A']","['Kots IaI', 'Libis RA']",,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Cardiovascular Diseases/diagnosis/*psychology/therapy', 'Health Status', 'Humans', '*Quality of Life', 'Surveys and Questionnaires']",1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,"Kardiologiia. 1993;33(5):66-71, quiz 71-2.",5,,,,,,,,,,,,,,,Kachestvo zhizni u bolnykh s serdechno-sosudistymi zabolevaniiami.,,,,,,
2699848,NLM,MEDLINE,19900627,20111017,0253-3758 (Print) 0253-3758 (Linking),17,1989 Oct,[Recent advances in cardiology and angiology in China].,258-67,,"['Editorial, B']",['Editorial B'],,['chi'],"['Journal Article', 'Review']",,China,Zhonghua Xin Xue Guan Bing Za Zhi,Zhonghua xin xue guan bing za zhi,7910682,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'China/epidemiology', 'Humans']",1989/10/01 00:00,1989/10/01 00:01,['1989/10/01 00:00'],"['1989/10/01 00:00 [pubmed]', '1989/10/01 00:01 [medline]', '1989/10/01 00:00 [entrez]']",,ppublish,Zhonghua Xin Xue Guan Bing Za Zhi. 1989 Oct;17(5):258-67.,5,,,,,,,,,,0,,,,,,,,,,,
772863,NLM,MEDLINE,19760706,20071115,0040-3660 (Print) 0040-3660 (Linking),48,1976,[Results and ways of further development of scientific research in the field of cardiovascular diseases].,3-14,,"['Chazov, E I', 'Eliseev, O M']","['Chazov EI', 'Eliseev OM']",,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Arrhythmias, Cardiac', '*Cardiovascular Diseases/diagnosis/surgery', 'Coronary Disease', 'Diagnosis, Computer-Assisted', 'Humans', 'Hypertension', 'Male', 'Middle Aged', '*Research', 'USSR']",1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1976;48(1):3-14.,1,,,,,,,,,,,,,,,Rezul'taty i puti dal'neishego razvitiia nauchnykh issledovanii v oblasti serdechno-sosudistykh zabolevanii.,,,,,,
4564774,NLM,MEDLINE,19730201,20041117,0012-0219 (Print) 0012-0219 (Linking),27,1972 Oct 12,[Diagnostic and therapeutic strategy in cardiovascular diseases. An outline].,1921-4,,"['Gunther, K H']",['Gunther KH'],,['ger'],['Journal Article'],,Germany,Dtsch Gesundheitsw,Das Deutsche Gesundheitswesen,0433572,IM,"['Ambulatory Care', 'Cardiovascular Diseases/*diagnosis/epidemiology/prevention & control/therapy', 'Diagnosis, Computer-Assisted', 'Heart Function Tests', 'Humans', 'Methods', 'Multiphasic Screening']",1972/10/12 00:00,1972/10/12 00:01,['1972/10/12 00:00'],"['1972/10/12 00:00 [pubmed]', '1972/10/12 00:01 [medline]', '1972/10/12 00:00 [entrez]']",,ppublish,Dtsch Gesundheitsw. 1972 Oct 12;27(41):1921-4.,41,,,,,,,,,,,,,,,Diagnostisch-therapeutische Strategie bei Herz-Kreislaufkrankheiten. Ein Entwurf.,,,,,,
7041,NLM,MEDLINE,19760901,20181130,0506-2772 (Print) 0506-2772 (Linking),15,1976,"[Introdictory speech of Dr. Angel Todorov, Minister of Public Health, at the 1st National Conference on the Prevention of Cardiovascular Diseases].",1-9,,"['Todorov, A']",['Todorov A'],,['bul'],['Congress'],,Bulgaria,Vutr Boles,Vutreshni bolesti,0032666,IM,"['Bulgaria', 'Cardiovascular Diseases/diagnosis/epidemiology/mortality/*prevention & control/therapy', 'Congresses as Topic', 'Humans', 'Life Style', 'Risk']",1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Vutr Boles. 1976;15(2):1-9.,2,,,,,,,,,,,,,,,"Vstupitelno slovo na d-r Angel Todorov--ministur na narodnoto zdrave, na Purvata natsionalna konferentsiia po profilaktika na surdechno--sudovite zaboliavaniia.",,,,,,
14222165,NLM,MEDLINE,19961201,20181201,0021-3071 (Print) 0021-3071 (Linking),25,1964 Jul-Aug,[THE AGES OF PERSONS DYING OF CARDIOVASCULAR DISEASES IN ITALY (AVERAGES OF THE PERIODS 1953-55 AND 1959-61)].,807-27,,"['BIANCONE, S']",['BIANCONE S'],,['ita'],['Journal Article'],,Italy,Ann Sanita Pubblica,Annali della sanita pubblica,0071152,OM,"['*Adolescent', '*Arrhythmias, Cardiac', '*Arteriosclerosis', '*Cardiovascular Diseases', '*Cerebrovascular Disorders', '*Child', '*Coronary Disease', '*Embolism', '*Geriatrics', '*Heart Failure', '*Hypertension', '*Hypertension, Renal', '*Infant', 'Italy', '*Mortality', '*Myocarditis', '*Phlebitis', '*Rheumatic Heart Disease', '*Thromboangiitis Obliterans', '*Thrombosis']",1964/07/01 00:00,1964/07/01 00:01,['1964/07/01 00:00'],"['1964/07/01 00:00 [pubmed]', '1964/07/01 00:01 [medline]', '1964/07/01 00:00 [entrez]']",,ppublish,Ann Sanita Pubblica. 1964 Jul-Aug;25:807-27.,,,,,,['NLM'],"['*ADOLESCENCE', '*ARRHYTHMIA', '*ARTERIOSCLEROSIS', '*CARDIOVASCULAR DISEASES', '*CEREBROVASCULAR DISORDERS', '*CHILD', '*CORONARY DISEASE', '*EMBOLISM', '*GERIATRICS', '*HEART FAILURE, CONGESTIVE', '*HYPERTENSION', '*HYPERTENSION, RENAL', '*INFANT', '*ITALY', '*MORTALITY', '*MYOCARDITIS', '*PHLEBITIS', '*RHEUMATIC HEART DISEASE', '*THROMBOANGIITIS OBLITERANS', '*THROMBOSIS']",,,,,,,,,L'ET'A DEI MORTI PER MALATTIE CARDIOVASCOLARI IN ITALIA (MEDIE DEI TRIENNI 1953-55 E 1959-61).,,,,,,
20933196,NLM,MEDLINE,20101104,20121115,1557-8925 (Electronic) 1054-3589 (Linking),59,2010,The immense progress in preventing and treating cardiovascular disease. Foreword.,xi-xii,10.1016/S1054-3589(10)59013-6 [doi],"['Vanhoutte, Paul']",['Vanhoutte P'],"['Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.']",['eng'],['Introductory Journal Article'],,United States,Adv Pharmacol,"Advances in pharmacology (San Diego, Calif.)",9015397,IM,"['Cardiovascular Diseases/economics/epidemiology/etiology/physiopathology/*therapy', 'Drug Discovery/methods/trends', 'Forecasting', 'Genetic Therapy/trends', 'Health Knowledge, Attitudes, Practice', 'Humans', 'Life Style', 'Stem Cell Transplantation']",2010/10/12 06:00,2010/11/05 06:00,['2010/10/12 06:00'],"['2010/10/12 06:00 [entrez]', '2010/10/12 06:00 [pubmed]', '2010/11/05 06:00 [medline]']","['S1054-3589(10)59013-6 [pii]', '10.1016/S1054-3589(10)59013-6 [doi]']",ppublish,Adv Pharmacol. 2010;59:xi-xii. doi: 10.1016/S1054-3589(10)59013-6.,,,,,,,,,,,,,,,,,,,,,,
4777860,NLM,MEDLINE,19740405,20211203,0037-5675 (Print) 0037-5675 (Linking),14,1973 Sep,Cardiovascular epidemiology in Polynesians in the Pacific.,223-7,,"['Prior, I']",['Prior I'],,['eng'],['Journal Article'],,India,Singapore Med J,Singapore medical journal,0404516,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/*epidemiology/etiology/mortality', 'Coronary Disease/mortality', '*Ethnicity', 'Female', 'Humans', 'Hypertension/epidemiology', 'Male', 'Middle Aged', 'New Zealand', 'Polynesia']",1973/09/01 00:00,1973/09/01 00:01,['1973/09/01 00:00'],"['1973/09/01 00:00 [pubmed]', '1973/09/01 00:01 [medline]', '1973/09/01 00:00 [entrez]']",,ppublish,Singapore Med J. 1973 Sep;14(3):223-7.,3,,,,,,,,,,,,,,,,,,,,,
7223043,NLM,MEDLINE,19810613,20041117,0070-4067 (Print) 0070-4067 (Linking),86,1980,[Primary and secondary prevention of cardiovascular diseases - metabolic aspects].,546-50,,"['Schlierf, G']",['Schlierf G'],,['ger'],['Journal Article'],,Germany,Verh Dtsch Ges Inn Med,Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,7503702,IM,"['Cardiovascular Diseases/etiology/metabolism/*prevention & control', 'Humans']",1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,Verh Dtsch Ges Inn Med. 1980;86:546-50.,,,,,,,,,,,,,,,,Primare und sekundare Pravention kardiovaskularer Erkrankungen - Metabolische Aspekte.,,,,,,
2815417,NLM,MEDLINE,19891212,20091111,0041-6959 (Print) 0041-6959 (Linking),118,1989 Sep-Oct,"[Regression of cardiovascular diseases: prevention, surgical and pharmacologic advances].","174-8, 181",,"['Bourassa, M']",['Bourassa M'],,['fre'],['Interview'],,Canada,Union Med Can,L'union medicale du Canada,0030444,IM,"['*Cardiovascular Diseases/epidemiology/prevention & control/therapy', 'Humans']",1989/09/01 00:00,1989/09/01 00:01,['1989/09/01 00:00'],"['1989/09/01 00:00 [pubmed]', '1989/09/01 00:01 [medline]', '1989/09/01 00:00 [entrez]']",,ppublish,"Union Med Can. 1989 Sep-Oct;118(5):174-8, 181.",5,,,,,,,,,,,,,,,"Regression des maladies cardiovasculaires: prevention, progres chirurgicaux et pharmacologiques.",,,,,,
14724968,NLM,MEDLINE,20040527,20161020,0869-6047 (Print) 0869-6047 (Linking),,2003,[Psychological and psychiatric approaches to the prevention and treatment of cardiovascular diseases].,24-9,,"['Aleksandrovskii, Iu A', 'Romasenko, L V']","['Aleksandrovskii IuA', 'Romasenko LV']",,['rus'],"['Comparative Study', 'Journal Article']",,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Cardiovascular Diseases/*etiology/prevention & control/psychology/therapy', 'Diagnosis, Differential', 'Humans', 'Mental Disorders/*complications/diagnosis/metabolism', '*Psychophysiologic Disorders/diagnosis', 'Stress, Psychological/*complications']",2004/01/17 05:00,2004/05/28 05:00,['2004/01/17 05:00'],"['2004/01/17 05:00 [pubmed]', '2004/05/28 05:00 [medline]', '2004/01/17 05:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 2003;(12):24-9.,12,,,,,,,,,,,,,,,Psikhologo-psikhiatricheskie podkhody k profilaktike i lecheniiu serdechno-sosudistykh zabolevanii.,,,,,,
15226244,NLM,MEDLINE,20040728,20151119,1524-4539 (Electronic) 0009-7322 (Linking),109,2004 Jun 29,Markers of malign across the cardiovascular continuum: interpretation and application.,IV1-2,,"['Dzau, Victor J']",['Dzau VJ'],"[""Brigham and Women's Hospital, Boston, MA, USA.""]",['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Biomarkers/analysis', 'Cardiovascular Diseases/*diagnosis/etiology/therapy', 'Humans', 'Risk Factors']",2004/07/01 05:00,2004/07/29 05:00,['2004/07/01 05:00'],"['2004/07/01 05:00 [pubmed]', '2004/07/29 05:00 [medline]', '2004/07/01 05:00 [entrez]']","['109/25_suppl_1/IV-1 [pii]', '10.1161/01.CIR.0000133445.78855.aa [doi]']",ppublish,Circulation. 2004 Jun 29;109(25 Suppl 1):IV1-2. doi: 10.1161/01.CIR.0000133445.78855.aa.,25 Suppl 1,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
20047203,NLM,MEDLINE,20100115,20100104,1533-7294 (Electronic) 0094-3509 (Linking),58,2009 Nov,An Urgent Matter. Identifying Your Patients' Cardiovascular Risk and Improving Their Outcomes. Introduction.,S17-8,,"['Toth, Peter P']",['Toth PP'],"['Department of Family and Community Medicine, University of Illinois School of Medicine, Peoria, IL']",['eng'],['Introductory Journal Article'],,United States,J Fam Pract,The Journal of family practice,7502590,IM,"['Cardiovascular Diseases/diagnosis/*etiology/*therapy', 'Humans', 'Risk Factors', 'Treatment Outcome']",2010/01/06 06:00,2010/01/16 06:00,['2010/01/06 06:00'],"['2010/01/06 06:00 [entrez]', '2010/01/06 06:00 [pubmed]', '2010/01/16 06:00 [medline]']",,ppublish,J Fam Pract. 2009 Nov;58(11 Suppl Urgent):S17-8.,11 Suppl Urgent,,,,,,,,,,,,,,,,,,,,,
20991637,NLM,MEDLINE,20101028,20181201,0038-2310 (Print) 0038-2310 (Linking),11,1946 Apr,Cardio-vascular disease in the Bantu and coloured races of South Africa; congenital heart disease.,15-7,,"['BECKER, B J P']",['BECKER BJ'],,['eng'],['Journal Article'],,South Africa,S Afr J Med Sci,The South African journal of medical sciences,2984853R,OM,"['Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Heart', '*Heart Defects, Congenital', '*Heart Diseases', 'South Africa', '*Vascular Diseases']",1946/04/01 00:00,1946/04/01 00:01,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/04/01 00:00 [pubmed]', '1946/04/01 00:01 [medline]']",,ppublish,S Afr J Med Sci. 1946 Apr;11:15-7.,,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/epidemiology and statistics', '*HEART/diseases--in Negroes']",,,,,,,,,,,,,,['CLML: 4611:439o'],
16083571,NLM,MEDLINE,20100720,20181201,0578-1310 (Print) 0578-1310 (Linking),43,2005 Jul,[A summary of National Conference of Pediatric Cardiovascular Diseases in 2004].,555-7,,,,,['chi'],['Congress'],,China,Zhonghua Er Ke Za Zhi,Zhonghua er ke za zhi = Chinese journal of pediatrics,0417427,IM,"['Cardiomyopathies/diagnosis/therapy', 'Cardiovascular Diseases/*diagnosis/physiopathology/*therapy', 'Child', 'China', 'Endocarditis/diagnosis/therapy', 'Heart Failure/diagnosis/therapy', 'Humans']",2005/08/09 09:00,2010/07/21 06:00,['2005/08/09 09:00'],"['2005/08/09 09:00 [pubmed]', '2010/07/21 06:00 [medline]', '2005/08/09 09:00 [entrez]']",,ppublish,Zhonghua Er Ke Za Zhi. 2005 Jul;43(7):555-7.,7,,,,,,,,,,,,,,"['National Pediatric Cardiology Association of China', 'Editorial Board of Chinese Journal of Pediatrics']",,,,,,,
6805880,NLM,MEDLINE,19820826,20061115,0376-2491 (Print) 0376-2491 (Linking),61,1981 Jan,[A five-year report (1975-1979) of community control of cardiovascular diseases in Shijingshan People's commune of Beijing (author's transl)].,44-7,,"['Yu, J S']",['Yu JS'],,['chi'],"['English Abstract', 'Journal Article']",,China,Zhonghua Yi Xue Za Zhi,Zhonghua yi xue za zhi,7511141,IM,"['Adult', 'Cardiovascular Diseases/mortality/*prevention & control/therapy', 'China', 'Coronary Disease/prevention & control', 'Female', 'Humans', 'Hypertension/prevention & control', 'Male', 'Middle Aged', 'Time Factors']",1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Zhonghua Yi Xue Za Zhi. 1981 Jan;61(1):44-7.,1,,,,,,,,,,,,,,,,,,,,,
11073285,NLM,MEDLINE,20010222,20101118,0931-0509 (Print) 0931-0509 (Linking),15 Suppl 5,2000,V. Clinical algorithms on cardiovascular risk factors in renal patients.,123-54,,,,,['eng'],"['Guideline', 'Journal Article', 'Practice Guideline']",,England,Nephrol Dial Transplant,"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",8706402,IM,"['*Algorithms', 'Cardiovascular Agents/*therapeutic use', '*Cardiovascular Diseases/blood/diagnosis/etiology/therapy', 'Humans', '*Myocardial Revascularization', 'Renal Dialysis', 'Renal Insufficiency/*complications/therapy', 'Risk Factors']",2000/11/10 11:00,2001/03/03 10:01,['2000/11/10 11:00'],"['2000/11/10 11:00 [pubmed]', '2001/03/03 10:01 [medline]', '2000/11/10 11:00 [entrez]']",,ppublish,Nephrol Dial Transplant. 2000;15 Suppl 5:123-54.,,,,,,,,,['0 (Cardiovascular Agents)'],,,,,,,,,,,,,
18319229,NLM,MEDLINE,20080404,20181201,0003-3197 (Print) 0003-3197 (Linking),59,2008 Feb-Mar,Fernando Martorell (1906-1984): centenary of a pioneer in angiology.,98-9,10.1177/0003319707304535 [doi],"['Lozano, Francisco S', 'Cabot, Xabier', 'Silva, Isabel', 'Roche, Enric', 'Callejas, Jose M']","['Lozano FS', 'Cabot X', 'Silva I', 'Roche E', 'Callejas JM']","['Clinic Hospital, Salamanca, Spain. lozano@usal.es']",['eng'],"['Biography', 'Historical Article', 'Journal Article', 'Portrait']",,United States,Angiology,Angiology,0203706,IM,"['Angiography/*history', '*Anniversaries and Special Events', 'Cardiovascular Diseases/classification/diagnosis/*history/therapy', 'History, 20th Century', 'Humans', 'Male', 'Periodicals as Topic/history', 'Spain', 'United States', 'Vascular Surgical Procedures/*history']",2008/03/06 09:00,2008/04/05 09:00,['2008/03/06 09:00'],"['2008/03/06 09:00 [pubmed]', '2008/04/05 09:00 [medline]', '2008/03/06 09:00 [entrez]']","['59/1/98 [pii]', '10.1177/0003319707304535 [doi]']",ppublish,Angiology. 2008 Feb-Mar;59(1):98-9. doi: 10.1177/0003319707304535.,1,,,,,,,,,,,,,,,,['Martorell F'],"['Martorell, Fernando']",,,,
6808669,NLM,MEDLINE,19820924,20161018,0038-5239 (Print) 0038-5239 (Linking),,1982,[Economic effectiveness of prophylactic and therapeutic measures in cardiovascular diseases].,50-4,,"['Roitman, M P', 'Lunskaia, L L']","['Roitman MP', 'Lunskaia LL']",,['rus'],['Journal Article'],,Russia (Federation),Sov Zdravookhr,Sovetskoe zdravookhranenie,0404526,IM,"['Cardiovascular Diseases/*economics/prevention & control/therapy', 'Cost-Benefit Analysis', 'Health Expenditures', 'Humans', 'Time Factors', 'USSR']",1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,Sov Zdravookhr. 1982;(5):50-4.,5,,,,,,,,,,,,,,,Ekonomicheskaia effektivnost' profilakticheskikh i lechebnykh meropriiatii pri serdechno-sosudistykh zabolevaniiakh.,,,,,,
5576709,NLM,MEDLINE,19710706,20161122,0012-0219 (Print) 0012-0219 (Linking),26,1971 Apr 15,[Methods in clinical examination with the help of x-ray evaluation of detection of suspected cardiovascular diseases].,722-7,,"['Heublein, B', 'Pocher, K', 'Parsi, R A']","['Heublein B', 'Pocher K', 'Parsi RA']",,['ger'],['Journal Article'],,Germany,Dtsch Gesundheitsw,Das Deutsche Gesundheitswesen,0433572,IM,"['Cardiovascular Diseases/classification/diagnosis/*diagnostic imaging', 'Electrocardiography', 'Humans', '*Mass Chest X-Ray']",1971/04/15 00:00,1971/04/15 00:01,['1971/04/15 00:00'],"['1971/04/15 00:00 [pubmed]', '1971/04/15 00:01 [medline]', '1971/04/15 00:00 [entrez]']",,ppublish,Dtsch Gesundheitsw. 1971 Apr 15;26(16):722-7.,16,,,,,,,,,,,,,,,Die Methodik der klinische Untersuchung durch die Schirmbildauswertung erfasster kardiovaskular Befundverdachtiger.,,,,,,
20620419,NLM,MEDLINE,20100809,20141120,1873-1740 (Electronic) 0033-0620 (Linking),53,2010 Jul-Aug,"Interview of William Kannel, MD. Interview by Peter Wilson, Henry Greenberg.",4-9,10.1016/j.pcad.2010.03.007 [doi],"['Kannel, William']",['Kannel W'],,['eng'],"['Historical Article', 'Interview']",,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Cardiovascular Diseases/*epidemiology/etiology/history/mortality/prevention & control', 'Evidence-Based Medicine', 'Global Health', 'History, 20th Century', 'History, 21st Century', 'Humans', 'International Cooperation', 'National Health Programs', 'National Institutes of Health (U.S.)', '*Population Surveillance', 'Risk Assessment', 'Risk Factors', 'Time Factors', 'United States/epidemiology']",2010/07/14 06:00,2010/08/10 06:00,['2010/07/13 06:00'],"['2010/07/13 06:00 [entrez]', '2010/07/14 06:00 [pubmed]', '2010/08/10 06:00 [medline]']","['S0033-0620(10)00059-9 [pii]', '10.1016/j.pcad.2010.03.007 [doi]']",ppublish,Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):4-9. doi: 10.1016/j.pcad.2010.03.007.,1,,,,,,,,,,,,,,,,,,,,,
2376059,NLM,MEDLINE,19900904,20041117,0008-6312 (Print) 0008-6312 (Linking),77 Suppl 2,1990,Cardiovascular disease in women. Introductory article. Clinical highlights and future directions.,1-5,,"['Becker, R C']",['Becker RC'],"['Thrombosis Research Center, University of Massachusetts Medical Center, Worchester.']",['eng'],['Journal Article'],,Switzerland,Cardiology,Cardiology,1266406,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/etiology/therapy', 'Female', 'Humans', 'Incidence', 'Male', 'Risk Factors', 'Sex Factors']",1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']",,ppublish,Cardiology. 1990;77 Suppl 2:1-5.,,,,,,,,,,,,,,,,,,,,,,
14759313,NLM,MEDLINE,20040422,20181130,0578-1310 (Print) 0578-1310 (Linking),41,2003 Feb,[Summary of 2002 national conferences of pediatric cardiac arrhythmia and cardiovascular diseases].,114-6,,,,,['chi'],['Congress'],,China,Zhonghua Er Ke Za Zhi,Zhonghua er ke za zhi = Chinese journal of pediatrics,0417427,IM,"['Arrhythmias, Cardiac/diagnosis/*therapy', 'Cardiovascular Diseases/diagnosis/*therapy', 'Child', 'China', 'Humans']",2004/02/05 05:00,2004/04/23 05:00,['2004/02/05 05:00'],"['2004/02/05 05:00 [pubmed]', '2004/04/23 05:00 [medline]', '2004/02/05 05:00 [entrez]']",,ppublish,Zhonghua Er Ke Za Zhi. 2003 Feb;41(2):114-6.,2,,,,,,,,,,,,,,"['Editorial Board, Chinese Medical Journal', 'Group of Cardiovascular Diseases, Chinese Pediatric Society, Chinese Medical', 'Association']",,,,,,,
1876924,NLM,MEDLINE,19910925,20041117,0038-5077 (Print) 0038-5077 (Linking),,1991,[Psychological characteristics of patients with borderline arterial hypertension and prophylaxis of cardiovascular diseases].,50-2,,"['Zaitsev, V P', 'Dvortsov, S A']","['Zaitsev VP', 'Dvortsov SA']",,['rus'],['Journal Article'],,Russia (Federation),Sov Med,Sovetskaia meditsina,0404525,IM,"['Adult', 'Attitude to Health', 'Cardiovascular Diseases/etiology/*prevention & control/psychology', 'Female', 'Health Education', 'Humans', 'Hypertension/complications/*psychology/therapy', 'Male', 'Personality', 'Risk Factors']",1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",,ppublish,Sov Med. 1991;(5):50-2.,5,,,,,,,,,,,,,,,Psikhologicheskie osobennosti lits s pogranichnoi arterial'noi gipertenziei i profilaktika serdechno-sosudistykh zabolevanii.,,,,,,
26316606,NLM,MEDLINE,20151116,20150828,1524-4571 (Electronic) 0009-7330 (Linking),117,2015 Aug 28,2015 Lucian Award: Jeffery Molkentin.,498-501,10.1161/CIRCRESAHA.115.307326 [doi],"['Ince, Susan']",['Ince S'],,['eng'],"['Biography', 'Historical Article', 'Journal Article']",,United States,Circ Res,Circulation research,0047103,IM,"['*Awards and Prizes', 'Cardiovascular Diseases/diagnosis/*history/therapy', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Male', 'Medical Laboratory Personnel/*history']",2015/09/01 06:00,2015/11/17 06:00,['2015/08/29 06:00'],"['2015/08/29 06:00 [entrez]', '2015/09/01 06:00 [pubmed]', '2015/11/17 06:00 [medline]']","['CIRCRESAHA.115.307326 [pii]', '10.1161/CIRCRESAHA.115.307326 [doi]']",ppublish,Circ Res. 2015 Aug 28;117(6):498-501. doi: 10.1161/CIRCRESAHA.115.307326.,6,,,,,,,,,,,,,,,,['Molkentin J'],"['Molkentin, Jeffery']",,,,
12622109,NLM,MEDLINE,20030307,20181130,1049-510X (Print) 1049-510X (Linking),12,2002 Fall,"Reversing the Cardiovascular Disease Epidemic Among Ethnic Minority Populations: Translating Strategies into Success. 17th Annual International Interdisciplinary Conference on Hypertension and Related Risk Factors in Ethnic Populations. June 8-12, 2002, Miami, Florida, USA. Proceedings and abstracts.",S3-1-156,,,,,['eng'],"['Congress', 'Overall']",,United States,Ethn Dis,Ethnicity & disease,9109034,IM,"['Cardiovascular Diseases/epidemiology/*ethnology/genetics/*prevention & control', 'Humans', 'Hypertension/epidemiology/*ethnology/genetics/*prevention & control', 'Risk Factors']",2003/03/08 04:00,2003/03/08 04:01,['2003/03/08 04:00'],"['2003/03/08 04:00 [pubmed]', '2003/03/08 04:01 [medline]', '2003/03/08 04:00 [entrez]']",,ppublish,Ethn Dis. 2002 Fall;12(4):S3-1-156.,4,,,,,,,,,,,,,,,,,,,,,
3854209,NLM,MEDLINE,19860418,20041117,0048-4148 (Print) 0048-4148 (Linking),,1985,[Diseases of the circulatory system in infants].,10-1,,"['Duchinski, W']",['Duchinski W'],,['pol'],['Journal Article'],,Poland,Pieleg Polozna,Pielegniarka i polozna,19630310R,,"['Cardiovascular Diseases/congenital/diagnosis/*nursing', 'Humans', 'Infant', 'Infant, Newborn']",1985/01/01 00:00,1985/01/01 00:01,['1985/01/01 00:00'],"['1985/01/01 00:00 [pubmed]', '1985/01/01 00:01 [medline]', '1985/01/01 00:00 [entrez]']",,ppublish,Pieleg Polozna. 1985;(12):10-1.,12,,,,,,,,,,,,,,,Choroby ukladu krazenia u dzieci.,,,,,,
105685,NLM,MEDLINE,19790425,20090213,0003-9683 (Print) 0003-9683 (Linking),71,1978 Nov,[Histological dysplasias and cardiovascular pathology].,1307-10,,"['Pernot, C']",['Pernot C'],,['fre'],['Journal Article'],,France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,IM,"['Abnormalities, Multiple/pathology', 'Adult', 'Cardiovascular Diseases/congenital/*embryology/pathology', 'Child', 'Female', 'Humans', 'Male']",1978/11/01 00:00,1978/11/01 00:01,['1978/11/01 00:00'],"['1978/11/01 00:00 [pubmed]', '1978/11/01 00:01 [medline]', '1978/11/01 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1978 Nov;71(11):1307-10.,11,,,,,,,,,,,,,,,Histodysplasies et pathologie cardiovasculaire.,,,,,,
10182485,NLM,MEDLINE,19980723,20221207,0163-4089 (Print) 0163-4089 (Linking),20,1998 May,Strokes and the South.,26-9,,"['Braus, R']",['Braus R'],,['eng'],['Journal Article'],,United States,Am Demogr,American demographics,9878837,,"['Black or African American', 'Age Factors', 'Cardiovascular Diseases/*epidemiology/ethnology/etiology/therapy', 'Female', 'Health Behavior', 'Humans', 'Hypertension/complications/therapy', 'Male', 'Racial Groups', '*Risk Factors', 'Socioeconomic Factors', 'Southeastern United States/ethnology', 'White People']",1999/04/02 00:00,1999/04/02 00:01,['1999/04/02 00:00'],"['1999/04/02 00:00 [pubmed]', '1999/04/02 00:01 [medline]', '1999/04/02 00:00 [entrez]']",,ppublish,Am Demogr. 1998 May;20(5):26-9.,5,,,,,,,,,,,,,,,,,,,,,
6126643,NLM,MEDLINE,19821203,20190611,0140-6736 (Print) 0140-6736 (Linking),2,1982 Sep 25,Diet and the heart.,711,,"['Lyon, J L']",['Lyon JL'],,['eng'],['Letter'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Adult', 'Cardiovascular Diseases/*epidemiology/mortality/prevention & control', '*Diet', 'Female', 'Humans', 'Male', 'Middle Aged', 'United States']",1982/09/25 00:00,1982/09/25 00:01,['1982/09/25 00:00'],"['1982/09/25 00:00 [pubmed]', '1982/09/25 00:01 [medline]', '1982/09/25 00:00 [entrez]']","['S0140-6736(82)90730-9 [pii]', '10.1016/s0140-6736(82)90730-9 [doi]']",ppublish,Lancet. 1982 Sep 25;2(8300):711. doi: 10.1016/s0140-6736(82)90730-9.,8300,,,,,,,,,,,,,,,,,,,,,
18441637,NLM,MEDLINE,20080523,20080429,0028-9604 (Print) 0028-9604 (Linking),144,2004 Sep 27,For a happy heart.,54-6,,"['Underwood, Anne']",['Underwood A'],,['eng'],['News'],,United States,Newsweek,Newsweek,9877127,,"['*Anger', 'Biomedical Research', 'Cardiovascular Diseases/*etiology/prevention & control/*psychology', '*Depression', 'Humans', '*Loneliness', 'United States']",2008/04/30 09:00,2008/05/24 09:00,['2008/04/30 09:00'],"['2008/04/30 09:00 [pubmed]', '2008/05/24 09:00 [medline]', '2008/04/30 09:00 [entrez]']",,ppublish,Newsweek. 2004 Sep 27;144(13):54-6.,13,,,,,,,,,,,,,,,,,,,,,
16167378,NLM,MEDLINE,20050916,20181201,1552-4922 (Print) 1552-4922 (Linking),64,2005 Apr,"Regenerative and predictive medicine of cardiovascular disease. Abstracts from the 9th Leipziger Workshop and the 2nd International Workshop on Slide Based Cytometry. April 22-24, 2004. Leipzig, Germany.",116-27,,,,,['eng'],"['Congress', 'Overall']",,United States,Cytometry A,Cytometry. Part A : the journal of the International Society for Analytical Cytology,101235694,IM,"['*Cardiovascular Diseases/diagnosis/pathology/prevention & control/therapy', 'Cytophotometry/*methods', 'Humans', '*Regenerative Medicine']",2005/09/17 09:00,2005/09/17 09:01,['2005/09/17 09:00'],"['2005/09/17 09:00 [pubmed]', '2005/09/17 09:01 [medline]', '2005/09/17 09:00 [entrez]']",,ppublish,Cytometry A. 2005 Apr;64(2):116-27.,2,,,,,,,,,,,,,,,,,,,,,
29186437,NLM,MEDLINE,20190314,20190314,1755-3245 (Electronic) 0008-6363 (Linking),113,2017 Dec 1,Dr Jeremy Fauconnier talks with Prof Goran K. Hansson.,e57-e58,10.1093/cvr/cvx189 [doi],"['Hansson, Goran K']",['Hansson GK'],,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Advisory Committees/*history', 'Biomedical Research/*history', 'Cardiovascular Diseases/diagnosis/*history/physiopathology/therapy', 'History, 20th Century', 'History, 21st Century', 'Humans', '*Nobel Prize', 'Sweden']",2017/12/01 06:00,2019/03/15 06:00,['2017/11/30 06:00'],"['2017/11/30 06:00 [entrez]', '2017/12/01 06:00 [pubmed]', '2019/03/15 06:00 [medline]']","['4652954 [pii]', '10.1093/cvr/cvx189 [doi]']",ppublish,Cardiovasc Res. 2017 Dec 1;113(14):e57-e58. doi: 10.1093/cvr/cvx189.,14,,,,,,,,,,,,,,,,['Hansson GK'],"['Hansson, Goran K']",,,,
15510422,NLM,MEDLINE,20050128,20041028,1070-5295 (Print) 1070-5295 (Linking),10,2004 Oct,Bibliography. Current World Literature. Cardiovascular system.,406-13,,,,,['eng'],['Bibliography'],,United States,Curr Opin Crit Care,Current opinion in critical care,9504454,IM,"['*Cardiovascular Diseases/complications/physiopathology/therapy', 'Cardiovascular System/*physiopathology', '*Critical Care', 'Humans']",2004/10/30 09:00,2005/01/29 09:00,['2004/10/30 09:00'],"['2004/10/30 09:00 [pubmed]', '2005/01/29 09:00 [medline]', '2004/10/30 09:00 [entrez]']",,ppublish,Curr Opin Crit Care. 2004 Oct;10(5):406-13.,5,,,,,,,,,,,,,,,,,,,,,
11021423,NLM,MEDLINE,20010322,20041117,1040-8703 (Print) 1040-8703 (Linking),12,2000 Oct,Bibliography. Current world literature. Cardiovascular medicine.,B211-21,,,,,['eng'],['Bibliography'],,United States,Curr Opin Pediatr,Current opinion in pediatrics,9000850,IM,"['Cardiac Surgical Procedures', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Child', 'Fetal Diseases/diagnosis', 'Humans']",2000/10/06 11:00,2001/03/27 10:01,['2000/10/06 11:00'],"['2000/10/06 11:00 [pubmed]', '2001/03/27 10:01 [medline]', '2000/10/06 11:00 [entrez]']",,ppublish,Curr Opin Pediatr. 2000 Oct;12(5):B211-21.,5,,,,,,,,,,,,,,,,,,,,,
2637448,NLM,MEDLINE,19900713,20041117,0048-4148 (Print) 0048-4148 (Linking),,1989,[The risk factors for diseases of the circulatory system].,3-6,,"['Tomaszewska, L', 'Jankowska, B K']","['Tomaszewska L', 'Jankowska BK']",,['pol'],['Journal Article'],,Poland,Pieleg Polozna,Pielegniarka i polozna,19630310R,,"['Cardiovascular Diseases/*epidemiology/etiology/physiopathology', 'Humans', 'Risk Factors']",1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Pieleg Polozna. 1989;(10-12):3-6.,10-12,,,,,,,,,,,,,,,Czynniki ryzyka chorob ukladu krazenia.,,,,,,
5733164,NLM,MEDLINE,19690929,20041117,0037-878X (Print) 0037-878X (Linking),13,1968,[Findings and considerations on cardiovascular disease control in Friuli].,465-72,,"['Feruglio, G A', 'Passerelli, A']","['Feruglio GA', 'Passerelli A']",,['ita'],['Journal Article'],,Italy,Boll Soc Ital Cardiol,Bollettino della Societa italiana di cardiologia,7506963,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/mortality/*prevention & control', 'Humans', 'Italy', 'Mass Screening', 'Rheumatic Fever/prevention & control']",1968/01/01 00:00,1968/01/01 00:01,['1968/01/01 00:00'],"['1968/01/01 00:00 [pubmed]', '1968/01/01 00:01 [medline]', '1968/01/01 00:00 [entrez]']",,ppublish,Boll Soc Ital Cardiol. 1968;13(4):465-72.,4,,,,,,,,,,,,,,,Rilievi e considerazioni sulla lotta contro le malattie cardiovascolari nel Friuli.,,,,,,
3594779,NLM,MEDLINE,19870810,20061115,0009-7322 (Print) 0009-7322 (Linking),76,1987 Jul,Conference on behavioral medicine and cardiovascular disease.,I1-227,,,,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Circulation,Circulation,0147763,IM,"['*Behavior', 'Cardiovascular Diseases/etiology/*psychology', 'Heart Diseases/etiology/*psychology', 'Humans']",1987/07/01 00:00,1987/07/01 00:01,['1987/07/01 00:00'],"['1987/07/01 00:00 [pubmed]', '1987/07/01 00:01 [medline]', '1987/07/01 00:00 [entrez]']",,ppublish,Circulation. 1987 Jul;76(1 Pt 2):I1-227.,1 Pt 2,,,,,,,,,,,,,,,,,,,,,
25477484,NLM,MEDLINE,20150212,20181202,1524-4571 (Electronic) 0009-7330 (Linking),115,2014 Dec 5,2014 Lucian Award: Jeffrey Robbins.,969-72,10.1161/CIRCRESAHA.114.305558 [doi],"['Ince, Susan']",['Ince S'],,['eng'],"['Biography', 'Historical Article', 'News', 'Portrait']",,United States,Circ Res,Circulation research,0047103,IM,"['*Awards and Prizes', 'Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/genetics/*history/physiopathology/therapy', 'Genetic Predisposition to Disease', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Risk Factors']",2014/12/06 06:00,2015/02/13 06:00,['2014/12/06 06:00'],"['2014/12/06 06:00 [entrez]', '2014/12/06 06:00 [pubmed]', '2015/02/13 06:00 [medline]']","['CIRCRESAHA.114.305558 [pii]', '10.1161/CIRCRESAHA.114.305558 [doi]']",ppublish,Circ Res. 2014 Dec 5;115(12):969-72. doi: 10.1161/CIRCRESAHA.114.305558.,12,,,,,,,,,,,,,,,,['Robbins J'],"['Robbins, Jeffrey']",,,,
13178195,NLM,MEDLINE,20030501,20181201,0014-2565 (Print) 0014-2565 (Linking),52,1954 Mar 31,[Psychological reactions in cardioangiopathies].,381-7,,"['GIBERT-QUERALTO, J']",['GIBERT-QUERALTO J'],,['spa'],['Journal Article'],,Spain,Rev Clin Esp,Revista clinica espanola,8608576,OM,"['Cardiovascular Diseases/*physiology/*psychology', 'Humans']",1954/03/31 00:00,1954/03/31 00:01,['1954/03/31 00:00'],"['1954/03/31 00:00 [pubmed]', '1954/03/31 00:01 [medline]', '1954/03/31 00:00 [entrez]']",,ppublish,Rev Clin Esp. 1954 Mar 31;52(6):381-7.,6,,,,,['NLM'],['*CARDIOVASCULAR DISEASES/physiology'],,,,,,,,,Las reacciones psiquicas en las cardioangiopatias.,,,,,['CLML: 5426:41071:94'],
15687115,NLM,MEDLINE,20050711,20161124,1524-4539 (Electronic) 0009-7322 (Linking),111,2005 Feb 1,Cardiology patient page. How to make sure the beat goes on: protecting a woman's heart.,e28-33,,"['Johnson, Paula A', 'Manson, JoAnn E']","['Johnson PA', 'Manson JE']","[""Division of Women's Health, Brigham and Women's Hospital, 75 Francis St, Boston, Mass 02115, USA. pajohnson@partners.org""]",['eng'],"['Journal Article', 'Patient Education Handout']",,United States,Circulation,Circulation,0147763,IM,"['Aged', 'Cardiac Rehabilitation', 'Cardiovascular Agents/therapeutic use', 'Cardiovascular Diseases/diagnosis/epidemiology/etiology/*prevention & control/therapy', 'Cohort Studies', 'Comorbidity', 'Diagnostic Techniques, Cardiovascular', 'Female', 'Health Promotion', 'Humans', 'Life Style', 'Middle Aged', 'Myocardial Revascularization/methods', 'Risk Factors', ""*Women's Health""]",2005/02/03 09:00,2005/07/12 09:00,['2005/02/03 09:00'],"['2005/02/03 09:00 [pubmed]', '2005/07/12 09:00 [medline]', '2005/02/03 09:00 [entrez]']","['111/4/e28 [pii]', '10.1161/01.CIR.0000155364.54434.E6 [doi]']",ppublish,Circulation. 2005 Feb 1;111(4):e28-33. doi: 10.1161/01.CIR.0000155364.54434.E6.,4,,,,,,,,['0 (Cardiovascular Agents)'],,,,,,,,,,,,,['Circulation. 2005 Feb 1;111(4):383-4. PMID: 15687121']
10330376,NLM,MEDLINE,19990608,20190623,0009-7322 (Print) 0009-7322 (Linking),99,1999 May 18,Meeting highlights. Highlights of the 71st scientific sessions of the American Heart Association.,2486-91,,"['Ferguson, J J']",['Ferguson JJ'],,['eng'],"['Congress', 'News']",,United States,Circulation,Circulation,0147763,IM,"['*Cardiovascular Diseases/etiology/physiopathology/therapy', 'Humans']",1999/05/20 00:00,1999/05/20 00:01,['1999/05/20 00:00'],"['1999/05/20 00:00 [pubmed]', '1999/05/20 00:01 [medline]', '1999/05/20 00:00 [entrez]']",['10.1161/01.cir.99.19.2486 [doi]'],ppublish,Circulation. 1999 May 18;99(19):2486-91. doi: 10.1161/01.cir.99.19.2486.,19,,,,,,,,,,,,,,,,,,,,,
13019776,NLM,MEDLINE,20030501,20191107,0366-5313 (Print) 0366-5313 (Linking),21,1952,Heart disease a generation ago and now.,218-26,,"['WHITE, P D']",['WHITE PD'],,['eng'],['Journal Article'],,Switzerland,Cardiologia (Basel),Cardiologia,1265351,OM,"['*Cardanolides', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Diuretics', 'Heart Diseases/*therapy']",1952/01/01 00:00,1952/01/01 00:01,['1952/01/01 00:00'],"['1952/01/01 00:00 [pubmed]', '1952/01/01 00:01 [medline]', '1952/01/01 00:00 [entrez]']",['10.1159/000165200 [doi]'],ppublish,Cardiologia (Basel). 1952;21(4):218-26. doi: 10.1159/000165200.,4,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/epidemiology and statistics', '*HEART DISEASE/therapy']",,"['0 (Cardanolides)', '0 (Diuretics)']",,,,,,,,,,,,['CLML: 5323:44682:105:238'],
1296906,NLM,MEDLINE,19930429,20170214,0145-7217 (Print) 0145-7217 (Linking),18,1992 Nov-Dec,Nutritional recommendations for cardiovascular complications of diabetes.,543-4,,"['Delahanty, L']",['Delahanty L'],,['eng'],['Journal Article'],,United States,Diabetes Educ,The Diabetes educator,7701401,,"['Cardiovascular Diseases/*diet therapy/epidemiology/etiology', '*Diabetes Complications', 'Humans', 'Nutritional Sciences/*education', 'Risk Factors']",1992/11/01 00:00,1992/11/01 00:01,['1992/11/01 00:00'],"['1992/11/01 00:00 [pubmed]', '1992/11/01 00:01 [medline]', '1992/11/01 00:00 [entrez]']",['10.1177/014572179201800615 [doi]'],ppublish,Diabetes Educ. 1992 Nov-Dec;18(6):543-4. doi: 10.1177/014572179201800615.,6,,,,,,,,,,,,,,,,,,,,,
5532192,NLM,MEDLINE,19710324,20071115,0010-0234 (Print) 0010-0234 (Linking),9,1970 Oct,[Cardiovascular manifestations and complications of hiatal hernias. 25 cases].,413-32,,"['Bouhey, J', 'Louis, P', 'Carcher, C', 'Petit, A', 'Faure, D', 'Wilkening, M']","['Bouhey J', 'Louis P', 'Carcher C', 'Petit A', 'Faure D', 'Wilkening M']",,['fre'],['Journal Article'],,France,Coeur Med Interne,Coeur et medecine interne,0373165,IM,"['Adult', 'Aged', 'Arrhythmias, Cardiac/etiology', 'Cardiovascular Diseases/diagnosis/*etiology/surgery', 'Diagnosis, Differential', 'Hernia, Diaphragmatic/*complications', 'Humans']",1970/10/01 00:00,1970/10/01 00:01,['1970/10/01 00:00'],"['1970/10/01 00:00 [pubmed]', '1970/10/01 00:01 [medline]', '1970/10/01 00:00 [entrez]']",,ppublish,Coeur Med Interne. 1970 Oct;9(4):413-32.,4,,,,,,,,,,,,,,,Manifestations et complications cardio-vasculaires des hernies hiatales. A propos de 25 observations.,,,,,,
9577959,NLM,MEDLINE,19980527,20190623,0009-7322 (Print) 0009-7322 (Linking),97,1998 Apr 14,Sulfonylureas and cardiovascular mortality in diabetes: a class effect?,1427-8,,"['Wascher, T C']",['Wascher TC'],,['eng'],"['Comment', 'Letter']",,United States,Circulation,Circulation,0147763,IM,"['Animals', 'Cardiovascular Diseases/*drug therapy/etiology/mortality', 'Diabetic Angiopathies/*drug therapy/mortality', 'Humans', 'Sulfonylurea Compounds/*therapeutic use']",1998/05/13 00:00,1998/05/13 00:01,['1998/05/13 00:00'],"['1998/05/13 00:00 [pubmed]', '1998/05/13 00:01 [medline]', '1998/05/13 00:00 [entrez]']",['10.1161/01.cir.97.14.1427 [doi]'],ppublish,Circulation. 1998 Apr 14;97(14):1427-8. doi: 10.1161/01.cir.97.14.1427.,14,,,,,,,,['0 (Sulfonylurea Compounds)'],,,['Circulation. 1997 Jul 1;96(1):29-32. PMID: 9236412'],,,,,,,,,,
3974103,NLM,MEDLINE,19850425,20161017,0098-7484 (Print) 0098-7484 (Linking),253,1985 Apr 19,"Cardioverters, proteins, receptors studied in cardiovascular disorders.","2173-5, 2179-80",,,,,['eng'],['News'],,United States,JAMA,JAMA,7501160,IM,"['Cardiovascular Diseases/blood/*metabolism/therapy', 'Electric Countershock/*instrumentation', 'Heart/innervation', 'Humans', 'Proteins/*physiology']",1985/04/19 00:00,1985/04/19 00:01,['1985/04/19 00:00'],"['1985/04/19 00:00 [pubmed]', '1985/04/19 00:01 [medline]', '1985/04/19 00:00 [entrez]']",,ppublish,"JAMA. 1985 Apr 19;253(15):2173-5, 2179-80.",15,,,,,,,,['0 (Proteins)'],,,,,,,,,,,,,
5489939,NLM,MEDLINE,19710210,20091111,0021-7263 (Print) 0021-7263 (Linking),127,1970 Dec,A simple mnemonic code for cardiovascular data.,344-51,,"['Krovetz, L J']",['Krovetz LJ'],,['eng'],['Journal Article'],,United States,Johns Hopkins Med J,The Johns Hopkins medical journal,0072456,IM,"['*Cardiovascular Diseases/diagnosis/physiopathology/surgery', '*Computers', 'Humans', '*Memory', 'Pediatrics']",1970/12/01 00:00,1970/12/01 00:01,['1970/12/01 00:00'],"['1970/12/01 00:00 [pubmed]', '1970/12/01 00:01 [medline]', '1970/12/01 00:00 [entrez]']",,ppublish,Johns Hopkins Med J. 1970 Dec;127(6):344-51.,6,,,,,,,,,,,,,,,,,,,,,
8187458,NLM,MEDLINE,19940621,20041117,0098-8243 (Print) 0098-8243 (Linking),20,1994,Fibrinogen and viscosity: risk factors for cardiovascular events.,170-3,,"['Resch, K L', 'Ernst, E']","['Resch KL', 'Ernst E']","['Centre for Complementary Medicine, Postgraduate Medical School, University of Exeter, United Kingdom.']",['eng'],['Journal Article'],,United States,Compr Ther,Comprehensive therapy,7605837,IM,"['Arterial Occlusive Diseases/etiology/physiopathology', 'Arteriosclerosis/blood/etiology/physiopathology', '*Blood Viscosity', 'Cardiovascular Diseases/blood/etiology/*physiopathology', 'Cerebrovascular Disorders/etiology/physiopathology', 'Fibrinogen/*analysis', 'Humans', 'Myocardial Ischemia/etiology/physiopathology', 'Risk Factors']",1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",,ppublish,Compr Ther. 1994;20(3):170-3.,3,,,,,,,,['9001-32-5 (Fibrinogen)'],,,,,,,,,,,,,
20991638,NLM,MEDLINE,20101028,20181201,0038-2310 (Print) 0038-2310 (Linking),11,1946 Apr,Cardio-vascular disease in the Bantu and coloured races of South Africa; rheumatic heart disease.,18-34,,"['BECKER, B J P']",['BECKER BJ'],,['eng'],['Journal Article'],,South Africa,S Afr J Med Sci,The South African journal of medical sciences,2984853R,OM,"['Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Heart Diseases', 'Humans', '*Rheumatic Fever', '*Rheumatic Heart Disease', 'South Africa', '*Vascular Diseases']",1946/04/01 00:00,1946/04/01 00:01,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/04/01 00:00 [pubmed]', '1946/04/01 00:01 [medline]']",,ppublish,S Afr J Med Sci. 1946 Apr;11:18-34.,,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/epidemiology and statistics', '*RHEUMATIC FEVER/cardiac complications']",,,,,,,,,,,,,,['CLML: 4611:439p'],
12180430,NLM,MEDLINE,20030127,20061115,0957-9672 (Print) 0957-9672 (Linking),13,2002 Aug,Bibliography. Current world literature. Hyperlipidaemia and cardiovascular disease.,421-35,,,,,['eng'],['Bibliography'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Animals', '*Cardiovascular Diseases/diagnosis/diet therapy/metabolism/prevention & control', 'Humans', '*Hyperlipidemias/diagnosis/diet therapy/metabolism/prevention & control']",2002/08/16 10:00,2003/01/28 04:00,['2002/08/16 10:00'],"['2002/08/16 10:00 [pubmed]', '2003/01/28 04:00 [medline]', '2002/08/16 10:00 [entrez]']",,ppublish,Curr Opin Lipidol. 2002 Aug;13(4):421-35.,4,,,,,,,,,,,,,,,,,,,,,
2357432,NLM,MEDLINE,19900802,20041117,1046-7467 (Print) 1046-7467 (Linking),1,1990 May,Advances in cardiac care.,1-157,,,,,['eng'],['Journal Article'],,United States,AACN Clin Issues Crit Care Nurs,AACN clinical issues in critical care nursing,9009969,,"['Cardiovascular Diseases/drug therapy/*nursing/surgery', '*Critical Care', 'Humans']",1990/05/01 00:00,1990/05/01 00:01,['1990/05/01 00:00'],"['1990/05/01 00:00 [pubmed]', '1990/05/01 00:01 [medline]', '1990/05/01 00:00 [entrez]']",,ppublish,AACN Clin Issues Crit Care Nurs. 1990 May;1(1):1-157.,1,,,,,,,,,,,,,,,,,,,,,
15200465,NLM,MEDLINE,20050103,20040617,0085-2538 (Print) 0085-2538 (Linking),66,2004 Jul,Are associational studies obfuscating?,462; author reply 462-3,,"['Thamer, Mae']",['Thamer M'],,['eng'],"['Comment', 'Letter']",,United States,Kidney Int,Kidney international,0323470,IM,"['Cardiovascular Diseases/blood/*epidemiology/*mortality', '*Hematocrit', 'Humans', '*Renal Dialysis']",2004/06/18 05:00,2005/01/04 09:00,['2004/06/18 05:00'],"['2004/06/18 05:00 [pubmed]', '2005/01/04 09:00 [medline]', '2004/06/18 05:00 [entrez]']","['S0085-2538(15)50059-8 [pii]', '10.1111/j.1523-1755.2004.669_7.x [doi]']",ppublish,Kidney Int. 2004 Jul;66(1):462; author reply 462-3. doi: 10.1111/j.1523-1755.2004.669_7.x.,1,,,,,,,,,,,['Kidney Int. 2004 Feb;65(2):626-33. PMID: 14717934'],,,,,,,,,,
9865674,NLM,MEDLINE,19990218,20191102,1350-6277 (Print) 1350-6277 (Linking),4,1997 Oct-Dec,Bibliography. Current world literature.,423-52,,,,,['eng'],['Bibliography'],,England,J Cardiovasc Risk,Journal of cardiovascular risk,9436980,IM,"['*Cardiovascular Diseases/diagnosis/etiology/therapy', 'Humans']",1998/12/29 00:00,1998/12/29 00:01,['1998/12/29 00:00'],"['1998/12/29 00:00 [pubmed]', '1998/12/29 00:01 [medline]', '1998/12/29 00:00 [entrez]']",['10.1097/00043798-199710000-00014 [doi]'],ppublish,J Cardiovasc Risk. 1997 Oct-Dec;4(5-6):423-52. doi: 10.1097/00043798-199710000-00014.,5-6,,,,,,,,,,,,,,,,,,,,,
9431487,NLM,MEDLINE,19980224,20041117,0954-6928 (Print) 0954-6928 (Linking),8,1997 Aug-Sep,Bibliography current world literature.,577-90,,,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['Cardiovascular Diseases/*diagnosis/etiology/physiopathology/*therapy', 'Humans']",1997/08/01 00:00,1998/02/12 00:01,['1997/08/01 00:00'],"['1997/08/01 00:00 [pubmed]', '1998/02/12 00:01 [medline]', '1997/08/01 00:00 [entrez]']",,ppublish,Coron Artery Dis. 1997 Aug-Sep;8(8-9):577-90.,8-9,,,,,,,,,,,,,,,,,,,,,
12557901,NLM,MEDLINE,20030515,20191025,0954-6928 (Print) 0954-6928 (Linking),13,2002 Dec,Bibliography. Current world literature.,449-51,,,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['Cardiovascular Diseases/diagnosis/etiology/therapy', '*Coronary Artery Disease', 'Humans']",2003/02/01 04:00,2003/05/16 05:00,['2003/02/01 04:00'],"['2003/02/01 04:00 [pubmed]', '2003/05/16 05:00 [medline]', '2003/02/01 04:00 [entrez]']",['10.1097/00019501-200212000-00010 [doi]'],ppublish,Coron Artery Dis. 2002 Dec;13(8):449-51. doi: 10.1097/00019501-200212000-00010.,8,,,,,,,,,,,,,,,,,,,,,
9821064,NLM,MEDLINE,19990202,20191102,1350-6277 (Print) 1350-6277 (Linking),5,1998 Apr,Bibliography. Current world literature.,109-40,,,,,['eng'],['Bibliography'],,England,J Cardiovasc Risk,Journal of cardiovascular risk,9436980,IM,"['*Cardiovascular Diseases/epidemiology/physiopathology/therapy', 'Humans', 'Risk Factors']",1998/11/20 00:00,1998/11/20 00:01,['1998/11/20 00:00'],"['1998/11/20 00:00 [pubmed]', '1998/11/20 00:01 [medline]', '1998/11/20 00:00 [entrez]']",['10.1097/00043798-199804000-00007 [doi]'],ppublish,J Cardiovasc Risk. 1998 Apr;5(2):109-40. doi: 10.1097/00043798-199804000-00007.,2,,,,,,,,,,,,,,,,,,,,,
6914584,NLM,MEDLINE,19820225,20041117,0954-7762 (Print) 0954-7762 (Linking),77,1981 Nov 11-17,The heart of the matter.,1961,,,,,['eng'],['Journal Article'],,England,Nurs Times,Nursing times,0423236,,"['Cardiovascular Diseases/epidemiology/*etiology/prevention & control', 'Humans', 'United States']",1981/11/11 00:00,1981/11/11 00:01,['1981/11/11 00:00'],"['1981/11/11 00:00 [pubmed]', '1981/11/11 00:01 [medline]', '1981/11/11 00:00 [entrez]']",,ppublish,Nurs Times. 1981 Nov 11-17;77(46):1961.,46,,,,,,,,,,,,,,,,,,,,,
9738155,NLM,MEDLINE,19980924,20080409,0828-282X (Print) 0828-282X (Linking),14,1998 Aug,The mind of the machine.,993-4,,"['Malik, P']",['Malik P'],['University of Calgary.'],['eng'],['Journal Article'],,England,Can J Cardiol,The Canadian journal of cardiology,8510280,IM,"['*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', '*Computer Communication Networks', 'Humans']",1998/09/17 00:00,1998/09/17 00:01,['1998/09/17 00:00'],"['1998/09/17 00:00 [pubmed]', '1998/09/17 00:01 [medline]', '1998/09/17 00:00 [entrez]']",,ppublish,Can J Cardiol. 1998 Aug;14(8):993-4.,8,,,,,,,,,,,,,,,,,,,,,
12785427,NLM,MEDLINE,20030829,20221207,1049-510X (Print) 1049-510X (Linking),13,2003 Spring,Effects of diet in lowering homocysteine levels and cardiovascular disease.,297,,,,,['eng'],['Journal Article'],,United States,Ethn Dis,Ethnicity & disease,9109034,IM,"['Aged', 'Cardiovascular Diseases/blood/diet therapy/ethnology/*prevention & control', 'Female', 'Hispanic or Latino', 'Homocysteine/*blood', 'Humans', 'Male', 'New Mexico', 'White People']",2003/06/06 05:00,2003/08/30 05:00,['2003/06/06 05:00'],"['2003/06/06 05:00 [pubmed]', '2003/08/30 05:00 [medline]', '2003/06/06 05:00 [entrez]']",,ppublish,Ethn Dis. 2003 Spring;13(2):297.,2,,,,,,,,['0LVT1QZ0BA (Homocysteine)'],,,,,,,,,,,,,
5410017,NLM,MEDLINE,19700206,20001218,0028-2162 (Print) 0028-2162 (Linking),114,1970 Jan 3,"[A ""Deltaplan"" for the campaign against heart and vascular diseases].",19-21,,"['Meijler, F L']",['Meijler FL'],,['dut'],['Journal Article'],,Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['Cardiovascular Diseases/diagnosis/mortality/*prevention & control', 'Computers', 'Electrocardiography', 'Mass Screening', 'Netherlands']",1970/01/03 00:00,1970/01/03 00:01,['1970/01/03 00:00'],"['1970/01/03 00:00 [pubmed]', '1970/01/03 00:01 [medline]', '1970/01/03 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1970 Jan 3;114(1):19-21.,1,,,,,,,,,,,,,,,"Een ""Deltaplan"" ter bestrijding van de sterfte aan hart- en vaatziekten.",,,,,,
8240043,NLM,MEDLINE,19931203,20041117,0066-782X (Print) 0066-782X (Linking),60,1993 Jan,[Pregnancy in cardiovascular disease. Experience with 1000 cases].,5-11,,"['Avila, W S', 'Grinberg, M']","['Avila WS', 'Grinberg M']",['Instituto do Coracao do Hospital das Clinicas-FMUSP.'],['por'],['Journal Article'],,Brazil,Arq Bras Cardiol,Arquivos brasileiros de cardiologia,0421031,IM,"['Cardiovascular Diseases/complications/etiology/*physiopathology/therapy', 'Chagas Cardiomyopathy/complications', 'Female', 'Heart Defects, Congenital/complications', 'Humans', 'Pregnancy', 'Pregnancy Complications, Cardiovascular/etiology/*physiopathology/therapy', 'Prenatal Care', 'Prognosis', 'Rheumatic Heart Disease/complications']",1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Arq Bras Cardiol. 1993 Jan;60(1):5-11.,1,,,,,,,,,,,,,,,Gestacao em portadoras de afeccoes cardiovasculares. Experiencia com 1000 casos.,,,,,,
11213899,NLM,MEDLINE,20010329,20190515,0149-5992 (Print) 0149-5992 (Linking),24,2001 Feb,"American Diabetes Association 60th Scientific Sessions, 2000: cardiovascular disease in diabetes.",399-404,,"['Bloomgarden, Z T']",['Bloomgarden ZT'],,['eng'],"['Congress', 'News']",,United States,Diabetes Care,Diabetes care,7805975,IM,"['*Cardiovascular Diseases/diagnosis/prevention & control/therapy', '*Diabetes Complications', 'Humans', 'Societies, Medical', 'United States']",2001/02/24 12:00,2001/04/03 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/04/03 10:01 [medline]', '2001/02/24 12:00 [entrez]']",['10.2337/diacare.24.2.399 [doi]'],ppublish,Diabetes Care. 2001 Feb;24(2):399-404. doi: 10.2337/diacare.24.2.399.,2,,,,,,,,,,,,,,,,,,,,,
20109416,NLM,MEDLINE,20100513,20190917,1579-2242 (Electronic) 0300-8932 (Linking),63,2010 Feb,"Summary of the clinical studies reported in the annual scientific sessions of the American Heart Association (Orlando, United States, November 14-18, 2009).",190-9,,"['Perez de Isla, Leopoldo', 'Bayes-Genis, Antoni', 'Sanchis, Juan', 'Heras, Magda']","['Perez de Isla L', 'Bayes-Genis A', 'Sanchis J', 'Heras M']","['Sociedad Espanola de Cardiologia, Nuestra Senora de Guadalupe, 5-7. 28028 Madrid, Spain.']","['eng', 'spa']",['Congress'],,Spain,Rev Esp Cardiol,Revista espanola de cardiologia,0404277,IM,"['*American Heart Association', 'Arrhythmias, Cardiac/therapy', 'Cardiovascular Diseases/diagnosis/diagnostic imaging/prevention & control/*therapy', 'Heart Failure/etiology/therapy', 'Myocardial Ischemia/therapy', 'Radiography', 'Thoracic Surgery/trends', 'United States']",2010/01/30 06:00,2010/05/14 06:00,['2010/01/30 06:00'],"['2010/01/30 06:00 [entrez]', '2010/01/30 06:00 [pubmed]', '2010/05/14 06:00 [medline]']","['13146806 [pii]', '10.1016/s1885-5857(10)70037-2 [doi]']",ppublish,Rev Esp Cardiol. 2010 Feb;63(2):190-9. doi: 10.1016/s1885-5857(10)70037-2.,2,,,,,,,,,,,,,,,,,,,,,
17896712,NLM,MEDLINE,20071025,20070927,0028-9604 (Print) 0028-9604 (Linking),146,2005 Oct 3,When should you start to worry?,93-4,,"['Lee, Thomas H']",['Lee TH'],,['eng'],['News'],,United States,Newsweek,Newsweek,9877127,,"['Cardiovascular Diseases/*diagnosis/physiopathology/surgery', 'Fear/*psychology', 'Humans', 'United States']",2007/09/28 09:00,2007/10/27 09:00,['2007/09/28 09:00'],"['2007/09/28 09:00 [pubmed]', '2007/10/27 09:00 [medline]', '2007/09/28 09:00 [entrez]']",,ppublish,Newsweek. 2005 Oct 3;146(14):93-4.,14,,,,,,,,,,,,,,,,,,,,,
11068538,NLM,MEDLINE,20001120,20161124,0041-5782 (Print) 0041-5782 (Linking),162,2000 Oct 9,[Food and heart disease].,5523,,"['Osler, M', 'Godtfredsen, J', 'Gronbaek, M', 'Marckmann, P', 'Overvad, O K']","['Osler M', 'Godtfredsen J', 'Gronbaek M', 'Marckmann P', 'Overvad OK']",,['dan'],['Letter'],,Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,IM,"['*Cardiovascular Diseases/etiology/mortality/prevention & control', '*Feeding Behavior', 'Humans']",2000/11/09 11:00,2001/02/28 10:01,['2000/11/09 11:00'],"['2000/11/09 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/11/09 11:00 [entrez]']",,ppublish,Ugeskr Laeger. 2000 Oct 9;162(41):5523.,41,,,,,,,,,,,,,,,Kost og hjertesygdom.,,,,,,
4518148,NLM,MEDLINE,19731218,20140918,0044-4030 (Print) 0044-4030 (Linking),117,1973,[Comparison between clinical and postmortem diagnosis of diseases of the circulatory system (author's transl)].,118-26,,"['Thierbach, R']",['Thierbach R'],,['ger'],"['Comparative Study', 'Journal Article']",,Germany,Zentralbl Allg Pathol,Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie,9105593,IM,"['Autopsy', 'Cardiovascular Diseases/*diagnosis/epidemiology/pathology', 'Diagnostic Errors', 'Germany, East', 'Humans']",1973/01/01 00:00,1973/01/01 00:01,['1973/01/01 00:00'],"['1973/01/01 00:00 [pubmed]', '1973/01/01 00:01 [medline]', '1973/01/01 00:00 [entrez]']",,ppublish,Zentralbl Allg Pathol. 1973;117(2):118-26.,2,,,,,,,,,,,,,,,Klinisch-autoptischer Diagnosenvergleich bei Krankheiten des Herz-Kreislauf-Systems.,,,,,,
7906755,NLM,MEDLINE,19940331,20190611,0140-6736 (Print) 0140-6736 (Linking),343,1994 Feb 26,Which hypertensive patients should be treated?,496-7,,"['Jackson, R']",['Jackson R'],"['Department of Community Health, University of Auckland, New Zealand.']",['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Aged', 'Cardiovascular Diseases/epidemiology/*etiology/prevention & control', 'Clinical Protocols', 'Humans', 'Hypertension/*complications/*drug therapy', 'Middle Aged', 'Risk Factors']",1994/02/26 00:00,1994/02/26 00:01,['1994/02/26 00:00'],"['1994/02/26 00:00 [pubmed]', '1994/02/26 00:01 [medline]', '1994/02/26 00:00 [entrez]']","['S0140-6736(94)91456-7 [pii]', '10.1016/s0140-6736(94)91456-7 [doi]']",ppublish,Lancet. 1994 Feb 26;343(8896):496-7. doi: 10.1016/s0140-6736(94)91456-7.,8896,,,,,,,,,,,,,,,,,,,,,
10641410,NLM,MEDLINE,20000217,20041117,0026-4725 (Print) 0026-4725 (Linking),47,1999 Nov,[New metabolic risk factors. Genetic basis].,391-400,,"['Bertolini, S']",['Bertolini S'],"['Dipartimento di Medicina Interna, Universita degli Studi, Genova.']",['ita'],['Journal Article'],,Italy,Minerva Cardioangiol,Minerva cardioangiologica,0400725,IM,"['Cardiovascular Diseases/epidemiology/*genetics/*metabolism', 'Humans', 'Risk Factors']",2000/01/21 09:00,2000/02/19 09:00,['2000/01/21 09:00'],"['2000/01/21 09:00 [pubmed]', '2000/02/19 09:00 [medline]', '2000/01/21 09:00 [entrez]']",,ppublish,Minerva Cardioangiol. 1999 Nov;47(11):391-400.,11,,,,,,,,,,,,,,,I nuovi fattori di rischio metabolici. Le basi genetiche.,,,,,,
1573927,NLM,MEDLINE,19920604,20041117,0023-7205 (Print) 0023-7205 (Linking),89,1992 Apr 22,[Do we neglect the treatment of elderly patients with heart diseases?].,"1446, 1451",,"['Erhardt, L', 'Cline, C']","['Erhardt L', 'Cline C']","['Medicinska kliniken, Malmo allmanna sjukhus.']",['swe'],['Journal Article'],,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Age Factors', 'Aged', 'Cardiovascular Diseases/complications/mortality/*therapy', 'Humans', 'Patient Advocacy', 'Treatment Outcome']",1992/04/22 00:00,1992/04/22 00:01,['1992/04/22 00:00'],"['1992/04/22 00:00 [pubmed]', '1992/04/22 00:01 [medline]', '1992/04/22 00:00 [entrez]']",,ppublish,"Lakartidningen. 1992 Apr 22;89(17):1446, 1451.",17,,,,,,,,,,,,,,,Missgynnar vi aldre patienter vid behandling av hjartsjukdomar?,,,,,,
23568105,NLM,MEDLINE,20131017,20130409,1473-5830 (Electronic) 0954-6928 (Linking),24,2013 May,Bibliography - editors' selection of current world literature.,253-7,10.1097/MCA.0b013e328360852b [doi],,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['Animals', 'Anticoagulants/therapeutic use', '*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/blood/diagnosis/physiopathology/therapy', 'Echocardiography, Doppler', 'Humans', 'Magnetic Resonance Imaging', 'Platelet Aggregation Inhibitors/therapeutic use', 'Stem Cell Transplantation']",2013/04/10 06:00,2013/10/18 06:00,['2013/04/10 06:00'],"['2013/04/10 06:00 [entrez]', '2013/04/10 06:00 [pubmed]', '2013/10/18 06:00 [medline]']","['00019501-201305000-00013 [pii]', '10.1097/MCA.0b013e328360852b [doi]']",ppublish,Coron Artery Dis. 2013 May;24(3):253-7. doi: 10.1097/MCA.0b013e328360852b.,3,,,,,,,,"['0 (Anticoagulants)', '0 (Platelet Aggregation Inhibitors)']",,,,,,,,,,,,,
9612795,NLM,MEDLINE,19980807,20191102,1357-4310 (Print) 1357-4310 (Linking),4,1998 May,"The new cardiology. The American College of Cardiology 47th Annual Scientific Session. Atlanta, GA, USA, 29 March-1 April 1998.",191,,"['Brooksbank, C']",['Brooksbank C'],,['eng'],['Congress'],,England,Mol Med Today,Molecular medicine today,9508560,IM,"['Adolescent', 'Animals', 'Cardiovascular Diseases/diagnosis/*genetics/therapy', 'Disease Susceptibility', 'Heart/physiology', 'Humans', 'Mutation']",1998/06/05 00:00,1998/06/05 00:01,['1998/06/05 00:00'],"['1998/06/05 00:00 [pubmed]', '1998/06/05 00:01 [medline]', '1998/06/05 00:00 [entrez]']","['S1357431098012568 [pii]', '10.1016/s1357-4310(98)01256-8 [doi]']",ppublish,Mol Med Today. 1998 May;4(5):191. doi: 10.1016/s1357-4310(98)01256-8.,5,,,,,,,,,,,,,,,,,,,,,
12108186,NLM,MEDLINE,20020731,20190826,0248-8663 (Print) 0248-8663 (Linking),23 Suppl 1,2002 May,[Treatment of arterial hypertension: does it modify cardiovascular morbidity and mortality?].,10s-12s,,"['Godin, M', 'Legallicier, B']","['Godin M', 'Legallicier B']","['Service de nephrologie, hopital de Boisguillaume, CHU Rouen, 76031 Rouen, France. michel.godin@chu-rouen.fr']",['fre'],['Journal Article'],,France,Rev Med Interne,La Revue de medecine interne,8101383,IM,"['Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Humans', 'Hypertension/complications/*therapy', 'Morbidity']",2002/07/11 10:00,2002/08/01 10:01,['2002/07/11 10:00'],"['2002/07/11 10:00 [pubmed]', '2002/08/01 10:01 [medline]', '2002/07/11 10:00 [entrez]']","['S0248-8663(02)80065-0 [pii]', '10.1016/s0248-8663(02)80065-0 [doi]']",ppublish,Rev Med Interne. 2002 May;23 Suppl 1:10s-12s. doi: 10.1016/s0248-8663(02)80065-0.,,,,,,,,,,,,,,,,La prise en charge de l'hypertension arterielle modifie-t-elle la morbidite et la mortalite cardiovasculaires?,,,,,,
21491709,NLM,MEDLINE,20110829,20110414,1016-5169 (Print) 1016-5169 (Linking),38 Suppl 1,2010 Mar,[Women's Heart Health Red Alert. Summary report and proposals of scientific specialty organizations].,9-12,,,,,['tur'],['Journal Article'],,Turkey,Turk Kardiyol Dern Ars,Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,9426239,IM,"['*Cardiovascular Diseases/epidemiology/etiology/therapy', 'Female', 'Humans', 'Risk Factors', ""*Women's Health""]",2011/04/16 06:00,2011/08/30 06:00,['2011/04/16 06:00'],"['2011/04/16 06:00 [entrez]', '2011/04/16 06:00 [pubmed]', '2011/08/30 06:00 [medline]']",,ppublish,Turk Kardiyol Dern Ars. 2010 Mar;38 Suppl 1:9-12.,,,,,,,,,,,,,,,,Kadin Kalbinde Kirmizi Alarm. Bilimsel uzmanlik orgutleri icin ozet rapor ve oneriler.,,,,,,
2247976,NLM,MEDLINE,19910110,20041117,0042-773X (Print) 0042-773X (Linking),36,1990 Jul,"[International Forum for the Evaluation of Cardiovascular Therapy--Lisbon, Portugal, March 3-6 1990].",720-5,,"['Widimsky, J']",['Widimsky J'],,['cze'],['Journal Article'],,Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['*Cardiovascular Diseases/economics/prevention & control/therapy', 'Humans']",1990/07/01 00:00,1990/07/01 00:01,['1990/07/01 00:00'],"['1990/07/01 00:00 [pubmed]', '1990/07/01 00:01 [medline]', '1990/07/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1990 Jul;36(7):720-5.,7,,,,,,,,,,,,,,,"Mezinarodni forum pro vyhodnoceni kardiovaskularui lecby--Lisabon, Portugalsko, 3.- 6. 3. 1990.",,,,,,
14390343,NLM,MEDLINE,20030501,20181201,0008-7335 (Print) 0008-7335 (Linking),91,1952 Sep 5,[Role of neural factors in formation of circulatory disorders in cardiac insufficiency].,1033-7,,"['FEJFAR, Z', 'BROD, J']","['FEJFAR Z', 'BROD J']",,['cze'],['Journal Article'],,Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,OM,"['Cardiovascular Diseases/*physiology/*physiopathology', '*Heart Failure', 'Humans', '*Nervous System']",1952/09/05 00:00,1952/09/05 00:01,['1952/09/05 00:00'],"['1952/09/05 00:00 [pubmed]', '1952/09/05 00:01 [medline]', '1952/09/05 00:00 [entrez]']",,ppublish,Cas Lek Cesk. 1952 Sep 5;91(36):1033-7.,36,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/physiology', '*NERVOUS SYSTEM']",,,,,,,,,Vyznam nervovych cinitelu pro vznik obehovych zmen pri srdecna nedostatecnosti.,,,,,['CLML: 5528:41504:121:387'],
16705758,NLM,MEDLINE,20060609,20060516,1524-4539 (Electronic) 0009-7322 (Linking),113,2006 May 16,"Spotlight on Silvia Priori, MD.",f75-6,,"['Nicholls, Mark']",['Nicholls M'],,['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/physiopathology/*therapy', 'Europe/epidemiology', 'Female', 'Health Services Accessibility', 'Humans', 'Male', 'Myocardial Infarction/diagnosis/epidemiology/physiopathology/therapy', 'Risk Factors', 'Sex Characteristics', 'Societies, Medical', ""*Women's Health""]",2006/05/18 09:00,2006/06/10 09:00,['2006/05/18 09:00'],"['2006/05/18 09:00 [pubmed]', '2006/06/10 09:00 [medline]', '2006/05/18 09:00 [entrez]']",,ppublish,Circulation. 2006 May 16;113(19):f75-6.,19,,,,,,,,,,,,,,,,,,,,,
17312574,NLM,MEDLINE,20070301,20161124,1524-4539 (Electronic) 0009-7322 (Linking),115,2007 Feb 20,"Spotlight: Vilmundur Gudnason, MD, PhD.",f27-8,,"['Wilkinson, Emma']",['Wilkinson E'],,['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/*diagnosis/epidemiology/genetics/prevention & control', 'Genetics', 'Humans', 'Iceland', 'United Kingdom']",2007/02/22 09:00,2007/03/03 09:00,['2007/02/22 09:00'],"['2007/02/22 09:00 [pubmed]', '2007/03/03 09:00 [medline]', '2007/02/22 09:00 [entrez]']",,ppublish,Circulation. 2007 Feb 20;115(7):f27-8.,7,,,,,,,,,,,,,,,,,,,,,
17966805,NLM,MEDLINE,20071106,20071115,0023-7205 (Print) 0023-7205 (Linking),104,2007 Oct 3-9,[Introduction of the National Board of Health and Welfare's cardiologic care guidelines in Region Skane. Evaluation of guideline impact resulted in a unified care program].,2889-91,,"['Juhlin, Tord', 'Engblom, Viveca', 'Fredholm, Olle', 'Kongstad, Ole']","['Juhlin T', 'Engblom V', 'Fredholm O', 'Kongstad O']","['Universitetssjukhuset MAS, Malmo. tord.juhlin@skane.se']",['swe'],['Journal Article'],,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Atrial Fibrillation/diagnosis/drug therapy/therapy', 'Cardiovascular Diseases/diagnosis/drug therapy/therapy', '*Guideline Adherence', '*Heart Diseases/diagnosis/drug therapy/therapy', 'Humans', '*Practice Guidelines as Topic', '*Regional Medical Programs', 'Sweden']",2007/10/31 09:00,2007/11/07 09:00,['2007/10/31 09:00'],"['2007/10/31 09:00 [pubmed]', '2007/11/07 09:00 [medline]', '2007/10/31 09:00 [entrez]']",,ppublish,Lakartidningen. 2007 Oct 3-9;104(40):2889-91.,40,,,,,,,,,,,,,,,Granskning av riktlinjernas genomslag gav enat vardprogram.,,,,,,
9475677,NLM,MEDLINE,19980402,20191102,1350-6277 (Print) 1350-6277 (Linking),4,1997 Jun,Bibliography of current world literature.,215-37,,,,,['eng'],['Bibliography'],,England,J Cardiovasc Risk,Journal of cardiovascular risk,9436980,IM,"['Adult', 'Cardiovascular Diseases/*diagnosis/epidemiology/*therapy', 'Cerebrovascular Disorders/*diagnosis/epidemiology/*therapy', 'Child', 'Child Welfare', 'Female', 'Humans', 'Risk Factors', ""Women's Health""]",1997/06/01 00:00,1998/02/25 00:01,['1997/06/01 00:00'],"['1997/06/01 00:00 [pubmed]', '1998/02/25 00:01 [medline]', '1997/06/01 00:00 [entrez]']",['10.1097/00043798-199706000-00009 [doi]'],ppublish,J Cardiovasc Risk. 1997 Jun;4(3):215-37. doi: 10.1097/00043798-199706000-00009.,3,,,,,,,,,,,,,,,,,,,,,
15505908,NLM,MEDLINE,20050128,20060504,0268-4705 (Print) 0268-4705 (Linking),19,2004 Sep,Bibliography. Current world literature. Prevention.,535-48,,,,,['eng'],['Bibliography'],,United States,Curr Opin Cardiol,Current opinion in cardiology,8608087,IM,"['*Cardiology', 'Cardiovascular Diseases/complications/diagnosis/*prevention & control', 'Humans', 'Primary Prevention/*methods']",2004/10/28 09:00,2005/01/29 09:00,['2004/10/28 09:00'],"['2004/10/28 09:00 [pubmed]', '2005/01/29 09:00 [medline]', '2004/10/28 09:00 [entrez]']",,ppublish,Curr Opin Cardiol. 2004 Sep;19(5):535-48.,5,,,,,,,,,,,,,,,,,,,,,
15237526,NLM,MEDLINE,20040707,20181130,0066-782X (Print) 0066-782X (Linking),82 Suppl 7,2004 May,"[XXVI Congress of the Brazilian Society of Hemodynamics and Interventional Cardiology and the IX Meeting of Nursing. 9-11 June 2004, Joao Pessoa, Paraiba. Abstracts].",4-42,,,,,['por'],"['Congress', 'Overall']",,Brazil,Arq Bras Cardiol,Arquivos brasileiros de cardiologia,0421031,IM,"['*Cardiovascular Diseases/diagnosis/nursing/therapy', '*Catheterization', 'Hemodynamics', 'Humans']",2004/07/09 05:00,2004/07/09 05:01,['2004/07/09 05:00'],"['2004/07/09 05:00 [pubmed]', '2004/07/09 05:01 [medline]', '2004/07/09 05:00 [entrez]']",,ppublish,Arq Bras Cardiol. 2004 May;82 Suppl 7:4-42.,,,,,,,,,,,,,,,,"XXVI Congresso da Sociedade Brasileira de Hemodinamica e Cardiologia Intervencionista e IX Jornada de Enfermagem. 9-11 Junho 2004, Joao Pessoa, Paraiba.",,,,,,
3764716,NLM,MEDLINE,19861030,20041117,0040-3660 (Print) 0040-3660 (Linking),58,1986,[Achievements in the development and tasks of Soviet cardiology in light of the decisions of the 27th Congress of the CPSU].,7-11,,"['Chazov, E I']",['Chazov EI'],,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Cardiology/*trends', 'Cardiovascular Diseases/diagnosis/prevention & control/therapy', '*Communism', 'Humans', 'Research', 'USSR']",1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1986;58(6):7-11.,6,,,,,,,,,,,,,,,Itogi razvitiia i zadachi sovetskoi kardiologii v svete reshenii XXVII s''ezda KPSU.,,,,,,
19440069,NLM,MEDLINE,20090723,20090514,1473-5830 (Electronic) 0954-6928 (Linking),20,2009 Jun,Bibliography--editors' selection of current world literature.,300-2,10.1097/MCA.0b013e32832d8246 [doi],,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['Animals', 'Anticoagulants/therapeutic use', 'Cardiomyopathies', '*Cardiovascular Diseases/blood/diagnosis/therapy', 'Coronary Artery Disease', 'Echocardiography, Doppler', 'Humans', 'Magnetic Resonance Imaging', 'Myocardial Ischemia', 'Pharmacogenetics', 'Platelet Activation', 'Stem Cell Transplantation']",2009/05/15 09:00,2009/07/25 09:00,['2009/05/15 09:00'],"['2009/05/15 09:00 [entrez]', '2009/05/15 09:00 [pubmed]', '2009/07/25 09:00 [medline]']","['00019501-200906000-00008 [pii]', '10.1097/MCA.0b013e32832d8246 [doi]']",ppublish,Coron Artery Dis. 2009 Jun;20(4):300-2. doi: 10.1097/MCA.0b013e32832d8246.,4,,,,,,,,['0 (Anticoagulants)'],,,,,,,,,,,,,
4503088,NLM,MEDLINE,19720725,20041117,0044-1643 (Print) 0044-1643 (Linking),62,1972 May 1,[Think about your heart--motor of life].,462-8,,"['Bock, H E']",['Bock HE'],,['ger'],['Journal Article'],,Germany,Zahnarztl Mitt,Zahnarztliche Mitteilungen,0422566,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Humans']",1972/05/01 00:00,1972/05/01 00:01,['1972/05/01 00:00'],"['1972/05/01 00:00 [pubmed]', '1972/05/01 00:01 [medline]', '1972/05/01 00:00 [entrez]']",,ppublish,Zahnarztl Mitt. 1972 May 1;62(9):462-8.,9,,,,,,,,,,,,,,,Denk an Dein Herz--Motor des Lebens.,,,,,,
12497776,NLM,MEDLINE,20030312,20041117,0393-1978 (Print) 0393-1978 (Linking),44 Suppl 1,1999 Dec,[Strategies for primary and secondary prevention in women].,519-23,,"['Modena, M G', 'Muia, N', 'Origliani, G', 'Aveta, P', 'Rossi, R']","['Modena MG', 'Muia N', 'Origliani G', 'Aveta P', 'Rossi R']","['Cattedra di Cardiologia Dipartimento di Medicina Interna Universita degli Studi, Policlinico Via del Pozzo, 71, 41100 Modena.']",['ita'],['Journal Article'],,Italy,Cardiologia,"Cardiologia (Rome, Italy)",8506637,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Female', 'Humans', 'Primary Prevention']",2002/12/25 04:00,2003/03/13 04:00,['2002/12/25 04:00'],"['2002/12/25 04:00 [pubmed]', '2003/03/13 04:00 [medline]', '2002/12/25 04:00 [entrez]']",,ppublish,Cardiologia. 1999 Dec;44 Suppl 1(Pt 2):519-23.,Pt 2,,,,,,,,,,,,,,,Strategie di prevenzione primaria e secondaria nella donna.,,,,,,
20217906,NLM,MEDLINE,20100325,20100225,1051-5313 (Print) 1051-5313 (Linking),20,2010 Jan,DNA 'caps' offer target for heart drugs.,7,,,,,['eng'],['News'],,United States,Harv Heart Lett,Harvard heart letter : from Harvard Medical School,9425723,,"['Cardiovascular Diseases/*drug therapy/etiology/*physiopathology', 'Humans', 'Telomere/*physiology']",2010/03/11 06:00,2010/03/26 06:00,['2010/03/11 06:00'],"['2010/03/11 06:00 [entrez]', '2010/03/11 06:00 [pubmed]', '2010/03/26 06:00 [medline]']",,ppublish,Harv Heart Lett. 2010 Jan;20(5):7.,5,,,,,,,,,,,,,,,,,,,,,
21769812,NLM,MEDLINE,20120410,20110719,1897-4279 (Electronic) 0022-9032 (Linking),69,2011,[Conclusions from the meeting of the National Cardiology Supervision Team].,761,,"['Opolski, Grzegorz', 'Banasiak, Waldemar', 'Stepinska, Janina']","['Opolski G', 'Banasiak W', 'Stepinska J']",,['pol'],['Journal Article'],,Poland,Kardiol Pol,Kardiologia polska,0376352,IM,"['*Cardiovascular Diseases/diagnosis/economics/therapy', 'Humans']",2011/07/20 06:00,2012/04/11 06:00,['2011/07/20 06:00'],"['2011/07/20 06:00 [entrez]', '2011/07/20 06:00 [pubmed]', '2012/04/11 06:00 [medline]']",,ppublish,Kardiol Pol. 2011;69(7):761.,7,,,,,,,,,,,,,,,Wnioski ze spotkania Krajowego ZespoluNadzoru Specjalistycznego w dziedzinie kardiologii.,,,,,,
14692106,NLM,MEDLINE,20040525,20161020,0869-6047 (Print) 0869-6047 (Linking),,2003,[Reality and expectations of cardiology].,3-6,,"['Chazov, E I']",['Chazov EI'],,['rus'],['Journal Article'],,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Cardiology/*trends', '*Cardiovascular Diseases/epidemiology/etiology/therapy', 'Humans']",2003/12/25 05:00,2004/05/27 05:00,['2003/12/25 05:00'],"['2003/12/25 05:00 [pubmed]', '2004/05/27 05:00 [medline]', '2003/12/25 05:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 2003;(11):3-6.,11,,,,,,,,,,,,,,,Real'nost' i nadezhdy kardiologii.,,,,,,
16247284,NLM,MEDLINE,20060915,20191109,1076-7460 (Print) 1076-7460 (Linking),14,2005 Sep-Oct,Third pivotal research in cardiology in the elderly (PRICE-III) symposium: heart failure in the elderly: mechanisms and management.,250-61,,"['Rich, Michael W', 'Kitzman, Dalane W']","['Rich MW', 'Kitzman DW']","['Washington University School of Medicine, St. Louis, MO 63110, USA. mrich@im.wustl.edu']",['eng'],"['Congress', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S.""]",,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Aged', '*Biomedical Research', 'Cardiovascular Agents/*therapeutic use', '*Cardiovascular Diseases/diagnosis/genetics/physiopathology/therapy', 'Heart Failure/diagnosis/genetics/physiopathology/therapy', 'Humans', 'Nutritional Physiological Phenomena']",2005/10/26 09:00,2006/09/16 09:00,['2005/10/26 09:00'],"['2005/10/26 09:00 [pubmed]', '2006/09/16 09:00 [medline]', '2005/10/26 09:00 [entrez]']",['10.1111/j.1076-7460.2005.04658.x [doi]'],ppublish,Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):250-61. doi: 10.1111/j.1076-7460.2005.04658.x.,5,,,,,,,['R13 AG23743/AG/NIA NIH HHS/United States'],['0 (Cardiovascular Agents)'],,,,,['Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):221-3. PMID: 16247279'],"['PRICE-III Organizing Committee', 'PRICE-III Investigators']",,,,,,,
17606847,NLM,MEDLINE,20070720,20181201,1524-4539 (Electronic) 0009-7322 (Linking),116,2007 Jul 3,"Conference report: Bosnia and Herzegovina. The Fourth International Congress of Cardiologists and Angiologists, Mostar; Bosnia and Herzegovina, May 17 to 19, 2007.",f3-5,,"['Barnard, Keith']",['Barnard K'],,['eng'],['Congress'],,United States,Circulation,Circulation,0147763,IM,"['Bosnia and Herzegovina', 'Cardiology/*trends', 'Cardiovascular Diseases/epidemiology/nursing/prevention & control/therapy', 'Health Promotion', 'Humans', 'Social Change', 'Warfare']",2007/07/04 09:00,2007/07/21 09:00,['2007/07/04 09:00'],"['2007/07/04 09:00 [pubmed]', '2007/07/21 09:00 [medline]', '2007/07/04 09:00 [entrez]']","['116/1/F1 [pii]', '10.1161/CIRCULATIONAHA.107.185417 [doi]']",ppublish,Circulation. 2007 Jul 3;116(1):f3-5. doi: 10.1161/CIRCULATIONAHA.107.185417.,1,,,,,,,,,,,,,,,,,,,,,
7952415,NLM,MEDLINE,19941128,20041117,0954-6928 (Print) 0954-6928 (Linking),5,1994 Jun,Bibliography of the current world literature.,551-9,,,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['*Cardiovascular Diseases/diagnosis/etiology/therapy', 'Coronary Disease/diagnosis/etiology/therapy', 'Heart Diseases/diagnosis/etiology/therapy', 'Humans']",1994/06/01 00:00,1994/06/01 00:01,['1994/06/01 00:00'],"['1994/06/01 00:00 [pubmed]', '1994/06/01 00:01 [medline]', '1994/06/01 00:00 [entrez]']",,ppublish,Coron Artery Dis. 1994 Jun;5(6):551-9.,6,,,,,,,,,,,,,,,,,,,,,
12192773,NLM,MEDLINE,20020917,20161124,1053-5330 (Print) 1053-5330 (Linking),13,2002 Jul-Aug,Bringing cardiac healthcare directly to your hospital--and we do it with heart.,10-1,,,,,['eng'],['Journal Article'],,United States,J Cardiovasc Manag,The Journal of cardiovascular management : the official journal of the American College of Cardiovascular Administrators,9111437,,"['*Cardiovascular Diseases/diagnosis/diagnostic imaging/surgery', 'Humans', '*Mobile Health Units', 'Radionuclide Imaging', 'United States']",2002/08/24 10:00,2002/09/18 10:01,['2002/08/24 10:00'],"['2002/08/24 10:00 [pubmed]', '2002/09/18 10:01 [medline]', '2002/08/24 10:00 [entrez]']",,ppublish,J Cardiovasc Manag. 2002 Jul-Aug;13(4):10-1.,4,,,,,,,,,,,,,,,,,,,,,
1942758,NLM,MEDLINE,19911216,20141120,0022-9032 (Print) 0022-9032 (Linking),35,1991,[Cardiology in Poland and in the world].,132-54,,,,,['pol'],['Journal Article'],,Poland,Kardiol Pol,Kardiologia polska,0376352,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control', 'Global Health', 'Humans', 'Poland/epidemiology']",1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",,ppublish,Kardiol Pol. 1991;35(8):132-54.,8,,,,,,,,,,,,,,,Kardiologia w Polsce i swiecie.,,,,,,
19044103,NLM,MEDLINE,20090107,20101118,1086-5462 (Print) 1086-5462 (Linking),91,2008 Oct,"Vascular disease: medical therapy, surgery and interventional technologies.",300,,"['Korr, Kenneth S']",['Korr KS'],"['Division of Cardiology, The Miriam Hospital, 164 Summit Ave., Providence, RI 02906, USA. kkorr@lifespan.org']",['eng'],['Journal Article'],,United States,Med Health R I,"Medicine and health, Rhode Island",9603446,IM,"['Angioplasty, Balloon, Coronary', 'Cardiovascular Diseases/*drug therapy/surgery/therapy', 'Humans', 'Peripheral Vascular Diseases/*drug therapy/surgery/therapy', 'Platelet Aggregation Inhibitors/therapeutic use', 'Stents']",2008/12/03 09:00,2009/01/08 09:00,['2008/12/03 09:00'],"['2008/12/03 09:00 [pubmed]', '2009/01/08 09:00 [medline]', '2008/12/03 09:00 [entrez]']",,ppublish,Med Health R I. 2008 Oct;91(10):300.,10,,,,,,,,['0 (Platelet Aggregation Inhibitors)'],,,,,,,,,,,,,
16900020,NLM,MEDLINE,20061212,20060810,0268-4705 (Print) 0268-4705 (Linking),21,2006 Sep,Bibliography. Current world literature. Imaging and echocardiography.,529-35,,,,,['eng'],['Bibliography'],,United States,Curr Opin Cardiol,Current opinion in cardiology,8608087,IM,"['Cardiovascular Diseases/*diagnosis/pathology/physiopathology', '*Diagnostic Techniques, Cardiovascular', 'Heart/physiopathology', 'Humans', 'Tissue Survival/physiology']",2006/08/11 09:00,2006/12/13 09:00,['2006/08/11 09:00'],"['2006/08/11 09:00 [pubmed]', '2006/12/13 09:00 [medline]', '2006/08/11 09:00 [entrez]']","['00001573-200609000-00019 [pii]', '10.1097/01.hco.0000240595.37333.68 [doi]']",ppublish,Curr Opin Cardiol. 2006 Sep;21(5):529-35. doi: 10.1097/01.hco.0000240595.37333.68.,5,,,,,,,,,,,,,,,,,,,,,
4783448,NLM,MEDLINE,19740516,20170310,0022-9040 (Print) 0022-9040 (Linking),13,1973 Nov,[State and perspectives of the development of cardiological service to help the population of the USSR].,5-14,,"['Petrovskii, B V']",['Petrovskii BV'],,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Adult', 'Cardiology/education', 'Cardiovascular Diseases/diagnosis/etiology/mortality/*therapy', 'Community Health Services', 'Death, Sudden', 'Education, Medical', 'Humans', 'Intensive Care Units', 'Middle Aged', 'Patient Care Planning', 'Public Health Administration', 'State Medicine', 'USSR']",1973/11/01 00:00,1973/11/01 00:01,['1973/11/01 00:00'],"['1973/11/01 00:00 [pubmed]', '1973/11/01 00:01 [medline]', '1973/11/01 00:00 [entrez]']",,ppublish,Kardiologiia. 1973 Nov;13(11):5-14.,11,,,,,,,,,,,,,,,Sostoianie i perspektivy razvitiia kardiologicheskoi pomoshchi naseleniiu SSS.,,,,,,
21591397,NLM,MEDLINE,20110719,20170310,0022-9040 (Print) 0022-9040 (Linking),50,2010,"[Russian National Congress of Cardiology, 5-7 October, 2010].",78,,"['Mamedov, M N', 'Koltunov, I E']","['Mamedov MN', 'Koltunov IE']",,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Cardiology/*methods', '*Cardiovascular Diseases/classification/diagnosis/therapy', '*Congresses as Topic', 'Humans', 'Russia']",2010/01/01 00:00,2011/07/20 06:00,['2011/05/20 06:00'],"['2011/05/20 06:00 [entrez]', '2010/01/01 00:00 [pubmed]', '2011/07/20 06:00 [medline]']",,ppublish,Kardiologiia. 2010;50(12):78.,12,,,,,,,,,,,,,,,,,,,,,
19577981,NLM,MEDLINE,20090724,20191111,1774-024X (Print) 1774-024X (Linking),5,2009 May,Sustain Health development in Africa through Responsible Education (SHARE).,37-8,EIJV5I1A7 [pii],"['Bourlon, Francois', 'Robillon, Jean-Francois', 'Jolly, Patrick', 'Wijns, William', 'Marco, Jean']","['Bourlon F', 'Robillon JF', 'Jolly P', 'Wijns W', 'Marco J']",,['eng'],['Journal Article'],,France,EuroIntervention,EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,101251040,IM,"['Africa/epidemiology', 'Cardiology/*education', 'Cardiovascular Diseases/diagnosis/mortality/prevention & control/*therapy', '*Developing Countries', 'Europe', 'Health Knowledge, Attitudes, Practice', 'Humans', '*International Cooperation', 'Program Development']",2009/07/07 09:00,2009/07/25 09:00,['2009/07/07 09:00'],"['2009/07/07 09:00 [entrez]', '2009/07/07 09:00 [pubmed]', '2009/07/25 09:00 [medline]']","['EIJV5I1A7 [pii]', '10.4244/eijv5i1a7 [doi]']",ppublish,EuroIntervention. 2009 May;5(1):37-8. doi: 10.4244/eijv5i1a7.,1,,,,,,,,,,,,,,,,,,,,,
12523337,NLM,MEDLINE,20030612,20071115,0957-9672 (Print) 0957-9672 (Linking),13,2002 Dec,Bibliography. Current world literature. Therapy and clinical trials.,671-2,,,,,['eng'],['Bibliography'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Cardiovascular Diseases/drug therapy/prevention & control/*therapy', 'Clinical Trials as Topic', 'Humans']",2003/01/14 04:00,2003/06/13 05:00,['2003/01/14 04:00'],"['2003/01/14 04:00 [pubmed]', '2003/06/13 05:00 [medline]', '2003/01/14 04:00 [entrez]']",,ppublish,Curr Opin Lipidol. 2002 Dec;13(6):671-2.,6,,,,,,,,,,,,,,,,,,,,,
9766131,NLM,MEDLINE,19981021,20071115,0023-7205 (Print) 0023-7205 (Linking),95,1998 Sep 2,[Over-interpretation of the HOT and CAPP studies].,3757,,"['Lindeberg, S']",['Lindeberg S'],,['swe'],"['Comment', 'Letter']",,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Cardiovascular Diseases/etiology/*mortality/prevention & control', 'Clinical Trials as Topic', 'Guidelines as Topic', 'Humans', 'Hypertension/complications/*drug therapy']",1998/10/10 00:00,1998/10/10 00:01,['1998/10/10 00:00'],"['1998/10/10 00:00 [pubmed]', '1998/10/10 00:01 [medline]', '1998/10/10 00:00 [entrez]']",,ppublish,Lakartidningen. 1998 Sep 2;95(36):3757.,36,,,,,,,,,,,['Lakartidningen. 1998 Aug 5;95(32-33):3380-1. PMID: 9725941'],,,,Overtolkning av HOT- och CAPP-studierna.,,,,,,
12494115,NLM,MEDLINE,20031106,20181130,0022-9040 (Print) 0022-9040 (Linking),42,2002,[Current problems in diagnosis and treatment of cardiological patients (data from the XXIIIrd Congress of the European Society of Cardiology)].,63-6,,"['Pogosova, G V']",['Pogosova GV'],,['rus'],['Congress'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['*Cardiology', 'Cardiovascular Diseases/*diagnosis/surgery/*therapy', 'Humans']",2002/12/21 04:00,2003/11/07 05:00,['2002/12/21 04:00'],"['2002/12/21 04:00 [pubmed]', '2003/11/07 05:00 [medline]', '2002/12/21 04:00 [entrez]']",,ppublish,Kardiologiia. 2002;42(7):63-6.,7,,,,,,,,,,,,,,,"Aktual'nye voprosy diagnostiki i lecheniia kardiologicheskikh bol'nykh (po materialam XXIII kongressa Evropeiskogo kardiologicheskogo obshchestva, Stokgol'm, sentiabr' 2001 g.).",,,,,,
17180170,NLM,MEDLINE,20070108,20181201,1579-0789 (Electronic) 1579-0789 (Linking),10,2006 Dec 12,Highlights from the 2006 Scientific Sessions of the American Heart Association.,E31,,"['Zareba, K']",['Zareba K'],"['University of Rochester School of Medicine, Rochester, New York, USA.']",['eng'],['Congress'],20061212,United States,Timely Top Med Cardiovasc Dis,Timely topics in medicine. Cardiovascular diseases,101166310,IM,"['*American Heart Association', '*Cardiovascular Diseases/etiology/physiopathology/therapy', 'Humans', 'United States']",2006/12/21 09:00,2007/01/09 09:00,['2006/12/21 09:00'],"['2006/12/21 09:00 [pubmed]', '2007/01/09 09:00 [medline]', '2006/12/21 09:00 [entrez]']",['696S17 [pii]'],epublish,Timely Top Med Cardiovasc Dis. 2006 Dec 12;10:E31.,,,,,,,,,,,,,,,,,,,,,,
2752472,NLM,MEDLINE,19890905,20061115,0009-0689 (Print) 0009-0689 (Linking),37,1989 May,[Personal experience with implementation of the nationwide program in cardiology in the West Bohemia Region].,224-7,,"['Hula, J', 'Cepelak, V']","['Hula J', 'Cepelak V']",,['cze'],"['English Abstract', 'Journal Article']",,Czech Republic,Cesk Zdrav,Ceskoslovenske zdravotnictvi,0416604,IM,"['*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Czechoslovakia', 'Humans', '*National Health Programs']",1989/05/01 00:00,1989/05/01 00:01,['1989/05/01 00:00'],"['1989/05/01 00:00 [pubmed]', '1989/05/01 00:01 [medline]', '1989/05/01 00:00 [entrez]']",,ppublish,Cesk Zdrav. 1989 May;37(5):224-7.,5,"The authors submit experience regarding the implementation of the cardiovascular programme in the West Bohemian region. The implementation of the programme is pretentious as regards staff as well as investments and treatment. In these spheres reasons must be sought why the cardiovascular programme is not always implemented, as required by the authorities and our medical responsibility.",,,,,,,,,,,,,,Nase zkusenosti s plnenim celospolecenskeho programu v oblasti kardiologie v Zapadoceskem kraji.,,,,,,
11203505,NLM,MEDLINE,20010104,20041117,0029-6465 (Print) 0029-6465 (Linking),35,2000 Dec,Continuing Care in Adult Cardiology: Living with a Cardiac Diagnosis. Preface.,961-2,,"['Prinkey-Briggs, L A']",['Prinkey-Briggs LA'],,['eng'],['Journal Article'],,United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,IM,"['Adult', '*Cardiovascular Diseases/epidemiology/nursing/prevention & control/therapy', 'Holistic Health', 'Humans']",2001/02/24 12:00,2001/02/28 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/02/28 10:01 [medline]', '2001/02/24 12:00 [entrez]']",,ppublish,Nurs Clin North Am. 2000 Dec;35(4):961-2.,4,,,,,,,,,,,,,,,,,,,,,
5085756,NLM,MEDLINE,19730116,20041117,0019-5456 (Print) 0019-5456 (Linking),39,1972 Apr,"World Health Day, 7 April 1972. ""Your heart is your health"".",114-5,,,,,['eng'],['Journal Article'],,India,Indian J Pediatr,Indian journal of pediatrics,0417442,IM,"['Adolescent', 'Adult', 'Cardiovascular Diseases/epidemiology/etiology/*prevention & control/therapy', 'Child', 'Humans', '*International Cooperation']",1972/04/01 00:00,1972/04/01 00:01,['1972/04/01 00:00'],"['1972/04/01 00:00 [pubmed]', '1972/04/01 00:01 [medline]', '1972/04/01 00:00 [entrez]']",,ppublish,Indian J Pediatr. 1972 Apr;39(291):114-5.,291,,,,,,,,,,,,,,,,,,,,,
7614892,NLM,MEDLINE,19950824,20041117,0730-4625 (Print) 0730-4625 (Linking),14,1995 Jul-Aug,Women and heart disease: unique aspects of teaching women.,179-80,,"['Romeo, K C']",['Romeo KC'],,['eng'],['Journal Article'],,United States,Dimens Crit Care Nurs,Dimensions of critical care nursing : DCCN,8211489,,"['Cardiovascular Diseases/epidemiology/nursing/*physiopathology', 'Critical Care', '*Curriculum', '*Education, Nursing, Continuing', 'Female', 'Humans', ""*Women's Health""]",1995/07/01 00:00,1995/07/01 00:01,['1995/07/01 00:00'],"['1995/07/01 00:00 [pubmed]', '1995/07/01 00:01 [medline]', '1995/07/01 00:00 [entrez]']",,ppublish,Dimens Crit Care Nurs. 1995 Jul-Aug;14(4):179-80.,4,,,,,,,,,,,,,,,,,,,,,
3727907,NLM,MEDLINE,19860821,20070906,0001-7604 (Print) 0001-7604 (Linking),28,1986 Mar,Workshop on psychophysiological risk factors in preventive health care.,59-80,,,,,['eng'],['Journal Article'],,Czech Republic,Act Nerv Super (Praha),Activitas nervosa superior,0400662,IM,"['Cardiovascular Diseases/etiology/prevention & control/*psychology', 'Humans', '*Psychophysiologic Disorders', 'Risk']",1986/03/01 00:00,1986/03/01 00:01,['1986/03/01 00:00'],"['1986/03/01 00:00 [pubmed]', '1986/03/01 00:01 [medline]', '1986/03/01 00:00 [entrez]']",,ppublish,Act Nerv Super (Praha). 1986 Mar;28(1):59-80.,1,,,,,,,,,,,,,,,,,,,,,
17285695,NLM,MEDLINE,20070320,20180417,0755-4982 (Print) 0755-4982 (Linking),36,2007 Jan,[As the heart and coronary vessels grow old].,79-80,,"['Letonturier, Philippe']",['Letonturier P'],,['fre'],['News'],,France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,IM,"['Aging/*physiology', 'Cardiovascular Diseases/diagnosis/*physiopathology/therapy', 'Humans', 'Risk Factors']",2007/02/08 09:00,2007/03/21 09:00,['2007/02/08 09:00'],"['2007/02/08 09:00 [pubmed]', '2007/03/21 09:00 [medline]', '2007/02/08 09:00 [entrez]']",['S0755-4982(06)00140-0 [pii]'],ppublish,Presse Med. 2007 Jan;36(1 Pt 1):79-80.,1 Pt 1,,,,,,,,,,,,,,,Quand coeur et vaisseaux sont victimes de leur age.,,,,,,
6899798,NLM,MEDLINE,19800627,20041117,0014-9772 (Print) 0014-9772 (Linking),45,1980,[Clinical aspects and diagnosis of chronic circulatory insufficiency].,17-20,,"['Li, E D']",['Li ED'],,['rus'],['Journal Article'],,Russia (Federation),Feldsher Akush,Fel'dsher i akusherka,16930040R,,"['Cardiovascular Diseases/*diagnosis/etiology/physiopathology', 'Chronic Disease', 'Heart Ventricles/physiopathology', 'Humans']",1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,Feldsher Akush. 1980;45(3):17-20.,3,,,,,,,,,,,,,,,Klinika i diagnostika khronicheskoi nedostatochnosti krovoobrashcheniia.,,,,,,
17168411,NLM,MEDLINE,20070207,20061215,0008-7335 (Print) 0008-7335 (Linking),145,2006,[Doubts and controversy--open questions and missing answers. Epidemiology and statistics of physiology and clinics?].,823-4,,"['Jerie, P']",['Jerie P'],,['cze'],['Journal Article'],,Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,IM,"['*Cardiovascular Diseases/etiology/mortality/prevention & control/therapy', 'Czech Republic/epidemiology', 'Humans', 'Life Style']",2006/12/16 09:00,2007/02/08 09:00,['2006/12/16 09:00'],"['2006/12/16 09:00 [pubmed]', '2007/02/08 09:00 [medline]', '2006/12/16 09:00 [entrez]']",,ppublish,Cas Lek Cesk. 2006;145(11):823-4.,11,,,,,,,,,,,,,,,Pochybnosti a kontroverze - otevrene otazky a chybejici odpovedi Epidemiologie a statistika ci fyziologie a klinika?,,,,,,
14724982,NLM,MEDLINE,20040527,20161020,0869-6047 (Print) 0869-6047 (Linking),,2003,[The Resolution of the LXXV Session of the General Assembly of the Russian Academy of Medical Sciences].,80-2,,,,,['rus'],['Journal Article'],,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Adult', 'Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control/therapy', 'Child', 'Coronary Disease/prevention & control/therapy', 'Female', 'Humans', 'Infant, Newborn', 'Male', 'Mass Screening', 'Primary Prevention', 'Russia/epidemiology']",2004/01/17 05:00,2004/05/28 05:00,['2004/01/17 05:00'],"['2004/01/17 05:00 [pubmed]', '2004/05/28 05:00 [medline]', '2004/01/17 05:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 2003;(12):80-2.,12,,,,,,,,,,,,,,,Postanovlenie dvenadtsatoi (LXXV) sessii Obshchego sobraniia Rossiiskoi akademii meditsinskikh nauk.,,,,,,
8249212,NLM,MEDLINE,19931228,20091111,0041-6959 (Print) 0041-6959 (Linking),122,1993 Sep-Oct,"[In cardiology: no miracles, but regression of mortality with therapeutic options that multiply].",310-4,,"['Roy, D']",['Roy D'],,['fre'],['Interview'],,Canada,Union Med Can,L'union medicale du Canada,0030444,IM,"['Cardiology/*methods/trends', 'Cardiovascular Diseases/etiology/*mortality/*therapy', 'Humans']",1993/09/01 00:00,1993/09/01 00:01,['1993/09/01 00:00'],"['1993/09/01 00:00 [pubmed]', '1993/09/01 00:01 [medline]', '1993/09/01 00:00 [entrez]']",,ppublish,Union Med Can. 1993 Sep-Oct;122(5):310-4.,5,,,,,,,,,,,,,,,"En cardiologie, pas de miracles, mais la mortalite recule devant les options therapeutiques qui se multiplient.",,,,,,
3102009,NLM,MEDLINE,19870401,20061115,0376-2491 (Print) 0376-2491 (Linking),66,1986 Nov,"[Epidemiologic analysis of cerebral apoplexy in a population of 700,000 in Beijing].",653-7,,"['Chen, D Y']",['Chen DY'],,['chi'],"['English Abstract', 'Journal Article']",,China,Zhonghua Yi Xue Za Zhi,Zhonghua yi xue za zhi,7511141,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/classification/*epidemiology/mortality', 'China', 'Female', 'Humans', 'Male', 'Middle Aged']",1986/11/01 00:00,1986/11/01 00:01,['1986/11/01 00:00'],"['1986/11/01 00:00 [pubmed]', '1986/11/01 00:01 [medline]', '1986/11/01 00:00 [entrez]']",,ppublish,Zhonghua Yi Xue Za Zhi. 1986 Nov;66(11):653-7.,11,,,,,,,,,,,,,,,,,,,,,
2674545,NLM,MEDLINE,19891026,20041117,0023-2149 (Print) 0023-2149 (Linking),67,1989 Jun,[The role of V.Kh. Vasilenko in the development of Russian cardiology].,3-7,,"['Golochevskaia, V S']",['Golochevskaia VS'],,['rus'],"['Biography', 'Historical Article', 'Journal Article']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Cardiology/*history', 'Cardiovascular Diseases/diagnosis/*history/therapy', 'History, 20th Century', 'Humans', 'Russia (Pre-1917)', 'USSR']",1989/06/01 00:00,1989/06/01 00:01,['1989/06/01 00:00'],"['1989/06/01 00:00 [pubmed]', '1989/06/01 00:01 [medline]', '1989/06/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1989 Jun;67(6):3-7.,6,,,,,,,,,,,,,,,Ro'l V.Kh. Vasilenko v razvitii otechestvennoi kardiologii.,['Vasilenko VKh'],"['Vasilenko, V Kh']",,,,
17691165,NLM,MEDLINE,20070830,20191110,1532-6551 (Electronic) 1071-3581 (Linking),14,2007 Jul,President's message: The global burden of cardiovascular disease.,621-2,,"['Thomas, Gregory S']",['Thomas GS'],,['eng'],['News'],,United States,J Nucl Cardiol,Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,9423534,IM,"['Cardiology/methods/*trends', 'Cardiovascular Diseases/*diagnosis/*epidemiology/prevention & control/therapy', 'Developing Countries', 'Diagnostic Imaging/methods/trends', 'Global Health', 'Humans', 'Risk Factors']",2007/08/19 09:00,2007/08/31 09:00,['2007/08/19 09:00'],"['2007/08/19 09:00 [pubmed]', '2007/08/31 09:00 [medline]', '2007/08/19 09:00 [entrez]']",['10.1016/j.nuclcard.2007.06.001 [doi]'],ppublish,J Nucl Cardiol. 2007 Jul;14(4):621-2. doi: 10.1016/j.nuclcard.2007.06.001.,4,,,,,,,,,,,,,,,,,,,,,
11016194,NLM,MEDLINE,20001018,20121115,0023-7205 (Print) 0023-7205 (Linking),97,2000 Jul 26,[Development in cardiovascular genetics. Drugs adapted to patient's genetic profile soon available].,3348-51,,"['Nilsson, P']",['Nilsson P'],"['Avdelningen for medicin, Universitetssjukhuset MAS, Malmo. Peter.Nilsson@medforsk.mas.lu.se']",['swe'],"['Journal Article', 'Review']",,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Cardiovascular Diseases/classification/diagnosis/drug therapy/*genetics', 'Chromosome Mapping', 'Female', 'Genetic Predisposition to Disease', 'Genetic Therapy/*trends', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Neovascularization, Physiologic', 'Risk Factors']",2000/10/04 11:00,2000/10/21 11:01,['2000/10/04 11:00'],"['2000/10/04 11:00 [pubmed]', '2000/10/21 11:01 [medline]', '2000/10/04 11:00 [entrez]']",,ppublish,Lakartidningen. 2000 Jul 26;97(30-31):3348-51.,30-31,,,,,,,,,,20,,,,,Utvecklingslinjer inom den kardiovaskulara genetiken. Inom rackhall ligger lakemedel anpassade till patientens genetiska profil.,,,,,,
19098395,NLM,MEDLINE,20090109,20081222,0385-0684 (Print) 0385-0684 (Linking),35,2008 Dec,[Treatment for oncogenic emergencies of the cardiovascular system].,2307-10,,"['Sakai, Takehiro', 'Fukuda, Ikuo']","['Sakai T', 'Fukuda I']","['Dept. of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.']",['jpn'],"['English Abstract', 'Journal Article']",,Japan,Gan To Kagaku Ryoho,Gan to kagaku ryoho. Cancer & chemotherapy,7810034,IM,"['Angiocardiography', 'Cardiovascular Diseases/*etiology/pathology/surgery/*therapy', 'Emergency Medical Services', 'Humans', 'Neoplasms/*complications', 'Tomography, X-Ray Computed']",2008/12/23 09:00,2009/01/10 09:00,['2008/12/23 09:00'],"['2008/12/23 09:00 [entrez]', '2008/12/23 09:00 [pubmed]', '2009/01/10 09:00 [medline]']",,ppublish,Gan To Kagaku Ryoho. 2008 Dec;35(13):2307-10.,13,"Cardiac tamponade and superior vena cava(SVC)syndrome are important oncogenic emergencies of the cardiovascular system. Depending on the nature of the emergency, its severity, the progression of malignancies, general condition and proper treatment should be chosen in each patient. The treatment to be first considered for cardiac tamponade is percardiocentesis and tube pericardiotomy. It is important to improve cardiac function by prompt drainage after diagnosis with cardiac ultrasonography. To avoid recurrence of cardiac tamponade, pericardial fenestration and instillation of anticancer agents into the pericardium are sometimes added. In patients with SVC syndrome, treatment should be determined after enhanced computed tomography. Although surgery, chemotherapy and radiation are important treatments for malignances, stenting in obstruction of SVC is a safe and effective method to improve symptoms promptly.",,,,,,,,,,,,,,,,,,,,
11098732,NLM,MEDLINE,20010108,20071115,0040-5957 (Print) 0040-5957 (Linking),55,2000 Jul-Aug,"[Global cardiovascular risk: definition, evaluation and management strategies. Round table no. 1. XV].",533-9,,"['Amouyel, P', 'Deverly, A']","['Amouyel P', 'Deverly A']","['INSERM U508, Institut Pasteur de Lille, France.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Therapie,Therapie,0420544,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Humans', 'Risk Assessment', 'Terminology as Topic']",2000/12/01 11:00,2001/02/28 10:01,['2000/12/01 11:00'],"['2000/12/01 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/12/01 11:00 [entrez]']",,ppublish,Therapie. 2000 Jul-Aug;55(4):533-9.,4,"The global cardiovascular risk is the probability of developing a cardiovascular disease within a defined period of time, taking into account several risk factors simultaneously. Born 50 years ago with the analytical epidemiology of cardiovascular diseases, this concept may be considered today as a potential prevention tool integrating the multifactorial aspect of these diseases. Its implementation in clinical practice raises numerous questions related to its estimation, practical use and consequences for the health system. This new approach to cardiovascular diseases does not aim to cure a complaint but to try to avoid its appearance by means of restricting measures. This will modify the relationships between physician and patient and will imply major modifications of our treatment habits. For this strategy to be effective three main prerequisites are needed: management choices will have to be the result of a deal between the patient and the physician, the responsibility for decisions will be endorsed by both of them, and the actions should be maintained over time.",,,,,,,,,26,,,,,"Risque cardiovasculaire global: definition, strategies d'evaluation et de prise en charge. Table Ronde no 1 de Giens. XV.",,,,,,
19207509,NLM,MEDLINE,20090521,20090211,1751-486X (Electronic) 1751-4851 (Linking),13,2009 Feb,Cardiometabolic health: connecting the dots.,78-82,10.1111/j.1751-486X.2009.01384.x [doi],"['Ruhl, Catherine']",['Ruhl C'],"['AWHONN in Washington, DC, USA. cruhl@awhonn.org']",['eng'],['Journal Article'],,United States,Nurs Womens Health,Nursing for women's health,101304602,,"['Cardiovascular Diseases/metabolism/prevention & control/*therapy', 'Female', 'Humans', ""Nurse's Role"", 'Risk Factors', ""*Women's Health""]",2009/02/12 09:00,2009/05/22 09:00,['2009/02/12 09:00'],"['2009/02/12 09:00 [entrez]', '2009/02/12 09:00 [pubmed]', '2009/05/22 09:00 [medline]']","['S1751-4851(15)30365-2 [pii]', '10.1111/j.1751-486X.2009.01384.x [doi]']",ppublish,Nurs Womens Health. 2009 Feb;13(1):78-82. doi: 10.1111/j.1751-486X.2009.01384.x.,1,,,,,,,,,,,,,,,,,,,,,
10090108,NLM,MEDLINE,19990407,20190812,0003-9926 (Print) 0003-9926 (Linking),159,1999 Mar 22,Antihypertensives: much ado about lipids.,535-7,,"['Golomb, B A', 'Criqui, M H']","['Golomb BA', 'Criqui MH']",,['eng'],['Editorial'],,United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Antihypertensive Agents/*pharmacology', 'Cardiovascular Diseases/blood/mortality/*prevention & control', 'Humans', 'Lipids/*blood']",1999/03/25 00:00,1999/03/25 00:01,['1999/03/25 00:00'],"['1999/03/25 00:00 [pubmed]', '1999/03/25 00:01 [medline]', '1999/03/25 00:00 [entrez]']",['10.1001/archinte.159.6.535 [doi]'],ppublish,Arch Intern Med. 1999 Mar 22;159(6):535-7. doi: 10.1001/archinte.159.6.535.,6,,,,,,,,"['0 (Antihypertensive Agents)', '0 (Lipids)']",,,,,['Arch Intern Med. 1999 Mar 22;159(6):541-2. PMID: 10090109'],,,,,,,,
947678,NLM,MEDLINE,19761001,20041117,0010-8650 (Print) 0010-8650 (Linking),18,1976,Preventive cardiology.,81-3,,"['Widimsky, J']",['Widimsky J'],,['eng'],['Journal Article'],,Czech Republic,Cor Vasa,Cor et vasa,0372614,IM,"['Cardiovascular Diseases/epidemiology/*prevention & control/therapy', 'Coronary Care Units', 'Czechoslovakia', 'Humans', 'Male', 'Middle Aged', 'Public Health Administration', 'Rural Population', 'Urban Population']",1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Cor Vasa. 1976;18(2):81-3.,2,,,,,,,,,,,,,,,,,,,,,
34929043,NLM,MEDLINE,20220404,20220405,2047-4881 (Electronic) 2047-4873 (Linking),28,2021 Dec 20,Editor comment: Focus on cardiovascular prevention.,1523-1525,10.1093/eurjpc/zwab194 [doi],"['Halasz, Geza', 'Parati, Gianfranco', 'Piepoli, Massimo F']","['Halasz G', 'Parati G', 'Piepoli MF']","['Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Parma, Italy.', 'University of Milano-Bicocca and IRCCS, Istituto Auxologico Italiano, Milan, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Heart', 'Humans']",2021/12/21 06:00,2022/04/05 06:00,['2021/12/20 17:26'],"['2021/11/03 00:00 [accepted]', '2021/12/20 17:26 [entrez]', '2021/12/21 06:00 [pubmed]', '2022/04/05 06:00 [medline]']","['6431767 [pii]', '10.1093/eurjpc/zwab194 [doi]']",ppublish,Eur J Prev Cardiol. 2021 Dec 20;28(14):1523-1525. doi: 10.1093/eurjpc/zwab194.,14,,"['ORCID: 0000-0001-7220-123X', 'ORCID: 0000-0003-1124-234X']",,,,,,,,,,,,,,,,,,,
17394977,NLM,MEDLINE,20070430,20181201,1558-3597 (Electronic) 0735-1097 (Linking),49,2007 Mar 27,ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.,1373-412,,"['Mensah, George A', 'Grant, Augustus O', 'Pepine, Carl J', 'Baddour, Larry M', 'Cooper, Leslie T Jr', 'Dunbar, Sandra B', 'Froelicher, Erika S', 'Greenlund, Kurt J', 'Kaplan, Edward L', 'Kloner, Robert A', 'Labarthe, Darwin R', 'Luepker, Russell V', 'Madjid, Mohammad', 'Muller, James E', ""O'Connor, Siobhan"", 'Ornato, Joseph P', 'Robertson, Rose Marie', 'Roy, Michael J', 'Shah, Prediman K', 'Taubert, Kathryn A', 'Wilson, Walter R', 'Zheng, Zhi-Jie', 'Harrington, Robert A', 'Abrams, Jonathan', 'Anderson, Jeffrey L', 'Bates, Eric R', 'Eisenberg, Mark J', 'Grines, Cindy L', 'Hlatky, Mark A', 'Lichtenberg, Robert C', 'Lindner, Jonathan R', 'Pohost, Gerald M', 'Schofield, Richard S', 'Shubrooks, Samuel J Jr', 'Stein, James H', 'Tracy, Cynthia M', 'Vogel, Robert A', 'Wesley, Deborah J']","['Mensah GA', 'Grant AO', 'Pepine CJ', 'Baddour LM', 'Cooper LT Jr', 'Dunbar SB', 'Froelicher ES', 'Greenlund KJ', 'Kaplan EL', 'Kloner RA', 'Labarthe DR', 'Luepker RV', 'Madjid M', 'Muller JE', ""O'Connor S"", 'Ornato JP', 'Robertson RM', 'Roy MJ', 'Shah PK', 'Taubert KA', 'Wilson WR', 'Zheng ZJ', 'Harrington RA', 'Abrams J', 'Anderson JL', 'Bates ER', 'Eisenberg MJ', 'Grines CL', 'Hlatky MA', 'Lichtenberg RC', 'Lindner JR', 'Pohost GM', 'Schofield RS', 'Shubrooks SJ Jr', 'Stein JH', 'Tracy CM', 'Vogel RA', 'Wesley DJ']",,['eng'],"['Congress', 'Overall']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['*Bioterrorism', 'Cardiovascular Diseases/diagnosis/*etiology/*prevention & control/therapy', '*Communicable Diseases, Emerging/complications', 'Humans', '*Public Health']",2007/03/31 09:00,2007/05/30 09:00,['2007/03/31 09:00'],"['2007/03/31 09:00 [pubmed]', '2007/05/30 09:00 [medline]', '2007/03/31 09:00 [entrez]']","['S0735-1097(07)00218-5 [pii]', '10.1016/j.jacc.2007.01.017 [doi]']",ppublish,J Am Coll Cardiol. 2007 Mar 27;49(12):1373-412. doi: 10.1016/j.jacc.2007.01.017.,12,,,,,,,,,,,,,,,,,,,,,
28511155,NLM,MEDLINE,20170707,20170707,0043-5147 (Print) 0043-5147 (Linking),70,2017,[The role of inflammatory biomarkers in cardiovascular risk stratification].,182-186,,"['capital PE, Cyrillicsmall u, Cyrillicsmall ze, Cyrillicsmall i, Ukrainiansmall ka, Cyrillic, capital ES, Cyrillicsmall ve, Cyrillicsmall i, Ukrainiansmall te, Cyrillicsmall el, Cyrillicsmall a, Cyrillicsmall en, Cyrillicsmall a, Cyrillic capital GHE, Cyrillic']","['capital PE, Cyrillicsmall u, Cyrillicsmall ze, Cyrillicsmall i, Ukrainiansmall ka, Cyrillic capital ES, Cyrilliccapital GHE, Cyrillic']","['capital DE, Cyrilliccapital ZE, Cyrillic capital ZE, Cyrilliccapital A, Cyrilliccapital PE, Cyrilliccapital O, Cyrilliccapital ER, Cyrilliccapital I, Ukrainiancapital ZE, Cyrilliccapital SOFT sign, Cyrilliccapital KA, Cyrilliccapital A, Cyrillic capital EM, Cyrilliccapital IE, Cyrilliccapital DE, Cyrilliccapital I, Cyrilliccapital CHE, Cyrilliccapital EN, Cyrilliccapital A, Cyrillic capital A, Cyrilliccapital KA, Cyrilliccapital A, Cyrilliccapital DE, Cyrilliccapital IE, Cyrilliccapital EM, Cyrilliccapital I, Ukrainiancapital YA, Cyrillic capital PE, Cyrilliccapital I, Ukrainiancapital ES, Cyrilliccapital EL, Cyrilliccapital YA, Cyrilliccapital DE, Cyrilliccapital I, Cyrilliccapital PE, Cyrilliccapital EL, Cyrilliccapital O, Cyrilliccapital EM, Cyrilliccapital EN, Cyrilliccapital O, Cyrilliccapital YI, Ukrainian capital O, Cyrilliccapital ES, Cyrilliccapital VE, Cyrilliccapital I, Ukrainiancapital TE, Cyrilliccapital I, Cyrillic capital EM, Cyrilliccapital O, Cyrilliccapital ZE, Cyrillic capital U, Cyrilliccapital KA, Cyrilliccapital ER, Cyrilliccapital A, Cyrilliccapital YI, Ukrainiancapital EN, Cyrilliccapital I, Cyrillic, capital ZE, Cyrilliccapital A, Cyrilliccapital PE, Cyrilliccapital O, Cyrilliccapital ER, Cyrilliccapital I, Ukrainiancapital ZHE, Cyrilliccapital ZHE, Cyrilliccapital YA, Cyrillic, capital U, Cyrilliccapital KA, Cyrilliccapital ER, Cyrilliccapital A, Cyrilliccapital YI, Ukrainiancapital EN, Cyrilliccapital A, Cyrillic.']",['ukr'],['Journal Article'],,Poland,Wiad Lek,"Wiadomosci lekarskie (Warsaw, Poland : 1960)",9705467,IM,"['*Atherosclerosis', 'Biomarkers', 'Cardiovascular Diseases/epidemiology/*etiology/pathology', 'Disease Progression', 'Humans', '*Inflammation', 'Risk Factors']",2017/05/17 06:00,2017/07/08 06:00,['2017/05/17 06:00'],"['2017/05/17 06:00 [entrez]', '2017/05/17 06:00 [pubmed]', '2017/07/08 06:00 [medline]']",,ppublish,Wiad Lek. 2017;70(2):182-186.,2,"INTRODUCTION: The increase in cardiovascular diseases requires the search for ways to predict complications based on research additional to traditional risk factors, conduct a study of the formation mechanisms of these complications and to design new treatment strategies. AIM: To get an idea about the relationship between inflammation in the blood vessels, atherosclerosis and cardiovascular consequences based on the study of the role of biomarkers of inflammation. MATERIAL AND METHODS: the literature on the estimation of risk development of cardiovascular diseases based on the study of the role of biomarkers of vascular inflammation; bibliographic, a systematic approach. RESULTS: Algorithm stratification of cardiovascular risk includes a review of the traditional risk factors for the purpose of preventive therapy. A large number of cases of cardiovascular events (myocardial infarction, stroke) occurs in bessimptomnom patients with normal lipid. The use of additional risk factors for development of cerebral and cardiac disorders will allow to foresee the consequences and to prevent mortality from cardiovascular disease. Study of the role of inflammation in development of cardiovascular diseases allows the use of SB and PL-capital EF, Cyrilliccapital EL, Cyrilliccapital A, Cyrillic2 as an important additional cardiovascular markers, independent of traditional risk factors. CONCLUSIONS: The use of biomarkers LP-capital EF, Cyrilliccapital EL, Cyrilliccapital A, Cyrillic2 and SB specific to vascular inflammation, allows to establish the relationship between endovascular inflammation, atherosclerosis development and progression of cardiovascular diseases and to prevent cerebral and cardiac disorders in patients with traditional risk factor .",,,,['NOTNLM'],"['biomarkers', 'cardiovascular disease', 'cerebrovascular disease', 'the instability of the plaque', 'inflammation in the blood vessels']",,['0 (Biomarkers)'],,,,,,,,,,,,,
15106815,NLM,MEDLINE,20041106,20190823,0263-6352 (Print) 0263-6352 (Linking),22,2004 Jan,What lies behind the intense criticism of ALLHAT?,223-4; author reply 224-7,,"['Lasaridis, Anastasios N', 'Sarafidis, Pantelis A']","['Lasaridis AN', 'Sarafidis PA']",,['eng'],"['Comment', 'Letter']",,Netherlands,J Hypertens,Journal of hypertension,8306882,IM,"['Antihypertensive Agents/*therapeutic use', 'Cardiovascular Diseases/epidemiology/physiopathology/prevention & control', 'Humans', 'Hypertension/classification/*drug therapy/epidemiology/physiopathology', 'Risk Factors', 'Treatment Outcome']",2004/04/27 05:00,2004/11/09 09:00,['2004/04/27 05:00'],"['2004/04/27 05:00 [pubmed]', '2004/11/09 09:00 [medline]', '2004/04/27 05:00 [entrez]']",['10.1097/00004872-200401000-00033 [doi]'],ppublish,J Hypertens. 2004 Jan;22(1):223-4; author reply 224-7. doi: 10.1097/00004872-200401000-00033.,1,,,,,,,,['0 (Antihypertensive Agents)'],,,"['J Hypertens. 2003 Mar;21(3):453-4. PMID: 12640229', 'J Hypertens. 2003 Mar;21(3):455-7. PMID: 12640230', 'J Hypertens. 2003 Mar;21(3):459-61. PMID: 12640231', 'Am J Hypertens. 2003 May;16(5 Pt 1):416-20. PMID: 12745205']",,,,,,,,,,
7671887,NLM,MEDLINE,19951017,20190512,0195-668X (Print) 0195-668X (Linking),16,1995 Apr,Primary antiphospholipid syndrome and cardiovascular disease.,441-5,,"['Ducceschi, V', 'Sarubbi, B', 'Iacono, A']","['Ducceschi V', 'Sarubbi B', 'Iacono A']","['Seconda Universita degli Studi di Napoli, Italy.']",['eng'],"['Journal Article', 'Review']",,England,Eur Heart J,European heart journal,8006263,IM,"['Antiphospholipid Syndrome/*complications/diagnosis/therapy', 'Cardiovascular Diseases/*complications/diagnosis/therapy', 'Humans']",1995/04/01 00:00,1995/04/01 00:01,['1995/04/01 00:00'],"['1995/04/01 00:00 [pubmed]', '1995/04/01 00:01 [medline]', '1995/04/01 00:00 [entrez]']",['10.1093/oxfordjournals.eurheartj.a060934 [doi]'],ppublish,Eur Heart J. 1995 Apr;16(4):441-5. doi: 10.1093/oxfordjournals.eurheartj.a060934.,4,,,,,,,,,,47,,,,,,,,,,,
37880865,NLM,MEDLINE,20231027,20231101,2047-4881 (Electronic) 2047-4873 (Linking),30,2023 Oct 26,Editorial comments: focus on cardiovascular risk burden.,1549-1551,10.1093/eurjpc/zwad310 [doi],"['Attanasio, Andrea', 'Piepoli, Massimo F']","['Attanasio A', 'Piepoli MF']","['Clinical Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, San Donato Milanese, Milan 20097, Italy.', 'Clinical Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, San Donato Milanese, Milan 20097, Italy.', 'Department of Preventive Cardiology, Wroclaw Medical University, Wroclaw, Poland.']",['eng'],['Journal Article'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Risk Factors']",2023/10/26 06:42,2023/10/27 06:42,['2023/10/26 00:33'],"['2023/10/27 06:42 [medline]', '2023/10/26 06:42 [pubmed]', '2023/10/26 00:33 [entrez]']","['7325323 [pii]', '10.1093/eurjpc/zwad310 [doi]']",ppublish,Eur J Prev Cardiol. 2023 Oct 26;30(15):1549-1551. doi: 10.1093/eurjpc/zwad310.,15,,['ORCID: 0000-0003-1124-234X'],,['Conflict of interest: None declared.'],,,,,,,,,,,,,,,,,
24330974,NLM,MEDLINE,20150402,20131216,1578-1879 (Electronic) 0214-9168 (Linking),25,2013 Nov-Dec,[Introduction].,201-2,S0214-9168(13)00115-0 [pii] 10.1016/j.arteri.2013.10.005 [doi],"['Pinto Sala, Xavier']",['Pinto Sala X'],"['Unidad de Lipidos y Riesgo Vascular. Servicio de Medicina Interna. Hospital Universitario de Bellvitge. Universidad de Barcelona, Idibell, CIBERobn. Electronic address: xpinto@bellvitgehospital.cat.']",['spa'],['Journal Article'],,Spain,Clin Investig Arterioscler,Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis,9208512,IM,"['*Aging', 'Cardiovascular Diseases/epidemiology/physiopathology/*therapy', 'Humans', 'Spain/epidemiology']",2013/12/18 06:00,2015/04/04 06:00,['2013/12/17 06:00'],"['2013/10/22 00:00 [received]', '2013/10/23 00:00 [accepted]', '2013/12/17 06:00 [entrez]', '2013/12/18 06:00 [pubmed]', '2015/04/04 06:00 [medline]']","['S0214-9168(13)00115-0 [pii]', '10.1016/j.arteri.2013.10.005 [doi]']",ppublish,Clin Investig Arterioscler. 2013 Nov-Dec;25(5):201-2. doi: 10.1016/j.arteri.2013.10.005.,5,,,,,,,,,,,,,,,Introduccion.,,,,,,
28450364,NLM,MEDLINE,20190501,20190501,1524-4571 (Electronic) 0009-7330 (Linking),120,2017 Apr 28,The Emerging Role of miR-200 Family in Cardiovascular Diseases.,1399-1402,10.1161/CIRCRESAHA.116.310274 [doi],"['Magenta, Alessandra', 'Ciarapica, Roberta', 'Capogrossi, Maurizio C']","['Magenta A', 'Ciarapica R', 'Capogrossi MC']","[""From the Istituto Dermopatico dell'Immacolata-IRCCS, FLMM, Laboratorio di Patologia Vascolare, Rome, Italy."", ""From the Istituto Dermopatico dell'Immacolata-IRCCS, FLMM, Laboratorio di Patologia Vascolare, Rome, Italy."", ""From the Istituto Dermopatico dell'Immacolata-IRCCS, FLMM, Laboratorio di Patologia Vascolare, Rome, Italy. capogrossi@idi.it.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Circ Res,Circulation research,0047103,IM,"['Animals', 'Cardiovascular Diseases/*genetics/*metabolism/therapy', 'Epigenesis, Genetic/physiology', 'Humans', 'MicroRNAs/*physiology', 'Oxidative Stress/physiology']",2017/04/30 06:00,2019/05/02 06:00,['2017/04/29 06:00'],"['2017/04/29 06:00 [entrez]', '2017/04/30 06:00 [pubmed]', '2019/05/02 06:00 [medline]']","['CIRCRESAHA.116.310274 [pii]', '10.1161/CIRCRESAHA.116.310274 [doi]']",ppublish,Circ Res. 2017 Apr 28;120(9):1399-1402. doi: 10.1161/CIRCRESAHA.116.310274.,9,,,,,['NOTNLM'],"['aging', 'cardiovascular diseases', 'insulin resistance', 'microRNAs', 'oxidative stress']",,"['0 (MIRN200 microRNA, human)', '0 (MicroRNAs)']",,,,,,,,,,,,,
19777415,NLM,MEDLINE,20091005,20090924,1439-4413 (Electronic) 0012-0472 (Linking),134,2009 Oct,[Modern risk scores in cardiology].,2001-5,10.1055/s-0029-1237546 [doi],"['Gohlke, H']",['Gohlke H'],"['Klinische Kardiologie II, Herz-Zentrum Bad Krozingen. helmut.gohlke@herzzentrum.de']",['ger'],"['Journal Article', 'Review']",20090923,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Humans', '*Primary Prevention', 'Risk Assessment']",2009/09/25 06:00,2009/10/06 06:00,['2009/09/25 06:00'],"['2009/09/25 06:00 [entrez]', '2009/09/25 06:00 [pubmed]', '2009/10/06 06:00 [medline]']",['10.1055/s-0029-1237546 [doi]'],ppublish,Dtsch Med Wochenschr. 2009 Oct;134(40):2001-5. doi: 10.1055/s-0029-1237546. Epub 2009 Sep 23.,40,,,,,,,,,,19,,,,,Moderne Risiko-Scores in der Kardiologie.,,,,,,
8431821,NLM,MEDLINE,19930318,20181113,0820-3946 (Print) 1488-2329 (Electronic) 0820-3946 (Linking),148,1993 Feb 15,Symposium on fats in human nutrition. 1957.,581-4,,"['leRiche, H']",['leRiche H'],,['eng'],"['Biography', 'Classical Article', 'Historical Article', 'Journal Article']",,Canada,CMAJ,CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,9711805,IM,"['Cardiovascular Diseases/epidemiology/etiology/*history', 'Dietary Fats/*history', 'History, 20th Century', 'Humans', '*Nutritional Physiological Phenomena']",1993/02/15 00:00,1993/02/15 00:01,['1993/02/15 00:00'],"['1993/02/15 00:00 [pubmed]', '1993/02/15 00:01 [medline]', '1993/02/15 00:00 [entrez]']",,ppublish,CMAJ. 1993 Feb 15;148(4):581-4.,4,,,PMC1490524,,,,,['0 (Dietary Fats)'],,,,,,,,['leRiche H'],"['leRiche, H']",,,,
9667312,NLM,MEDLINE,19980805,20190628,0003-3022 (Print) 0003-3022 (Linking),89,1998 Jul,Magnesium and cardiovascular disease.,222-40,,"['Gomez, M N']",['Gomez MN'],"['Department of Anesthesia, University of Iowa College of Medicine, Iowa City 52242, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Anesthesiology,Anesthesiology,1300217,IM,"['Cardiovascular Diseases/*drug therapy/*metabolism/*physiopathology', 'Humans', 'Magnesium/*physiology/*therapeutic use']",1998/07/17 00:00,1998/07/17 00:01,['1998/07/17 00:00'],"['1998/07/17 00:00 [pubmed]', '1998/07/17 00:01 [medline]', '1998/07/17 00:00 [entrez]']",['10.1097/00000542-199807000-00029 [doi]'],ppublish,Anesthesiology. 1998 Jul;89(1):222-40. doi: 10.1097/00000542-199807000-00029.,1,,,,,,,,['I38ZP9992A (Magnesium)'],,289,,,,,,,,,,,
21821497,NLM,MEDLINE,20120125,20110817,1308-0032 (Electronic) 1302-8723 (Linking),11,2011 Sep,"[Cardiovascular risk assessment and risk stratification- guided therapy: predict, prevent and individualize].",551-6,10.5152/akd.2011.141 [doi],"['Ural, Dilek']",['Ural D'],"['Kocaeli Universitesi, Tip Fakultesi, Kardiyoloji Anabilim Dali, Kocaeli, Turkiye. dilekural@kocaeli.edu.tr']",['tur'],"['English Abstract', 'Journal Article', 'Review']",20110808,Turkey,Anadolu Kardiyol Derg,Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,101095069,IM,"['Cardiovascular Diseases/*diagnosis/pathology/*prevention & control/therapy', 'Humans', 'Risk Assessment', 'Risk Management', 'Severity of Illness Index']",2011/08/09 06:00,2012/01/26 06:00,['2011/08/09 06:00'],"['2011/08/09 06:00 [entrez]', '2011/08/09 06:00 [pubmed]', '2012/01/26 06:00 [medline]']",['10.5152/akd.2011.141 [doi]'],ppublish,Anadolu Kardiyol Derg. 2011 Sep;11(6):551-6. doi: 10.5152/akd.2011.141. Epub 2011 Aug 8.,6,"Modern concept in primary prevention of cardiovascular diseases (CVD) entails assessing the person's global risk and making the right management in accordance with these results. Correspondingly, 3 steps recommended for the prevention of CVD under risk guidance are: (a) risk assessment via a proper system like Framingham Risk Score, SCORE, QRISK, PROCAM; (b) decision-making in the proper management in terms of informing the patient about lifestyle changes that he or she can cope and drug selection; and (c) evaluation of treatment decision in terms of cost effectiveness. Although, a significant decline is observed in CVD morbidity and mortality, particularly in the western countries, we still are trying to approach to competent quality measures about management under CV risk guidance. This review summarizes the main challenges regarding risk stratification-guided management strategy in primary prevention of CVD.",,,,,,,,,,,,,,"Kardiyovaskuler risk belirlenmesi ve tabakalandirilmasinin kilavuzluguyla yapilan tedavi yaklasimi: Ongor, onle ve bireysellestir.",,,,,,
27169921,NLM,MEDLINE,20170413,20200819,1880-3873 (Electronic) 1340-3478 (Print) 1340-3478 (Linking),23,2016 Jun 1,Large-Scale Pooled Data and Beyond.,671-2,10.5551/jat.ED044 [doi],"['Metoki, Hirohito']",['Metoki H'],"['Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University.']",['eng'],['Editorial'],20160509,Japan,J Atheroscler Thromb,Journal of atherosclerosis and thrombosis,9506298,IM,"['Cardiovascular Diseases/genetics/metabolism/*mortality/pathology', 'Computational Biology', 'Gene Expression Profiling', 'Genetic Variation/*genetics', 'Genomics', 'Humans', 'Survival Rate', 'Uric Acid/*metabolism']",2016/05/14 06:00,2017/04/14 06:00,['2016/05/13 06:00'],"['2016/05/13 06:00 [entrez]', '2016/05/14 06:00 [pubmed]', '2017/04/14 06:00 [medline]']",['10.5551/jat.ED044 [doi]'],ppublish,J Atheroscler Thromb. 2016 Jun 1;23(6):671-2. doi: 10.5551/jat.ED044. Epub 2016 May 9.,6,,,PMC7399281,['None.'],,,,['268B43MJ25 (Uric Acid)'],,,,,,,,,,,,,
30744392,NLM,MEDLINE,20191202,20191202,1942-0080 (Electronic) 1941-9651 (Linking),12,2019 Feb,In This Issue of the Journal.,e008931,10.1161/CIRCIMAGING.119.008931 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['Cardiovascular Diseases/*diagnostic imaging/epidemiology/therapy', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors']",2019/02/13 06:00,2019/12/04 06:00,['2019/02/13 06:00'],"['2019/02/13 06:00 [entrez]', '2019/02/13 06:00 [pubmed]', '2019/12/04 06:00 [medline]']",['10.1161/CIRCIMAGING.119.008931 [doi]'],ppublish,Circ Cardiovasc Imaging. 2019 Feb;12(2):e008931. doi: 10.1161/CIRCIMAGING.119.008931.,2,,,,,,,,,,,,,,,,,,,,,
4124428,NLM,MEDLINE,19731002,20151119,0140-6736 (Print) 0140-6736 (Linking),2,1973 Aug 4,Risko.,243-4,,,,,['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Body Weight', 'Cardiovascular Diseases/epidemiology/*etiology/genetics/prevention & control', 'Child', 'Humans', 'Middle Aged', 'Personality', 'Physical Exertion', 'Smoking/complications', 'Stress, Psychological', 'Surveys and Questionnaires']",1973/08/04 00:00,1973/08/04 00:01,['1973/08/04 00:00'],"['1973/08/04 00:00 [pubmed]', '1973/08/04 00:01 [medline]', '1973/08/04 00:00 [entrez]']",['S0140-6736(73)93141-3 [pii]'],ppublish,Lancet. 1973 Aug 4;2(7823):243-4.,7823,,,,,,,,,,,,,,,,,,,,,
10575932,NLM,MEDLINE,19991202,20041117,1135-5727 (Print) 1135-5727 (Linking),73,1999 Jul-Aug,"[Secondary prevention of cardiovascular diseases is a priority, yet the results, so far, are insufficient].",441-3,,"['Rodriguez Artalejo, F', 'del Rey Calero, J']","['Rodriguez Artalejo F', 'del Rey Calero J']",,['spa'],['Editorial'],,Spain,Rev Esp Salud Publica,Revista espanola de salud publica,9600212,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Female', 'Humans', 'Male', 'Middle Aged', 'Primary Prevention', 'Spain/epidemiology']",1999/11/27 00:00,1999/11/27 00:01,['1999/11/27 00:00'],"['1999/11/27 00:00 [pubmed]', '1999/11/27 00:01 [medline]', '1999/11/27 00:00 [entrez]']",,ppublish,Rev Esp Salud Publica. 1999 Jul-Aug;73(4):441-3.,4,,,,,,,,,,,,,,,La prevencion secundaria de la enfermedad cardiovascular es prioritaria pero resulta insuficiente.,,,,,,
8217246,NLM,MEDLINE,19931217,20041117,0870-2551 (Print) 0870-2551 (Linking),12,1993 Sep,[In praise of prevention].,707-12,,"['Lopes, M M']",['Lopes MM'],,['por'],['Editorial'],,Portugal,Rev Port Cardiol,Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,8710716,IM,"['Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Female', 'Humans', 'Male', 'Portugal/epidemiology', 'Risk Factors']",1993/09/01 00:00,1993/09/01 00:01,['1993/09/01 00:00'],"['1993/09/01 00:00 [pubmed]', '1993/09/01 00:01 [medline]', '1993/09/01 00:00 [entrez]']",,ppublish,Rev Port Cardiol. 1993 Sep;12(9):707-12.,9,,,,,,,,,,,,,,,Em louvor da prevencao.,,,,,,
28289100,NLM,MEDLINE,20180201,20180201,1468-201X (Electronic) 1355-6037 (Linking),103,2017 Apr,Heartbeat: Challenges in primary prevention of cardiovascular disease.,475-476,10.1136/heartjnl-2017-311392 [doi],"['Otto, Catherine M']",['Otto CM'],"['Division of Cardiology , University of Washington, Seattle, Washington, USA cmotto@uw.edu.']",['eng'],['Journal Article'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Cardiovascular Diseases/*diagnosis/epidemiology/*prevention & control', 'Humans', '*Primary Prevention', 'Risk Factors']",2017/03/16 06:00,2018/02/02 06:00,['2017/03/15 06:00'],"['2017/02/15 00:00 [received]', '2017/02/15 00:00 [accepted]', '2017/03/15 06:00 [entrez]', '2017/03/16 06:00 [pubmed]', '2018/02/02 06:00 [medline]']","['heartjnl-2017-311392 [pii]', '10.1136/heartjnl-2017-311392 [doi]']",ppublish,Heart. 2017 Apr;103(7):475-476. doi: 10.1136/heartjnl-2017-311392.,7,,,,,['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
22089727,NLM,MEDLINE,20111207,20161017,1538-3598 (Electronic) 0098-7484 (Linking),306,2011 Nov 16,"Cardiology in 2011--amazing opportunities, huge challenges.",2158-9,10.1001/jama.2011.1691 [doi],"['Peterson, Eric D', 'Gaziano, J Michael']","['Peterson ED', 'Gaziano JM']",,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,JAMA,JAMA,7501160,IM,"['Cardiology/*trends', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control/therapy', 'Humans', 'Hypercholesterolemia/complications/prevention & control', 'Hypertension/complications/prevention & control', 'Periodicals as Topic/trends', 'Risk Factors']",2011/11/18 06:00,2011/12/13 00:00,['2011/11/18 06:00'],"['2011/11/18 06:00 [entrez]', '2011/11/18 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['306/19/2158 [pii]', '10.1001/jama.2011.1691 [doi]']",ppublish,JAMA. 2011 Nov 16;306(19):2158-9. doi: 10.1001/jama.2011.1691.,19,,,,,,,,,,,,,,,,,,,,,
30615511,NLM,MEDLINE,20191022,20191022,1524-4539 (Electronic) 0009-7322 (Linking),139,2019 Jan 8,European Society of Cardiology Congress 2018.,286-288,10.1161/CIRCULATIONAHA.118.039093 [doi],"['Bax, Jeroen J', 'Achenbach, Stephan']","['Bax JJ', 'Achenbach S']","['Department of Cardiology, Leiden University Medical Center, The Netherlands (J.J.B.).', 'Department of Cardiology, Friedrich Alexander University Erlangen-Nurnberg, Germany (S.A.).']",['eng'],"['Congress', 'News']",,United States,Circulation,Circulation,0147763,IM,"['Animals', 'Biomedical Research/*methods', 'Cardiology/*methods', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Humans']",2019/01/08 06:00,2019/10/23 06:00,['2019/01/08 06:00'],"['2019/01/08 06:00 [entrez]', '2019/01/08 06:00 [pubmed]', '2019/10/23 06:00 [medline]']",['10.1161/CIRCULATIONAHA.118.039093 [doi]'],ppublish,Circulation. 2019 Jan 8;139(2):286-288. doi: 10.1161/CIRCULATIONAHA.118.039093.,2,,,,,,,,,,,,,,,,,,,,,
19863436,NLM,MEDLINE,20100924,20191027,1748-295X (Electronic) 1748-2941 (Linking),11,2009,Acute cardiac care--from symptoms to diagnosis and to interventions.,129-30,,"['Beyar, Rafael']",['Beyar R'],,['eng'],['Editorial'],,England,Acute Card Care,Acute cardiac care,101276603,IM,"['*Cardiovascular Diseases/complications/diagnosis/therapy', 'Humans', 'Hypereosinophilic Syndrome/complications', 'Hyperglycemia/complications']",2009/10/30 06:00,2010/09/25 06:00,['2009/10/30 06:00'],"['2009/10/30 06:00 [entrez]', '2009/10/30 06:00 [pubmed]', '2010/09/25 06:00 [medline]']","['10.1080/17482940903308953 [pii]', '10.1080/17482940903308953 [doi]']",ppublish,Acute Card Care. 2009;11(3):129-30. doi: 10.1080/17482940903308953.,3,,,,,,,,,,,,,,,,,,,,,
15911716,NLM,MEDLINE,20060112,20221207,1524-4539 (Electronic) 0009-7322 (Linking),111,2005 May 24,"Health, housing, and the heart: cardiovascular disparities in homeless people.",2555-6,,"['McCary, Jessie M', ""O'Connell, James J""]","['McCary JM', ""O'Connell JJ""]",,['eng'],"['Comment', 'Editorial']",,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/*epidemiology/etiology/prevention & control', 'Delivery of Health Care', '*Ill-Housed Persons', 'Humans', 'Risk Factors']",2005/05/25 09:00,2006/01/13 09:00,['2005/05/25 09:00'],"['2005/05/25 09:00 [pubmed]', '2006/01/13 09:00 [medline]', '2005/05/25 09:00 [entrez]']","['111/20/2555 [pii]', '10.1161/CIRCULATIONAHA.105.540856 [doi]']",ppublish,Circulation. 2005 May 24;111(20):2555-6. doi: 10.1161/CIRCULATIONAHA.105.540856.,20,,,,,,,,,,,['Circulation. 2005 May 24;111(20):2629-35. PMID: 15897342'],,,,,,,,,,
14596044,NLM,MEDLINE,20031205,20071115,0094-6575 (Print) 0094-6575 (Linking),32,2003 Oct,The spectrum of cardiovascular disease.,"65-8, 70-2; quiz 90",,"['Hatlestad, Dan']",['Hatlestad D'],"['Inter-Canyon Fire/Rescue, Morrison, CO, USA. prioritymed@mindspring.com']",['eng'],['Journal Article'],,United States,Emerg Med Serv,Emergency medical services,0431735,,"['Aortic Aneurysm/diagnosis/physiopathology', 'Cardiovascular Diseases/classification/*diagnosis/physiopathology/*therapy', 'Coronary Artery Disease/diagnosis/physiopathology', 'Education, Continuing', 'Emergency Medical Services/*methods', 'Emergency Treatment/*methods', 'Heart Defects, Congenital/diagnosis/physiopathology', 'Heart Failure/diagnosis/physiopathology', 'Humans', 'Monitoring, Physiologic', 'Myocardial Infarction/diagnosis/physiopathology', 'Risk Factors', 'United States']",2003/11/05 05:00,2003/12/06 05:00,['2003/11/05 05:00'],"['2003/11/05 05:00 [pubmed]', '2003/12/06 05:00 [medline]', '2003/11/05 05:00 [entrez]']",,ppublish,"Emerg Med Serv. 2003 Oct;32(10):65-8, 70-2; quiz 90.",10,,,,,,,,,,,,,,,,,,,,,
30139358,NLM,MEDLINE,20181015,20230928,1741-7015 (Electronic) 1741-7015 (Linking),16,2018 Aug 24,Cardiovascular medicine in China: what can we do to achieve the Healthy China 2030 plan?,132,10.1186/s12916-018-1133-4 [doi] 132,"['Bei, Yihua', 'Yang, Tingting', 'Xiao, Junjie']","['Bei Y', 'Yang T', 'Xiao J']","['Institute of Cardiovascular Sciences, Shanghai University, 381 Nan Chen Road, Shanghai, 200444, China.', 'Institute of Cardiovascular Sciences, Shanghai University, 381 Nan Chen Road, Shanghai, 200444, China.', 'Institute of Cardiovascular Sciences, Shanghai University, 381 Nan Chen Road, Shanghai, 200444, China. junjiexiao@live.cn.']",['eng'],"['Letter', ""Research Support, Non-U.S. Gov't""]",20180824,England,BMC Med,BMC medicine,101190723,IM,"['Cardiovascular Diseases/mortality/*prevention & control/*therapy', 'China', 'Humans', 'Preventive Medicine/*methods']",2018/08/25 06:00,2018/10/16 06:00,['2018/08/25 06:00'],"['2018/07/11 00:00 [received]', '2018/07/23 00:00 [accepted]', '2018/08/25 06:00 [entrez]', '2018/08/25 06:00 [pubmed]', '2018/10/16 06:00 [medline]']","['10.1186/s12916-018-1133-4 [pii]', '1133 [pii]', '10.1186/s12916-018-1133-4 [doi]']",epublish,BMC Med. 2018 Aug 24;16(1):132. doi: 10.1186/s12916-018-1133-4.,1,"Cardiovascular diseases (CVDs) represent the leading cause of death in China. The Chinese government approved the Healthy China 2030 plan (jiankang zhongguo 2030), emphasizing the strategic role of health in China's development. As morbidity and mortality from CVDs are constantly increasing in China, the prevention and treatment of CVDs are vital to achieve this plan. Following the major principles of health priority, science and technology innovation, scientific development, and balanced medical resource allocation outlined in the Healthy China 2030 plan, this Commentary briefly introduces the current status of CVDs in China and marks the important events undertaken to achieve this plan.",,PMC6107941,"['COMPETING INTERESTS: The authors declare that they have no competing interests.', ""PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional"", 'claims in published maps and institutional affiliations.']",['NOTNLM'],"['Cardiovascular diseases', 'China', 'Healthy China 2030']",,,,,,,,,,,,,,,
34678421,NLM,MEDLINE,20221128,20221206,1873-2615 (Electronic) 1050-1738 (Linking),32,2022 Nov,Editorial commentary: Air pollution: The most important environmental threat to the cardiovascular system.,499-500,S1050-1738(21)00120-1 [pii] 10.1016/j.tcm.2021.10.005 [doi],"['Bourdrel, Thomas']",['Bourdrel T'],"['CNRS, IMIS, ICube Laboratory, UMR 7357, Strasbourg University, Strasbourg, France. Electronic address: thomasbourdrel@yahoo.fr.']",['eng'],"['Comment', 'Editorial']",20211019,United States,Trends Cardiovasc Med,Trends in cardiovascular medicine,9108337,IM,"['Humans', '*Air Pollution/adverse effects', '*Air Pollutants/adverse effects', '*Cardiovascular System', '*Cardiovascular Diseases/diagnosis/epidemiology/etiology']",2021/10/23 06:00,2022/11/29 06:00,['2021/10/22 20:33'],"['2021/10/14 00:00 [received]', '2021/10/15 00:00 [accepted]', '2021/10/23 06:00 [pubmed]', '2022/11/29 06:00 [medline]', '2021/10/22 20:33 [entrez]']","['S1050-1738(21)00120-1 [pii]', '10.1016/j.tcm.2021.10.005 [doi]']",ppublish,Trends Cardiovasc Med. 2022 Nov;32(8):499-500. doi: 10.1016/j.tcm.2021.10.005. Epub 2021 Oct 19.,8,,,,,['NOTNLM'],"['Air pollution', 'Autophagy', 'Cardiovascular diseases', 'Oxidative stress', 'Particulate matter', 'Ultrafine particles']",,['0 (Air Pollutants)'],,,['Trends Cardiovasc Med. 2022 Nov;32(8):487-498. PMID: 34619335'],,,,,,,,,,
34280422,NLM,MEDLINE,20211020,20211020,1874-1754 (Electronic) 0167-5273 (Linking),339,2021 Sep 15,Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine?,106-107,S0167-5273(21)01171-2 [pii] 10.1016/j.ijcard.2021.07.026 [doi],"['Barison, Andrea', 'Aimo, Alberto']","['Barison A', 'Aimo A']","[""Fondazione Toscana G. Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy. Electronic address: barison@ftgm.it."", ""Fondazione Toscana G. Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.""]",['eng'],"['Comment', 'Editorial']",20210717,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['Anti-Arrhythmia Agents/therapeutic use', 'Arrhythmias, Cardiac/drug therapy', '*Cardiovascular Diseases/diagnosis/drug therapy/epidemiology', '*Digoxin', 'Humans']",2021/07/20 06:00,2021/10/21 06:00,['2021/07/19 20:11'],"['2021/06/25 00:00 [received]', '2021/07/12 00:00 [accepted]', '2021/07/20 06:00 [pubmed]', '2021/10/21 06:00 [medline]', '2021/07/19 20:11 [entrez]']","['S0167-5273(21)01171-2 [pii]', '10.1016/j.ijcard.2021.07.026 [doi]']",ppublish,Int J Cardiol. 2021 Sep 15;339:106-107. doi: 10.1016/j.ijcard.2021.07.026. Epub 2021 Jul 17.,,,,,,['NOTNLM'],"['Arrhythmias', 'Defibrillator', 'Digoxin', 'Glycosides', 'Heart failure', 'Mortality']",,"['0 (Anti-Arrhythmia Agents)', '73K4184T59 (Digoxin)']",,,['Int J Cardiol. 2021 Sep 1;338:109-114. PMID: 34087337'],,,,,,,,,,
32868066,NLM,MEDLINE,20210712,20210712,1097-685X (Electronic) 0022-5223 (Linking),162,2021 Jul,Trial sequential analysis in meta-analyses: A clinically oriented approach with real-world example.,167-173,S0022-5223(20)31795-5 [pii] 10.1016/j.jtcvs.2020.06.063 [doi],"['Chan, Jeffrey Shi Kai', 'Harky, Amer']","['Chan JSK', 'Harky A']","['Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong; Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong. Electronic address: skjchan@link.cuhk.edu.hk.', 'Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.']",['eng'],['Editorial'],20200627,United States,J Thorac Cardiovasc Surg,The Journal of thoracic and cardiovascular surgery,0376343,IM,"['Anticoagulants/therapeutic use', '*Cardiovascular Diseases/complications/drug therapy/epidemiology/etiology', 'Humans', '*Meta-Analysis as Topic', 'Models, Cardiovascular', 'Platelet Aggregation Inhibitors/therapeutic use', 'Research Design']",2020/09/02 06:00,2021/07/13 06:00,['2020/09/02 06:00'],"['2020/03/23 00:00 [received]', '2020/06/06 00:00 [revised]', '2020/06/10 00:00 [accepted]', '2020/09/02 06:00 [pubmed]', '2021/07/13 06:00 [medline]', '2020/09/02 06:00 [entrez]']","['S0022-5223(20)31795-5 [pii]', '10.1016/j.jtcvs.2020.06.063 [doi]']",ppublish,J Thorac Cardiovasc Surg. 2021 Jul;162(1):167-173. doi: 10.1016/j.jtcvs.2020.06.063. Epub 2020 Jun 27.,1,,,,,,,,"['0 (Anticoagulants)', '0 (Platelet Aggregation Inhibitors)']",,,,,"['J Thorac Cardiovasc Surg. 2021 Jul;162(1):176-177. PMID: 32778461', 'J Thorac Cardiovasc Surg. 2021 Jul;162(1):174-175. PMID: 32800370', 'J Thorac Cardiovasc Surg. 2021 Jul;162(1):175-176. PMID: 32807558']",,,,,,,,
22712270,NLM,MEDLINE,20120829,20181201,0869-6047 (Print) 0869-6047 (Linking),,2012,[Problems in medical care for patients with cardiovascular diseases].,15-22,,"['Maksimova, T M', 'Lushkina, N P', 'Ogryzko, E V']","['Maksimova TM', 'Lushkina NP', 'Ogryzko EV']",,['rus'],['Journal Article'],,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Cardiovascular Diseases/*diagnosis/*epidemiology/mortality/prevention & control/*therapy', 'Delivery of Health Care/organization & administration/statistics & numerical data', 'Education, Medical', 'Female', 'Humans', 'Life Expectancy/trends', 'Male', 'Physicians/statistics & numerical data', 'Russia', 'Workforce']",2012/06/21 06:00,2012/08/30 06:00,['2012/06/21 06:00'],"['2012/06/21 06:00 [entrez]', '2012/06/21 06:00 [pubmed]', '2012/08/30 06:00 [medline]']",,ppublish,Vestn Ross Akad Med Nauk. 2012;(3):15-22.,3,"Despite showing that cardiovascular disease mortality in Russia is declining evaluation of medical care for cardiovascular patients, using different information sources, revealed a lot of problems in this field need it's solving. Together with modernization of medical services it is urgently necessary to transform the medical education, including post graduate, information support for medical professionals in field of modern medical technologies, using in countries with low mortality rates, creation the conditions for regular updating professional knowledge. It is necessary to reconsider formal criteria for medical care evaluation, especially taking into account co morbidity of cardiovascular diseases. Our data illustrate that social disparities influence on outcomes of diseases and so for further decreasing mortality rates and increasing the life expectancy adequate treatment must be provide for all patients independently of their material wellbeing.",,,,,,,,,,,,,,,,,,,,
32126603,NLM,MEDLINE,20200611,20200611,1592-7830 (Print) 1592-7830 (Linking),41,2019 Dec,"[Lights and shadows of combined epigenomic and transcriptomic profiling to identify novel diagnostic, prognostic or therapeutic targets for cardiovascular diseases.].",328-332,,"['Paolillo, Roberta', 'Boccella, Nicola', ""D'Apice, Stefania"", 'Esposito, Giovanni', 'Perrino, Cinzia']","['Paolillo R', 'Boccella N', ""D'Apice S"", 'Esposito G', 'Perrino C']","['Dipartimento di Scienze Biomediche Avanzate, Universita Federico II, Napoli.', 'Dipartimento di Scienze Biomediche Avanzate, Universita Federico II, Napoli.', 'Dipartimento di Scienze Biomediche Avanzate, Universita Federico II, Napoli.', 'Dipartimento di Scienze Biomediche Avanzate, Universita Federico II, Napoli.', 'Dipartimento di Scienze Biomediche Avanzate, Universita Federico II, Napoli.']",['ita'],['Journal Article'],,Italy,G Ital Med Lav Ergon,Giornale italiano di medicina del lavoro ed ergonomia,9712708,IM,"['Cardiovascular Diseases/diagnosis/*physiopathology/therapy', 'Epigenesis, Genetic', 'Epigenomics/*methods', 'Gene Expression Profiling/*methods', 'Humans', 'Prognosis', 'Transcriptome']",2020/03/04 06:00,2020/06/12 06:00,['2020/03/04 06:00'],"['2019/07/01 00:00 [received]', '2019/09/01 00:00 [accepted]', '2020/03/04 06:00 [entrez]', '2020/03/04 06:00 [pubmed]', '2020/06/12 06:00 [medline]']",['SIML12 [pii]'],ppublish,G Ital Med Lav Ergon. 2019 Dec;41(4):328-332.,4,"Cardiovascular diseases are the major cause of morbidity and mortality worldwide. Given the complex pathophysiology of cardiovascular diseases, an experimental approach capable of identifying multiple signaling networks activated in the heart upon pathological conditions could be particularly effective to identify new diagnostic, prognostic or therapeutic targets. Latest generation techniques now allow high-resolution investigations of the entire genome, the proteome and the cellular metabolome, as well as epigenetic modifications and associated gene expression profiles. In particular, the integration of epigenomic and transcriptomic data in the normal or pathological heart is a promising approach to identify novel molecular targets. These methods, although promising and innovative, can present several technical and analytical pitfalls. Here we will briefly describe these aspects and possible strategies to optimize the search for new diagnostic or therapeutic targets for cardiovascular diseases in the post-genomic era.",,,['The authors of this article have no conflict of interests to disclose.'],['NOTNLM'],"['cardiovascular diseases', 'epigenetic', 'heart failure', 'omics', 'transcriptomic']",,,"['Copyright(c) by Aracne Editrice, Roma, Italy.']",,,,,,Limiti e potenzialita dell'analisi combinata epigenetica e trascrizionale su ampia scala per individuare obiettivi terapeutici nelle malattie cardiovascolari.,,,,,,
23046366,NLM,MEDLINE,20130319,20121010,1744-9987 (Electronic) 1744-9979 (Linking),16,2012 Oct,Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.,384-6,10.1111/j.1744-9987.2012.01117.x [doi],"['Tsuruya, Kazuhiko', 'Hirakata, Hideki']","['Tsuruya K', 'Hirakata H']",,['eng'],['Editorial'],,Australia,Ther Apher Dial,"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy",101181252,IM,"['Cardiovascular Diseases/epidemiology/physiopathology/*therapy', 'Humans', 'Japan/epidemiology', '*Practice Guidelines as Topic', 'Renal Dialysis/*methods', 'Societies, Medical']",2012/10/11 06:00,2013/03/21 06:00,['2012/10/11 06:00'],"['2012/10/11 06:00 [entrez]', '2012/10/11 06:00 [pubmed]', '2013/03/21 06:00 [medline]']",['10.1111/j.1744-9987.2012.01117.x [doi]'],ppublish,Ther Apher Dial. 2012 Oct;16(5):384-6. doi: 10.1111/j.1744-9987.2012.01117.x.,5,,,,,,,,,,,,,,,,,,,,,
20467924,NLM,MEDLINE,20100914,20100514,1615-6692 (Electronic) 0340-9937 (Linking),35,2010 May,Diabetes and the heart--a never-ending story.,129,10.1007/s00059-010-3343-1 [doi],"['Dorr, Rolf', 'Muller-Wieland, Dirk', 'Tschoepe, Diethelm']","['Dorr R', 'Muller-Wieland D', 'Tschoepe D']",,['eng'],"['Editorial', 'Introductory Journal Article']",,Germany,Herz,Herz,7801231,IM,"['Cardiovascular Diseases/*complications/*diagnosis/therapy', 'Diabetes Complications/*diagnosis/*physiopathology/therapy', 'Humans']",2010/05/15 06:00,2010/09/15 06:00,['2010/05/15 06:00'],"['2010/05/15 06:00 [entrez]', '2010/05/15 06:00 [pubmed]', '2010/09/15 06:00 [medline]']",['10.1007/s00059-010-3343-1 [doi]'],ppublish,Herz. 2010 May;35(3):129. doi: 10.1007/s00059-010-3343-1.,3,,,,,,,,,,,,,,,,,,,,,
6795805,NLM,MEDLINE,19820128,20041117,,29,1981 Jul,[Complications of cardiovascular diseases].,153-6,,"['Gordin, A', 'Baras, V']","['Gordin A', 'Baras V']",,['rum'],['Journal Article'],,Romania,Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit,Viata medicala; revista de informare profesionala si stiintifica a cadrelor medii sanitare,7609486,,"['Cardiovascular Diseases/*complications/therapy', 'Humans']",1981/07/01 00:00,1981/07/01 00:01,['1981/07/01 00:00'],"['1981/07/01 00:00 [pubmed]', '1981/07/01 00:01 [medline]', '1981/07/01 00:00 [entrez]']",,ppublish,Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit. 1981 Jul;29(7):153-6.,7,,,,,,,,,,,,,,,Complicatiile in bolile cardio-vasculare.,,,,,,
15785184,NLM,MEDLINE,20050411,20191109,1541-9215 (Print) 1541-9215 (Linking),1,2003 Winter,Crunch time for clinical cardiology.,104-6,,"['Lewis, Richard P']",['Lewis RP'],"['Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH 43210-1252, USA.']",['eng'],"['Comparative Study', 'Journal Article']",,England,Am Heart Hosp J,The American heart hospital journal,101156064,IM,"['Cardiac Care Facilities', 'Cardiology/economics/education/*trends', 'Cardiovascular Diseases/economics/epidemiology/mortality/*therapy', 'Career Choice', 'Coronary Disease/mortality', 'Forecasting', 'Health Care Costs', 'Heart Diseases/epidemiology/mortality', 'Humans', 'Hypertension/mortality', 'Prevalence', 'Quality of Health Care', 'Stroke/mortality', 'United States', 'Workforce']",2005/03/24 09:00,2005/04/12 09:00,['2005/03/24 09:00'],"['2005/03/24 09:00 [pubmed]', '2005/04/12 09:00 [medline]', '2005/03/24 09:00 [entrez]']",['10.1111/j.1541-9215.2003.02088.x [doi]'],ppublish,Am Heart Hosp J. 2003 Winter;1(1):104-6. doi: 10.1111/j.1541-9215.2003.02088.x.,1,,,,,,,,,,,,,,,,,,,,,
10362207,NLM,MEDLINE,19990622,20190708,0735-1097 (Print) 0735-1097 (Linking),33,1999 Jun,"""Prophylactic"" valve replacement for mild aortic valve disease at time of surgery for other cardiovascular disease?...No.",2009-15,,"['Rahimtoola, S H']",['Rahimtoola SH'],,['eng'],"['Comment', 'Editorial', 'Review']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Aortic Valve/*surgery', 'Cardiovascular Diseases/complications/diagnosis/*surgery', 'Decision Making', 'Heart Valve Diseases/complications/diagnosis/*surgery', '*Heart Valve Prosthesis Implantation', 'Humans', 'Intraoperative Period', 'Severity of Illness Index']",1999/06/11 00:00,1999/06/11 00:01,['1999/06/11 00:00'],"['1999/06/11 00:00 [pubmed]', '1999/06/11 00:01 [medline]', '1999/06/11 00:00 [entrez]']","['S0735109799000935 [pii]', '10.1016/s0735-1097(99)00093-5 [doi]']",ppublish,J Am Coll Cardiol. 1999 Jun;33(7):2009-15. doi: 10.1016/s0735-1097(99)00093-5.,7,,,,,,,,,,55,['J Am Coll Cardiol. 1999 Jun;33(7):2003-8. PMID: 10362206'],,,,,,,,,,
37500318,NLM,MEDLINE,20230912,20230912,1879-1913 (Electronic) 0002-9149 (Linking),203,2023 Sep 15,Cardiovascular Disease in South Asians in the United States: Lifestyle Strategies for Risk Factor Reduction.,513-514,S0002-9149(23)00575-1 [pii] 10.1016/j.amjcard.2023.07.054 [doi],"['Bhambi, Neil', 'Lee, Ming-Sum']","['Bhambi N', 'Lee MS']","['Department of Cardiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.', 'Department of Cardiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. Electronic address: mingsum.lee@kp.org.']",['eng'],"['Comment', 'Editorial']",20230725,United States,Am J Cardiol,The American journal of cardiology,0207277,IM,"['Humans', 'Asian People', '*Cardiovascular Diseases/epidemiology/ethnology/etiology/prevention & control', '*Life Style/ethnology', 'Risk Factors', '*South Asian People', 'United States/epidemiology', '*Risk Reduction Behavior']",2023/07/28 01:08,2023/08/28 06:43,['2023/07/27 22:00'],"['2023/07/07 00:00 [received]', '2023/07/08 00:00 [accepted]', '2023/08/28 06:43 [medline]', '2023/07/28 01:08 [pubmed]', '2023/07/27 22:00 [entrez]']","['S0002-9149(23)00575-1 [pii]', '10.1016/j.amjcard.2023.07.054 [doi]']",ppublish,Am J Cardiol. 2023 Sep 15;203:513-514. doi: 10.1016/j.amjcard.2023.07.054. Epub 2023 Jul 25.,,,,,"['Declaration of Competing Interest The authors have no competing interests to', 'declare.']",,,,,,,['Am J Cardiol. 2023 Sep 15;203:113-121. PMID: 37487405'],,,,,,,,,,
18350717,NLM,MEDLINE,20080422,20080320,0043-5147 (Print) 0043-5147 (Linking),60,2007,[Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target].,433-8,,"['Bielecka-Dabrowa, Agata', 'Wierzbicka, Magdalena', 'Goch, Jan H']","['Bielecka-Dabrowa A', 'Wierzbicka M', 'Goch JH']",['Z Kliniki Kardiologii I Katedry Kardiologil i Kardiochirurgii Uniwersytctu Medycznego w Lodzi. agatbiel7@poczta.onet.pl'],['pol'],"['English Abstract', 'Journal Article', 'Review']",,Poland,Wiad Lek,"Wiadomosci lekarskie (Warsaw, Poland : 1960)",9705467,IM,"['Cardiovascular Diseases/diagnosis/*immunology/*physiopathology/therapy', 'Cytokines/*immunology', 'Heart Failure/immunology/physiopathology', 'Humans', 'Inflammation Mediators/immunology']",2008/03/21 09:00,2008/04/23 09:00,['2008/03/21 09:00'],"['2008/03/21 09:00 [pubmed]', '2008/04/23 09:00 [medline]', '2008/03/21 09:00 [entrez]']",,ppublish,Wiad Lek. 2007;60(9-10):433-8.,9-10,"Several lines of evidence suggest that inflammation plays a pathogenic role in the development and progression of congestive heart failure, influencing heart contractility and hypertrophy, promoting apoptosis, and contributing to the myocardial remodeling process. Proinflammatory cytokines are important mediators of immune response, associated with endothelial dysfunction in patients with coronary artery disease or heart failure. The presence, both at tissue level and in the circulation, of increased levels of pro-inflammatory cytokines suggests that immune activation might be a relevant mechanism contributing to cardiac as well as peripheral manifestations of the disease. Traditional cardiovascular drugs have little influence on the cytokine network. Results from randomized, placebo controlled anti-TNF studies suggest lack of effect of such therapy, but the concept of immune modulation is still intensively studied. In this review we evaluate the diagnostic and prognostic value of the activation of proinflammatory cytokines, theirs role in the pathogenesis of the cardiovascular diseases and the new ways of treatment.",,,,,,,"['0 (Cytokines)', '0 (Inflammation Mediators)']",,29,,,,,Cytokiny prozapalne w chorobach ukladu krazenia jako potencjalny cel terapeutyczny.,,,,,,
21154295,NLM,MEDLINE,20120123,20101214,2081-3252 (Electronic) 1641-9251 (Linking),62,2010,Cardiovascular diseases in modern maritime industry.,101-6,,"['Oldenburg, Marcus', 'Baur, Xaver', 'Schlaich, Clara']","['Oldenburg M', 'Baur X', 'Schlaich C']",,['eng'],['Editorial'],,Poland,Int Marit Health,International maritime health,100958373,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control/therapy', 'Humans', '*Naval Medicine', 'Patient Education as Topic', 'Population Surveillance', 'Prognosis', 'Risk Factors', 'Telemedicine']",2010/12/15 06:00,2012/01/24 06:00,['2010/12/15 06:00'],"['2010/12/15 06:00 [entrez]', '2010/12/15 06:00 [pubmed]', '2012/01/24 06:00 [medline]']",,ppublish,Int Marit Health. 2010;62(3):101-6.,3,"Acute cardiovascular diseases (CVD) are the main natural causes of death in industrialized countries - both at sea and on land. Seafarers face very specific job-related cardiac risk factors, such as time pressure, long working hours, or high stress factors onboard [1, 2]. Taking into consideration the healthy worker effect of seafarers, cardiac risk factors are shown to occur slightly more frequently in seafarers than in the general population. Owing to the lack of health professionals onboard and the limited treatment options of events at sea, effective cardiopulmonary resuscitation is often delayed and the outcome of cardiac events may be worse compared to that in other occupations ashore. Seafarers' medical surveillance examinations should be used more intensively as an opportunity for education of crews in CVD risks and the possibilities to reduce them. Further, enhancement of treatment options (e.g. by implementation of advanced therapy and diagnostics such as telemedicine or AED onboard) may contribute to improved CVD prognosis at sea.",,,,,,,,,,,,,,,,,,,,
7869795,NLM,MEDLINE,19950327,20041117,0023-7205 (Print) 0023-7205 (Linking),92,1995 Feb 22,[Prevention of cardiovascular diseases in Kiruna. A research project in primary health care].,"741-2, 747",,"['Sihm, H', 'Messner, T']","['Sihm H', 'Messner T']","['LKAB, Kiruna, medicinkliniken, Kiruna sjukhus.']",['swe'],['Journal Article'],,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Cardiovascular Diseases/etiology/*prevention & control/psychology', 'Coronary Disease/etiology/prevention & control/psychology', 'Humans', 'Mass Screening', 'Primary Health Care', 'Research', 'Risk Factors', 'Sweden/epidemiology']",1995/02/22 00:00,1995/02/22 00:01,['1995/02/22 00:00'],"['1995/02/22 00:00 [pubmed]', '1995/02/22 00:01 [medline]', '1995/02/22 00:00 [entrez]']",,ppublish,"Lakartidningen. 1995 Feb 22;92(8):741-2, 747.",8,,,,,,,,,,,,,,,Prevention av hjart-karlsjukdom i Kiruna. Forskningsprojekt inom primarvarden tar form.,,,,,,
25926472,NLM,MEDLINE,20160516,20160115,1940-1574 (Electronic) 0003-3197 (Linking),67,2016 Feb,Neutrophil-Lympocyte Ratio and Cardiovascular Diseases: An Update.,105-6,10.1177/0003319715584135 [doi],"['Koza, Yavuzer']",['Koza Y'],"['Department of Cardiology, Ataturk University Faculty of Medicine, Erzurum, Turkey yavuzerkoza@hotmail.com.']",['eng'],['Editorial'],20150429,United States,Angiology,Angiology,0203706,IM,"['Cardiovascular Diseases/*blood/diagnosis/mortality/therapy', 'Decision Support Techniques', 'Humans', '*Lymphocyte Count', '*Lymphocytes', '*Neutrophils', 'Predictive Value of Tests', 'Prognosis', 'Risk Assessment', 'Risk Factors']",2015/05/01 06:00,2016/05/18 06:00,['2015/05/01 06:00'],"['2015/05/01 06:00 [entrez]', '2015/05/01 06:00 [pubmed]', '2016/05/18 06:00 [medline]']","['0003319715584135 [pii]', '10.1177/0003319715584135 [doi]']",ppublish,Angiology. 2016 Feb;67(2):105-6. doi: 10.1177/0003319715584135. Epub 2015 Apr 29.,2,,,,,,,,,,,,,,,,,,,,,
15010650,NLM,MEDLINE,20040622,20191108,1076-7460 (Print) 1076-7460 (Linking),13,2004 Mar-Apr,The Cardiovascular Health Study: a national treasure of cardiovascular information about the elderly.,57-8,,"['Wenger, Nanette K', 'Weber, Michael A', 'Scheidt, Stephen']","['Wenger NK', 'Weber MA', 'Scheidt S']",,['eng'],['Editorial'],,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Aged', 'Cardiovascular Diseases/*diagnosis/epidemiology/therapy', '*Geriatric Assessment', 'Humans', 'Risk Factors']",2004/03/11 05:00,2004/06/23 05:00,['2004/03/11 05:00'],"['2004/03/11 05:00 [pubmed]', '2004/06/23 05:00 [medline]', '2004/03/11 05:00 [entrez]']",['10.1111/j.1076-7460.2004.02735.x [doi]'],ppublish,Am J Geriatr Cardiol. 2004 Mar-Apr;13(2):57-8. doi: 10.1111/j.1076-7460.2004.02735.x.,2,,,,,,,,,,,,,,,,,,,,,
3505177,NLM,MEDLINE,19890222,20041117,0887-8005 (Print) 0887-8005 (Linking),1,1987,Selected topics in cardiovascular disease in children.,145-6,,"['Naeye, R L']",['Naeye RL'],"['Department of Pathology, M.S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey 17033.']",['eng'],['Journal Article'],,United States,Am J Cardiovasc Pathol,The American journal of cardiovascular pathology,8702438,IM,"['*Cardiovascular Diseases/diagnosis/pathology/therapy', 'Child', 'Child, Preschool', 'Humans', 'Infant', 'Infant, Newborn', 'Pediatrics/trends']",1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",,ppublish,Am J Cardiovasc Pathol. 1987;1(2):145-6.,2,,,,,,,,,,,,,,,,,,,,,
34078763,NLM,MEDLINE,20220221,20220221,1880-3873 (Electronic) 1340-3478 (Print) 1340-3478 (Linking),28,2021 Dec 1,Triglycerides on the Rise!,1263-1265,10.5551/jat.ED178 [doi],"['Tada, Hayato', 'Takamura, Masayuki', 'Kawashiri, Masa-Aki']","['Tada H', 'Takamura M', 'Kawashiri MA']","['Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.', 'Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.', 'Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.']",['eng'],['Editorial'],20210602,Japan,J Atheroscler Thromb,Journal of atherosclerosis and thrombosis,9506298,IM,"['Cardiovascular Diseases/*blood/etiology/prevention & control', 'Humans', 'Triglycerides/*blood']",2021/06/04 06:00,2022/02/22 06:00,['2021/06/03 05:53'],"['2021/06/04 06:00 [pubmed]', '2022/02/22 06:00 [medline]', '2021/06/03 05:53 [entrez]']","['DN/JST.JSTAGE/jat/ED178 [pii]', '10.5551/jat.ED178 [doi]']",ppublish,J Atheroscler Thromb. 2021 Dec 1;28(12):1263-1265. doi: 10.5551/jat.ED178. Epub 2021 Jun 2.,12,,,PMC8629705,,['NOTNLM'],"['Cardiovascular disease', 'LDL cholesterol', 'Lipoprotein', 'Residual risk', 'Triglycerides']",,['0 (Triglycerides)'],,,,,,,,,,,,,
12187591,NLM,MEDLINE,20020903,20191210,0869-2084 (Print) 0869-2084 (Linking),,2002 Jul,"[Computer program for diagnosis, monitoring, and prophylaxis of cardiovascular diseases].",42-5,,"[""Vorob'eva, E N"", 'Varshavskii, B Ia', 'Shoikhet, Ia N', ""Garkol', N S"", 'Tushev, A N']","[""Vorob'eva EN"", 'Varshavskii BIa', 'Shoikhet IaN', ""Garkol' NS"", 'Tushev AN']",,['rus'],['Journal Article'],,Russia (Federation),Klin Lab Diagn,Klinicheskaia laboratornaia diagnostika,9432021,IM,"['Adult', '*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Neural Networks, Computer', 'Prognosis', '*Software']",2002/08/22 10:00,2002/09/11 10:01,['2002/08/22 10:00'],"['2002/08/22 10:00 [pubmed]', '2002/09/11 10:01 [medline]', '2002/08/22 10:00 [entrez]']",,ppublish,Klin Lab Diagn. 2002 Jul;(7):42-5.,7,"Cardiovascular diseases remain the main cause of death among adult population; their incidence can be reduced only using an effective system of primary and secondary prevention. The aim of our study was to develop software for automated recognition of cardiovascular risk factors, prognosis, and evaluation of dyslipoproteinemia phenotypes in lipid centers. Prognostic indexes, lipidogram values are estimated, and the program detects the risk factors (overweight, poor physical training, irrational nutrition, tobacco smoking, etc.) and predicts the summary risk of coronary disease. Neuronal network was used for evaluating the types of dyslipoproteinemias and for cardiovascular prognosis. The input vectors were lipid and lipoprotein concentrations. Output neurons were diagnostic signs of dislipoproteinemia phenotypes or cardiovascular prognosis.",,,,,,,,,,,,,,"Komp'iuternaia programma diagnostiki, monitoringa i profilaktiki serdechno-sosudistykh zabolevanii.",,,,,,
30169939,NLM,MEDLINE,20190111,20190111,0021-5384 (Print) 0021-5384 (Linking),105,2016 Sep,[113th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Gut Microbiota and Cardiovascular Disease].,1706-11,,"['Hirata, Ken-ichi', 'Yamashita, Tomoya']","['Hirata KI', 'Yamashita T']",,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Animals', 'Cardiovascular Diseases/*etiology/prevention & control/therapy', '*Gastrointestinal Microbiome', 'Humans', 'Internal Medicine', 'Japan', 'Societies, Medical']",2016/09/01 00:00,2019/01/12 06:00,['2018/09/01 06:00'],"['2018/09/01 06:00 [entrez]', '2016/09/01 00:00 [pubmed]', '2019/01/12 06:00 [medline]']",,ppublish,Nihon Naika Gakkai Zasshi. 2016 Sep;105(9):1706-11.,9,,,,,,,,,,,,,,,,,,,,,
20060326,NLM,MEDLINE,20100813,20181201,1879-1336 (Electronic) 1054-8807 (Linking),19,2010 May-Jun,Molecular basis and diagnosis of both inherited and acquired cardiovascular diseases: introduction.,165,10.1016/j.carpath.2009.06.002 [doi],"['Thiene, Gaetano']",['Thiene G'],,['eng'],['Congress'],20100108,United States,Cardiovasc Pathol,Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology,9212060,IM,"['Cardiovascular Diseases/*diagnosis/*genetics', 'Humans']",2010/01/12 06:00,2010/08/14 06:00,['2010/01/12 06:00'],"['2009/05/04 00:00 [received]', '2009/05/29 00:00 [revised]', '2009/06/15 00:00 [accepted]', '2010/01/12 06:00 [entrez]', '2010/01/12 06:00 [pubmed]', '2010/08/14 06:00 [medline]']","['S1054-8807(09)00071-4 [pii]', '10.1016/j.carpath.2009.06.002 [doi]']",ppublish,Cardiovasc Pathol. 2010 May-Jun;19(3):165. doi: 10.1016/j.carpath.2009.06.002. Epub 2010 Jan 8.,3,,,,,,,,,,,,,,,,,,,,,
32516176,NLM,MEDLINE,20210802,20210802,1473-5687 (Electronic) 0954-691X (Linking),32,2021 Feb 1,The interplay between gastrointestinal and cardiovascular diseases: a narrative review focusing on the clinical perspective.,132-139,10.1097/MEG.0000000000001779 [doi],"['Sbeit, Wisam', 'Kadah, Anas', 'Mahamid, Mahmud', 'Mari, Amir', 'Khoury, Tawfik']","['Sbeit W', 'Kadah A', 'Mahamid M', 'Mari A', 'Khoury T']","['Department of Gastroenterology, Galilee Medical Center, Nahariya.', 'Faculty of Medicine in the Galilee, Bar-Ilan University, Safed.', 'Department of Gastroenterology, Galilee Medical Center, Nahariya.', 'Faculty of Medicine in the Galilee, Bar-Ilan University, Safed.', 'Gastroenterology Department, Shaare Zedek Medical Center.', 'Faculty of Medicine in the Galilee, Bar-Ilan University, Safed.', 'Gastroenterology and Endoscopy Units, The Nazareth Hospital, EMMS, Nazareth 22100, Israel.', 'Department of Gastroenterology, Galilee Medical Center, Nahariya.', 'Faculty of Medicine in the Galilee, Bar-Ilan University, Safed.']",['eng'],"['Journal Article', 'Review']",,England,Eur J Gastroenterol Hepatol,European journal of gastroenterology & hepatology,9000874,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Gastrointestinal Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Inflammation']",2020/06/10 06:00,2021/08/03 06:00,['2020/06/10 06:00'],"['2020/06/10 06:00 [pubmed]', '2021/08/03 06:00 [medline]', '2020/06/10 06:00 [entrez]']","['00042737-202102000-00002 [pii]', '10.1097/MEG.0000000000001779 [doi]']",ppublish,Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):132-139. doi: 10.1097/MEG.0000000000001779.,2,"Both cardiovascular and gastrointestinal disorders represent considerable health burden on community clinics and hospitals with overwhelming economic cost. An overlap in the occurrence of these disorders is encountered in daily practice. Both affect each other in bidirectional manner through several mechanisms including altered hemodynamics, systemic inflammation, bacterial overgrowth and interactions and adverse effects of medications. In addition, to the known overlap in the symptoms occurrence of upper gastrointestinal tract diseases and cardiovascular diseases (CVDs). Awareness of this interplay and its clinical manifestations optimizes patient management, and could prevent catastrophic consequences and even save lives. In this review, we highlighted the clinical aspects of this bidirectional association between gastrointestinal and CVDs aiming to shed light on this topic and improve patients' care.",,,,,,,,"['Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved.']",,,,,,,,,,,,
20974753,NLM,MEDLINE,20110331,20101214,1532-2092 (Electronic) 1099-5129 (Linking),13,2011 Jan,Can we predict cost of care in atrial fibrillation patients?,1-2,10.1093/europace/euq379 [doi],"['Le Heuzey, Jean-Yves']",['Le Heuzey JY'],,['eng'],"['Comment', 'Editorial']",20101025,England,Europace,"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",100883649,IM,"['Atrial Fibrillation/*economics/epidemiology/*therapy', 'Cardiovascular Diseases/economics/epidemiology/therapy', 'Comorbidity', 'Cost-Benefit Analysis', 'Europe', '*Health Care Costs', 'Humans']",2010/10/27 06:00,2011/04/01 06:00,['2010/10/27 06:00'],"['2010/10/27 06:00 [entrez]', '2010/10/27 06:00 [pubmed]', '2011/04/01 06:00 [medline]']","['euq379 [pii]', '10.1093/europace/euq379 [doi]']",ppublish,Europace. 2011 Jan;13(1):1-2. doi: 10.1093/europace/euq379. Epub 2010 Oct 25.,1,,,,,,,,,,,['Europace. 2011 Jan;13(1):23-30. PMID: 20823043'],,,,,,,,,,
23977825,NLM,MEDLINE,20131029,20130827,2159-3000 (Print) 2159-3000 (Linking),411,2013 Aug,Understanding of the unique risks of CVD that women face. Foreword.,2,,"['Delzell, John E Jr']",['Delzell JE Jr'],"['University of Kansas School of Medicine, Kansas City, USA. jdelzell@kumc.edu']",['eng'],['Introductory Journal Article'],,United States,FP Essent,FP essentials,101578821,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Female', 'Humans', 'Peripheral Arterial Disease/epidemiology', 'Risk Factors', ""*Women's Health""]",2013/08/28 06:00,2013/10/30 06:00,['2013/08/28 06:00'],"['2013/08/28 06:00 [entrez]', '2013/08/28 06:00 [pubmed]', '2013/10/30 06:00 [medline]']",,ppublish,FP Essent. 2013 Aug;411:2.,,,,,,,,,,,,,,,,,,,,,,
20408253,NLM,MEDLINE,20100513,20190623,1524-4539 (Electronic) 0009-7322 (Linking),121,2010 Apr 20,The importance and urgency of preventing CVD.,1685,,"['Vasan, Ramachandran S']",['Vasan RS'],,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circulation,Circulation,0147763,IM,"['Biomarkers', 'Cardiovascular Diseases/diagnosis/*epidemiology/*prevention & control', 'Humans', 'Risk Factors', 'United States/epidemiology']",2010/04/22 06:00,2010/05/14 06:00,['2010/04/22 06:00'],"['2010/04/22 06:00 [entrez]', '2010/04/22 06:00 [pubmed]', '2010/05/14 06:00 [medline]']",['10.1161/circulationaha.110.953836 [doi]'],ppublish,Circulation. 2010 Apr 20;121(15):1685. doi: 10.1161/circulationaha.110.953836.,15,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
8582887,NLM,MEDLINE,19960321,20071115,0004-1858 (Print) 0004-1858 (Linking),92,1996 Jan,The complete cardiac diagnosis.,401-2,,"['Talley, J D']",['Talley JD'],"['Division of Cardiology, UAMS, USA.']",['eng'],['Journal Article'],,United States,J Ark Med Soc,The Journal of the Arkansas Medical Society,7503069,IM,"['Activities of Daily Living/classification', 'Cardiovascular Diseases/*diagnosis/etiology/physiopathology', 'Hemodynamics/physiology', 'Humans', 'Prognosis']",1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,J Ark Med Soc. 1996 Jan;92(8):401-2.,8,,,,,,,,,,,,,,,,,,,,,
23244361,NLM,MEDLINE,20130522,20171116,1744-8344 (Electronic) 1477-9072 (Linking),10,2012 Nov,Gender disparity in cardiovascular disease: bias or biology?,1401-11,10.1586/erc.12.133 [doi],"['Wenger, Nanette K']",['Wenger NK'],"['Department of Medicine (Cardiology), Emory University School of Medicine, Consultant, Emory Heart and Vascular Center, Atlanta, GA, USA. nwenger@emory.edu']",['eng'],"['Journal Article', 'Review']",,England,Expert Rev Cardiovasc Ther,Expert review of cardiovascular therapy,101182328,IM,"['Bias', 'Cardiovascular Diseases/diagnosis/*epidemiology/prevention & control/therapy', 'Cardiovascular System/*physiopathology', 'Evidence-Based Medicine', 'Female', 'Humans', 'Male', 'Prognosis', 'Risk Factors', 'Sex Factors']",2012/12/19 06:00,2013/05/23 06:00,['2012/12/19 06:00'],"['2012/12/19 06:00 [entrez]', '2012/12/19 06:00 [pubmed]', '2013/05/23 06:00 [medline]']",['10.1586/erc.12.133 [doi]'],ppublish,Expert Rev Cardiovasc Ther. 2012 Nov;10(11):1401-11. doi: 10.1586/erc.12.133.,11,"This article addresses gender disparity in cardiovascular disease, with selected examples used to explore whether these disparities represent bias, biology or both. Gender-specific basic and clinical cardiovascular research is needed to address these issues, with rigorous application required for the emerging knowledge. These explorations offer promise to improve cardiovascular outcomes for women and are the basis for the application of gender-based evaluation of pathophysiology, clinical presentations, preventive interventions, diagnostic strategies, therapies and outcomes of cardiovascular disease in women.",,,,,,,,,,,,,,,,,,,,
18181347,NLM,MEDLINE,20080125,20080109,0125-2208 (Print) 0125-2208 (Linking),90,2007 Nov,Prognostic value of heart rate in cardiovascular disease.,2538-40,,"['Sukonthasarn, Apichard']",['Sukonthasarn A'],"['Department of Medicine, Faculty of Medicine, Chaing Mai University, Chaing Mai, Thailand.']",['eng'],"['Journal Article', 'Review']",,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,IM,"['Cardiovascular Diseases/drug therapy/*physiopathology/therapy', 'Coronary Artery Disease/physiopathology', 'Heart Failure/physiopathology', 'Heart Rate/*physiology', 'Humans', 'Prognosis']",2008/01/10 09:00,2008/01/26 09:00,['2008/01/10 09:00'],"['2008/01/10 09:00 [pubmed]', '2008/01/26 09:00 [medline]', '2008/01/10 09:00 [entrez]']",,ppublish,J Med Assoc Thai. 2007 Nov;90(11):2538-40.,11,,,,,,,,,,21,,,,,,,,,,,
10456189,NLM,MEDLINE,19990930,20051116,0242-6498 (Print) 0242-6498 (Linking),19,1999 Jun,[Cardiovascular diseases: from epidemiology to biology].,162-5,,"['Bruneval, P']",['Bruneval P'],,['fre'],"['Editorial', 'Review']",,France,Ann Pathol,Annales de pathologie,8106337,IM,"['Angioplasty', 'Arteriosclerosis/epidemiology/pathology/physiopathology', 'Cardiomyopathies/epidemiology/pathology', 'Cardiovascular Diseases/*epidemiology/pathology', 'Coronary Disease/therapy', 'Heart Transplantation', 'Humans', 'Neovascularization, Pathologic', 'Recurrence']",1999/08/24 00:00,1999/08/24 00:01,['1999/08/24 00:00'],"['1999/08/24 00:00 [pubmed]', '1999/08/24 00:01 [medline]', '1999/08/24 00:00 [entrez]']",['MDOI-AP-06-1999-19-3-0242-6498-101019-ART98 [pii]'],ppublish,Ann Pathol. 1999 Jun;19(3):162-5.,3,,,,,,,,,,36,,,,,La pathologie cardio-vasculaire: de l'epidemiologie a la biologie.,,,,,,
33245753,NLM,MEDLINE,20210823,20210823,1755-3245 (Electronic) 0008-6363 (Linking),116,2020 Dec 1,Leaders in Cardiovascular Research: Stefanie Dimmeler.,e202-e204,10.1093/cvr/cvaa317 [doi],"['Guzik, Tomasz J', 'Dimmeler, Stefanie']","['Guzik TJ', 'Dimmeler S']","['Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.', 'Department of Internal Medicine, Jagiellonian University, Collegium Medicum, Krakow, Poland.', 'Institute for Cardiovascular Regeneration, Goethe University, Frankfurt am Main, Germany.']",['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait', 'Video-Audio Media']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/genetics/*history/physiopathology/therapy', 'Genetic Therapy/history', 'History, 20th Century', 'History, 21st Century', 'Humans', 'RNA, Untranslated/history']",2020/11/28 06:00,2021/08/24 06:00,['2020/11/27 17:05'],"['2020/11/27 17:05 [entrez]', '2020/11/28 06:00 [pubmed]', '2021/08/24 06:00 [medline]']","['6007715 [pii]', '10.1093/cvr/cvaa317 [doi]']",ppublish,Cardiovasc Res. 2020 Dec 1;116(14):e202-e204. doi: 10.1093/cvr/cvaa317.,14,,,,,['NOTNLM'],"['Basic science', 'ESC', 'Nitric oxide', 'Non-coding RNA', 'Regeneration']",,"['0 (RNA, Untranslated)']",,,,,,,,['Dimmeler S'],"['Dimmeler, Stefanie']",,,,
19357057,NLM,MEDLINE,20100510,20090409,1308-0032 (Electronic) 1302-8723 (Linking),9,2009 Apr,The growth of death rate from cardiovascular diseases in the Kyrgyz Republic.,139-40,,"['Kydyralieva, Ryskul B', 'Dzhumagulova, Ainagul S']","['Kydyralieva RB', 'Dzhumagulova AS']","['M. Mirrahimov National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan. cardio@elcat.kg']",['eng'],['Letter'],,Turkey,Anadolu Kardiyol Derg,Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,101095069,IM,"['Adult', 'Cardiovascular Diseases/economics/*mortality/prevention & control', 'Humans', 'Kyrgyzstan/epidemiology', 'Middle Aged']",2009/04/10 09:00,2010/05/11 06:00,['2009/04/10 09:00'],"['2009/04/10 09:00 [entrez]', '2009/04/10 09:00 [pubmed]', '2010/05/11 06:00 [medline]']",,ppublish,Anadolu Kardiyol Derg. 2009 Apr;9(2):139-40.,2,,,,,,,,,,,,,,,,,,,,,
20078422,NLM,MEDLINE,20100323,20201219,0025-729X (Print) 0025-729X (Linking),192,2010 Jan 18,Poll tax and preventive cardiology in Australia.,112,,"['Jelinek, V Michael']",['Jelinek VM'],,['eng'],['Letter'],,Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Australia', 'Cardiovascular Diseases/diagnosis/economics/*prevention & control', '*Health Care Costs', 'Humans', 'Socioeconomic Factors', 'Taxes/*economics']",2010/01/19 06:00,2010/03/24 06:00,['2010/01/19 06:00'],"['2009/09/25 00:00 [received]', '2009/10/30 00:00 [accepted]', '2010/01/19 06:00 [entrez]', '2010/01/19 06:00 [pubmed]', '2010/03/24 06:00 [medline]']","['letters_180109_fm-10 [pii]', '10.5694/j.1326-5377.2010.tb03442.x [doi]']",ppublish,Med J Aust. 2010 Jan 18;192(2):112. doi: 10.5694/j.1326-5377.2010.tb03442.x.,2,,,,,,,,,,,,,,,,,,,,,
8888891,NLM,MEDLINE,19970129,20170511,0001-5385 (Print) 0001-5385 (Linking),51,1996,Nutrition and cardiovascular disease.,327-30,,"['Kesteloot, H']",['Kesteloot H'],,['eng'],['Editorial'],,England,Acta Cardiol,Acta cardiologica,0370570,IM,"['Cardiovascular Diseases/epidemiology/*etiology/prevention & control', 'Diet/*adverse effects', 'Europe/epidemiology', 'Health Promotion', 'Humans']",1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Acta Cardiol. 1996;51(4):327-30.,4,,,,,,,,,,,,,,,,,,,,,
32276570,NLM,MEDLINE,20211213,20220712,2047-4881 (Electronic) 2047-4873 (Linking),28,2021 Jul 23,"After surviving cancer, cardiovascular prevention should not be forgotten.",862-863,10.1177/2047487320918426 [doi],"['Regieli, Jakub J', 'Twickler, Marcel Th B']","['Regieli JJ', 'Twickler MTB']","['European Society of Clinical Investigation, The Netherlands.', 'Hartdokters Centre for Primary Cardiovascular Prevention and Care, The Netherlands.', 'Alert Foundation, The Netherlands.', 'University of Antwerp, Faculty of Medicine and Health Sciences, Belgium.', 'AZ Monica Hospital, Belgium.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Heart', 'Humans', '*Neoplasms/epidemiology/prevention & control']",2020/04/12 06:00,2021/12/15 06:00,['2020/04/12 06:00'],"['2020/04/12 06:00 [pubmed]', '2021/12/15 06:00 [medline]', '2020/04/12 06:00 [entrez]']","['6145638 [pii]', '10.1177/2047487320918426 [doi]']",ppublish,Eur J Prev Cardiol. 2021 Jul 23;28(8):862-863. doi: 10.1177/2047487320918426.,8,,,,,,,,,,,['Eur J Prev Cardiol. 2021 Jul 23;28(8):864-872. PMID: 34298552'],,,,,,,,,,
34297032,NLM,MEDLINE,20211221,20220204,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),32,2021 May-Jun,PASCAR and WHF Cardiovascular Diseases Scorecard project.,161-167,10.5830/CVJA-2021-022 [doi],"['Mbau, Lilian', 'Fourie, Jean M', 'Scholtz, Wihan', 'Scarlatescu, Oana', 'Nel, George', 'Gathecha, Gladwell']","['Mbau L', 'Fourie JM', 'Scholtz W', 'Scarlatescu O', 'Nel G', 'Gathecha G']","['Kenya Cardiac Society, Nairobi, Kenya.', 'Pan-African Society of Cardiology, Cape Town, South Africa.', 'Pan-African Society of Cardiology, Cape Town, South Africa. Email: wihan@medsoc.co.za.', 'World Heart Federation, Geneva, Switzerland.', 'Pan-African Society of Cardiology, Cape Town, South Africa.', 'Department of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya.']",['eng'],"['Case Reports', 'Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['Aged', '*Cardiovascular Diseases/diagnosis/epidemiology/mortality/therapy', 'Female', 'Humans', 'Kenya/epidemiology', 'Male', 'Middle Aged', 'Tobacco Use/*adverse effects', 'World Health Organization']",2021/07/24 06:00,2021/12/22 06:00,['2021/07/23 12:21'],"['2021/07/23 12:21 [entrez]', '2021/07/24 06:00 [pubmed]', '2021/12/22 06:00 [medline]']",['10.5830/CVJA-2021-022 [doi]'],ppublish,Cardiovasc J Afr. 2021 May-Jun;32(3):161-167. doi: 10.5830/CVJA-2021-022.,3,"Data collected for the World Heart Federation's Scorecard project regarding the current state of cardiovascular disease prevention, control and management, along with related non-communicable diseases in Kenya are presented. Furthermore, the strengths, threats, weaknesses and priorities identified from these data are highlighted in concurrence with related sections in the accompanying infographic. Information was collected using open-source data sets from the World Bank, the World Health Organization, the Institute for Health Metrics and Evaluation, the International Diabetes Federation and relevant government publications.",,PMC8756039,,,,,,,,,,,,,,,,,,
36907446,NLM,MEDLINE,20230425,20230626,1874-1754 (Electronic) 0167-5273 (Linking),380,2023 Jun 1,Mobile cardiac rehabilitation: A feasible alternative for patients with cardiovascular diseases having insufficient social support and hospital access.,39,S0167-5273(23)00353-4 [pii] 10.1016/j.ijcard.2023.03.017 [doi],"['Kambayashi, Saya', 'Kato, Yuki', 'Hori, Asuka', 'Momosaki, Ryo']","['Kambayashi S', 'Kato Y', 'Hori A', 'Momosaki R']","['Department of Rehabilitation Medicine, Mie University Graduate School of Medicine, Mie, Japan.', 'Department of Rehabilitation Medicine, Mie University Graduate School of Medicine, Mie, Japan.', 'Department of Rehabilitation Medicine, Mie University Graduate School of Medicine, Mie, Japan.', 'Department of Rehabilitation Medicine, Mie University Graduate School of Medicine, Mie, Japan. Electronic address: momosakiryo@gmail.com.']",['eng'],"['Comment', 'Letter']",20230311,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Cardiac Rehabilitation', 'Exercise', '*Cell Phone', 'Social Support']",2023/03/13 06:00,2023/04/25 10:20,['2023/03/12 20:30'],"['2023/03/01 00:00 [received]', '2023/03/07 00:00 [accepted]', '2023/04/25 10:20 [medline]', '2023/03/13 06:00 [pubmed]', '2023/03/12 20:30 [entrez]']","['S0167-5273(23)00353-4 [pii]', '10.1016/j.ijcard.2023.03.017 [doi]']",ppublish,Int J Cardiol. 2023 Jun 1;380:39. doi: 10.1016/j.ijcard.2023.03.017. Epub 2023 Mar 11.,,,,,['Declaration of Competing Interest No conflict of interests.'],,,,,,,['Int J Cardiol. 2023 Apr 01;376:18-21. PMID: 36731633'],,,,,,,,,,
25804050,NLM,MEDLINE,20150504,20191113,0040-3660 (Print) 0040-3660 (Linking),86,2014,[Magnesium deficiency in cardiology].,104-6,,"['Drapkina, O M', 'Gegnava, B B']","['Drapkina OM', 'Gegnava BB']",,['rus'],"['English Abstract', 'Journal Article', 'Review']",,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['*Cardiovascular Diseases/drug therapy/etiology/prevention & control', 'Humans', 'Magnesium/*therapeutic use', 'Magnesium Deficiency/*complications']",2014/01/01 00:00,2015/05/06 06:00,['2015/03/26 06:00'],"['2015/03/26 06:00 [entrez]', '2014/01/01 00:00 [pubmed]', '2015/05/06 06:00 [medline]']",['10.17116/terarkh20148612104-106 [doi]'],ppublish,Ter Arkh. 2014;86(12):104-6. doi: 10.17116/terarkh20148612104-106.,12,"The paper considers the consequences and causes of magnesium deficiency in patients with cardiovascular diseases. The features of magnesium metabolism in atherosclerosis, hypertension, and heart failure are described. Prospects of magnesium therapy in cardiology practice are discussed.",,,,,,,['I38ZP9992A (Magnesium)'],,,,,,,,,,,,,
25602945,NLM,MEDLINE,20150921,20181113,1475-925X (Electronic) 1475-925X (Linking),14 Suppl 1,2015,"Cardiovascular diseases and vulnerable plaques: data, modeling, predictions and clinical applications.",S1,10.1186/1475-925X-14-S1-S1 [doi],"['Tang, Dalin', 'Li, Zhi-Yong', 'Gijsen, Frank', 'Giddens, Don P']","['Tang D', 'Li ZY', 'Gijsen F', 'Giddens DP']",,['eng'],['Introductory Journal Article'],20150109,England,Biomed Eng Online,Biomedical engineering online,101147518,IM,"['Cardiovascular Diseases/*diagnosis/epidemiology/physiopathology', 'Humans', '*Models, Biological', 'Plaque, Atherosclerotic/*diagnosis/epidemiology/physiopathology']",2015/01/21 06:00,2015/09/22 06:00,['2015/01/21 06:00'],"['2015/01/21 06:00 [entrez]', '2015/01/21 06:00 [pubmed]', '2015/09/22 06:00 [medline]']","['1475-925X-14-S1-S1 [pii]', '10.1186/1475-925X-14-S1-S1 [doi]']",ppublish,Biomed Eng Online. 2015;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1475-925X-14-S1-S1. Epub 2015 Jan 9.,Suppl 1,,,PMC4306097,,,,,,,,,,,,,,,,,,
20031791,NLM,MEDLINE,20100610,20091224,1941-7705 (Electronic) 1941-7713 (Linking),1,2008 Nov,Pharmacotherapy for pediatric cardiovascular diseases: the role of off-label drug use in the 21st century.,69-71,10.1161/CIRCOUTCOMES.108.830935 [doi],"['Ring, John C']",['Ring JC'],,['eng'],"['Comment', 'Editorial']",,United States,Circ Cardiovasc Qual Outcomes,Circulation. Cardiovascular quality and outcomes,101489148,IM,"['Cardiovascular Diseases/*drug therapy/epidemiology/physiopathology', 'Child', 'Child, Preschool', 'Databases as Topic', '*Drug Therapy/trends', 'Humans', 'Infant', '*Off-Label Use', 'Pediatrics']",2009/12/25 06:00,2010/06/11 06:00,['2009/12/25 06:00'],"['2009/12/25 06:00 [entrez]', '2009/12/25 06:00 [pubmed]', '2010/06/11 06:00 [medline]']","['1/2/69 [pii]', '10.1161/CIRCOUTCOMES.108.830935 [doi]']",ppublish,Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):69-71. doi: 10.1161/CIRCOUTCOMES.108.830935.,2,,,,,,,,,,,['Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):74-83. PMID: 20031793'],,,,,,,,,,
29277219,NLM,MEDLINE,20190314,20190314,1590-3729 (Electronic) 0939-4753 (Linking),28,2018 Jan,Welcome from the new Editor-in-Chief.,1-2,S0939-4753(17)30300-9 [pii] 10.1016/j.numecd.2017.12.002 [doi],"['Siani, A']",['Siani A'],"['Institute of Food Sciences, CNR, Via Roma 64, 83100 Avellino, Italy. Electronic address: asiani@isa.cnr.it.']",['eng'],['Editorial'],,Netherlands,Nutr Metab Cardiovasc Dis,"Nutrition, metabolism, and cardiovascular diseases : NMCD",9111474,IM,"['*Biomedical Research/trends', 'Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', '*Editorial Policies', 'Forecasting', 'Humans', '*Metabolic Diseases/diagnosis/epidemiology/physiopathology/therapy', '*Nutritional Sciences/trends', '*Periodicals as Topic/trends']",2017/12/27 06:00,2019/03/15 06:00,['2017/12/27 06:00'],"['2017/12/05 00:00 [received]', '2017/12/05 00:00 [accepted]', '2017/12/27 06:00 [entrez]', '2017/12/27 06:00 [pubmed]', '2019/03/15 06:00 [medline]']","['S0939-4753(17)30300-9 [pii]', '10.1016/j.numecd.2017.12.002 [doi]']",ppublish,Nutr Metab Cardiovasc Dis. 2018 Jan;28(1):1-2. doi: 10.1016/j.numecd.2017.12.002.,1,,,,,,,,,,,,,,,,,,,,,
11530175,NLM,MEDLINE,20010927,20150616,0140-6736 (Print) 0140-6736 (Linking),358,2001 Aug 25,Global cardiovascular disease prevention: time to get serious.,661-3,,"['Beaglehole, R']",['Beaglehole R'],"['University of Auckland, New Zealand. rbeaglehole@compuserve.com']",['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', '*Global Health', 'Health Priorities', 'Humans', '*Primary Prevention', 'Risk Factors']",2001/09/01 10:00,2001/09/28 10:01,['2001/09/01 10:00'],"['2001/09/01 10:00 [pubmed]', '2001/09/28 10:01 [medline]', '2001/09/01 10:00 [entrez]']","['S0140-6736(01)05784-1 [pii]', '10.1016/S0140-6736(01)05784-1 [doi]']",ppublish,Lancet. 2001 Aug 25;358(9282):661-3. doi: 10.1016/S0140-6736(01)05784-1.,9282,,,,,,,,,,,,,['Lancet. 2001 Nov 10;358(9293):1642. PMID: 11716912'],,,,,,,,
10149314,NLM,MEDLINE,19920827,20191024,0268-4705 (Print) 0268-4705 (Linking),5,1990 Feb,Cardiovascular imaging.,33-9,,"['Rigby, M L']",['Rigby ML'],"['Brompton Hospital and National Heart and Lung Institute, London, UK.']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Cardiol,Current opinion in cardiology,8608087,,"['Cardiac Catheterization/methods', 'Cardiovascular Diseases/*diagnosis/diagnostic imaging/physiopathology', '*Diagnostic Imaging', 'Humans', 'Radiography', 'Ultrasonography']",1990/02/01 00:00,1999/04/02 00:01,['1990/02/01 00:00'],"['1990/02/01 00:00 [pubmed]', '1999/04/02 00:01 [medline]', '1990/02/01 00:00 [entrez]']",['10.1097/00001573-199002000-00006 [doi]'],ppublish,Curr Opin Cardiol. 1990 Feb;5(1):33-9. doi: 10.1097/00001573-199002000-00006.,1,,,,,,,,,,28,,,,,,,,,,,
11507330,NLM,MEDLINE,20010927,20191025,0957-9672 (Print) 0957-9672 (Linking),12,2001 Aug,Nutrition and metabolism.,457-9,,"['Griffin, B A']",['Griffin BA'],,['eng'],['Editorial'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['*Cardiovascular Diseases/etiology/genetics/prevention & control', 'Coffee', 'Diet', 'Humans', '*Nutritional Physiological Phenomena', 'Tea']",2001/08/17 10:00,2001/09/28 10:01,['2001/08/17 10:00'],"['2001/08/17 10:00 [pubmed]', '2001/09/28 10:01 [medline]', '2001/08/17 10:00 [entrez]']",['10.1097/00041433-200108000-00012 [doi]'],ppublish,Curr Opin Lipidol. 2001 Aug;12(4):457-9. doi: 10.1097/00041433-200108000-00012.,4,,,,,,,,"['0 (Coffee)', '0 (Tea)']",,,,,,,,,,,,,
15633352,NLM,MEDLINE,20050124,20071115,0023-7205 (Print) 0023-7205 (Linking),101,2004 Dec 2,[Psychosocial risk factors in therapeutic guidelines for cardiovascular risk].,4053,,"['Orth-Gomer, Kristina']",['Orth-Gomer K'],,['swe'],"['Comment', 'Letter']",,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Cardiovascular Diseases/etiology/*prevention & control/psychology', 'Europe', 'Humans', 'Practice Guidelines as Topic', 'Risk Factors', 'Socioeconomic Factors']",2005/01/07 09:00,2005/01/26 09:00,['2005/01/07 09:00'],"['2005/01/07 09:00 [pubmed]', '2005/01/26 09:00 [medline]', '2005/01/07 09:00 [entrez]']",,ppublish,Lakartidningen. 2004 Dec 2;101(49):4053.,49,,,,,,,,,,,"['Lakartidningen. 2004 Nov 11;101(46):3677-8, 3680-2. PMID: 15586492']",,,,Psykosociala riskfaktorer i behandlingsriktlinjer for hjart-karlrisk.,,,,,,
8029583,NLM,MEDLINE,19940811,20041117,0249-6429 (Print) 0249-6429 (Linking),,1994 May,[Cardiovascular diseases in the elderly. Epidemiology].,4-6,,"['Villard, J']",['Villard J'],,['fre'],['Journal Article'],,France,Soins Chir,"Soins. Chirurgie (Paris, France : 1982)",8406864,,"['Aged', 'Cardiovascular Diseases/classification/*epidemiology', 'Humans']",1994/05/01 00:00,1994/05/01 00:01,['1994/05/01 00:00'],"['1994/05/01 00:00 [pubmed]', '1994/05/01 00:01 [medline]', '1994/05/01 00:00 [entrez]']",,ppublish,Soins Chir. 1994 May;(159):4-6.,159,,,,,,,,,,,,,,,Maladies cardio-vasculaires et sujet age. Epidemiologie.,,,,,,
36805654,NLM,MEDLINE,20230511,20230522,2047-4881 (Electronic) 2047-4873 (Linking),30,2023 May 9,Cardiovascular prevention in young: the healthy eightfold path.,592,10.1093/eurjpc/zwad051 [doi],"['Marques-Vidal, Pedro']",['Marques-Vidal P'],"['Department of Medicine, Internal Medicine, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, Lausanne 1011, Switzerland.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', 'Risk Factors', '*Cardiovascular System', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control']",2023/02/23 06:00,2023/05/11 06:42,['2023/02/22 09:52'],"['2023/05/11 06:42 [medline]', '2023/02/23 06:00 [pubmed]', '2023/02/22 09:52 [entrez]']","['7048908 [pii]', '10.1093/eurjpc/zwad051 [doi]']",ppublish,Eur J Prev Cardiol. 2023 May 9;30(7):592. doi: 10.1093/eurjpc/zwad051.,7,,['ORCID: 0000-0002-4548-8500'],,['Conflict of interest: None declared.'],,,,,,,['Eur J Prev Cardiol. 2023 May 9;30(7):593-600. PMID: 36757396'],,,,,,,,,,
9314647,NLM,MEDLINE,19980116,20190515,0149-5992 (Print) 0149-5992 (Linking),20,1997 Oct,Topics in cardiovascular disease and diabetes.,1624-7,,"['Bloomgarden, Z T']",['Bloomgarden ZT'],,['eng'],['Congress'],,United States,Diabetes Care,Diabetes care,7805975,IM,"['Cardiovascular Diseases/*epidemiology/etiology/mortality', 'Coronary Disease/epidemiology/prevention & control', 'Diabetes Mellitus/*physiopathology', 'Diabetic Angiopathies/*epidemiology/mortality/physiopathology', 'Humans']",1997/10/07 00:00,1997/10/07 00:01,['1997/10/07 00:00'],"['1997/10/07 00:00 [pubmed]', '1997/10/07 00:01 [medline]', '1997/10/07 00:00 [entrez]']",['10.2337/diacare.20.10.1624 [doi]'],ppublish,Diabetes Care. 1997 Oct;20(10):1624-7. doi: 10.2337/diacare.20.10.1624.,10,,,,,,,,,,,,,,,,,,,,,
30354501,NLM,MEDLINE,20190812,20190812,1942-0080 (Electronic) 1941-9651 (Linking),11,2018 Aug,In This Issue of the Journal.,e008262,10.1161/CIRCIMAGING.118.008262 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor in Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,,"['*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Cardiovascular System/*diagnostic imaging/physiopathology', 'Humans', 'Predictive Value of Tests', 'Prognosis']",2018/10/26 06:00,2019/08/14 06:00,['2018/10/26 06:00'],"['2018/10/26 06:00 [entrez]', '2018/10/26 06:00 [pubmed]', '2019/08/14 06:00 [medline]']",['10.1161/CIRCIMAGING.118.008262 [doi]'],ppublish,Circ Cardiovasc Imaging. 2018 Aug;11(8):e008262. doi: 10.1161/CIRCIMAGING.118.008262.,8,,,,,,,,,,,,,,,,,,,,,
30012831,NLM,MEDLINE,20190812,20190812,1942-0080 (Electronic) 1941-9651 (Linking),11,2018 Jul,In This Issue of the Journal.,e008136,10.1161/CIRCIMAGING.118.008136 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,,"['*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Cardiovascular System/*diagnostic imaging/physiopathology', 'Humans', 'Predictive Value of Tests', 'Prognosis']",2018/07/18 06:00,2019/08/14 06:00,['2018/07/18 06:00'],"['2018/07/18 06:00 [entrez]', '2018/07/18 06:00 [pubmed]', '2019/08/14 06:00 [medline]']","['CIRCIMAGING.118.008136 [pii]', '10.1161/CIRCIMAGING.118.008136 [doi]']",ppublish,Circ Cardiovasc Imaging. 2018 Jul;11(7):e008136. doi: 10.1161/CIRCIMAGING.118.008136.,7,,,,,,,,,,,,,,,,,,,,,
12109863,NLM,MEDLINE,20030116,20190829,0160-9289 (Print) 1932-8737 (Electronic) 0160-9289 (Linking),25,2002 Jul,Clinical endpoints.,311-2,,"['Conti, C Richard']",['Conti CR'],,['eng'],['Editorial'],,United States,Clin Cardiol,Clinical cardiology,7903272,IM,"['*Cardiovascular Diseases/complications/mortality/therapy', 'Clinical Trials as Topic/*methods', 'Humans', '*Research Design']",2002/07/12 10:00,2003/01/17 04:00,['2002/07/12 10:00'],"['2002/07/12 10:00 [pubmed]', '2003/01/17 04:00 [medline]', '2002/07/12 10:00 [entrez]']","['CLC4950250702 [pii]', '10.1002/clc.4950250702 [doi]']",ppublish,Clin Cardiol. 2002 Jul;25(7):311-2. doi: 10.1002/clc.4950250702.,7,,,PMC6654670,,,,,,,,,,,,,,,,,,
1344594,NLM,MEDLINE,19940509,20131121,0301-2514 (Print) 0301-2514 (Linking),133,1992,[Magnesium in cardiology].,31-3,,"['Ficker, L', 'Weinbergova, O', 'Smoldas, J']","['Ficker L', 'Weinbergova O', 'Smoldas J']","['III. Medizinische Universitatsklinik mit Poliklinik, Medizinische Fakultat, Palacky Universitat, Olomouc, Tschechoslowakei.']",['ger'],['Journal Article'],,Czech Republic,Acta Univ Palacki Olomuc Fac Med,Acta Universitatis Palackianae Olomucensis Facultatis Medicae,0363112,IM,"['Cardiology/*methods', 'Cardiovascular Diseases/diagnosis/metabolism/*physiopathology', 'Humans', 'Magnesium/*metabolism']",1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",,ppublish,Acta Univ Palacki Olomuc Fac Med. 1992;133:31-3.,,,,,,,,,['I38ZP9992A (Magnesium)'],,,,,,,Magnesium in der Kardiologie.,,,,,,
32713458,NLM,MEDLINE,20211019,20211019,1557-9840 (Electronic) 0095-5108 (Linking),47,2020 Sep,Advances in Cardiovascular Care in Neonates: Challenging Current Concepts.,xix-xx,S0095-5108(20)30069-5 [pii] 10.1016/j.clp.2020.06.001 [doi],"['El-Khuffash, Afif', 'Dempsey, Eugene']","['El-Khuffash A', 'Dempsey E']","['The Rotunda Hospital, The Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: akhuffash@rotunda.ie.', 'Department of Paediatrics and Child Health, INFANT Centre, University College Cork, Ireland. Electronic address: g.dempsey@ucc.ie.']",['eng'],"['Editorial', 'Introductory Journal Article']",20200701,United States,Clin Perinatol,Clinics in perinatology,7501306,IM,"['Cardiovascular Diseases/diagnosis/physiopathology/*therapy', 'Hemodynamic Monitoring', 'Humans', 'Infant, Newborn', 'Infant, Newborn, Diseases', 'Infant, Premature', 'Infant, Premature, Diseases', '*Neonatology']",2020/07/28 06:00,2021/10/21 06:00,['2020/07/28 06:00'],"['2020/07/28 06:00 [entrez]', '2020/07/28 06:00 [pubmed]', '2021/10/21 06:00 [medline]']","['S0095-5108(20)30069-5 [pii]', '10.1016/j.clp.2020.06.001 [doi]']",ppublish,Clin Perinatol. 2020 Sep;47(3):xix-xx. doi: 10.1016/j.clp.2020.06.001. Epub 2020 Jul 1.,3,,,,,,,,,,,,,,,,,,,,,
542040,NLM,MEDLINE,19800627,20091109,0350-199X (Linking),33,1979 May-Jun,[Socio-medical factors in the development of heart and blood vessel disease].,239-42,,"['Masic, I', 'Cabak, V']","['Masic I', 'Cabak V']",,['hrv'],"['English Abstract', 'Journal Article']",,Bosnia and Herzegovina,Med Arh,Medicinski arhiv,0400722,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/*etiology/mortality/prevention & control', 'Humans', 'Middle Aged', 'Mortality', 'Yugoslavia']",1979/05/01 00:00,1979/05/01 00:01,['1979/05/01 00:00'],"['1979/05/01 00:00 [pubmed]', '1979/05/01 00:01 [medline]', '1979/05/01 00:00 [entrez]']",,ppublish,Med Arh. 1979 May-Jun;33(3):239-42.,3,,,,,,,,,,,,,,,Socijalno-medicinski faktori u nastanku oboljenja srca i krvnih sudova.,,,,,,
14197830,NLM,MEDLINE,19961201,20190623,0009-7322 (Print) 0009-7322 (Linking),30,1964 Jul,GENETIC ASPECTS OF CARDIOVASCULAR DISEASES IN ANIMALS.,114-27,,"['DETWEILER, D K']",['DETWEILER DK'],,['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,OM,"['Animals', '*Arrhythmias, Cardiac', '*Arteriosclerosis', '*Blood Pressure', '*Cardiomegaly', '*Cardiovascular Diseases', '*Congenital Abnormalities', '*Dog Diseases', 'Dogs', '*Genetics', '*Heart Defects, Congenital', '*Heart Failure', '*Hypertension', '*Veterinary Medicine']",1964/07/01 00:00,1964/07/01 00:01,['1964/07/01 00:00'],"['1964/07/01 00:00 [pubmed]', '1964/07/01 00:01 [medline]', '1964/07/01 00:00 [entrez]']",['10.1161/01.cir.30.1.114 [doi]'],ppublish,Circulation. 1964 Jul;30:114-27. doi: 10.1161/01.cir.30.1.114.,,,,,,['NLM'],"['*ABNORMALITIES', '*ARRHYTHMIA', '*ARTERIOSCLEROSIS', '*BLOOD PRESSURE', '*CARDIOVASCULAR DISEASES', '*DOG DISEASES', '*GENETICS', '*HEART DEFECTS, CONGENITAL', '*HEART ENLARGEMENT', '*HEART FAILURE, CONGESTIVE', '*HYPERTENSION', '*REVIEW', '*VETERINARY MEDICINE']",,,,0,,,,,,,,,,,
12469973,NLM,MEDLINE,20030106,20070214,1368-5031 (Print) 1368-5031 (Linking),56,2002 Nov,Public perceptions of cardiovascular risk.,632-3,,"['Cooper, Alethea']",['Cooper A'],,['eng'],"['Comment', 'Editorial']",,India,Int J Clin Pract,International journal of clinical practice,9712381,IM,"['*Attitude to Health', 'Cardiovascular Diseases/etiology/*psychology/therapy', 'Female', '*Health Behavior', 'Humans', 'Male', 'Perception', 'Risk Factors', 'Smoking/psychology']",2002/12/10 04:00,2003/01/08 04:00,['2002/12/10 04:00'],"['2002/12/10 04:00 [pubmed]', '2003/01/08 04:00 [medline]', '2002/12/10 04:00 [entrez]']",,ppublish,Int J Clin Pract. 2002 Nov;56(9):632-3.,9,,,,,,,,,,,['Int J Clin Pract. 2002 Nov;56(9):638-44. PMID: 12469975'],,,,,,,,,,
146107,NLM,MEDLINE,19780310,20170310,0022-9040 (Print) 0022-9040 (Linking),17,1977 Nov,[Problems of cardiovascular diseases in the RSFSR].,15-9,,"['Chikin, S Ia']",['Chikin SIa'],,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Cardiac Care Facilities', 'Cardiovascular Diseases/diagnosis/*mortality/prevention & control', 'Humans', 'Physical Education and Training', 'Rural Population', 'Russia', 'Stress, Psychological/physiology', 'Urban Population']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Kardiologiia. 1977 Nov;17(11):15-9.,11,,,,,,,,,,,,,,,Problemy serdechno-sosudistykh zabolevannii v RSFSR.,,,,,,
34038521,NLM,MEDLINE,20220405,20220405,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Mar 11,Evaluation of health-related quality of life in cardiovascular research: a call for action.,e79-e81,10.1093/eurjpc/zwab008 [doi],"['Oldridge, Neil', 'Hofer, Stefan', 'McGee, Hannah', 'Saner, Hugo']","['Oldridge N', 'Hofer S', 'McGee H', 'Saner H']","['College of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, USA.', 'Department of Medical Psychology, Innsbruck Medical University, Innsbruck, Austria.', 'Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.', 'Institute for Social and Preventive Medicine, University of Bern, Mittelstrasse 43, CH-3012 Bern, Switzerland.']",['eng'],"['Letter', ""Research Support, Non-U.S. Gov't""]",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', '*Cardiovascular System', 'Humans', 'Quality of Life']",2021/05/27 06:00,2022/04/06 06:00,['2021/05/26 17:42'],"['2020/12/31 00:00 [received]', '2021/05/27 06:00 [pubmed]', '2022/04/06 06:00 [medline]', '2021/05/26 17:42 [entrez]']","['6127617 [pii]', '10.1093/eurjpc/zwab008 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Mar 11;29(2):e79-e81. doi: 10.1093/eurjpc/zwab008.,2,,,,,,,,,,,,,,,,,,,,,
15457588,NLM,MEDLINE,20041006,20071115,0095-8301 (Print) 0095-8301 (Linking),57,2004 Sep,"Diabetes care. Defining standards, Part 2.","38, 40",,"['Roberts, Shauna S']",['Roberts SS'],,['eng'],['Journal Article'],,United States,Diabetes Forecast,Diabetes forecast,7504241,,"['Cardiovascular Diseases/complications/physiopathology/prevention & control', 'Diabetes Complications', 'Diabetes Mellitus/*therapy', 'Humans', '*Practice Guidelines as Topic', 'United States']",2004/10/02 05:00,2004/10/07 09:00,['2004/10/02 05:00'],"['2004/10/02 05:00 [pubmed]', '2004/10/07 09:00 [medline]', '2004/10/02 05:00 [entrez]']",,ppublish,"Diabetes Forecast. 2004 Sep;57(9):38, 40.",9,,,,,,,,,,,,,,,,,,,,,
7883530,NLM,MEDLINE,19950412,20071115,0020-9554 (Print) 0020-9554 (Linking),36,1995 Jan,[Noninvasive diagnosis of major circulatory function].,42-52,,"['Drude, L', 'Maisch, B']","['Drude L', 'Maisch B']","['Abteilung Kardiologie, Zentrum fur Innere Medizin, Philipps-Universitat Marburg.']",['ger'],"['Journal Article', 'Review']",,Germany,Internist (Berl),Der Internist,0264620,IM,"['Cardiovascular Diseases/*diagnosis/etiology/physiopathology', 'Cardiovascular System/physiopathology', 'Echocardiography/methods', 'Exercise Test/methods', 'Heart Failure/diagnosis/etiology/physiopathology', 'Hemodynamics/*physiology', 'Humans', 'Reference Values']",1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']",,ppublish,Internist (Berl). 1995 Jan;36(1):42-52.,1,,,,,,,,,,53,,,,,Nichtinvasive Funktionsprufungen des grossen Kreislaufs.,,,,,,
33393996,NLM,MEDLINE,20210706,20210706,1530-8561 (Electronic) 0009-9147 (Linking),67,2021 Jan 8,Cardiovascular Disease in Women: Understanding the Journey.,24-29,10.1093/clinchem/hvaa297 [doi],"['Wenger, Nanette K']",['Wenger NK'],"[""Emory University School of Medicine, Atlanta, GA; Emory Heart and Vascular Center, Atlanta, GA; and Emory Women's Heart Center, Atlanta, GA.""]",['eng'],"['Historical Article', 'Journal Article']",,England,Clin Chem,Clinical chemistry,9421549,IM,"['Cardiovascular Diseases/diagnosis/drug therapy/*epidemiology/*history', 'Cost of Illness', 'Female', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Male', 'Patient Advocacy', 'Randomized Controlled Trials as Topic', 'Risk Factors', 'Sex Factors']",2021/01/05 06:00,2021/07/07 06:00,['2021/01/04 12:13'],"['2020/07/21 00:00 [received]', '2020/07/24 00:00 [accepted]', '2021/01/05 06:00 [pubmed]', '2021/07/07 06:00 [medline]', '2021/01/04 12:13 [entrez]']","['6062022 [pii]', '10.1093/clinchem/hvaa297 [doi]']",ppublish,Clin Chem. 2021 Jan 8;67(1):24-29. doi: 10.1093/clinchem/hvaa297.,1,,,,,,,,,,,,,,,,,,,,,
15895792,NLM,MEDLINE,20050715,20091021,0030-6002 (Print) 0030-6002 (Linking),146,2005 Apr 10,[Epidemiology and prevention of cardiovascular diseases].,683-8,,"['Janosi, Andras']",['Janosi A'],"['Fovarosi Onkormanyzat Szent Janos Korhaz-Rendelointezet, III Belgyogyaszat-Kardiologia. andras.janosi@mail.janoskorhaz.hu']",['hun'],"['English Abstract', 'Journal Article', 'Review']",,Hungary,Orv Hetil,Orvosi hetilap,0376412,IM,"['Arteriosclerosis/epidemiology/prevention & control', 'Cardiovascular Agents/*therapeutic use', 'Cardiovascular Diseases/drug therapy/*epidemiology/etiology/*prevention & control', 'Coronary Disease/epidemiology/prevention & control', 'Humans', 'Hungary/epidemiology', 'Primary Prevention/methods', 'Risk Factors', 'Smoking/*adverse effects']",2005/05/18 09:00,2005/07/16 09:00,['2005/05/18 09:00'],"['2005/05/18 09:00 [pubmed]', '2005/07/16 09:00 [medline]', '2005/05/18 09:00 [entrez]']",,ppublish,Orv Hetil. 2005 Apr 10;146(15):683-8.,15,"Epidemiology and prevention of coronary artery disease. The author summarizes the most important risk factors of atherosclerosis and epidemiological data of coronary heart disease. According to epidemiological data during the next 10-20 years cardiovascular diseases will be the leading cause of death all around the world. Smoking is the most important risk factor causing half of all avoidable death, half of these deaths caused by cardiovascular diseases. Three strategies of prevention are discussed: population strategies, high risk strategy and secondary prevention. All of these preventive strategies should be implemented to reach the goal. During the last years many drug studies were finished proving the effectiveness of aspirin, statins, ACE inhibitors and beta blockers as an effective tool of prevention.",,,,,,,['0 (Cardiovascular Agents)'],,36,,,,,A cardiovascularis betegsegek epidemiologiaja es megelozese.,,,,,,
9396659,NLM,MEDLINE,19971223,20161017,0098-7484 (Print) 0098-7484 (Linking),278,1997 Dec 10,Immunologic aspects of vasculitis and cardiovascular disease.,1962-71,,"['Ledford, D K']",['Ledford DK'],,['eng'],"['Journal Article', 'Review']",,United States,JAMA,JAMA,7501160,IM,"['Cardiovascular Diseases/*immunology/physiopathology', 'Humans', 'Myocarditis/*immunology/physiopathology', 'Vasculitis/*immunology/physiopathology']",1997/12/13 00:00,1997/12/13 00:01,['1997/12/13 00:00'],"['1997/12/13 00:00 [pubmed]', '1997/12/13 00:01 [medline]', '1997/12/13 00:00 [entrez]']",,ppublish,JAMA. 1997 Dec 10;278(22):1962-71.,22,"The immunologic cardiovascular diseases are a heterogeneous group of conditions. Many of these entities are associated with serious morbidity and mortality resulting from cardiac impairment, ischemic complications, or organ dysfunction, particularly of the kidneys, lung, and nervous system. The systemic nature of these conditions, coupled with vague symptoms and nonspecific initial physical findings, makes the differential diagnosis complicated. Research has identified specific mediators and primary origins in some conditions, with infections often being responsible. Immunosuppressive therapy, despite the potential complications, has improved the prognosis of some of the more serious immunologic cardiovascular diseases. Improvement in the treatment of immunologic cardiovascular diseases awaits identification of additional causes, improved definition of host factors that predispose an individual to develop these conditions, and better understanding of the immune dysregulation responsible for the progression of disease. The potential pathophysiologic role of immunologic mechanisms in common disorders such as congestive heart failure and atherosclerosis is intriguing and offers the possibility of novel therapies in these prevalent conditions.",,,,,,,,,58,,,,,,,,,,,
8513543,NLM,MEDLINE,19930721,20190905,0891-1150 (Print) 0891-1150 (Linking),60,1993 May-Jun,The role of multiple risk factors in cardiovascular morbidity and mortality.,211-8,,"['Gifford, R W Jr']",['Gifford RW Jr'],"['Department of Hypertension and Nephrology, Cleveland Clinic Foundation, OH 44195.']",['eng'],"['Journal Article', 'Review']",,United States,Cleve Clin J Med,Cleveland Clinic journal of medicine,8703441,IM,"['Cardiovascular Diseases/epidemiology/*etiology/mortality/prevention & control', 'Humans', 'Morbidity', 'Risk Factors']",1993/05/01 00:00,2001/03/28 10:01,['1993/05/01 00:00'],"['1993/05/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1993/05/01 00:00 [entrez]']",['10.3949/ccjm.60.3.211 [doi]'],ppublish,Cleve Clin J Med. 1993 May-Jun;60(3):211-8. doi: 10.3949/ccjm.60.3.211.,3,"BACKGROUND: Cardiovascular disease remains the leading cause of death in the United States. OBJECTIVE: To identify important modifiable cardiovascular risk factors and appropriate interventions. DISCUSSION: The three most important modifiable risk factors are hypertension, cigarette smoking, and dyslipidemia. Systolic hypertension poses a greater risk than diastolic, but the prognostic significance of diastolic blood pressure may have been underestimated. When a smoker quits, the cardiovascular risk soon approaches that of the nonsmoker. Cardiovascular risk increases progressively with elevations of the serum total cholesterol level above 200 mg/dL. Recently identified risk factors include hyperinsulinemia and left ventricular hypertrophy. CONCLUSION: Each patient deserves an evaluation of cardiovascular risk followed by education about and therapy for those risk factors that can be changed. When more than one risk factor is present, as is often the case, the increase in risk may be synergistic rather than additive.",,,,,,,,,44,,,,,,,,,,,
8172027,NLM,MEDLINE,19940601,20190622,0065-2598 (Print) 0065-2598 (Linking),348,1993,Dietary fiber in the prevention of cardiovascular disease.,99-104,,"['Riccardi, G', 'Ciardullo, A V']","['Riccardi G', 'Ciardullo AV']","['Institute of Internal Medicine and Metabolic Diseases, 2nd Medical School, University of Naples, Italy.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Adv Exp Med Biol,Advances in experimental medicine and biology,0121103,IM,"['Cardiovascular Diseases/epidemiology/physiopathology/*prevention & control', 'Clinical Trials as Topic', '*Dietary Fiber', 'Humans']",1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",['10.1007/978-1-4615-2942-2_10 [doi]'],ppublish,Adv Exp Med Biol. 1993;348:99-104. doi: 10.1007/978-1-4615-2942-2_10.,,,,,,,,,,,30,,,,,,,,,,,
9048116,NLM,MEDLINE,19970501,20071115,0065-2822 (Print) 0065-2822 (Linking),42,1997,Comparison of risk profiles for cardiovascular events: implications for prevention.,39-66,,"['Kannel, W B', 'Wilson, P W']","['Kannel WB', 'Wilson PW']","['Boston University School of Medicine, Framingham Heart Study, Massachusetts, USA.']",['eng'],"['Comparative Study', 'Journal Article', 'Review']",,United States,Adv Intern Med,Advances in internal medicine,0370427,IM,"['Age Factors', 'Cardiovascular Diseases/*etiology/mortality/*prevention & control', 'Cerebrovascular Disorders/etiology/prevention & control', 'Coronary Disease/etiology/prevention & control', 'Heart Failure/etiology/prevention & control', 'Humans', 'Risk', 'Risk Factors', 'Sex Factors']",1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Adv Intern Med. 1997;42:39-66.,,,,,,,,,,,66,,,,,,,,,,,
20136598,NLM,MEDLINE,20100504,20100208,1744-8344 (Electronic) 1477-9072 (Linking),8,2010 Feb,Cardiovascular disease in women.,141-2,10.1586/erc.09.189 [doi],"['Redberg, Rita F']",['Redberg RF'],,['eng'],['Editorial'],,England,Expert Rev Cardiovasc Ther,Expert review of cardiovascular therapy,101182328,IM,"['*Cardiovascular Diseases/epidemiology/etiology/prevention & control/therapy', 'Contraceptives, Oral/adverse effects', 'Female', 'Heart Defects, Congenital/complications/therapy', 'Heart Diseases/mortality', 'Humans', 'Pregnancy', 'Pregnancy Complications, Cardiovascular/therapy', 'Risk Factors', 'Stroke/mortality', 'Venous Thromboembolism/chemically induced', ""*Women's Health/legislation & jurisprudence""]",2010/02/09 06:00,2010/05/05 06:00,['2010/02/09 06:00'],"['2010/02/09 06:00 [entrez]', '2010/02/09 06:00 [pubmed]', '2010/05/05 06:00 [medline]']",['10.1586/erc.09.189 [doi]'],ppublish,Expert Rev Cardiovasc Ther. 2010 Feb;8(2):141-2. doi: 10.1586/erc.09.189.,2,,,,,,,,"['0 (Contraceptives, Oral)']",,,,,,,,,,,,,
11388338,NLM,MEDLINE,20011018,20220311,1129-4728 (Print) 1129-4728 (Linking),2,2001 May,[Physical activity and risk for cardiovascular events in diabetic women].,563-5,,"['Sclavo, M']",['Sclavo M'],"[""Unita Operativa di Cardiologia, USL Regione Valle d'Aosta, Ospedale Mauriziano, IRCC, Torino.""]",['ita'],['Journal Article'],,Italy,Ital Heart J Suppl,Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology,101223651,IM,"['Cardiovascular Diseases/*epidemiology/etiology/prevention & control', '*Diabetes Complications', '*Exercise', 'Female', 'Humans', 'Risk Factors']",2001/06/05 10:00,2001/10/19 10:01,['2001/06/05 10:00'],"['2001/06/05 10:00 [pubmed]', '2001/10/19 10:01 [medline]', '2001/06/05 10:00 [entrez]']",,ppublish,Ital Heart J Suppl. 2001 May;2(5):563-5.,5,,,,,,,,,,,,,,,Attivita fisica e rischio di eventi cardiovascolari nelle donne con diabete.,,,,,,
30794922,NLM,MEDLINE,20200213,20200213,1096-1186 (Electronic) 1043-6618 (Linking),142,2019 Apr,"Using herbal medicine to target the ""microbiota-metabolism-immunity"" axis as possible therapy for cardiovascular disease.",205-222,S1043-6618(18)31422-1 [pii] 10.1016/j.phrs.2019.02.018 [doi],"['Anlu, Wang', 'Dongcheng, Cai', 'He, Zhang', 'Qiuyi, Li', 'Yan, Zhang', 'Yu, Qiu', 'Hao, Xu', 'Keji, Chen']","['Anlu W', 'Dongcheng C', 'He Z', 'Qiuyi L', 'Yan Z', 'Yu Q', 'Hao X', 'Keji C']","['Graduate School, Beijing University of Chinese Medicine, Beijing, 10029, China.', 'State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Nanjing 210009, China.', 'Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.', 'Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.', 'Graduate School, Beijing University of Chinese Medicine, Beijing, 10029, China.', 'Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.', 'Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China. Electronic address: xuhaotcm@hotmail.com.', 'Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China. Electronic address: kjchenvip@163.com.']",['eng'],"['Journal Article', 'Review']",20190219,Netherlands,Pharmacol Res,Pharmacological research,8907422,IM,"['Animals', 'Cardiovascular Diseases/*drug therapy/immunology/metabolism/microbiology', 'Humans', '*Microbiota', '*Phytotherapy']",2019/02/23 06:00,2020/02/14 06:00,['2019/02/23 06:00'],"['2018/09/21 00:00 [received]', '2019/02/18 00:00 [revised]', '2019/02/18 00:00 [accepted]', '2019/02/23 06:00 [pubmed]', '2020/02/14 06:00 [medline]', '2019/02/23 06:00 [entrez]']","['S1043-6618(18)31422-1 [pii]', '10.1016/j.phrs.2019.02.018 [doi]']",ppublish,Pharmacol Res. 2019 Apr;142:205-222. doi: 10.1016/j.phrs.2019.02.018. Epub 2019 Feb 19.,,"The gut microbiota harvests nutrients from the host while making possible the digestion of complex nutrients and regulating and balancing the immune and metabolic functions. The microbiota itself, and the dysbiosis of the gut flora, are correlated to the onset and progress of diabetes, obesity, and atherosclerosis. Herbal medicine (HM) plays a role in modulating gut microbiota and is widely used in the prevention and treatment of cardiovascular disease (CVD) and its associated conditions, such as diabetes, obesity, and hyperlipidemia. In this review, we focus on the relationship between the microbiota-metabolism-immunity (MMI) axis and CVD (including its risk factors) and the beneficial effects of HM to regulate this crosstalk. The insights may redefine our understanding of how HM works and spark a revolution in HM-based drug discovery.",,,,['NOTNLM'],"['Berberine (PubChem CID:2353)', 'Cardiovascular diseases', 'Curcumin (PubChem CID:969516)', 'Epigallocatechin-3-gallate (PubChem CID:65064)', 'Gut microbiota', 'Herbal medicine', 'Inflammation', 'Metabolism', 'Ophiopogonin D (PubChem CID:46173859)', 'Piceatannol (PubChem CID:667639)', 'Pterostilbene (PubChem CID:5281727)', 'Quercetin (PubChem CID:5280343)', 'Resveratrol (PubChem CID:445154)']",,,['Copyright (c) 2019 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,
21069633,NLM,MEDLINE,20110308,20220112,1098-9064 (Electronic) 0094-6176 (Linking),36,2010 Nov,Microparticles: key protagonists in cardiovascular disorders.,907-16,10.1055/s-0030-1267044 [doi],"['Amabile, Nicolas', 'Rautou, Pierre-Emmanuel', 'Tedgui, Alain', 'Boulanger, Chantal M']","['Amabile N', 'Rautou PE', 'Tedgui A', 'Boulanger CM']","['INSERM, U970, Paris Cardiovascular Research Center - PARCC, Paris, France.']",['eng'],"['Journal Article', 'Review']",20101110,United States,Semin Thromb Hemost,Seminars in thrombosis and hemostasis,0431155,IM,"['Atherosclerosis/etiology/pathology', 'Cardiovascular Diseases/*blood/diagnosis/*pathology', 'Cell-Derived Microparticles/*physiology', 'Humans']",2010/11/12 06:00,2011/03/09 06:00,['2010/11/12 06:00'],"['2010/11/12 06:00 [entrez]', '2010/11/12 06:00 [pubmed]', '2011/03/09 06:00 [medline]']",['10.1055/s-0030-1267044 [doi]'],ppublish,Semin Thromb Hemost. 2010 Nov;36(8):907-16. doi: 10.1055/s-0030-1267044. Epub 2010 Nov 10.,8,"Microparticles (MP) are shed membrane vesicles released by various cell types following apoptosis or activation. MP circulate in human plasma and also accumulate in atherosclerotic lesions. A growing body of evidence has highlighted their involvement in inflammation, angiogenesis, coagulation, and the regulation of vascular tone. MP may therefore contribute to the initiation and development of atherosclerosis and its complications. Plasma MP originate from platelets, leukocytes, erythrocytes, and endothelial cells, and their levels increase in patients with cardiovascular diseases; specific cardiovascular medications also affect plasma MP levels. Most recent data suggest a potential prognostic role of circulating MP for identification of subjects prone to develop cardiovascular complications.",,,,,,,,['(c) Thieme Medical Publishers.'],,,,,,,,,,,,
1395196,NLM,MEDLINE,19921119,20190509,0160-9289 (Print) 0160-9289 (Linking),15,1992 Sep,Aging in the Americas: its impact on cardiovascular health.,627-9,,"['Wenger, N K']",['Wenger NK'],,['eng'],['Editorial'],,United States,Clin Cardiol,Clinical cardiology,7903272,IM,"['Aged', '*Aging', 'Cardiovascular Diseases/economics/*epidemiology/therapy', 'Female', 'Health Care Rationing', 'Humans', 'Male', 'United States/epidemiology']",1992/09/01 00:00,1992/09/01 00:01,['1992/09/01 00:00'],"['1992/09/01 00:00 [pubmed]', '1992/09/01 00:01 [medline]', '1992/09/01 00:00 [entrez]']",['10.1002/clc.4960150903 [doi]'],ppublish,Clin Cardiol. 1992 Sep;15(9):627-9. doi: 10.1002/clc.4960150903.,9,,,,,,,,,,,,,,,,,,,,,
4250978,NLM,MEDLINE,19710413,20161122,0003-1488 (Print) 0003-1488 (Linking),158,1971 Feb 1,A critical evaluation of the radiographic findings in canine cardiovascular diseases.,358-71,,"['Suter, P F', 'Lord, P F']","['Suter PF', 'Lord PF']",,['eng'],['Journal Article'],,United States,J Am Vet Med Assoc,Journal of the American Veterinary Medical Association,7503067,IM,"['Angiocardiography', 'Animals', 'Cardiac Catheterization', 'Cardiomegaly/diagnosis/veterinary', 'Cardiovascular Diseases/diagnostic imaging/pathology/*veterinary', 'Coronary Vessels', 'Diagnosis, Differential', 'Dog Diseases/*diagnostic imaging/pathology', 'Dogs', 'Heart Failure/diagnosis/veterinary', 'Hemodynamics', 'Pulmonary Circulation', 'Radiography, Thoracic', 'Thorax/blood supply']",1971/02/01 00:00,1971/02/01 00:01,['1971/02/01 00:00'],"['1971/02/01 00:00 [pubmed]', '1971/02/01 00:01 [medline]', '1971/02/01 00:00 [entrez]']",,ppublish,J Am Vet Med Assoc. 1971 Feb 1;158(3):358-71.,3,,,,,,,,,,,,,,,,,,,,,
18223542,NLM,MEDLINE,20080207,20080128,1743-4300 (Electronic) 1743-4297 (Linking),5,2008 Feb,The aging hypertensive heart: a brief update.,104-10,10.1038/ncpcardio1091 [doi],"['Susic, Dinko', 'Frohlich, Edward D']","['Susic D', 'Frohlich ED']","['Division of Research, Ochsner Clinic Foundation, New Orleans, LA 70121, USA. dsusic@ochsner.org']",['eng'],"['Journal Article', 'Review']",,England,Nat Clin Pract Cardiovasc Med,Nature clinical practice. Cardiovascular medicine,101226507,IM,"['Age Factors', '*Aging/metabolism/pathology', 'Antihypertensive Agents/therapeutic use', 'Cardiovascular Diseases/*etiology/metabolism/pathology/physiopathology/therapy', 'Collagen/metabolism', 'Coronary Circulation', 'Diet, Sodium-Restricted', 'Endothelium, Vascular/physiopathology', 'Fibrosis', 'Heart Failure/etiology', 'Humans', 'Hypertension/*complications/metabolism/pathology/physiopathology/therapy', 'Hypertrophy, Left Ventricular/etiology', 'Risk Factors', 'Ventricular Dysfunction, Left/etiology']",2008/01/29 09:00,2008/02/08 09:00,['2008/01/29 09:00'],"['2007/05/23 00:00 [received]', '2007/10/04 00:00 [accepted]', '2008/01/29 09:00 [pubmed]', '2008/02/08 09:00 [medline]', '2008/01/29 09:00 [entrez]']","['ncpcardio1091 [pii]', '10.1038/ncpcardio1091 [doi]']",ppublish,Nat Clin Pract Cardiovasc Med. 2008 Feb;5(2):104-10. doi: 10.1038/ncpcardio1091.,2,"Hypertension and aging are major independent risk factors for cardiovascular-related morbidity and mortality. Although independent, these two entities are closely related and operate simultaneously to adversely affect the cardiovascular system. In many aspects the morphologic and functional changes that occur in the cardiovascular system with aging and hypertension are similar; both include left ventricular hypertrophy, fibrosis and dysfunction. In this report we briefly summarize the primary pathophysiology of cardiovascular aging and hypertension and describe the clinical and therapeutic impact that hypertension and aging combined have on the cardiovascular system.",,,,,,,"['0 (Antihypertensive Agents)', '9007-34-5 (Collagen)']",,59,,,,,,,,,,,
6918143,NLM,MEDLINE,19820624,20041117,0038-0814 (Print) 0038-0814 (Linking),27,1982 Feb,[Complementary tests in arterial hypertension].,17-20,,"['Bernard, D', 'Grillot, A']","['Bernard D', 'Grillot A']",,['fre'],['Journal Article'],,France,Soins,Soins; la revue de reference infirmiere,20910580R,,"['Cardiovascular Diseases/diagnosis/etiology', 'Humans', 'Hypertension/complications/*diagnosis']",1982/02/01 00:00,1982/02/01 00:01,['1982/02/01 00:00'],"['1982/02/01 00:00 [pubmed]', '1982/02/01 00:01 [medline]', '1982/02/01 00:00 [entrez]']",,ppublish,Soins. 1982 Feb;27(4):17-20.,4,,,,,,,,,,,,,,,Les examens complementaires dans l'hypertension arterielle.,,,,,,
8284427,NLM,MEDLINE,19940217,20181130,0033-8419 (Print) 0033-8419 (Linking),190,1994 Feb,Cardiovascular/interventional radiology.,603-7,,"['Miller, D L', 'Cardella, J F', 'Cronan, J J', 'Darcy, M D', 'Freedman, A M', 'Matsumoto, A H', 'Parker, B C', 'Sandler, C M', 'Schwab, F J', 'Stokes, K R']","['Miller DL', 'Cardella JF', 'Cronan JJ', 'Darcy MD', 'Freedman AM', 'Matsumoto AH', 'Parker BC', 'Sandler CM', 'Schwab FJ', 'Stokes KR', 'et al.']","['Walter Reed Army Medical Center, Washington, DC.']",['eng'],['Congress'],,United States,Radiology,Radiology,0401260,IM,"['Cardiovascular Diseases/diagnosis/*diagnostic imaging/therapy', 'Humans', 'Magnetic Resonance Imaging', '*Radiography, Interventional', 'Tomography, X-Ray Computed']",1994/02/01 00:00,1994/02/01 00:01,['1994/02/01 00:00'],"['1994/02/01 00:00 [pubmed]', '1994/02/01 00:01 [medline]', '1994/02/01 00:00 [entrez]']",['10.1148/radiology.190.2.8284427 [doi]'],ppublish,Radiology. 1994 Feb;190(2):603-7. doi: 10.1148/radiology.190.2.8284427.,2,,,,,,,,,,,,,,,,,,,,,
23437608,NLM,MEDLINE,20130402,20130625,2325-6699 (Print) 2325-6699 (Linking),4,2013 Feb,Close-up on heart health.,7,,"['Pronsati, Michelle Perron']",['Pronsati MP'],,['eng'],['Introductory Journal Article'],,United States,Adv NPs PAs,Advance for NPs & PAs,101549550,,"['*Cardiovascular Diseases/economics/mortality/therapy', 'Humans', '*Nurse Practitioners', '*Physician Assistants', 'United States/epidemiology']",2013/02/27 06:00,2013/04/03 06:00,['2013/02/27 06:00'],"['2013/02/27 06:00 [entrez]', '2013/02/27 06:00 [pubmed]', '2013/04/03 06:00 [medline]']",,ppublish,Adv NPs PAs. 2013 Feb;4(2):7.,2,,,,,,,,,,,,,,,,,,,,,
35138870,NLM,MEDLINE,20220221,20220221,1524-4563 (Electronic) 0194-911X (Linking),79,2022 Mar,"Interrelations Between High Blood Pressure, Organ Damage, and Cardiovascular Disease: No More Room for Doubt.",516-517,10.1161/HYPERTENSIONAHA.121.18786 [doi],"['Suvila, Karri', 'Niiranen, Teemu J']","['Suvila K', 'Niiranen TJ']","['Department of Medicine, Turku University Hospital and University of Turku, Finland (K.S., T.J.N.).', 'Department of Medicine, Turku University Hospital and University of Turku, Finland (K.S., T.J.N.).', 'Department of Public Health Solutions, Finnish Institute for Health and Welfare, Turku, Finland (T.J.N.).']",['eng'],"['Comment', 'Editorial']",20220209,United States,Hypertension,"Hypertension (Dallas, Tex. : 1979)",7906255,IM,"['Blood Pressure Monitoring, Ambulatory', '*Cardiovascular Diseases/epidemiology/etiology/physiopathology', 'Humans', '*Hypertension/epidemiology/etiology/physiopathology']",2022/02/10 06:00,2022/02/22 06:00,['2022/02/09 17:11'],"['2022/02/09 17:11 [entrez]', '2022/02/10 06:00 [pubmed]', '2022/02/22 06:00 [medline]']",['10.1161/HYPERTENSIONAHA.121.18786 [doi]'],ppublish,Hypertension. 2022 Mar;79(3):516-517. doi: 10.1161/HYPERTENSIONAHA.121.18786. Epub 2022 Feb 9.,3,,"['ORCID: 0000-0002-3543-9350', 'ORCID: 0000-0002-7394-7487']",,,,,,,,,['Hypertension. 2022 Mar;79(3):505-515. PMID: 35138872'],,,,,,,,,,
23575701,NLM,MEDLINE,20130610,20130411,1897-4279 (Electronic) 0022-9032 (Linking),71,2013,[Editorial word].,114,10.5603/KP.2013.0001 [doi],"['Filipiak, Krzysztof J']",['Filipiak KJ'],,['pol'],"['Editorial', 'Introductory Journal Article']",,Poland,Kardiol Pol,Kardiologia polska,0376352,IM,"['Cardiovascular Diseases/complications/diagnosis/*therapy', 'Defibrillators, Implantable', 'Humans', 'Kidney Diseases/complications/therapy']",2013/04/12 06:00,2013/06/12 06:00,['2013/04/12 06:00'],"['2013/02/20 00:00 [received]', '2013/02/20 00:00 [accepted]', '2013/04/12 06:00 [entrez]', '2013/04/12 06:00 [pubmed]', '2013/06/12 06:00 [medline]']","['VM/OJS/KP/7682 [pii]', '10.5603/KP.2013.0001 [doi]']",ppublish,Kardiol Pol. 2013;71(2):114. doi: 10.5603/KP.2013.0001.,2,,,,,,,,,,,,,,,Slowo redakcyjne.,,,,,,
17372165,NLM,MEDLINE,20070529,20181201,1524-4539 (Electronic) 0009-7322 (Linking),115,2007 Mar 27,ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.,1656-95,,"['Mensah, George A', 'Grant, Augustus O', 'Pepine, Carl J', 'Baddour, Larry M', 'Cooper, Leslie T Jr', 'Dunbar, Sandra B', 'Froelicher, Erika S', 'Greenlund, Kurt J', 'Kaplan, Edward L', 'Kloner, Robert A', 'Labarthe, Darwin R', 'Luepker, Russell V', 'Madjid, Mohammad', 'Muller, James E', ""O'Connor, Siobhan"", 'Ornato, Joseph P', 'Robertson, Rose Marie', 'Roy, Michael J', 'Shah, Prediman K', 'Taubert, Kathryn A', 'Wilson, Walter R', 'Zheng, Zhi-Jie', 'Harrington, Robert A', 'Abrams, Jonathan', 'Anderson, Jeffrey L', 'Bates, Eric R', 'Eisenberg, Mark J', 'Grines, Cindy L', 'Hlatky, Mark A', 'Lichtenberg, Robert C', 'Lindner, Jonathan R', 'Pohost, Gerald M', 'Schofield, Richard S', 'Shubrooks, Samuel J Jr', 'Stein, James H', 'Tracy, Cynthia M', 'Vogel, Robert A', 'Wesley, Deborah J']","['Mensah GA', 'Grant AO', 'Pepine CJ', 'Baddour LM', 'Cooper LT Jr', 'Dunbar SB', 'Froelicher ES', 'Greenlund KJ', 'Kaplan EL', 'Kloner RA', 'Labarthe DR', 'Luepker RV', 'Madjid M', 'Muller JE', ""O'Connor S"", 'Ornato JP', 'Robertson RM', 'Roy MJ', 'Shah PK', 'Taubert KA', 'Wilson WR', 'Zheng ZJ', 'Harrington RA', 'Abrams J', 'Anderson JL', 'Bates ER', 'Eisenberg MJ', 'Grines CL', 'Hlatky MA', 'Lichtenberg RC', 'Lindner JR', 'Pohost GM', 'Schofield RS', 'Shubrooks SJ Jr', 'Stein JH', 'Tracy CM', 'Vogel RA', 'Wesley DJ']","['National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341-3717, USA.']",['eng'],"['Congress', 'Overall']",20070319,United States,Circulation,Circulation,0147763,IM,"['*Bioterrorism', 'Cardiovascular Diseases/diagnosis/*etiology/*prevention & control/therapy', '*Communicable Diseases, Emerging/complications', 'Humans', '*Public Health']",2007/03/21 09:00,2007/05/30 09:00,['2007/03/21 09:00'],"['2007/03/21 09:00 [pubmed]', '2007/05/30 09:00 [medline]', '2007/03/21 09:00 [entrez]']","['CIRCULATIONAHA.107.181939 [pii]', '10.1161/CIRCULATIONAHA.107.181939 [doi]']",ppublish,Circulation. 2007 Mar 27;115(12):1656-95. doi: 10.1161/CIRCULATIONAHA.107.181939. Epub 2007 Mar 19.,12,,,,,,,,,,,,,,,,,,,,,
30895487,NLM,MEDLINE,20200219,20200219,1573-7241 (Electronic) 0920-3206 (Linking),33,2019 Apr,Special Issue: British Society for Cardiovascular Research : Introduction.,201,10.1007/s10557-019-06877-x [doi],"['Grieve, David J']",['Grieve DJ'],"[""Centre for Experimental Medicine, Queen's University Belfast, Belfast, BT9 7AE, UK. d.grieve@qub.ac.uk.""]",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Cardiovasc Drugs Ther,Cardiovascular drugs and therapy,8712220,IM,"['Animals', 'Awards and Prizes', '*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', '*Congresses as Topic', 'Humans', '*Societies, Medical', 'United Kingdom']",2019/03/22 06:00,2020/02/20 06:00,['2019/03/22 06:00'],"['2019/03/22 06:00 [pubmed]', '2020/02/20 06:00 [medline]', '2019/03/22 06:00 [entrez]']","['10.1007/s10557-019-06877-x [pii]', '10.1007/s10557-019-06877-x [doi]']",ppublish,Cardiovasc Drugs Ther. 2019 Apr;33(2):201. doi: 10.1007/s10557-019-06877-x.,2,,,,,,,,,,,,,,,,,,,,,
7700108,NLM,MEDLINE,19950501,20061115,0023-7205 (Print) 0023-7205 (Linking),92,1995 Mar 15,[The MONICA project speaks. WHO's survey on cardiovascular diseases in 26 countries shows big differences].,1073-6,,"['Asplund, K']",['Asplund K'],"['Medicinska kliniken, Norrlands universitetsjukhus, Umea.']",['swe'],"['Comparative Study', 'Journal Article']",,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/*epidemiology/etiology/mortality', 'Europe/epidemiology', 'Humans', 'Middle Aged', 'Risk Factors', 'World Health Organization']",1995/03/15 00:00,1995/03/15 00:01,['1995/03/15 00:00'],"['1995/03/15 00:00 [pubmed]', '1995/03/15 00:01 [medline]', '1995/03/15 00:00 [entrez]']",,ppublish,Lakartidningen. 1995 Mar 15;92(11):1073-6.,11,,,,,,,,,,,,,,,Sa talar Monica. WHOs kartlaggning av hjart-karlsjukdom i 26 lander visar stora skillnader.,,,,,,
4775786,NLM,MEDLINE,19740402,20170310,0022-9040 (Print) 0022-9040 (Linking),13,1973 Feb,[Control of cardiovascular diseases].,5-10,,"['Chazov, E I']",['Chazov EI'],,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Adult', 'Age Factors', 'Cardiac Surgical Procedures', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Electronics, Medical', 'Extracorporeal Circulation', 'Heart, Artificial', 'Humans', 'Methods', 'Social Problems', 'USSR']",1973/02/01 00:00,1973/02/01 00:01,['1973/02/01 00:00'],"['1973/02/01 00:00 [pubmed]', '1973/02/01 00:01 [medline]', '1973/02/01 00:00 [entrez]']",,ppublish,Kardiologiia. 1973 Feb;13(2):5-10.,2,,,,,,,,,,,,,,,Problemy bor'by s serdechno-sosudistymi zabolevaniiami.,,,,,,
21118185,NLM,MEDLINE,20110426,20170310,0022-9040 (Print) 0022-9040 (Linking),50,2010,[Updates of European recommendations on arterial hypertension].,80-5,,"['Mamedov, M N', 'Kontsevaia, A V']","['Mamedov MN', 'Kontsevaia AV']",,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Aged', 'Antihypertensive Agents/*pharmacology', 'Blood Pressure Determination/standards', 'Cardiovascular Diseases/diagnosis/*etiology/physiopathology/*prevention & control', 'Child', 'Congresses as Topic', 'Critical Pathways/standards', 'Drug Therapy, Combination/standards', 'Humans', '*Hypertension/complications/diagnosis/drug therapy/physiopathology', 'Practice Guidelines as Topic', 'Risk Assessment']",2010/12/02 06:00,2011/04/27 06:00,['2010/12/02 06:00'],"['2010/12/02 06:00 [entrez]', '2010/12/02 06:00 [pubmed]', '2011/04/27 06:00 [medline]']",,ppublish,Kardiologiia. 2010;50(10):80-5.,10,,,,,,,,['0 (Antihypertensive Agents)'],,,,,,,,,,,,,
23481368,NLM,MEDLINE,20131202,20161125,1468-201X (Electronic) 1355-6037 (Linking),99,2013 Nov,Reflections on 40 years of the British Society for Cardiovascular Research (BSCR).,1551-3,10.1136/heartjnl-2013-303790 [doi],"['Davidson, Sean M', 'Hearse, David']","['Davidson SM', 'Hearse D']","['The Hatter Cardiovascular Institute, University College London, , London, UK.']",['eng'],"['Editorial', 'Historical Article', ""Research Support, Non-U.S. Gov't""]",20130312,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Animals', 'Anniversaries and Special Events', 'Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/diagnosis/*history/physiopathology/therapy', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Societies, Scientific/*history', 'United Kingdom']",2013/03/14 06:00,2013/12/16 06:00,['2013/03/14 06:00'],"['2013/03/14 06:00 [entrez]', '2013/03/14 06:00 [pubmed]', '2013/12/16 06:00 [medline]']","['heartjnl-2013-303790 [pii]', '10.1136/heartjnl-2013-303790 [doi]']",ppublish,Heart. 2013 Nov;99(21):1551-3. doi: 10.1136/heartjnl-2013-303790. Epub 2013 Mar 12.,21,,,,,['NOTNLM'],['ALLIED SPECIALITIES'],"['MR/K002066/1/Medical Research Council/United Kingdom', 'PG/10/005/British Heart Foundation/United Kingdom']",,,,,,,,,,,,,,
16418446,NLM,MEDLINE,20060320,20071115,1524-4539 (Electronic) 0009-7322 (Linking),113,2006 Jan 17,Evidence-based medicine: making the grade: miles to go before we sleep.,178-9,,"['Smith, Sidney C Jr']",['Smith SC Jr'],,['eng'],"['Comment', 'Editorial']",,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/drug therapy/mortality/*prevention & control', 'Coronary Artery Disease/drug therapy', '*Evidence-Based Medicine', 'Humans', 'Hypertension/drug therapy', 'Patient Compliance']",2006/01/19 09:00,2006/03/21 09:00,['2006/01/19 09:00'],"['2006/01/19 09:00 [pubmed]', '2006/03/21 09:00 [medline]', '2006/01/19 09:00 [entrez]']","['113/2/178 [pii]', '10.1161/CIRCULATIONAHA.105.592238 [doi]']",ppublish,Circulation. 2006 Jan 17;113(2):178-9. doi: 10.1161/CIRCULATIONAHA.105.592238.,2,,,,,,,,,,,['Circulation. 2006 Jan 17;113(2):203-12. PMID: 16401776'],,,,,,,,,,
35915551,NLM,MEDLINE,20221020,20221110,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Oct 18,Genetic testing for cardiomyopathies-when science and health policies join in personalizing cardiovascular prevention.,1785-1788,10.1093/eurjpc/zwac160 [doi],"['Jurcut, Ruxandra', 'Fetecau, Bogdana']","['Jurcut R', 'Fetecau B']","[""Expert Center for Rare Cardiac Genetic Diseases, Emergency Institute for Cardiovascular Diseases 'Prof.dr.C.C.Iliescu', Bucharest, Romania."", ""Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila', BucharestRomania."", ""Expert Center for Rare Cardiac Genetic Diseases, Emergency Institute for Cardiovascular Diseases 'Prof.dr.C.C.Iliescu', Bucharest, Romania."", ""Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila', BucharestRomania.""]",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', 'Genetic Testing', '*Cardiomyopathies/diagnosis/genetics/prevention & control', '*Cardiovascular Diseases/diagnosis/epidemiology/genetics', 'Health Policy', 'Molecular Biology']",2022/08/03 06:00,2022/10/21 06:00,['2022/08/02 00:12'],"['2022/08/03 06:00 [pubmed]', '2022/10/21 06:00 [medline]', '2022/08/02 00:12 [entrez]']","['6653125 [pii]', '10.1093/eurjpc/zwac160 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Oct 18;29(13):1785-1788. doi: 10.1093/eurjpc/zwac160.,13,,"['ORCID: 0000-0002-3438-2612', 'ORCID: 0000-0002-2250-9196']",,['Conflict of interest: None declared.'],,,,,,,['Eur J Prev Cardiol. 2022 Oct 18;29(13):1789-1799. PMID: 35653365'],,,,,,,,,,
19376984,NLM,MEDLINE,20090722,20090420,1939-2869 (Electronic) 0891-1150 (Linking),76 Suppl 2,2009 Apr,Heart-brain medicine: Update 2008.,S5-7,10.3949/ccjm.76.s2.01 [doi],"['Penn, Marc S', 'Bakken, Earl E']","['Penn MS', 'Bakken EE']","['Bakken Heart-Brain Institute, Cleveland Clinic, 9500 Euclid Avenue, J2-4, Cleveland, OH 44195, USA. pennm@ccf.org']",['eng'],['Introductory Journal Article'],,United States,Cleve Clin J Med,Cleveland Clinic journal of medicine,8703441,IM,"['*Brain Diseases/complications/physiopathology/psychology', '*Cardiovascular Diseases/complications/physiopathology/psychology', 'Humans']",2009/04/25 09:00,2009/07/23 09:00,['2009/04/21 09:00'],"['2009/04/21 09:00 [entrez]', '2009/04/25 09:00 [pubmed]', '2009/07/23 09:00 [medline]']","['76/Suppl_2/S5 [pii]', '10.3949/ccjm.76.s2.01 [doi]']",ppublish,Cleve Clin J Med. 2009 Apr;76 Suppl 2:S5-7. doi: 10.3949/ccjm.76.s2.01.,,,,,,,,,,,,,,,,,,,,,,
37742061,NLM,MEDLINE,20231201,20231201,2047-4881 (Electronic) 2047-4873 (Linking),30,2023 Nov 30,Association of cumulative remnant cholesterol with incident adverse cardiovascular events in the elderly: another piece in the puzzle.,1922-1923,10.1093/eurjpc/zwad315 [doi],"['Klingenberg, Roland']",['Klingenberg R'],"['Kerckhoff Heart and Thorax Center, Department of Cardiology, Campus of the Justus Liebig University of Giessen, Kerckhoff-Klinik, Benekestrasse 2-8, D-61231 Bad Nauheim, Germany.', 'German Center for Cardiovascular Research (DZHK), partner site Rhein Main, Bad Nauheim, Germany.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', 'Aged', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Cholesterol', '*Atherosclerosis', '*Cardiovascular System']",2023/09/24 06:41,2023/12/01 06:44,['2023/09/24 00:43'],"['2023/12/01 06:44 [medline]', '2023/09/24 06:41 [pubmed]', '2023/09/24 00:43 [entrez]']","['7281643 [pii]', '10.1093/eurjpc/zwad315 [doi]']",ppublish,Eur J Prev Cardiol. 2023 Nov 30;30(17):1922-1923. doi: 10.1093/eurjpc/zwad315.,17,,['ORCID: 0000-0002-7726-4421'],,"['Conflict of interest: R.K. reports speaker and consulting fees from Amarin,', 'Amgen, Bristol Myers Squibb, Daiichi-Sankyo, Novartis and Pfizer, all Germany.']",,,,['97C5T2UQ7J (Cholesterol)'],,,['Eur J Prev Cardiol. 2023 Nov 30;30(17):1924-1934. PMID: 37708385'],,,,,,,,,,
30898018,NLM,MEDLINE,20200819,20200819,2047-4881 (Electronic) 2047-4873 (Linking),26,2019 Apr,Editor's presentation.,563-565,10.1177/2047487319839923 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['1 Heart Failure Unit, G. da Saliceto Hospital, AUSL Piacenza, Italy.', ""2 Institute of Life Sciences, Scuola Superiore Sant'Anna, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/blood/diagnosis/mortality/therapy', 'Evidence-Based Medicine', 'Humans', 'Mass Screening', 'Patient Reported Outcome Measures', 'Randomized Controlled Trials as Topic', 'Risk Factors']",2019/03/23 06:00,2020/08/20 06:00,['2019/03/23 06:00'],"['2019/03/23 06:00 [entrez]', '2019/03/23 06:00 [pubmed]', '2020/08/20 06:00 [medline]']",['10.1177/2047487319839923 [doi]'],ppublish,Eur J Prev Cardiol. 2019 Apr;26(6):563-565. doi: 10.1177/2047487319839923.,6,,,,,,,,,,,,,,,,,,,,,
29088376,NLM,MEDLINE,20190128,20190128,1755-3245 (Electronic) 0008-6363 (Linking),113,2017 Nov 1,"Dr Jyoti Patel talks with Dr Oliver Sohnlein, 2017 outstanding investigator award of the European Society of Cardiology council for basic cardiovascular sciences.",e47,10.1093/cvr/cvx173 [doi],"['Sohnlein, Oliver']",['Sohnlein O'],"['Institute for Cardiovascular Prevention, Pettenkoferstr. 9, 81679 Munich, Germany.']",['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait', 'Video-Audio Media']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Biomedical Research/*history', 'Cardiology/*history', 'Cardiovascular Diseases/*history/immunology/metabolism/therapy', 'History, 21st Century', 'Humans', 'Inflammation Mediators/history/immunology/metabolism', 'Myeloid Cells/immunology/metabolism']",2017/11/01 06:00,2019/01/29 06:00,['2017/11/01 06:00'],"['2017/11/01 06:00 [entrez]', '2017/11/01 06:00 [pubmed]', '2019/01/29 06:00 [medline]']","['4561033 [pii]', '10.1093/cvr/cvx173 [doi]']",ppublish,Cardiovasc Res. 2017 Nov 1;113(13):e47. doi: 10.1093/cvr/cvx173.,13,,,,,,,,['0 (Inflammation Mediators)'],,,,,,,,['Sohnlein O'],"['Sohnlein, Oliver']",,,,
30529641,NLM,MEDLINE,20190409,20190409,1879-3649 (Electronic) 1537-1891 (Linking),112,2019 Jan,Pioneering updates in vascular biology.,1,S1537-1891(18)30434-8 [pii] 10.1016/j.vph.2018.12.001 [doi],"['Alexander, M Yvonne', 'Bussolati, Benedetta', 'Banfi, Andrea']","['Alexander MY', 'Bussolati B', 'Banfi A']","['Centre for Bioscience, Cardiovascular Research Group, Manchester Metropolitan University, United Kingdom. Electronic address: Y.Alexander@mmu.ac.uk.', 'Dept. of Molecular Biotechnology and Health Sciences, via Nizza 52 10126, Torino. Italy.. Electronic address: benedetta.bussolati@unito.it.', 'Department of Biomedicine, University Hospital, University of Basel, DBM 407, Hebelstrasse 20, 4031 Basel, Switzerland.. Electronic address: Andrea.Banfi@usb.ch.']",['eng'],"['Editorial', 'Introductory Journal Article']",20181207,United States,Vascul Pharmacol,Vascular pharmacology,101130615,IM,"['Animals', 'Biomedical Research/*trends', '*Blood Vessels/diagnostic imaging/metabolism/pathology/physiopathology', '*Cardiovascular Diseases/diagnostic imaging/metabolism/pathology/physiopathology', 'Congresses as Topic', 'Humans']",2018/12/12 06:00,2019/04/10 06:00,['2018/12/12 06:00'],"['2018/12/12 06:00 [pubmed]', '2019/04/10 06:00 [medline]', '2018/12/12 06:00 [entrez]']","['S1537-1891(18)30434-8 [pii]', '10.1016/j.vph.2018.12.001 [doi]']",ppublish,Vascul Pharmacol. 2019 Jan;112:1. doi: 10.1016/j.vph.2018.12.001. Epub 2018 Dec 7.,,,,,,,,,,,,,,,,,,,,,,
21070350,NLM,MEDLINE,20110303,20101112,1472-8206 (Electronic) 0767-3981 (Linking),24,2010 Dec,Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology.,662-3,10.1111/j.1472-8206.2010.00895_2.x [doi],"['Rosano, Giuseppe M C', 'Collins, Peter']","['Rosano GM', 'Collins P']",,['eng'],"['Editorial', 'Introductory Journal Article']",,England,Fundam Clin Pharmacol,Fundamental & clinical pharmacology,8710411,IM,"['Cardiovascular Diseases/etiology/physiopathology/*therapy', 'Disease Susceptibility', 'Female', 'Humans', 'Male', 'Risk Factors', 'Sex Factors']",2010/11/13 06:00,2011/03/04 06:00,['2010/11/13 06:00'],"['2010/11/13 06:00 [entrez]', '2010/11/13 06:00 [pubmed]', '2011/03/04 06:00 [medline]']",['10.1111/j.1472-8206.2010.00895_2.x [doi]'],ppublish,Fundam Clin Pharmacol. 2010 Dec;24(6):662-3. doi: 10.1111/j.1472-8206.2010.00895_2.x.,6,,,,,,,,,,,,,,,,,,,,,
26420112,NLM,MEDLINE,20151123,20150930,0253-3758 (Print) 0253-3758 (Linking),43,2015 Jun,[Biomarkers and individualized precise treatment of cardiovascular diseases].,469-70,,"['Xu, Wenrui', 'Du, Junbao']","['Xu W', 'Du J']",['Email: junbaodu1@126.com.'],['chi'],['Journal Article'],,China,Zhonghua Xin Xue Guan Bing Za Zhi,Zhonghua xin xue guan bing za zhi,7910682,IM,"['*Biomarkers', 'Cardiovascular Diseases/diagnosis/*therapy', 'Humans']",2015/10/01 06:00,2015/12/15 06:00,['2015/10/01 06:00'],"['2015/10/01 06:00 [entrez]', '2015/10/01 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Jun;43(6):469-70.,6,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
36464482,NLM,MEDLINE,20221206,20221216,1873-1740 (Electronic) 0033-0620 (Linking),74,2022 Sep-Oct,Artificial intelligence in cardiovascular disease: Challenges and benefits in developing nations.,129-130,S0033-0620(22)00119-0 [pii] 10.1016/j.pcad.2022.11.007 [doi],"['Mittan, Sandeep', 'Lee, Sooyun', 'Mehra, Mandeep R']","['Mittan S', 'Lee S', 'Mehra MR']","['Department of Obstetrics, Gynecology and Medical Oncology, Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine, New York, USA.', 'Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.', ""Center for Advanced Heart Disease, Brigham and Women's Hospital and Harvard Medical School, Boston, USA. Electronic address: mmehra@bwh.harvard.edu.""]",['eng'],['Letter'],,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Humans', '*Artificial Intelligence', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Developing Countries']",2022/12/05 06:00,2022/12/07 06:00,['2022/12/04 21:07'],"['2022/12/04 21:07 [entrez]', '2022/12/05 06:00 [pubmed]', '2022/12/07 06:00 [medline]']","['S0033-0620(22)00119-0 [pii]', '10.1016/j.pcad.2022.11.007 [doi]']",ppublish,Prog Cardiovasc Dis. 2022 Sep-Oct;74:129-130. doi: 10.1016/j.pcad.2022.11.007.,,,,,"['Declaration of Competing Interest The authors have no disclosures relevant to', 'this topic.']",,,,,,,,,,,,,,,,,
19469087,NLM,MEDLINE,20090610,20190724,0021-5384 (Print) 0021-5384 (Linking),98,2009 Apr 10,[Internal medicine specialists and care for patients with cardiovascular disorders].,918-20,,"['Kihara, Yasuki']",['Kihara Y'],,['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Cardiac Rehabilitation', '*Cardiovascular Diseases/etiology/prevention & control/therapy', 'Humans', '*Internal Medicine', 'Japan', '*Medicine', ""Physician's Role"", '*Specialization']",2009/05/28 09:00,2009/06/11 09:00,['2009/05/28 09:00'],"['2009/05/28 09:00 [entrez]', '2009/05/28 09:00 [pubmed]', '2009/06/11 09:00 [medline]']",['10.2169/naika.98.918 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2009 Apr 10;98(4):918-20. doi: 10.2169/naika.98.918.,4,,,,,,,,,,11,,,,,,,,,,,
10562272,NLM,MEDLINE,19991119,20190623,1524-4539 (Electronic) 0009-7322 (Linking),100,1999 Nov 16,Global epidemic of cardiovascular disease expected by the year 2050.,e101,,"['SoRelle, R']",['SoRelle R'],,['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/*epidemiology/prevention & control/therapy', '*Disease Outbreaks/prevention & control', 'Global Health', 'Humans', 'Preventive Medicine/economics']",1999/11/16 00:00,1999/11/16 00:01,['1999/11/16 00:00'],"['1999/11/16 00:00 [pubmed]', '1999/11/16 00:01 [medline]', '1999/11/16 00:00 [entrez]']",['10.1161/01.cir.100.20.e101 [doi]'],ppublish,Circulation. 1999 Nov 16;100(20):e101. doi: 10.1161/01.cir.100.20.e101.,20,,,,,,,,,,,,,,,,,,,,,
35791966,NLM,MEDLINE,20220726,20220805,1879-1484 (Electronic) 0021-9150 (Linking),354,2022 Aug,Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.,55-56,S0021-9150(22)01302-8 [pii] 10.1016/j.atherosclerosis.2022.06.1015 [doi],"['Cicero, Arrigo F G', 'Salvetti, Massimo']","['Cicero AFG', 'Salvetti M']","['IRCCS AOU S. Orsola-Malpighi, Italy; Hypertension and Cardiovascular Risk Factors Research Unit, Alma Mater Studiorum University of Bologna, Bologna, Italy. Electronic address: arrigo.cicero@unibo.it.', 'Department of Clinical and Experimental Sciences, University of Brescia & Emergency Medicine ASST Spedali Civili di Brescia, Brescia, Italy.']",['eng'],"['Comment', 'Editorial']",20220620,Ireland,Atherosclerosis,Atherosclerosis,0242543,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', '*Myocardial Infarction', '*Peripheral Arterial Disease/diagnosis/epidemiology/therapy', '*Stroke']",2022/07/07 06:00,2022/07/27 06:00,['2022/07/06 06:23'],"['2022/05/29 00:00 [received]', '2022/06/14 00:00 [accepted]', '2022/07/07 06:00 [pubmed]', '2022/07/27 06:00 [medline]', '2022/07/06 06:23 [entrez]']","['S0021-9150(22)01302-8 [pii]', '10.1016/j.atherosclerosis.2022.06.1015 [doi]']",ppublish,Atherosclerosis. 2022 Aug;354:55-56. doi: 10.1016/j.atherosclerosis.2022.06.1015. Epub 2022 Jun 20.,,,,,,['NOTNLM'],"['Comorbidity', 'Epidemiology', 'Myocardial infarction', 'Peripheral artery disease', 'Stroke']",,,,,['Atherosclerosis. 2022 Aug;354:57-62. PMID: 35584971'],,,,,,,,,,
5530954,NLM,MEDLINE,19710211,20071115,0002-9645 (Print) 0002-9645 (Linking),31,1970 Nov,Acquired cardiac lesions leading to congestive heart failure in the cat.,2071-88,,"['Liu, S K']",['Liu SK'],,['eng'],['Journal Article'],,United States,Am J Vet Res,American journal of veterinary research,0375011,IM,"['Animals', 'Arteries', 'Cardiovascular Diseases/complications/pathology/*veterinary', 'Cat Diseases/complications/diagnosis/*etiology/pathology', 'Cats', 'Dilatation/complications/veterinary', 'Endocarditis/veterinary', 'Endomyocardial Fibrosis/veterinary', 'Female', 'Heart Failure/diagnosis/etiology/pathology/*veterinary', 'Heart Valve Diseases/veterinary', 'Infarction/veterinary', 'Kidney Diseases/veterinary', 'Liver Diseases/veterinary', 'Lung Diseases/veterinary', 'Male', 'Myocarditis/veterinary', 'Thromboembolism/veterinary']",1970/11/01 00:00,1970/11/01 00:01,['1970/11/01 00:00'],"['1970/11/01 00:00 [pubmed]', '1970/11/01 00:01 [medline]', '1970/11/01 00:00 [entrez]']",,ppublish,Am J Vet Res. 1970 Nov;31(11):2071-88.,11,,,,,,,,,,,,,,,,,,,,,
30354222,NLM,MEDLINE,20190805,20191001,1524-4636 (Electronic) 1079-5642 (Print) 1079-5642 (Linking),38,2018 Oct,Reporting Sex and Sex Differences in Preclinical Studies.,e171-e184,10.1161/ATVBAHA.118.311717 [doi],"['Lu, Hong S', 'Schmidt, Ann Marie', 'Hegele, Robert A', 'Mackman, Nigel', 'Rader, Daniel J', 'Weber, Christian', 'Daugherty, Alan']","['Lu HS', 'Schmidt AM', 'Hegele RA', 'Mackman N', 'Rader DJ', 'Weber C', 'Daugherty A']","['From the Department of Physiology, Saha Cardiovascular Research Center, University of Kentucky, Lexington (H.S.L., A.D.).', 'Diabetes Research Program, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, New York University Langone Medical Center, New York, NY (A.M.S.).', 'Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada (R.A.H.).', 'Department of Medicine, University of North Carolina at Chapel Hill (N.M.).', 'Department of Medicine (D.J.R.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.', 'Department of Genetics (D.J.R.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.', 'Department of Medicine, Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universitat, Munich, Germany (C.W.).', 'German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany (C.W.).', 'From the Department of Physiology, Saha Cardiovascular Research Center, University of Kentucky, Lexington (H.S.L., A.D.).']",['eng'],['Journal Article'],,United States,Arterioscler Thromb Vasc Biol,"Arteriosclerosis, thrombosis, and vascular biology",9505803,,"['Animals', '*Cardiovascular Diseases/genetics/metabolism/physiopathology/therapy', 'Disease Models, Animal', 'Female', 'Male', '*Sex Characteristics', 'Sex Factors', 'Species Specificity']",2018/10/26 06:00,2019/08/06 06:00,['2018/10/26 06:00'],"['2018/10/26 06:00 [entrez]', '2018/10/26 06:00 [pubmed]', '2019/08/06 06:00 [medline]']",['10.1161/ATVBAHA.118.311717 [doi]'],ppublish,Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):e171-e184. doi: 10.1161/ATVBAHA.118.311717.,10,,,PMC6207213,,['NOTNLM'],"['arteriosclerosis', 'humans', 'mice', 'rats', 'thrombosis']",['R01 HL139748/HL/NHLBI NIH HHS/United States'],,,,,['NIHMS1504442'],,,,,,,,,
18183049,NLM,MEDLINE,20080122,20080716,0807-7096 (Electronic) 0029-2001 (Linking),128,2008 Jan 3,[Current health statistics].,15,,"['Stoltenberg, Camilla']",['Stoltenberg C'],,['nor'],['Editorial'],,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Cardiovascular Diseases/epidemiology/mortality/therapy', 'Humans', 'Norway/epidemiology', '*Quality Assurance, Health Care', '*Registries']",2008/01/10 09:00,2008/01/23 09:00,['2008/01/10 09:00'],"['2008/01/10 09:00 [pubmed]', '2008/01/23 09:00 [medline]', '2008/01/10 09:00 [entrez]']",['1634618 [pii]'],ppublish,Tidsskr Nor Laegeforen. 2008 Jan 3;128(1):15.,1,,,,,,,,,,,,,,,Dagens helsetall.,,,,,,
9603694,NLM,MEDLINE,19980629,20180317,0883-6612 (Print) 0883-6612 (Linking),19,1997 Summer,Making cardiovascular disease prevention a reality.,193-6,,"['Greenland, P', 'Hayman, L L']","['Greenland P', 'Hayman LL']","['Department of Preventive Medicine, Northwestern University Medical School, Chicago, IL 60611, USA.']",['eng'],['Journal Article'],,England,Ann Behav Med,Annals of behavioral medicine : a publication of the Society of Behavioral Medicine,8510246,IM,"['Cardiovascular Diseases/mortality/*prevention & control/psychology', 'Causality', '*Health Behavior', 'Humans', '*Life Style', 'United States/epidemiology']",1997/07/01 00:00,1998/05/29 00:01,['1997/07/01 00:00'],"['1997/07/01 00:00 [pubmed]', '1998/05/29 00:01 [medline]', '1997/07/01 00:00 [entrez]']",['10.1007/BF02892284 [doi]'],ppublish,Ann Behav Med. 1997 Summer;19(3):193-6. doi: 10.1007/BF02892284.,3,,,,,,,,,,,,,,,,,,,,,
16707964,NLM,MEDLINE,20061114,20191026,0954-6928 (Print) 0954-6928 (Linking),17,2006 May,Bibliography. Current world literature.,391-400,,,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['Arrhythmias, Cardiac', 'Cardiology/methods', 'Cardiomyopathies', '*Cardiovascular Diseases/diagnosis/surgery', 'Coronary Artery Disease', 'Diagnostic Imaging', 'Humans']",2006/05/19 09:00,2006/11/15 09:00,['2006/05/19 09:00'],"['2006/05/19 09:00 [pubmed]', '2006/11/15 09:00 [medline]', '2006/05/19 09:00 [entrez]']","['00019501-200606000-00011 [pii]', '10.1097/00019501-200606000-00011 [doi]']",ppublish,Coron Artery Dis. 2006 May;17(4):391-400. doi: 10.1097/00019501-200606000-00011.,4,,,,,,,,,,,,,,,,,,,,,
32978323,NLM,MEDLINE,20210628,20210628,1468-201X (Electronic) 1355-6037 (Linking),106,2020 Oct,Heartbeat: empowering patients with digital home management.,1537-1539,10.1136/heartjnl-2020-318237 [doi],"['Otto, Catherine M']",['Otto CM'],"['Division of Cardiology, University of Washington, Seattle, WA 98195, USA cmotto@uw.edu.']",['eng'],['Introductory Journal Article'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Acute Coronary Syndrome/diagnosis/therapy', 'Algorithms', 'Cardiovascular Diseases/diagnosis/physiopathology/*therapy', 'Decision Support Techniques', 'Humans', 'Pericarditis/diagnosis/drug therapy', 'Predictive Value of Tests', '*Self Care', '*Telemedicine']",2020/09/27 06:00,2021/06/29 06:00,['2020/09/26 05:25'],"['2020/09/26 05:25 [entrez]', '2020/09/27 06:00 [pubmed]', '2021/06/29 06:00 [medline]']","['heartjnl-2020-318237 [pii]', '10.1136/heartjnl-2020-318237 [doi]']",ppublish,Heart. 2020 Oct;106(20):1537-1539. doi: 10.1136/heartjnl-2020-318237.,20,,['ORCID: 0000-0002-0527-9392'],,['Competing interests: None declared.'],['NOTNLM'],['aortic diseases'],,,,,,,,,,,,,,,
23817189,NLM,MEDLINE,20140303,20211021,1759-5010 (Electronic) 1759-5002 (Linking),10,2013 Aug,Public health: Cardiovascular disease insights--something new out of Africa.,433-4,10.1038/nrcardio.2013.96 [doi],"['Mensah, George A']",['Mensah GA'],,['eng'],['News'],20130702,England,Nat Rev Cardiol,Nature reviews. Cardiology,101500075,IM,"['Africa/epidemiology', 'Age Factors', 'Aging', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control/therapy', 'Comorbidity', '*Developing Countries', 'Health Services Accessibility', 'Humans', 'Population Dynamics', 'Preventive Health Services', 'Prognosis', '*Public Health', 'Risk Factors']",2013/07/03 06:00,2014/03/04 06:00,['2013/07/03 06:00'],"['2013/07/03 06:00 [entrez]', '2013/07/03 06:00 [pubmed]', '2014/03/04 06:00 [medline]']","['nrcardio.2013.96 [pii]', '10.1038/nrcardio.2013.96 [doi]']",ppublish,Nat Rev Cardiol. 2013 Aug;10(8):433-4. doi: 10.1038/nrcardio.2013.96. Epub 2013 Jul 2.,8,"Adverse trends in blood pressure, diabetes mellitus, and other cardiometabolic risk factors, together with population growth and ageing, are contributing to the burden of cardiovascular diseases in Africa. This increasing problem, coupled with inadequate access to effective interventions for prevention, diagnosis, and treatment, is creating major public-health challenges across the continent.",,,,,,,,,,,,,,,,,,,,
10609042,NLM,MEDLINE,20000127,20051116,0939-2661 (Print) 0939-2661 (Linking),34,1999 Nov,[Anesthesia in patients with cardiovascular diseases].,689-719,,"['von Spiegel, T', 'Schroder, S', 'Hoeft, A']","['von Spiegel T', 'Schroder S', 'Hoeft A']",['Klinik u. Poliklinik f. Anasthesiologie und spezielle Intensivmedizin Universitat Bonn.'],['ger'],"['Journal Article', 'Review']",,Germany,Anasthesiol Intensivmed Notfallmed Schmerzther,"Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS",9109478,IM,"['*Anesthesia', 'Cardiovascular Diseases/*complications/physiopathology', 'Heart Diseases/*complications/physiopathology', 'Humans', 'Risk Factors']",1999/12/28 00:00,1999/12/28 00:01,['1999/12/28 00:00'],"['1999/12/28 00:00 [pubmed]', '1999/12/28 00:01 [medline]', '1999/12/28 00:00 [entrez]']",,ppublish,Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 Nov;34(11):689-719.,11,,,,,,,,,,43,,,,,Anasthesie bei Patienten mit Herz-Kreislauferkrankungen.,,,,,,
18752461,NLM,MEDLINE,20090226,20080925,1931-843X (Electronic) 1540-9996 (Linking),17,2008 Oct,Toward optimal health: strategies for prevention of heart disease in women. Interview by Jodi Godfrey.,1271-6,10.1089/jwh.2008.1074 [doi],"['Manson, Joann E']",['Manson JE'],,['eng'],['Interview'],,United States,J Womens Health (Larchmt),Journal of women's health (2002),101159262,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/*prevention & control/therapy', 'Diabetes Complications', 'Exercise', 'Female', 'Health Promotion/*methods', 'Humans', 'Practice Guidelines as Topic', 'Risk Factors', 'Societies, Medical', 'United States/epidemiology', ""*Women's Health""]",2008/08/30 09:00,2009/02/27 09:00,['2008/08/30 09:00'],"['2008/08/30 09:00 [pubmed]', '2009/02/27 09:00 [medline]', '2008/08/30 09:00 [entrez]']",['10.1089/jwh.2008.1074 [doi]'],ppublish,J Womens Health (Larchmt). 2008 Oct;17(8):1271-6. doi: 10.1089/jwh.2008.1074.,8,,,,,,,,,,,,,,,,,,,,,
23518372,NLM,MEDLINE,20130516,20130322,1873-1740 (Electronic) 0033-0620 (Linking),55,2013 Mar-Apr,Introduction.,465,S0033-0620(13)00002-9 [pii] 10.1016/j.pcad.2013.01.001 [doi],"['Bangalore, Sripal', 'Katz, Stuart D']","['Bangalore S', 'Katz SD']",,['eng'],['Editorial'],,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Cardiovascular Diseases/epidemiology/physiopathology/therapy', 'Coronary Artery Disease/diagnosis/*epidemiology/therapy', 'Female', 'Forecasting', 'Heart Failure/*epidemiology/physiopathology/therapy', 'Heart Valve Diseases/diagnosis/*epidemiology/therapy', 'Humans', 'Male', 'Prevalence', 'Severity of Illness Index', 'Survival Analysis', 'United States/epidemiology']",2013/03/23 06:00,2013/05/17 06:00,['2013/03/23 06:00'],"['2013/03/23 06:00 [entrez]', '2013/03/23 06:00 [pubmed]', '2013/05/17 06:00 [medline]']","['S0033-0620(13)00002-9 [pii]', '10.1016/j.pcad.2013.01.001 [doi]']",ppublish,Prog Cardiovasc Dis. 2013 Mar-Apr;55(5):465. doi: 10.1016/j.pcad.2013.01.001.,5,,,,,,,,,,,,,,,,,,,,,
1304982,NLM,MEDLINE,19930712,20140226,0578-1426 (Print) 0578-1426 (Linking),31,1992 Aug,[Advances in cardiovascular diseases in recent 10 years].,478-82,,"['Liu, L S', 'Hen, Z J', 'Wu, N']","['Liu LS', 'Hen ZJ', 'Wu N']",,['chi'],"['Journal Article', 'Review']",,China,Zhonghua Nei Ke Za Zhi,Zhonghua nei ke za zhi,16210490R,IM,"['Animals', 'Arrhythmias, Cardiac/diagnosis/therapy', '*Cardiovascular Diseases/diagnosis/therapy', 'China/epidemiology', 'Coronary Disease/diagnosis/therapy', 'Humans', 'Hypertension/epidemiology/etiology/prevention & control', 'Internal Medicine/trends']",1992/08/01 00:00,1992/08/01 00:01,['1992/08/01 00:00'],"['1992/08/01 00:00 [pubmed]', '1992/08/01 00:01 [medline]', '1992/08/01 00:00 [entrez]']",,ppublish,Zhonghua Nei Ke Za Zhi. 1992 Aug;31(8):478-82.,8,,,,,,,,,,0,,,,,,,,,,,
28231916,NLM,MEDLINE,20190128,20190128,1876-7605 (Electronic) 1936-8798 (Linking),10,2017 Feb 27,"""Thanks for the Memories"".",423-424,S1936-8798(17)30108-5 [pii] 10.1016/j.jcin.2017.01.018 [doi],"['King, Spencer B 3rd']",['King SB 3rd'],,['eng'],['Editorial'],,United States,JACC Cardiovasc Interv,JACC. Cardiovascular interventions,101467004,IM,"['*Biomedical Research', '*Cardiac Catheterization', 'Cardiovascular Diseases/diagnosis/physiopathology/*therapy', '*Editorial Policies', 'Humans', 'Interpersonal Relations', '*Memory', '*Periodicals as Topic', '*Retirement']",2017/02/25 06:00,2019/01/29 06:00,['2017/02/25 06:00'],"['2017/02/25 06:00 [entrez]', '2017/02/25 06:00 [pubmed]', '2019/01/29 06:00 [medline]']","['S1936-8798(17)30108-5 [pii]', '10.1016/j.jcin.2017.01.018 [doi]']",ppublish,JACC Cardiovasc Interv. 2017 Feb 27;10(4):423-424. doi: 10.1016/j.jcin.2017.01.018.,4,,,,,,,,,,,,,,,,,,,,,
4644946,NLM,MEDLINE,19730302,20170310,0022-9040 (Print) 0022-9040 (Linking),12,1972 Sep,[Various morphologic and biochemical changes in rabbits with severely restricted movement].,144-6,,"['Vikhert, A M', 'Metelitsa, V I', 'Baranova, V D', 'Galakhov, I E']","['Vikhert AM', 'Metelitsa VI', 'Baranova VD', 'Galakhov IE']",,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Animals', 'Aorta/*pathology', 'Cardiovascular Diseases/*etiology/metabolism/pathology', '*Immobilization', 'Lipids/*blood', 'Rabbits', 'Time Factors']",1972/09/01 00:00,1972/09/01 00:01,['1972/09/01 00:00'],"['1972/09/01 00:00 [pubmed]', '1972/09/01 00:01 [medline]', '1972/09/01 00:00 [entrez]']",,ppublish,Kardiologiia. 1972 Sep;12(9):144-6.,9,,,,,,,,['0 (Lipids)'],,,,,,,O nekotorykh morfologicheskikh i biokhimicheskikh izmeneniiakh u krolikov pri rezkom ogranichenii ikh podvizhnosti.,,,,,['NASA: 73071319'],
26205601,NLM,MEDLINE,20151002,20150724,1558-3597 (Electronic) 0735-1097 (Linking),66,2015 Jul 28,The Evolving Future of Cardiovascular Practice: Technology + Clinicians: A Means to a Better End.,481-3,S0735-1097(15)02733-3 [pii] 10.1016/j.jacc.2015.06.008 [doi],"['Fuster, Valentin']",['Fuster V'],"['Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: valentin.fuster@mountsinai.org.']",['eng'],['Editorial'],,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Biomedical Technology/*trends', 'Cardiology/*trends', 'Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Humans']",2015/07/25 06:00,2015/10/03 06:00,['2015/07/25 06:00'],"['2015/07/25 06:00 [entrez]', '2015/07/25 06:00 [pubmed]', '2015/10/03 06:00 [medline]']","['S0735-1097(15)02733-3 [pii]', '10.1016/j.jacc.2015.06.008 [doi]']",ppublish,J Am Coll Cardiol. 2015 Jul 28;66(4):481-3. doi: 10.1016/j.jacc.2015.06.008.,4,,,,,,,,,,,,,,,,,,,,,
17435640,NLM,MEDLINE,20070719,20181113,1531-0132 (Electronic) 1531-0132 (Linking),9,2007 Feb 20,Multiple biomarkers for the prediction of first major cardiovascular events and death: considerable costs and limited benefits.,34,,"['Lippi, Giuseppe', 'Salvagno, Gian Luca', 'Targher, Giovanni', 'Guidi, Gian Cesare']","['Lippi G', 'Salvagno GL', 'Targher G', 'Guidi GC']",,['eng'],['Letter'],20070220,United States,MedGenMed,MedGenMed : Medscape general medicine,100894134,IM,"['*Biomarkers', 'Cardiovascular Diseases/diagnosis/*economics/*mortality', 'Cause of Death', 'Humans', 'Predictive Value of Tests']",2007/04/17 09:00,2007/07/20 09:00,['2007/04/17 09:00'],"['2007/04/17 09:00 [pubmed]', '2007/07/20 09:00 [medline]', '2007/04/17 09:00 [entrez]']",['551839 [pii]'],epublish,MedGenMed. 2007 Feb 20;9(1):34.,1,,,PMC1925020,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
5401577,NLM,MEDLINE,19710425,20161122,0300-8894 (Print) 0300-8894 (Linking),53,1969 Jun,"[Refresher course on epidemiology, prevention and rehabilitation in cardiovascular diseases organized by the Center for Cardiovascular Diseases of the Ospedale Riuniti, at the Ospedale S. Camillo, in Rome, 15-19 December 1969].",95-134,,"['Menotti, A']",['Menotti A'],,['ita'],['Journal Article'],,Italy,Cuore Circ,Cuore e circolazione,1270323,IM,"['Cardiac Rehabilitation', 'Cardiovascular Diseases/*epidemiology/prevention & control', 'Coronary Disease/prevention & control', 'Heart Diseases/prevention & control', 'Humans']",1969/06/01 00:00,1969/06/01 00:01,['1969/06/01 00:00'],"['1969/06/01 00:00 [pubmed]', '1969/06/01 00:01 [medline]', '1969/06/01 00:00 [entrez]']",,ppublish,Cuore Circ. 1969 Jun;53(3):95-134.,3,,,,,,,,,,,,,,,"Corso di aggiornamento di epidemiologia, prevenzione e riabilitazione delle malattie cardiovascuolari degli Ospedali Riuniti, Ospedale S. Camillo, Roma, 15-19 Dicembre 1969.",,,,,,
10622118,NLM,MEDLINE,20000124,20161026,0006-9248 (Print) 0006-9248 (Linking),100,1999 Jul,[Epidemiology and prevention of cardiovascular diseases after 1989].,395-404,,"['Cagan, S', 'Pavlovic, M', 'Besedova, I']","['Cagan S', 'Pavlovic M', 'Besedova I']","['Dpt of Internal Medicine, Slovak Postgraduate Academy of Medicine Bratislava.']",['slo'],"['English Abstract', 'Journal Article']",,Slovakia,Bratisl Lek Listy,Bratislavske lekarske listy,0065324,IM,"['Cardiovascular Diseases/*epidemiology/etiology/prevention & control', 'Europe/epidemiology', 'Health Promotion', 'Humans', 'Risk Factors', 'Slovakia/epidemiology']",2000/01/06 00:00,2000/01/06 00:01,['2000/01/06 00:00'],"['2000/01/06 00:00 [pubmed]', '2000/01/06 00:01 [medline]', '2000/01/06 00:00 [entrez]']",,ppublish,Bratisl Lek Listy. 1999 Jul;100(7):395-404.,7,"During the past 30 years the geographical distribution of cardiovascular diseases in Europe has substantially changed. The highest rates that were reported in the mid sixties in Finland occurred in 1990/91 occurred in central and eastern Europe. The reasons for such different development of cardiovascular mortality have not been explained yet. The epidemy of cardiovascular diseases in post-socialist countries may be only partially associated with high prevalence of the three classical risk factors (hypercholesterolemia, smoking, hypertension). Presumably other, yet unrecognized risk factors have potentiated the classical ones (psychosocial stress, specific nutritional deficiencies). A decrease in mortality from cardiovascular diseases can be attributed to improvements in care of patients with cardiovascular diseases, mainly with coronary heart disease including AMI, with favourable effects on survival and to a decline in risk factors prevalence or to a combination of both. Similar detailed information for Slovakia is lacking. Therefore it is difficult to predict the future incidence of cardiovascular diseases and AMI in Slovakia. The authors in the review article focused on some epidemiological and preventive aspects of cardiovascular diseases and their implementation at present. In order to achieve a reversal of the unfavourable trend of cardiovascular mortality it is insufficient only to answer the basic questions, as e.g., what was the reason for such differing trends in disease rates and mortality from cardiovascular diseases in our country (and in post-socialist countries of central and eastern Europe) and e.g. in Finland or in the U.S.A., where cardiovascular mortality decreased almost by half. For the appropriate formulation of prevention measures with a focus on cardiovascular diseases, detailed analysis of the current specific situation in our country is also necessary.",,,,,,,,,,,,,,Poznamky k epidemiologii a prevencii kardiovaskularnych chorob po roku 1989.,,,,,,
28958918,NLM,MEDLINE,20181113,20181202,2241-5955 (Electronic) 1109-9666 (Linking),58,2017 Jul-Aug,"Neurocardiology: An emerging concept in a ""stressed-out"" world.",314-315,S1109-9666(17)30466-9 [pii] 10.1016/j.hjc.2017.07.010 [doi],"['Tsioufis, Costas']",['Tsioufis C'],"['President of Hellenic Society of Cardiology, First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece. Electronic address: ktsioufis@hippocratio.gr.']",['eng'],['Address'],20170927,Netherlands,Hellenic J Cardiol,Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,101257381,IM,"['*Cardiology', '*Cardiovascular Diseases/diagnosis/etiology/therapy', '*Disease Management', 'Humans', 'Stress, Psychological/*complications']",2017/09/30 06:00,2018/11/14 06:00,['2017/09/30 06:00'],"['2017/07/16 00:00 [received]', '2017/07/20 00:00 [accepted]', '2017/09/30 06:00 [pubmed]', '2018/11/14 06:00 [medline]', '2017/09/30 06:00 [entrez]']","['S1109-9666(17)30466-9 [pii]', '10.1016/j.hjc.2017.07.010 [doi]']",ppublish,Hellenic J Cardiol. 2017 Jul-Aug;58(4):314-315. doi: 10.1016/j.hjc.2017.07.010. Epub 2017 Sep 27.,4,,,,,,,,,,,,,,,,,,,,,
7671173,NLM,MEDLINE,19951019,20080409,0828-282X (Print) 0828-282X (Linking),11,1995 Sep,Collaborative cardiovascular clinical research in Canada: coming of age.,645-7,,"['Armstrong, P W']",['Armstrong PW'],,['eng'],['Editorial'],,England,Can J Cardiol,The Canadian journal of cardiology,8510280,IM,"['Animals', 'Canada/epidemiology', 'Cardiovascular Diseases/diagnosis/*epidemiology/prevention & control', 'Cricetinae', 'Female', 'Humans', 'Male', '*Research']",1995/09/01 00:00,1995/09/01 00:01,['1995/09/01 00:00'],"['1995/09/01 00:00 [pubmed]', '1995/09/01 00:01 [medline]', '1995/09/01 00:00 [entrez]']",,ppublish,Can J Cardiol. 1995 Sep;11(8):645-7.,8,,,,,,,,,,,,,,,,,,,,,
35792634,NLM,MEDLINE,20220802,20220815,1530-0374 (Electronic) 1072-3714 (Linking),29,2022 Aug 1,A new tool in the prediction of cardiovascular disease? Perhaps.,892-893,10.1097/GME.0000000000002038 [doi],"['Black, Denise R']",['Black DR'],"['From the University of Manitoba, Winnipeg, Manitoba, Canada.']",['eng'],"['Comment', 'Editorial']",20220705,United States,Menopause,"Menopause (New York, N.Y.)",9433353,IM,"['*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Humans', 'Risk Assessment', 'Risk Factors']",2022/07/07 06:00,2022/08/03 06:00,['2022/07/06 10:20'],"['2022/07/07 06:00 [pubmed]', '2022/08/03 06:00 [medline]', '2022/07/06 10:20 [entrez]']","['00042192-990000000-00009 [pii]', '10.1097/GME.0000000000002038 [doi]']",ppublish,Menopause. 2022 Aug 1;29(8):892-893. doi: 10.1097/GME.0000000000002038. Epub 2022 Jul 5.,8,,,,"['Financial disclosure/conflicts of interest: D.R.B. receives financial support', ""from Duchesnay, Organon, and Pfizer and is on the speakers' bureau for Merck,"", 'Abbvie, Amgen, and Searchlight.']",,,,,,,['Menopause. 2022 Aug 1;29(8):905-910. PMID: 35819859'],,,,,,,,,,
16352287,NLM,MEDLINE,20060914,20051214,1443-9506 (Print) 1443-9506 (Linking),14 Suppl 2,2005,Cardiovascular magnetic resonance imaging.,S39-45,,"['Anavekar, Nagesh S']",['Anavekar NS'],"['Cardiac MRI Unit, Epworth Hospital, 89 Bridge Road, Richmond, Melbourne, Vic. 3121, Australia. nageshsa@unimelb.edu.au']",['eng'],"['Journal Article', 'Review']",20051111,Australia,Heart Lung Circ,"Heart, lung & circulation",100963739,IM,"['Cardiovascular Diseases/*diagnosis/pathology/physiopathology', 'Humans', 'Image Interpretation, Computer-Assisted', 'Image Processing, Computer-Assisted', '*Magnetic Resonance Imaging', 'Myocardial Reperfusion']",2005/12/15 09:00,2006/09/15 09:00,['2005/12/15 09:00'],"['2005/12/15 09:00 [pubmed]', '2006/09/15 09:00 [medline]', '2005/12/15 09:00 [entrez]']","['S1443-9506(05)00190-3 [pii]', '10.1016/j.hlc.2005.08.011 [doi]']",ppublish,Heart Lung Circ. 2005;14 Suppl 2:S39-45. doi: 10.1016/j.hlc.2005.08.011. Epub 2005 Nov 11.,,,,,,,,,,,14,,,,,,,,,,,
28596178,NLM,MEDLINE,20190523,20190523,1524-4571 (Electronic) 0009-7330 (Linking),120,2017 Jun 9,"Circulation Research ""In This Issue"" Anthology.",e58-e84,10.1161/RES.0000000000000152 [doi],"['Williams, Ruth']",['Williams R'],,['eng'],['Introductory Journal Article'],,United States,Circ Res,Circulation research,0047103,IM,"['Animals', 'Biomedical Research/*methods/trends', 'Blood Circulation/*physiology', 'Cardiovascular Diseases/diagnosis/physiopathology/*therapy', 'Humans']",2017/06/10 06:00,2019/05/24 06:00,['2017/06/10 06:00'],"['2017/06/10 06:00 [entrez]', '2017/06/10 06:00 [pubmed]', '2019/05/24 06:00 [medline]']","['RES.0000000000000152 [pii]', '10.1161/RES.0000000000000152 [doi]']",ppublish,Circ Res. 2017 Jun 9;120(12):e58-e84. doi: 10.1161/RES.0000000000000152.,12,,,,,,,,,,,,,,['Editors'],,,,,,,
14560360,NLM,MEDLINE,20040112,20071115,0022-9032 (Print) 0022-9032 (Linking),59,2003 Jul,"[Symposium of Cardiology, Zakopane, April 11-13, 2003].",86,,"['Olczyk, Slawomir']",['Olczyk S'],,['pol'],['Letter'],,Poland,Kardiol Pol,Kardiologia polska,0376352,IM,"['Cardiology/standards', 'Cardiovascular Diseases/*diagnosis/prevention & control/*therapy', '*Clinical Competence', 'Congresses as Topic', 'Humans', 'Poland', 'Societies, Medical']",2003/10/16 05:00,2004/01/13 05:00,['2003/10/16 05:00'],"['2003/10/16 05:00 [pubmed]', '2004/01/13 05:00 [medline]', '2003/10/16 05:00 [entrez]']",,ppublish,Kardiol Pol. 2003 Jul;59(7):86.,7,,,,,,,,,,,,,,,Listy do redakcji.,,,,,,
18110990,NLM,MEDLINE,20071227,20181201,0028-4793 (Print) 0028-4793 (Linking),240,1949 Mar 3,The treatment of hypertensive cerebrovascular disease by splanchnicectomy.,319-23,,"['PEET, M M', 'ISBERG, E M']","['PEET MM', 'ISBERG EM']",,['eng'],['Journal Article'],,United States,N Engl J Med,The New England journal of medicine,0255562,OM,"['*Blood Vessels', 'Cardiovascular Diseases/*therapy', '*Cerebrovascular Disorders', '*Disease', 'Humans', '*Hypertension', '*Vascular Diseases']",1949/03/03 00:00,2014/08/13 06:00,['1949/03/03 00:00'],"['1949/03/03 00:00 [pubmed]', '2014/08/13 06:00 [medline]', '1949/03/03 00:00 [entrez]']",['10.1056/NEJM194903032400901 [doi]'],ppublish,N Engl J Med. 1949 Mar 3;240(9):319-23. doi: 10.1056/NEJM194903032400901.,9,,,,,['NLM'],"['*BLOOD VESSELS/diseases', '*CARDIOVASCULAR DISEASES/therapy']",,,,,,,,,,,,,,['CLML: 4916:673h'],
26328516,NLM,MEDLINE,20160115,20150928,1557-8194 (Electronic) 0011-5029 (Linking),61,2015 Sep,Cardiovascular disease and chronic kidney disease.,403-13,S0011-5029(15)00103-0 [pii] 10.1016/j.disamonth.2015.07.005 [doi],"['Gargiulo, Richard', 'Suhail, Faten', 'Lerma, Edgar V']","['Gargiulo R', 'Suhail F', 'Lerma EV']",,['eng'],"['Journal Article', 'Review']",20150829,United States,Dis Mon,Disease-a-month : DM,0370657,IM,"['Cardiovascular Diseases/diagnosis/*etiology/physiopathology/therapy', 'Coronary Artery Disease/etiology', 'Heart Diseases/etiology', 'Humans', 'Peripheral Vascular Diseases/etiology', 'Renal Insufficiency, Chronic/*complications/physiopathology', 'gamma-Aminobutyric Acid/analogs & derivatives']",2015/09/04 06:00,2016/01/16 06:00,['2015/09/03 06:00'],"['2015/09/03 06:00 [entrez]', '2015/09/04 06:00 [pubmed]', '2016/01/16 06:00 [medline]']","['S0011-5029(15)00103-0 [pii]', '10.1016/j.disamonth.2015.07.005 [doi]']",ppublish,Dis Mon. 2015 Sep;61(9):403-13. doi: 10.1016/j.disamonth.2015.07.005. Epub 2015 Aug 29.,9,,,,,,,,"['38C836J57Z (progabide)', '56-12-2 (gamma-Aminobutyric Acid)']",,,,,,,,,,,,,
17195538,NLM,MEDLINE,20070207,20070101,0040-3660 (Print) 0040-3660 (Linking),78,2006,[Effects of depressive disorders on development and outcome of cardiovascular diseases].,87-92,,"['Buriachkovskaia, L I', 'Poliakova, E O', 'Sumarokova, A B']","['Buriachkovskaia LI', 'Poliakova EO', 'Sumarokova AB']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Cardiovascular Diseases/complications/*physiopathology/therapy', 'Central Nervous System/physiopathology', 'Depressive Disorder/complications/*diagnosis/*drug therapy', 'Humans']",2007/01/02 09:00,2007/02/08 09:00,['2007/01/02 09:00'],"['2007/01/02 09:00 [pubmed]', '2007/02/08 09:00 [medline]', '2007/01/02 09:00 [entrez]']",,ppublish,Ter Arkh. 2006;78(11):87-92.,11,,,,,,,,,,115,,,,,,,,,,,
9884368,NLM,MEDLINE,19990210,20190623,0009-7322 (Print) 0009-7322 (Linking),99,1999 Jan 5-12,From global to microscopic views of cardiovascular disease.,3-5,,"['SoRelle, R']",['SoRelle R'],,['eng'],['News'],,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/genetics/mortality/*therapy', 'Genetic Therapy', 'Humans', 'Risk Factors', 'United States/epidemiology']",1999/01/13 00:00,1999/01/13 00:01,['1999/01/13 00:00'],"['1999/01/13 00:00 [pubmed]', '1999/01/13 00:01 [medline]', '1999/01/13 00:00 [entrez]']",['10.1161/01.cir.99.1.3 [doi]'],ppublish,Circulation. 1999 Jan 5-12;99(1):3-5. doi: 10.1161/01.cir.99.1.3.,1,,,,,,,,,,,,,,,,,,,,,
20921953,NLM,MEDLINE,20110217,20211020,1745-7254 (Electronic) 1671-4083 (Print) 1671-4083 (Linking),31,2010 Oct,Frontiers of vascular biology and disease research.,1241-2,10.1038/aps.2010.179 [doi],"['Chen, Alex F', 'Tang, Chao-shu']","['Chen AF', 'Tang CS']",,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Acta Pharmacol Sin,Acta pharmacologica Sinica,100956087,IM,"['*Biology', '*Biomedical Research', 'Blood Circulation/*physiology', 'Blood Vessels/*physiology', 'Cardiovascular Diseases/physiopathology/prevention & control/therapy', 'Heart/physiology', 'Humans']",2010/10/06 06:00,2011/02/18 06:00,['2010/10/06 06:00'],"['2010/10/06 06:00 [entrez]', '2010/10/06 06:00 [pubmed]', '2011/02/18 06:00 [medline]']","['aps2010179 [pii]', '10.1038/aps.2010.179 [doi]']",ppublish,Acta Pharmacol Sin. 2010 Oct;31(10):1241-2. doi: 10.1038/aps.2010.179.,10,,,PMC4012917,,,,,,,,,,,,,,,,,,
15185910,NLM,MEDLINE,20040930,20041117,1129-471X (Print) 1129-471X (Linking),5 Suppl 6,2004 Jun,Prevention of cardiovascular disease: challenges and opportunities.,6S-8S,,"['Bonow, Robert O']",['Bonow RO'],,['eng'],['Editorial'],,Italy,Ital Heart J,Italian heart journal : official journal of the Italian Federation of Cardiology,100909716,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Humans', 'Italy/epidemiology', 'Public Health', 'United States/epidemiology']",2004/06/10 05:00,2004/10/01 05:00,['2004/06/10 05:00'],"['2004/06/10 05:00 [pubmed]', '2004/10/01 05:00 [medline]', '2004/06/10 05:00 [entrez]']",,ppublish,Ital Heart J. 2004 Jun;5 Suppl 6:6S-8S.,,,,,,,,,,,,,,,,,,,,,,
12837006,NLM,MEDLINE,20030916,20191107,0889-4655 (Print) 0889-4655 (Linking),18,2003 Jul-Aug,The complex challenge of helping older adults manage cardiovascular disease.,157-60,,"['Bennett, Jill A', 'Deaton, Christi']","['Bennett JA', 'Deaton C']","['School of Nursing, Oregon Health & Science University, Portland, USA.']",['eng'],['Journal Article'],,United States,J Cardiovasc Nurs,The Journal of cardiovascular nursing,8703516,IM,"['Aged', 'Aging/*physiology', 'Cardiovascular Diseases/epidemiology/*physiopathology/*therapy', 'Humans', 'Population Dynamics', 'United States/epidemiology']",2003/07/03 05:00,2003/09/17 05:00,['2003/07/03 05:00'],"['2003/07/03 05:00 [pubmed]', '2003/09/17 05:00 [medline]', '2003/07/03 05:00 [entrez]']",['10.1097/00005082-200307000-00001 [doi]'],ppublish,J Cardiovasc Nurs. 2003 Jul-Aug;18(3):157-60. doi: 10.1097/00005082-200307000-00001.,3,,,,,,,,,,,,,,,,,,,,,
4681495,NLM,MEDLINE,19760802,20081121,0363-5872 (Print) 0363-5872 (Linking),1,1972,"Stress, hormones, and cardiovascular disease.",701-6,,"['Selye, H']",['Selye H'],,['eng'],['Journal Article'],,United States,Recent Adv Stud Cardiac Struct Metab,Recent advances in studies on cardiac structure and metabolism,0325677,IM,"['Cardiovascular Diseases/complications/drug therapy/*prevention & control', 'Humans', 'Steroids/*therapeutic use', 'Stress, Physiological/*complications/drug therapy']",1972/01/01 00:00,1972/01/01 00:01,['1972/01/01 00:00'],"['1972/01/01 00:00 [pubmed]', '1972/01/01 00:01 [medline]', '1972/01/01 00:00 [entrez]']",,ppublish,Recent Adv Stud Cardiac Struct Metab. 1972;1:701-6.,,,,,,,,,['0 (Steroids)'],,,,,,,,,,,,,
30355235,NLM,MEDLINE,20191007,20191007,1524-4571 (Electronic) 0009-7330 (Linking),123,2018 Aug 31,Hiroaki Shimokawa.,641-644,10.1161/CIRCRESAHA.118.313803 [doi],"['Ince, Susan']",['Ince S'],,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait']",,United States,Circ Res,Circulation research,0047103,IM,"['Biomedical Research/education/*history', 'Cardiology/education/*history', 'Cardiovascular Diseases/*history/metabolism/physiopathology/therapy', 'Career Choice', 'Education, Medical/history', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Mentors/history', 'Ultrasonic Therapy/history']",2018/10/26 06:00,2019/10/08 06:00,['2018/10/26 06:00'],"['2018/10/26 06:00 [entrez]', '2018/10/26 06:00 [pubmed]', '2019/10/08 06:00 [medline]']",['10.1161/CIRCRESAHA.118.313803 [doi]'],ppublish,Circ Res. 2018 Aug 31;123(6):641-644. doi: 10.1161/CIRCRESAHA.118.313803.,6,,,,,,,,,,,,,,,,['Shimokawa H'],"['Shimokawa, Hiroaki']",,,,
3353790,NLM,MEDLINE,19880502,20161018,0038-5239 (Print) 0038-5239 (Linking),,1988,[Cardiovascular and cancer diseases in the population of the developing countries of Africa].,46-50,,"['Rozov, A A', 'Makhlina, V S']","['Rozov AA', 'Makhlina VS']",,['rus'],['Journal Article'],,Russia (Federation),Sov Zdravookhr,Sovetskoe zdravookhranenie,0404526,IM,"['Africa', 'Cardiovascular Diseases/*epidemiology/mortality/prevention & control', '*Developing Countries', 'Female', 'Humans', 'Male', 'Neoplasms/*epidemiology/mortality/prevention & control']",1988/01/01 00:00,1988/01/01 00:01,['1988/01/01 00:00'],"['1988/01/01 00:00 [pubmed]', '1988/01/01 00:01 [medline]', '1988/01/01 00:00 [entrez]']",,ppublish,Sov Zdravookhr. 1988;(1):46-50.,1,,,,,,,,,,,,,,,Serdechno-sosudistye i onkologicheskie zabolevaniia u naseleniia nekotorykh razvivaiushchikhsia stran Afriki.,,,,,,
10694595,NLM,MEDLINE,20000327,20141120,0828-282X (Print) 0828-282X (Linking),16,2000 Feb,Cardiovascular disease and the global village.,"230-1, 234-5",,"['Smith, E R']",['Smith ER'],"['The University of Calgary, Calgary, Canada.']","['eng', 'fre']","['Comment', 'Editorial']",,England,Can J Cardiol,The Canadian journal of cardiology,8510280,IM,"['Cardiovascular Diseases/etiology/mortality/*prevention & control', 'Cause of Death', '*Developing Countries', '*Global Health', 'Health Resources', 'Humans', 'International Cooperation']",2000/03/01 09:00,2000/04/01 09:00,['2000/03/01 09:00'],"['2000/03/01 09:00 [pubmed]', '2000/04/01 09:00 [medline]', '2000/03/01 09:00 [entrez]']",,ppublish,"Can J Cardiol. 2000 Feb;16(2):230-1, 234-5.",2,,,,,,,,,,,['Can J Cardiol. 2000 Feb;16(2):227-9. PMID: 10694594'],,,,,,,,,,
31454841,NLM,MEDLINE,20200113,20200113,1439-4413 (Electronic) 0012-0472 (Linking),144,2019 Aug,[Cardiologic Check-ups].,1192-1201,10.1055/a-0818-8169 [doi],"['Rudolph, Ulrike', 'Laufs, Ulrich']","['Rudolph U', 'Laufs U']",,['ger'],['Journal Article'],20190827,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Aged', 'Angina Pectoris', 'Blood Pressure', '*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Female', 'Humans', 'Hypertension', 'Male', 'Middle Aged', 'Physical Examination', 'Risk Factors', 'Smoking']",2019/08/28 06:00,2020/01/14 06:00,['2019/08/28 06:00'],"['2019/08/28 06:00 [entrez]', '2019/08/28 06:00 [pubmed]', '2020/01/14 06:00 [medline]']",['10.1055/a-0818-8169 [doi]'],ppublish,Dtsch Med Wochenschr. 2019 Aug;144(17):1192-1201. doi: 10.1055/a-0818-8169. Epub 2019 Aug 27.,17,"Cardiovascular diseases (CVD), especially coronary artery disease (CAD), are the leading causes of morbidity and mortality worldwide. Elimination of modifiable risk factors has the potential to prevent up to 80 % of CVD. Therefore, disease prevention is based on the assessment of individual total CVD risk by using risk scores such as SCORE-algorithm that include the known main cardiovascular risk factors such as age, sex, smoking status, arterial hypertension und cholesterol.",,,"['Die Autoren geben an, dass kein Interessenkonflikt besteht.']",,,,,['(c) Georg Thieme Verlag KG Stuttgart . New York.'],,,,,,Vorsorgeuntersuchungen und Check-ups in der Kardiologie.,,,,,,
36866662,NLM,MEDLINE,20230420,20230518,1941-7705 (Electronic) 1941-7713 (Linking),16,2023 Apr,Outcomes From Cardiovascular Disease Extend Beyond Traditional Risk Factors: We Are What We Eat (or Don't Eat).,e009886,10.1161/CIRCOUTCOMES.123.009886 [doi],"['Brandt, Eric J']",['Brandt EJ'],"['Institute for Healthcare Policy and Innovation and Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor.']",['eng'],"['Comment', 'Editorial']",20230303,United States,Circ Cardiovasc Qual Outcomes,Circulation. Cardiovascular quality and outcomes,101489148,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Risk Factors']",2023/03/04 06:00,2023/04/20 10:17,['2023/03/03 05:02'],"['2023/04/20 10:17 [medline]', '2023/03/04 06:00 [pubmed]', '2023/03/03 05:02 [entrez]']",['10.1161/CIRCOUTCOMES.123.009886 [doi]'],ppublish,Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009886. doi: 10.1161/CIRCOUTCOMES.123.009886. Epub 2023 Mar 3.,4,,['ORCID: 0000-0001-5463-4533'],,,['NOTNLM'],"['Editorials', 'body mass index', 'malnutrition', 'nutrients', 'risk factors']",,,,,['Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009340. PMID: 36866663'],,,,,,,,,,
30576435,NLM,MEDLINE,20200129,20200129,1755-3245 (Electronic) 0008-6363 (Linking),115,2019 Jan 1, pound30 million award to transform cardiovascular research.,e7-e8,10.1093/cvr/cvy291 [doi],"['Samani, Nilesh J']",['Samani NJ'],"['Medical Director, British Heart Foundation, Greater London House 180 Hampstead Road, London, UK.']",['eng'],"['Journal Article', 'Video-Audio Media']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['*Awards and Prizes', 'Biomedical Research/*economics', 'Cardiology/*economics', 'Cardiovascular Diseases/diagnosis/*economics/physiopathology/therapy', 'Charities/*economics', 'Competitive Behavior', 'Humans', 'Interdisciplinary Communication', 'Research Support as Topic/*economics']",2018/12/24 06:00,2020/01/30 06:00,['2018/12/22 06:00'],"['2018/12/22 06:00 [entrez]', '2018/12/24 06:00 [pubmed]', '2020/01/30 06:00 [medline]']","['5255153 [pii]', '10.1093/cvr/cvy291 [doi]']",ppublish,Cardiovasc Res. 2019 Jan 1;115(1):e7-e8. doi: 10.1093/cvr/cvy291.,1,,,,,,,,,,,,,,,,,,,,,
18689213,NLM,MEDLINE,20081027,20080811,0210-5020 (Print) 0210-5020 (Linking),31,2008 May,[Cardiovascular diseases].,43-6,,"['Jimenez de Luque, Pilar', 'Mejias Jimenez, Araceli', 'Avis Alvarado, Maria', 'Biota Jimenez, Pilar', 'Sanchez Inchausti, Felisa']","['Jimenez de Luque P', 'Mejias Jimenez A', 'Avis Alvarado M', 'Biota Jimenez P', 'Sanchez Inchausti F']",['CAM Ermitanaga.'],['spa'],"['English Abstract', 'Journal Article']",,Spain,Rev Enferm,"Revista de enfermeria (Barcelona, Spain)",8309920,,"['*Cardiovascular Diseases/etiology/prevention & control', 'Female', 'Humans', '*Menopause']",2008/08/12 09:00,2008/10/28 09:00,['2008/08/12 09:00'],"['2008/08/12 09:00 [pubmed]', '2008/10/28 09:00 [medline]', '2008/08/12 09:00 [entrez]']",,ppublish,Rev Enferm. 2008 May;31(5):43-6.,5,"The authors of this article analyze the relationship between menopause and cardiovascular diseases, specifying the healthiest recommendations in terms of living habits and specifically recommendations with regards to diet.",,,,,,,,,,,,,,Enfermedad cardiovascular (ECV).,,,,,,
4139604,NLM,MEDLINE,19750128,20190611,0140-6736 (Print) 0140-6736 (Linking),2,1974 Nov 16,Cardiovascular diseases.,1189-91,,"['Sackett, D L']",['Sackett DL'],,['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Blood Pressure Determination', 'Cardiovascular Diseases/blood/*diagnosis/etiology', 'Community Participation', 'Cooperative Behavior', 'Diet, Atherogenic', 'Electrocardiography', 'Hyperlipidemias/complications', 'Hypertension/diagnosis/etiology/therapy', '*Mass Screening', 'Obesity/complications', 'Physical Exertion', 'Physician-Patient Relations', 'Smoking']",1974/11/16 00:00,1974/11/16 00:01,['1974/11/16 00:00'],"['1974/11/16 00:00 [pubmed]', '1974/11/16 00:01 [medline]', '1974/11/16 00:00 [entrez]']","['S0140-6736(74)90827-7 [pii]', '10.1016/s0140-6736(74)90827-7 [doi]']",ppublish,Lancet. 1974 Nov 16;2(7890):1189-91. doi: 10.1016/s0140-6736(74)90827-7.,7890,,,,,,,,,,,,,,,,,,,,,
10833117,NLM,MEDLINE,20000906,20211203,0004-8291 (Print) 0004-8291 (Linking),30,2000 Apr,Cardiovascular disease towards 2000: activities of the West Australian Heart Research Institute.,236-40,,"['Beilin, L J', 'Watts, G F', 'Taylor, R R', 'Thompson, P L']","['Beilin LJ', 'Watts GF', 'Taylor RR', 'Thompson PL']","['Department of Internal Medicine, Royal Perth Hospital, West Australian Heart Research Institute and University of Western Australia.']",['eng'],"['Journal Article', 'Review']",,Australia,Aust N Z J Med,Australian and New Zealand journal of medicine,1264322,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/*prevention & control', 'Child', 'Diet', 'Female', 'Humans', 'Male', 'Models, Biological', 'Native Hawaiian or Other Pacific Islander', 'Research', 'Risk Factors', 'Western Australia/epidemiology']",2000/06/01 09:00,2000/09/09 11:01,['2000/06/01 09:00'],"['2000/06/01 09:00 [pubmed]', '2000/09/09 11:01 [medline]', '2000/06/01 09:00 [entrez]']",['10.1111/j.1445-5994.2000.tb00814.x [doi]'],ppublish,Aust N Z J Med. 2000 Apr;30(2):236-40. doi: 10.1111/j.1445-5994.2000.tb00814.x.,2,,,,,,,,,,31,,,,,,,,,,,
25366196,NLM,MEDLINE,20150821,20211021,0971-5916 (Print) 0975-9174 (Electronic) 0971-5916 (Linking),140,2014 Sep,World Heart Day--creating heart healthy environments.,327-9,,"['Sinha, Nakul', 'Saran, R K', 'Hasan, Mansoor']","['Sinha N', 'Saran RK', 'Hasan M']","['Sahara Hospital, Former Head Department of Cardiology Sanjay Gandhi Postgraduate Institute of Medical, India.']",['eng'],['Editorial'],,India,Indian J Med Res,The Indian journal of medical research,0374701,IM,"['Cardiovascular Diseases/chemically induced/*epidemiology/etiology', 'Humans', 'Particulate Matter/*toxicity', 'Risk Factors']",2014/11/05 06:00,2015/08/22 06:00,['2014/11/05 06:00'],"['2014/11/05 06:00 [entrez]', '2014/11/05 06:00 [pubmed]', '2015/08/22 06:00 [medline]']","['IndianJMedRes_2014_140_3_327_143761 [pii]', 'IJMR-140-327 [pii]']",ppublish,Indian J Med Res. 2014 Sep;140(3):327-9.,3,,,PMC4248375,,,,,['0 (Particulate Matter)'],,,,,,,,,,,,,
19967917,NLM,MEDLINE,20100218,20151119,0894-959X (Print) 0894-959X (Linking),22,2009 Fall,Cardiovascular risk assessment. Introduction.,223-5,,"['Foley, Kevin F']",['Foley KF'],"['Kaiser Permanente NW Laboratories, 13705 NE Airport Way, Portland, OR 97230, USA. kevin.f.foley@kp.org']",['eng'],['Introductory Journal Article'],,United States,Clin Lab Sci,Clinical laboratory science : journal of the American Society for Medical Technology,8806547,,"['Biomarkers/blood', 'Cardiovascular Diseases/blood/*etiology/genetics', 'Humans', 'Risk Assessment']",2009/12/09 06:00,2010/02/19 06:00,['2009/12/09 06:00'],"['2009/12/09 06:00 [entrez]', '2009/12/09 06:00 [pubmed]', '2010/02/19 06:00 [medline]']",,ppublish,Clin Lab Sci. 2009 Fall;22(4):223-5.,4,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
23745812,NLM,MEDLINE,20140207,20190907,1873-4294 (Electronic) 1568-0266 (Linking),13,2013,MicroRNAs in cardiovascular therapeutics.,1605-18,,"['Siasos, Gerasimos', 'Tousoulis, Dimitris', 'Tourikis, Panagiotis', 'Mazaris, Savas', 'Zakynthinos, Giorgos', 'Oikonomou, Evangelos', 'Kokkou, Eleni', 'Kollia, Christina', 'Stefanadis, Christodoulos']","['Siasos G', 'Tousoulis D', 'Tourikis P', 'Mazaris S', 'Zakynthinos G', 'Oikonomou E', 'Kokkou E', 'Kollia C', 'Stefanadis C']","['1st Cardiology Department, University of Athens Medical School, Hippokration Hospital, Athens, Greece. gsiasos@med.uoa.gr']",['eng'],"['Journal Article', 'Review']",,United Arab Emirates,Curr Top Med Chem,Current topics in medicinal chemistry,101119673,IM,"['Animals', 'Cardiovascular Diseases/*drug therapy/*metabolism/physiopathology', 'Humans', 'MicroRNAs/*metabolism']",2013/06/12 06:00,2014/02/08 06:00,['2013/06/11 06:00'],"['2013/03/14 00:00 [received]', '2013/04/29 00:00 [revised]', '2013/02/13 00:00 [accepted]', '2013/06/11 06:00 [entrez]', '2013/06/12 06:00 [pubmed]', '2014/02/08 06:00 [medline]']","['CTMC-EPUB-20130531-13 [pii]', '10.2174/15680266113139990109 [doi]']",ppublish,Curr Top Med Chem. 2013;13(13):1605-18. doi: 10.2174/15680266113139990109.,13,"Recent research reveals the crucial role microRNAs (miRNAs) in the pathogenesis and progression of many pathological conditions, including cardiovascular diseases. It is widely documented that miRNAs represent critical regulators of cardiovascular function and participate in almost all aspects of cardiovascular biology. In particular, they are involved in several pathophysiological pathways of various manifestations of cardiovascular disease, such as coronary artery disease, heart failure, stroke, diabetes mellitus, arterial hypertension and cardiac arrhythmias. In the present article we review the available literature regarding to the role of miRNAs in certain cardiovascular conditions. Moreover, we discuss the therapeutic potential of miRNAs for treating cardiovascular diseases and we attempt to highlight future directions.",,,,,,,['0 (MicroRNAs)'],,,,,,,,,,,,,
16330695,NLM,MEDLINE,20060222,20220409,1524-4539 (Electronic) 0009-7322 (Linking),112,2005 Dec 6,Cardiovascular disease in the developing world and its cost-effective management.,3547-53,,"['Gaziano, Thomas A']",['Gaziano TA'],"[""Division of Cardiology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02120, USA. tgaziano@partners.org""]",['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Africa/epidemiology', 'Cardiovascular Diseases/*economics/epidemiology/mortality/therapy', 'Cause of Death/trends', 'Cost-Benefit Analysis', 'Developing Countries/economics', 'Disease Management', 'Health Care Costs', 'Humans']",2005/12/07 09:00,2006/02/24 09:00,['2005/12/07 09:00'],"['2005/12/07 09:00 [pubmed]', '2006/02/24 09:00 [medline]', '2005/12/07 09:00 [entrez]']","['112/23/3547 [pii]', '10.1161/CIRCULATIONAHA.105.591792 [doi]']",ppublish,Circulation. 2005 Dec 6;112(23):3547-53. doi: 10.1161/CIRCULATIONAHA.105.591792.,23,,,,,,,,,,23,,,,,,,,,,,
23050406,NLM,MEDLINE,20121101,20150612,0042-8450 (Print) 0042-8450 (Linking),69,2012 Sep,Heart rate--predictor of cardiovascular risk.,799-802,,"['Ivanovic, Branislava A', 'Tadic, Marijana', 'Dincic, Dragan']","['Ivanovic BA', 'Tadic M', 'Dincic D']","['Clinic for Cardiology, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. lole@scnet.rs']",['eng'],"['Journal Article', 'Review']",,Serbia,Vojnosanit Pregl,Vojnosanitetski pregled,21530700R,IM,"['Arrhythmias, Cardiac/complications/drug therapy', 'Cardiovascular Diseases/complications/*diagnosis/prevention & control', 'Humans', 'Risk Factors', 'Tachycardia/*complications/drug therapy']",2012/10/12 06:00,2012/11/02 06:00,['2012/10/12 06:00'],"['2012/10/12 06:00 [entrez]', '2012/10/12 06:00 [pubmed]', '2012/11/02 06:00 [medline]']",,ppublish,Vojnosanit Pregl. 2012 Sep;69(9):799-802.,9,,,,,,,,,,,,,,,,,,,,,
15481873,NLM,MEDLINE,20041116,20061215,0040-781X (Print) 0040-781X (Linking),164,2004 Sep 13,I've got a problem.,71,,"['Lemonick, Michael D']",['Lemonick MD'],,['eng'],"['Biography', 'Historical Article', 'News']",,United States,Time,Time,9877130,,"['Cardiovascular Diseases/etiology/*prevention & control/surgery', 'Coronary Artery Bypass', '*Famous Persons', 'History, 21st Century', 'Humans', 'Male', 'Middle Aged', '*Politics', 'United States']",2004/10/16 09:00,2004/11/17 09:00,['2004/10/16 09:00'],"['2004/10/16 09:00 [pubmed]', '2004/11/17 09:00 [medline]', '2004/10/16 09:00 [entrez]']",,ppublish,Time. 2004 Sep 13;164(11):71.,11,,,,,,,,,,,,,,,,['Clinton W'],"['Clinton, William']",,,,
6462493,NLM,MEDLINE,19840905,20161123,0026-4733 (Print) 0026-4733 (Linking),39,1984 Mar 31,[Usefulness of Doppler ultrasonography in the screening of patients undergoing angiographic examination prior to surgical treatment].,367-81,,"['Musso, L', 'Gozzoli, C', 'Dabala, A', 'Scarpini, S', 'Finzi, M']","['Musso L', 'Gozzoli C', 'Dabala A', 'Scarpini S', 'Finzi M']",,['ita'],['Journal Article'],,Italy,Minerva Chir,Minerva chirurgica,0400726,IM,"['Adolescent', 'Adult', 'Aged', '*Angiography', 'Cardiovascular Diseases/*diagnosis/diagnostic imaging/surgery', 'Female', 'Humans', 'Male', 'Middle Aged', '*Ultrasonography']",1984/03/31 00:00,1984/03/31 00:01,['1984/03/31 00:00'],"['1984/03/31 00:00 [pubmed]', '1984/03/31 00:01 [medline]', '1984/03/31 00:00 [entrez]']",,ppublish,Minerva Chir. 1984 Mar 31;39(6):367-81.,6,,,,,,,,,,,,,,,Utilita della ultrasonografia Doppler nello screening dei pazienti da sottoporre ad indagine angiografica in previsione di una terapia chirurgica.,,,,,,
10665904,NLM,MEDLINE,20000224,20190812,0003-9926 (Print) 0003-9926 (Linking),159,1999 Nov 8,To E or not to E.,2485,,"['Schattner, A']",['Schattner A'],,['eng'],['Letter'],,United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Arteriosclerosis/*drug therapy/metabolism/*prevention & control', 'Cardiovascular Diseases/*drug therapy/metabolism/*prevention & control', 'Humans', 'Lipid Peroxidation/drug effects', 'Risk', 'Vitamin E/*therapeutic use']",2000/02/09 09:00,2000/02/26 09:00,['2000/02/09 09:00'],"['2000/02/09 09:00 [pubmed]', '2000/02/26 09:00 [medline]', '2000/02/09 09:00 [entrez]']",['10.1001/archinte.159.20.2485-a [doi]'],ppublish,Arch Intern Med. 1999 Nov 8;159(20):2485. doi: 10.1001/archinte.159.20.2485-a.,20,,,,,,,,['1406-18-4 (Vitamin E)'],,,,,,,,,,,,,
4686609,NLM,MEDLINE,19730405,20161123,0009-7322 (Print) 0009-7322 (Linking),47,1973 Jan,Cardiovascular disease--unanswered questions. Problems that require intensive study and planning or basic or applied research.,A341-57,,"['Wright, I S']",['Wright IS'],,['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Allied Health Personnel', 'Angiography', 'Arteriosclerosis', 'Cardiac Rehabilitation', 'Cardiac Surgical Procedures', 'Cardiology/instrumentation', '*Cardiovascular Diseases/diagnostic imaging/nursing', 'Coronary Disease', 'Heart Defects, Congenital', 'Heart Diseases', 'Humans', 'Hypertension', 'Mental Disorders', 'Psychophysiologic Disorders', 'Pulmonary Heart Disease', 'Research', 'Rheumatic Fever', 'Rheumatic Heart Disease', 'Thromboembolism', 'Vascular Diseases']",1973/01/01 00:00,1973/01/01 00:01,['1973/01/01 00:00'],"['1973/01/01 00:00 [pubmed]', '1973/01/01 00:01 [medline]', '1973/01/01 00:00 [entrez]']",,ppublish,Circulation. 1973 Jan;47(1):A341-57.,1,,,,,,,,,,,,,,,,,,,,,
15171393,NLM,MEDLINE,20040818,20110727,0047-1852 (Print) 0047-1852 (Linking),62 Suppl 3,2004 Mar,[Cardiovascular events due to hypertension].,327-32,,"['Saruta, Takao']",['Saruta T'],"['Department of Internal Medicine, School of Medicine, Keio University.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Albuminuria', 'Cardiovascular Diseases/diagnosis/epidemiology/*etiology', 'Humans', 'Hypertension/*complications/epidemiology', 'Japan/epidemiology', 'Kidney Diseases/diagnosis/etiology', 'Risk', 'Stroke/diagnosis/epidemiology/*etiology']",2004/06/03 05:00,2004/08/19 05:00,['2004/06/03 05:00'],"['2004/06/03 05:00 [pubmed]', '2004/08/19 05:00 [medline]', '2004/06/03 05:00 [entrez]']",,ppublish,Nihon Rinsho. 2004 Mar;62 Suppl 3:327-32.,,,,,,,,,,,11,,,,,,,,,,,
30668680,NLM,MEDLINE,20200305,20210211,1755-3245 (Electronic) 0008-6363 (Linking),115,2019 Feb 1,Leaders in Cardiovascular Research: Barbara Casadei.,e17-e19,10.1093/cvr/cvy303 [doi],"['Guzik, Tomasz J', 'Casadei, Barbara']","['Guzik TJ', 'Casadei B']","['Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, UK.', 'Department of Internal and Agricultural Medicine, Jagiellonian University Collegium Medicum, 31-008 Anny 12, Krakow, Poland; and.', 'University of Oxford, Oxford, Oxon, UK.']",['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait', 'Video-Audio Media']",,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Biomedical Research/education/*history', 'Cardiology/education/*history', 'Cardiovascular Diseases/diagnosis/*history/physiopathology/therapy', 'History, 20th Century', 'History, 21st Century', 'Leadership', 'Mentors', 'Societies, Medical', 'Societies, Scientific']",2019/01/23 06:00,2020/03/07 06:00,['2019/01/23 06:00'],"['2019/01/23 06:00 [entrez]', '2019/01/23 06:00 [pubmed]', '2020/03/07 06:00 [medline]']","['5298392 [pii]', '10.1093/cvr/cvy303 [doi]']",ppublish,Cardiovasc Res. 2019 Feb 1;115(2):e17-e19. doi: 10.1093/cvr/cvy303.,2,,,,,,,['RG/16/12/32451/BHF_/British Heart Foundation/United Kingdom'],,,,,,,,,['Casadei B'],"['Casadei, Barbara']",,,,
33589426,NLM,MEDLINE,20210826,20210903,1468-201X (Electronic) 1355-6037 (Print) 1355-6037 (Linking),107,2021 Apr,Young at heart? Drugs of abuse cause early-onset cardiovascular disease in the young.,604-606,10.1136/heartjnl-2020-318856 [doi],"['Scott, Matthew L', 'Murnane, Kevin S', 'Orr, Anthony Wayne']","['Scott ML', 'Murnane KS', 'Orr AW']","['Department of Pathology, LSU Health Shreveport, Shreveport, Louisiana, USA.', 'Departments of Pharmacology, Toxicology and Neuroscience and Psychiatry, LSU Health Shreveport, Shreveport, Louisiana, USA.', 'Departments of Pathology, Cellular Biology and Anatomy, and Molecular and Cellular Physiology, LSU Health Shreveport, Shreveport, Louisiana, USA aorr@lsuhsc.edu.']",['eng'],"['Comment', 'Editorial', 'Research Support, N.I.H., Extramural']",20210215,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*Atherosclerosis', '*Cardiovascular Diseases/chemically induced/diagnosis/epidemiology', '*Cardiovascular System', 'Humans', '*Pharmaceutical Preparations', '*Stroke']",2021/02/17 06:00,2021/08/27 06:00,['2021/02/16 06:01'],"['2021/02/17 06:00 [pubmed]', '2021/08/27 06:00 [medline]', '2021/02/16 06:01 [entrez]']","['heartjnl-2020-318856 [pii]', '10.1136/heartjnl-2020-318856 [doi]']",ppublish,Heart. 2021 Apr;107(8):604-606. doi: 10.1136/heartjnl-2020-318856. Epub 2021 Feb 15.,8,,['ORCID: 0000-0002-2377-213X'],PMC8075271,['Competing interests: None declared.'],['NOTNLM'],"['atherosclerosis', 'drug interactions', 'peripheral vascular diseases', 'stroke']","['P20 GM121307/GM/NIGMS NIH HHS/United States', 'R01 HL098435/HL/NHLBI NIH HHS/United States', 'R01 HL133497/HL/NHLBI NIH HHS/United States', 'R01 HL141155/HL/NHLBI NIH HHS/United States']",['0 (Pharmaceutical Preparations)'],,,['Heart. 2021 Apr;107(8):650-656. PMID: 33589427'],['NIHMS1694355'],,,,,,,,,
8026350,NLM,MEDLINE,19940811,20220311,0012-835X (Print) 0012-835X (Linking),70,1993 Dec,The changing pattern of cardiovascular diseases in Ethiopia.,772-6,,"['Maru, M']",['Maru M'],"['Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Ethiopia.']",['eng'],"['Journal Article', 'Review']",,Kenya,East Afr Med J,East African medical journal,0372766,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Aged', 'Cardiovascular Diseases/classification/diagnosis/*epidemiology/etiology/prevention & control', 'Child', 'Ethiopia/epidemiology', 'Female', 'Humans', 'Incidence', 'Male', 'Middle Aged', '*Population Surveillance', 'Prevalence', 'Prospective Studies', 'Sex Distribution']",1993/12/01 00:00,1993/12/01 00:01,['1993/12/01 00:00'],"['1993/12/01 00:00 [pubmed]', '1993/12/01 00:01 [medline]', '1993/12/01 00:00 [entrez]']",,ppublish,East Afr Med J. 1993 Dec;70(12):772-6.,12,"A total of 474 patients (216 males and 258 females) with cardiovascular diseases which were followed in the cardiac clinic of the Gondar College of Medical Science Hospital, Gondar, Ethiopia, between 1985 and 1988 were studied. The commonest form of heart disease in Ethiopians was found to be rheumatic heart disease (42%), and affects mostly young people, who often have advanced valvular lesions. Hypertension (38.1%) was the second most common cause of heart disease. It affects mostly young people and 77% of the cases are of essential type. The incidences of atherosclerotic and congenital heart disease have not changed but that of syphilitic heart disease and cardiomyopathy have markedly decreased in the last 20 years. The incidences of rheumatic and hypertensive heart diseases have shown a significant increase. However, the rise in the incidence of myocardial infarction over a 20 year period from 0.88 per 1000 in 1963-68 to 6.4 per 1000 in 1985-88 is distinctively impressive.",,,,,,,,,19,,,,,,,,,,,
10898450,NLM,MEDLINE,20000801,20190708,0735-1097 (Print) 0735-1097 (Linking),36,2000 Jul,Presient's page: the human genome project: implications for cardiologists and their patients.,295-8,,"['Beller, G A']",['Beller GA'],,['eng'],"['Case Reports', 'News']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['*Cardiology/education/methods', 'Cardiovascular Diseases/diagnosis/genetics/therapy', '*Human Genome Project', 'Humans']",2000/07/18 11:00,2000/08/06 11:00,['2000/07/18 11:00'],"['2000/07/18 11:00 [pubmed]', '2000/08/06 11:00 [medline]', '2000/07/18 11:00 [entrez]']","['S0735109700007841 [pii]', '10.1016/s0735-1097(00)00784-1 [doi]']",ppublish,J Am Coll Cardiol. 2000 Jul;36(1):295-8. doi: 10.1016/s0735-1097(00)00784-1.,1,,,,,,,,,,,,,,,,,,,,,
25051136,NLM,MEDLINE,20140821,20220223,1530-6550 (Print) 1530-6550 (Linking),15,2014,"ACC.14: update on the prevention, diagnosis, and treatment of cardiovascular disease.",178-88,10.3909/ricm0740 [doi],"['Krishnan, Sandeep', 'Lepor, Norman E']","['Krishnan S', 'Lepor NE']","['Department of Medicine, Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA.']",['eng'],['Congress'],,Singapore,Rev Cardiovasc Med,Reviews in cardiovascular medicine,100960007,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Heart Valve Prosthesis Implantation', 'Humans', 'Male', 'Percutaneous Coronary Intervention', 'Stem Cell Transplantation']",2014/07/23 06:00,2014/08/22 06:00,['2014/07/23 06:00'],"['2014/07/23 06:00 [entrez]', '2014/07/23 06:00 [pubmed]', '2014/08/22 06:00 [medline]']",['10.3909/ricm0740 [doi]'],ppublish,Rev Cardiovasc Med. 2014;15(2):178-88. doi: 10.3909/ricm0740.,2,,,,,,,,,,,,,,,,,,,,,
13123554,NLM,MEDLINE,20030501,20190916,0888-2479 (Print) 0888-2479 (Linking),93,1954 Feb,Cardiovascular diseases; a review of some significant publications (July 1949-June 1952).,254-98; contd,,"['SCHAFF, R S']",['SCHAFF RS'],,['eng'],['Journal Article'],,United States,AMA Arch Intern Med,A.M.A. archives of internal medicine,14470100R,OM,"['*Cardiovascular Abnormalities', 'Cardiovascular Diseases/*therapy', 'Coronary Disease/*therapy', '*Endocarditis', 'Endocarditis, Bacterial/*therapy', 'Humans', '*Rheumatic Fever']",1954/02/01 00:00,1954/02/01 00:01,['1954/02/01 00:00'],"['1954/02/01 00:00 [pubmed]', '1954/02/01 00:01 [medline]', '1954/02/01 00:00 [entrez]']",['10.1001/archinte.1954.00240260090008 [doi]'],ppublish,AMA Arch Intern Med. 1954 Feb;93(2):254-98; contd. doi: 10.1001/archinte.1954.00240260090008.,2,,,,,['NLM'],"['*CARDIOVASCULAR DEFECTS, CONGENITAL', '*CARDIOVASCULAR DISEASES/therapy', '*CORONARY DISEASE/therapy', '*ENDOCARDITIS, BACTERIAL/therapy', '*RHEUMATIC FEVER']",,,,,,,,,,,,,,['CLML: 5425:44928:93:94:121:158:406'],
17429299,NLM,MEDLINE,20070703,20161124,0954-6928 (Print) 0954-6928 (Linking),18,2007 May,Bibliography of current world literature.,239-40,,,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['Anticoagulants/therapeutic use', 'Blood Platelets/physiology', 'Cardiomyopathies/etiology', '*Cardiovascular Diseases/diagnosis/diagnostic imaging/therapy', 'Humans', 'Magnetic Resonance Imaging', 'Myocardial Ischemia/complications', 'Pharmacogenetics', 'Stem Cell Transplantation', 'Ultrasonography']",2007/04/13 09:00,2007/07/04 09:00,['2007/04/13 09:00'],"['2007/04/13 09:00 [pubmed]', '2007/07/04 09:00 [medline]', '2007/04/13 09:00 [entrez]']","['00019501-200705000-00014 [pii]', '10.1097/01.mca.0000267545.39031.ad [doi]']",ppublish,Coron Artery Dis. 2007 May;18(3):239-40. doi: 10.1097/01.mca.0000267545.39031.ad.,3,,,,,,,,['0 (Anticoagulants)'],,,,,,,,,,,,,
2749318,NLM,MEDLINE,19890818,20041117,0038-0814 (Print) 0038-0814 (Linking),,1989 Jun,[Tobacco--a risk factor in cardiovascular diseases].,11-4,,"['Mazzola, C']",['Mazzola C'],,['fre'],['Journal Article'],,France,Soins,Soins; la revue de reference infirmiere,20910580R,,"['Cardiovascular Diseases/*etiology/mortality/physiopathology', 'Humans', 'Risk Factors', 'Smoking/*adverse effects', 'Tobacco Use Disorder/physiopathology']",1989/06/01 00:00,1989/06/01 00:01,['1989/06/01 00:00'],"['1989/06/01 00:00 [pubmed]', '1989/06/01 00:01 [medline]', '1989/06/01 00:00 [entrez]']",,ppublish,Soins. 1989 Jun;(525):11-4.,525,,,,,,,,,,,,,,,Les risques cardio-vasculaires du tabac.,,,,,,
29590389,NLM,MEDLINE,20190729,20190729,1755-3245 (Electronic) 0008-6363 (Linking),114,2018 Apr 1,"Katie Thomas talks to Rory Collins, international leader in population and epidemiology studies in cardiovascular disease.",e32,10.1093/cvr/cvy046 [doi],,,,['eng'],"['Biography', 'Historical Article', 'Interview', 'Portrait', 'Video-Audio Media']",,England,Cardiovasc Res,Cardiovascular research,0077427,,"['Biomedical Research/*history', 'Cardiovascular Diseases/diagnosis/epidemiology/*history', '*Epidemiologic Methods', 'History, 20th Century', 'History, 21st Century', 'Humans', '*Leadership']",2018/03/29 06:00,2019/07/30 06:00,['2018/03/29 06:00'],"['2018/03/29 06:00 [entrez]', '2018/03/29 06:00 [pubmed]', '2019/07/30 06:00 [medline]']","['4953546 [pii]', '10.1093/cvr/cvy046 [doi]']",ppublish,Cardiovasc Res. 2018 Apr 1;114(5):e32. doi: 10.1093/cvr/cvy046.,5,,,,,,,,,,,,,,,,['Collins R'],"['Collins, Rory']",,,,
15190135,NLM,MEDLINE,20040615,20220331,1533-4406 (Electronic) 0028-4793 (Linking),350,2004 Jun 10,Cardiovascular disease in non-Western countries.,2438-40,,"['Reddy, K Srinath']",['Reddy KS'],"['All India Institute of Medical Sciences, New Delhi.']",['eng'],['Journal Article'],,United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Cardiovascular Diseases/epidemiology/*mortality/*prevention & control', '*Developing Countries', '*Disease Outbreaks', 'Health Education', '*Health Promotion', 'Humans', 'Urbanization']",2004/06/11 05:00,2004/06/16 05:00,['2004/06/11 05:00'],"['2004/06/11 05:00 [pubmed]', '2004/06/16 05:00 [medline]', '2004/06/11 05:00 [entrez]']","['350/24/2438 [pii]', '10.1056/NEJMp048024 [doi]']",ppublish,N Engl J Med. 2004 Jun 10;350(24):2438-40. doi: 10.1056/NEJMp048024.,24,,,,,,,,,,,,,,,,,,,,,
14915663,NLM,MEDLINE,20040215,20181201,0003-9683 (Print) 0003-9683 (Linking),44,1951 Oct,[Sexual differentiation in cardiovascular pathology].,893-900,,"['JOUVE, A', 'VAGUE, J', 'MONGIN, M']","['JOUVE A', 'VAGUE J', 'MONGIN M']",,['und'],['Journal Article'],,France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,OM,"['*Biometry', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Sex Differentiation']",1951/10/01 00:00,1951/10/01 00:01,['1951/10/01 00:00'],"['1951/10/01 00:00 [pubmed]', '1951/10/01 00:01 [medline]', '1951/10/01 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1951 Oct;44(10):893-900.,10,,,,,['NLM'],['*CARDIOVASCULAR DISEASES/epidemiology and statistics'],,,,,,,,,La differenciation sexuelle en pathologie cardio-vasculaire.,,,,,['CLML: 5222:1517:90'],
31727292,NLM,MEDLINE,20200522,20200522,1558-3597 (Electronic) 0735-1097 (Linking),74,2019 Nov 19,The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond.,2529-2532,S0735-1097(19)37928-8 [pii] 10.1016/j.jacc.2019.10.009 [doi],"['Mensah, George A', 'Roth, Gregory A', 'Fuster, Valentin']","['Mensah GA', 'Roth GA', 'Fuster V']","['Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: George.Mensah@nih.gov.', 'Division of Cardiology, Department of Medicine, and the Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington.', 'The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.']",['eng'],['Editorial'],,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Cost of Illness', 'Global Health/*statistics & numerical data', 'Humans']",2019/11/16 06:00,2020/05/23 06:00,['2019/11/16 06:00'],"['2019/11/16 06:00 [entrez]', '2019/11/16 06:00 [pubmed]', '2020/05/23 06:00 [medline]']","['S0735-1097(19)37928-8 [pii]', '10.1016/j.jacc.2019.10.009 [doi]']",ppublish,J Am Coll Cardiol. 2019 Nov 19;74(20):2529-2532. doi: 10.1016/j.jacc.2019.10.009.,20,,,,,,,,,,,,,,,,,,,,,
8880015,NLM,MEDLINE,19970130,20190512,0195-668X (Print) 0195-668X (Linking),17,1996 Sep,Prospects for gene therapy in cardiovascular disease.,1312-7,,"['Lafont, A', 'Guerot, C', 'Lemarchand, P']","['Lafont A', 'Guerot C', 'Lemarchand P']","['Universite Rene Descartes, Paris, France.']",['eng'],"['Journal Article', 'Review']",,England,Eur Heart J,European heart journal,8006263,IM,"['Cardiovascular Diseases/diagnosis/physiopathology/*therapy', '*Forecasting', '*Genetic Therapy/methods/trends', 'Humans', 'Prognosis']",1996/09/01 00:00,1996/09/01 00:01,['1996/09/01 00:00'],"['1996/09/01 00:00 [pubmed]', '1996/09/01 00:01 [medline]', '1996/09/01 00:00 [entrez]']",['10.1093/oxfordjournals.eurheartj.a015064 [doi]'],ppublish,Eur Heart J. 1996 Sep;17(9):1312-7. doi: 10.1093/oxfordjournals.eurheartj.a015064.,9,,,,,,,,,,69,,,,,,,,,,,
13658027,NLM,MEDLINE,20000701,20181201,0032-7867 (Print) 0032-7867 (Linking),67,1959 May 2,[Vasculitis].,898,,"['VILOTIJEVIC, R', 'STRINIC, F', 'MASULOVIC, M', 'MILOVIC, K']","['VILOTIJEVIC R', 'STRINIC F', 'MASULOVIC M', 'MILOVIC K']",,['fre'],['Journal Article'],,France,Presse Med (1893),La Presse medicale,0312556,OM,"['Cardiovascular Diseases/*pathology', 'Humans', '*Peripheral Vascular Diseases', '*Vascular Diseases']",1959/05/02 00:00,1959/05/02 00:01,['1959/05/02 00:00'],"['1959/05/02 00:00 [pubmed]', '1959/05/02 00:01 [medline]', '1959/05/02 00:00 [entrez]']",,ppublish,Presse Med (1893). 1959 May 2;67(22):898.,22,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/pathology', '*VASCULAR DISEASES, PERIPHERAL']",,,,,,,,,Vascularites.,,,,,['CLML: 5936:31995:112:561'],
27269933,NLM,MEDLINE,20180205,20180205,1468-201X (Electronic) 1355-6037 (Linking),102,2016 Jun 15,Heartbeat: Go with the flow in aortic stenosis?,895-6,10.1136/heartjnl-2016-309883 [doi],"['Otto, Catherine M']",['Otto CM'],,['eng'],"['Editorial', 'Introductory Journal Article']",,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Aortic Valve/diagnostic imaging/*physiopathology', 'Aortic Valve Stenosis/diagnostic imaging/*physiopathology', '*Biomedical Research', '*Cardiology', 'Cardiovascular Diseases/diagnosis/epidemiology/physiopathology/therapy', '*Hemodynamics', 'Humans', 'Risk Factors', '*Ventricular Function, Left']",2016/06/09 06:00,2018/02/06 06:00,['2016/06/09 06:00'],"['2016/06/09 06:00 [entrez]', '2016/06/09 06:00 [pubmed]', '2018/02/06 06:00 [medline]']","['heartjnl-2016-309883 [pii]', '10.1136/heartjnl-2016-309883 [doi]']",ppublish,Heart. 2016 Jun 15;102(12):895-6. doi: 10.1136/heartjnl-2016-309883.,12,,['ORCID: 0000-0002-0527-9392'],,,['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
11179253,NLM,MEDLINE,20010524,20190503,1468-201X (Electronic) 1355-6037 (Print) 1355-6037 (Linking),85,2001 Mar,Diabetic cardiomyopathy: fact or fiction?,247-8,,"['Francis, G S']",['Francis GS'],,['eng'],['Editorial'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Cardiovascular Diseases/etiology/mortality', '*Diabetes Complications', 'Heart Diseases/*etiology', 'Humans']",2001/02/17 11:00,2001/05/26 10:01,['2001/02/17 11:00'],"['2001/02/17 11:00 [pubmed]', '2001/05/26 10:01 [medline]', '2001/02/17 11:00 [entrez]']",['10.1136/heart.85.3.247 [doi]'],ppublish,Heart. 2001 Mar;85(3):247-8. doi: 10.1136/heart.85.3.247.,3,,,PMC1729638,,,,,,,,,,,,,,,,,,
22843177,NLM,MEDLINE,20121221,20211021,1862-1783 (Electronic) 1673-1581 (Print) 1673-1581 (Linking),13,2012 Aug,Progress and challenges in the cardiovascular field.,587-8,10.1631/jzus.B1201010 [doi],"['Wang, Jian-an']",['Wang JA'],,['eng'],"['Editorial', 'Introductory Journal Article']",,China,J Zhejiang Univ Sci B,Journal of Zhejiang University. Science. B,101236535,IM,"['Cardiology/*methods/*trends', 'Cardiovascular Diseases/epidemiology/genetics/*therapy', 'China', 'Congresses as Topic', 'Humans']",2012/07/31 06:00,2012/12/22 06:00,['2012/07/31 06:00'],"['2012/07/31 06:00 [entrez]', '2012/07/31 06:00 [pubmed]', '2012/12/22 06:00 [medline]']",['10.1631/jzus.B1201010 [doi]'],ppublish,J Zhejiang Univ Sci B. 2012 Aug;13(8):587-8. doi: 10.1631/jzus.B1201010.,8,,,PMC3411090,,,,,,,,,,,,,,,,,,
2290277,NLM,MEDLINE,19910329,20170310,0022-9040 (Print) 0022-9040 (Linking),30,1990 Oct,[Analysis of several methods of detection of biorhythms in chronodiagnosis and chronotherapy of cardiovascular diseases].,72-7,,"['Chirkova, E N', 'Egorov, V A', 'Nikitin, Iu M']","['Chirkova EN', 'Egorov VA', 'Nikitin IuM']",,['rus'],"['Case Reports', 'English Abstract', 'Journal Article']",,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Cardiovascular Diseases/diagnosis/*physiopathology/therapy', '*Circadian Rhythm', 'Electrocardiography', 'Female', 'Humans', 'Male', 'Middle Aged', 'Prognosis']",1990/10/01 00:00,1990/10/01 00:01,['1990/10/01 00:00'],"['1990/10/01 00:00 [pubmed]', '1990/10/01 00:01 [medline]', '1990/10/01 00:00 [entrez]']",,ppublish,Kardiologiia. 1990 Oct;30(10):72-7.,10,"The paper analyses the characteristics of mathematical methods for detecting the biorhythms currently used for the chronodiagnosis and chronotherapy of cardiovascular diseases. Emphasis is laid on the assessment of the resolving power of algorithms and programs applied to the detection of circadian biological rhythms. The paper also discusses whether chronodiagnosis and chronotherapy of cardiovascular diseases are admissible by clinically available mathematical methods for detecting circadian rhythms. In addition, it deals with theoretical conditions required for accurate detection of varying frequency biological rhythms from length-limited data arrays and proposes a mathematical method suitable to a problem to detect biological rhythms with periods unknown in advance.",,,,,,,,,,,,,,Analiz nekotorykh metodov vyiavleniia bioritmov dlia khronodiagnostiki i khronoterapii serdechno-sosudistykh zabolevanii.,,,,,,
23486683,NLM,MEDLINE,20130618,20200219,0023-7213 (Print) 0023-7213 (Linking),99,2013 Mar,[Chronic non-communicable diseases: - the greatest threat to modern health].,119,10.17992/lbl.2013.03.484 [doi],"['Hrafnkelsson, Hannes']",['Hrafnkelsson H'],,['ice'],['Editorial'],,Iceland,Laeknabladid,Laeknabladid,7901326,IM,"['Cardiovascular Diseases/*epidemiology/mortality/prevention & control', 'Chronic Disease', '*Global Health', 'Health Status', 'Humans', 'Prognosis', 'Risk Factors']",2013/03/15 06:00,2013/06/19 06:00,['2013/03/15 06:00'],"['2013/03/15 06:00 [entrez]', '2013/03/15 06:00 [pubmed]', '2013/06/19 06:00 [medline]']",['10.17992/lbl.2013.03.484 [doi]'],ppublish,Laeknabladid. 2013 Mar;99(3):119. doi: 10.17992/lbl.2013.03.484.,3,,,,,,,,,,,,,,,Langvinnir lifsstilssjukdomar - mesta ogn nutimans vid heilbrigdi.,,,,,,
1989778,NLM,MEDLINE,19910307,20190514,0012-3692 (Print) 0012-3692 (Linking),99,1991 Feb,Pulmonary function as a phenotype physiologic marker of cardiovascular morbidity and mortality.,265-6,,"['Weiss, S T']",['Weiss ST'],,['eng'],"['Comment', 'Editorial']",,United States,Chest,Chest,0231335,IM,"['Cardiovascular Diseases/*diagnosis/mortality/physiopathology', 'Humans', 'Obesity/physiopathology', '*Vital Capacity']",1991/02/01 00:00,1991/02/01 00:01,['1991/02/01 00:00'],"['1991/02/01 00:00 [pubmed]', '1991/02/01 00:01 [medline]', '1991/02/01 00:00 [entrez]']","['S0012-3692(16)48817-3 [pii]', '10.1378/chest.99.2.265 [doi]']",ppublish,Chest. 1991 Feb;99(2):265-6. doi: 10.1378/chest.99.2.265.,2,,,,,,,,,,,['Chest. 1991 Feb;99(2):315-22. PMID: 1989788'],,,,,,,,,,
17581223,NLM,MEDLINE,20070801,20151119,0305-1870 (Print) 0305-1870 (Linking),34,2007 Jul,Frontiers in research reviews: arterial function: introduction.,645-6,,"['McGrath, Barry P', 'Laurent, Stephane']","['McGrath BP', 'Laurent S']","['Monash University, Centre for Vascular Health and Department of Vascular Sciences Dandenong Hospital Southern Health Victoria, Australia.']",['eng'],['Journal Article'],,Australia,Clin Exp Pharmacol Physiol,Clinical and experimental pharmacology & physiology,0425076,IM,"['Animals', 'Arteries/drug effects/*physiopathology', 'Biomarkers/*blood', 'Cardiovascular Agents/pharmacology/therapeutic use', 'Cardiovascular Diseases/blood/drug therapy/*etiology/physiopathology', 'Humans', 'Prognosis', 'Treatment Outcome']",2007/06/22 09:00,2007/08/02 09:00,['2007/06/22 09:00'],"['2007/06/22 09:00 [pubmed]', '2007/08/02 09:00 [medline]', '2007/06/22 09:00 [entrez]']","['CEP4653 [pii]', '10.1111/j.1440-1681.2007.04653.x [doi]']",ppublish,Clin Exp Pharmacol Physiol. 2007 Jul;34(7):645-6. doi: 10.1111/j.1440-1681.2007.04653.x.,7,,,,,,,,"['0 (Biomarkers)', '0 (Cardiovascular Agents)']",,,,,,,,,,,,,
10694594,NLM,MEDLINE,20000327,20141120,0828-282X (Print) 0828-282X (Linking),16,2000 Feb,The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition.,227-9,,"['Chockalingam, A', 'Balaguer-Vintro, I', 'Achutti, A', 'de Luna, A B', 'Chalmers, J', 'Farinaro, E', 'Lauzon, R', 'Martin, I', 'Papp, J G', 'Postiglione, A', 'Reddy, K S', 'Tse, T F']","['Chockalingam A', 'Balaguer-Vintro I', 'Achutti A', 'de Luna AB', 'Chalmers J', 'Farinaro E', 'Lauzon R', 'Martin I', 'Papp JG', 'Postiglione A', 'Reddy KS', 'Tse TF']","['Health Canada, Ottawa, Canada. arun_chockalingam']",['eng'],['Journal Article'],,England,Can J Cardiol,The Canadian journal of cardiology,8510280,IM,"['Cardiovascular Diseases/etiology/mortality/*prevention & control', 'Cause of Death', '*Developing Countries', '*Global Health', 'Health Resources', 'Humans', 'International Cooperation', 'Risk Factors']",2000/03/01 09:00,2000/04/01 09:00,['2000/03/01 09:00'],"['2000/03/01 09:00 [pubmed]', '2000/04/01 09:00 [medline]', '2000/03/01 09:00 [entrez]']",,ppublish,Can J Cardiol. 2000 Feb;16(2):227-9.,2,,,,,,,,,,,,,"['Can J Cardiol. 2000 Feb;16(2):230-1, 234-5. PMID: 10694595']",,,,,,,,
11218962,NLM,MEDLINE,20010315,20161026,0006-9248 (Print) 0006-9248 (Linking),101,2000,[Cardiovascular diseases at the turn of the millenium].,619-21,,"['Riecansky, I']",['Riecansky I'],['Kardiologicka klinika Slovenskeho ustavu srdcovych a cievnych chorob v Bratislave. bll@fmed.uniba.sk'],['slo'],"['English Abstract', 'Journal Article']",,Slovakia,Bratisl Lek Listy,Bratislavske lekarske listy,0065324,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/therapy', 'Forecasting', 'Global Health', 'Humans']",2001/02/24 12:00,2001/03/17 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/03/17 10:01 [medline]', '2001/02/24 12:00 [entrez]']",,ppublish,Bratisl Lek Listy. 2000;101(11):619-21.,11,"The coronary disease of the heart (CDH) will be the most frequent cause of mortality and inability to work in the 21st century not only in industrially advanced countries but also in the developing countries. This unfavourable, assumedly paradoxical tendency persevering despite the significant progress in diagnosis and therapy is caused by two circumstances: ageing of population (prolonged mean life expectancy) and the increase in the number of individuals afflicted with (CDH) and living up to high age. In result of this development, the rapid increase in the prevalence of heart failure, especially in the aged, becomes the main cause of mortality, morbidity and hospitalisation.",,,,,,,,,,,,,,Srdcovocievne choroby na prelome tisicroci.,,,,,,
27784850,NLM,MEDLINE,20181120,20181120,1880-3873 (Electronic) 1340-3478 (Print) 1340-3478 (Linking),24,2017 Mar 1,Risk Factor of Cardiovascular Disease Among Older Individuals.,258-261,10.5551/jat.ED064 [doi],"['Yatsuya, Hiroshi', 'Matsunaga, Masaaki', 'Li, Yuanying', 'Ota, Atsuhiko']","['Yatsuya H', 'Matsunaga M', 'Li Y', 'Ota A']","['Department of Public Health, Fujita Health University School of Medicine.']",['eng'],['Editorial'],20161026,Japan,J Atheroscler Thromb,Journal of atherosclerosis and thrombosis,9506298,IM,"['Aged', 'Cardiovascular Diseases/epidemiology/*etiology/physiopathology', 'Humans', 'Japan/epidemiology', 'Risk Factors']",2016/10/28 06:00,2018/11/21 06:00,['2016/10/28 06:00'],"['2016/10/28 06:00 [pubmed]', '2018/11/21 06:00 [medline]', '2016/10/28 06:00 [entrez]']",['10.5551/jat.ED064 [doi]'],ppublish,J Atheroscler Thromb. 2017 Mar 1;24(3):258-261. doi: 10.5551/jat.ED064. Epub 2016 Oct 26.,3,,,PMC5383542,['None.'],,,,,,,,,,,,,,,,,
11503387,NLM,MEDLINE,20010927,20131121,1547-1896 (Print) 0893-7400 (Linking),13,2000 Apr,Here comes tomorrow. Advances in cardiovascular medicine.,"86-8, 94, 96 passim",,"['Currey, R']",['Currey R'],"['Matthews Media Group, Inc., Rockville, Md., USA.']",['eng'],['Journal Article'],,United States,JAAPA,JAAPA : official journal of the American Academy of Physician Assistants,9513102,,"['Body Surface Potential Mapping', '*Cardiovascular Diseases/etiology/physiopathology/therapy', 'Genetic Therapy', 'Homocysteine/*physiology', 'Humans', 'Risk Factors']",2001/08/16 10:00,2001/09/28 10:01,['2001/08/16 10:00'],"['2001/08/16 10:00 [pubmed]', '2001/09/28 10:01 [medline]', '2001/08/16 10:00 [entrez]']",,ppublish,"JAAPA. 2000 Apr;13(4):86-8, 94, 96 passim.",4,,,,,,,,['0LVT1QZ0BA (Homocysteine)'],,,,,,,,,,,,,
33812949,NLM,MEDLINE,20210528,20210528,1874-1754 (Electronic) 0167-5273 (Linking),332,2021 Jun 1,Editorial to: The role of Saccharibacteria (TM7) in the oral microbiome as a predictor for secondary cardiovascular events.,202-203,S0167-5273(21)00629-X [pii] 10.1016/j.ijcard.2021.03.070 [doi],"['Cotti, Elisabetta', 'Mercuro, Giuseppe']","['Cotti E', 'Mercuro G']","['Department of Surgical Sciences, University of Cagliari, Italy. Electronic address: cottiendo@gmail.com.', 'Department of Medical Sciences, University of Cagliari, Italy.']",['eng'],"['Comment', 'Editorial']",20210401,Netherlands,Int J Cardiol,International journal of cardiology,8200291,IM,"['Bacteria', '*Cardiovascular Diseases/diagnosis/epidemiology', 'Humans', '*Microbiota']",2021/04/05 06:00,2021/05/29 06:00,['2021/04/04 20:40'],"['2021/03/27 00:00 [received]', '2021/03/29 00:00 [accepted]', '2021/04/05 06:00 [pubmed]', '2021/05/29 06:00 [medline]', '2021/04/04 20:40 [entrez]']","['S0167-5273(21)00629-X [pii]', '10.1016/j.ijcard.2021.03.070 [doi]']",ppublish,Int J Cardiol. 2021 Jun 1;332:202-203. doi: 10.1016/j.ijcard.2021.03.070. Epub 2021 Apr 1.,,,,,,['NOTNLM'],"['Apical periodontitis and cardiovascular diseases', 'Periodontitis and cardiovascular diseases']",,,,,['Int J Cardiol. 2021 May 15;331:255-261. PMID: 33529661'],,,,,,,,,,
2224925,NLM,MEDLINE,19901213,20091111,0008-6355 (Print) 0008-6355 (Linking),26,1990 Nov-Dec,Cardiovascular response to exercise.,31-6,,"['Oka, R K']",['Oka RK'],,['eng'],['Journal Article'],,United States,Cardiovasc Nurs,Cardio-vascular nursing,0004704,,"['Cardiac Output', 'Cardiovascular Diseases/*nursing/physiopathology/therapy', '*Cardiovascular Physiological Phenomena', 'Cardiovascular System/physiopathology', 'Heart Rate', 'Humans', '*Physical Exertion', 'Stroke Volume']",1990/11/01 00:00,1990/11/01 00:01,['1990/11/01 00:00'],"['1990/11/01 00:00 [pubmed]', '1990/11/01 00:01 [medline]', '1990/11/01 00:00 [entrez]']",,ppublish,Cardiovasc Nurs. 1990 Nov-Dec;26(6):31-6.,6,,,,,,,,,,,,,,,,,,,,,
33985391,NLM,MEDLINE,20210811,20220308,1477-0377 (Electronic) 1358-863X (Linking),26,2021 Aug,Taking a 'stand' against cardiovascular disease in the era of COVID-19.,383-385,10.1177/1358863X211012750 [doi],"['Rana, Mariam N', 'Neeland, Ian J']","['Rana MN', 'Neeland IJ']","['Department of Medicine, University Hospitals, Cleveland, OH, USA.', 'Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.', 'Department of Medicine, University Hospitals, Cleveland, OH, USA.', 'Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.', 'Harrington Heart and Vascular Institute, University Hospitals, Cleveland, OH, USA.']",['eng'],"['Comment', 'Editorial']",20210514,England,Vasc Med,"Vascular medicine (London, England)",9610930,IM,"['*COVID-19', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Humans', 'SARS-CoV-2', 'Sedentary Behavior']",2021/05/15 06:00,2021/08/12 06:00,['2021/05/14 05:32'],"['2021/05/15 06:00 [pubmed]', '2021/08/12 06:00 [medline]', '2021/05/14 05:32 [entrez]']",['10.1177/1358863X211012750 [doi]'],ppublish,Vasc Med. 2021 Aug;26(4):383-385. doi: 10.1177/1358863X211012750. Epub 2021 May 14.,4,,,,,['NOTNLM'],"['COVID-19', 'occupational health', 'sedentary behavior', 'standing desk']",,,,,['Vasc Med. 2021 Aug;26(4):374-382. PMID: 33813968'],,,,,,,,,,
33404581,NLM,MEDLINE,20210713,20220204,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),31,2020 Nov-Dec,From the Editor's Desk.,285,,"['Commerford, Pat']",['Commerford P'],['Editor-in-Chief.'],['eng'],"['Editorial', 'Introductory Journal Article']",,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['*Biomedical Research', '*Cardiovascular Diseases/diagnosis/epidemiology/physiopathology', 'Heart Disease Risk Factors', 'Humans', 'Prognosis', 'Risk Assessment']",2021/01/07 06:00,2021/07/14 06:00,['2021/01/06 12:17'],"['2021/01/06 12:17 [entrez]', '2021/01/07 06:00 [pubmed]', '2021/07/14 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2020 Nov-Dec;31(6):285.,6,,,PMC8762851,,,,,,,,,,,,,,,,,,
12636901,NLM,MEDLINE,20030729,20190822,0025-7753 (Print) 0025-7753 (Linking),120,2003 Mar 8,[Hypertriglyceridemia as a cardiovascular risk factor. The end of a controversy?].,303-7,,"['Rubies-Prat, Juan', 'Pedro-Botet, Juan']","['Rubies-Prat J', 'Pedro-Botet J']",['Departamento de Medicina. Universidad Autonoma de Barcelona. Barcelona. Espana.'],['spa'],"['Journal Article', 'Review']",,Spain,Med Clin (Barc),Medicina clinica,0376377,IM,"['Cardiovascular Diseases/blood/epidemiology/*etiology/prevention & control', 'Humans', 'Hypertriglyceridemia/*complications/physiopathology/prevention & control', 'Risk Factors']",2003/03/15 04:00,2003/07/30 05:00,['2003/03/15 04:00'],"['2003/03/15 04:00 [pubmed]', '2003/07/30 05:00 [medline]', '2003/03/15 04:00 [entrez]']","['S0025-7753(03)73683-5 [pii]', '10.1016/s0025-7753(03)73683-5 [doi]']",ppublish,Med Clin (Barc). 2003 Mar 8;120(8):303-7. doi: 10.1016/s0025-7753(03)73683-5.,8,,,,,,,,,,46,,,,,Hipertrigliceridemia como factor de riesgo cardiovascular. Fin de la controversia?,,,,,,
33025121,NLM,MEDLINE,20201106,20210922,1432-1289 (Electronic) 0020-9554 (Linking),61,2020 Nov,[Cardio-oncology: At the crossroads between two fields].,1111-1113,10.1007/s00108-020-00888-9 [doi],"['von Haehling, S', 'Hasenfuss, G']","['von Haehling S', 'Hasenfuss G']","['Klinik fur Kardiologie und Pneumologie, Universitatsmedizin Gottingen, Robert-Koch-Str. 40, 37075, Gottingen, Deutschland. stephan.von.haehling@med.uni-goettingen.de.', 'Klinik fur Kardiologie und Pneumologie, Universitatsmedizin Gottingen, Robert-Koch-Str. 40, 37075, Gottingen, Deutschland. hasenfus@med.uni-goettingen.de.']",['ger'],['Editorial'],,Germany,Internist (Berl),Der Internist,0264620,IM,"['*Cardiology', '*Cardiovascular Diseases/complications/diagnosis/therapy', 'Humans', '*Medical Oncology', '*Neoplasms/complications/diagnosis/therapy']",2020/10/08 06:00,2020/11/11 06:00,['2020/10/07 05:52'],"['2020/10/08 06:00 [pubmed]', '2020/11/11 06:00 [medline]', '2020/10/07 05:52 [entrez]']","['10.1007/s00108-020-00888-9 [pii]', '10.1007/s00108-020-00888-9 [doi]']",ppublish,Internist (Berl). 2020 Nov;61(11):1111-1113. doi: 10.1007/s00108-020-00888-9.,11,,,,,,,,,,,,,,,Die Kardioonkologie als Schnittstelle zwischen den Disziplinen.,,,,,,
15314934,NLM,MEDLINE,20040824,20041117,0023-7205 (Print) 0023-7205 (Linking),101,2004 Jul 22,[Report on the MONICA project in Umea. A good instruction on the prevention of cardiovascular diseases].,2390-1,,"['Berglund, Goran']",['Berglund G'],"['Lunds universitet, institutionen for medicin, kirurgi och ortopedi, Universitetssjukhuset MAS, Malmo. Goran.Berglund@medforsk.mas.lu.se']",['swe'],['Journal Article'],,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'Humans', 'Life Style', 'Risk Factors', 'Socioeconomic Factors', 'Sweden/epidemiology']",2004/08/19 05:00,2004/08/25 05:00,['2004/08/19 05:00'],"['2004/08/19 05:00 [pubmed]', '2004/08/25 05:00 [medline]', '2004/08/19 05:00 [entrez]']",,ppublish,Lakartidningen. 2004 Jul 22;101(30-31):2390-1.,30-31,,,,,,,,,,,,,,,MONICA-projektet i Umea redovisas. Bra vagledning for hur hjart-karlsjukdom kan forebyggas.,,,,,,
274986,NLM,MEDLINE,19780828,20220318,0028-7091 (Print) 0028-7091 (Linking),54,1978 Jun,Evaluation of cardiovascular risk in the elderly: the Framingham study.,573-91,,"['Kannel, W B', 'Gordan, T']","['Kannel WB', 'Gordan T']",,['eng'],['Journal Article'],,United States,Bull N Y Acad Med,Bulletin of the New York Academy of Medicine,7505398,IM,"['Adult', 'Age Factors', 'Aged', 'Blood Pressure', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Female', 'Humans', 'Hypertension/complications', 'Male', 'Middle Aged', 'Risk']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Bull N Y Acad Med. 1978 Jun;54(6):573-91.,6,,,PMC1807497,,,,,,,,,,,,,,,,,,
4454017,NLM,MEDLINE,19750609,20061115,0040-3660 (Print) 0040-3660 (Linking),46,1974,[Some pathogenetic characteristics of the development of circulatory insufficiency in the aged and the principles of treating it with cardiac glycosides].,25-33,,"['Morozov, K A', 'Slupskii, N N', 'Goriainova, A N', 'Koriakin, N N']","['Morozov KA', 'Slupskii NN', 'Goriainova AN', 'Koriakin NN']",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Aged', 'Arteriosclerosis/drug therapy/physiopathology', 'Cardiac Glycosides/*therapeutic use', 'Cardiovascular Diseases/drug therapy/*etiology/physiopathology', 'Heart Function Tests', 'Humans', 'Middle Aged']",1974/01/01 00:00,1974/01/01 00:01,['1974/01/01 00:00'],"['1974/01/01 00:00 [pubmed]', '1974/01/01 00:01 [medline]', '1974/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1974;46(12):25-33.,12,,,,,,,,['0 (Cardiac Glycosides)'],,,,,,,O nekotorykh patogeneticheskikh osobennostiakh razvitiia nedostatochnosti krovoobrashcheniia v pozhilom vozraste i o printsipakh ee lecheniia serdechnymi glikozidami.,,,,,,
19935679,NLM,MEDLINE,20100128,20211020,1759-5010 (Electronic) 1759-5002 (Linking),6,2009 Dec,The dual challenge of BP control.,729-30,10.1038/nrcardio.2009.202 [doi],"['Fuster, Valentin', 'King, Alexandra']","['Fuster V', 'King A']",,['eng'],['Editorial'],,England,Nat Rev Cardiol,Nature reviews. Cardiology,101500075,IM,"['Adult', 'Aged', 'Aged, 80 and over', 'Antihypertensive Agents/*therapeutic use', 'Blood Pressure/*drug effects', 'Cardiovascular Diseases/etiology/mortality/physiopathology/*prevention & control', 'Global Health', 'Humans', 'Hypertension/complications/*drug therapy/mortality/physiopathology', 'Middle Aged', 'Risk Assessment', 'Risk Factors', '*Risk Reduction Behavior', 'Treatment Outcome']",2009/11/26 06:00,2010/01/29 06:00,['2009/11/26 06:00'],"['2009/11/26 06:00 [entrez]', '2009/11/26 06:00 [pubmed]', '2010/01/29 06:00 [medline]']","['nrcardio.2009.202 [pii]', '10.1038/nrcardio.2009.202 [doi]']",ppublish,Nat Rev Cardiol. 2009 Dec;6(12):729-30. doi: 10.1038/nrcardio.2009.202.,12,,,,,,,,['0 (Antihypertensive Agents)'],,,,,,,,,,,,,
34619849,NLM,MEDLINE,20211011,20211011,0578-1426 (Print) 0578-1426 (Linking),60,2021 Jul 1,[Adverse psychological factors and atherosclerotic cardiovascular disease].,677-680,10.3760/cma.j.cn112138-20210507-00332 [doi],"['Dong, B']",['Dong B'],"[""Department of Cardiology, Provincial Hospital Affiliated to Shandong First Medical University, Ji'nan 250021, China, Email: bodong@sdu.edu.cn.""]",['chi'],['Journal Article'],,China,Zhonghua Nei Ke Za Zhi,Zhonghua nei ke za zhi,16210490R,IM,"['*Atherosclerosis', '*Cardiovascular Diseases/epidemiology/etiology', 'Humans', '*Myocardial Infarction']",2021/10/09 06:00,2021/10/12 06:00,['2021/10/08 01:48'],"['2021/10/08 01:48 [entrez]', '2021/10/09 06:00 [pubmed]', '2021/10/12 06:00 [medline]']",['10.3760/cma.j.cn112138-20210507-00332 [doi]'],ppublish,Zhonghua Nei Ke Za Zhi. 2021 Jul 1;60(7):677-680. doi: 10.3760/cma.j.cn112138-20210507-00332.,7,,,,,,,,,,,,,,,,,,,,,
32671754,NLM,MEDLINE,20200907,20200907,0065-2598 (Print) 0065-2598 (Linking),1207,2020,Application of Autophagy in Cardiovascular Diseases.,265-270,10.1007/978-981-15-4272-5_19 [doi],"['Du, Jie', 'Li, Yulin', 'Zhang, Congcong']","['Du J', 'Li Y', 'Zhang C']","['Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China. jiedubj@126.com.', 'Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China.', 'Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China.']",['eng'],"['Journal Article', 'Review']",,United States,Adv Exp Med Biol,Advances in experimental medicine and biology,0121103,IM,"['*Autophagy/drug effects', '*Cardiovascular Diseases/drug therapy/pathology', 'Disease Progression', 'Humans']",2020/07/17 06:00,2020/09/08 06:00,['2020/07/17 06:00'],"['2020/07/17 06:00 [entrez]', '2020/07/17 06:00 [pubmed]', '2020/09/08 06:00 [medline]']",['10.1007/978-981-15-4272-5_19 [doi]'],ppublish,Adv Exp Med Biol. 2020;1207:265-270. doi: 10.1007/978-981-15-4272-5_19.,,"Autophagy is closely related to the pathogenesis and progression of cardiovascular diseases. Autophagy may be a therapeutic target for many cardiovascular diseases. In this chapter, we will summarize autophagy activators and inhibitors as potential drugs for cardiovascular diseases.",,,,['NOTNLM'],"['Autophagy activators', 'Autophagy inhibitors', 'Drug']",,,,,,,,,,,,,,,
12963857,NLM,MEDLINE,20031218,20191107,1076-7460 (Print) 1076-7460 (Linking),12,2003 Sep-Oct,Executive summary: Second Pivotal Research in Cardiovascular Syndromes in the Elderly (PRICE-2) symposium. Acute coronary syndromes in the elderly: mechanisms and management.,"307-18, 327",,"['Rich, Michael W']",['Rich MW'],"['Washington University School of Medicine, St. Louis, MO 63110, USA. mrich@im.wustl.edu']",['eng'],['Congress'],,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Acute Disease', 'Aged', 'Aging/physiology', 'Cardiovascular Diseases/epidemiology/*physiopathology/*therapy', 'Humans', 'Research', 'Syndrome']",2003/09/10 05:00,2003/12/19 05:00,['2003/09/10 05:00'],"['2003/09/10 05:00 [pubmed]', '2003/12/19 05:00 [medline]', '2003/09/10 05:00 [entrez]']",['10.1111/j.1076-7460.2003.02225.x [doi]'],ppublish,"Am J Geriatr Cardiol. 2003 Sep-Oct;12(5):307-18, 327. doi: 10.1111/j.1076-7460.2003.02225.x.",5,,,,,,,,,,,,,,"['PRICE-2 Organizing Committee', 'PRICE-2 Investigators']",,,,,,,
10150346,NLM,MEDLINE,19950712,20051116,1042-9646 (Print) 1042-9646 (Linking),7,1995 Apr,Secondary prevention of cardiovascular disease.,48-56,,"['Robinson, J G']",['Robinson JG'],"['Heart Disease Prevention Clinic, University of Minnesota, Minneapolis, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Contemp Intern Med,Contemporary internal medicine,9007257,,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Cerebrovascular Disorders/prevention & control', 'Humans', 'Myocardial Infarction/prevention & control']",1995/03/09 00:00,1995/03/09 00:01,['1995/03/09 00:00'],"['1995/03/09 00:00 [pubmed]', '1995/03/09 00:01 [medline]', '1995/03/09 00:00 [entrez]']",,ppublish,Contemp Intern Med. 1995 Apr;7(4):48-56.,4,"In addition to proven approaches, new possibilities generate excitement in the medical community and in the press. Refinements of accepted options for secondary prevention and current data about others that are promising are the focus of this review.",,,,,,,,,34,,,,,,,,,,,
4428407,NLM,MEDLINE,19750128,20081121,0040-3660 (Print) 0040-3660 (Linking),46,1974,[Results and perspectives of scientific studies in the field of cardiology].,3-9,,"['Chazov, E I']",['Chazov EI'],,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Arteriosclerosis/etiology', '*Cardiology', '*Cardiovascular Diseases/diagnosis/etiology/therapy', 'Cardiovascular Physiological Phenomena', 'Electric Countershock', 'Electrocardiography', 'Humans', 'Hypertension/etiology', 'Myocardial Infarction/etiology/metabolism/therapy', 'Myocardium/metabolism', 'USSR']",1974/01/01 00:00,1974/01/01 00:01,['1974/01/01 00:00'],"['1974/01/01 00:00 [pubmed]', '1974/01/01 00:01 [medline]', '1974/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1974;46(6):3-9.,6,,,,,,,,,,,,,,,Itogi i perspektivy nauchnykh issledovanii v oblasti kardiologii.,,,,,,
5247263,NLM,MEDLINE,19690125,20221207,,23,1966 Jan-Feb,[The study of cardiovascular diseases].,89-106,,,,,['spa'],['Journal Article'],,Mexico,ADM,ADM; revista de la Asociacion Dental Mexicana,0370411,,"['Africa', 'Animals', 'Arteriosclerosis/complications/etiology/pathology', 'Black People', 'Cardiomyopathies/epidemiology', '*Cardiovascular Diseases/epidemiology/mortality', 'China', 'Coronary Disease/etiology', 'Dogs', 'Electrocardiography', 'Humans', 'Hypertension/etiology', 'Myocardial Infarction/epidemiology', 'Pulmonary Heart Disease/etiology', 'Swine']",1966/01/01 00:00,1966/01/01 00:01,['1966/01/01 00:00'],"['1966/01/01 00:00 [pubmed]', '1966/01/01 00:01 [medline]', '1966/01/01 00:00 [entrez]']",,ppublish,ADM. 1966 Jan-Feb;23(1):89-106.,1,,,,,,,,,,,,,,,La investigacion de las enfermedades cardiovasculares.,,,,,,
20333655,NLM,MEDLINE,20100618,20181201,1522-726X (Electronic) 1522-1946 (Linking),75,2010 Mar 1,Women in interventions: a win for cardiovascular medicine.,648-50,10.1002/ccd.22454 [doi],"['Bailey, Steven R']",['Bailey SR'],"['Division of Cardiology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA.']",['eng'],"['Journal Article', 'Portrait']",,United States,Catheter Cardiovasc Interv,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,100884139,IM,"['*Cardiology', '*Cardiovascular Diseases/diagnosis/etiology/mortality/therapy', '*Career Choice', 'Cooperative Behavior', 'Evidence-Based Medicine', 'Female', '*Health Status Disparities', '*Healthcare Disparities', 'Humans', 'Interinstitutional Relations', 'International Cooperation', 'Male', 'Sex Factors', 'Treatment Outcome', 'United States', ""*Women's Health"", 'Workforce']",2010/03/25 06:00,2010/06/19 06:00,['2010/03/25 06:00'],"['2010/03/25 06:00 [entrez]', '2010/03/25 06:00 [pubmed]', '2010/06/19 06:00 [medline]']",['10.1002/ccd.22454 [doi]'],ppublish,Catheter Cardiovasc Interv. 2010 Mar 1;75(4):648-50. doi: 10.1002/ccd.22454.,4,,,,,,,,,,,,,,,,,,,,,
25820059,NLM,MEDLINE,20161213,20161230,2213-3763 (Electronic) 0019-4832 (Print) 0019-4832 (Linking),67,2015 Jan-Feb,Yoga: from cardiovascular benefit to the gates of God.,83-4,S0019-4832(15)00022-X [pii] 10.1016/j.ihj.2015.02.018 [doi],"['Natarajan, Deepak']",['Natarajan D'],"['Director Interventional Cardiology, Park Hospitals, Delhi NCR, India. Electronic address: deepaknatarajan19@gmail.com.']",['eng'],"['Journal Article', 'Review']",20150311,India,Indian Heart J,Indian heart journal,0374675,IM,"['*Cardiovascular Diseases/physiopathology/prevention & control/psychology', 'Cardiovascular System/*physiopathology', 'Humans', 'Meditation/*methods', '*Yoga']",2015/03/31 06:00,2016/12/15 06:00,['2015/03/31 06:00'],"['2015/03/31 06:00 [entrez]', '2015/03/31 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['S0019-4832(15)00022-X [pii]', '10.1016/j.ihj.2015.02.018 [doi]']",ppublish,Indian Heart J. 2015 Jan-Feb;67(1):83-4. doi: 10.1016/j.ihj.2015.02.018. Epub 2015 Mar 11.,1,,,PMC4382557,,,,,,,,,,['Indian Heart J. 2015 Nov-Dec;67(6):617. PMID: 26702704'],,,,,,,,
26323123,NLM,MEDLINE,20150928,20191210,1001-5302 (Print) 1001-5302 (Linking),40,2015 May,[Advances in cardiovascular effects of tanshinone II(A)].,1649-53,,"['Chen, Fen-yan', 'Guo, Ren', 'Zhang, Bi-kui']","['Chen FY', 'Guo R', 'Zhang BK']",,['chi'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,China,Zhongguo Zhong Yao Za Zhi,Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,8913656,IM,"['Abietanes/*therapeutic use', 'Animals', 'Cardiovascular Diseases/*drug therapy/genetics/metabolism/physiopathology', 'Coronary Vessels/drug effects/physiopathology', 'Humans']",2015/09/02 06:00,2015/09/29 06:00,['2015/09/02 06:00'],"['2015/09/02 06:00 [entrez]', '2015/09/02 06:00 [pubmed]', '2015/09/29 06:00 [medline]']",,ppublish,Zhongguo Zhong Yao Za Zhi. 2015 May;40(9):1649-53.,9,"Cardiovascular diseases, like coronary heart disease and myocardial infarction, are the most common cause of death worldwide. Chinese medicines have demonstrated rich cardioprotective activities for clinical applications. Salvia miltiorrhiza, a very important component of traditional Chinese medicine, can promote blood circulation and relieve blood stasis. Salvia miltiorrhiza is widely used in treatment of cardiovascular and cerebrovascular disease such as coronary heart disease and cerebral infarction ( CI). Tanshinone II(A), the major lipophilic components extracted from the root of S. miltiorrhiza, possesses anti-atherosclerosis, anti-cardiac hypertrophy, anti-oxidant, anti-arrhythmia and so on. This paper discusses current research status of tanshinone II(A) in cardioprotective effects.",,,,,,,"['0 (Abietanes)', '03UUH3J385 (tanshinone)']",,,,,,,,,,,,,
23716577,NLM,MEDLINE,20130730,20211021,1091-6490 (Electronic) 0027-8424 (Print) 0027-8424 (Linking),110,2013 May 28,PM 2.5.,8756,10.1073/pnas.1307735110 [doi],"['Marshall, Jessica']",['Marshall J'],,['eng'],['Journal Article'],,United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Cardiovascular Diseases/*epidemiology/*etiology/*prevention & control', 'Global Health', 'Government Regulation', 'Humans', 'Particulate Matter/*adverse effects/analysis']",2013/05/30 06:00,2013/07/31 06:00,['2013/05/30 06:00'],"['2013/05/30 06:00 [entrez]', '2013/05/30 06:00 [pubmed]', '2013/07/31 06:00 [medline]']","['110/22/8756 [pii]', '201307735 [pii]', '10.1073/pnas.1307735110 [doi]']",ppublish,Proc Natl Acad Sci U S A. 2013 May 28;110(22):8756. doi: 10.1073/pnas.1307735110.,22,,,PMC3670349,,,,,['0 (Particulate Matter)'],,,,,,,,,,,,,
16194655,NLM,MEDLINE,20051209,20161124,0002-9343 (Print) 0002-9343 (Linking),118,2005 Oct,Cardiovascular abnormalities in hyperthyroidism.,1175,,"['Osman, Faizel', 'Franklyn, Jayne A', 'Gammage, Michael D']","['Osman F', 'Franklyn JA', 'Gammage MD']",,['eng'],"['Comment', 'Letter']",,United States,Am J Med,The American journal of medicine,0267200,IM,"['Cardiovascular Diseases/diagnostic imaging/epidemiology/*etiology', 'Case-Control Studies', 'Echocardiography, Doppler', 'Humans', 'Hyperthyroidism/*complications', 'Patient Selection']",2005/10/01 09:00,2005/12/13 09:00,['2005/10/01 09:00'],"['2005/02/18 00:00 [received]', '2005/02/21 00:00 [accepted]', '2005/10/01 09:00 [pubmed]', '2005/12/13 09:00 [medline]', '2005/10/01 09:00 [entrez]']","['S0002-9343(05)00196-8 [pii]', '10.1016/j.amjmed.2005.02.030 [doi]']",ppublish,Am J Med. 2005 Oct;118(10):1175. doi: 10.1016/j.amjmed.2005.02.030.,10,,,,,,,,,,,['Am J Med. 2005 Feb;118(2):126-31. PMID: 15694895'],,['Am J Med. 2006 May;119(5):e25. PMID: 16651042'],,,,,,,,
12125590,NLM,MEDLINE,20020722,20181130,0160-2446 (Print) 0160-2446 (Linking),38 Suppl 2,2001 Nov,"Proceedings of the meeting New Insights and Therapeutic Strategies in Cardiovascular Disease: Focus on Endothelial Targets. Venice, Italy, April 28-29, 2000.",S1-87,,,,,['eng'],"['Congress', 'Overall']",,United States,J Cardiovasc Pharmacol,Journal of cardiovascular pharmacology,7902492,IM,"['Animals', 'Cardiovascular Diseases/etiology/*physiopathology/therapy', 'Endothelium, Vascular/drug effects/*physiology', 'Humans']",2002/07/20 10:00,2002/07/23 10:01,['2002/07/20 10:00'],"['2002/07/20 10:00 [pubmed]', '2002/07/23 10:01 [medline]', '2002/07/20 10:00 [entrez]']",,ppublish,J Cardiovasc Pharmacol. 2001 Nov;38 Suppl 2:S1-87.,,,,,,,,,,,,,,,,,,,,,,
3424191,NLM,MEDLINE,19880128,20071115,0040-3660 (Print) 0040-3660 (Linking),59,1987,[Improvement in the diagnosis of the causes of death from the main cardiovascular diseases].,61-4,,"['Belenkov, Iu N', 'Zhdanov, V S', 'Pichugin, V N', 'Marchenko, O V', 'Iurova, I V']","['Belenkov IuN', 'Zhdanov VS', 'Pichugin VN', 'Marchenko OV', 'Iurova IV']",,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Cardiovascular Diseases/diagnosis/*mortality/pathology', '*Cause of Death', 'Coronary Artery Disease/diagnosis/mortality/pathology', 'Coronary Disease/diagnosis/mortality/pathology', 'Humans', 'Hypertension/diagnosis/mortality/pathology', 'Myocardium/pathology', 'USSR']",1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1987;59(9):61-4.,9,,,,,,,,,,,,,,,Sovershenstvovanie diagnostiki prichin smerti ot osnovnykh boleznei serdechno-sosudistoi sistemy.,,,,,,
12680569,NLM,MEDLINE,20030430,20191107,0889-4655 (Print) 0889-4655 (Linking),18,2003 Apr-Jun,Aggressive blood pressure management.,108-15,,"['Miller, Nancy Houston']",['Miller NH'],"['Stanford University, Stanford, Calif, USA. nhm@stanford.edu']",['eng'],"['Journal Article', 'Review']",,United States,J Cardiovasc Nurs,The Journal of cardiovascular nursing,8703516,IM,"['Cardiovascular Diseases/*diagnosis/etiology/*prevention & control', 'Female', 'Humans', 'Hypertension/complications/*diagnosis/*therapy', 'Male']",2003/04/12 05:00,2003/05/06 05:00,['2003/04/12 05:00'],"['2003/04/12 05:00 [pubmed]', '2003/05/06 05:00 [medline]', '2003/04/12 05:00 [entrez]']",['10.1097/00005082-200304000-00006 [doi]'],ppublish,J Cardiovasc Nurs. 2003 Apr-Jun;18(2):108-15. doi: 10.1097/00005082-200304000-00006.,2,"More than one third of all Americans have high or high-normal blood pressure and are at risk for stroke, cardiovascular disease, kidney disease, and heart failure. Many of these are not diagnosed or are inadequately treated. The large number of untreated individuals at risk for the complications of hypertension, or who have not achieved goal pressures on therapy, require a concerted effort by health care professionals to screen and treat this condition. Aggressive identification and treatment of even high-normal hypertension can reduce adverse outcomes. The importance of aggressive management is outlined in this article.",,,,,,,,,41,,,,,,,,,,,
21098469,NLM,MEDLINE,20120110,20211020,1524-4539 (Electronic) 0009-7322 (Linking),122,2010 Nov 16,"The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.",2078-88,10.1161/CIRCULATIONAHA.109.873232 [doi],"['Lonn, Eva', 'Bosch, Jackie', 'Teo, Koon K', 'Pais, Prem', 'Xavier, Denis', 'Yusuf, Salim']","['Lonn E', 'Bosch J', 'Teo KK', 'Pais P', 'Xavier D', 'Yusuf S']","['Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada. Eva.Lonn@phri.ca']",['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Age Factors', 'Cardiovascular Diseases/epidemiology/metabolism/*prevention & control', 'Drug Therapy, Combination/*methods', 'Female', 'Humans', 'Male', 'Risk Factors']",2010/11/26 06:00,2012/01/11 06:00,['2010/11/25 06:00'],"['2010/11/25 06:00 [entrez]', '2010/11/26 06:00 [pubmed]', '2012/01/11 06:00 [medline]']","['122/20/2078 [pii]', '10.1161/CIRCULATIONAHA.109.873232 [doi]']",ppublish,Circulation. 2010 Nov 16;122(20):2078-88. doi: 10.1161/CIRCULATIONAHA.109.873232.,20,,,,,,,['089725/WT_/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,
23786122,NLM,MEDLINE,20130730,20151119,0040-7453 (Print) 0040-7453 (Linking),138,2013 May 1,[Development in veterinary cardiology].,304,,"['Thissen, Simone']",['Thissen S'],,['dut'],['Journal Article'],,Netherlands,Tijdschr Diergeneeskd,Tijdschrift voor diergeneeskunde,0031550,IM,"['Animals', 'Biomarkers/analysis', 'Cardiovascular Diseases/diagnosis/prevention & control/therapy/*veterinary', 'Cat Diseases/*diagnosis/prevention & control/therapy', 'Cats', 'Dog Diseases/*diagnosis/prevention & control/therapy', 'Dogs', 'Practice Guidelines as Topic', 'Prognosis', 'Veterinary Medicine/standards/*trends']",2013/06/22 06:00,2013/07/31 06:00,['2013/06/22 06:00'],"['2013/06/22 06:00 [entrez]', '2013/06/22 06:00 [pubmed]', '2013/07/31 06:00 [medline]']",,ppublish,Tijdschr Diergeneeskd. 2013 May 1;138(5):304.,5,,,,,,,,['0 (Biomarkers)'],,,,,,,Ontwikkelingen in de veterinaire cardiologie.,,,,,,
10872693,NLM,MEDLINE,20001103,20191104,1401-7431 (Print) 1401-7431 (Linking),34,2000,Prevention of cardiovascular diseases--a scientific dilemma.,103-5,,"['Thelle, D']",['Thelle D'],"['Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden.']",['eng'],['Journal Article'],,England,Scand Cardiovasc J,Scandinavian cardiovascular journal : SCJ,9708377,IM,"['Cardiovascular Diseases/etiology/*prevention & control', 'Community Medicine', 'Humans']",2000/06/29 11:00,2001/02/28 10:01,['2000/06/29 11:00'],"['2000/06/29 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/06/29 11:00 [entrez]']",['10.1080/14017430050142080 [doi]'],ppublish,Scand Cardiovasc J. 2000;34(2):103-5. doi: 10.1080/14017430050142080.,2,,,,,,,,,,,,,['Scand Cardiovasc J. 2000 Jun;34(3):229-30. PMID: 10935766'],,,,,,,,
1497591,NLM,MEDLINE,19920910,20191028,0067-8198 (Print) 0067-8198 (Linking),,1992,"Oxygen free radicals, lipid metabolism, and whole blood and plasma viscosity in the prevention and treatment of human cardiovascular diseases.",111-24,,"['Mozsik, G', 'Fiegler, M', 'Juricskay, I', 'Mezey, B', 'Toth, K']","['Mozsik G', 'Fiegler M', 'Juricskay I', 'Mezey B', 'Toth K']","['First Department of Medicine, Medical University of Pecs, Hungary.']",['eng'],"['Journal Article', 'Review']",,Switzerland,Bibl Nutr Dieta,Bibliotheca nutritio et dieta,0413657,IM,"['Animals', '*Blood Viscosity', 'Cardiovascular Diseases/blood/*prevention & control/therapy', '*Free Radical Scavengers', 'Humans', '*Lipid Metabolism', 'Oxygen/*metabolism']",1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",['10.1159/000421440 [doi]'],ppublish,Bibl Nutr Dieta. 1992;(49):111-24. doi: 10.1159/000421440.,49,,,,,,,,"['0 (Free Radical Scavengers)', 'S88TT14065 (Oxygen)']",,24,,,,,,,,,,,
24169589,NLM,MEDLINE,20140801,20131030,2047-4881 (Electronic) 2047-4873 (Linking),20,2013 Dec,Psychosocial interventions in cardiovascular disease--what are they?,916-7,10.1177/2047487313494031 [doi],"['Thompson, David R', 'Ski, Chantal F']","['Thompson DR', 'Ski CF']","['Cardiovascular Research Centre, Australian Catholic University, Melbourne, Australia.']",['eng'],['Editorial'],20130607,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiovascular Diseases/diagnosis/psychology/*therapy', 'Humans', 'Psychotherapy/classification/*methods', 'Research Design', '*Social Support', '*Terminology as Topic', 'Treatment Outcome']",2013/10/31 06:00,2014/08/02 06:00,['2013/10/31 06:00'],"['2013/10/31 06:00 [entrez]', '2013/10/31 06:00 [pubmed]', '2014/08/02 06:00 [medline]']","['2047487313494031 [pii]', '10.1177/2047487313494031 [doi]']",ppublish,Eur J Prev Cardiol. 2013 Dec;20(6):916-7. doi: 10.1177/2047487313494031. Epub 2013 Jun 7.,6,,,,,,,,,,,,,,,,,,,,,
9926281,NLM,MEDLINE,19990330,20190915,0920-3206 (Print) 0920-3206 (Linking),12,1998 Oct,The limits of evidence-based cardiovascular therapy.,487-91,,"['Hampton, J R']",['Hampton JR'],"['Cardiovascular Medicine, University Hospital, Nottingham, England. John.Hampton@nottingham.ac.uk']",['eng'],"['Journal Article', 'Review']",,United States,Cardiovasc Drugs Ther,Cardiovascular drugs and therapy,8712220,IM,"['Cardiovascular Diseases/drug therapy/mortality/*therapy', 'Clinical Trials as Topic', '*Evidence-Based Medicine', 'Humans', 'Meta-Analysis as Topic', 'Therapeutic Equivalency']",1999/02/02 00:00,1999/02/02 00:01,['1999/02/02 00:00'],"['1999/02/02 00:00 [pubmed]', '1999/02/02 00:01 [medline]', '1999/02/02 00:00 [entrez]']",['10.1023/a:1007762318098 [doi]'],ppublish,Cardiovasc Drugs Ther. 1998 Oct;12(5):487-91. doi: 10.1023/a:1007762318098.,5,,,,,,,,,,37,,,,,,,,,,,
24716312,NLM,MEDLINE,20140512,20140410,0095-8301 (Print) 0095-8301 (Linking),67,2014 Feb,Listen to your heart.,"34, 36-7",,"['Berg, Erika Gebel']",['Berg EG'],,['eng'],['Journal Article'],,United States,Diabetes Forecast,Diabetes forecast,7504241,,"['Cardiovascular Diseases/complications/physiopathology/*prevention & control', 'Coronary Angiography/methods', 'Diabetes Complications', 'Echocardiography', 'Electrocardiography', 'Humans']",2014/04/11 06:00,2014/05/13 06:00,['2014/04/11 06:00'],"['2014/04/11 06:00 [entrez]', '2014/04/11 06:00 [pubmed]', '2014/05/13 06:00 [medline]']",,ppublish,"Diabetes Forecast. 2014 Feb;67(2):34, 36-7.",2,,,,,,,,,,,,,,,,,,,,,
24288918,NLM,MEDLINE,20140204,20201209,1438-3276 (Print) 1438-3276 (Linking),155,2013 Oct 24,[With a dog heart disease patients live longer].,36,,"['Holzgreve, H']",['Holzgreve H'],,['ger'],['News'],,Germany,MMW Fortschr Med,MMW Fortschritte der Medizin,100893959,IM,"['Animals', 'Cardiovascular Diseases/mortality/*prevention & control/*psychology', 'Dogs/*psychology', '*Human-Animal Bond', 'Humans', 'Longevity', 'United States']",2013/12/03 06:00,2014/02/05 06:00,['2013/12/03 06:00'],"['2013/12/03 06:00 [entrez]', '2013/12/03 06:00 [pubmed]', '2014/02/05 06:00 [medline]']",['10.1007/s15006-013-2275-0 [doi]'],ppublish,MMW Fortschr Med. 2013 Oct 24;155(18):36. doi: 10.1007/s15006-013-2275-0.,18,,,,,,,,,,,,,,,Mit Hund leben Herzkranke Ianger.,,,,,,
21900771,NLM,MEDLINE,20120403,20110908,1531-7072 (Electronic) 1070-5295 (Linking),17,2011 Oct,Current world literature.,538-45,10.1097/MCC.0b013e32834b7d59 [doi],,,,['eng'],['Bibliography'],,United States,Curr Opin Crit Care,Current opinion in critical care,9504454,IM,"['*Cardiovascular Diseases/diagnosis/etiology/therapy', '*Communicable Diseases/diagnosis/etiology/therapy', '*Critical Care/organization & administration', 'Humans']",2011/09/09 06:00,2012/04/04 06:00,['2011/09/09 06:00'],"['2011/09/09 06:00 [entrez]', '2011/09/09 06:00 [pubmed]', '2012/04/04 06:00 [medline]']","['00075198-201110000-00020 [pii]', '10.1097/MCC.0b013e32834b7d59 [doi]']",ppublish,Curr Opin Crit Care. 2011 Oct;17(5):538-45. doi: 10.1097/MCC.0b013e32834b7d59.,5,,,,,,,,,,,,,,,,,,,,,
20991636,NLM,MEDLINE,20101028,20221207,0038-2310 (Print) 0038-2310 (Linking),11,1946 Apr,"Cardio-vascular disease in the Bantu and coloured races of South Africa; incidence, pathology and general features.",1-4,,"['BECKER, B J P']",['BECKER BJ'],,['eng'],['Journal Article'],,South Africa,S Afr J Med Sci,The South African journal of medical sciences,2984853R,OM,"['Africa', '*Black People', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Geography', 'Humans', 'Incidence', '*Racial Groups', 'South Africa', '*Vascular Diseases']",1946/04/01 00:00,1946/04/01 00:01,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/04/01 00:00 [pubmed]', '1946/04/01 00:01 [medline]']",,ppublish,S Afr J Med Sci. 1946 Apr;11:1-4.,,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/epidemiology and statistics', '*CARDIOVASCULAR DISEASES/racial aspects', '*GEOGRAPHY, MEDICAL/Africa', '*NEGROES']",,,,,,,,,,,,,,['CLML: 4611:439n'],
28111417,NLM,MEDLINE,20170302,20170817,1347-4820 (Electronic) 1346-9843 (Linking),81,2017 Jan 25,Guidelines for Perioperative Cardiovascular Evaluation and Management for Noncardiac Surgery (JCS 2014)- Digest Version.,245-267,10.1253/circj.CJ-66-0135 [doi],"['Kyo, Shunei', 'Imanaka, Kazuhito', 'Masuda, Munetaka', 'Miyata, Tetsuro', 'Morita, Kiyozo', 'Morota, Tetsuro', 'Nomura, Minoru', 'Saiki, Yoshikatsu', 'Sawa, Yoshiki', 'Sueda, Taijiro', 'Ueda, Yuichi', 'Yamazaki, Kenji', 'Yozu, Ryohei', 'Iwamoto, Mari', 'Kawamoto, Shunsuke', 'Koyama, Isamu', 'Kudo, Mikihiko', 'Matsumiya, Goro', 'Orihashi, Kazumasa', 'Oshima, Hideki', 'Saito, Satoshi', 'Sakamoto, Yoshimasa', 'Shigematsu, Kunihiro', 'Taketani, Tsuyoshi', 'Komuro, Issei', 'Takamoto, Shinichi', 'Tei, Chuwa', 'Yamamoto, Fumio']","['Kyo S', 'Imanaka K', 'Masuda M', 'Miyata T', 'Morita K', 'Morota T', 'Nomura M', 'Saiki Y', 'Sawa Y', 'Sueda T', 'Ueda Y', 'Yamazaki K', 'Yozu R', 'Iwamoto M', 'Kawamoto S', 'Koyama I', 'Kudo M', 'Matsumiya G', 'Orihashi K', 'Oshima H', 'Saito S', 'Sakamoto Y', 'Shigematsu K', 'Taketani T', 'Komuro I', 'Takamoto S', 'Tei C', 'Yamamoto F']",,['eng'],"['Journal Article', 'Practice Guideline']",20170120,Japan,Circ J,Circulation journal : official journal of the Japanese Circulation Society,101137683,IM,"['*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Female', 'Humans', 'Male', 'Perioperative Care', 'Pregnancy']",2017/01/24 06:00,2017/03/03 06:00,['2017/01/24 06:00'],"['2017/01/24 06:00 [pubmed]', '2017/03/03 06:00 [medline]', '2017/01/24 06:00 [entrez]']",['10.1253/circj.CJ-66-0135 [doi]'],ppublish,Circ J. 2017 Jan 25;81(2):245-267. doi: 10.1253/circj.CJ-66-0135. Epub 2017 Jan 20.,2,,,,,,,,,,,,,,['Japanese Circulation Society Joint Working Group'],,,,,,,
19364987,NLM,MEDLINE,20090514,20151119,1524-4539 (Electronic) 0009-7322 (Linking),119,2009 Apr 14,Is the horse already out of the barn in rural India?,1850-2,10.1161/CIRCULATIONAHA.109.853614 [doi],"['Gaziano, Thomas A']",['Gaziano TA'],,['eng'],"['Comment', 'Editorial']",,United States,Circulation,Circulation,0147763,IM,"['Autopsy', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control/*therapy', 'Cost of Illness', 'Developing Countries/statistics & numerical data', 'Humans', 'India/epidemiology', 'Rural Population', '*Secondary Prevention', 'Surveys and Questionnaires']",2009/04/15 09:00,2009/05/15 09:00,['2009/04/15 09:00'],"['2009/04/15 09:00 [entrez]', '2009/04/15 09:00 [pubmed]', '2009/05/15 09:00 [medline]']","['119/14/1850 [pii]', '10.1161/CIRCULATIONAHA.109.853614 [doi]']",ppublish,Circulation. 2009 Apr 14;119(14):1850-2. doi: 10.1161/CIRCULATIONAHA.109.853614.,14,,,,,,,,,,,['Circulation. 2009 Apr 14;119(14):1950-5. PMID: 19332466'],,,,,,,,,,
19505269,NLM,MEDLINE,20090817,20090609,1744-8344 (Electronic) 1477-9072 (Linking),7,2009 Jun,Assessment of endothelial function: implications for hypertension and cardiovascular disorders.,561-3,10.1586/erc.09.36 [doi],"['Butt, Mehmood', 'Dwivedi, Girish', 'Khair, Omer', 'Lip, Gregory Yh']","['Butt M', 'Dwivedi G', 'Khair O', 'Lip GY']",,['eng'],['Editorial'],,England,Expert Rev Cardiovasc Ther,Expert review of cardiovascular therapy,101182328,IM,"['Animals', 'Cardiovascular Diseases/drug therapy/etiology/*physiopathology', 'Endothelium, Vascular/metabolism/*pathology', 'Humans', 'Hypertension/drug therapy/etiology/*physiopathology', 'Prognosis']",2009/06/10 09:00,2009/08/18 09:00,['2009/06/10 09:00'],"['2009/06/10 09:00 [entrez]', '2009/06/10 09:00 [pubmed]', '2009/08/18 09:00 [medline]']",['10.1586/erc.09.36 [doi]'],ppublish,Expert Rev Cardiovasc Ther. 2009 Jun;7(6):561-3. doi: 10.1586/erc.09.36.,6,,,,,,,,,,,,,,,,,,,,,
9157767,NLM,MEDLINE,19970521,20161018,1997-7298 (Print) 1997-7298 (Linking),97,1997,[Cardiovascular diseases and depressions].,71-5,,"['Lapin, I P', 'Annalova, N A']","['Lapin IP', 'Annalova NA']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Zh Nevrol Psikhiatr Im S S Korsakova,Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,9712194,IM,"['Cardiovascular Diseases/*complications/psychology/therapy', 'Chronic Disease', 'Combined Modality Therapy', 'Depression/*etiology/psychology/therapy', 'Depressive Disorder/*etiology/psychology/therapy', 'Humans', 'Hypertension/complications/psychology/therapy', 'Myocardial Ischemia/complications/psychology/therapy', 'Psychophysiologic Disorders/etiology/psychology/therapy']",1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(3):71-5.,3,,,,,,,,,,50,,,,,Serdechno-sosudistye zabolevaniia i depressii.,,,,,,
11203506,NLM,MEDLINE,20010104,20041117,0029-6465 (Print) 0029-6465 (Linking),35,2000 Dec,"Acute Care Cardiology, Preface.",xiii-xiv,,"['Cheek, D J', 'Granger, B B']","['Cheek DJ', 'Granger BB']","['Duke University School of Nursing, DUMC, Durham, NC 27710, USA.']",['eng'],['Journal Article'],,United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,IM,"['*Cardiovascular Diseases/epidemiology/mortality/therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Research/*trends', 'United States/epidemiology']",2001/02/24 12:00,2001/02/28 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/02/28 10:01 [medline]', '2001/02/24 12:00 [entrez]']",,ppublish,Nurs Clin North Am. 2000 Dec;35(4):xiii-xiv.,4,,,,,,,,,,,,,,,,,,,,,
24240914,NLM,MEDLINE,20131204,20161017,1538-3598 (Electronic) 0098-7484 (Linking),310,2013 Nov 20,"Costs of cardiac care likely to increase, despite advances in prevention, care.",2029,10.1001/jama.2013.282805 [doi],"['Kuehn, Bridget M']",['Kuehn BM'],,['eng'],['News'],,United States,JAMA,JAMA,7501160,IM,"['Cardiovascular Diseases/*economics/*epidemiology/prevention & control/therapy', 'Forecasting', 'Health Care Costs/*trends', 'Humans', 'Life Expectancy', 'Nutrition Surveys', 'Prevalence', 'Risk', 'United States/epidemiology']",2013/11/19 06:00,2013/12/16 06:00,['2013/11/19 06:00'],"['2013/11/19 06:00 [entrez]', '2013/11/19 06:00 [pubmed]', '2013/12/16 06:00 [medline]']","['1779531 [pii]', '10.1001/jama.2013.282805 [doi]']",ppublish,JAMA. 2013 Nov 20;310(19):2029. doi: 10.1001/jama.2013.282805.,19,,,,,,,,,,,,,,,,,,,,,
10476602,NLM,MEDLINE,19990930,20041117,0393-1978 (Print) 0393-1978 (Linking),44,1999 Aug,"[Recommendations for cardiovascular assessment and risk reduction in diabetes--1999. Societa Italiana di Diabetologia, the Diabetes and Atherosclerosis Study Group, Associazione Medici Diabetologi].",751-8,,"['Ceriello, A', 'Boemi, M', 'Cucinotta, D', 'De Feo, P', 'Gensini, G F', 'Lala, A', 'Manzato, E', 'Rivellese, A', 'Ruotolo, G', 'Vannuzzo, D', 'Zavaroni, I']","['Ceriello A', 'Boemi M', 'Cucinotta D', 'De Feo P', 'Gensini GF', 'Lala A', 'Manzato E', 'Rivellese A', 'Ruotolo G', 'Vannuzzo D', 'Zavaroni I']","['Cattedra di Medicina Interna, Universita degli Studi, Udine. antonio.ceriello@dpmsc.uniud.it']",['ita'],"['Guideline', 'Journal Article', 'Practice Guideline']",,Italy,Cardiologia,"Cardiologia (Rome, Italy)",8506637,IM,"['Cardiovascular Diseases/*diagnosis/prevention & control/therapy', 'Diabetic Angiopathies/*diagnosis/prevention & control/therapy', 'Humans', 'Italy', 'Risk Factors']",1999/09/07 00:00,1999/09/07 00:01,['1999/09/07 00:00'],"['1999/09/07 00:00 [pubmed]', '1999/09/07 00:01 [medline]', '1999/09/07 00:00 [entrez]']",,ppublish,Cardiologia. 1999 Aug;44(8):751-8.,8,,,,,,,,,,,,,,,"Raccomandazioni per la valutazione e la riduzione del rischio cardiovascolare nel diabete--1999. Societa di Diabetologia, Gruppo di Studio ""Diabete e Aterosclerosi"", Associazione Medici Diabetologi.",,,,,,
11122779,NLM,MEDLINE,20010712,20191104,1523-3804 (Print) 1523-3804 (Linking),2,2000 Nov,Beyond cholesterol lowering: deciphering the benefits of dietary intervention on cardiovascular diseases.,461-6,,"['Mustad, V A', 'Kris-Etherton, P M']","['Mustad VA', 'Kris-Etherton PM']","['Strategic-Discovery Research Development, Ross Products Division Abbott Laboratories, 625 Cleveland Avenue, RP3-2, #105670, Columbus, OH 43215, USA. vikkie.mustad@rossnutrition.com']",['eng'],"['Journal Article', 'Review']",,United States,Curr Atheroscler Rep,Current atherosclerosis reports,100897685,IM,"['Cardiovascular Diseases/*diet therapy/epidemiology/prevention & control', 'Female', 'Humans', 'Incidence', 'Male', 'Meta-Analysis as Topic', 'Risk Factors']",2000/12/21 11:00,2001/07/13 10:01,['2000/12/21 11:00'],"['2000/12/21 11:00 [pubmed]', '2001/07/13 10:01 [medline]', '2000/12/21 11:00 [entrez]']",['10.1007/s11883-000-0044-x [doi]'],ppublish,Curr Atheroscler Rep. 2000 Nov;2(6):461-6. doi: 10.1007/s11883-000-0044-x.,6,,,,,,,,,,25,,,,,,,,,,,
16563268,NLM,MEDLINE,20100216,20111017,0253-3758 (Print) 0253-3758 (Linking),33,2005 Nov,[RNAi and its application for treatment of cardiovascular diseases].,1058-60,,"['Tang, Yu', 'Ge, Yu-zhi', 'Yin, Qin-wei']","['Tang Y', 'Ge YZ', 'Yin QW']",,['chi'],"['Journal Article', 'Review']",,China,Zhonghua Xin Xue Guan Bing Za Zhi,Zhonghua xin xue guan bing za zhi,7910682,IM,"['Cardiovascular Diseases/*diagnosis/*therapy', 'Humans', '*RNA Interference']",2006/03/28 09:00,2010/02/17 06:00,['2006/03/28 09:00'],"['2006/03/28 09:00 [pubmed]', '2010/02/17 06:00 [medline]', '2006/03/28 09:00 [entrez]']",,ppublish,Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Nov;33(11):1058-60.,11,,,,,,,,,,31,,,,,,,,,,,
28700418,NLM,MEDLINE,20180921,20180921,1531-698X (Electronic) 1040-8703 (Linking),29,2017 Oct,Advances in paediatric cardiology 2017: the genetics of paediatric cardiovascular disease.,511-512,10.1097/MOP.0000000000000525 [doi],"['Bernstein, Daniel']",['Bernstein D'],"['Department of Pediatrics (Cardiology), Stanford University, Stanford, California, USA.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Curr Opin Pediatr,Current opinion in pediatrics,9000850,IM,"['Cardiology/trends', 'Cardiovascular Diseases/diagnosis/*genetics/therapy', 'Child', '*Genetic Predisposition to Disease', 'Humans', 'Pediatrics/trends']",2017/07/13 06:00,2018/09/22 06:00,['2017/07/13 06:00'],"['2017/07/13 06:00 [pubmed]', '2018/09/22 06:00 [medline]', '2017/07/13 06:00 [entrez]']",['10.1097/MOP.0000000000000525 [doi]'],ppublish,Curr Opin Pediatr. 2017 Oct;29(5):511-512. doi: 10.1097/MOP.0000000000000525.,5,,,,,,,,,,,,,,,,,,,,,
18300776,NLM,MEDLINE,20080411,20080227,0361-1817 (Print) 0361-1817 (Linking),33,2008 Feb,Promising practice for diverse populations.,5,10.1097/01.NPR.0000309090.27259.a8 [doi],"['Newland, Jamesetta']",['Newland J'],,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Nurse Pract,The Nurse practitioner,7603663,IM,"['Cardiovascular Diseases/drug therapy/ethnology/genetics/*nursing', '*Cultural Diversity', 'Humans', 'Nurse Practitioners/education/*organization & administration', 'Pharmacogenetics', 'Primary Health Care/organization & administration', 'Transcultural Nursing/education/organization & administration']",2008/02/28 09:00,2008/04/12 09:00,['2008/02/28 09:00'],"['2008/02/28 09:00 [pubmed]', '2008/04/12 09:00 [medline]', '2008/02/28 09:00 [entrez]']","['00006205-200802000-00001 [pii]', '10.1097/01.NPR.0000309090.27259.a8 [doi]']",ppublish,Nurse Pract. 2008 Feb;33(2):5. doi: 10.1097/01.NPR.0000309090.27259.a8.,2,,,,,,,,,,,,,,,,,,,,,
32683887,NLM,MEDLINE,20210315,20210315,1942-0080 (Electronic) 1941-9651 (Linking),13,2020 Jul,In This Issue of the Journal.,e011449,10.1161/CIRCIMAGING.120.011449 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor in Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",20200720,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Biomedical Research', '*Cardiac Imaging Techniques', '*Cardiology', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Editorial Policies', 'Humans', 'Peer Review', 'Periodicals as Topic']",2020/07/21 06:00,2021/03/16 06:00,['2020/07/21 06:00'],"['2020/07/21 06:00 [entrez]', '2020/07/21 06:00 [pubmed]', '2021/03/16 06:00 [medline]']",['10.1161/CIRCIMAGING.120.011449 [doi]'],ppublish,Circ Cardiovasc Imaging. 2020 Jul;13(7):e011449. doi: 10.1161/CIRCIMAGING.120.011449. Epub 2020 Jul 20.,7,,,,,,,,,,,,,,,,,,,,,
15756501,NLM,MEDLINE,20050428,20181201,0340-1855 (Print) 0340-1855 (Linking),64,2005 Feb,[Rheumatism and heart: autoimmune mechanisms link rheumatic to cardiovascular diseases].,48-51,,"['Voswinkel, J']",['Voswinkel J'],"['Poliklinik fur Rheumatologie, Universitat zu Lubeck und Rheumaklinik Bad Bramstedt, Ratzeburger Allee 160, 23538 Lubeck, Germany.']",['ger'],['Congress'],,Germany,Z Rheumatol,Zeitschrift fur Rheumatologie,0414162,IM,"['Autoimmune Diseases/complications/*diagnosis/*therapy', 'Cardiovascular Diseases/complications/*diagnosis/*therapy', 'Humans', 'Italy', 'Rheumatic Diseases/complications/*diagnosis/*therapy']",2005/03/10 09:00,2005/04/29 09:00,['2005/03/10 09:00'],"['2005/03/10 09:00 [pubmed]', '2005/04/29 09:00 [medline]', '2005/03/10 09:00 [entrez]']",['10.1007/s00393-005-0621-z [doi]'],ppublish,Z Rheumatol. 2005 Feb;64(1):48-51. doi: 10.1007/s00393-005-0621-z.,1,,,,,,,,,,,,,,,Rheuma und Herz: autoimmune Prozesse verbinden rheumatische mit kardiovaskularen Erkrankungen.,,,,,,
3342425,NLM,MEDLINE,19880328,20220409,0008-6312 (Print) 0008-6312 (Linking),75,1988,Emergence of cardiovascular diseases in developing countries.,56-64,,"['Dodu, S R']",['Dodu SR'],"['Cardiovascular Diseases Unit, World Health Organization, Geneva, Switzerland.']",['eng'],['Journal Article'],,Switzerland,Cardiology,Cardiology,1266406,IM,"['Cardiovascular Diseases/*epidemiology/mortality/prevention & control', '*Developing Countries', 'Health Priorities', 'Humans', 'Life Expectancy', 'Time Factors']",1988/01/01 00:00,1988/01/01 00:01,['1988/01/01 00:00'],"['1988/01/01 00:00 [pubmed]', '1988/01/01 00:01 [medline]', '1988/01/01 00:00 [entrez]']",['10.1159/000174349 [doi]'],ppublish,Cardiology. 1988;75(1):56-64. doi: 10.1159/000174349.,1,"Developing countries are subject to the same risks that have contributed to the high incidence of cardiovascular diseases in the already developed countries. Improvements in life expectancy at birth lead to predictable shifts in the cause-of-death structure over time. The stage at which cardiovascular diseases may be considered to be 'actively emerging' corresponds to a life expectancy level between 50 and 60 years and, at this level, cardiovascular disease mortality accounts for 15-25% of all deaths. The average life expectancy at birth in developing countries for the year 2000 is projected to be 60 years or more and it may be expected that by that time cardiovascular diseases would be actively emerging or established in virtually every country. In many developing countries today, life-style pattern that is associated with high rates of coronary heart disease is not yet widespread and it is therefore logical that a strategy of prevention should include efforts to inhibit the entrenchment and spread of unhealthy life-styles in the community (i.e., primordial prevention). At the country level, cardiovascular disease prevention and control cannot be considered in isolation and must be related to prevailing national health priorities and competing claims from other sectors of development. In poorer countries where life expectancy is below 50 years primordial prevention activities are likely to be restricted--perhaps to smoking and hypertension control. In middle-income countries a broader based approach to primordial prevention is feasible and is more likely to be acceptable.",,,,,,,,,,,,,,,,,,,,
34824676,NLM,MEDLINE,20211208,20211214,1947-6108 (Electronic) 1947-6094 (Print) 1947-6108 (Linking),17,2021,The Evolving Landscape of Cardiovascular Disease Prevention.,1-7,10.14797/mdcvj.383 [doi],"['Cainzos-Achirica, Miguel', 'Patel, Kershaw V', 'Nasir, Khurram']","['Cainzos-Achirica M', 'Patel KV', 'Nasir K']","['Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, US.', 'Center for Outcomes Research, Houston Methodist, Houston, TX, US.', 'Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins Medical Institutions, Baltimore, MD, US.', 'Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, US.', 'Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, US.', 'Center for Outcomes Research, Houston Methodist, Houston, TX, US.', 'Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins Medical Institutions, Baltimore, MD, US.']",['eng'],['Editorial'],20210924,United States,Methodist Debakey Cardiovasc J,Methodist DeBakey cardiovascular journal,101508600,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans']",2021/11/27 06:00,2021/12/15 06:00,['2021/11/26 06:54'],"['2021/08/16 00:00 [received]', '2021/08/17 00:00 [accepted]', '2021/11/26 06:54 [entrez]', '2021/11/27 06:00 [pubmed]', '2021/12/15 06:00 [medline]']",['10.14797/mdcvj.383 [doi]'],epublish,Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):1-7. doi: 10.14797/mdcvj.383. eCollection 2021.,4,,"['ORCID: 0000-0002-8073-2337', 'ORCID: 0000-0003-2002-4096', 'ORCID: 0000-0001-5376-2269']",PMC8588765,['The authors have no competing interests to declare.'],,,,,,,,,,,,,,,,,
7736485,NLM,MEDLINE,19950606,20180215,0008-6312 (Print) 0008-6312 (Linking),85 Suppl 2,1994,Circadian variation and triggers of cardiovascular disease.,3-10,,"['Muller, J E', 'Mangel, B']","['Muller JE', 'Mangel B']","['Cardiology Division, Deaconess Hospital, Boston, MA 02215, USA.']",['eng'],"['Journal Article', 'Review']",,Switzerland,Cardiology,Cardiology,1266406,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*etiology/therapy', '*Circadian Rhythm', 'Electrocardiography, Ambulatory', 'Humans']",1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",['10.1159/000177040 [doi]'],ppublish,Cardiology. 1994;85 Suppl 2:3-10. doi: 10.1159/000177040.,,"It has recently been shown that approximately 90% of cases of non-fatal myocardial infarction and many cases of sudden cardiac death are caused by disruption of a coronary atherosclerotic plaque, followed by occlusive thrombus formation. Secondly, the circadian pattern of myocardial infarction is well known to feature a prominent increase in the morning hours. Taken together, these factors may provide an opportunity to reduce deaths caused by cardiovascular disease. Findings indicate that, in many cases, plaque disruption and thrombus formation are triggered by the activities of the patient. It is postulated that onset occurs when a 'vulnerable' atherosclerotic plaque becomes disrupted and occlusive thrombus formation occurs. The occurrence of a myocardial infarction in the morning hours could result from the synchronization of a number of potential triggers. The importance of the recognition of the circadian variation of acute onset of myocardial infarction is that pharmacologic protection can be directed at the early waking hours. It would seem reasonable to propose that long-acting anti-ischemic agents would have an advantage over short-acting agents in providing protection against the morning occurrence of myocardial infarction. A future goal would be to design therapeutic regimens that would have the ability to sever the linkage between a potential triggering activity and the development of myocardial infarction.",,,,,,,,,13,,,,,,,,,,,
19113024,NLM,MEDLINE,20090219,20161124,0029-6570 (Print) 0029-6570 (Linking),23,2008 Dec 10-16,Learning the skills to save lives.,62-3,,"['Nuttall, Michaela']",['Nuttall M'],"['Bromley Primary Care Trust, Kent.']",['eng'],['Journal Article'],,England,Nurs Stand,Nursing standard (Royal College of Nursing (Great Britain) : 1987),9012906,,"['Cardiovascular Diseases/blood/diagnosis/*nursing/therapy', 'Cholesterol/blood', 'Cost of Illness', 'Early Diagnosis', 'Humans', '*Inservice Training', 'Life Style', '*Nurses', 'United Kingdom/epidemiology']",2008/12/31 09:00,2009/02/20 09:00,['2008/12/31 09:00'],"['2008/12/31 09:00 [entrez]', '2008/12/31 09:00 [pubmed]', '2009/02/20 09:00 [medline]']",['10.7748/ns2008.12.23.14.62.p4213 [doi]'],ppublish,Nurs Stand. 2008 Dec 10-16;23(14):62-3. doi: 10.7748/ns2008.12.23.14.62.p4213.,14,,,,,,,,['97C5T2UQ7J (Cholesterol)'],,,,,,,,,,,,,
22622121,NLM,MEDLINE,20121109,20120524,1827-6806 (Print) 1827-6806 (Linking),13,2012 Jun,[Does cardiac surgery in women carry a higher risk than in men?].,419-23,10.1714/1073.11760 [doi],"['Torracca, Lucia', 'Capestro, Filippo', 'Zingaro, Carlo', 'Massi, Francesco', 'Rescigno, Giuseppe', 'Pierri, Michele Danilo']","['Torracca L', 'Capestro F', 'Zingaro C', 'Massi F', 'Rescigno G', 'Pierri MD']","['Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona. toracca.lucia@gmail.com']",['ita'],"['English Abstract', 'Journal Article', 'Review']",,Italy,G Ital Cardiol (Rome),Giornale italiano di cardiologia (2006),101263411,IM,"['Cardiac Surgical Procedures/*mortality', 'Cardiovascular Diseases/diagnosis/*mortality/*surgery/therapy', 'Female', 'Humans', 'Male', 'Risk Factors', 'Sex Distribution', 'Sex Factors', 'Treatment Outcome']",2012/05/25 06:00,2012/11/10 06:00,['2012/05/25 06:00'],"['2012/05/25 06:00 [entrez]', '2012/05/25 06:00 [pubmed]', '2012/11/10 06:00 [medline]']",['10.1714/1073.11760 [doi]'],ppublish,G Ital Cardiol (Rome). 2012 Jun;13(6):419-23. doi: 10.1714/1073.11760.,6,"Cardiovascular diseases are the leading cause of death in women, and female patients exhibit peculiar features as to symptoms, diagnosis and treatment. This sex difference is also observed in cardiac surgery, with mortality and morbidity being higher in female patients. Whether female gender is an independent variable for mortality still remains controversial. This review summarizes the data available in the literature on cardiac surgery in the female population.",,,,,,,,,,,,,,La cardiochirurgia nella donna: rischio piu alto?,,,,,,
29032740,NLM,MEDLINE,20180827,20180827,2047-4881 (Electronic) 2047-4873 (Linking),24,2017 Oct,Editor's presentation.,1571-1574,10.1177/2047487317736953 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit Cardiology, G da Saliceto Hospital, Piacenza, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiac Rehabilitation', 'Cardiovascular Diseases/diagnosis/*epidemiology/physiopathology/therapy', 'Death, Sudden, Cardiac/epidemiology/prevention & control', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Assessment', 'Risk Factors']",2017/10/17 06:00,2018/08/28 06:00,['2017/10/17 06:00'],"['2017/10/17 06:00 [entrez]', '2017/10/17 06:00 [pubmed]', '2018/08/28 06:00 [medline]']",['10.1177/2047487317736953 [doi]'],ppublish,Eur J Prev Cardiol. 2017 Oct;24(15):1571-1574. doi: 10.1177/2047487317736953.,15,,,,,,,,,,,,,,,,,,,,,
19454903,NLM,MEDLINE,20090825,20151119,1473-5598 (Electronic) 0263-6352 (Linking),27,2009 Jun,Risk prediction in subjects with high-normal blood pressure.,1126-8,10.1097/HJH.0b013e32832c4e2a [doi],"['Schneider, Markus P', 'Schmieder, Roland E']","['Schneider MP', 'Schmieder RE']",,['eng'],"['Comment', 'Editorial', 'Review']",,Netherlands,J Hypertens,Journal of hypertension,8306882,IM,"['Antihypertensive Agents/therapeutic use', 'Biomarkers/analysis', '*Blood Pressure', 'Cardiovascular Diseases/etiology/physiopathology/prevention & control', 'Humans', 'Hypertension/*diagnosis/drug therapy/physiopathology', 'Prognosis', 'Risk Factors']",2009/05/21 09:00,2009/08/26 09:00,['2009/05/21 09:00'],"['2009/05/21 09:00 [entrez]', '2009/05/21 09:00 [pubmed]', '2009/08/26 09:00 [medline]']","['00004872-200906000-00005 [pii]', '10.1097/HJH.0b013e32832c4e2a [doi]']",ppublish,J Hypertens. 2009 Jun;27(6):1126-8. doi: 10.1097/HJH.0b013e32832c4e2a.,6,,,,,,,,"['0 (Antihypertensive Agents)', '0 (Biomarkers)']",,13,['J Hypertens. 2009 Jun;27(6):1165-71. PMID: 19387364'],,,,,,,,,,
11735783,NLM,MEDLINE,20020103,20190717,0003-9942 (Print) 0003-9942 (Linking),58,2001 Dec,Patterns on cranial magnetic resonance imaging in elderly people and vascular disease outcomes.,2074,,"['Longstreth, W T Jr', 'Diehr, P', 'Beauchamp, N J', 'Manolio, T A']","['Longstreth WT Jr', 'Diehr P', 'Beauchamp NJ', 'Manolio TA']",,['eng'],['Letter'],,United States,Arch Neurol,Archives of neurology,0372436,IM,"['Aged', 'Brain/*pathology', 'Cardiovascular Diseases/complications/*epidemiology/*pathology', 'Cluster Analysis', 'Humans', '*Magnetic Resonance Imaging']",2001/12/26 10:00,2002/01/05 10:01,['2001/12/26 10:00'],"['2001/12/26 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/12/26 10:00 [entrez]']","['nlt1201-1 [pii]', '10.1001/archneur.58.12.2074 [doi]']",ppublish,Arch Neurol. 2001 Dec;58(12):2074. doi: 10.1001/archneur.58.12.2074.,12,,,,,,,,,,,,,,,,,,,,,
24860054,NLM,MEDLINE,20140820,20140526,0030-6002 (Print) 0030-6002 (Linking),155,2014 Jun 1,[Long-forgotten machines and devices used in the diagnostics and therapy of cardiovascular diseases].,880-2,10.1556/OH.2014.HO2488 [doi],"['Szabo, Katalin']",['Szabo K'],['Semmelweis Orvostorteneti Muzeum Budapest Aprod u. 1-3. 1013.'],['hun'],"['Historical Article', 'Journal Article']",,Hungary,Orv Hetil,Orvosi hetilap,0376412,IM,"['Cardiovascular Diseases/diagnosis/*history/therapy', 'Electrocardiography/*history', 'Equipment and Supplies/*history', 'Europe', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Hungary', 'Ventilators, Mechanical/*history']",2014/05/27 06:00,2014/08/21 06:00,['2014/05/27 06:00'],"['2014/05/27 06:00 [entrez]', '2014/05/27 06:00 [pubmed]', '2014/08/21 06:00 [medline]']","['G0H35002720J7K01 [pii]', '10.1556/OH.2014.HO2488 [doi]']",ppublish,Orv Hetil. 2014 Jun 1;155(22):880-2. doi: 10.1556/OH.2014.HO2488.,22,,,,,,,,,,,,,,,Regen elfeledett gepek es eszkozok a sziv- es errendszeri betegsegek diagnosztikajaban es terapiajaban.,,,,,,
25959384,NLM,MEDLINE,20161221,20220310,1879-0712 (Electronic) 0014-2999 (Linking),778,2016 May 5,The impact of mast cells on cardiovascular diseases.,103-15,S0014-2999(15)00412-4 [pii] 10.1016/j.ejphar.2015.04.050 [doi],"['Kritikou, Eva', 'Kuiper, Johan', 'Kovanen, Petri T', 'Bot, Ilze']","['Kritikou E', 'Kuiper J', 'Kovanen PT', 'Bot I']","['Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.', 'Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.', 'Wihuri Research Institute, Helsinki, Finland.', 'Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. Electronic address: i.bot@lacdr.leidenuniv.nl.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20150508,Netherlands,Eur J Pharmacol,European journal of pharmacology,1254354,IM,"['Animals', 'Cardiovascular Diseases/etiology/*immunology/*pathology/therapy', 'Diet/adverse effects', 'Humans', 'Mast Cells/*immunology/*pathology']",2015/05/12 06:00,2016/12/22 06:00,['2015/05/12 06:00'],"['2014/12/10 00:00 [received]', '2015/04/10 00:00 [revised]', '2015/04/21 00:00 [accepted]', '2015/05/12 06:00 [entrez]', '2015/05/12 06:00 [pubmed]', '2016/12/22 06:00 [medline]']","['S0014-2999(15)00412-4 [pii]', '10.1016/j.ejphar.2015.04.050 [doi]']",ppublish,Eur J Pharmacol. 2016 May 5;778:103-15. doi: 10.1016/j.ejphar.2015.04.050. Epub 2015 May 8.,,"Mast cells comprise an innate immune cell population, which accumulates in tissues proximal to the outside environment and, upon activation, augments the progression of immunological reactions through the release and diffusion of either pre-formed or newly generated mediators. The released products of mast cells include histamine, proteases, as well as a variety of cytokines, chemokines and growth factors, which act on the surrounding microenvironment thereby shaping the immune responses triggered in various diseased states. Mast cells have also been detected in the arterial wall and are implicated in the onset and progression of numerous cardiovascular diseases. Notably, modulation of distinct mast cell actions using genetic and pharmacological approaches highlights the crucial role of this cell type in cardiovascular syndromes. The acquired evidence renders mast cells and their mediators as potential prognostic markers and therapeutic targets in a broad spectrum of pathophysiological conditions related to cardiovascular diseases.",,,,['NOTNLM'],"['Aneurysm', 'Arrhythmia', 'Atherosclerosis', 'Diabetes', 'Mast cells', 'Myocardial infarction', 'Obesity', 'Restenosis']",,,['Copyright (c) 2015 Elsevier B.V. All rights reserved.'],,,,,,,,,,,,
28894039,NLM,MEDLINE,20190425,20220211,1467-3045 (Electronic) 1467-3037 (Linking),28,2018,Translational Approaches In Cardiovascular Diseases by Omics.,1-14,10.21775/cimb.028.001 [doi],"['Rabani, Vahideh', 'Davani, Siamak']","['Rabani V', 'Davani S']","['EA 3920, Univ. Bourgogne-Franche Comte, Besancon, France.', 'EA 3920, Univ. Bourgogne-Franche Comte, Besancon, France and Laboratoire de Pharmacologie Clinique et Toxicologie, CHU de Besancon, France.']",['eng'],"['Journal Article', 'Review']",20170912,Switzerland,Curr Issues Mol Biol,Current issues in molecular biology,100931761,IM,"['*Biomarkers', 'Cardiovascular Diseases/*genetics/pathology/therapy', 'Genomics/*methods', 'Humans', 'Molecular Targeted Therapy', 'Proteomics/*methods']",2017/09/13 06:00,2019/04/26 06:00,['2017/09/13 06:00'],"['2017/09/13 06:00 [pubmed]', '2019/04/26 06:00 [medline]', '2017/09/13 06:00 [entrez]']","['cimb.028.001 [pii]', '10.21775/cimb.028.001 [doi]']",ppublish,Curr Issues Mol Biol. 2018;28:1-14. doi: 10.21775/cimb.028.001. Epub 2017 Sep 12.,,"Cardiovascular diseases are among the leading causes of morbidity and mortality. Despite scientific and technical progress in risk prediction, diagnostics, prognostication and therapy of cardiovascular pathologies, new biomarkers and therapeutic targets remain the subject of intense research to reduce the burden of these diseases. High throughput analyses, termed ""omics"", are a promising avenue of research. These recently developed technical fields have revolutionized biological and medical research in a very short time. By their interdisciplinary nature, these new methods have already provided a wide vision of cell and tissue pathways and functions. Here, we review how these methods can help to discover new biomarkers and therapeutic targets in cardiovascular diseases.",,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
12460831,NLM,MEDLINE,20030310,20061115,1302-8723 (Print) 1302-8723 (Linking),2,2002 Dec,[Apoptosis and cardiovascular disease].,323-9,,"['Kultursay, Hakan', 'Kayikcioglu, Meral']","['Kultursay H', 'Kayikcioglu M']","['Department of Cardiology, Medical Faculty, Ege University, Izmir, Turkey. omkay@superonline.com']",['tur'],"['English Abstract', 'Journal Article', 'Review']",,Turkey,Anadolu Kardiyol Derg,Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,101095069,IM,"['*Apoptosis', 'Cardiovascular Diseases/etiology/*pathology/prevention & control', 'Humans']",2002/12/04 04:00,2003/03/11 04:00,['2002/12/04 04:00'],"['2002/12/04 04:00 [pubmed]', '2003/03/11 04:00 [medline]', '2002/12/04 04:00 [entrez]']",,ppublish,Anadolu Kardiyol Derg. 2002 Dec;2(4):323-9.,4,Apoptosis is defined as a genetically programmed cell death. Apoptotic cell death plays an important role both in heart development and cardiac disease. This review deals with the key features of this process. The modification of possible interactions between extrinsic and intrinsic factors affecting the cell during apoptotic process may be of major interest in preventing the progression of cardiovascular disease. Current issues on the pathogenetic role of apoptosis in heart disease and how these knowledge can be applied in clinical usage is also evaluated in this review.,,,,,,,,,49,,,,,Apoptozis ve Kardiyovaskuler Hastaliklar.,,,,,,
14061783,NLM,MEDLINE,19961201,20181201,0366-5313 (Print) 0366-5313 (Linking),43,1963,CLINICAL VALUE OF THE POLYGRAPHIC TRACING IN THE STUDY OF THE SEQUENCE OF EVENTS DURING CARDIAC CONTRACTION.,298-316,,"['JEZEK, V']",['JEZEK V'],,['eng'],['Journal Article'],,Switzerland,Cardiologia (Basel),Cardiologia,1265351,OM,"['*Aortic Diseases', '*Arrhythmias, Cardiac', '*Cardiovascular Diseases', '*Heart Failure', '*Heart Function Tests', 'Humans', '*Hypertension', '*Mitral Valve Stenosis', '*Myocardial Infarction']",1963/01/01 00:00,1963/01/01 00:01,['1963/01/01 00:00'],"['1963/01/01 00:00 [pubmed]', '1963/01/01 00:01 [medline]', '1963/01/01 00:00 [entrez]']",,ppublish,Cardiologia (Basel). 1963;43:298-316.,,,,,,['NLM'],"['*AORTIC DISEASES', '*ARRHYTHMIA', '*CARDIOVASCULAR DISEASES', '*HEART FAILURE, CONGESTIVE', '*HEART FUNCTION TESTS', '*HYPERTENSION', '*MITRAL VALVE STENOSIS', '*MYOCARDIAL INFARCT']",,,,,,,,,,,,,,,
15005262,NLM,MEDLINE,20040601,20190605,0918-2918 (Print) 0918-2918 (Linking),43,2004 Feb,Menopause and cardiovascular diseases in women.,151-4,,"['Sakuma, Ichiro', 'Kitabatake, Akira']","['Sakuma I', 'Kitabatake A']","['Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo.']",['eng'],['Journal Article'],,Japan,Intern Med,"Internal medicine (Tokyo, Japan)",9204241,IM,"['Adult', 'Cardiovascular Diseases/epidemiology/physiopathology/*prevention & control', 'Estrogen Replacement Therapy', 'Female', '*Hormone Replacement Therapy', 'Humans', 'Japan/epidemiology', 'Randomized Controlled Trials as Topic']",2004/03/10 05:00,2004/06/02 05:00,['2004/03/10 05:00'],"['2004/03/10 05:00 [pubmed]', '2004/06/02 05:00 [medline]', '2004/03/10 05:00 [entrez]']",['10.2169/internalmedicine.43.151 [doi]'],ppublish,Intern Med. 2004 Feb;43(2):151-4. doi: 10.2169/internalmedicine.43.151.,2,,,,,,,,,,,,,,,,,,,,,
17095904,NLM,MEDLINE,20070312,20131121,0957-9672 (Print) 0957-9672 (Linking),17,2006 Dec,Peering through the darkened glass: success and disappointment in the management of cardiovascular risk.,615-8,,"['McPherson, Ruth', 'Shepherd, Jim']","['McPherson R', 'Shepherd J']","['University of Ottawa Heart Institute, Ottawa, Canada.']",['eng'],"['Journal Article', 'Review']",,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['Cardiovascular Diseases/*drug therapy/metabolism/*prevention & control', 'Homocysteine/metabolism', 'Humans', 'Risk Factors']",2006/11/11 09:00,2007/03/14 09:00,['2006/11/11 09:00'],"['2006/11/11 09:00 [pubmed]', '2007/03/14 09:00 [medline]', '2006/11/11 09:00 [entrez]']","['00041433-200612000-00002 [pii]', '10.1097/MOL.0b013e32801140ce [doi]']",ppublish,Curr Opin Lipidol. 2006 Dec;17(6):615-8. doi: 10.1097/MOL.0b013e32801140ce.,6,,,,,,,,['0LVT1QZ0BA (Homocysteine)'],,40,,,,,,,,,,,
22801387,NLM,MEDLINE,20121116,20120717,1473-6535 (Electronic) 0957-9672 (Linking),23,2012 Aug,Bibliography. Hyperlipidaemia and cardiovascular disease. Current world literature.,386-91,10.1097/MOL.0b013e32835670af [doi],,,,['eng'],['Bibliography'],,England,Curr Opin Lipidol,Current opinion in lipidology,9010000,IM,"['*Cardiovascular Diseases/complications/metabolism/therapy', 'Humans', '*Hyperlipidemias/complications/metabolism/therapy']",2012/07/18 06:00,2012/12/10 06:00,['2012/07/18 06:00'],"['2012/07/18 06:00 [entrez]', '2012/07/18 06:00 [pubmed]', '2012/12/10 06:00 [medline]']","['00041433-201208000-00016 [pii]', '10.1097/MOL.0b013e32835670af [doi]']",ppublish,Curr Opin Lipidol. 2012 Aug;23(4):386-91. doi: 10.1097/MOL.0b013e32835670af.,4,,,,,,,,,,,,,,,,,,,,,
30198781,NLM,MEDLINE,20191125,20191125,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Sep,ESC CardioMed - the new electronic ESC Textbook of Cardiovascular Medicine.,1563-1566,10.1177/2047487318791111 [doi],,,,['eng'],['Journal Article'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiology/*education', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', '*Computer-Assisted Instruction', '*Databases, Factual', 'Education, Medical/*methods', 'Humans', '*Textbooks as Topic']",2018/09/11 06:00,2019/11/26 06:00,['2018/09/11 06:00'],"['2018/09/11 06:00 [entrez]', '2018/09/11 06:00 [pubmed]', '2019/11/26 06:00 [medline]']",['10.1177/2047487318791111 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Sep;25(14):1563-1566. doi: 10.1177/2047487318791111.,14,,,,,,,,,,,,,,,,,,,,,
10935766,NLM,MEDLINE,20010108,20191104,1401-7431 (Print) 1401-7431 (Linking),34,2000 Jun,Community prevention of cardiovascular disease: how much do we know?,229-30,,"['Werko, L']",['Werko L'],,['eng'],"['Comment', 'Journal Article']",,England,Scand Cardiovasc J,Scandinavian cardiovascular journal : SCJ,9708377,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', '*Community Health Services', 'Cross-Sectional Studies', '*Health Education', 'Humans', 'Risk Factors', 'Sweden']",2000/08/10 11:00,2001/02/28 10:01,['2000/08/10 11:00'],"['2000/08/10 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/08/10 11:00 [entrez]']",['10.1080/713783126 [doi]'],ppublish,Scand Cardiovasc J. 2000 Jun;34(3):229-30. doi: 10.1080/713783126.,3,,,,,,,,,,,['Scand Cardiovasc J. 2000;34(2):103-5. PMID: 10872693'],,,,,,,,,,
10477542,NLM,MEDLINE,20000113,20220410,1524-4539 (Electronic) 0009-7322 (Linking),100,1999 Sep 7,Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.,1134-46,,"['Grundy, S M', 'Benjamin, I J', 'Burke, G L', 'Chait, A', 'Eckel, R H', 'Howard, B V', 'Mitch, W', 'Smith, S C Jr', 'Sowers, J R']","['Grundy SM', 'Benjamin IJ', 'Burke GL', 'Chait A', 'Eckel RH', 'Howard BV', 'Mitch W', 'Smith SC Jr', 'Sowers JR']",,['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['American Heart Association', 'Cardiovascular Diseases/*etiology/prevention & control/therapy', '*Diabetes Complications', 'Health Personnel', 'Humans', 'Risk Factors']",1999/09/08 09:00,2000/06/03 09:00,['1999/09/08 09:00'],"['1999/09/08 09:00 [pubmed]', '2000/06/03 09:00 [medline]', '1999/09/08 09:00 [entrez]']",['10.1161/01.cir.100.10.1134 [doi]'],ppublish,Circulation. 1999 Sep 7;100(10):1134-46. doi: 10.1161/01.cir.100.10.1134.,10,,,,,,,,,,120,,,['Circulation. 1999 Sep 7;100(10):1132-3. PMID: 10477541'],,,,,,['Circulation 2000 Apr 4;101(13):1629-31'],,
20723808,NLM,MEDLINE,20100922,20100820,1558-3597 (Electronic) 0735-1097 (Linking),56,2010 Aug 24,Discordance of individual risk estimates.,743; author reply 743-4,10.1016/j.jacc.2010.04.034 [doi],"['Stern, Ralph']",['Stern R'],,['eng'],"['Comment', 'Letter']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control', 'Decision Making', 'Humans', 'Risk Assessment/*statistics & numerical data']",2010/08/21 06:00,2010/09/24 06:00,['2010/08/21 06:00'],"['2010/03/23 00:00 [received]', '2010/04/05 00:00 [accepted]', '2010/08/21 06:00 [entrez]', '2010/08/21 06:00 [pubmed]', '2010/09/24 06:00 [medline]']","['S0735-1097(10)02233-3 [pii]', '10.1016/j.jacc.2010.04.034 [doi]']",ppublish,J Am Coll Cardiol. 2010 Aug 24;56(9):743; author reply 743-4. doi: 10.1016/j.jacc.2010.04.034.,9,,,,,,,,,,,['J Am Coll Cardiol. 2010 Mar 23;55(12):1169-77. PMID: 20298922'],,,,,,,,,,
6598387,NLM,MEDLINE,19850628,20041117,0004-4849 (Print) 0004-4849 (Linking),75,1983 Jul,On the present and future of cardiology in Puerto Rico.,317-8,,"['Torres-Gomez, J M']",['Torres-Gomez JM'],,['eng'],['Journal Article'],,Puerto Rico,Bol Asoc Med P R,Boletin de la Asociacion Medica de Puerto Rico,7505267,IM,"['Cardiology/*trends', 'Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Ethics, Medical', 'Humans', 'Physician-Patient Relations', 'Puerto Rico']",1983/07/01 00:00,1983/07/01 00:01,['1983/07/01 00:00'],"['1983/07/01 00:00 [pubmed]', '1983/07/01 00:01 [medline]', '1983/07/01 00:00 [entrez]']",,ppublish,Bol Asoc Med P R. 1983 Jul;75(7):317-8.,7,,,,,,,,,,,,,,,,,,,,,
25117881,NLM,MEDLINE,20150528,20161125,1423-0143 (Electronic) 1420-4096 (Linking),39,2014,Exercise and cardiovascular diseases.,147-53,10.1159/000355790 [doi],"['Villella, Massimo', 'Villella, Alessandro']","['Villella M', 'Villella A']","['Cardiac Rehabilitation Unit, IRCCS ""Casa Sollievo della Sofferenza"", San Giovanni Rotondo, Italy.']",['eng'],"['Journal Article', 'Review']",20140729,Switzerland,Kidney Blood Press Res,Kidney & blood pressure research,9610505,IM,"['Cardiac Rehabilitation', 'Cardiovascular Diseases/*epidemiology/physiopathology/therapy', '*Exercise', '*Exercise Therapy', 'Humans']",2014/08/15 06:00,2015/05/29 06:00,['2014/08/14 06:00'],"['2014/04/11 00:00 [accepted]', '2014/08/14 06:00 [entrez]', '2014/08/15 06:00 [pubmed]', '2015/05/29 06:00 [medline]']","['000355790 [pii]', '10.1159/000355790 [doi]']",ppublish,Kidney Blood Press Res. 2014;39(2-3):147-53. doi: 10.1159/000355790. Epub 2014 Jul 29.,2-3,"Exercise is a physiologic stressor that has multiple beneficial effects on cardiovascular system. Currently exercise training is a class I intervention as part of a multifactorial long-term process that includes: clinical assistance, assessment of global cardiovascular risk, identification of specific objective for each cardiovascular risk factor, formulation of an individual treatment plan with multiple intervention aimed at reduction of the risk, educational programs, planning of long term follow-up. This paper reviews the evidences of benefit of exercise in the most common heart diseases and describes the role of exercise training in the cardiac rehabilitation programs.",,,,,,,,"['(c) 2014 S. Karger AG, Basel.']",,,,,,,,,,,,
30639431,NLM,MEDLINE,20190829,20200309,1878-5875 (Electronic) 1357-2725 (Print) 1357-2725 (Linking),108,2019 Mar,Sympathetic nervous system in age-related cardiovascular dysfunction: Pathophysiology and therapeutic perspective.,29-33,S1357-2725(19)30004-4 [pii] 10.1016/j.biocel.2019.01.004 [doi],"['de Lucia, Claudio', 'Piedepalumbo, Michela', 'Paolisso, Giuseppe', 'Koch, Walter J']","['de Lucia C', 'Piedepalumbo M', 'Paolisso G', 'Koch WJ']","['Center for Translational Medicine and Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, USA. Electronic address: claudio.de.lucia@temple.edu.', 'Center for Translational Medicine and Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, USA; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania ""Luigi Vanvitelli"", Naples, Italy. Electronic address: michela.piedepalumbo@studenti.unicampania.it.', 'Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania ""Luigi Vanvitelli"", Naples, Italy. Electronic address: giuseppe.paolisso@unicampania.it.', 'Center for Translational Medicine and Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, USA. Electronic address: walter.koch@temple.edu.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",20190109,Netherlands,Int J Biochem Cell Biol,The international journal of biochemistry & cell biology,9508482,IM,"['Aging/*physiology', 'Animals', 'Cardiovascular Diseases/pathology/*physiopathology/therapy', 'Humans', 'Sympathetic Nervous System/*physiopathology']",2019/01/15 06:00,2019/08/30 06:00,['2019/01/15 06:00'],"['2018/10/30 00:00 [received]', '2018/12/30 00:00 [revised]', '2019/01/08 00:00 [accepted]', '2019/01/15 06:00 [pubmed]', '2019/08/30 06:00 [medline]', '2019/01/15 06:00 [entrez]']","['S1357-2725(19)30004-4 [pii]', '10.1016/j.biocel.2019.01.004 [doi]']",ppublish,Int J Biochem Cell Biol. 2019 Mar;108:29-33. doi: 10.1016/j.biocel.2019.01.004. Epub 2019 Jan 9.,,"Cardiovascular diseases such as heart failure and metabolic syndrome have high prevalence in the elderly population and are leading causes of death, disability, hospitalization, driving high healthcare costs worldwide. To reduce this social and economic burden there is urgency to find effective therapeutic targets. Several studies have linked the dysfunction of the Sympathetic Nervous System and beta-adrenergic receptor signaling with the pathogenesis of age-related cardiovascular diseases. Therapeutic treatments that restore their functions have been shown to be effective in subjects with cardiovascular comorbidities. In fact, lifestyle interventions (such as exercise training and diet) as well as pharmacologic treatments (e.g. beta-blockers or moxonidine) and mini-invasive interventions (renal sympathetic denervation) have beneficial effects on age-related cardiovascular diseases. In the current ""Medicine in focus"" article we will discuss the pathogenic role of the Sympathetic Nervous System in age-related cardiovascular diseases as well as current and new therapeutic approaches.",,PMC6383565,,['NOTNLM'],"['Adrenergic nervous system', 'Aging', 'Cardiovascular diseases', 'beta-Adrenergic signaling']",['P01 HL091799/HL/NHLBI NIH HHS/United States'],,['Copyright (c) 2019 Elsevier Ltd. All rights reserved.'],,,['NIHMS1518828'],,,,,,,,,
24130314,NLM,MEDLINE,20140620,20220331,1469-7793 (Electronic) 0022-3751 (Print) 0022-3751 (Linking),591,2013 Oct 15,CrossTalk opposing view: Prolonged intense exercise does not lead to cardiac damage.,4943-5,10.1113/jphysiol.2013.257147 [doi],"['Ruiz, Jonatan R', 'Joyner, Michael', 'Lucia, Alejandro']","['Ruiz JR', 'Joyner M', 'Lucia A']",['joyner.michael@mayo.edu.'],['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,J Physiol,The Journal of physiology,0266262,IM,"['Animals', 'Cardiovascular Diseases/*epidemiology/etiology/physiopathology', '*Exercise', 'Humans', 'Myocardium/*pathology']",2013/10/17 06:00,2014/06/21 06:00,['2013/10/17 06:00'],"['2013/10/17 06:00 [entrez]', '2013/10/17 06:00 [pubmed]', '2014/06/21 06:00 [medline]']","['591/20/4943 [pii]', '10.1113/jphysiol.2013.257147 [doi]']",ppublish,J Physiol. 2013 Oct 15;591(20):4943-5. doi: 10.1113/jphysiol.2013.257147.,20,,,PMC3810794,,,,,,,,,,['J Physiol. 2013 Oct 15;591(20):4947. PMID: 24130315'],,,,,,,,
18987903,NLM,MEDLINE,20090220,20181113,1741-0444 (Electronic) 0140-0118 (Linking),46,2008 Nov,Personalised imaging and biomechanical modelling of large vessels.,1057-8,10.1007/s11517-008-0417-9 [doi],"['Krams, Rob', 'Breeuwer, Marcel', 'van de Vosse, Frans']","['Krams R', 'Breeuwer M', 'van de Vosse F']",,['eng'],"['Editorial', 'Introductory Journal Article']",20081106,United States,Med Biol Eng Comput,Medical & biological engineering & computing,7704869,IM,"['Arteries/physiopathology', 'Cardiovascular Diseases/*diagnosis/physiopathology/surgery', 'Hemodynamics', 'Hemorheology', 'Humans', 'Image Processing, Computer-Assisted/methods']",2008/11/07 09:00,2009/02/21 09:00,['2008/11/07 09:00'],"['2008/10/12 00:00 [received]', '2008/10/13 00:00 [accepted]', '2008/11/07 09:00 [pubmed]', '2009/02/21 09:00 [medline]', '2008/11/07 09:00 [entrez]']",['10.1007/s11517-008-0417-9 [doi]'],ppublish,Med Biol Eng Comput. 2008 Nov;46(11):1057-8. doi: 10.1007/s11517-008-0417-9. Epub 2008 Nov 6.,11,,,,,,,,,,,,,,,,,,,,,
30701463,NLM,MEDLINE,20190617,20200225,1573-742X (Electronic) 0929-5305 (Linking),47,2019 Feb,"Highlights from the 2018 European Society of Cardiology Congress in Munich, Germany.",312-315,10.1007/s11239-019-01810-3 [doi],"['Steen, Dylan L']",['Steen DL'],"['University of Cincinnati, Cincinnati, OH, USA. dylan.steen@uc.edu.']",['eng'],['Journal Article'],,Netherlands,J Thromb Thrombolysis,Journal of thrombosis and thrombolysis,9502018,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Clinical Trials as Topic', 'Congresses as Topic', 'Humans']",2019/02/01 06:00,2019/06/18 06:00,['2019/02/01 06:00'],"['2019/02/01 06:00 [pubmed]', '2019/06/18 06:00 [medline]', '2019/02/01 06:00 [entrez]']","['10.1007/s11239-019-01810-3 [pii]', '10.1007/s11239-019-01810-3 [doi]']",ppublish,J Thromb Thrombolysis. 2019 Feb;47(2):312-315. doi: 10.1007/s11239-019-01810-3.,2,,['ORCID: 0000-0003-2383-895X'],,,['NOTNLM'],"['Cardiology', 'Late-breakers', 'Scientific meetings', 'Trials']",,,,,,,,,,,,,,,
30476014,NLM,MEDLINE,20191101,20191101,1755-3245 (Electronic) 0008-6363 (Linking),114,2018 Dec 1,New heights and hot topics in Cardiovascular Research.,e114-e119,10.1093/cvr/cvy265 [doi],"['Small, Heather Y', 'Guzik, Tomasz J']","['Small HY', 'Guzik TJ']","['Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, UK.', 'Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, UK.', 'Department of Internal and Agricultural Medicine, Jagiellonian University Collegium Medicum, 31-008 Anny 12, Krakow, Poland.']",['eng'],['Editorial'],,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Diffusion of Innovation', '*Editorial Policies', 'Humans', 'Journal Impact Factor', '*Periodicals as Topic']",2018/11/27 06:00,2019/11/02 06:00,['2018/11/27 06:00'],"['2018/11/27 06:00 [entrez]', '2018/11/27 06:00 [pubmed]', '2019/11/02 06:00 [medline]']","['5208902 [pii]', '10.1093/cvr/cvy265 [doi]']",ppublish,Cardiovasc Res. 2018 Dec 1;114(14):e114-e119. doi: 10.1093/cvr/cvy265.,14,,,,,,,,,,,,,,,,,,,,,
15790823,NLM,MEDLINE,20050405,20071115,1095-9203 (Electronic) 0036-8075 (Linking),307,2005 Mar 25,Epidemiology. How dirty air hurts the heart.,1858-9,,"['Kaiser, Jocelyn']",['Kaiser J'],,['eng'],['News'],,United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Air Pollution/*adverse effects', 'Animals', 'Arrhythmias, Cardiac/etiology', 'Arteriosclerosis/etiology', 'Carbon/*toxicity', 'Cardiovascular Diseases/epidemiology/*etiology/mortality', 'Cause of Death', '*Dust', 'Heart Diseases/epidemiology/etiology', '*Heart Rate/drug effects', 'Humans', 'Inflammation/*etiology', 'Particle Size']",2005/03/26 09:00,2005/04/06 09:00,['2005/03/26 09:00'],"['2005/03/26 09:00 [pubmed]', '2005/04/06 09:00 [medline]', '2005/03/26 09:00 [entrez]']","['307/5717/1858b [pii]', '10.1126/science.307.5717.1858b [doi]']",ppublish,Science. 2005 Mar 25;307(5717):1858-9. doi: 10.1126/science.307.5717.1858b.,5717,,,,,,,,"['0 (Dust)', '7440-44-0 (Carbon)']",,,,,,,,,,,,,
32327524,NLM,MEDLINE,20210217,20210217,1468-201X (Electronic) 1355-6037 (Linking),106,2020 May,Heartbeat: bathing daily is associated with a lower cardiovascular risk.,707-709,10.1136/heartjnl-2020-317029 [doi],"['Otto, Catherine M']",['Otto CM'],"['Division of Cardiology, University of Washington, Seattle, WA 98195, USA cmotto@uw.edu.']",['eng'],['Introductory Journal Article'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Baths', '*Cardiovascular Diseases/physiopathology/prevention & control/psychology/therapy', '*Disease Management', 'Disease Progression', 'Food Analysis', 'Health Risk Behaviors/physiology', '*Heart Disease Risk Factors', 'Humans', 'Nutritional Requirements', 'Primary Prevention/*methods', '*Risk Reduction Behavior']",2020/04/25 06:00,2021/02/18 06:00,['2020/04/25 06:00'],"['2020/04/25 06:00 [entrez]', '2020/04/25 06:00 [pubmed]', '2021/02/18 06:00 [medline]']","['heartjnl-2020-317029 [pii]', '10.1136/heartjnl-2020-317029 [doi]']",ppublish,Heart. 2020 May;106(10):707-709. doi: 10.1136/heartjnl-2020-317029.,10,,['ORCID: 0000-0002-0527-9392'],,['Competing interests: None declared.'],['NOTNLM'],['cardiac procedures and therapy'],,,,,,,,,,,,,,,
29744024,NLM,MEDLINE,20190314,20190314,1947-6108 (Electronic) 1947-6094 (Print) 1947-6108 (Linking),13,2017 Oct-Dec,Letter to the Editor.,260,10.14797/mdcj-13-4-260 [doi],"['Fuller, Colin']",['Fuller C'],,['eng'],"['Editorial', 'Portrait']",,United States,Methodist Debakey Cardiovasc J,Methodist DeBakey cardiovascular journal,101508600,IM,"['*Cardiac Surgical Procedures', 'Cardiovascular Diseases/diagnosis/psychology/*surgery', 'Humans', 'Patients/psychology', 'Physician-Patient Relations', '*Surgeons', '*Teaching Rounds', 'Television']",2018/05/11 06:00,2019/03/15 06:00,['2018/05/11 06:00'],"['2018/05/11 06:00 [entrez]', '2018/05/11 06:00 [pubmed]', '2019/03/15 06:00 [medline]']",['10.14797/mdcj-13-4-260 [doi]'],ppublish,Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):260. doi: 10.14797/mdcj-13-4-260.,4,,,PMC5935291,,,,,,,,,,,,,,,,,,
29575828,NLM,MEDLINE,20190520,20190520,1565-1088 (Print),19,2017 Jun,"The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches, 1st edition.",395-396,,"['Shoenfeld, Yehuda']",['Shoenfeld Y'],,['eng'],"['Journal Article', 'Review']",,Israel,Isr Med Assoc J,The Israel Medical Association journal : IMAJ,100930740,IM,"['Autoimmune Diseases/*complications', '*Cardiovascular Diseases/etiology/immunology/therapy', 'Disease Management', 'Humans', 'Inflammation/*immunology', 'Rheumatic Diseases/*complications']",2018/03/27 06:00,2019/05/21 06:00,['2018/03/26 06:00'],"['2018/03/26 06:00 [entrez]', '2018/03/27 06:00 [pubmed]', '2019/05/21 06:00 [medline]']",,ppublish,Isr Med Assoc J. 2017 Jun;19(6):395-396.,6,,,,,,,,,,,,,,,,,,,,,
21627059,NLM,MEDLINE,20110712,20110601,0891-0162 (Print) 0891-0162 (Linking),59,2011 Jun,A family history intervention.,241; author reply 241,10.3928/08910162-20110525-02 [doi],"['Strasser, Patricia B']",['Strasser PB'],,['eng'],"['Comment', 'Letter']",,United States,AAOHN J,AAOHN journal : official journal of the American Association of Occupational Health Nurses,8608669,,"['*Cardiovascular Diseases/epidemiology/genetics/nursing', '*Family Health', 'Humans', 'Occupational Health/*legislation & jurisprudence', '*Prejudice', 'Risk Factors']",2011/06/02 06:00,2011/07/13 06:00,['2011/06/02 06:00'],"['2011/06/02 06:00 [entrez]', '2011/06/02 06:00 [pubmed]', '2011/07/13 06:00 [medline]']",['10.3928/08910162-20110525-02 [doi]'],ppublish,AAOHN J. 2011 Jun;59(6):241; author reply 241. doi: 10.3928/08910162-20110525-02.,6,,,,,,,,,,,['AAOHN J. 2011 Apr;59(4):181-92; quiz 193-4. PMID: 21462901'],,,,,,,,,,
21932950,NLM,MEDLINE,20120120,20110921,1744-8344 (Electronic) 1477-9072 (Linking),9,2011 Sep,"The diabetic heart: sweet, fatty and stressed.",1093-6,10.1586/erc.11.109 [doi],"['Stratmann, Bernd', 'Tschoepe, Diethelm']","['Stratmann B', 'Tschoepe D']",,['eng'],['Editorial'],,England,Expert Rev Cardiovasc Ther,Expert review of cardiovascular therapy,101182328,IM,"['Animals', 'Cardiovascular Diseases/*etiology/mortality/physiopathology', 'Diabetes Mellitus/*physiopathology', 'Diabetic Cardiomyopathies/mortality/*physiopathology', 'Heart Failure/etiology/mortality', 'Humans', 'Hyperglycemia/complications/etiology']",2011/09/22 06:00,2012/01/21 06:00,['2011/09/22 06:00'],"['2011/09/22 06:00 [entrez]', '2011/09/22 06:00 [pubmed]', '2012/01/21 06:00 [medline]']",['10.1586/erc.11.109 [doi]'],ppublish,Expert Rev Cardiovasc Ther. 2011 Sep;9(9):1093-6. doi: 10.1586/erc.11.109.,9,,,,,,,,,,,,,,,,,,,,,
21934716,NLM,MEDLINE,20111123,20141120,1532-6535 (Electronic) 0009-9236 (Linking),90,2011 Oct,Cardiovascular health: the global challenge.,483-5,10.1038/clpt.2011.213 [doi],"['Waldman, S A', 'Terzic, A']","['Waldman SA', 'Terzic A']",,['eng'],['Editorial'],,United States,Clin Pharmacol Ther,Clinical pharmacology and therapeutics,0372741,IM,"['Cardiovascular Diseases/*epidemiology/physiopathology/*prevention & control', '*Global Health', '*Health Behavior', 'Humans', 'Motor Activity/physiology', 'Smoking Cessation/methods']",2011/09/22 06:00,2011/12/13 00:00,['2011/09/22 06:00'],"['2011/09/22 06:00 [entrez]', '2011/09/22 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['clpt2011213 [pii]', '10.1038/clpt.2011.213 [doi]']",ppublish,Clin Pharmacol Ther. 2011 Oct;90(4):483-5. doi: 10.1038/clpt.2011.213.,4,,,,,,,,,,,,,"['Clin Pharmacol Ther. 2011 Oct;90(4):630-3. PMID: 21881563', 'Clin Pharmacol Ther. 2011 Oct;90(4):509-18. PMID: 21900892', 'Clin Pharmacol Ther. 2011 Oct;90(4):519-31. PMID: 21918509', 'Clin Pharmacol Ther. 2011 Oct;90(4):493-5. PMID: 21934720', 'Clin Pharmacol Ther. 2011 Oct;90(4):496-9. PMID: 21934721']",,,,,,,,
21492768,NLM,MEDLINE,20110616,20110415,1558-3597 (Electronic) 0735-1097 (Linking),57,2011 Apr 19,Achieving cardiovascular health: a bleak outlook or tremendous potential?,1697-9,10.1016/j.jacc.2010.12.024 [doi],"['Mozaffarian, Dariush']",['Mozaffarian D'],,['eng'],"['Comment', 'Editorial']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['*Achievement', '*American Heart Association', 'Cardiovascular Diseases/*epidemiology/physiopathology/*prevention & control', '*Health Behavior', '*Health Status', 'Humans', 'United States/epidemiology']",2011/04/16 06:00,2011/06/17 06:00,['2011/04/16 06:00'],"['2010/12/01 00:00 [received]', '2010/12/04 00:00 [accepted]', '2011/04/16 06:00 [entrez]', '2011/04/16 06:00 [pubmed]', '2011/06/17 06:00 [medline]']","['S0735-1097(11)00516-X [pii]', '10.1016/j.jacc.2010.12.024 [doi]']",ppublish,J Am Coll Cardiol. 2011 Apr 19;57(16):1697-9. doi: 10.1016/j.jacc.2010.12.024.,16,,,,,,,,,,,['J Am Coll Cardiol. 2011 Apr 19;57(16):1690-6. PMID: 21492767'],,,,,,,,,,
10643229,NLM,MEDLINE,20000201,20101118,0023-7205 (Print) 0023-7205 (Linking),96,1999 Dec 15,[Evolutionary biological discoveries can increase the understanding of cardiovascular diseases. It can contribute to more realistic preventive strategies].,5630-2,,"['Nilsson, P', 'Haglund, O']","['Nilsson P', 'Haglund O']","['Avdelningen for medicin, Lunds universitet, Universitetssjukhuset MAS, Malmo. Peter.Nilsson@medforsk.mas.lu.se']",['swe'],"['English Abstract', 'Journal Article', 'Review']",,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['*Biological Evolution', 'Cardiovascular Diseases/etiology/genetics/*prevention & control', 'Evolution, Molecular', 'Humans', 'Selection, Genetic']",2000/01/22 00:00,2000/01/22 00:01,['2000/01/22 00:00'],"['2000/01/22 00:00 [pubmed]', '2000/01/22 00:01 [medline]', '2000/01/22 00:00 [entrez]']",,ppublish,Lakartidningen. 1999 Dec 15;96(50):5630-2.,50,"Recent findings in evolutionary biology offer new insights into the historical emergence of widespread medical disorders such as cardiovascular disease and type 2 diabetes. This has been named evolutionary medicine. When individuals with a genetic program for retention of sodium and calories (insulin resistance) encounter the stress and unwholesome lifestyle of modern society, cardiovascular disease may soon develop, potential consequences being myocardial infarction or stroke. Focusing on historical changes in climate, social circumstances and food availability in the Nordic countries, factors which very much defined living conditions for our ancestors, we discuss cardiovascular disease from the point of view of evolutionary medicine. A better understanding of this perspective will hopefully increase the likelihood of success in preventive efforts such as lifestyle intervention.",,,,,,,,,35,,,,,Evolutionsbiologiska ron kan oka forstaelsen av hjart--karlsjukdom. Kan bidra till mer realistiska preventiva strategier.,,,,,,
11888500,NLM,MEDLINE,20021104,20190822,0025-7753 (Print) 0025-7753 (Linking),118,2002 Mar 9,[Cardiovascular disease in diabetes mellitus].,306-11,,"['Ampudia-Blasco, Francisco Javier', 'Navarro, Jorge']","['Ampudia-Blasco FJ', 'Navarro J']",['Unidad de Referencia de Diabetes. Servicio de Endocrinologia. Hospital Clinico Universitario de Valencia. Spain. Francisco.J.Ampudia@uv.es'],['spa'],"['Journal Article', 'Review']",,Spain,Med Clin (Barc),Medicina clinica,0376377,IM,"['Cardiovascular Diseases/diagnosis/*etiology/therapy', '*Diabetes Complications', 'Humans', 'Myocardial Infarction/etiology/mortality', 'Myocardial Ischemia/diagnosis/etiology/therapy']",2002/03/13 10:00,2002/11/26 04:00,['2002/03/13 10:00'],"['2002/03/13 10:00 [pubmed]', '2002/11/26 04:00 [medline]', '2002/03/13 10:00 [entrez]']","['S0025-7753(02)72367-1 [pii]', '10.1016/s0025-7753(02)72367-1 [doi]']",ppublish,Med Clin (Barc). 2002 Mar 9;118(8):306-11. doi: 10.1016/s0025-7753(02)72367-1.,8,,,,,,,,,,64,,,,,Enfermedad cardiovascular en la diabetes mellitus.,,,,,,
18378625,NLM,MEDLINE,20080416,20220419,1524-4539 (Electronic) 0009-7322 (Linking),117,2008 Apr 1,"Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.",1717-31,10.1161/CIRCULATIONAHA.107.653584 [doi],"['Haddad, Francois', 'Doyle, Ramona', 'Murphy, Daniel J', 'Hunt, Sharon A']","['Haddad F', 'Doyle R', 'Murphy DJ', 'Hunt SA']","['Division of Cardiovascular Medicine, Stanford University, 770 Welch Rd, Ste 400, Palo Alto, CA 94304-5715, USA. fhaddad@cvmed.stanford.edu']",['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Biomarkers/metabolism', 'Cardiovascular Diseases/metabolism/physiopathology/therapy', 'Disease Management', 'Heart Failure/metabolism/*physiopathology/therapy', 'Humans', 'Ventricular Dysfunction, Right/metabolism/*physiopathology/therapy', 'Ventricular Function, Right/*physiology']",2008/04/02 09:00,2008/04/17 09:00,['2008/04/02 09:00'],"['2008/04/02 09:00 [pubmed]', '2008/04/17 09:00 [medline]', '2008/04/02 09:00 [entrez]']","['117/13/1717 [pii]', '10.1161/CIRCULATIONAHA.107.653584 [doi]']",ppublish,Circulation. 2008 Apr 1;117(13):1717-31. doi: 10.1161/CIRCULATIONAHA.107.653584.,13,,,,,,,,['0 (Biomarkers)'],,96,,,,,,,,,,,
19498049,NLM,MEDLINE,20090824,20190722,1530-8561 (Electronic) 0009-9147 (Linking),55,2009 Aug,Burden of cardiovascular disease in Asia: big challenges and ample opportunities for action and making a difference.,1450-2,10.1373/clinchem.2009.125369 [doi],"['Hong, Yuling']",['Hong Y'],"['Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. yhong1@cdc.gov']",['eng'],['Journal Article'],20090604,England,Clin Chem,Clinical chemistry,9421549,IM,"['Asia/epidemiology', 'Biomarkers/analysis', 'Cardiovascular Diseases/*epidemiology/etiology/mortality/*prevention & control', 'Humans', 'Hypertension/complications', 'Obesity/complications', 'Patient Education as Topic', 'Public Health', 'Risk Factors', 'Smoking/adverse effects']",2009/06/06 09:00,2009/08/25 09:00,['2009/06/06 09:00'],"['2009/06/06 09:00 [entrez]', '2009/06/06 09:00 [pubmed]', '2009/08/25 09:00 [medline]']","['clinchem.2009.125369 [pii]', '10.1373/clinchem.2009.125369 [doi]']",ppublish,Clin Chem. 2009 Aug;55(8):1450-2. doi: 10.1373/clinchem.2009.125369. Epub 2009 Jun 4.,8,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
34686270,NLM,MEDLINE,20220228,20220228,1558-2264 (Electronic) 0733-8651 (Linking),39,2021 Nov,Management of Vascular Disorders in Cardiovascular Practice.,ix-x,S0733-8651(21)00063-1 [pii] 10.1016/j.ccl.2021.07.001 [doi],"['Henkin, Stanislav', 'Creager, Mark A']","['Henkin S', 'Creager MA']","['Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA. Electronic address: stanislav.henkin@hitchcock.org.', 'Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA. Electronic address: Mark.A.Creager@hitchcock.org.']",['eng'],['Editorial'],,Netherlands,Cardiol Clin,Cardiology clinics,8300331,IM,"['*Cardiovascular Diseases/epidemiology/therapy', 'Humans', 'Risk Factors', '*Vascular Diseases/diagnosis/epidemiology/therapy']",2021/10/24 06:00,2022/03/01 06:00,['2021/10/23 05:28'],"['2021/10/23 05:28 [entrez]', '2021/10/24 06:00 [pubmed]', '2022/03/01 06:00 [medline]']","['S0733-8651(21)00063-1 [pii]', '10.1016/j.ccl.2021.07.001 [doi]']",ppublish,Cardiol Clin. 2021 Nov;39(4):ix-x. doi: 10.1016/j.ccl.2021.07.001.,4,,,,,,,,,,,,,,,,,,,,,
10961979,NLM,MEDLINE,20000914,20190623,1524-4539 (Electronic) 0009-7322 (Linking),102,2000 Aug 29,C-reactive protein as a clinical marker of risk.,E63-4,,"['Kaski, J C', 'Garcia-Moll, X']","['Kaski JC', 'Garcia-Moll X']",,['eng'],"['Comment', 'Letter']",,United States,Circulation,Circulation,0147763,IM,"['Biomarkers', 'C-Reactive Protein/*analysis', 'Cardiovascular Diseases/blood/*epidemiology/etiology', 'Humans', 'Inflammation/etiology', 'Male', 'Myocardial Ischemia/etiology', 'Prognosis', 'Risk Factors']",2000/08/30 00:00,2000/09/19 00:00,['2000/08/30 00:00'],"['2000/08/30 00:00 [pubmed]', '2000/09/19 00:00 [medline]', '2000/08/30 00:00 [entrez]']",['10.1161/01.cir.102.9.e63 [doi]'],ppublish,Circulation. 2000 Aug 29;102(9):E63-4. doi: 10.1161/01.cir.102.9.e63.,9,,,,,,,,"['0 (Biomarkers)', '9007-41-4 (C-Reactive Protein)']",,,['Circulation. 1999 Jul 6;100(1):96-102. PMID: 10393687'],,,,,,,,,,
27898424,NLM,MEDLINE,20190111,20190111,1421-9670 (Electronic) 0250-8095 (Linking),45,2017,Arterial Stiffness as a Cardiovascular Risk Factor in Stage 5D Chronic Kidney Disease Patients: An Age Affair.,69-71,10.1159/000453339 [doi],"['Zoccali, Carmine', 'Mallamaci, Francesca']","['Zoccali C', 'Mallamaci F']","['CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases, Ospedali Riuniti, Reggio Calabria, Italy.']",['eng'],['Editorial'],20161130,Switzerland,Am J Nephrol,American journal of nephrology,8109361,IM,"['Age Factors', 'Cardiovascular Diseases/diagnosis/etiology/mortality/*physiopathology', 'Female', 'Humans', 'Kidney Failure, Chronic/*complications', 'Male', 'Prognosis', '*Pulse Wave Analysis', 'Risk Factors', 'Sex Factors', '*Vascular Stiffness']",2016/11/30 06:00,2019/01/12 06:00,['2016/11/30 06:00'],"['2016/11/30 06:00 [pubmed]', '2019/01/12 06:00 [medline]', '2016/11/30 06:00 [entrez]']","['000453339 [pii]', '10.1159/000453339 [doi]']",ppublish,Am J Nephrol. 2017;45(1):69-71. doi: 10.1159/000453339. Epub 2016 Nov 30.,1,,,,,,,,,,,,,,,,,,,,,
17146003,NLM,MEDLINE,20061229,20220331,1524-4539 (Electronic) 0009-7322 (Linking),114,2006 Dec 5,Rethinking primary prevention of atherosclerosis-related diseases.,2517-27,,"['Napoli, Claudio', 'Lerman, Lilach O', 'de Nigris, Filomena', 'Gossl, Mario', 'Balestrieri, Maria Luisa', 'Lerman, Amir']","['Napoli C', 'Lerman LO', 'de Nigris F', 'Gossl M', 'Balestrieri ML', 'Lerman A']","['Department of General Pathology and Excellence Research Center on Cardiovascular Diseases, 1st School of Medicine, II University of Naples, Complesso S. Andrea delle Dame, Naples 80134, Italy. claunap@tin.it']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Atherosclerosis/complications/diagnosis/*physiopathology/*prevention & control/therapy', 'Cardiovascular Diseases/etiology/physiopathology/prevention & control/therapy', 'Cerebrovascular Disorders/etiology/physiopathology/prevention & control/therapy', 'Disease Progression', 'Humans', 'Inflammation/etiology/physiopathology/prevention & control/therapy', 'Primary Prevention/*methods']",2006/12/06 09:00,2006/12/30 09:00,['2006/12/06 09:00'],"['2006/12/06 09:00 [pubmed]', '2006/12/30 09:00 [medline]', '2006/12/06 09:00 [entrez]']","['114/23/2517 [pii]', '10.1161/CIRCULATIONAHA.105.570358 [doi]']",ppublish,Circulation. 2006 Dec 5;114(23):2517-27. doi: 10.1161/CIRCULATIONAHA.105.570358.,23,,,,,,,"['HL63911/HL/NHLBI NIH HHS/United States', 'HL69840/HL/NHLBI NIH HHS/United States', 'HL77131/HL/NHLBI NIH HHS/United States']",,,118,,,,,,,,,,,
7146369,NLM,MEDLINE,19830127,20161123,0033-8354 (Print) 0033-8354 (Linking),23,1982,[Possibilities and limits of decision-making in basic roentgen diagnosis of cardiovascular diseases].,459-68,,"['Bock, G', 'Dietze, R']","['Bock G', 'Dietze R']",,['ger'],['Journal Article'],,Germany,Radiol Diagn (Berl),Radiologia diagnostica,0401253,IM,"['Cardiovascular Diseases/classification/*diagnostic imaging', 'Humans', 'Radiography']",1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,Radiol Diagn (Berl). 1982;23(4):459-68.,4,,,,,,,,,,,,,,,Moglichkeiten und Grenzen der Urteilsbildung bei Herz-Kreislauf-Krankheiten in der Basis-Rontgendiagnostik.,,,,,,
23716381,NLM,MEDLINE,20130830,20220409,1524-4539 (Electronic) 0009-7322 (Linking),127,2013 May 28,Cardiovascular disease in Williams syndrome.,2125-34,10.1161/CIRCULATIONAHA.112.000064 [doi],"['Collins, R Thomas 2nd']",['Collins RT 2nd'],"[""Arkansas Children's Hospital and University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA. rtcollins@uams.edu""]",['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Aortic Stenosis, Supravalvular/etiology/physiopathology/therapy', 'Cardiovascular Diseases/*etiology/*physiopathology/therapy', 'Coronary Vessel Anomalies/etiology/physiopathology/therapy', 'Disease Management', 'Electrocardiography', 'Humans', 'Williams Syndrome/*complications']",2013/05/30 06:00,2013/08/31 06:00,['2013/05/30 06:00'],"['2013/05/30 06:00 [entrez]', '2013/05/30 06:00 [pubmed]', '2013/08/31 06:00 [medline]']","['127/21/2125 [pii]', '10.1161/CIRCULATIONAHA.112.000064 [doi]']",ppublish,Circulation. 2013 May 28;127(21):2125-34. doi: 10.1161/CIRCULATIONAHA.112.000064.,21,,,,,['NOTNLM'],"['Williams syndrome', 'aortic stenosis, supravalvular', 'cardiovascular diseases', 'genetics', 'heart diseases', 'humans', 'pulmonary artery']",,,,,,,,,,,,,,,
19263622,NLM,MEDLINE,20090429,20090306,0011-7781 (Print) 0011-7781 (Linking),80,2008 Dec,Cardiovascular risk management case.,453-5,,"['Myers, G Robert', 'Goldenberg, Edward']","['Myers GR', 'Goldenberg E']","['Christiana Care Health System, Newark, Deleware, USA.']",['eng'],"['Case Reports', 'Journal Article']",,United States,Del Med J,Delaware medical journal,0370077,IM,"['*Cardiovascular Diseases/blood/diagnosis/prevention & control', 'Humans', 'Male', 'Middle Aged', 'Risk Factors', 'Severity of Illness Index']",2009/03/07 09:00,2009/04/30 09:00,['2009/03/07 09:00'],"['2009/03/07 09:00 [entrez]', '2009/03/07 09:00 [pubmed]', '2009/04/30 09:00 [medline]']",,ppublish,Del Med J. 2008 Dec;80(12):453-5.,12,,,,,,,,,,,,,,,,,,,,,
18494228,NLM,MEDLINE,20080610,20080522,1565-1088 (Print),10,2008 Mar,Cardiovascular management of Marfan syndrome.,182-5,,"['Motro, Michael', 'Fisman, Enrique Z', 'Tenenbaum, Alexander']","['Motro M', 'Fisman EZ', 'Tenenbaum A']","['Ringers Unit for Clinical Cardiac Research, Sheba Medical Center, Tel Hashomer, Israel. michael.motro@sheba.health.gov.il']",['eng'],"['Journal Article', 'Review']",,Israel,Isr Med Assoc J,The Israel Medical Association journal : IMAJ,100930740,IM,"['Cardiovascular Diseases/*diagnosis/etiology/*therapy', 'Humans', 'Marfan Syndrome/*complications/diagnosis/*therapy']",2008/05/23 09:00,2008/06/11 09:00,['2008/05/23 09:00'],"['2008/05/23 09:00 [pubmed]', '2008/06/11 09:00 [medline]', '2008/05/23 09:00 [entrez]']",,ppublish,Isr Med Assoc J. 2008 Mar;10(3):182-5.,3,,,,,,,,,,25,,,,,,,,,,,
7960010,NLM,MEDLINE,19941202,20190722,0194-911X (Print) 0194-911X (Linking),24,1994 Nov,New drug development and the health care crisis.,529-30,,"['Frohlich, E D']",['Frohlich ED'],,['eng'],['Editorial'],,United States,Hypertension,"Hypertension (Dallas, Tex. : 1979)",7906255,IM,"['Cardiovascular Diseases/*drug therapy/epidemiology/mortality', 'Costs and Cost Analysis', '*Delivery of Health Care', 'Humans', 'Hypertension/drug therapy/mortality/prevention & control', 'Pharmaceutical Preparations/*economics', 'Research/*economics', 'United States/epidemiology']",1994/11/01 00:00,1994/11/01 00:01,['1994/11/01 00:00'],"['1994/11/01 00:00 [pubmed]', '1994/11/01 00:01 [medline]', '1994/11/01 00:00 [entrez]']",['10.1161/01.hyp.24.5.529 [doi]'],ppublish,Hypertension. 1994 Nov;24(5):529-30. doi: 10.1161/01.hyp.24.5.529.,5,,,,,,,,['0 (Pharmaceutical Preparations)'],,,,,,,,,,,,,
7227947,NLM,MEDLINE,19810720,20041117,0015-8178 (Print) 0015-8178 (Linking),99,1981 Apr 23,[How can the care of patients with cardiovascular diseases be improved in West Germany?].,561-2,,"['Kaltenbach, M']",['Kaltenbach M'],,['ger'],['Journal Article'],,Germany,Fortschr Med,Fortschritte der Medizin,2984763R,IM,"['Cardiovascular Diseases/mortality/*therapy', 'Germany, West', 'Humans']",1981/04/23 00:00,1981/04/23 00:01,['1981/04/23 00:00'],"['1981/04/23 00:00 [pubmed]', '1981/04/23 00:01 [medline]', '1981/04/23 00:00 [entrez]']",,ppublish,Fortschr Med. 1981 Apr 23;99(16):561-2.,16,,,,,,,,,,,,,,,Wie kann die Versorgung der Kreislauf-Kranken in der Bundesrepublik Deutschland verbessert werden?,,,,,,
14618824,NLM,MEDLINE,20040329,20161018,1019-5297 (Print) 1019-5297 (Linking),,2003 Jul-Aug,[The scientific legacy of N. D. Strazhesko in occupational pathology].,121-4,,"['Krasniuk, E P']",['Krasniuk EP'],,['rus'],"['Biography', 'English Abstract', 'Historical Article', 'Journal Article']",,Ukraine,Lik Sprava,Likars'ka sprava,9601540,IM,"['Cardiovascular Diseases/diagnosis/etiology/*pathology', 'History, 20th Century', 'Occupational Diseases/*pathology', 'Occupational Medicine/*history', 'USSR']",2003/11/19 05:00,2004/03/30 05:00,['2003/11/19 05:00'],"['2003/11/19 05:00 [pubmed]', '2004/03/30 05:00 [medline]', '2003/11/19 05:00 [entrez]']",,ppublish,Lik Sprava. 2003 Jul-Aug;(5-6):121-4.,5-6,"The author draws a parallel between pathogenetic mechanisms of those changes described by N. D. Strazhesko in different forms of pathology of the cardiovascular system and its disorders in different forms of occupational pathology caused by adverse impact on the organism of chemical, physical, biological, and other factors of the working environment and labour process. This permits the methodological principles of diagnosis of the cardiovascular pathologies laid by N. D. Strazhesko to be used in management of occupational diseases.",,,,,,,,,,,,,,Nauchnoe nasledie N. D. Strazhesko v professional'noi patologii.,['Strazhesko ND'],"['Strazhesko, N D']",,,,
11874585,NLM,MEDLINE,20021021,20191105,0894-0959 (Print) 0894-0959 (Linking),15,2002 Jan-Feb,How can the cardiac death rate be reduced in dialysis patients?,20-1,,"['Zeier, Martin', 'Ritz, Eberhard']","['Zeier M', 'Ritz E']","['Department of Nephrology, University of Heidelberg, Heidelberg, Germany.']",['eng'],['Journal Article'],,United States,Semin Dial,Seminars in dialysis,8911629,IM,"['Cardiovascular Diseases/etiology/*mortality/prevention & control', 'Humans', 'Peritoneal Dialysis, Continuous Ambulatory', 'Renal Dialysis/*adverse effects']",2002/03/05 10:00,2002/10/22 04:00,['2002/03/05 10:00'],"['2002/03/05 10:00 [pubmed]', '2002/10/22 04:00 [medline]', '2002/03/05 10:00 [entrez]']",['10.1046/j.1525-139x.2002.0006b.x [doi]'],ppublish,Semin Dial. 2002 Jan-Feb;15(1):20-1. doi: 10.1046/j.1525-139x.2002.0006b.x.,1,,,,,,,,,,,,,,,,,,,,,
14475260,NLM,MEDLINE,19981101,20181201,0030-6002 (Print) 0030-6002 (Linking),102,1961 Sep 24,[Recent clinical observations on the pathogenesis of obliterative vascular diseases].,1836-7,,"['MOLNAR, L']",['MOLNAR L'],,['hun'],['Journal Article'],,Hungary,Orv Hetil,Orvosi hetilap,0376412,OM,"['Cardiovascular Diseases/*etiology', '*Cardiovascular System', '*Cerebrovascular Disorders', 'Humans', '*Vascular Diseases']",1961/09/24 00:00,1961/09/24 00:01,['1961/09/24 00:00'],"['1961/09/24 00:00 [pubmed]', '1961/09/24 00:01 [medline]', '1961/09/24 00:00 [entrez]']",,ppublish,Orv Hetil. 1961 Sep 24;102:1836-7.,,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/etiology', '*CEREBROVASCULAR DISORDERS']",,,,,,,,,,,,,,,
23978094,NLM,MEDLINE,20141121,20190728,1873-4286 (Electronic) 1381-6128 (Linking),20,2014,Editorial: cardio-metabolic complications: current perspective and future developments.,1303-4,,"['Ndisang, Joseph Fomusi']",['Ndisang JF'],"['Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5. joseph.ndisang@usask.ca.']",['eng'],['Journal Article'],,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Cardiovascular Diseases/complications/etiology/*physiopathology', 'Humans', 'Metabolic Diseases/complications/etiology/*physiopathology', 'Risk Factors']",2013/08/28 06:00,2014/12/15 06:00,['2013/08/28 06:00'],"['2013/08/28 06:00 [entrez]', '2013/08/28 06:00 [pubmed]', '2014/12/15 06:00 [medline]']","['CPD-EPUB-54533 [pii]', '10.2174/138161282009140312122437 [doi]']",ppublish,Curr Pharm Des. 2014;20(9):1303-4. doi: 10.2174/138161282009140312122437.,9,,,,,,,,,,,,,,,,,,,,,
10489378,NLM,MEDLINE,19990930,20190722,0194-911X (Print) 0194-911X (Linking),34,1999 Sep,Pulse pressure: Is this a clinically useful risk factor?,372-4,,"[""O'Rourke, M"", 'Frohlich, E D']","[""O'Rourke M"", 'Frohlich ED']",,['eng'],"['Comment', 'Editorial']",,United States,Hypertension,"Hypertension (Dallas, Tex. : 1979)",7906255,IM,"['*Blood Pressure', 'Cardiovascular Diseases/*diagnosis/mortality/physiopathology', 'Humans', 'Prognosis', '*Pulse', 'Risk Factors', 'Survival Analysis']",1999/09/18 00:00,1999/09/18 00:01,['1999/09/18 00:00'],"['1999/09/18 00:00 [pubmed]', '1999/09/18 00:01 [medline]', '1999/09/18 00:00 [entrez]']",['10.1161/01.hyp.34.3.372 [doi]'],ppublish,Hypertension. 1999 Sep;34(3):372-4. doi: 10.1161/01.hyp.34.3.372.,3,,,,,,,,,,,"['Hypertension. 1997 Dec;30(6):1410-5. PMID: 9403561', 'Hypertension. 1998 Sep;32(3):560-4. PMID: 9740626']",,,,,,,,,,
25677520,NLM,MEDLINE,20150409,20220408,1524-4571 (Electronic) 0009-7330 (Linking),116,2015 Feb 13,Long noncoding RNAs in cardiovascular diseases.,737-50,10.1161/CIRCRESAHA.116.302521 [doi],"['Uchida, Shizuka', 'Dimmeler, Stefanie']","['Uchida S', 'Dimmeler S']","['From the Institute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt, Germany (S.U., S.D.); and German Center for Cardiovascular Research, Partner side Rhein-Main, Frankfurt, Germany (S.U., S.D.).', 'From the Institute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt, Germany (S.U., S.D.); and German Center for Cardiovascular Research, Partner side Rhein-Main, Frankfurt, Germany (S.U., S.D.). dimmeler@em.uni-frankfurt.de.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Circ Res,Circulation research,0047103,IM,"['Animals', 'Cardiovascular Diseases/genetics/*metabolism/pathology/physiopathology', 'Cardiovascular System/*metabolism/pathology/physiopathology', 'Gene Expression Regulation', 'Humans', 'Phenotype', 'RNA, Long Noncoding/*metabolism', 'Signal Transduction']",2015/02/14 06:00,2015/04/10 06:00,['2015/02/14 06:00'],"['2015/02/14 06:00 [entrez]', '2015/02/14 06:00 [pubmed]', '2015/04/10 06:00 [medline]']","['CIRCRESAHA.116.302521 [pii]', '10.1161/CIRCRESAHA.116.302521 [doi]']",ppublish,Circ Res. 2015 Feb 13;116(4):737-50. doi: 10.1161/CIRCRESAHA.116.302521.,4,"In recent year, increasing evidence suggests that noncoding RNAs play important roles in the regulation of tissue homeostasis and pathophysiological conditions. Besides small noncoding RNAs (eg, microRNAs), >200-nucleotide long transcripts, namely long noncoding RNAs (lncRNAs), can interfere with gene expressions and signaling pathways at various stages. In the cardiovascular system, studies have detected and characterized the expression of lncRNAs under normal physiological condition and in disease states. Several lncRNAs are regulated during acute myocardial infarction (eg, Novlnc6) and heart failure (eg, Mhrt), whereas others control hypertrophy, mitochondrial function and apoptosis of cardiomyocytes. In the vascular system, the endothelial-expressed lncRNAs (eg, MALAT1 and Tie-1-AS) can regulate vessel growth and function, whereas the smooth-muscle-expressed lncRNA smooth muscle and endothelial cell-enriched migration/differentiation-associated long noncoding RNA was recently shown to control the contractile phenotype of smooth muscle cells. This review article summarizes the data on lncRNA expressions in mouse and human and highlights identified cardiovascular lncRNAs that might play a role in cardiovascular diseases. Although our understanding of lncRNAs is still in its infancy, these examples may provide helpful insights how lncRNAs interfere with cardiovascular diseases.",,,,['NOTNLM'],"['RNA, long noncoding', 'angiogenesis effect', 'atherosclerosis', 'heart failure', 'hypertrophy']",,"['0 (RNA, Long Noncoding)']","['(c) 2015 American Heart Association, Inc.']",,,,,,,,,,,,
35605846,NLM,MEDLINE,20220816,20221122,1916-7075 (Electronic) 0828-282X (Linking),38,2022 Aug,Preventing Cardiovascular Events in Patients With Inflammatory Arthritis: Are We Missing the Mark?,1138-1140,S0828-282X(22)00322-1 [pii] 10.1016/j.cjca.2022.05.014 [doi],"['Appleton, C Thomas', 'Hegele, Robert A']","['Appleton CT', 'Hegele RA']","['Bone and Joint Institute, University of Western Ontario, London Health Sciences Centre-University Hospital, London, Ontario, Canada; Department of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.', 'Department of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada. Electronic address: hegele@robarts.ca.']",['eng'],"['Comment', 'Editorial', ""Research Support, Non-U.S. Gov't""]",20220521,England,Can J Cardiol,The Canadian journal of cardiology,8510280,IM,"['*Arthritis, Rheumatoid', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Humans']",2022/05/24 06:00,2022/08/17 06:00,['2022/05/23 19:27'],"['2022/04/26 00:00 [received]', '2022/05/14 00:00 [revised]', '2022/05/16 00:00 [accepted]', '2022/05/24 06:00 [pubmed]', '2022/08/17 06:00 [medline]', '2022/05/23 19:27 [entrez]']","['S0828-282X(22)00322-1 [pii]', '10.1016/j.cjca.2022.05.014 [doi]']",ppublish,Can J Cardiol. 2022 Aug;38(8):1138-1140. doi: 10.1016/j.cjca.2022.05.014. Epub 2022 May 21.,8,,,,,,,['R-169027/CIHR/Canada'],,,,['Can J Cardiol. 2022 Aug;38(8):1244-1252. PMID: 35429590'],,,,,,,,,,
30354681,NLM,MEDLINE,20190902,20190902,1942-0080 (Electronic) 1941-9651 (Linking),11,2018 Sep,In This Issue of the Journal.,e008375,10.1161/CIRCIMAGING.118.008375 [doi],"['Gropler, Robert J']",['Gropler RJ'],"['Editor-in-Chief, Circulation: Cardiovascular Imaging.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circ Cardiovasc Imaging,Circulation. Cardiovascular imaging,101479935,IM,"['*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnostic imaging/physiopathology/therapy', 'Humans', 'Models, Cardiovascular', 'Patient-Specific Modeling', 'Predictive Value of Tests', 'Printing, Three-Dimensional', 'Prognosis']",2018/10/26 06:00,2019/09/03 06:00,['2018/10/26 06:00'],"['2018/10/26 06:00 [entrez]', '2018/10/26 06:00 [pubmed]', '2019/09/03 06:00 [medline]']",['10.1161/CIRCIMAGING.118.008375 [doi]'],ppublish,Circ Cardiovasc Imaging. 2018 Sep;11(9):e008375. doi: 10.1161/CIRCIMAGING.118.008375.,9,,,,,,,,,,,,,,,,,,,,,
32406499,NLM,MEDLINE,20210208,20210208,1755-3245 (Electronic) 0008-6363 (Linking),116,2020 Jun 1,Cardiovascular Research at the frontier of biomedical science.,e83-e86,10.1093/cvr/cvaa119 [doi],"['Brown, Sarah K', 'Sheikh, Adam M', 'Guzik, Tomasz J']","['Brown SK', 'Sheikh AM', 'Guzik TJ']","['Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.', 'Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.', 'Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.']",['eng'],['Introductory Journal Article'],,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['Animals', '*Biomedical Research', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', '*Congresses as Topic', 'Diffusion of Innovation', 'Humans', 'Information Dissemination', '*Periodicals as Topic', '*Telecommunications']",2020/05/15 06:00,2021/02/09 06:00,['2020/05/15 06:00'],"['2020/05/15 06:00 [pubmed]', '2021/02/09 06:00 [medline]', '2020/05/15 06:00 [entrez]']","['5836934 [pii]', '10.1093/cvr/cvaa119 [doi]']",ppublish,Cardiovasc Res. 2020 Jun 1;116(7):e83-e86. doi: 10.1093/cvr/cvaa119.,7,,,,,['NOTNLM'],"['Cardio-oncology', 'Cardioprotection', 'Genetics', 'Metabolism', 'Non-coding RNAs']",,,,,,,,,,,,,,,
17226105,NLM,MEDLINE,20070328,20090219,0018-5043 (Print) 0018-5043 (Linking),39,2007 Jan,"Adiponectin and cardiovascular mortality: evidence for ""reverse epidemiology"".",1-2,,"['Rathmann, W', 'Herder, C']","['Rathmann W', 'Herder C']","['Institute of Biometrics and Epidemiology, German Diabetes Center at Heinrich Heine University, Dusseldorf, Germany. rathmann@ddz.uni-duesseldorf.de']",['eng'],['Journal Article'],,Germany,Horm Metab Res,Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,0177722,IM,"['Adiponectin/*physiology', 'Cardiovascular Diseases/diagnosis/etiology/*mortality', 'Humans', 'Prognosis', 'Risk Factors']",2007/01/18 09:00,2007/03/29 09:00,['2007/01/18 09:00'],"['2007/01/18 09:00 [pubmed]', '2007/03/29 09:00 [medline]', '2007/01/18 09:00 [entrez]']",['10.1055/s-2007-958630 [doi]'],ppublish,Horm Metab Res. 2007 Jan;39(1):1-2. doi: 10.1055/s-2007-958630.,1,,,,,,,,['0 (Adiponectin)'],,,,,,,,,,,,,
36561087,NLM,MEDLINE,20230103,20230115,1947-6108 (Electronic) 1947-6094 (Print) 1947-6108 (Linking),18,2022,Future Impact of mRNA Therapy on Cardiovascular Diseases.,64-73,10.14797/mdcvj.1169 [doi],"['Cooke, John P', 'Youker, Keith A']","['Cooke JP', 'Youker KA']","['Houston Methodist Research Institute, Houston, Texas, US.', 'Houston Methodist Research Institute, Houston, Texas, US.']",['eng'],"['Journal Article', 'Review']",20221206,United States,Methodist Debakey Cardiovasc J,Methodist DeBakey cardiovascular journal,101508600,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/genetics/therapy', '*Coronary Artery Disease', '*Heart Failure', '*Myocardial Ischemia', 'RNA, Messenger/genetics', 'Clinical Trials, Phase II as Topic']",2022/12/24 06:00,2022/12/27 06:00,['2022/12/23 02:16'],"['2022/10/11 00:00 [received]', '2022/10/19 00:00 [accepted]', '2022/12/23 02:16 [entrez]', '2022/12/24 06:00 [pubmed]', '2022/12/27 06:00 [medline]']",['10.14797/mdcvj.1169 [doi]'],epublish,Methodist Debakey Cardiovasc J. 2022 Dec 6;18(5):64-73. doi: 10.14797/mdcvj.1169. eCollection 2022.,5,"The silver lining of the recent pandemic was that it accelerated the emergence of messenger ribonucleic acid (mRNA) therapeutics. The great promise of mRNA therapeutics was highlighted by the speed at which the vaccines were created, tested, and proven to be relatively safe and highly effective. There are a wide variety of mRNA therapeutics now under development, and dozens of these are in clinical trials. These therapeutics are generating a major paradigm shift in medical therapy, including the treatment of cardiovascular disease. Most of the cardiovascular mRNA therapies are still in preclinical development, although a phase 2a trial of mRNA therapy for myocardial ischemia has been completed with promising results.(1) The application of mRNA therapies to cardiovascular diseases is virtually limitless, and ongoing work includes mRNA therapies for myocardial ischemia, heart failure, arrhythmias, hypercholesterolemia, and arterial occlusive diseases. In addition, mRNA may be used to enhance cell therapies. In the future, mRNA therapies for cardiovascular disease are destined to supplant some of our current biologics and pharmacotherapies and will be used to treat previously untreatable cardiovascular diseases. Furthermore, mRNA therapies can be personalized, and they can be rapidly generated in current Good Manufacturing Practice facilities with a modest footprint, facilitating the rise of hospital-based regional centers of RNA therapeutics.","['ORCID: 0000-0003-0033-9138', 'ORCID: 0000-0003-2535-7973']",PMC9733127,"['Dr. Cooke is a member of the Scientific Advisory Board for Humann, the founder of', 'Cooke Consulting, and has a sponsored research agreement with VGXI Inc. He is the', 'inventor of related mRNA technologies assigned to Stanford University and Houston', 'Methodist Hospital, some of which are licensed to ChromeX Bio, founded by Dr.', 'Cooke. Dr. Youker has no competing interests to declare.']",['NOTNLM'],"['arrhythmias', 'heart failure', 'hypercholesterolemia', 'myocardial infarction', 'senescence', 'telomerase', 'vaccine']",['R01 HL148338/HL/NHLBI NIH HHS/United States'],"['0 (RNA, Messenger)']",['Copyright: (c) 2022 The Author(s).'],,,,,,,,,,,,
2208760,NLM,MEDLINE,19901115,20190918,0730-0077 (Print) 0730-0077 (Linking),12,1990,Experimental intervention of hypertension and cardiovascular diseases.,939-52,,"['Yamori, Y']",['Yamori Y'],"['Department of Pathology, Shimane Medical University, Izumo, Japan.']",['eng'],"['Journal Article', 'Review']",,United States,Clin Exp Hypertens A,"Clinical and experimental hypertension. Part A, Theory and practice",8207790,IM,"['Animals', 'Cardiovascular Diseases/epidemiology/*prevention & control', 'Cerebrovascular Disorders/etiology/prevention & control', 'Cross-Sectional Studies', 'Diet', 'Disease Models, Animal', 'Hypertension/etiology/*prevention & control', 'Rats']",1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']",['10.3109/10641969009073511 [doi]'],ppublish,Clin Exp Hypertens A. 1990;12(5):939-52. doi: 10.3109/10641969009073511.,5,"Experimental prevention of hypertension and related cardiovascular diseases has been studied in rat models for hypertension and stroke and not only salt reduction but also increased intakes of potassium, calcium, magnesium, protein, some amino acids and fatty acids and dietary fibers have been proven to be effective and indicated the importance of nonpharmacological dietary prevention of cardiovascular diseases. These experimental findings contribute to dietary risk factor analyses and the prevention of hypertension and its complications in man, as demonstrated by a cross-sectional epidemiological study on cardiovascular diseases and alimentary comparison (WHO-CARDIAC Study).",,,,,,,,,50,,,,,,,,,,,
35861748,NLM,MEDLINE,20220725,20221105,1524-4563 (Electronic) 0194-911X (Linking),79,2022 Aug,Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension-Con Side of the Argument.,1571-1578,10.1161/HYPERTENSIONAHA.122.18458 [doi],"['Jacobsen, Alan P', 'McKittrick, Myles', 'Daya, Natalie', 'Al Rifai, Mahmoud', 'McEvoy, John W']","['Jacobsen AP', 'McKittrick M', 'Daya N', 'Al Rifai M', 'McEvoy JW']","['Ciccarone Center for the Prevention of Cardiovascular Disease, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (A.P.J., J.W.M.).', 'National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway (M.M., J.W.M.).', 'Welch Center for Prevention, Epidemiology and Clinical Research, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (N.D.).', 'Section of Cardiology, Baylor College of Medicine, Houston, TX (M.A.R.).', 'Ciccarone Center for the Prevention of Cardiovascular Disease, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (A.P.J., J.W.M.).', 'National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway (M.M., J.W.M.).']",['eng'],['Journal Article'],20220713,United States,Hypertension,"Hypertension (Dallas, Tex. : 1979)",7906255,IM,"['Antihypertensive Agents/therapeutic use', 'Blood Pressure', '*Cardiovascular Diseases/drug therapy/epidemiology/etiology', 'Humans', '*Hypertension']",2022/07/22 06:00,2022/07/26 06:00,['2022/07/21 11:03'],"['2022/07/21 11:03 [entrez]', '2022/07/22 06:00 [pubmed]', '2022/07/26 06:00 [medline]']",['10.1161/HYPERTENSIONAHA.122.18458 [doi]'],ppublish,Hypertension. 2022 Aug;79(8):1571-1578. doi: 10.1161/HYPERTENSIONAHA.122.18458. Epub 2022 Jul 13.,8,,"['ORCID: 0000-0003-0587-8333', 'ORCID: 0000-0002-2257-0480', 'ORCID: 0000-0002-6933-790X', 'ORCID: 0000-0001-6530-5479']",,,['NOTNLM'],"['cardiovascular diseases', 'diastolic blood pressure', 'guidelines', 'isolated diastolic hypertension', 'phenotype']",,['0 (Antihypertensive Agents)'],,,,,['Hypertension. 2022 Aug;79(8):1579. PMID: 35861747'],,,,,,,,
19655022,NLM,MEDLINE,20101004,20211203,1937-5395 (Electronic) 1937-5387 (Print) 1937-5387 (Linking),2,2009 Sep,Women and cardiovascular medicine.,335-6,10.1007/s12265-009-9107-8 [doi],"['Tate, Lisa M']",['Tate LM'],,['eng'],['Letter'],20090714,United States,J Cardiovasc Transl Res,Journal of cardiovascular translational research,101468585,IM,"['Adult', 'Cardiovascular Diseases/diagnosis/etiology/mortality/*prevention & control', 'Evidence-Based Medicine', 'Female', 'Health Promotion', 'Health Status Disparities', 'Healthcare Disparities', 'Humans', 'Male', 'Middle Aged', 'Risk Assessment', 'Risk Factors', 'Translational Research, Biomedical', ""*Women's Health"", ""*Women's Health Services""]",2009/08/06 09:00,2010/10/05 06:00,['2009/08/06 09:00'],"['2009/04/22 00:00 [received]', '2009/05/07 00:00 [accepted]', '2009/08/06 09:00 [entrez]', '2009/08/06 09:00 [pubmed]', '2010/10/05 06:00 [medline]']","['9107 [pii]', '10.1007/s12265-009-9107-8 [doi]']",ppublish,J Cardiovasc Transl Res. 2009 Sep;2(3):335-6. doi: 10.1007/s12265-009-9107-8. Epub 2009 Jul 14.,3,,,PMC2719745,,,,,,,,,,,,,,,,,,
471732,NLM,MEDLINE,19791017,20221207,0301-1518 (Print) 0301-1518 (Linking),8,1979 May 5,[The present and future of cardiovascular diseases in black Africa].,1643-4,,"['Bertrand, E']",['Bertrand E'],,['fre'],['Editorial'],,France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Adult', 'Africa', 'Black People', 'Cardiology/*trends', 'Cardiomyopathies/epidemiology', 'Cardiovascular Diseases/*epidemiology/prevention & control', 'Child', 'Endomyocardial Fibrosis/epidemiology', 'Female', 'Humans', 'Hypertension/epidemiology', 'Male', 'Pericarditis/epidemiology', 'Thromboembolism/epidemiology']",1979/05/05 00:00,1979/05/05 00:01,['1979/05/05 00:00'],"['1979/05/05 00:00 [pubmed]', '1979/05/05 00:01 [medline]', '1979/05/05 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1979 May 5;8(20):1643-4.,20,,,,,,,,,,,,,,,Le present et l'avenir des maladies cardio-vasculaires en Afrique noire.,,,,,,
12184129,NLM,MEDLINE,20021007,20051116,0012-7183 (Print) 0012-7183 (Linking),117,2001,[Blood pressure in children].,1377-81,,"['Taittonen, L', 'Uhari, M']","['Taittonen L', 'Uhari M']","['Oulun yliopiston lastentautien klinikka PL 5000, 90014 Oulun yliopisto.']",['fin'],"['Journal Article', 'Review']",,Finland,Duodecim,Duodecim; laaketieteellinen aikakauskirja,0373207,IM,"['Birth Weight', 'Blood Pressure', 'Cardiovascular Diseases/etiology/metabolism/*prevention & control', 'Child', 'Humans', 'Hypertension/complications/*diagnosis/*epidemiology', 'Insulin Resistance', 'Prognosis', 'Reference Values', 'Risk Factors']",2002/08/20 10:00,2002/10/09 04:00,['2002/08/20 10:00'],"['2002/08/20 10:00 [pubmed]', '2002/10/09 04:00 [medline]', '2002/08/20 10:00 [entrez]']",,ppublish,Duodecim. 2001;117(13):1377-81.,13,,,,,,,,,,28,,,,,Lasten verenpaine.,,,,,,
3943323,NLM,MEDLINE,19860314,20041117,0090-3493 (Print) 0090-3493 (Linking),14,1986 Feb,Pulsus paradoxus in pulmonary embolism: reversal with thrombolytic therapy.,165-6,,"['Silverman, H J', 'Haponik, E F']","['Silverman HJ', 'Haponik EF']",,['eng'],"['Case Reports', 'Journal Article']",,United States,Crit Care Med,Critical care medicine,0355501,IM,"['Cardiovascular Diseases/drug therapy/etiology/*physiopathology', 'Female', 'Humans', 'Middle Aged', 'Pulmonary Embolism/complications/etiology/*physiopathology', '*Pulse', 'Streptokinase/therapeutic use']",1986/02/01 00:00,1986/02/01 00:01,['1986/02/01 00:00'],"['1986/02/01 00:00 [pubmed]', '1986/02/01 00:01 [medline]', '1986/02/01 00:00 [entrez]']",,ppublish,Crit Care Med. 1986 Feb;14(2):165-6.,2,,,,,,,,['EC 3.4.- (Streptokinase)'],,,,,,,,,,,,,
10318652,NLM,MEDLINE,19990526,20190623,1524-4539 (Electronic) 0009-7322 (Linking),99,1999 May 11,AHA's new strategic impact goal designed to curb epidemic of cardiovascular disease and stroke.,2360,,"['Fuster, V', 'Smaha, L']","['Fuster V', 'Smaha L']",,['eng'],['News'],,United States,Circulation,Circulation,0147763,IM,"['*American Heart Association', 'Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control', 'Cerebrovascular Disorders/diagnosis/epidemiology/*prevention & control/therapy', 'Emergency Medical Services', 'Forecasting', 'Goals', '*Health Policy', 'Heart Arrest/therapy', 'Humans', 'Myocardial Infarction/therapy', 'Time Factors', 'United States']",1999/05/11 00:00,1999/05/11 00:01,['1999/05/11 00:00'],"['1999/05/11 00:00 [pubmed]', '1999/05/11 00:01 [medline]', '1999/05/11 00:00 [entrez]']",['10.1161/01.cir.99.18.2360 [doi]'],ppublish,Circulation. 1999 May 11;99(18):2360. doi: 10.1161/01.cir.99.18.2360.,18,,,,,,,,,,,,,,,,,,,,,
14879085,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,1951 Dec 1,CARDIOVASCULAR disease in cotton workers.,1329-30,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Gossypium', 'Humans', '*Occupational Diseases', '*Textiles']",1951/12/01 00:00,1951/12/01 00:01,['1951/12/01 00:00'],"['1951/12/01 00:00 [pubmed]', '1951/12/01 00:01 [medline]', '1951/12/01 00:00 [entrez]']",,ppublish,Br Med J. 1951 Dec 1;2(4743):1329-30.,4743,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/epidemiology and statistics', '*OCCUPATIONAL DISEASES']",,,,,,,,,,,,,,['CLML: 5221:9356:72:264'],
10074827,NLM,MEDLINE,19990318,20080716,0029-2001 (Print) 0029-2001 (Linking),119,1999 Jan 30,[Has the HOT study taught us something new?].,353,,"['Thelle, D S']",['Thelle DS'],"['Institut for allmennmedisin og samfunnsmedisinske fag Postboks, Blindern, Oslo.']",['nor'],['Journal Article'],,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Antihypertensive Agents/*administration & dosage', 'Cardiovascular Diseases/etiology/mortality/prevention & control', 'Humans', 'Hypertension/complications/*drug therapy/mortality', 'Randomized Controlled Trials as Topic']",1999/03/13 00:00,1999/03/13 00:01,['1999/03/13 00:00'],"['1999/03/13 00:00 [pubmed]', '1999/03/13 00:01 [medline]', '1999/03/13 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1999 Jan 30;119(3):353.,3,,,,,,,,['0 (Antihypertensive Agents)'],,,,,,,Har HOT-studien laert oss noe nytt?,,,,,,
2929177,NLM,MEDLINE,19890421,20041117,0303-8408 (Print) 0303-8408 (Linking),Suppl 1,1989,[Improved quality of life through the prevention of cardiovascular diseases?].,S1-31,,,,,['ger'],['Journal Article'],,Switzerland,Soz Praventivmed,Sozial- und Praventivmedizin,7502479,IM,"['Cardiovascular Diseases/*prevention & control/psychology', 'Coronary Disease/*prevention & control/psychology', 'Humans', '*Quality of Life']",1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Soz Praventivmed. 1989;Suppl 1:S1-31.,,,,,,,,,,,,,,,,Mehr Lebensqualitat durch kardiovaskulare Pravention?,,,,,,
14088339,NLM,MEDLINE,19961201,20181201,0008-9176 (Print) 0008-9176 (Linking),9,1963 Dec,CARDIOVASCULAR DISEASE IN THE AFRICAN IN MATABELELAND.,463-9,,"['BALDACHIN, B J']",['BALDACHIN BJ'],,['eng'],['Journal Article'],,Zimbabwe,Cent Afr J Med,The Central African journal of medicine,0372566,OM,"['Adolescent', '*Cardiovascular Diseases', 'Child', '*Heart Defects, Congenital', '*Heart Diseases', 'Humans', '*Hypertension', 'Infant', '*Pericarditis', '*Pulmonary Heart Disease', '*Rheumatic Heart Disease', '*Statistics as Topic', '*Syphilis', '*Syphilis, Cardiovascular', 'Zimbabwe']",1963/12/01 00:00,1963/12/01 00:01,['1963/12/01 00:00'],"['1963/12/01 00:00 [pubmed]', '1963/12/01 00:01 [medline]', '1963/12/01 00:00 [entrez]']",,ppublish,Cent Afr J Med. 1963 Dec;9:463-9.,,,,,,['NLM'],"['*ADOLESCENCE', '*CARDIOVASCULAR DISEASES', '*CHILD', '*HEART DEFECTS, CONGENITAL', '*HEART DISEASES', '*HYPERTENSION', '*INFANT', '*PERICARDITIS', '*PULMONARY HEART DISEASE', '*RHEUMATIC HEART DISEASE', '*RHODESIA', '*STATISTICS', '*SYPHILIS, CARDIOVASCULAR']",,,,,,,,,,,,,,,
25969848,NLM,MEDLINE,20151221,20191113,1875-8312 (Electronic) 1569-5794 (Linking),31,2015 Mar,Cardiovascular imaging 2014 in the International Journal of Cardiovascular Imaging.,447-61,,,,,['eng'],"['Editorial', 'Review']",,United States,Int J Cardiovasc Imaging,The international journal of cardiovascular imaging,100969716,IM,"['Animals', 'Cardiovascular Diseases/*diagnosis/physiopathology/therapy', 'Diagnostic Imaging/*methods', 'Heart Function Tests/*methods', 'Humans', '*Periodicals as Topic', 'Predictive Value of Tests', 'Prognosis']",2015/05/15 06:00,2015/12/22 06:00,['2015/05/14 06:00'],"['2015/05/14 06:00 [entrez]', '2015/05/15 06:00 [pubmed]', '2015/12/22 06:00 [medline]']",['10.1007/s10554-015-0627-9 [doi]'],ppublish,Int J Cardiovasc Imaging. 2015 Mar;31(3):447-61. doi: 10.1007/s10554-015-0627-9.,3,,,,,,,,,,,,,,,,,,,,,
11128191,NLM,MEDLINE,20010125,20060504,0268-4705 (Print) 0268-4705 (Linking),15,2000 Sep,"Bibliography. Current world literature. Diseases of the aorta, pulmonary and peripheral vessels.",B217-58,,,,,['eng'],['Bibliography'],,United States,Curr Opin Cardiol,Current opinion in cardiology,8608087,IM,"['Cardiovascular Diseases/*diagnosis/*therapy', 'Humans']",2000/12/29 11:00,2001/02/28 10:01,['2000/12/29 11:00'],"['2000/12/29 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/12/29 11:00 [entrez]']",,ppublish,Curr Opin Cardiol. 2000 Sep;15(5):B217-58.,5,,,,,,,,,,,,,,,,,,,,,
1729423,NLM,MEDLINE,19920213,20131121,0889-4655 (Print) 0889-4655 (Linking),6,1992 Jan,Cardiovascular effects of methamphetamine.,12-8,,"['Lynch, J', 'House, M A']","['Lynch J', 'House MA']",,['eng'],['Journal Article'],,United States,J Cardiovasc Nurs,The Journal of cardiovascular nursing,8703516,,"['Cardiovascular Diseases/*chemically induced/nursing/physiopathology', 'Humans', '*Methamphetamine', 'Substance-Related Disorders/*complications']",1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",,ppublish,J Cardiovasc Nurs. 1992 Jan;6(2):12-8.,2,"Stimulant abuse has grown in popularity, particularly since the advent of crack cocaine. Another commonly abused drug is methamphetamine (MAP) hydrochloride. Known as crank, crystal, ice, crystal meth, and speed, MAP can be produced easily from ephedrine, and it is widely available. This article describes the pharmacology, cardiovascular effects, and toxicology of MAP, as well as the management principles of MAP abuse.",,,,,,,['44RAL3456C (Methamphetamine)'],,,,,,,,,,,,,
5193347,NLM,MEDLINE,19690807,20001218,0029-6457 (Print) 0029-6457 (Linking),41,1969 Apr,"[Social, medical, family repercussions of heart disorders].",1-6,,['Colin'],['Colin'],,['fre'],['Journal Article'],,Belgium,Nursing (Brux),Nursing,19230340R,,"['Cardiovascular Diseases/prevention & control/therapy', 'Psychology']",1969/04/01 00:00,1969/04/01 00:01,['1969/04/01 00:00'],"['1969/04/01 00:00 [pubmed]', '1969/04/01 00:01 [medline]', '1969/04/01 00:00 [entrez]']",,ppublish,Nursing (Brux). 1969 Apr;41(2):1-6.,2,,,,,,,,,,,,,,,"Retentissement social, medical, familial des troubles cardiaques.",,,,,,
28408026,NLM,MEDLINE,20170502,20220330,1558-3597 (Electronic) 0735-1097 (Linking),69,2017 Apr 18,The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels.,1952-1967,S0735-1097(17)30790-8 [pii] 10.1016/j.jacc.2017.01.064 [doi],"['Paneni, Francesco', 'Diaz Canestro, Candela', 'Libby, Peter', 'Luscher, Thomas F', 'Camici, Giovanni G']","['Paneni F', 'Diaz Canestro C', 'Libby P', 'Luscher TF', 'Camici GG']","['Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland; University Heart Center, Cardiology, University Hospital Zurich, Zurich, Switzerland.', 'Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.', ""Brigham and Women's Hospital, Division of Cardiovascular Medicine, Boston, Massachusetts."", 'Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland; University Heart Center, Cardiology, University Hospital Zurich, Zurich, Switzerland.', 'Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland; University Heart Center, Cardiology, University Hospital Zurich, Zurich, Switzerland. Electronic address: giovanni.camici@uzh.ch.']",['eng'],"['Journal Article', 'Review']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Aged', 'Aging/*physiology', '*Cardiovascular Diseases/etiology/metabolism/physiopathology/prevention & control', 'Cardiovascular System/*physiopathology', 'Disease Management', 'Humans']",2017/04/15 06:00,2017/05/04 06:00,['2017/04/15 06:00'],"['2016/07/12 00:00 [received]', '2017/01/23 00:00 [revised]', '2017/01/24 00:00 [accepted]', '2017/04/15 06:00 [entrez]', '2017/04/15 06:00 [pubmed]', '2017/05/04 06:00 [medline]']","['S0735-1097(17)30790-8 [pii]', '10.1016/j.jacc.2017.01.064 [doi]']",ppublish,J Am Coll Cardiol. 2017 Apr 18;69(15):1952-1967. doi: 10.1016/j.jacc.2017.01.064.,15,"Cardiovascular disease (CVD) presents a great burden for elderly patients, their caregivers, and health systems. Structural and functional alterations of vessels accumulate throughout life, culminating in increased risk of developing CVD. The growing elderly population worldwide highlights the need to understand how aging promotes CVD in order to develop new strategies to confront this challenge. This review provides examples of some major unresolved clinical problems encountered in daily cardiovascular practice as we care for elderly patients. Next, the authors summarize the current understanding of the mechanisms implicated in cardiovascular aging, and the potential for targeting novel pathways implicated in endothelial dysfunction, mitochondrial oxidative stress, chromatin remodeling, and genomic instability. Lastly, the authors consider critical aspects of vascular repair, including autologous transplantation of bone marrow-derived stem cells in elderly patients.",,,,['NOTNLM'],"['arterial stiffness', 'endothelium', 'epigenetics', 'stem cells']",,,"['Copyright (c) 2017 American College of Cardiology Foundation. Published by Elsevier', 'Inc. All rights reserved.']",,,,,,,,,,,,
20560021,NLM,MEDLINE,20101004,20181201,1937-5395 (Electronic) 1937-5387 (Linking),2,2009 Sep,The progress of women's health in cardiovascular medicine.,337,10.1007/s12265-009-9112-y [doi],"['Hall, Jennifer L']",['Hall JL'],,['eng'],"['Editorial', 'Introductory Journal Article', 'Portrait']",20090618,United States,J Cardiovasc Transl Res,Journal of cardiovascular translational research,101468585,IM,"['Cardiovascular Diseases/diagnosis/mortality/*prevention & control', 'Female', 'Health Promotion', '*Health Status Disparities', '*Healthcare Disparities', 'Humans', ""*Women's Health"", ""*Women's Health Services""]",2010/06/19 06:00,2010/10/05 06:00,['2010/06/19 06:00'],"['2009/05/20 00:00 [received]', '2009/05/20 00:00 [accepted]', '2010/06/19 06:00 [entrez]', '2010/06/19 06:00 [pubmed]', '2010/10/05 06:00 [medline]']",['10.1007/s12265-009-9112-y [doi]'],ppublish,J Cardiovasc Transl Res. 2009 Sep;2(3):337. doi: 10.1007/s12265-009-9112-y. Epub 2009 Jun 18.,3,,,,,,,,,,,,,,,,,,,,,
16764430,NLM,MEDLINE,20061101,20191026,0739-5175 (Print) 0739-5175 (Linking),25,2006 May-Jun,The evolution of pacemakers.,38-48,,"['Haddad, Sandro A P', 'Houben, Richard P M', 'Serdijn, Wouter A']","['Haddad SA', 'Houben RP', 'Serdijn WA']","['Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, The Netherlands. s.haddad@ewi.tudelft.nl']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,United States,IEEE Eng Med Biol Mag,IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society,8305985,IM,"['Cardiovascular Diseases/history/mortality/*therapy', 'Equipment Design/history', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Pacemaker, Artificial/*history']",2006/06/13 09:00,2006/11/02 09:00,['2006/06/13 09:00'],"['2006/06/13 09:00 [pubmed]', '2006/11/02 09:00 [medline]', '2006/06/13 09:00 [entrez]']",['10.1109/memb.2006.1636350 [doi]'],ppublish,IEEE Eng Med Biol Mag. 2006 May-Jun;25(3):38-48. doi: 10.1109/memb.2006.1636350.,3,,,,,,,,,,30,,,,,,,,,,,
36443875,NLM,MEDLINE,20230216,20230325,2047-4881 (Electronic) 2047-4873 (Linking),30,2023 Feb 14,Factors potentially influencing the association between physical activity timing and cardiovascular disease risk.,e3,10.1093/eurjpc/zwac281 [doi],"['Sun, Zhen', 'Liu, Mengsi']","['Sun Z', 'Liu M']","['Department of Clinical Medicine, Hengyang Medical School, University of South China, No. 28 Changsheng West Road, Hengyang 421001, China.', 'Department of Clinical Medicine, Hengyang Medical School, University of South China, No. 28 Changsheng West Road, Hengyang 421001, China.']",['eng'],"['Comment', 'Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Exercise', 'Risk Factors']",2022/11/30 06:00,2023/02/17 06:00,['2022/11/29 00:12'],"['2022/11/30 06:00 [pubmed]', '2023/02/17 06:00 [medline]', '2022/11/29 00:12 [entrez]']","['6850523 [pii]', '10.1093/eurjpc/zwac281 [doi]']",ppublish,Eur J Prev Cardiol. 2023 Feb 14;30(3):e3. doi: 10.1093/eurjpc/zwac281.,3,,"['ORCID: 0000-0002-5395-2131', 'ORCID: 0000-0001-6149-0769']",,,,,,,,,['Eur J Prev Cardiol. 2023 Feb 14;30(3):232-240. PMID: 36372091'],,,,,,,,,,
15269568,NLM,MEDLINE,20050208,20191108,1076-7460 (Print) 1076-7460 (Linking),13,2004 Jul-Aug,Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: commentary by Editorial Board Members of The American Journal of Geriatric Cardiology.,209-16,,"['Wenger, Nanette K', 'Gregoratos, Gabriel', 'Kitzman, Dalane W', 'Scheidt, Stephen', 'Weber, Michael A', 'Alpert, Joseph S']","['Wenger NK', 'Gregoratos G', 'Kitzman DW', 'Scheidt S', 'Weber MA', 'Alpert JS']","['Emory University School of Medicine, Atlanta, GA 30303, USA.']",['eng'],['Journal Article'],,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Arrhythmias, Cardiac/diagnosis/epidemiology/therapy', '*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Coronary Artery Disease/diagnosis/epidemiology/therapy', 'Heart Failure/diagnosis/epidemiology/therapy', 'Heart Valve Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Hypertension/diagnosis/epidemiology/therapy', '*Practice Guidelines as Topic', 'Risk Management']",2004/07/23 05:00,2005/02/09 09:00,['2004/07/23 05:00'],"['2004/07/23 05:00 [pubmed]', '2005/02/09 09:00 [medline]', '2004/07/23 05:00 [entrez]']",['10.1111/j.1076-7460.2004.03491.x [doi]'],ppublish,Am J Geriatr Cardiol. 2004 Jul-Aug;13(4):209-16. doi: 10.1111/j.1076-7460.2004.03491.x.,4,,,,,,,,,,,,,,['Editorial Board Members of The American Journal of Geriatric Cardiology'],,,,,,,
13562740,NLM,MEDLINE,20000701,20201218,0018-0203 (Print) 0018-0203 (Linking),25,1958 Jun,[Mucoid degeneration of annulus fibrosus; report of functional aortic insufficiency].,208-34,,"['FERNEX, M']",['FERNEX M'],,['fre'],['Journal Article'],,Switzerland,Helv Med Acta,Helvetica medica acta,0401174,OM,"['*Aortic Valve', '*Aortic Valve Insufficiency', 'Bicuspid Aortic Valve Disease', 'Cardiovascular Diseases/*complications', '*Disease', '*Heart Defects, Congenital', '*Heart Valve Diseases', 'Humans']",1958/06/01 00:00,1958/06/01 00:01,['1958/06/01 00:00'],"['1958/06/01 00:00 [pubmed]', '1958/06/01 00:01 [medline]', '1958/06/01 00:00 [entrez]']",,ppublish,Helv Med Acta. 1958 Jun;25(3):208-34.,3,,,,,['NLM'],"['*AORTIC VALVE/diseases', '*CARDIOVASCULAR DISEASES/complications']",,,,,,,,,La degenerescence mucoide de l'anneau fibreux; a propos de l'insuffisance aortique fonctionnelle.,,,,,['CLML: 5834:55499:54:122'],
6475765,NLM,MEDLINE,19841004,20190622,0002-9149 (Print) 0002-9149 (Linking),54,1984 Aug 27,Causes of the decrease in cardiovascular mortality.,7C-13C,,"['Levy, R I']",['Levy RI'],,['eng'],['Journal Article'],,United States,Am J Cardiol,The American journal of cardiology,0207277,IM,"['Adult', 'Cardiovascular Diseases/drug therapy/*mortality/prevention & control/surgery', 'Coronary Disease/drug therapy/mortality/surgery', 'Humans', 'Hypertension/therapy', 'Risk', 'Smoking', 'United States']",1984/08/27 00:00,1984/08/27 00:01,['1984/08/27 00:00'],"['1984/08/27 00:00 [pubmed]', '1984/08/27 00:01 [medline]', '1984/08/27 00:00 [entrez]']","['0002-9149(84)90850-6 [pii]', '10.1016/0002-9149(84)90850-6 [doi]']",ppublish,Am J Cardiol. 1984 Aug 27;54(5):7C-13C. doi: 10.1016/0002-9149(84)90850-6.,5,"In the last 15 years there has been a dramatic, unprecedented decrease in the mortality rate from cardiovascular disease in the United States, especially from coronary heart disease and stroke. Possible causes of the decline in the coronary heart disease mortality rate include the development of the concept of acute coronary care, new drugs, sophisticated surgical techniques such as coronary artery bypass, noninvasive diagnostic methods for earlier disease detection, and the identification of specific cardiovascular risk factors. The decrease has been temporarily related to increased risk factor awareness and modification (cigarette smoking cessation, hypertension control, diet change and reduction in cholesterol). Thus, both primary prevention through lifestyle changes and improved treatment regimens have played a role in the decline. Recent studies showing the benefit of cholesterol reduction emphasize the potential for even greater decreases.",,,,,,,,,,,,,,,,,,,,
16757493,NLM,MEDLINE,20070315,20060620,0195-668X (Print) 0195-668X (Linking),27,2006 Jul,How much does Europe invest in the treatment of cardiovascular diseases?,1521-2,,"['Tendera, Michal']",['Tendera M'],,['eng'],"['Comment', 'Editorial']",20060606,England,Eur Heart J,European heart journal,8006263,IM,"['Cardiovascular Diseases/economics/*therapy', 'Europe', '*Health Expenditures', 'Humans']",2006/06/08 09:00,2007/03/16 09:00,['2006/06/08 09:00'],"['2006/06/08 09:00 [pubmed]', '2007/03/16 09:00 [medline]', '2006/06/08 09:00 [entrez]']","['ehl075 [pii]', '10.1093/eurheartj/ehl075 [doi]']",ppublish,Eur Heart J. 2006 Jul;27(13):1521-2. doi: 10.1093/eurheartj/ehl075. Epub 2006 Jun 6.,13,,,,,,,,,,,['Eur Heart J. 2006 Jul;27(13):1610-9. PMID: 16495286'],,,,,,,,,,
19920731,NLM,MEDLINE,20100119,20091120,1473-5598 (Electronic) 0263-6352 (Linking),27,2009 Dec,Comparing methods for assessing cardiovascular risk.,2342-3,10.1097/HJH.0b013e3283324684 [doi],"['Mancia, Giuseppe']",['Mancia G'],,['eng'],"['Comment', 'Comparative Study', 'Editorial']",,Netherlands,J Hypertens,Journal of hypertension,8306882,IM,"['Cardiovascular Diseases/*epidemiology/etiology/physiopathology', 'Humans', 'Risk Assessment/*methods', 'Risk Factors']",2009/11/19 06:00,2010/01/20 06:00,['2009/11/19 06:00'],"['2009/11/19 06:00 [entrez]', '2009/11/19 06:00 [pubmed]', '2010/01/20 06:00 [medline]']","['00004872-200912000-00005 [pii]', '10.1097/HJH.0b013e3283324684 [doi]']",ppublish,J Hypertens. 2009 Dec;27(12):2342-3. doi: 10.1097/HJH.0b013e3283324684.,12,,,,,,,,,,,['J Hypertens. 2009 Dec;27(12):2351-7. PMID: 19915482'],,,,,,,,,,
17477108,NLM,MEDLINE,20070525,20070504,0024-7758 (Print) 0024-7758 (Linking),52,2007 Feb,Risk of cardiovascular disease as a woman ages.,147-51,,"['Lewis, Sandra J']",['Lewis SJ'],"['Department of Medicine, Oregon Health and Science University, and Legacy Heart Institute, Portland, USA. sandral@nw-ci.com']",['eng'],"['Journal Article', 'Review']",,United States,J Reprod Med,The Journal of reproductive medicine,0173343,IM,"['Aging/*physiology', 'Cardiovascular Diseases/diagnosis/*epidemiology/prevention & control', 'Female', 'Humans', 'Hypertension/prevention & control/*therapy', 'Postmenopause/*physiology', 'Risk Factors']",2007/05/05 09:00,2007/05/26 09:00,['2007/05/05 09:00'],"['2007/05/05 09:00 [pubmed]', '2007/05/26 09:00 [medline]', '2007/05/05 09:00 [entrez]']",,ppublish,J Reprod Med. 2007 Feb;52(2 Suppl):147-51.,2 Suppl,The prevalence of heart disease and hypertension are increased in postmenopausal women. Gynecologists who have the role of primary care clinicians need to be aware of these risks and recognize cardiovascular problems in their patients.,,,,,,,,,13,,,,,,,,,,,
5374373,NLM,MEDLINE,19700427,20041117,0023-7205 (Print) 0023-7205 (Linking),66,1969 Dec 10,[Why preventive cardiology?].,5229-34,,"['Werko, L']",['Werko L'],,['swe'],['Journal Article'],,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Adolescent', 'Adult', 'Aged', 'Cardiovascular Diseases/*epidemiology/mortality/prevention & control', 'Cerebrovascular Disorders/mortality', 'Child', 'Child, Preschool', 'Female', 'Heart Diseases/mortality', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Netherlands', '*Preventive Medicine']",1969/12/10 00:00,1969/12/10 00:01,['1969/12/10 00:00'],"['1969/12/10 00:00 [pubmed]', '1969/12/10 00:01 [medline]', '1969/12/10 00:00 [entrez]']",,ppublish,Lakartidningen. 1969 Dec 10;66(50):5229-34.,50,,,,,,,,,,,,,,,Varfor preventiv kardiologi?,,,,,,
1751750,NLM,MEDLINE,19920124,20161018,0212-6567 (Print) 0212-6567 (Linking),8,1991 Jul-Aug,[The detection of cardiovascular risk factors via a program of preventive activities].,581,,"['Rubio, M L', 'Fernandez Zueco, M F', 'Calvo Hornillo, D', 'Bunuel Alvarez, J C']","['Rubio ML', 'Fernandez Zueco MF', 'Calvo Hornillo D', 'Bunuel Alvarez JC']",,['spa'],['Letter'],,Spain,Aten Primaria,Atencion primaria,9111075,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/prevention & control', 'Humans', 'Prevalence', 'Risk Factors', 'Spain/epidemiology']",1991/07/01 00:00,1991/07/01 00:01,['1991/07/01 00:00'],"['1991/07/01 00:00 [pubmed]', '1991/07/01 00:01 [medline]', '1991/07/01 00:00 [entrez]']",,ppublish,Aten Primaria. 1991 Jul-Aug;8(7):581.,7,,,,,,,,,,,,,,,Deteccion de los factores de riesgo cardiovascular a traves de un programa de actividades preventivas.,,,,,,
15226250,NLM,MEDLINE,20040728,20051116,1524-4539 (Electronic) 0009-7322 (Linking),109,2004 Jun 29,Genetic markers: progress and potential for cardiovascular disease.,IV47-58,,"['Gibbons, Gary H', 'Liew, Choong Chin', 'Goodarzi, Mark O', 'Rotter, Jerome I', 'Hsueh, Willa A', 'Siragy, Helmy M', 'Pratt, Richard', 'Dzau, Victor J']","['Gibbons GH', 'Liew CC', 'Goodarzi MO', 'Rotter JI', 'Hsueh WA', 'Siragy HM', 'Pratt R', 'Dzau VJ']","['Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Ga, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/*diagnosis/genetics/therapy', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Genomics', 'Humans', 'Proteomics']",2004/07/01 05:00,2004/07/29 05:00,['2004/07/01 05:00'],"['2004/07/01 05:00 [pubmed]', '2004/07/29 05:00 [medline]', '2004/07/01 05:00 [entrez]']","['109/25_suppl_1/IV-47 [pii]', '10.1161/01.CIR.0000133440.86427.26 [doi]']",ppublish,Circulation. 2004 Jun 29;109(25 Suppl 1):IV47-58. doi: 10.1161/01.CIR.0000133440.86427.26.,25 Suppl 1,,,,,,,,['0 (Genetic Markers)'],,153,,,,,,,,,,,
12497837,NLM,MEDLINE,20030312,20041117,0393-1978 (Print) 0393-1978 (Linking),44 Suppl 1,1999 Dec,[Epidemiology and natural history of cardiovascular diseases].,865-7,,"['Giampaoli, S', 'Ferrario, M']","['Giampaoli S', 'Ferrario M']","['Laboratorio di Epidemiologia e Biostatistica Istituto Superiore di Sanita Viale Regina Elena, 299, 00161 Roma. sgiamp@iss.it']",['ita'],['Journal Article'],,Italy,Cardiologia,"Cardiologia (Rome, Italy)",8506637,IM,"['Cardiovascular Diseases/*diagnosis/*epidemiology', 'Humans']",2002/12/25 04:00,2003/03/13 04:00,['2002/12/25 04:00'],"['2002/12/25 04:00 [pubmed]', '2003/03/13 04:00 [medline]', '2002/12/25 04:00 [entrez]']",,ppublish,Cardiologia. 1999 Dec;44 Suppl 1(Pt 2):865-7.,Pt 2,,,,,,,,,,,,,,,Epidemiologia e storia naturale delle malattie cardiovascolari.,,,,,,
18325021,NLM,MEDLINE,20080612,20151113,1468-1331 (Electronic) 1351-5101 (Linking),15,2008 May,The relationship between restless legs syndrome and cardiovascular disease.,e42,10.1111/j.1468-1331.2008.02113.x [doi],"['Kapoor, Shailendra']",['Kapoor S'],,['eng'],"['Comment', 'Letter']",20080305,England,Eur J Neurol,European journal of neurology,9506311,IM,"['Cardiovascular Diseases/*complications/epidemiology/therapy', 'Humans', 'Restless Legs Syndrome/epidemiology/*etiology']",2008/03/08 09:00,2008/06/13 09:00,['2008/03/08 09:00'],"['2008/03/08 09:00 [pubmed]', '2008/06/13 09:00 [medline]', '2008/03/08 09:00 [entrez]']","['ENE2113 [pii]', '10.1111/j.1468-1331.2008.02113.x [doi]']",ppublish,Eur J Neurol. 2008 May;15(5):e42. doi: 10.1111/j.1468-1331.2008.02113.x. Epub 2008 Mar 5.,5,,,,,,,,,,,['Eur J Neurol. 2008 Jan;15(1):16-21. PMID: 18005055'],,,,,,,,,,
33674356,NLM,MEDLINE,20220429,20220429,1468-201X (Electronic) 1355-6037 (Print) 1355-6037 (Linking),108,2022 Jan,Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice.,73-79,10.1136/heartjnl-2019-316378 [doi],"['Agca, Rabia', 'Smulders, Yvo', 'Nurmohamed, Michael']","['Agca R', 'Smulders Y', 'Nurmohamed M']","['Rheumatology, Amsterdam UMC and Reade, Amsterdam, Noord-Holland, The Netherlands r.agca@amsterdamumc.nl.', 'Internal Medicine, Amsterdam UMC, Amsterdam, Noord-Holland, The Netherlands.', 'Rheumatology, Amsterdam UMC and Reade, Amsterdam, Noord-Holland, The Netherlands.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20210304,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/etiology', '*Coronary Artery Disease', 'Humans', 'Risk Assessment', 'Risk Factors']",2021/03/07 06:00,2022/04/30 06:00,['2021/03/06 05:34'],"['2021/03/07 06:00 [pubmed]', '2022/04/30 06:00 [medline]', '2021/03/06 05:34 [entrez]']","['heartjnl-2019-316378 [pii]', '10.1136/heartjnl-2019-316378 [doi]']",ppublish,Heart. 2022 Jan;108(1):73-79. doi: 10.1136/heartjnl-2019-316378. Epub 2021 Mar 4.,1,,['ORCID: 0000-0002-2477-0945'],PMC8666803,['Competing interests: None declared.'],['NOTNLM'],"['cardiac risk factors and prevention', 'coronary artery disease', 'systemic inflammatory diseases']",,,,,,,,,,,,,,,
21929342,NLM,MEDLINE,20120125,20110920,1744-8298 (Electronic) 1479-6678 (Linking),7,2011 Sep,Cardiovascular disease in women.,613-27,10.2217/fca.11.30 [doi],"['Bhakta, Mayurkumar D', 'Mookadam, Farouk', 'Wilansky, Susan']","['Bhakta MD', 'Mookadam F', 'Wilansky S']","['Department of Cardiology, Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA.']",['eng'],['Journal Article'],,England,Future Cardiol,Future cardiology,101239345,IM,"['C-Reactive Protein/analysis', 'Cardiovascular Diseases/blood/diagnosis/*epidemiology/prevention & control/therapy', 'Female', 'Health Behavior', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use', 'Life Style', 'Primary Prevention', 'Risk Assessment', 'Risk Factors', 'Sex Factors', ""Women's Health""]",2011/09/21 06:00,2012/01/26 06:00,['2011/09/21 06:00'],"['2011/09/21 06:00 [entrez]', '2011/09/21 06:00 [pubmed]', '2012/01/26 06:00 [medline]']",['10.2217/fca.11.30 [doi]'],ppublish,Future Cardiol. 2011 Sep;7(5):613-27. doi: 10.2217/fca.11.30.,5,"Cardiovascular disease remains the leading cause of mortality in women despite advances in treatment strategies. Challenges currently exist when making the diagnosis of coronary artery disease. Equitable treatment of women once the disease has been identified is a further conundrum. Observational data have helped to identify those women at a higher risk of mortality and morbidity attributable to coronary artery disease. Interpretation of individual risk factors differs between the genders. Treatment may also differ depending on appropriate proper risk stratification, using newer models that take into account gender differences. Outcomes can be improved with the proper use of existing risk stratification tools.",,,,,,,"['0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors)', '9007-41-4 (C-Reactive Protein)']",,,,,,,,,,,,,
28796640,NLM,MEDLINE,20171030,20171030,1437-4331 (Electronic) 1434-6621 (Linking),55,2017 Aug 28,Reporting LDL-cholesterol levels in the era of intensive lipid management: a clarion call.,1447-1449,10.1515/cclm-2017-0639 [doi],"['Jialal, Ishwarlal', 'Gounden, Verena']","['Jialal I', 'Gounden V']","['.', '.']",['eng'],['Editorial'],,Germany,Clin Chem Lab Med,Clinical chemistry and laboratory medicine,9806306,IM,"['Cardiovascular Diseases/*diagnosis/prevention & control/therapy', 'Cholesterol, LDL/*analysis', 'Diabetes Mellitus/diagnosis', 'Humans']",2017/08/11 06:00,2017/10/31 06:00,['2017/08/11 06:00'],"['2017/08/11 06:00 [pubmed]', '2017/10/31 06:00 [medline]', '2017/08/11 06:00 [entrez]']","['/j/cclm.ahead-of-print/cclm-2017-0639/cclm-2017-0639.xml [pii]', '10.1515/cclm-2017-0639 [doi]']",ppublish,Clin Chem Lab Med. 2017 Aug 28;55(10):1447-1449. doi: 10.1515/cclm-2017-0639.,10,,,,,,,,"['0 (Cholesterol, LDL)']",,,,,,,,,,,,,
14068258,NLM,MEDLINE,19961201,20181201,0038-5239 (Print) 0038-5239 (Linking),22,1963,[STATISTICAL CHARACTERISTICS OF MORTALITY FROM CARDIOVASCULAR DISEASES AMONG THE POPULATION OF IAROSLAVL].,32-7,,"['BREZGIN, V D']",['BREZGIN VD'],,['rus'],['Journal Article'],,Russia (Federation),Sov Zdravookhr,Sovetskoe zdravookhranenie,0404526,OM,"['*Arteriosclerosis', '*Cardiovascular Diseases', '*Cerebrovascular Disorders', 'Humans', '*Hypertension', '*Mortality', '*Myocardial Infarction', '*Rheumatic Heart Disease', 'USSR']",1963/01/01 00:00,1963/01/01 00:01,['1963/01/01 00:00'],"['1963/01/01 00:00 [pubmed]', '1963/01/01 00:01 [medline]', '1963/01/01 00:00 [entrez]']",,ppublish,Sov Zdravookhr. 1963;22:32-7.,,,,,,['NLM'],"['*ARTERIOSCLEROSIS', '*CARDIOVASCULAR DISEASES', '*CEREBROVASCULAR DISORDERS', '*HYPERTENSION', '*MORTALITY', '*MYOCARDIAL INFARCT', '*RHEUMATIC HEART DISEASE', '*USSR']",,,,,,,,,STATISTICHESKAIA KHARAKTERISTIKA SMERTNOSTI OT SERDECHNO-SOSUDISTYKH ZABOLEVANII NASELENIIA IAROSLAVLIA.,,,,,,
25748397,NLM,MEDLINE,20150517,20181202,0578-1310 (Print) 0578-1310 (Linking),53,2015 Jan,[Steadily improve the diagnostic and therapeutic level for functional cardiovascular diseases in children].,3-5,,"['Du, Junbao', 'Chen, Jie']","['Du J', 'Chen J']",['Email: junbaodu1@126.com.'],['chi'],['Editorial'],,China,Zhonghua Er Ke Za Zhi,Zhonghua er ke za zhi = Chinese journal of pediatrics,0417427,IM,"['Cardiovascular Diseases/*diagnosis/*therapy', 'Child', 'Humans', 'Quality of Health Care']",2015/03/10 06:00,2015/05/20 06:00,['2015/03/10 06:00'],"['2015/03/10 06:00 [entrez]', '2015/03/10 06:00 [pubmed]', '2015/05/20 06:00 [medline]']",,ppublish,Zhonghua Er Ke Za Zhi. 2015 Jan;53(1):3-5.,1,,,,,,,,,,,,,,,,,,,,,
35512452,NLM,MEDLINE,20220909,20221110,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 Sep 7,"In lifestyle and prevention, the whole is surely greater than the sum of its parts.",1615-1617,10.1093/eurjpc/zwac086 [doi],"['Gonzalez-Jaramillo, Nathalia', 'Bano, Arjola', 'Franco, Oscar H']","['Gonzalez-Jaramillo N', 'Bano A', 'Franco OH']","['Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.', 'Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.', 'Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.', 'Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.', 'Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.']",['eng'],"['Comment', 'Editorial']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Adult', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Cohort Studies', '*Coronary Disease/prevention & control', 'Exercise', 'Humans', 'Life Style']",2022/05/06 06:00,2022/09/11 06:00,['2022/05/05 18:05'],"['2022/05/06 06:00 [pubmed]', '2022/09/11 06:00 [medline]', '2022/05/05 18:05 [entrez]']","['6581263 [pii]', '10.1093/eurjpc/zwac086 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Sep 7;29(12):1615-1617. doi: 10.1093/eurjpc/zwac086.,12,,,,['Conflict of interest: None declared.'],,,,,,,['Eur J Prev Cardiol. 2022 Sep 7;29(12):1618-1629. PMID: 35403197'],,,,,,,,,,
22200601,NLM,MEDLINE,20120725,20161020,1769-714X (Electronic) 1286-4579 (Linking),14,2012 May,Does a causal relation between cardiovascular disease and periodontitis exist?,411-8,10.1016/j.micinf.2011.12.004 [doi],"['Belstrom, Daniel', 'Damgaard, Christian', 'Nielsen, Claus H', 'Holmstrup, Palle']","['Belstrom D', 'Damgaard C', 'Nielsen CH', 'Holmstrup P']","['Institute for Inflammation Research, Department of Infectious Medicine and Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. dbel@sund.ku.dk']",['eng'],"['Journal Article', 'Review']",20111213,France,Microbes Infect,Microbes and infection,100883508,IM,"['Atherosclerosis/epidemiology/etiology/pathology', 'Cardiovascular Diseases/*epidemiology/*etiology/pathology', 'Humans', 'Periodontitis/*complications']",2011/12/28 06:00,2012/07/26 06:00,['2011/12/28 06:00'],"['2011/10/25 00:00 [received]', '2011/12/01 00:00 [revised]', '2011/12/04 00:00 [accepted]', '2011/12/28 06:00 [entrez]', '2011/12/28 06:00 [pubmed]', '2012/07/26 06:00 [medline]']","['S1286-4579(11)00308-X [pii]', '10.1016/j.micinf.2011.12.004 [doi]']",ppublish,Microbes Infect. 2012 May;14(5):411-8. doi: 10.1016/j.micinf.2011.12.004. Epub 2011 Dec 13.,5,"Inflammation is believed to play a central part in the pathogenesis of atherosclerosis, and much attention has been paid to the possible association between atherosclerosis and other inflammatory diseases. Periodontal disease is a common inflammatory disease affecting up to 50% of the adult population, and during the past two decades much research has focused on a possible association between periodontitis and cardiovascular disease. Here, we review the existing literature on the association between the two diseases.",,,,,,,,"['Copyright (c) 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights', 'reserved.']",,,,,,,,,,,,
21525446,NLM,MEDLINE,20110701,20220311,1935-5548 (Electronic) 0149-5992 (Print) 0149-5992 (Linking),34 Suppl 2,2011 May,Heart in diabetes: a microvascular disease.,S145-9,10.2337/dc11-s209 [doi],"['Laakso, Markku']",['Laakso M'],"['Department of Medicine, University of Eastern Finland, Kuopio, Finland. markku.laakso@kuh.fi']",['eng'],['Journal Article'],,United States,Diabetes Care,Diabetes care,7805975,IM,"['Cardiovascular Diseases/epidemiology/etiology/metabolism/mortality', 'Diabetes Mellitus/epidemiology/metabolism/mortality/*physiopathology', 'Diabetic Cardiomyopathies/epidemiology/*etiology/metabolism/mortality', 'Humans']",2011/05/06 06:00,2011/07/02 06:00,['2011/04/29 06:00'],"['2011/04/29 06:00 [entrez]', '2011/05/06 06:00 [pubmed]', '2011/07/02 06:00 [medline]']","['34/Supplement_2/S145 [pii]', 's209 [pii]', '10.2337/dc11-s209 [doi]']",ppublish,Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S145-9. doi: 10.2337/dc11-s209.,Suppl 2,,,PMC3632152,,,,,,,,,,,,,,,,,,
6690826,NLM,MEDLINE,19840223,20161017,0098-7484 (Print) 0098-7484 (Linking),251,1984 Feb 3,Leads from the MMWR. Smoking and cardiovascular diseases.,"574, 579",,,,,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,IM,"['Cardiovascular Diseases/epidemiology/*etiology', 'Coronary Disease/epidemiology/etiology', 'Female', 'Humans', 'Male', 'Risk', '*Smoking', 'United States']",1984/02/03 00:00,1984/02/03 00:01,['1984/02/03 00:00'],"['1984/02/03 00:00 [pubmed]', '1984/02/03 00:01 [medline]', '1984/02/03 00:00 [entrez]']",,ppublish,"JAMA. 1984 Feb 3;251(5):574, 579.",5,,,,,,,,,,,,,,,,,,,,,
33638640,NLM,MEDLINE,20211210,20211214,2047-4881 (Electronic) 2047-4873 (Linking),28,2021 Apr 10,Editors' presentation: focus on cardiovascular risk assessment.,137-139,10.1093/eurjpc/zwab019 [doi],"['Halasz, Geza', 'Piepoli, Massimo F']","['Halasz G', 'Piepoli MF']","['Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Parma, Italy.', 'Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Parma, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', '*Cardiovascular System', 'Editorial Policies', 'Humans', 'Risk Assessment', 'Risk Factors']",2021/02/28 06:00,2021/12/15 06:00,['2021/02/27 12:06'],"['2021/02/28 06:00 [pubmed]', '2021/12/15 06:00 [medline]', '2021/02/27 12:06 [entrez]']","['6151688 [pii]', '10.1093/eurjpc/zwab019 [doi]']",ppublish,Eur J Prev Cardiol. 2021 Apr 10;28(2):137-139. doi: 10.1093/eurjpc/zwab019.,2,,,,,,,,,,,,,,,,,,,,,
37907844,NLM,MEDLINE,20231102,20231111,1471-2261 (Electronic) 1471-2261 (Linking),23,2023 Oct 31,Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study.,529,10.1186/s12872-023-03567-3 [doi] 529,"['Wang, Zhe', 'Chen, Jiawei', 'Zhu, Longyang', 'Jiao, Siqi', 'Chen, Yinong', 'Sun, Yihong']","['Wang Z', 'Chen J', 'Zhu L', 'Jiao S', 'Chen Y', 'Sun Y']","['Department of Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.', 'Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.', 'Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.', 'Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.', 'Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.', 'Department of Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. yihongsun72@163.com.', 'Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. yihongsun72@163.com.', 'Department of Cardiology, China-Japan Friendship Hospital, No.2 East Yinghua Road, Chaoyang District, Beijing, 100029, China. yihongsun72@163.com.']",['eng'],['Journal Article'],20231031,England,BMC Cardiovasc Disord,BMC cardiovascular disorders,100968539,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/genetics', 'Genome-Wide Association Study', 'Mendelian Randomization Analysis', '*Hypertension', '*Heart Failure', '*Myocardial Infarction', '*Metabolic Diseases', '*Stroke', '*Coronary Disease']",2023/11/01 06:43,2023/11/02 12:47,['2023/11/01 00:56'],"['2023/02/26 00:00 [received]', '2023/10/18 00:00 [accepted]', '2023/11/02 12:47 [medline]', '2023/11/01 06:43 [pubmed]', '2023/11/01 00:56 [entrez]']","['10.1186/s12872-023-03567-3 [pii]', '3567 [pii]', '10.1186/s12872-023-03567-3 [doi]']",epublish,BMC Cardiovasc Disord. 2023 Oct 31;23(1):529. doi: 10.1186/s12872-023-03567-3.,1,"BACKGROUND: Metabolic disorders are increasing worldwide and are characterized by various risk factors such as abdominal obesity, insulin resistance, impaired glucose metabolism, and dyslipidemia. Observational studies suggested a bidirectional association between cardiovascular diseases and metabolic disorders and its components. However, the causal associations between them remained unclear. This study aims to investigate the causal relationship between metabolic disorders and cardiovascular disease through Mendelian randomization (MR) analysis. METHODS: A two-sample MR analysis based on publicly available genome-wide association studies were used to infer the causality. The single-nucleotide polymorphisms with potential pleiotropy were excluded by MR-PRESSO. The effect estimates were constructed using the random-effects inverse-variance-weighted method as the primary estimate. Furthermore, MR-Egger and weighted median were also performed to detect heterogeneity and pleiotropy. RESULTS: Genetically predicted metabolic disorders increased the risk for coronary heart disease (OR = 1.77, 95% CI: 1.55-2.03, p < 0.001), myocardial infarction (OR = 1.75, 95% CI: 1.52-2.03, p < 0.001), heart failure (OR = 1.26, 95% CI: 1.14-1.39, p < 0.001), hypertension (OR = 1.01, 95% CI: 1.00-1.02, p = 0.002), and stroke (OR = 1.19, 95% CI: 1.08-1.32, p < 0.001). The concordance of the results of various complementary sensitivity MR methods reinforces the causal relationship further. CONCLUSION: This study provides evidence of a causal relationship between metabolic disorders and increased risk of coronary heart disease, myocardial infarction, heart failure, hypertension, and stroke. Special attention should be paid to improving metabolic disorders to reduce the development of cardiovascular diseases.",,PMC10617200,"['The authors declare no competing interests. The authors declare no conflict of', 'interest.']",['NOTNLM'],"['Cardiovascular diseases', 'Mendelian randomization analysis', 'Metabolic disorders']",,,['(c) 2023. The Author(s).'],,,,,,,,,,,,
15885973,NLM,MEDLINE,20050908,20050708,0750-7658 (Print) 0750-7658 (Linking),24,2005 Jul,[Cardiovascular and pulmonary consequences of severe subarachnoid haemorrhage].,734-8,,"['Hans, P', 'Audibert, G', 'Berre, J', 'Bruder, N', 'Ravussin, P', 'Ter Minassian, A', 'Puybasset, L', 'Beydon, L', 'Boulard, G', 'Bonafe, A', 'de Kersaint-Gilly, A', 'Gabrillargues, J', 'Lejeune, J-P', 'Proust, F', 'Dufour, H']","['Hans P', 'Audibert G', 'Berre J', 'Bruder N', 'Ravussin P', 'Ter Minassian A', 'Puybasset L', 'Beydon L', 'Boulard G', 'Bonafe A', 'de Kersaint-Gilly A', 'Gabrillargues J', 'Lejeune JP', 'Proust F', 'Dufour H']","[""Service universitaire d'anesthesie-reanimation, CHR de la Citadelle, boulevard du XII(e)-de-Ligue, 4000 Liege, Belgique. pol.hans@chu.ulg.ac.be""]",['fre'],"['Journal Article', 'Review']",,France,Ann Fr Anesth Reanim,Annales francaises d'anesthesie et de reanimation,8213275,IM,"['Cardiovascular Diseases/diagnosis/*etiology/physiopathology', 'Electrocardiography', 'Humans', 'Lung Diseases/diagnosis/*etiology/physiopathology', 'Subarachnoid Hemorrhage/*complications', 'Thromboembolism/etiology/prevention & control']",2005/05/12 09:00,2005/09/09 09:00,['2005/05/12 09:00'],"['2005/05/12 09:00 [pubmed]', '2005/09/09 09:00 [medline]', '2005/05/12 09:00 [entrez]']","['S0750-7658(05)00108-5 [pii]', '10.1016/j.annfar.2005.03.023 [doi]']",ppublish,Ann Fr Anesth Reanim. 2005 Jul;24(7):734-8. doi: 10.1016/j.annfar.2005.03.023.,7,,,,,,,,,,53,,,,,Repercussions cardiovasculaires et pulmonaires des hemorragies meningees graves.,,,,,,
31180976,NLM,MEDLINE,20201014,20201014,1550-5049 (Electronic) 0889-4655 (Linking),34,2019 Jul/Aug,Guideline on the Primary Prevention of Cardiovascular Disease: Let's Get It Into Practice!,285-288,10.1097/JCN.0000000000000586 [doi],"['Coke, Lola A', 'Dennison Himmelfarb, Cheryl']","['Coke LA', 'Dennison Himmelfarb C']","['Lola A. Coke, PhD, APRN-CNS, ACNS-BC, FAAN, FPCNA, FAHA, Johns Hopkins School of Nursing, Baltimore, Maryland. Cheryl Dennison Himmelfarb, PhD, ANP, FAAN, FAHA, FPCNA, Johns Hopkins School of Nursing, Baltimore, Maryland.']",['eng'],['Journal Article'],,United States,J Cardiovasc Nurs,The Journal of cardiovascular nursing,8703516,IM,"['Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Humans', 'Practice Guidelines as Topic', '*Primary Prevention', 'Risk Factors']",2019/06/11 06:00,2020/10/21 06:00,['2019/06/11 06:00'],"['2019/06/11 06:00 [entrez]', '2019/06/11 06:00 [pubmed]', '2020/10/21 06:00 [medline]']","['00005082-201907000-00002 [pii]', '10.1097/JCN.0000000000000586 [doi]']",ppublish,J Cardiovasc Nurs. 2019 Jul/Aug;34(4):285-288. doi: 10.1097/JCN.0000000000000586.,4,,,,,,,,,,,,,,,,,,,,,
14092065,NLM,MEDLINE,19961201,20181201,0003-973X (Print) 0003-973X (Linking),23,1963 Sep,[THE CARDIOVASCULAR MANIFESTATIONS OF THE GROENBLAD-STRANDBERG SYNDROME].,561-74,,"['FOUCAULT, J P']",['FOUCAULT JP'],,['fre'],"['Journal Article', 'Review']",,France,Arch Ophtalmol Rev Gen Ophtalmol,Archives d'ophtalmologie et revue generale d'ophtalmologie,7611921,OM,"['*Angina Pectoris', '*Aortic Diseases', '*Arteriosclerosis Obliterans', '*Cardiovascular Diseases', '*Coronary Disease', '*Gastrointestinal Hemorrhage', '*Hemorrhage', 'Humans', '*Intermittent Claudication', '*Pseudoxanthoma Elasticum', '*Raynaud Disease']",1963/09/01 00:00,1963/09/01 00:01,['1963/09/01 00:00'],"['1963/09/01 00:00 [pubmed]', '1963/09/01 00:01 [medline]', '1963/09/01 00:00 [entrez]']",,ppublish,Arch Ophtalmol Rev Gen Ophtalmol. 1963 Sep;23:561-74.,,,,,,['NLM'],"['*ANGINA PECTORIS', '*AORTIC DISEASES', '*ARTERIOSCLEROSIS OBLITERANS', '*CARDIOVASCULAR DISEASES', '*CORONARY DISEASE', '*HEMORRHAGE, GASTROINTESTINAL', '*INTERMITTENT CLAUDICATION', '*PSEUDOXANTHOMA ELASTICUM', ""*RAYNAUD'S DISEASE"", '*REVIEW']",,,,0,,,,,LES MANIFESTATIONS CARDIO-VASCULAIRES DU SYNDROME DE GROENBLAD-STRANDBERG.,,,,,,
37620618,NLM,MEDLINE,20231115,20231123,1546-170X (Electronic) 1078-8956 (Linking),29,2023 Oct,Weight-loss drug lowers cardiovascular disease risk in new trial of Novo Nordisk's Wegovy.,2381-2382,10.1038/d41591-023-00075-x [doi],"['Johnson, Ben']",['Johnson B'],,['eng'],['News'],,United States,Nat Med,Nature medicine,9502015,IM,"['Humans', '*Anti-Obesity Agents/therapeutic use', '*Cardiovascular Diseases/drug therapy/epidemiology/prevention & control', '*Diabetes Mellitus, Type 2', 'Risk Factors']",2023/08/25 00:42,2023/11/15 06:43,['2023/08/24 23:37'],"['2023/11/15 06:43 [medline]', '2023/08/25 00:42 [pubmed]', '2023/08/24 23:37 [entrez]']","['10.1038/d41591-023-00075-x [pii]', '10.1038/d41591-023-00075-x [doi]']",ppublish,Nat Med. 2023 Oct;29(10):2381-2382. doi: 10.1038/d41591-023-00075-x.,10,,,,,,,,['0 (Anti-Obesity Agents)'],,,,,,,,,,,,,
23570116,NLM,MEDLINE,20130620,20130410,1137-6627 (Print) 1137-6627 (Linking),Suppl 2,2003,[Cardiovascular risk. Evidence guiding the clinical approach].,5-101,,"['Serrano Martinez, Manuel', 'Berjon Reyero, Jesus', 'Salaberri, Aurora', 'Amezqueta Goni, Carlos']","['Serrano Martinez M', 'Berjon Reyero J', 'Salaberri A', 'Amezqueta Goni C']","['Gobierno de Navarra, Departamento de Salud.']",['spa'],['Journal Article'],,Spain,An Sist Sanit Navar,Anales del sistema sanitario de Navarra,9710381,IM,"['Algorithms', 'Cardiovascular Diseases/epidemiology/*etiology/prevention & control/*therapy', 'Chemoprevention', 'Diabetes Complications/etiology/therapy', 'Diet', 'Dyslipidemias/complications', 'Evidence-Based Medicine', 'Exercise', 'Health Education', 'Humans', 'Hypertension/complications', 'Life Style', 'Risk Factors', 'Smoking/adverse effects']",2003/01/01 00:00,2013/06/21 06:00,['2013/04/11 06:00'],"['2013/04/11 06:00 [entrez]', '2003/01/01 00:00 [pubmed]', '2013/06/21 06:00 [medline]']",,ppublish,An Sist Sanit Navar. 2003;Suppl 2:5-101.,,,,,,,,,,,,,,,,Riesgo cardiovascular. Evidencias que orientan la actuacion clinica.,,,,,,
23402471,NLM,MEDLINE,20130813,20130213,1558-299X (Electronic) 0095-4543 (Linking),40,2013 Mar,"""Life ticks away faster every day"".",xiii-xiv,S0095-4543(12)00109-1 [pii] 10.1016/j.pop.2012.12.002 [doi],"['Heidelbaugh, Joel J']",['Heidelbaugh JJ'],"['Departments of Family Medicine and Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. jheidel@umich.edu.']",['eng'],['Editorial'],20121229,United States,Prim Care,Primary care,0430463,IM,"['Cardiovascular Diseases/*epidemiology/prevention & control/therapy', 'Humans', 'Primary Health Care/*organization & administration', 'Risk Factors', 'United States']",2013/02/14 06:00,2013/08/14 06:00,['2013/02/14 06:00'],"['2013/02/14 06:00 [entrez]', '2013/02/14 06:00 [pubmed]', '2013/08/14 06:00 [medline]']","['S0095-4543(12)00109-1 [pii]', '10.1016/j.pop.2012.12.002 [doi]']",ppublish,Prim Care. 2013 Mar;40(1):xiii-xiv. doi: 10.1016/j.pop.2012.12.002. Epub 2012 Dec 29.,1,,,,,,,,,,,,,,,,,,,,,
31654562,NLM,MEDLINE,20191106,20200108,1875-533X (Electronic) 0929-8673 (Linking),26,2019,Twists and Turns in Cardio-metabolic Diseases and Related Complications.,4495-4497,10.2174/092986732624190927115059 [doi],"['Ndisang, Joseph Fomusi']",['Ndisang JF'],"['Department of Anatomy, Physiology & Pharmacology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada.']",['eng'],['Journal Article'],,United Arab Emirates,Curr Med Chem,Current medicinal chemistry,9440157,IM,"['Cardiovascular Diseases/economics/metabolism/*pathology', 'Cost of Illness', 'Humans', 'Metabolic Diseases/economics/metabolism/*pathology']",2019/10/28 06:00,2019/11/07 06:00,['2019/10/27 06:00'],"['2019/10/27 06:00 [entrez]', '2019/10/28 06:00 [pubmed]', '2019/11/07 06:00 [medline]']","['CMC-EPUB-101057 [pii]', '10.2174/092986732624190927115059 [doi]']",ppublish,Curr Med Chem. 2019;26(24):4495-4497. doi: 10.2174/092986732624190927115059.,24,,,,,,,,,"['Copyright(c) Bentham Science Publishers; For any queries, please email at', 'epub@benthamscience.net.']",,,,,,,,,,,,
10692671,NLM,MEDLINE,20000316,20080409,0828-282X (Print) 0828-282X (Linking),15 Suppl G,1999 Dec,The cost effectiveness of preventing cardiovascular diseases.,114G-6G,,"['Grover, S A']",['Grover SA'],"['The Montreal General Hospital; McGill University, Montreal, Canada.']",['eng'],"['Journal Article', 'Review']",,England,Can J Cardiol,The Canadian journal of cardiology,8510280,IM,"['Cardiovascular Diseases/*economics/etiology/prevention & control', 'Cost-Benefit Analysis', 'Health Education/*economics', 'Humans', 'Quality-Adjusted Life Years', 'Risk Factors']",2000/02/29 09:00,2000/03/18 09:00,['2000/02/29 09:00'],"['2000/02/29 09:00 [pubmed]', '2000/03/18 09:00 [medline]', '2000/02/29 09:00 [entrez]']",,ppublish,Can J Cardiol. 1999 Dec;15 Suppl G:114G-6G.,,,,,,,,,,,26,,,,,,,,,,,
19477360,NLM,MEDLINE,20090610,20090529,1558-3597 (Electronic) 0735-1097 (Linking),53,2009 Jun 2,The year in interventional cardiology.,2080-97,10.1016/j.jacc.2009.02.035 [doi],"['Dixon, Simon R', 'Grines, Cindy L', ""O'Neill, William W""]","['Dixon SR', 'Grines CL', ""O'Neill WW""]","['Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA. sdixon@beaumont.edu']",['eng'],"['Journal Article', 'Review']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Anticholesteremic Agents/therapeutic use', 'Cardiology/*trends', 'Cardiovascular Diseases/drug therapy/surgery/*therapy', 'Drug-Eluting Stents', 'Heart Valve Diseases/surgery', 'Humans']",2009/05/30 09:00,2009/06/11 09:00,['2009/05/30 09:00'],"['2009/02/07 00:00 [received]', '2009/02/18 00:00 [accepted]', '2009/05/30 09:00 [entrez]', '2009/05/30 09:00 [pubmed]', '2009/06/11 09:00 [medline]']","['S0735-1097(09)00843-2 [pii]', '10.1016/j.jacc.2009.02.035 [doi]']",ppublish,J Am Coll Cardiol. 2009 Jun 2;53(22):2080-97. doi: 10.1016/j.jacc.2009.02.035.,22,,,,,,,,['0 (Anticholesteremic Agents)'],,238,,,,,,,,,,,
19149614,NLM,MEDLINE,20090420,20190728,1873-4286 (Electronic) 1381-6128 (Linking),15,2009,"Central hemodynamics and arterial stiffness: methodological, clinical and pharmaceutical considerations.",243-4,,"['Papaioannou, Theodore G', 'Stefanadis, Christodoulos']","['Papaioannou TG', 'Stefanadis C']",,['eng'],"['Editorial', 'Introductory Journal Article']",,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Arteries/*physiopathology', 'Blood Pressure', 'Blood Pressure Determination/methods', 'Cardiovascular Diseases/mortality/*physiopathology/therapy', '*Hemodynamics', 'Humans']",2009/01/20 09:00,2009/04/21 09:00,['2009/01/20 09:00'],"['2009/01/20 09:00 [entrez]', '2009/01/20 09:00 [pubmed]', '2009/04/21 09:00 [medline]']",['10.2174/138161209787354212 [doi]'],ppublish,Curr Pharm Des. 2009;15(3):243-4. doi: 10.2174/138161209787354212.,3,,,,,,,,,,,,,,,,,,,,,
36624649,NLM,MEDLINE,20231016,20231016,1875-6506 (Electronic) 1573-4021 (Linking),19,2023,Insight on Cardiac Chronobiology and Latest Developments of Chronotherapeutic Antihypertensive Interventions for Better Clinical Outcomes.,106-122,10.2174/1573402119666230109142156 [doi],"['Joshi, Kumud', 'Das, Madhubanti', 'Sarma, Anupam', 'Arora, Mandeep K', 'SInghal, Manmohan', 'Kumar, Bhavna']","['Joshi K', 'Das M', 'Sarma A', 'Arora MK', 'SInghal M', 'Kumar B']","['Department of Pharmacy, Lloyd Institute of Management and Technology, Greater Noida, India.', 'Department of Zoology, Gauhati University, Guwahati, Assam, India.', 'Advanced Drug Delivery Laboratory, GIPS, Girijananda Chowdhury University, Guwahati, Assam, India.', 'School of Pharmacy and population health informatics, DIT University, Dehradun, India.', 'School of Pharmacy and population health informatics, DIT University, Dehradun, India.', 'School of Pharmacy and population health informatics, DIT University, Dehradun, India.']",['eng'],"['Journal Article', 'Review']",,United Arab Emirates,Curr Hypertens Rev,Current hypertension reviews,101239891,IM,"['Humans', 'Antihypertensive Agents/pharmacology', 'Blood Pressure', '*Cardiovascular Diseases/diagnosis/drug therapy/genetics', 'Chronotherapy', 'Circadian Rhythm/physiology', 'Drug Chronotherapy', '*Hypertension/diagnosis/drug therapy']",2023/01/11 06:00,2023/09/11 06:42,['2023/01/10 00:53'],"['2022/04/23 00:00 [received]', '2022/11/10 00:00 [revised]', '2022/11/15 00:00 [accepted]', '2023/09/11 06:42 [medline]', '2023/01/11 06:00 [pubmed]', '2023/01/10 00:53 [entrez]']","['CHYR-EPUB-128660 [pii]', '10.2174/1573402119666230109142156 [doi]']",ppublish,Curr Hypertens Rev. 2023;19(2):106-122. doi: 10.2174/1573402119666230109142156.,2,"Cardiac circadian rhythms are an important regulator of body functions, including cardiac activities and blood pressure. Disturbance of circadian rhythm is known to trigger and aggravate various cardiovascular diseases. Thus, modulating the circadian rhythm can be used as a therapeutic approach to cardiovascular diseases. Through this work, we intend to discuss the current understanding of cardiac circadian rhythms, in terms of quantifiable parameters like BP and HR. We also elaborate on the molecular regulators and the molecular cascades along with their specific genetic aspects involved in modulating circadian rhythms, with specific reference to cardiovascular health and cardiovascular diseases. Along with this, we also presented the latest pharmacogenomic and metabolomics markers involved in chronobiological control of the cardiovascular system along with their possible utility in cardiovascular disease diagnosis and therapeutics. Finally, we reviewed the current expert opinions on chronotherapeutic approaches for utilizing the conventional as well as the new pharmacological molecules for antihypertensive chronotherapy.",['ORCID: 0000-0002-8609-1606'],,,['NOTNLM'],"['Chronotherapy', 'blood pressure', 'cardiovascular risks', 'chrono-biomarkers', 'dipper pattern', 'hypertension']",,['0 (Antihypertensive Agents)'],"['Copyright(c) Bentham Science Publishers; For any queries, please email at', 'epub@benthamscience.net.']",,,,,,,,,,,,
30779649,NLM,MEDLINE,20191202,20191202,1524-4539 (Electronic) 0009-7322 (Linking),139,2019 Feb 19,Third Annual Go Red for Women Issue.,999-1000,10.1161/CIRCULATIONAHA.119.039778 [doi],"['Al-Khatib, Sana M', 'Hill, Joseph A', 'Bozkurt, Biykem']","['Al-Khatib SM', 'Hill JA', 'Bozkurt B']","['Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (S.M.A.).', 'Departments of Internal Medicine, Cardiology Division, and Molecular Biology, University of Texas Southwestern Medical Center, Dallas (J.A.H.).', 'Department of Medicine, Cardiology Section, Winters Center for Heart Failure Research, Cardiovascular Research Institute, Baylor College of Medicine, DeBakey VA Medical Center, Houston, TX (B.B.).']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Circulation,Circulation,0147763,IM,"['Cardiovascular Diseases/ethnology/mortality/physiopathology/*prevention & control', 'Female', '*Global Health', '*Health Promotion', 'Health Status Disparities', 'Healthcare Disparities', 'Humans', 'Prognosis', 'Risk Factors', 'Sex Factors', ""*Women's Health""]",2019/02/20 06:00,2019/12/04 06:00,['2019/02/20 06:00'],"['2019/02/20 06:00 [entrez]', '2019/02/20 06:00 [pubmed]', '2019/12/04 06:00 [medline]']",['10.1161/CIRCULATIONAHA.119.039778 [doi]'],ppublish,Circulation. 2019 Feb 19;139(8):999-1000. doi: 10.1161/CIRCULATIONAHA.119.039778.,8,,,,,,,,,,,,,,,,,,,,,
10074841,NLM,MEDLINE,19990318,20080716,0029-2001 (Print) 0029-2001 (Linking),119,1999 Jan 30,[The HOT study].,407,,"['Klovning, A', 'Sandvik, H', 'Straand, J']","['Klovning A', 'Sandvik H', 'Straand J']",,['nor'],['Letter'],,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Antihypertensive Agents/administration & dosage', 'Cardiovascular Diseases/etiology/*mortality/prevention & control', 'Humans', 'Hypertension/complications/*drug therapy/mortality', 'Randomized Controlled Trials as Topic', 'Risk Factors']",1999/03/13 00:00,1999/03/13 00:01,['1999/03/13 00:00'],"['1999/03/13 00:00 [pubmed]', '1999/03/13 00:01 [medline]', '1999/03/13 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1999 Jan 30;119(3):407.,3,,,,,,,,['0 (Antihypertensive Agents)'],,,,,,,Hot-studien.,,,,,,
26072643,NLM,MEDLINE,20150702,20150615,0098-1486 (Print) 0098-1486 (Linking),46,2014 May-Jun,"Optimizing heart health. Know the facts, have a plan, make a difference for you and your patients.",13,,"['Louie, Donna', 'Wedell, Robin']","['Louie D', 'Wedell R']",,['eng'],['Journal Article'],,United States,Am Nurse,The American nurse,7506499,,"['Cardiovascular Diseases/complications/physiopathology/*prevention & control', 'Diabetes Complications', 'Humans', 'Hypertension/complications', 'Life Style', 'Obesity/complications', 'Risk Factors', 'United States']",2015/06/16 06:00,2015/07/03 06:00,['2015/06/16 06:00'],"['2015/06/16 06:00 [entrez]', '2015/06/16 06:00 [pubmed]', '2015/07/03 06:00 [medline]']",,ppublish,Am Nurse. 2014 May-Jun;46(3):13.,3,,,,,,,,,,,,,,,,,,,,,
3187229,NLM,MEDLINE,19881222,20110113,0048-7848 (Print) 0048-7848 (Linking),92,1988 Apr-Jun,[Evaluation of risk factors and their correlation with aspects of cardiovascular pathology].,233-7,,"['Negoita, C I', 'Ivan, A', 'Marcu, C', 'Datcu, M D', 'Serban, F', 'Duda, R', 'Georgescu, G', 'Groll, M', 'Mitroi, I', 'Ardeleanu, M']","['Negoita CI', 'Ivan A', 'Marcu C', 'Datcu MD', 'Serban F', 'Duda R', 'Georgescu G', 'Groll M', 'Mitroi I', 'Ardeleanu M', 'et al.']",,['rum'],"['English Abstract', 'Journal Article']",,Romania,Rev Med Chir Soc Med Nat Iasi,Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,0413735,IM,"['Adult', 'Cardiovascular Diseases/*epidemiology/etiology/prevention & control', 'Female', 'Humans', 'Hypertension/epidemiology/etiology/prevention & control', 'Life Style', 'Male', 'Mass Screening', 'Middle Aged', 'Risk Factors', 'Romania']",1988/04/01 00:00,1988/04/01 00:01,['1988/04/01 00:00'],"['1988/04/01 00:00 [pubmed]', '1988/04/01 00:01 [medline]', '1988/04/01 00:00 [entrez]']",,ppublish,Rev Med Chir Soc Med Nat Iasi. 1988 Apr-Jun;92(2):233-7.,2,,,,,,,,,,,,,,,Evaluarea unor factori de risc si corelarea lor cu aspecte de patologie cardiovasculara.,,,,,,
16314225,NLM,MEDLINE,20060504,20051129,0939-4753 (Print) 0939-4753 (Linking),15,2005 Dec,Cardiovascular risk in the Mediterranean area is low: impact on clinical decision-making.,399-401,,"['Rubba, Paolo']",['Rubba P'],,['eng'],"['Comment', 'Editorial']",20051121,Netherlands,Nutr Metab Cardiovasc Dis,"Nutrition, metabolism, and cardiovascular diseases : NMCD",9111474,IM,"['Algorithms', 'Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Decision Making', '*Diet, Mediterranean', 'Evidence-Based Medicine', 'Humans', 'Risk Factors']",2005/11/30 09:00,2006/05/05 09:00,['2005/11/30 09:00'],"['2005/09/14 00:00 [received]', '2005/10/10 00:00 [revised]', '2005/10/17 00:00 [accepted]', '2005/11/30 09:00 [pubmed]', '2006/05/05 09:00 [medline]', '2005/11/30 09:00 [entrez]']","['S0939-4753(05)00188-2 [pii]', '10.1016/j.numecd.2005.10.005 [doi]']",ppublish,Nutr Metab Cardiovasc Dis. 2005 Dec;15(6):399-401. doi: 10.1016/j.numecd.2005.10.005. Epub 2005 Nov 21.,6,,,,,,,,,,,['Nutr Metab Cardiovasc Dis. 2005 Dec;15(6):426-40. PMID: 16314229'],,,,,,,,,,
21150004,NLM,MEDLINE,20110329,20220318,0971-5916 (Print) 0971-5916 (Electronic) 0971-5916 (Linking),132,2010 Nov,Cardiovascular disease in India: lessons learnt & challenges ahead.,529-30,,"['Prabhakaran, Dorairaj', 'Yusuf, Salim']","['Prabhakaran D', 'Yusuf S']",,['eng'],"['Editorial', 'Introductory Journal Article']",,India,Indian J Med Res,The Indian journal of medical research,0374701,IM,"['Cardiovascular Diseases/economics/*epidemiology/prevention & control', 'Humans', 'India/epidemiology', 'Prevalence', 'Research/*trends']",2010/12/15 06:00,2011/03/30 06:00,['2010/12/15 06:00'],"['2010/12/15 06:00 [entrez]', '2010/12/15 06:00 [pubmed]', '2011/03/30 06:00 [medline]']","['IndianJMedRes_2010_132_5_529_73399 [pii]', 'IJMR-132-529 [pii]']",ppublish,Indian J Med Res. 2010 Nov;132(5):529-30.,5,,,PMC3028960,,,,,,,,,,,,,,,,,,
27471189,NLM,MEDLINE,20180205,20180205,1468-201X (Electronic) 1355-6037 (Linking),102,2016 Aug 15,Heartbeat: Rule-out of acute myocardial infarction - risky business.,1249-50,10.1136/heartjnl-2016-310271 [doi],"['Bradley, Steven M', 'Otto, Catherine M']","['Bradley SM', 'Otto CM']",,['eng'],"['Editorial', 'Introductory Journal Article']",,England,Heart,Heart (British Cardiac Society),9602087,IM,"['*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Diagnosis, Differential', 'Humans', 'Myocardial Infarction/*diagnosis', 'Predictive Value of Tests']",2016/07/30 06:00,2018/02/06 06:00,['2016/07/30 06:00'],"['2016/07/30 06:00 [entrez]', '2016/07/30 06:00 [pubmed]', '2018/02/06 06:00 [medline]']","['heartjnl-2016-310271 [pii]', '10.1136/heartjnl-2016-310271 [doi]']",ppublish,Heart. 2016 Aug 15;102(16):1249-50. doi: 10.1136/heartjnl-2016-310271.,16,,['ORCID: 0000-0002-0527-9392'],,,['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
21674992,NLM,MEDLINE,20111018,20110614,1897-4279 (Electronic) 0022-9032 (Linking),69,2011,[Dear Readers].,1 p preceding 309,,,,,['pol'],"['Editorial', 'Introductory Journal Article']",,Poland,Kardiol Pol,Kardiologia polska,0376352,IM,"['*Cardiovascular Diseases/diagnosis/therapy', 'Humans']",2011/06/17 06:00,2011/10/19 06:00,['2011/06/17 06:00'],"['2011/06/17 06:00 [entrez]', '2011/06/17 06:00 [pubmed]', '2011/10/19 06:00 [medline]']",,ppublish,Kardiol Pol. 2011;69(4):1 p preceding 309.,4,,,,,,,,,,,,,,,Drodzy Czytelnicy.,,,,,,
9263972,NLM,MEDLINE,19971002,20190123,0035-8819 (Print) 0035-8819 (Linking),31,1997 Jul-Aug,Down at heart--the meaning and implications of social inequalities in cardiovascular disease.,414-24,,"['Smith, G D']",['Smith GD'],"['Department of Social Medicine, University of Bristol.']",['eng'],"['Historical Article', 'Journal Article', 'Lecture', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,J R Coll Physicians Lond,Journal of the Royal College of Physicians of London,7503108,IM,"['Adult', 'Automobile Driving', 'Cardiovascular Diseases/diagnosis/epidemiology/history/*mortality', 'Child', 'Female', 'History, 20th Century', 'Humans', 'Infant', 'Life Style', 'Male', 'Middle Aged', 'Risk Factors', '*Social Class', 'Socioeconomic Factors', 'Survival Rate', 'United Kingdom/epidemiology']",1997/07/01 00:00,1997/07/01 00:01,['1997/07/01 00:00'],"['1997/07/01 00:00 [pubmed]', '1997/07/01 00:01 [medline]', '1997/07/01 00:00 [entrez]']",,ppublish,J R Coll Physicians Lond. 1997 Jul-Aug;31(4):414-24.,4,,,PMC5420943,,,,,,,,,,,,,,,,,,
30744457,NLM,MEDLINE,20200831,20200831,2047-4881 (Electronic) 2047-4873 (Linking),26,2019 Feb,Editor's Presentation.,227-229,10.1177/2047487319829638 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, Cardiology, G da Saliceto Hospital, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiac Rehabilitation', 'Cardiovascular Diseases/epidemiology/physiopathology/*prevention & control', '*Exercise Therapy', 'Humans', '*Preventive Health Services', 'Risk Factors']",2019/02/13 06:00,2020/09/01 06:00,['2019/02/13 06:00'],"['2019/02/13 06:00 [entrez]', '2019/02/13 06:00 [pubmed]', '2020/09/01 06:00 [medline]']",['10.1177/2047487319829638 [doi]'],ppublish,Eur J Prev Cardiol. 2019 Feb;26(3):227-229. doi: 10.1177/2047487319829638.,3,,,,,,,,,,,,,,,,,,,,,
11470644,NLM,MEDLINE,20010920,20151119,0003-3898 (Print) 0003-3898 (Linking),59,2001 Jul-Aug,[CRP and cardiovascular prevention in the elderly].,469-73,,"['Benoit, M O']",['Benoit MO'],"[""Laboratoire de biochimie cardiovasculaire de l'Hopital europeen Georges-Pompidou, 20, rue Leblanc, 75908 Paris cedex 15.""]",['fre'],"['Journal Article', 'Review']",,France,Ann Biol Clin (Paris),Annales de biologie clinique,2984690R,IM,"['Aged', 'Aging/*blood', 'Arteriosclerosis/blood/physiopathology/prevention & control', 'Biomarkers/blood', 'C-Reactive Protein/*analysis/metabolism', 'Cardiovascular Diseases/blood/epidemiology/physiopathology/*prevention & control', 'Humans']",2001/07/27 10:00,2001/09/21 10:01,['2001/07/27 10:00'],"['2001/07/27 10:00 [pubmed]', '2001/09/21 10:01 [medline]', '2001/07/27 10:00 [entrez]']",,ppublish,Ann Biol Clin (Paris). 2001 Jul-Aug;59(4):469-73.,4,,,,,,,,"['0 (Biomarkers)', '9007-41-4 (C-Reactive Protein)']",,36,,,,,CRP et prevention cardiovasculaire chez le sujet age.,,,,,,
30571350,NLM,MEDLINE,20190927,20190927,1524-4539 (Electronic) 0009-7322 (Linking),138,2018 Nov 27,Tackling the Growing Burden of Cardiovascular Diseases in Sub-Saharan Africa.,2449-2451,10.1161/CIRCULATIONAHA.118.037367 [doi],"['Amegah, A Kofi']",['Amegah AK'],"['Public Health Research Group, Department of Biomedical Sciences, and Department of Clinical Nutrition and Dietetics, University of Cape Coast, Ghana.']",['eng'],['Journal Article'],,United States,Circulation,Circulation,0147763,IM,"['Africa South of the Sahara/epidemiology', 'Cardiovascular Diseases/*economics/epidemiology/pathology', '*Cost of Illness', 'Humans', 'Recommended Dietary Allowances', 'Risk Factors']",2018/12/21 06:00,2019/09/29 06:00,['2018/12/21 06:00'],"['2018/12/21 06:00 [entrez]', '2018/12/21 06:00 [pubmed]', '2019/09/29 06:00 [medline]']",['10.1161/CIRCULATIONAHA.118.037367 [doi]'],ppublish,Circulation. 2018 Nov 27;138(22):2449-2451. doi: 10.1161/CIRCULATIONAHA.118.037367.,22,,,,,['NOTNLM'],"['Africa South of the Sahara', 'cardiovascular diseases', 'diet', 'exercise', 'lifestyle', 'mortality', 'quality-adjusted life years']",,,,,,,,,,,,,,,
29574891,NLM,MEDLINE,20190607,20231112,1476-5381 (Electronic) 0007-1188 (Print) 0007-1188 (Linking),175,2018 Apr,Spotlight on small molecules in cardiovascular diseases.,1111-1113,10.1111/bph.14154 [doi],"['Wang, Xin', 'Huang, Yu', 'Ji, Yong']","['Wang X', 'Huang Y', 'Ji Y']","['Faculty of Life Sciences, The University of Manchester, Manchester, UK.', 'Institute of Vascular Biology, Chinese University of Hong Kong, Sha Tin, Hong Kong.', 'Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Br J Pharmacol,British journal of pharmacology,7502536,IM,"['Animals', 'Cardiovascular Agents/*therapeutic use', 'Cardiovascular Diseases/*drug therapy/metabolism']",2018/03/27 06:00,2019/06/08 06:00,['2018/03/26 06:00'],"['2018/03/26 06:00 [entrez]', '2018/03/27 06:00 [pubmed]', '2019/06/08 06:00 [medline]']","['BPH14154 [pii]', '10.1111/bph.14154 [doi]']",ppublish,Br J Pharmacol. 2018 Apr;175(8):1111-1113. doi: 10.1111/bph.14154.,8,This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.,,PMC5866956,,,,,['0 (Cardiovascular Agents)'],['(c) 2018 The British Pharmacological Society.'],,,,,,,,,,,,
2935102,NLM,MEDLINE,19860220,20141120,0020-3785 (Print),55,1985 Nov-Dec,[Sudden death].,441-3,,"['Paras Chavero, E']",['Paras Chavero E'],,['spa'],['Journal Article'],,Mexico,Arch Inst Cardiol Mex,Archivos del Instituto de Cardiologia de Mexico,0400463,IM,"['Cardiovascular Diseases/mortality/prevention & control/therapy', 'Death, Sudden/*etiology/prevention & control', 'Emergency Medical Services', 'Global Health', 'Humans']",1985/11/01 00:00,1985/11/01 00:01,['1985/11/01 00:00'],"['1985/11/01 00:00 [pubmed]', '1985/11/01 00:01 [medline]', '1985/11/01 00:00 [entrez]']",,ppublish,Arch Inst Cardiol Mex. 1985 Nov-Dec;55(6):441-3.,6,,,,,,,,,,,,,,,La muerte subita.,,,,,,
3580694,NLM,MEDLINE,19870720,20071115,0007-1064 (Print) 0007-1064 (Linking),37,1987 May,Anaesthesia for patients with cardiac disease. Preoperative management.,386-96,,"['Masey, S A', 'Burton, G W']","['Masey SA', 'Burton GW']",,['eng'],['Journal Article'],,England,Br J Hosp Med,British journal of hospital medicine,0171545,IM,"['Anesthesia/*methods', 'Cardiovascular Diseases/*diagnosis/physiopathology/therapy', 'Coronary Disease/physiopathology', 'Heart Failure/physiopathology', 'Heart Function Tests', 'Humans', 'Physical Examination', '*Preoperative Care', 'Respiratory Function Tests']",1987/05/01 00:00,1987/05/01 00:01,['1987/05/01 00:00'],"['1987/05/01 00:00 [pubmed]', '1987/05/01 00:01 [medline]', '1987/05/01 00:00 [entrez]']",,ppublish,Br J Hosp Med. 1987 May;37(5):386-96.,5,"Patients with cardiac disease have an increased risk of mortality and morbidity from anaesthesia and surgery. Adequate recognition of cardiac disease and its pathophysiological consequences will lead to appropriate preoperative management, which can greatly reduce these risks to the patient.",,,,,,,,,,,,,,,,,,,,
4017061,NLM,MEDLINE,19850916,20061115,0069-2328 (Print) 0069-2328 (Linking),40,1985 Apr,[Levels of blood lipids and blood pressure in children in families with a history of cardiovascular disease. II].,197-200,,"['Pohanka, P', 'Rigo, V', 'Svac, J']","['Pohanka P', 'Rigo V', 'Svac J']",,['slo'],"['English Abstract', 'Journal Article']",,Czech Republic,Cesk Pediatr,Ceskoslovenska pediatrie,0403576,IM,"['Adolescent', '*Blood Pressure', 'Cardiovascular Diseases/blood/*genetics/physiopathology', 'Child', 'Female', 'Humans', 'Lipids/*blood', 'Male']",1985/04/01 00:00,1985/04/01 00:01,['1985/04/01 00:00'],"['1985/04/01 00:00 [pubmed]', '1985/04/01 00:01 [medline]', '1985/04/01 00:00 [entrez]']",,ppublish,Cesk Pediatr. 1985 Apr;40(4):197-200.,4,,,,,,,,['0 (Lipids)'],,,,,,,Hodnoty serovych lipidov a TK u deti z rodin s kardiovaskularnou anamnezou. II. cast'.,,,,,,
14868920,NLM,MEDLINE,20040215,20211203,,104,1951 Jul-Aug,[The problem of detecting cardiac disorders. I. Critical study of diagnoses established in recruitment centers of the American Army].,177-82,,"['SEGERS, M']",['SEGERS M'],,['und'],['Journal Article'],,Belgium,Ann Belg Med Mil,Annales belges de medecine militaire. Belgisch tijdschrift voor militaire geneeskunde,14940340R,OM,"['Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Disease', '*Ethnicity', '*Heart', '*Heart Diseases', 'Humans', '*Military Personnel', 'United States']",1951/07/01 00:00,1951/07/01 00:01,['1951/07/01 00:00'],"['1951/07/01 00:00 [pubmed]', '1951/07/01 00:01 [medline]', '1951/07/01 00:00 [entrez]']",,ppublish,Ann Belg Med Mil. 1951 Jul-Aug;104(5):177-82.,5,,,,,['NLM'],"['*ARMED FORCES PERSONNEL/diseases', '*CARDIOVASCULAR DISEASES/epidemiology and statistics']",,,,,,,,,Le probleme de la detection des affections cardiaques. I. Etude critique des diagnostics etablis dans les centres de recrutement de l'Armee Americaine.,,,,,['CLML: 5221:1138:33:72'],
30518807,NLM,MEDLINE,20210818,20210818,1476-5527 (Electronic) 0950-9240 (Linking),34,2020 Apr,Estimating the effect of a reduction of sodium intake in childhood on cardiovascular diseases later in life.,335-337,10.1038/s41371-018-0137-z [doi],"['Rios-Leyvraz, Magali', 'Bovet, Pascal', 'Chiolero, Arnaud']","['Rios-Leyvraz M', 'Bovet P', 'Chiolero A']","['Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital (CHUV), Lausanne, Switzerland. magali.leyvraz@chuv.ch.', 'Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital (CHUV), Lausanne, Switzerland.', 'Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital (CHUV), Lausanne, Switzerland.', 'Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.', 'Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.']",['eng'],['Letter'],20181205,England,J Hum Hypertens,Journal of human hypertension,8811625,IM,"['Blood Pressure', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control', 'Humans', '*Hypertension', 'Sodium', 'Sodium Chloride, Dietary', '*Sodium, Dietary/adverse effects']",2018/12/07 06:00,2021/08/19 06:00,['2018/12/07 06:00'],"['2018/07/13 00:00 [received]', '2018/11/15 00:00 [accepted]', '2018/10/16 00:00 [revised]', '2018/12/07 06:00 [pubmed]', '2021/08/19 06:00 [medline]', '2018/12/07 06:00 [entrez]']","['10.1038/s41371-018-0137-z [pii]', '10.1038/s41371-018-0137-z [doi]']",ppublish,J Hum Hypertens. 2020 Apr;34(4):335-337. doi: 10.1038/s41371-018-0137-z. Epub 2018 Dec 5.,4,,['ORCID: 0000-0003-0455-197X'],,,,,,"['0 (Sodium Chloride, Dietary)', '0 (Sodium, Dietary)', '9NEZ333N27 (Sodium)']",,,,,,,,,,,,,
18570284,NLM,MEDLINE,20080910,20080717,0048-3664 (Print) 0048-3664 (Linking),37,2008,[Arterial hypertension--what's new?].,296-304,10.1002/pauz.200700272 [doi],"['Fiedler, Georg Martin']",['Fiedler GM'],"['Leitender Oberarzt, Institut fur Laboratoriumsmedizin, Klinische Chemie und Molekulare Diagnostik, Liebigstrasse 27, 04103 Leipzig, Germany. martin.fiedler@medizin.uni-leipzig.de']",['ger'],"['Journal Article', 'Review']",,Germany,Pharm Unserer Zeit,Pharmazie in unserer Zeit,0337763,IM,"['Antihypertensive Agents/*therapeutic use', 'Arteries/physiopathology', 'Cardiovascular Diseases/epidemiology/etiology/physiopathology', 'Germany/epidemiology', 'Humans', 'Hypertension/*drug therapy/epidemiology/mortality/physiopathology', 'Risk']",2008/06/24 09:00,2008/09/11 09:00,['2008/06/24 09:00'],"['2008/06/24 09:00 [pubmed]', '2008/09/11 09:00 [medline]', '2008/06/24 09:00 [entrez]']",['10.1002/pauz.200700272 [doi]'],ppublish,Pharm Unserer Zeit. 2008;37(4):296-304. doi: 10.1002/pauz.200700272.,4,,,,,,,,['0 (Antihypertensive Agents)'],,28,,,,,Arterielle Hypertonie--was gibt es Neues?,,,,,,
15506371,NLM,MEDLINE,20050111,20151119,0047-1852 (Print) 0047-1852 (Linking),62 Suppl 9,2004 Sep,[Localization and possible function of adrenomedullin in human tissues].,211-5,,"['Hatakeyama, Kinta', 'Marutsuka, Kousuke', 'Asada, Yujiro']","['Hatakeyama K', 'Marutsuka K', 'Asada Y']","['First Department of Pathology, Miyazaki Medical College, University of Miyazaki.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Adrenomedullin', 'Biomarkers/metabolism', 'Cardiovascular Diseases/diagnosis/drug therapy/etiology/metabolism', 'Cardiovascular System/metabolism', 'Humans', 'Lipoproteins/physiology', 'Mucous Membrane/physiology', 'Neurosecretory Systems/physiology', 'Peptides/metabolism/*physiology/therapeutic use', 'Thromboplastin/physiology', 'Tissue Distribution']",2004/10/28 09:00,2005/01/12 09:00,['2004/10/28 09:00'],"['2004/10/28 09:00 [pubmed]', '2005/01/12 09:00 [medline]', '2004/10/28 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2004 Sep;62 Suppl 9:211-5.,,,,,,,,,"['0 (Biomarkers)', '0 (Lipoproteins)', '0 (Peptides)', '0 (lipoprotein-associated coagulation inhibitor)', '148498-78-6 (Adrenomedullin)', '9035-58-9 (Thromboplastin)']",,13,,,,,,,,,,,
30185689,NLM,MEDLINE,20191119,20200309,1347-4820 (Electronic) 1346-9843 (Print) 1346-9843 (Linking),83,2018 Dec 25,Clonal Hematopoiesis and Its Impact on Cardiovascular Disease.,2-11,10.1253/circj.CJ-18-0871 [doi],"['Sano, Soichi', 'Wang, Ying', 'Walsh, Kenneth']","['Sano S', 'Wang Y', 'Walsh K']","['Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine.', 'Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine.', 'Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine.']",['eng'],"['Journal Article', 'Review']",20180904,Japan,Circ J,Circulation journal : official journal of the Japanese Circulation Society,101137683,IM,"['*Cardiovascular Diseases/genetics/metabolism/mortality/pathology', 'Chronic Disease', 'Hematopoiesis/*genetics', 'Humans', '*Mutation']",2018/09/07 06:00,2019/11/20 06:00,['2018/09/07 06:00'],"['2018/09/07 06:00 [pubmed]', '2019/11/20 06:00 [medline]', '2018/09/07 06:00 [entrez]']",['10.1253/circj.CJ-18-0871 [doi]'],ppublish,Circ J. 2018 Dec 25;83(1):2-11. doi: 10.1253/circj.CJ-18-0871. Epub 2018 Sep 4.,1,"A number of recent epidemiological studies have associated the clonal expansion of hematopoietic cells, a process referred to as clonal hematopoiesis, with increased mortality. Clonal hematopoiesis increases the risk of hematological cancer, but this overall risk cannot account for the increase in mortality in the general population. Surprisingly, these mutations have also been associated with higher rates of cardiovascular disease, suggesting a previously unrecognized link between somatic mutations in hematopoietic cells and chronic disease. Here, we review recent epidemiological and experimental studies on clonal hematopoiesis that relate to cardiovascular disease.",,PMC6310086,,['NOTNLM'],"['Atherosclerosis', 'Clonal hematopoiesis', 'Heart failure', 'Hematopoietic stem cells']","['R01 HL126141/HL/NHLBI NIH HHS/United States', 'R01 HL131006/HL/NHLBI NIH HHS/United States', 'R01 HL132564/HL/NHLBI NIH HHS/United States', 'R01 HL138014/HL/NHLBI NIH HHS/United States']",,,,,['NIHMS989079'],,,,,,,,,
15781107,NLM,MEDLINE,20050412,20150616,1474-547X (Electronic) 0140-6736 (Linking),365,2005 Mar 19-25,Hypertension--time to move on.,1108-9,,"['MacMahon, S', 'Neal, B', 'Rodgers, A']","['MacMahon S', 'Neal B', 'Rodgers A']","['The George Institute for International Health, University of Sydney, Sydney, Australia. smacmahon@thegeorgeinstitute.org']",['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Cardiovascular Diseases/etiology/*prevention & control', 'Humans', 'Hypertension/complications/diagnosis/*drug therapy']",2005/03/23 09:00,2005/04/13 09:00,['2005/03/23 09:00'],"['2005/03/23 09:00 [pubmed]', '2005/04/13 09:00 [medline]', '2005/03/23 09:00 [entrez]']","['S0140-6736(05)71148-X [pii]', '10.1016/S0140-6736(05)71148-X [doi]']",ppublish,Lancet. 2005 Mar 19-25;365(9464):1108-9. doi: 10.1016/S0140-6736(05)71148-X.,9464,,,,,,,,,,,,,['Lancet. 2005 Jul 2-8;366(9479):24. PMID: 15993222'],,,,,,,,
20210914,NLM,MEDLINE,20100928,20101110,1525-139X (Electronic) 0894-0959 (Linking),23,2010 Mar-Apr,Cardiovascular complications in diabetic kidney disease.,169-77,10.1111/j.1525-139X.2009.00704.x [doi],"['Patel, Tejas', 'Charytan, David M']","['Patel T', 'Charytan DM']","[""Renal Division, Brigham and Women's Hospital, Boston, MA 002120, USA.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20100222,United States,Semin Dial,Seminars in dialysis,8911629,IM,"['Cardiovascular Diseases/epidemiology/*etiology/physiopathology/therapy', 'Diabetic Nephropathies/*complications', 'Humans', 'Risk Factors']",2010/03/10 06:00,2010/09/30 06:00,['2010/03/10 06:00'],"['2010/03/10 06:00 [entrez]', '2010/03/10 06:00 [pubmed]', '2010/09/30 06:00 [medline]']","['SDI704 [pii]', '10.1111/j.1525-139X.2009.00704.x [doi]']",ppublish,Semin Dial. 2010 Mar-Apr;23(2):169-77. doi: 10.1111/j.1525-139X.2009.00704.x. Epub 2010 Feb 22.,2,"Diabetes mellitus (DM) is the leading cause of chronic kidney disease (CKD). Due to an explosion in the incidence and the prevalence of Type 2 DM, the burden of CKD is expected to increase proportionately. Both DM and CKD are associated with a high incidence of cardiovascular (CV) morbidity and mortality, and it is important to understand the unique nature of CV disease in patients with the combination of these two conditions. In this report, we review the traditional and nontraditional risk factors that underlie the high risk of CV disease in this population, with a particular focus on vascular calcification, mineral metabolism, and therapeutic paradigms for the treatment of cardiovascular disease in this unique and high-risk population.",,,,,,,,,110,,,,,,,,,,,
15010651,NLM,MEDLINE,20040622,20191108,1076-7460 (Print) 1076-7460 (Linking),13,2004 Mar-Apr,"The Cardiovascular Health Study: risk factors, subclinical disease, and clinical cardiovascular disease in older adults.",59-60,,"['Newman, Anne B', 'Siscovick, David']","['Newman AB', 'Siscovick D']","['University of Pittsburgh, Pittsburgh, PA, USA.']",['eng'],['Journal Article'],,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Aged', 'Cardiovascular Diseases/*diagnosis/epidemiology/prevention & control', 'Female', '*Geriatric Assessment', 'Humans', 'Male', 'Risk Factors']",2004/03/11 05:00,2004/06/23 05:00,['2004/03/11 05:00'],"['2004/03/11 05:00 [pubmed]', '2004/06/23 05:00 [medline]', '2004/03/11 05:00 [entrez]']",['10.1111/j.1076-7460.2004.02126.x [doi]'],ppublish,Am J Geriatr Cardiol. 2004 Mar-Apr;13(2):59-60. doi: 10.1111/j.1076-7460.2004.02126.x.,2,,,,,,,,,,,,,,,,,,,,,
7427384,NLM,MEDLINE,19810129,20190501,0007-1447 (Print) 0007-1447 (Linking),281,1980 Aug 30,Printed information for the lay public on cardiovascular disease.,597-9,,"[""O'Hanrahan, M"", ""O'Malley, K"", ""O'Brien, E T""]","[""O'Hanrahan M"", ""O'Malley K"", ""O'Brien ET""]",,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,IM,"['Activities of Daily Living', '*Books', 'Cardiovascular Diseases/etiology/*prevention & control/therapy', 'Humans', 'Pamphlets', 'Primary Health Care', 'Risk']",1980/08/30 00:00,1980/08/30 00:01,['1980/08/30 00:00'],"['1980/08/30 00:00 [pubmed]', '1980/08/30 00:01 [medline]', '1980/08/30 00:00 [entrez]']",['10.1136/bmj.281.6240.597 [doi]'],ppublish,Br Med J. 1980 Aug 30;281(6240):597-9. doi: 10.1136/bmj.281.6240.597.,6240,"Booklets from several countries on various aspects of cardiovascular disease, intended for distribution to the public and to patients, could be classified into three categories dealing with primary prevention, secondary prevention, and management. Much material was duplicated, whereas some diseases were completely ignored. Only two types of booklets should be available. One would deal with preventive measures for all cardiovascular diseases, while the other would be a series of booklets on individual conditions, combining information on secondary prevention and on management.",,PMC1713918,,,,,,,,,,,,,,,,,,
30355166,NLM,MEDLINE,20191003,20200309,1524-4571 (Electronic) 0009-7330 (Print) 0009-7330 (Linking),123,2018 Oct 12,Basic Cardiovascular Sciences Scientific Sessions 2018.,1024-1029,10.1161/CIRCRESAHA.118.313933 [doi],"['McNamara, James W', 'Grimes, Kelly M', 'Sadayappan, Sakthivel']","['McNamara JW', 'Grimes KM', 'Sadayappan S']","['From the Department of Internal Medicine, Heart, Lung and Vascular Institute, University of Cincinnati, OH (J.W.M., S.S.).', ""Department of Pediatrics, Cincinnati Children's Hospital Medical Center, OH (K.M.G.)."", 'From the Department of Internal Medicine, Heart, Lung and Vascular Institute, University of Cincinnati, OH (J.W.M., S.S.).']",['eng'],"['Congress', 'News', 'Portrait']",,United States,Circ Res,Circulation research,0047103,IM,"['Animals', 'Biomedical Research/*methods', 'Cardiology/*methods', 'Cardiovascular Diseases/genetics/immunology/metabolism/therapy', 'Diffusion of Innovation', 'Humans']",2018/10/26 06:00,2019/10/08 06:00,['2018/10/26 06:00'],"['2018/10/26 06:00 [entrez]', '2018/10/26 06:00 [pubmed]', '2019/10/08 06:00 [medline]']",['10.1161/CIRCRESAHA.118.313933 [doi]'],ppublish,Circ Res. 2018 Oct 12;123(9):1024-1029. doi: 10.1161/CIRCRESAHA.118.313933.,9,"Among its 16 councils, the Basic Cardiovascular Sciences (BCVS) Council of the American Heart Association (AHA) is leading the way, with strong membership and increasing popularity of its annual summer scientific sessions. The 2018 Scientific Sessions were held in San Antonio, Texas, between July 29 and August 2, 2018 with a focus on innovations in cardiovascular research. This theme predominated the scientific and early career sessions, as well as the women in science breakfast, poster sessions, council dinner, joint Academy of Cardiovascular Research Excellence and the Acta Pharmacologica Sinica satellite symposium. The present report summarizes the 2018 BCVS Scientific Sessions.",,PMC6317746,,,,"['F32 HL138747/HL/NHLBI NIH HHS/United States', 'K02 HL114749/HL/NHLBI NIH HHS/United States', 'R01 HL105826/HL/NHLBI NIH HHS/United States', 'R01 HL130356/HL/NHLBI NIH HHS/United States']",,,,,['NIHMS1507074'],,,,,,,,,
8958409,NLM,MEDLINE,19970228,20181130,0007-1064 (Print) 0007-1064 (Linking),56,1996 Nov 20-Dec 10,"Cardiovascular forum. A Ciba symposium. Heidelberg, Germany, 3-5 October 1996. Proceedings.",542-7,,,,,['eng'],"['Congress', 'Overall']",,England,Br J Hosp Med,British journal of hospital medicine,0171545,IM,"['Cardiovascular Diseases/epidemiology/*prevention & control', 'Humans', 'Hypertension/epidemiology/*prevention & control']",1996/11/10 00:00,1996/11/10 00:01,['1996/11/10 00:00'],"['1996/11/10 00:00 [pubmed]', '1996/11/10 00:01 [medline]', '1996/11/10 00:00 [entrez]']",,ppublish,Br J Hosp Med. 1996 Nov 20-Dec 10;56(10):542-7.,10,,,,,,,,,,,,,,,,,,,,,
21156678,NLM,MEDLINE,20110512,20161125,1468-201X (Electronic) 1355-6037 (Linking),97,2011 Apr,"South Asians, physical exercise and heart disease.",607-9,10.1136/hrt.2010.214908 [doi],"['Zaman, M Justin S', 'Jemni, Monem']","['Zaman MJ', 'Jemni M']",,['eng'],"['Comment', 'Editorial']",20101213,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Asia/ethnology', 'Cardiovascular Diseases/epidemiology/*ethnology/prevention & control', '*Exercise', 'Female', 'Humans', 'Male', 'United Kingdom/epidemiology']",2010/12/16 06:00,2011/05/13 06:00,['2010/12/16 06:00'],"['2010/12/16 06:00 [entrez]', '2010/12/16 06:00 [pubmed]', '2011/05/13 06:00 [medline]']","['hrt.2010.214908 [pii]', '10.1136/hrt.2010.214908 [doi]']",ppublish,Heart. 2011 Apr;97(8):607-9. doi: 10.1136/hrt.2010.214908. Epub 2010 Dec 13.,8,,,,,,,,,,,['Heart. 2011 Apr;97(8):655-9. PMID: 21131381'],,,,,,,,,,
17415977,NLM,MEDLINE,20100422,20171116,0254-6450 (Print) 0254-6450 (Linking),27,2006 Dec,[Metabolic syndrome and prevention of cardiovascular diseases].,1022-3,,"['Zhao, Dong', 'Liu, Jing']","['Zhao D', 'Liu J']",,['chi'],['Journal Article'],,China,Zhonghua Liu Xing Bing Xue Za Zhi,Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,8208604,IM,"['Cardiovascular Diseases/etiology/*prevention & control', 'Humans', '*Metabolic Syndrome']",2007/04/10 09:00,2010/04/23 06:00,['2007/04/10 09:00'],"['2007/04/10 09:00 [pubmed]', '2010/04/23 06:00 [medline]', '2007/04/10 09:00 [entrez]']",,ppublish,Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Dec;27(12):1022-3.,12,,,,,,,,,,,,,,,,,,,,,
31795760,NLM,MEDLINE,20210125,20210125,2047-4881 (Electronic) 2047-4873 (Linking),27,2020 Jul,Implications of the UK Biobank prognostic study for preventive cardiology.,1034-1035,10.1177/2047487319891518 [doi],"['Jelinek, Michael', 'Vale, Margarite']","['Jelinek M', 'Vale M']","[""St Vincent's Hospital Melbourne, Australia."", 'Department of Medicine, University of Melbourne, Australia.', 'Department of Medicine, University of Melbourne, Australia.']",['eng'],"['Comment', 'Editorial']",20191203,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Biological Specimen Banks', '*Cardiology', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans', 'Prognosis', 'United Kingdom/epidemiology', 'Walking Speed']",2019/12/05 06:00,2021/01/26 06:00,['2019/12/05 06:00'],"['2019/12/05 06:00 [pubmed]', '2021/01/26 06:00 [medline]', '2019/12/05 06:00 [entrez]']",['10.1177/2047487319891518 [doi]'],ppublish,Eur J Prev Cardiol. 2020 Jul;27(10):1034-1035. doi: 10.1177/2047487319891518. Epub 2019 Dec 3.,10,,,,,,,,,,,['Eur J Prev Cardiol. 2020 Jul;27(10):1036-1044. PMID: 31698963'],,,,,,,,,,
19258256,NLM,MEDLINE,20090604,20181201,0161-5505 (Print) 0161-5505 (Linking),50,2009 Mar,Cardiovascular MI symposium.,19N,,"['Sinusas, Albert J']",['Sinusas AJ'],,['eng'],"['Congress', 'News']",,United States,J Nucl Med,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",0217410,IM,"['*Cardiovascular Diseases/diagnosis/metabolism', 'Cardiovascular System/*metabolism', 'Diagnostic Imaging']",2009/03/05 09:00,2009/06/06 09:00,['2009/03/05 09:00'],"['2009/03/05 09:00 [entrez]', '2009/03/05 09:00 [pubmed]', '2009/06/06 09:00 [medline]']",['50/3/19N [pii]'],ppublish,J Nucl Med. 2009 Mar;50(3):19N.,3,,,,,,,,,,,,,,,,,,,,,
34389854,NLM,MEDLINE,20220404,20220405,2047-4881 (Electronic) 2047-4873 (Linking),28,2021 Sep 20,Editor comment: focus on cardiovascular risk factor control.,1163-1166,10.1093/eurjpc/zwab133 [doi],"['Halasz, Geza', 'Piepoli, Massimo F']","['Halasz G', 'Piepoli MF']","['Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Italy.', 'Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Heart Disease Risk Factors', 'Humans', 'Risk Factors']",2021/08/15 06:00,2022/04/05 06:00,['2021/08/14 06:21'],"['2021/07/28 00:00 [accepted]', '2021/08/15 06:00 [pubmed]', '2022/04/05 06:00 [medline]', '2021/08/14 06:21 [entrez]']","['6352230 [pii]', '10.1093/eurjpc/zwab133 [doi]']",ppublish,Eur J Prev Cardiol. 2021 Sep 20;28(11):1163-1166. doi: 10.1093/eurjpc/zwab133.,11,,['ORCID: 0000-0001-7220-123X'],,,,,,,,,,,,,,,,,,,
34541617,NLM,MEDLINE,20220321,20220321,1532-6551 (Electronic) 1071-3581 (Linking),28,2021 Oct,A quick glance at selected topics in this issue.,1817-1819,10.1007/s12350-021-02808-2 [doi],"['Bhambhvani, Pradeep', 'Hage, Fadi G', 'Iskandrian, Ami E']","['Bhambhvani P', 'Hage FG', 'Iskandrian AE']","['Division of Molecular Imaging and Therapeutics, Department of Radiology, The University of Alabama at Birmingham, 619 19th Street South, JT 777, Birmingham, AL, 35249, USA. pbhambhvani@uabmc.edu.', 'Division of Cardiovascular Disease, The University of Alabama at Birmingham, Birmingham, AL, USA.', 'Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA.', 'Division of Cardiovascular Disease, The University of Alabama at Birmingham, Birmingham, AL, USA.']",['eng'],"['Journal Article', 'Review']",20210919,United States,J Nucl Cardiol,Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,9423534,IM,"['*Cardiac Imaging Techniques', '*Cardiology', 'Cardiovascular Diseases/*diagnostic imaging/etiology/therapy', 'Humans', '*Nuclear Medicine']",2021/09/21 06:00,2022/03/22 06:00,['2021/09/20 06:26'],"['2021/09/02 00:00 [received]', '2021/09/02 00:00 [accepted]', '2021/09/21 06:00 [pubmed]', '2022/03/22 06:00 [medline]', '2021/09/20 06:26 [entrez]']","['10.1007/s12350-021-02808-2 [pii]', '10.1007/s12350-021-02808-2 [doi]']",ppublish,J Nucl Cardiol. 2021 Oct;28(5):1817-1819. doi: 10.1007/s12350-021-02808-2. Epub 2021 Sep 19.,5,"""A quick glance at selected topics in this issue"" aims to highlight contents of the Journal and provide a quick review to the readers.",,,,['NOTNLM'],"['Amyloid', 'Atherosclerosis', 'CAD', 'Heart disease', 'Heart failure', 'PET', 'SPECT']",,,['(c) 2021. American Society of Nuclear Cardiology.'],,,,,,,,,,,,
21541471,NLM,MEDLINE,20110915,20110504,2175-8239 (Electronic) 0101-2800 (Linking),33,2011 Mar,Assessment and management of cardiovascular disease in patients with chronic kidney disease.,113-4,S0101-28002011000100015 [pii],"['Tavares, Marcelo de Sousa']",['Tavares Mde S'],,"['eng', 'por']","['Comment', 'Letter']",,Brazil,J Bras Nefrol,Jornal brasileiro de nefrologia,9426946,IM,"['*Cardiovascular Diseases/diagnosis/etiology/therapy', 'Humans', '*Kidney Failure, Chronic/complications']",2011/05/05 06:00,2011/09/16 06:00,['2011/05/05 06:00'],"['2011/05/05 06:00 [entrez]', '2011/05/05 06:00 [pubmed]', '2011/09/16 06:00 [medline]']",['S0101-28002011000100015 [pii]'],ppublish,J Bras Nefrol. 2011 Mar;33(1):113-4.,1,,,,,,,,,,,['J Bras Nefrol. 2010 Mar;32(1):118-25. PMID: 21448530'],,,,,,,,,,
25714819,NLM,MEDLINE,20151204,20150306,1941-7705 (Electronic) 1941-7713 (Linking),8,2015 Mar,How the American Heart Association helped change women's heart health.,S60-2,10.1161/CIRCOUTCOMES.115.001734 [doi],"['Brown, Nancy']",['Brown N'],"['From the American Heart Association, Dallas, TX. nancy.brown@heart.org.']",['eng'],['Journal Article'],20150224,United States,Circ Cardiovasc Qual Outcomes,Circulation. Cardiovascular quality and outcomes,101489148,IM,"['*American Heart Association', '*Cardiovascular Diseases/diagnosis/mortality/physiopathology/therapy', '*Health Behavior', '*Health Knowledge, Attitudes, Practice', '*Health Promotion', 'Health Status Disparities', 'Healthcare Disparities', 'Humans', 'Risk Factors', 'Sex Factors', 'United States/epidemiology', ""*Women's Health""]",2015/02/26 06:00,2015/12/15 06:00,['2015/02/26 06:00'],"['2015/02/26 06:00 [entrez]', '2015/02/26 06:00 [pubmed]', '2015/12/15 06:00 [medline]']","['CIRCOUTCOMES.115.001734 [pii]', '10.1161/CIRCOUTCOMES.115.001734 [doi]']",ppublish,Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S60-2. doi: 10.1161/CIRCOUTCOMES.115.001734. Epub 2015 Feb 24.,2 Suppl 1,,,,,['NOTNLM'],['women'],,,,,,,,,,,,,,,
15125385,NLM,MEDLINE,20040629,20151119,0914-5087 (Print) 0914-5087 (Linking),43,2004 Apr,[Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2003)].,263-83,,,,,['jpn'],"['Guideline', 'Journal Article', 'Practice Guideline']",,Netherlands,J Cardiol,Journal of cardiology,8804703,IM,"['Adult', 'Biomarkers/blood', 'Cardiac Catheterization', 'Cardiovascular Agents/administration & dosage', 'Cardiovascular Diseases/*diagnosis/etiology/physiopathology/*therapy', 'Child', 'Coronary Artery Bypass', 'Diagnostic Imaging', 'Electrocardiography', 'Humans', 'Life Style', 'Mucocutaneous Lymph Node Syndrome/*complications', 'Severity of Illness Index']",2004/05/06 05:00,2004/06/30 05:00,['2004/05/06 05:00'],"['2004/05/06 05:00 [pubmed]', '2004/06/30 05:00 [medline]', '2004/05/06 05:00 [entrez]']",,ppublish,J Cardiol. 2004 Apr;43(4):263-83.,4,,,,,,,,"['0 (Biomarkers)', '0 (Cardiovascular Agents)']",,,,,,,,,,,,,
27559080,NLM,MEDLINE,20180205,20181202,1468-201X (Electronic) 1355-6037 (Linking),102,2016 Sep 15,Young investigators at the British Cardiovascular Society Annual Conference in June 2016.,1509-10,10.1136/heartjnl-2016-310261 [doi],"['Myat, Aung']",['Myat A'],,['eng'],"['Congress', 'Letter']",,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Age Factors', '*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnostic imaging/epidemiology/psychology', 'Humans', '*Research Personnel', 'Risk Factors', 'Societies, Medical']",2016/08/26 06:00,2018/02/06 06:00,['2016/08/26 06:00'],"['2016/08/26 06:00 [entrez]', '2016/08/26 06:00 [pubmed]', '2018/02/06 06:00 [medline]']","['heartjnl-2016-310261 [pii]', '10.1136/heartjnl-2016-310261 [doi]']",ppublish,Heart. 2016 Sep 15;102(18):1509-10. doi: 10.1136/heartjnl-2016-310261.,18,,,,,['NOTNLM'],['CARDIAC PROCEDURES AND THERAPY'],,,,,,,,,,,,,,,
19689345,NLM,MEDLINE,20091022,20190728,1873-4286 (Electronic) 1381-6128 (Linking),15,2009,Therapeutic angiogenesis and regeneration in cardiovascular diseases.,2759,,"['Takahashi, Masafumi']",['Takahashi M'],,['eng'],"['Editorial', 'Introductory Journal Article']",,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Animals', 'Cardiovascular Diseases/physiopathology/*therapy', 'Humans', '*Neovascularization, Physiologic', '*Regeneration']",2009/08/20 09:00,2009/10/23 06:00,['2009/08/20 09:00'],"['2009/08/20 09:00 [entrez]', '2009/08/20 09:00 [pubmed]', '2009/10/23 06:00 [medline]']",['10.2174/138161209788923831 [doi]'],ppublish,Curr Pharm Des. 2009;15(24):2759. doi: 10.2174/138161209788923831.,24,,,,,,,,,,,,,,,,,,,,,
947680,NLM,MEDLINE,19761001,20041117,0010-8650 (Print) 0010-8650 (Linking),18,1976,Community control of cardiovascular diseases. The pro and cons.,95-103,,"['Lamm, G']",['Lamm G'],,['eng'],['Journal Article'],,Czech Republic,Cor Vasa,Cor et vasa,0372614,IM,"['Cardiovascular Diseases/diet therapy/epidemiology/*prevention & control', 'Health Education', 'Health Planning', 'Humans', 'Physical Education and Training', 'World Health Organization']",1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Cor Vasa. 1976;18(2):95-103.,2,"The need for an effective control of cardiovascular diseases is evident. Possibilities to achieve this both in the curative and the preventive field are restricted mainly due to the insufficient knowledge of their etiopathogenesis. Although the cause is not known, the discovery to risk factors provides a sound evidence for prevention. Attempts to reverse elevated risk factor levels are all directed towards a more healthy way of life. Group oriented prevention is one of the most frequently applied approaches to test the hypothesis of preventability. While it offers many advantages, the delayed timing of the intervention and the restricted coverage limits the possibility of inference from its results. The community approach implies acting on the whole population by changing their behaviour towards a more healthy way of life. Apart from the beneficial ""side effects"" on other chronic diseases, their outcome in the pilot areas may be inferred to the total population. The final proof of any scientific evidence from the public health point of view is, after all, its applicability and effectiveness in real life situation.",,,,,,,,,,,,,,,,,,,,
7582199,NLM,MEDLINE,19951130,20041117,0954-6928 (Print) 0954-6928 (Linking),6,1995 Jul,Bibliography of the current world literature.,593-5,,,,,['eng'],['Bibliography'],,England,Coron Artery Dis,Coronary artery disease,9011445,IM,"['*Cardiovascular Diseases/diagnosis/therapy', 'Humans']",1995/07/01 00:00,1995/07/01 00:01,['1995/07/01 00:00'],"['1995/07/01 00:00 [pubmed]', '1995/07/01 00:01 [medline]', '1995/07/01 00:00 [entrez]']",,ppublish,Coron Artery Dis. 1995 Jul;6(7):593-5.,7,,,,,,,,,,,,,,,,,,,,,
14927432,NLM,MEDLINE,20040215,20190729,0002-9955 (Print) 0002-9955 (Linking),149,1952 Jun 21,Incidence of heart disease in mass x-ray surveys.,734-5,,"['SCHWARTZ, B', 'BERMAN, B']","['SCHWARTZ B', 'BERMAN B']",,['eng'],['Journal Article'],,United States,J Am Med Assoc,Journal of the American Medical Association,7507176,OM,"['*Biometry', 'Cardiovascular Diseases/*epidemiology/*statistics & numerical data', '*Data Collection', '*Heart Diseases', 'Incidence', 'X-Rays']",1952/06/21 00:00,1952/06/21 00:01,['1952/06/21 00:00'],"['1952/06/21 00:00 [pubmed]', '1952/06/21 00:01 [medline]', '1952/06/21 00:00 [entrez]']",['10.1001/jama.1952.02930250016005 [doi]'],ppublish,J Am Med Assoc. 1952 Jun 21;149(8):734-5. doi: 10.1001/jama.1952.02930250016005.,8,,,,,['NLM'],['*CARDIOVASCULAR DISEASES/epidemiology and statistics'],,,,,,,,,,,,,,['CLML: 5222:13420:90'],
19804854,NLM,MEDLINE,20100104,20091006,1535-6280 (Electronic) 0146-2806 (Linking),34,2009 Nov,How to identify the asymptomatic high-risk patient? Foreword.,535,10.1016/j.cpcardiol.2009.07.002 [doi],"['Rahimtoola, Shahbudin H']",['Rahimtoola SH'],,['eng'],['Introductory Journal Article'],,Netherlands,Curr Probl Cardiol,Current problems in cardiology,7701802,IM,['*Cardiovascular Diseases/diagnosis/prevention & control'],2009/10/07 06:00,2010/01/05 06:00,['2009/10/07 06:00'],"['2009/10/07 06:00 [entrez]', '2009/10/07 06:00 [pubmed]', '2010/01/05 06:00 [medline]']","['S0146-2806(09)00096-6 [pii]', '10.1016/j.cpcardiol.2009.07.002 [doi]']",ppublish,Curr Probl Cardiol. 2009 Nov;34(11):535. doi: 10.1016/j.cpcardiol.2009.07.002.,11,,,,,,,,,,,,,,,,,,,,,
8829686,NLM,MEDLINE,19961016,20051116,1069-3130 (Print) 1069-3130 (Linking),41,1996 Mar-Apr,Gender differences in cardiovascular outcomes.,101-8,,"['Hartz, R S']",['Hartz RS'],"['Division of Cardiac Surgery, University of Illinois, Chicago, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Int J Fertil Menopausal Stud,International journal of fertility and menopausal studies,9309760,IM,"['*Cardiovascular Diseases/epidemiology/prevention & control/therapy', 'Female', 'Humans', 'Prevalence', 'Prognosis', 'Risk Factors', 'Sex Factors', ""*Women's Health""]",1996/03/01 00:00,1996/03/01 00:01,['1996/03/01 00:00'],"['1996/03/01 00:00 [pubmed]', '1996/03/01 00:01 [medline]', '1996/03/01 00:00 [entrez]']",,ppublish,Int J Fertil Menopausal Stud. 1996 Mar-Apr;41(2):101-8.,2,"This review focuses on identifiable differences in prevalence, diagnosis, and treatment of cardiovascular diseases in the two genders. The specific task is to determine whether the differences identified are justifiable, as well as whether they can be altered over time. Since cardiovascular diseases kill more American woman than all other diseases combined, and since a great part of the health care budget is spent in this area, the review is highly pertinent in today's environment of cost containment in medicine. The Council of Ethical and Judicial Affairs of the American Medical Association, in its 1991 report, stated that ""the medical community cannot tolerate any discrepancy in the provision of care that is not based on appropriate biological or medical indications."" This review will, thus, attempt to determine which of the gender differences in cardiovascular outcomes can no longer be countenanced.",,,,,,,,,37,,,,,,,,,,,
2518499,NLM,MEDLINE,19901121,20041117,,37,1989 Aug,[Paramedical personnel--their presence in the prevention of risk factors for cardiovascular pathology].,185-90,,"['Banta, V', 'Lunceanu, I', 'Ghimisi, N', 'Pirlau, S']","['Banta V', 'Lunceanu I', 'Ghimisi N', 'Pirlau S']",,['rum'],['Journal Article'],,Romania,Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit,Viata medicala; revista de informare profesionala si stiintifica a cadrelor medii sanitare,7609486,,"['*Allied Health Personnel', 'Cardiovascular Diseases/epidemiology/etiology/*prevention & control', 'Humans', 'Risk Factors', 'Romania/epidemiology']",1989/08/01 00:00,1989/08/01 00:01,['1989/08/01 00:00'],"['1989/08/01 00:00 [pubmed]', '1989/08/01 00:01 [medline]', '1989/08/01 00:00 [entrez]']",,ppublish,Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit. 1989 Aug;37(8):185-90.,8,,,,,,,,,,,,,,,Cadrele medii sanitare--prezenta activa in profilaxia factorilor de risc ai patologiei cardiovasculare.,,,,,,
33413053,NLM,MEDLINE,20210607,20210607,1875-6212 (Electronic) 1570-1611 (Linking),19,2021,Emerging Cardiovascular Risk Factors and Specific Patient Populations at Increased Cardiovascular Risk.,241-242,10.2174/157016111903201231115755 [doi],"['Katsiki, Niki', 'Doumas, Michael']","['Katsiki N', 'Doumas M']","['First Department of Internal Medicine, Diabetes Center, Division of Endocrinology and Metabolism, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.', 'Second Propaedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United Arab Emirates,Curr Vasc Pharmacol,Current vascular pharmacology,101157208,IM,"['Biomarkers/metabolism', '*Cardiac Imaging Techniques', 'Cardiovascular Diseases/*diagnosis/epidemiology/metabolism/physiopathology', 'Comorbidity', '*Diagnostic Techniques, Cardiovascular', 'Health Status', 'Heart Disease Risk Factors', 'Hemodynamics', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Risk Assessment']",2021/01/09 06:00,2021/06/08 06:00,['2021/01/08 05:41'],"['2021/01/08 05:41 [entrez]', '2021/01/09 06:00 [pubmed]', '2021/06/08 06:00 [medline]']","['CVP-EPUB-112883 [pii]', '10.2174/157016111903201231115755 [doi]']",ppublish,Curr Vasc Pharmacol. 2021;19(3):241-242. doi: 10.2174/157016111903201231115755.,3,,,,,,,,['0 (Biomarkers)'],,,,,,,,,,,,,
4822853,NLM,MEDLINE,19740614,20161123,0015-8178 (Print) 0015-8178 (Linking),92,1974 Apr 11,[Vascular changes in Marfan's syndrome].,407-9,,"['Simonis, G', 'Hofmann, K T', 'Koch, B']","['Simonis G', 'Hofmann KT', 'Koch B']",,['ger'],['Journal Article'],,Germany,Fortschr Med,Fortschritte der Medizin,2984763R,IM,"['Adolescent', 'Adult', 'Aortography', 'Cardiovascular Diseases/diagnostic imaging/*etiology/pathology/surgery', 'Female', 'Humans', 'Male', 'Marfan Syndrome/*complications/diagnostic imaging/pathology/surgery', 'Syndrome']",1974/04/11 00:00,1974/04/11 00:01,['1974/04/11 00:00'],"['1974/04/11 00:00 [pubmed]', '1974/04/11 00:01 [medline]', '1974/04/11 00:00 [entrez]']",,ppublish,Fortschr Med. 1974 Apr 11;92(10):407-9.,10,,,,,,,,,,,,,,,Gefassveranderungen beim Marfan-Syndrom.,,,,,,
2200600,NLM,MEDLINE,19900920,20181113,0820-3946 (Print) 1488-2329 (Electronic) 0820-3946 (Linking),143,1990 Aug 15,New drugs for hypertension: should data precede conclusions?,265-7,,"['Myers, M G']",['Myers MG'],"['Division of Cardiology, Sunnybrook Medical Centre, Toronto, Ont.']",['eng'],"['Journal Article', 'Review']",,Canada,CMAJ,CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,9711805,IM,"['Antihypertensive Agents/adverse effects/*therapeutic use', 'Cardiovascular Diseases/etiology/mortality/prevention & control', 'Humans', 'Hypertension/complications/*drug therapy', 'Survival Rate']",1990/08/15 00:00,1990/08/15 00:01,['1990/08/15 00:00'],"['1990/08/15 00:00 [pubmed]', '1990/08/15 00:01 [medline]', '1990/08/15 00:00 [entrez]']",,ppublish,CMAJ. 1990 Aug 15;143(4):265-7.,4,,,PMC1452182,,,,,['0 (Antihypertensive Agents)'],,,,,,,,,,,,,
29808756,NLM,MEDLINE,20190624,20190624,2047-4881 (Electronic) 2047-4873 (Linking),25,2018 Jun,Assessing the risk factors associated with cardiovascular disease.,932-933,10.1177/2047487318778652 [doi],"['Chandra, Phanish', 'Bhave, Radhika']","['Chandra P', 'Bhave R']","['Docplexus Online Services, Pune, India.', 'Docplexus Online Services, Pune, India.']",['eng'],['Letter'],20180529,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Attitude of Health Personnel', 'Cardiovascular Diseases/diagnosis/*epidemiology/mortality/therapy', 'Decision Support Techniques', 'Health Knowledge, Attitudes, Practice', 'Health Surveys', 'Humans', 'India/epidemiology', ""*Practice Patterns, Physicians'"", 'Prognosis', 'Risk Assessment', 'Risk Factors']",2018/05/29 06:00,2019/06/25 06:00,['2018/05/30 06:00'],"['2018/05/29 06:00 [pubmed]', '2019/06/25 06:00 [medline]', '2018/05/30 06:00 [entrez]']",['10.1177/2047487318778652 [doi]'],ppublish,Eur J Prev Cardiol. 2018 Jun;25(9):932-933. doi: 10.1177/2047487318778652. Epub 2018 May 29.,9,,,,,,,,,,,,,,,,,,,,,
23190057,NLM,MEDLINE,20130503,20221207,1744-8344 (Electronic) 1477-9072 (Linking),10,2012 Oct,Should African-Americans with elevated blood pressure be routinely screened for hypertensive heart disease?,1201-4,10.1586/erc.12.130 [doi],"['Levy, Phillip D', 'Flack, John M']","['Levy PD', 'Flack JM']",,['eng'],"['Editorial', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",,England,Expert Rev Cardiovasc Ther,Expert review of cardiovascular therapy,101182328,IM,"['*Black or African American', 'Blood Pressure', 'Cardiovascular Diseases/diagnosis/ethnology/etiology/prevention & control', 'Cerebrovascular Disorders/ethnology/etiology/prevention & control', 'Humans', 'Hypertension/complications/*diagnosis/*ethnology', 'Mass Screening/*methods', 'Risk Factors']",2012/11/30 06:00,2013/05/04 06:00,['2012/11/30 06:00'],"['2012/11/30 06:00 [entrez]', '2012/11/30 06:00 [pubmed]', '2013/05/04 06:00 [medline]']",['10.1586/erc.12.130 [doi]'],ppublish,Expert Rev Cardiovasc Ther. 2012 Oct;10(10):1201-4. doi: 10.1586/erc.12.130.,10,,,,,,,['1R01 MD005849-01A1/MD/NIMHD NIH HHS/United States'],,,,,,,,,,,,,,
23019607,NLM,MEDLINE,20130104,20121023,1708-5381 (Print) 1708-5381 (Linking),20,2012 Oct,"Cardiovascular disease: primary prevention, disease modulation and regenerative therapy.",243-50,10.1258/vasc.2012.ra0062 [doi],"['Sultan, Sherif', 'Hynes, Niamh']","['Sultan S', 'Hynes N']","['Department of Vascular and Endovascular Surgery, Western Vascular Institute, University College Hospital Galway, Ireland. sherif.sultan@hse.ie']",['eng'],"['Journal Article', 'Review']",20120927,England,Vascular,Vascular,101196722,IM,"['Cardiovascular Diseases/metabolism/pathology/physiopathology/*prevention & control/*therapy', 'Humans', 'Myocardium/metabolism/pathology', '*Primary Prevention', 'Recovery of Function', 'Regeneration', '*Regenerative Medicine', 'Treatment Outcome']",2012/09/29 06:00,2013/01/05 06:00,['2012/09/29 06:00'],"['2012/09/29 06:00 [entrez]', '2012/09/29 06:00 [pubmed]', '2013/01/05 06:00 [medline]']","['vasc.2012.ra0062 [pii]', '10.1258/vasc.2012.ra0062 [doi]']",ppublish,Vascular. 2012 Oct;20(5):243-50. doi: 10.1258/vasc.2012.ra0062. Epub 2012 Sep 27.,5,"Cardiovascular primary prevention and regeneration programs are the contemporary frontiers in functional metabolic vascular medicine. This novel science perspective harnesses our inherent ability to modulate the interface between specialized gene receptors and bioavailable nutrients in what is labeled as the nutrient-gene interaction. By mimicking a natural process through the conveyance of highly absorbable receptor specific nutrients, it is feasible to accelerate cell repair and optimize mitochondrial function, thereby achieving cardiovascular cure. We performed a comprehensive review of PubMed, EMBASE and Cochrane Review databases for articles relating to cardiovascular regenerative medicine, nutrigenomics and primary prevention, with the aim of harmonizing their roles within contemporary clinical practice. We searched in particular for large-scale randomized controlled trials on contemporary cardiovascular pharmacotherapies and their specific adverse effects on metabolic pathways which feature prominently in cardiovascular regenerative programs, such as nitric oxide and glucose metabolism. Scientific research on 'cardiovascular-free' centenarians delineated that low sugar and low insulin are consistent findings. As we age, our insulin level increases. Those who can decelerate the rapidity of this process are prompting their cardiovascular rejuvenation. It is beginning to dawn on some clinicians that contemporary treatments are not only failing to impact on our most prevalent diseases, but they may be causing more damage than good. Primary prevention programs are crucial elements for a better outcome. Cardiovascular primary prevention and regeneration programs have enhanced clinical efficacy and quality of life and complement our conventional endovascular practice.",,,,,,,,,,,,,,,,,,,,
10423080,NLM,MEDLINE,19991201,20191103,1064-1963 (Print) 1064-1963 (Linking),21,1999 Jul-Aug,Blood pressure and the global burden of cardiovascular disease.,543-52,,"['Rodgers, A', 'MacMahon, S']","['Rodgers A', 'MacMahon S']","['Department of Medicine, University of Auckland, New Zealand.']",['eng'],"['Journal Article', 'Review']",,England,Clin Exp Hypertens,"Clinical and experimental hypertension (New York, N.Y. : 1993)",9305929,IM,"['Blood Pressure/*physiology', 'Cardiovascular Diseases/ethnology/*etiology/mortality/*prevention & control', 'China', 'Humans', 'India']",1999/07/28 00:00,1999/07/28 00:01,['1999/07/28 00:00'],"['1999/07/28 00:00 [pubmed]', '1999/07/28 00:01 [medline]', '1999/07/28 00:00 [entrez]']",['10.3109/10641969909060987 [doi]'],ppublish,Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):543-52. doi: 10.3109/10641969909060987.,5-6,"Cardiovascular disease is responsible for a large and increasing proportion of death and disability worldwide. Half of this burden occurs in Asia. This study assessed the possible effects of population-wide (2% lower DBP for all) and targeted (7% lower DBP for those with usual DBP > or = 95 mmHg) BP interventions in Asia, using data from surveys of blood pressure levels, the Global Burden of Disease Project, Eastern Asian cohort studies and randomised trials of blood pressure lowering. Overall each of the two interventions would be expected to avert about one million deaths per year throughout Asia in 2020. These benefits would be approximately additive. About half a million deaths might be averted annually by each intervention in China alone, with about four-fifths of this benefit due to averted stroke. The relative benefits of these two strategies are similar to estimates made for US and UK populations. However, the absolute benefits are many times greater due to the size of the predicted CVD burden in Asia.",,,,,,,,,15,,,,,,,,,,,
16025684,NLM,MEDLINE,20050808,20161124,1019-5297 (Print) 1019-5297 (Linking),,2005 Apr-May,[Cardiotropic characteristics of mildronat].,71-6,,"['Zagorodnyi, M I', 'Kazak, L I', 'Svintsitskii, A S', 'Chekman, I S']","['Zagorodnyi MI', 'Kazak LI', 'Svintsitskii AS', 'Chekman IS']",,['rus'],"['Journal Article', 'Review']",,Ukraine,Lik Sprava,Likars'ka sprava,9601540,IM,"['Cardiovascular Agents/*therapeutic use', 'Cardiovascular Diseases/*drug therapy/etiology/metabolism', 'Energy Metabolism/*drug effects', 'Humans', 'Methylhydrazines/*therapeutic use']",2005/07/20 09:00,2005/08/09 09:00,['2005/07/20 09:00'],"['2005/07/20 09:00 [pubmed]', '2005/08/09 09:00 [medline]', '2005/07/20 09:00 [entrez]']",,ppublish,Lik Sprava. 2005 Apr-May;(3):71-6.,3,"The paper summarizes the literature data and the authors' own investigations on cardiotropic and clinical-pharmacological properties of Mildronat. The medication normalizes energy metabolism, optimizes the functions of the heart, and improves the health state of patients with angina pectoris and cardiac insufficiency.",,,,,,,"['0 (Cardiovascular Agents)', '0 (Methylhydrazines)', '73H7UDN6EC (3-(2,2,2-trimethylhydrazine)propionate)']",,25,,,,,,,,,,,
8653883,NLM,MEDLINE,19960726,20190623,0009-7322 (Print) 0009-7322 (Linking),93,1996 May 1,Cardiovascular disease epidemiology: a journey from the past into the future.,1755-64,,"['Epstein, F H']",['Epstein FH'],"['Institute of Social and Preventive Medicine, University of Zurich, Switzerland.']",['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Asia', 'Cardiovascular Diseases/*epidemiology/mortality/prevention & control', 'Chronic Disease', 'Coronary Disease/epidemiology/mortality/prevention & control', 'Europe', 'Humans', 'Risk Factors', 'United States']",1996/05/01 00:00,1996/05/01 00:01,['1996/05/01 00:00'],"['1996/05/01 00:00 [pubmed]', '1996/05/01 00:01 [medline]', '1996/05/01 00:00 [entrez]']",['10.1161/01.cir.93.9.1755 [doi]'],ppublish,Circulation. 1996 May 1;93(9):1755-64. doi: 10.1161/01.cir.93.9.1755.,9,,,,,,,,,,83,,,,,,,,,,,
11011322,NLM,MEDLINE,20001102,20101118,1097-6744 (Electronic) 0002-8703 (Linking),140,2000 Oct,Genetic analysis for common complex disease.,S36-44,,"['Hauser, E R', 'Pericak-Vance, M A']","['Hauser ER', 'Pericak-Vance MA']","['Duke University Medical Center, Center for Human Genetics, Durham, NC, USA. bhauser@chg.mc.duke.edu']",['eng'],"['Journal Article', 'Review']",,United States,Am Heart J,American heart journal,0370465,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*genetics', 'Genetic Linkage', 'Genetic Predisposition to Disease', 'Genetic Techniques', 'Humans', 'Molecular Epidemiology', 'Phenotype']",2000/09/30 11:00,2001/02/28 10:01,['2000/09/30 11:00'],"['2000/09/30 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/09/30 11:00 [entrez]']","['S0002-8703(00)74186-X [pii]', '10.1067/mhj.2000.108946 [doi]']",ppublish,Am Heart J. 2000 Oct;140(4):S36-44. doi: 10.1067/mhj.2000.108946.,4,,,,,,,,,,78,,,,,,,,,,,
25399270,NLM,MEDLINE,20141208,20181202,1538-3598 (Electronic) 0098-7484 (Linking),312,2014 Nov 19,A piece of my mind. N of 1.,1975-6,10.1001/jama.2014.12223 [doi],"['Manning, Kimberly D']",['Manning KD'],"['Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.']",['eng'],"['Journal Article', 'Personal Narrative']",,United States,JAMA,JAMA,7501160,IM,"['Cardiovascular Diseases/diagnosis/*prevention & control/therapy', 'Family Relations', 'Female', 'Humans', 'Physicians/*psychology', 'Primary Prevention', 'Siblings']",2014/11/17 06:00,2014/12/15 06:00,['2014/11/17 06:00'],"['2014/11/17 06:00 [entrez]', '2014/11/17 06:00 [pubmed]', '2014/12/15 06:00 [medline]']","['1935128 [pii]', '10.1001/jama.2014.12223 [doi]']",ppublish,JAMA. 2014 Nov 19;312(19):1975-6. doi: 10.1001/jama.2014.12223.,19,,,,,,,,,,,,,,,,,,,,,
15376371,NLM,MEDLINE,20040924,20071115,0253-9624 (Print) 0253-9624 (Linking),37,2003 Mar,[Current status and prospects of the prevention and control of cardiovascular diseases].,75-6,,"['Gu, Dong-feng']",['Gu DF'],"['Division of Population Genetics and Prevention, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.']",['chi'],['Editorial'],,China,Zhonghua Yu Fang Yi Xue Za Zhi,Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],7904962,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/epidemiology/mortality/*prevention & control', 'China/epidemiology', 'Female', 'Humans', 'Hypertension/complications/prevention & control', 'Male', 'Middle Aged', 'Risk Factors', 'Stroke/epidemiology/mortality/*prevention & control']",2004/09/21 05:00,2004/09/25 05:00,['2004/09/21 05:00'],"['2004/09/21 05:00 [pubmed]', '2004/09/25 05:00 [medline]', '2004/09/21 05:00 [entrez]']",,ppublish,Zhonghua Yu Fang Yi Xue Za Zhi. 2003 Mar;37(2):75-6.,2,,,,,,,,,,,,,,,,,,,,,
947679,NLM,MEDLINE,19761001,20041117,0010-8650 (Print) 0010-8650 (Linking),18,1976,Community cardiovascular disease control programmes.,84-94,,"['Pisa, Z', 'Strasser, T']","['Pisa Z', 'Strasser T']",,['eng'],['Journal Article'],,Czech Republic,Cor Vasa,Cor et vasa,0372614,IM,"['Aged', 'Cardiovascular Diseases/diagnosis/*prevention & control', 'Cerebrovascular Disorders/diagnosis', 'Coronary Disease/diagnosis', 'Health Education', '*Health Planning', 'Heart Defects, Congenital/diagnosis', 'Humans', 'Hypertension/diagnosis', 'Middle Aged', 'Pulmonary Heart Disease/diagnosis', 'Research', 'Rheumatic Heart Disease/diagnosis', 'Time Factors']",1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Cor Vasa. 1976;18(2):84-94.,2,"A comprehensive approach to the control of cardiovascular diseases on community level is a new venture. There is not yet enough experience in any country with this approach. However, the attempts to develop new approaches are fully justified, since the present stress on hospital care and treatment of the patients has only little changed the incidence of cardiovascular diseases among our populations.",,,,,,,,,,,,,,,,,,,,
16247279,NLM,MEDLINE,20060915,20191109,1076-7460 (Print) 1076-7460 (Linking),14,2005 Sep-Oct,A focus on heart failure and other age-related cardiovascular conditions.,221-3,,"['Weber, Michael A', 'Wenger, Nanette K', 'Scheidt, Stephen']","['Weber MA', 'Wenger NK', 'Scheidt S']",,['eng'],"['Comment', 'Editorial']",,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Adrenergic beta-Antagonists/therapeutic use', 'Age Factors', '*Aging', 'Anticoagulants/therapeutic use', 'Atherosclerosis/etiology/therapy', 'Atrial Fibrillation/etiology/therapy', 'Cardiovascular Agents/adverse effects/*therapeutic use', 'Cardiovascular Diseases/drug therapy/*etiology/*therapy', 'Heart Failure/drug therapy/*etiology/*therapy', 'Humans', 'Hypertension/etiology/therapy', 'Hypotension, Orthostatic/etiology/therapy', 'International Normalized Ratio']",2005/10/26 09:00,2006/09/16 09:00,['2005/10/26 09:00'],"['2005/10/26 09:00 [pubmed]', '2006/09/16 09:00 [medline]', '2005/10/26 09:00 [entrez]']",['10.1111/j.1076-7460.2005.04223.x [doi]'],ppublish,Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):221-3. doi: 10.1111/j.1076-7460.2005.04223.x.,5,,,,,,,,"['0 (Adrenergic beta-Antagonists)', '0 (Anticoagulants)', '0 (Cardiovascular Agents)']",,,"['Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):224-9. PMID: 16247280', 'Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):230-5. PMID: 16247281', 'Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):236-41. PMID: 16247282', 'Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):242-7; quiz 248-9. PMID: 16247283', 'Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):250-61. PMID: 16247284', 'Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):262-4. PMID: 16247285']",,,,,,,,,,
12091768,NLM,MEDLINE,20021002,20191106,1076-7460 (Print) 1076-7460 (Linking),11,2002 Jul-Aug,Drug treatment of cardiovascular problems at elderly age.,"214, 232",,"['Wenger, Nanette K', 'Scheidt, Stephen', 'Weber, Michael']","['Wenger NK', 'Scheidt S', 'Weber M']",,['eng'],['Editorial'],,United States,Am J Geriatr Cardiol,The American journal of geriatric cardiology,9215283,IM,"['Aged', 'Atrial Fibrillation/drug therapy', 'Cardiovascular Diseases/*drug therapy/epidemiology/prevention & control', 'Female', 'Hormone Replacement Therapy', 'Humans', 'Hyperlipidemias/drug therapy', 'Hypertension/drug therapy', 'Male', 'Peripheral Vascular Diseases/drug therapy', 'Prevalence', 'Stroke/drug therapy', 'United States/epidemiology']",2002/07/02 10:00,2002/10/03 04:00,['2002/07/02 10:00'],"['2002/07/02 10:00 [pubmed]', '2002/10/03 04:00 [medline]', '2002/07/02 10:00 [entrez]']",['10.1111/j.1076-7460.2002.01396.x [doi]'],ppublish,"Am J Geriatr Cardiol. 2002 Jul-Aug;11(4):214, 232. doi: 10.1111/j.1076-7460.2002.01396.x.",4,,,,,,,,,,,,,,,,,,,,,
18474267,NLM,MEDLINE,20080702,20080513,0002-9149 (Print) 0002-9149 (Linking),101,2008 May 22,Introduction. Oxidative stress and heart disease.,1D-2D,10.1016/j.amjcard.2008.02.001 [doi],"['Bhatt, Deepak L', 'Pashkow, Fredric J']","['Bhatt DL', 'Pashkow FJ']","['Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. bhatt@ccf.org']",['eng'],['Introductory Journal Article'],,United States,Am J Cardiol,The American journal of cardiology,0207277,IM,"['Cardiovascular Diseases/drug therapy/*metabolism/*prevention & control', 'Disease Progression', 'Humans', 'Inflammation/metabolism', '*Oxidative Stress', 'Risk Factors']",2008/06/24 09:00,2008/07/03 09:00,['2008/06/24 09:00'],"['2008/06/24 09:00 [pubmed]', '2008/07/03 09:00 [medline]', '2008/06/24 09:00 [entrez]']","['S0002-9149(08)00211-7 [pii]', '10.1016/j.amjcard.2008.02.001 [doi]']",ppublish,Am J Cardiol. 2008 May 22;101(10A):1D-2D. doi: 10.1016/j.amjcard.2008.02.001.,10A,,,,,,,,,,,,,,,,,,,,,
37650634,NLM,MEDLINE,20230901,20230928,1530-6860 (Electronic) 0892-6638 (Linking),37,2023 Oct,"Electromagnetic field and cardiovascular diseases: A state-of-the-art review of diagnostic, therapeutic, and predictive values.",e23142,10.1096/fj.202300201RR [doi],"['Wang, Yan', 'Zhao, Zhen-Gang', 'Chai, Zheng', 'Fang, Jian-Cheng', 'Chen, Mao']","['Wang Y', 'Zhao ZG', 'Chai Z', 'Fang JC', 'Chen M']","['Laboratory of Heart Valve Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China.', 'Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.', 'Laboratory of Heart Valve Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China.', 'Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.', 'Laboratory of Heart Valve Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China.', 'Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.', 'School of Instrumentation Science and Opto-Electronics Engineering, Beihang University, Beijing, China.', 'Laboratory of Heart Valve Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China.', 'Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,FASEB J,FASEB journal : official publication of the Federation of American Societies for Experimental Biology,8804484,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/therapy', 'Electromagnetic Fields', '*Hypertension', '*Coronary Artery Disease', '*Myocardial Ischemia']",2023/08/31 12:42,2023/09/01 06:43,['2023/08/31 09:13'],"['2023/07/20 00:00 [revised]', '2023/02/04 00:00 [received]', '2023/08/02 00:00 [accepted]', '2023/09/01 06:43 [medline]', '2023/08/31 12:42 [pubmed]', '2023/08/31 09:13 [entrez]']",['10.1096/fj.202300201RR [doi]'],ppublish,FASEB J. 2023 Oct;37(10):e23142. doi: 10.1096/fj.202300201RR.,10,"Despite encouraging advances in early diagnosis and treatment, cardiovascular diseases (CVDs) remained a leading cause of morbidity and mortality worldwide. Increasing evidence has shown that the electromagnetic field (EMF) influences many biological processes, which has attracted much attention for its potential therapeutic and diagnostic modalities in multiple diseases, such as musculoskeletal disorders and neurodegenerative diseases. Nonionizing EMF has been studied as a therapeutic or diagnostic tool in CVDs. In this review, we summarize the current literature ranging from in vitro to clinical studies focusing on the therapeutic potential (external EMF) and diagnostic potential (internal EMF generated from the heart) of EMF in CVDs. First, we provided an overview of the therapeutic potential of EMF and associated mechanisms in the context of CVDs, including cardiac arrhythmia, myocardial ischemia, atherosclerosis, and hypertension. Furthermore, we investigated the diagnostic and predictive value of magnetocardiography in CVDs. Finally, we discussed the critical steps necessary to translate this promising approach into clinical practice.","['ORCID: 0000-0003-1600-5570', 'ORCID: 0000-0003-1237-1696', 'ORCID: 0000-0003-0004-7127', 'ORCID: 0000-0001-7453-0387', 'ORCID: 0000-0002-7352-0563']",,,['NOTNLM'],"['cardiovascular diseases', 'electromagnetic fields', 'magnetic field therapy', 'magnetocardiography']",,,['(c) 2023 Federation of American Societies for Experimental Biology.'],,,,,,,,,,,,
22732022,NLM,MEDLINE,20121217,20120807,1521-0669 (Electronic) 0888-0018 (Linking),29,2012 Aug,Cardiotoxicity of childhood cancer treatment: update and current knowledge on long-term follow-up.,395-414,10.3109/08880018.2012.694092 [doi],"['de Ville de Goyet, Maelle', 'Moniotte, Stephane', 'Brichard, Benedicte']","['de Ville de Goyet M', 'Moniotte S', 'Brichard B']","['Department of Paediatric Haematology and Oncology, Cliniques universitaires Saint-Luc, Institut de Recherche Experimentale et Clinique, Universite Catholique de Louvain, Brussels, Belgium.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20120625,England,Pediatr Hematol Oncol,Pediatric hematology and oncology,8700164,IM,"['Adolescent', 'Adult', 'Cardiovascular Diseases/*diagnosis/*etiology/mortality/*prevention & control', 'Child', 'Child, Preschool', 'Follow-Up Studies', 'Humans', 'Infant', 'Male', 'Monitoring, Physiologic/*methods', 'Neoplasms/diagnosis/mortality/*therapy']",2012/06/27 06:00,2012/12/18 06:00,['2012/06/27 06:00'],"['2012/06/27 06:00 [entrez]', '2012/06/27 06:00 [pubmed]', '2012/12/18 06:00 [medline]']",['10.3109/08880018.2012.694092 [doi]'],ppublish,Pediatr Hematol Oncol. 2012 Aug;29(5):395-414. doi: 10.3109/08880018.2012.694092. Epub 2012 Jun 25.,5,"Therapeutic advances in paediatric oncology allowed increasing numbers of children to survive until adulthood. However, chemotherapy and radiotherapy are potentially cardiotoxic and contribute to a significant morbidity and mortality, cardiovascular events remaining the leading cause of death among survivors. This review summarizes the physiopathology of treatment-related cardiovascular diseases, their incidence, and the risk factors associated with each specific therapy. Few studies have investigated the cardiac outcomes of adult surviving from childhood cancers but all demonstrated a substantial risk for late cardiac effects. Cardiovascular monitoring, prevention, and early detection of cardiac dysfunction are, therefore, the keystones of an improved long-term outcome.",,,,,,,,,,,,,,,,,,,,
30880460,NLM,MEDLINE,20200803,20200803,2047-4881 (Electronic) 2047-4873 (Linking),26,2019 Mar,Editor's presentation.,451-453,10.1177/2047487319837818 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['1 Heart Failure Unit, G. da Saliceto Hospital, AUSL Piacenza, Italy.', ""2 Institute of Life Sciences, Scuola Superiore Sant'Anna, Sant'Anna School of Advanced Studies, Pisa, Italy.""]",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control', 'Humans', 'Predictive Value of Tests', '*Preventive Health Services', 'Prognosis', 'Risk Factors']",2019/03/19 06:00,2020/08/04 06:00,['2019/03/19 06:00'],"['2019/03/19 06:00 [entrez]', '2019/03/19 06:00 [pubmed]', '2020/08/04 06:00 [medline]']",['10.1177/2047487319837818 [doi]'],ppublish,Eur J Prev Cardiol. 2019 Mar;26(5):451-453. doi: 10.1177/2047487319837818.,5,,,,,,,,,,,,,,,,,,,,,
18206030,NLM,MEDLINE,20090811,20111017,0253-3758 (Print) 0253-3758 (Linking),35,2007 Oct,[Pay attention to global cardiovascular diseases risk of hypertension patients].,883-4,,"['Wu, Zhao-Su']",['Wu ZS'],,['chi'],['Editorial'],,China,Zhonghua Xin Xue Guan Bing Za Zhi,Zhonghua xin xue guan bing za zhi,7910682,IM,"['Cardiovascular Diseases/*etiology/*prevention & control', 'Humans', 'Hypertension/*complications', 'Risk Factors']",2008/01/22 09:00,2009/08/12 09:00,['2008/01/22 09:00'],"['2008/01/22 09:00 [pubmed]', '2009/08/12 09:00 [medline]', '2008/01/22 09:00 [entrez]']",,ppublish,Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Oct;35(10):883-4.,10,,,,,,,,,,,,,,,,,,,,,
33430736,NLM,MEDLINE,20211025,20220531,1875-6506 (Electronic) 1573-4021 (Linking),17,2021,Pesticides-induced Cardiovascular Dysfunctions: Prevalence and Associated Mechanisms.,27-34,10.2174/1573402117666210111102508 [doi],"['Adeyemi, Joseph A', 'Ukwenya, Victor O', 'Arowolo, Olatunbosun K', 'Olise, Christian C']","['Adeyemi JA', 'Ukwenya VO', 'Arowolo OK', 'Olise CC']","['Department of Biology, School of Sciences, Federal University of Technology, P.M.B. 704, Akure, Ondo State, Nigeria.', 'Department of Human Anatomy, School of Health and Health Technology, Federal University of Technology, P.M.B. 704, Akure, Ondo State, Nigeria.', 'Department of Biology, School of Sciences, Federal University of Technology, P.M.B. 704, Akure, Ondo State, Nigeria.', 'Department of Biology, School of Sciences, Federal University of Technology, P.M.B. 704, Akure, Ondo State, Nigeria.']",['eng'],"['Journal Article', 'Review']",,United Arab Emirates,Curr Hypertens Rev,Current hypertension reviews,101239891,IM,"['*Cardiovascular Diseases/chemically induced/diagnosis/epidemiology', 'Humans', 'Oxidative Stress', '*Pesticides/toxicity', 'Prevalence', 'Reactive Oxygen Species', 'Risk Factors']",2021/01/13 06:00,2021/10/26 06:00,['2021/01/12 05:41'],"['2020/07/18 00:00 [received]', '2020/10/24 00:00 [revised]', '2020/10/28 00:00 [accepted]', '2021/01/13 06:00 [pubmed]', '2021/10/26 06:00 [medline]', '2021/01/12 05:41 [entrez]']","['CHYR-EPUB-113149 [pii]', '10.2174/1573402117666210111102508 [doi]']",ppublish,Curr Hypertens Rev. 2021;17(1):27-34. doi: 10.2174/1573402117666210111102508.,1,"Increased applications of pesticides, mainly in agriculture and public health, have resulted in increased chances of human exposure to pesticides. Chronic exposure to pesticides has been implicated in several human diseases, including cardiovascular diseases. Cardiovascular diseases are broadly used for various heart pathological conditions, including a defect in blood vessels, and they include myocardial infarction, atherosclerosis, stroke, cardiomyopathy, coronary heart disease, etc. In this review, the association between human exposure to pesticides and the development of cardiovascular diseases was discussed using epidemiological and laboratory data. The toxicokinetics of pesticides in humans was reviewed, as well as the risk factors for cardiovascular diseases. The important role of oxidative stress principally the induction of reactive oxygen species as the signaling molecules for various signaling pathways involved in pesticides-induced cardiovascular disease, was discussed.",,,,['NOTNLM'],"['Pesticides', 'ROS', 'cardiovascular diseases', 'endothelial dysfunction', 'occupational exposure', 'oxidative stress']",,"['0 (Pesticides)', '0 (Reactive Oxygen Species)']","['Copyright(c) Bentham Science Publishers; For any queries, please email at', 'epub@benthamscience.net.']",,,,,,,,,,,,
35532581,NLM,MEDLINE,20220511,20220716,0971-5916 (Print) 0975-9174 (Electronic) 0971-5916 (Linking),154,2021 May,Changing the diabetes treatment paradigm from glucose control to cardiorenal protection.,655-657,10.4103/ijmr.ijmr_3114_21 [doi],"['Ekanayake, Preethika', 'Mudaliar, Sunder']","['Ekanayake P', 'Mudaliar S']","['Veterans Affairs Medical Center; Department of Medicine, University of California, San Diego School of Medicine, San Diego, California, USA.', 'Veterans Affairs Medical Center; Department of Medicine, University of California, San Diego School of Medicine, San Diego, California, USA.']",['eng'],['Editorial'],,India,Indian J Med Res,The Indian journal of medical research,0374701,IM,"['Blood Glucose', '*Cardiovascular Diseases/drug therapy/epidemiology/prevention & control', '*Diabetes Mellitus, Type 2', 'Humans', '*Sodium-Glucose Transporter 2 Inhibitors']",2022/05/10 06:00,2022/05/12 06:00,['2022/05/09 10:58'],"['2022/05/09 10:58 [entrez]', '2022/05/10 06:00 [pubmed]', '2022/05/12 06:00 [medline]']","['IndianJMedRes_2021_154_5_655_344555 [pii]', 'IJMR-154-655 [pii]', '10.4103/ijmr.ijmr_3114_21 [doi]']",ppublish,Indian J Med Res. 2021 May;154(5):655-657. doi: 10.4103/ijmr.ijmr_3114_21.,5,,,PMC9210529,['Conflicts of Interest: None.'],,,,"['0 (Blood Glucose)', '0 (Sodium-Glucose Transporter 2 Inhibitors)']",,,,,['Indian J Med Res. 2021 May;154(5):658-660. PMID: 35532582'],,,,,,,,
6041569,NLM,MEDLINE,19671112,20001218,0028-2162 (Print) 0028-2162 (Linking),111,1967 Feb 11,[The significance of ballistocardiographic tests in symptoms of cerebral irritation and dysfunction caused by cardiovascular functional insufficiency].,298-300,,"['Knoop, A A', 'Folkerts, J F']","['Knoop AA', 'Folkerts JF']",,['dut'],['Journal Article'],,Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['*Ballistocardiography', 'Cardiovascular Diseases/complications/*diagnosis', 'Cerebrovascular Disorders/*etiology']",1967/02/11 00:00,1967/02/11 00:01,['1967/02/11 00:00'],"['1967/02/11 00:00 [pubmed]', '1967/02/11 00:01 [medline]', '1967/02/11 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1967 Feb 11;111(6):298-300.,6,,,,,,,,,,,,,,,De betekenis van het ballistocardiografisch onderzoek bij cerebrale prikkelings- en uitvalverschijnselen als gevolg van een insufficiente cardiovasculaire functie.,,,,,,
27039413,NLM,MEDLINE,20180427,20181202,1523-9004 (Print) 1523-9004 (Linking),18,2016 Mar,Know the four cardiovascular symptoms you should never ignore...,"1, 7",,,,,['eng'],['Journal Article'],,United States,Heart Advis,Heart advisor,9892190,,"['Cardiovascular Diseases/complications/*diagnosis', 'Humans']",2016/04/05 06:00,2018/04/28 06:00,['2016/04/05 06:00'],"['2016/04/05 06:00 [entrez]', '2016/04/05 06:00 [pubmed]', '2018/04/28 06:00 [medline]']",,ppublish,"Heart Advis. 2016 Mar;18(3):1, 7.",3,,,,,,,,,,,,,,,,,,,,,
16046559,NLM,MEDLINE,20060411,20181113,1544-1717 (Electronic) 1544-1709 (Print) 1544-1709 (Linking),3,2005 Jul-Aug,"Prehypertension, patient outcomes, and the knowledge base of family medicine.",292-3,,"['Green, Lee']",['Green L'],,['eng'],"['Comment', 'Editorial']",,United States,Ann Fam Med,Annals of family medicine,101167762,IM,"['Blood Pressure', 'Cardiovascular Diseases/etiology/*prevention & control', 'Humans', 'Hypertension/complications/diagnosis/*therapy']",2005/07/28 09:00,2006/04/12 09:00,['2005/07/28 09:00'],"['2005/07/28 09:00 [pubmed]', '2006/04/12 09:00 [medline]', '2005/07/28 09:00 [entrez]']","['3/4/292 [pii]', '0030292 [pii]', '10.1370/afm.374 [doi]']",ppublish,Ann Fam Med. 2005 Jul-Aug;3(4):292-3. doi: 10.1370/afm.374.,4,,,PMC1466900,,,,,,,,['Ann Fam Med. 2005 Jul-Aug;3(4):294-9. PMID: 16046560'],,,,,,,,,,
102838,NLM,MEDLINE,19790226,20121011,0386-9830 (Print) 0386-9830 (Linking),42,1978 Dec,[Combination of a diet and exercises as therapy in cardiovascular diseases].,1299-301,,"['Terashima, R', 'Yanagihara, J', 'Makakura, S', 'Maeda, K']","['Terashima R', 'Yanagihara J', 'Makakura S', 'Maeda K']",,['jpn'],['Journal Article'],,Japan,Kangogaku Zasshi,Kangogaku zasshi,18110590R,,"['Cardiovascular Diseases/diet therapy/*therapy', 'Energy Intake', 'Humans', '*Physical Exertion']",1978/12/01 00:00,1978/12/01 00:01,['1978/12/01 00:00'],"['1978/12/01 00:00 [pubmed]', '1978/12/01 00:01 [medline]', '1978/12/01 00:00 [entrez]']",,ppublish,Kangogaku Zasshi. 1978 Dec;42(12):1299-301.,12,,,,,,,,,,,,,,,,,,,,,
6009981,NLM,MEDLINE,19671111,20070221,0040-8905 (Print) 0040-8905 (Linking),24,1966 Jul,[Diagnosis and treatment of cardiovascular diseases].,357-71,,"['Takahashi, M', 'Furukawa, K', 'Kudo, T', 'Horiguchi, Y', 'Shimazaki, K']","['Takahashi M', 'Furukawa K', 'Kudo T', 'Horiguchi Y', 'Shimazaki K']",,['jpn'],['Journal Article'],,Japan,Zasshi Tokyo Ika Daigaku,Zasshi. Tokyo Ika Daigaku,0243625,IM,"['Adolescent', 'Adult', 'Cardiovascular Diseases/*diagnosis/*surgery', 'Female', 'Humans', 'Male']",1966/07/01 00:00,1966/07/01 00:01,['1966/07/01 00:00'],"['1966/07/01 00:00 [pubmed]', '1966/07/01 00:01 [medline]', '1966/07/01 00:00 [entrez]']",,ppublish,Zasshi Tokyo Ika Daigaku. 1966 Jul;24(3):357-71.,3,,,,,,,,,,,,,,,,,,,,,
18561534,NLM,MEDLINE,20080624,20080619,0023-7205 (Print) 0023-7205 (Linking),105,2008 Apr 23-May 6,[National guidelines for cardiology 2008: Description of the status or an instrument for change?].,1308-9,,"['Olsson, Anders G']",['Olsson AG'],"['Halsouniversitet, Linkoping. andol@imv.liu.se']",['swe'],['Journal Article'],,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['*Cardiology/standards/trends', '*Cardiovascular Diseases/diagnosis/prevention & control/therapy', 'Humans', '*Practice Guidelines as Topic', 'Sweden']",2008/06/20 09:00,2008/06/25 09:00,['2008/06/20 09:00'],"['2008/06/20 09:00 [pubmed]', '2008/06/25 09:00 [medline]', '2008/06/20 09:00 [entrez]']",,ppublish,Lakartidningen. 2008 Apr 23-May 6;105(17-18):1308-9.,17-18,,,,,,,,,,,,,,,Nationella riktlinjer for hjartsjukvard 2008. Lagesbeskrivning eller instrument for forandring?,,,,,,
16981524,NLM,MEDLINE,20061128,20110727,0047-1852 (Print) 0047-1852 (Linking),64 Suppl 6,2006 Aug,[Recent reports of the Framingham study].,87-90,,"['Saruta, Takao']",['Saruta T'],"['Department of Internal Medicine, School of Medicine, Keio University.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Cardiovascular Diseases/*epidemiology/etiology/*prevention & control', 'Cohort Studies', 'Diastole', 'Humans', 'Hypertension/complications/epidemiology', 'Massachusetts/epidemiology', 'Risk', 'Systole', 'Time Factors']",2006/09/20 09:00,2006/12/09 09:00,['2006/09/20 09:00'],"['2006/09/20 09:00 [pubmed]', '2006/12/09 09:00 [medline]', '2006/09/20 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2006 Aug;64 Suppl 6:87-90.,,,,,,,,,,,15,,,,,,,,,,,
26153088,NLM,MEDLINE,20160324,20161209,2213-0276 (Electronic) 0755-4982 (Linking),44,2015 Oct,[Drugs cardiotoxicity].,995-1002,S0755-4982(15)00301-2 [pii] 10.1016/j.lpm.2015.04.037 [doi],"['Capilla, Eleonore', 'Poyet, Raphael', 'Brocq, Francois-Xavier', 'Pons, Frederic', 'Kerebel, Sebastien', 'Jego, Christophe', 'Laurent, Pierre', 'Cellarier, Gilles Rolland']","['Capilla E', 'Poyet R', 'Brocq FX', 'Pons F', 'Kerebel S', 'Jego C', 'Laurent P', 'Cellarier GR']","['BCRM, hopital Sainte-Anne, Interne des hopitaux, service de cardiologie, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France. Electronic address: leocapilla@gmail.com.', 'BCRM, hopital Sainte-Anne, service de cardiologie, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France.', 'BCRM, CEMPN, hopital Sainte-Anne, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France.', 'BCRM, hopital Sainte-Anne, service de cardiologie, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France.', 'BCRM, hopital Sainte-Anne, service de cardiologie, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France.', 'BCRM, hopital Sainte-Anne, service de cardiologie, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France.', 'BCRM, hopital Sainte-Anne, service de cardiologie, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France.', 'BCRM, hopital Sainte-Anne, service de cardiologie, boulevard Sainte-Anne, BP 600, 83600 Toulon cedex 9, France.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",20150704,France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,IM,"['Antineoplastic Agents/*adverse effects', 'Cardiotoxicity', 'Cardiovascular Diseases/*chemically induced/diagnosis/epidemiology/prevention & control', 'Humans', 'Neoplasms/*drug therapy', 'Risk Assessment']",2015/07/15 06:00,2016/03/25 06:00,['2015/07/09 06:00'],"['2014/07/05 00:00 [received]', '2015/04/18 00:00 [revised]', '2015/04/28 00:00 [accepted]', '2015/07/09 06:00 [entrez]', '2015/07/15 06:00 [pubmed]', '2016/03/25 06:00 [medline]']","['S0755-4982(15)00301-2 [pii]', '10.1016/j.lpm.2015.04.037 [doi]']",ppublish,Presse Med. 2015 Oct;44(10):995-1002. doi: 10.1016/j.lpm.2015.04.037. Epub 2015 Jul 4.,10,"Thanks to science advances, cancer is no longer synonymous with death. Life expectancy improvement reveals a new problem: cancer treatment toxicity, including cardiovascular complications, responsible for significant morbidity and mortality. Media scandal of drug-induced valvular heart disease did revise the risk-benefit balance of drugs used (often off-label) as anorectics. Today's society uses drugs heavily but does not accept their side effects. Knowledge and information of these complications is essential. Coronary toxicity of some treatments or drugs commonly used must be known.",,,,,,,['0 (Antineoplastic Agents)'],['Copyright (c) 2015 Elsevier Masson SAS. All rights reserved.'],,,,,,Complications cardiaques des medicaments.,,,,,,
5986145,NLM,MEDLINE,19680121,20091111,0024-3477 (Print) 0024-3477 (Linking),88,1966 Sep,[Evaluation of working capacity in cardiovascular diseases].,1063-75,,"['Ivancic, R', 'Vukadinovic, D']","['Ivancic R', 'Vukadinovic D']",,['srp'],['Journal Article'],,Croatia,Lijec Vjesn,Lijecnicki vjesnik,0074253,IM,"['Cardiovascular Diseases/classification/*diagnosis', '*Disability Evaluation', 'Heart Function Tests', 'Humans', 'Yugoslavia']",1966/09/01 00:00,1966/09/01 00:01,['1966/09/01 00:00'],"['1966/09/01 00:00 [pubmed]', '1966/09/01 00:01 [medline]', '1966/09/01 00:00 [entrez]']",,ppublish,Lijec Vjesn. 1966 Sep;88(9):1063-75.,9,,,,,,,,,,,,,,,Ocjena radne sposobnosti kod kardiovaskularnih bolesti.,,,,,,
14525613,NLM,MEDLINE,20031224,20230124,1600-6135 (Print) 1600-6135 (Linking),3,2003 Nov,Use of surrogate outcomes for cardiovascular disease after renal transplantation.,1455-6,,"['Abbott, Kevin C']",['Abbott KC'],,['eng'],"['Comment', 'Letter']",,United States,Am J Transplant,American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,100968638,IM,"['Cardiovascular Diseases/*etiology/*mortality/prevention & control', 'Graft Rejection', 'Graft Survival', 'Humans', 'Kidney Transplantation/*methods', '*Postoperative Complications', 'Treatment Outcome']",2003/10/04 05:00,2003/12/25 05:00,['2003/10/04 05:00'],"['2003/10/04 05:00 [pubmed]', '2003/12/25 05:00 [medline]', '2003/10/04 05:00 [entrez]']","['S1600-6135(22)07414-7 [pii]', '10.1046/j.1600-6135.2003.00266.x [doi]']",ppublish,Am J Transplant. 2003 Nov;3(11):1455-6. doi: 10.1046/j.1600-6135.2003.00266.x.,11,,,,,,,,,,,['Am J Transplant. 2003 Aug;3(8):982-7. PMID: 12859533'],,,,,,,,,,
36642615,NLM,MEDLINE,20230214,20230219,1590-3729 (Electronic) 0939-4753 (Linking),33,2023 Feb,"Comment on ""Joint effects of physical activity and blood lipid levels on all-cause and cardiovascular disease mortality: The Rural Chinese Cohort Study"".",465-466,S0939-4753(22)00503-8 [pii] 10.1016/j.numecd.2022.12.013 [doi],"['Kawada, Tomoyuki']",['Kawada T'],"['Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo 113-8602, Japan. Electronic address: kawada@nms.ac.jp.']",['eng'],['Letter'],20221222,Netherlands,Nutr Metab Cardiovasc Dis,"Nutrition, metabolism, and cardiovascular diseases : NMCD",9111474,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Cohort Studies', 'East Asian People', 'Exercise', 'Lipids']",2023/01/16 06:00,2023/02/15 06:00,['2023/01/15 22:01'],"['2022/10/19 00:00 [received]', '2022/12/14 00:00 [accepted]', '2023/01/16 06:00 [pubmed]', '2023/02/15 06:00 [medline]', '2023/01/15 22:01 [entrez]']","['S0939-4753(22)00503-8 [pii]', '10.1016/j.numecd.2022.12.013 [doi]']",ppublish,Nutr Metab Cardiovasc Dis. 2023 Feb;33(2):465-466. doi: 10.1016/j.numecd.2022.12.013. Epub 2022 Dec 22.,2,,,,['Declaration of competing interest There is no conflict of interest in this study.'],,,,['0 (Lipids)'],,,,,,,,,,,,,
30547265,NLM,MEDLINE,20200219,20200219,1573-7241 (Electronic) 0920-3206 (Linking),33,2019 Apr,The Bernard and Joan Marshall Early Career Investigators and Distinguished Investigator Award 2018.,203-205,10.1007/s10557-018-6842-6 [doi],"['Fragiadaki, Maria', 'Evans, Paul C']","['Fragiadaki M', 'Evans PC']","['Department of Infection, Immunity and Cardiovascular Disease, the Bateson Centre, and INSIGNEO Institute for In Silico Medicine, University of Sheffield, Sheffield, UK. m.fragiadaki@sheffield.ac.uk.', 'Department of Infection, Immunity and Cardiovascular Disease, the Bateson Centre, and INSIGNEO Institute for In Silico Medicine, University of Sheffield, Sheffield, UK. paul.evans@sheffield.ac.uk.']",['eng'],['Journal Article'],,United States,Cardiovasc Drugs Ther,Cardiovascular drugs and therapy,8712220,IM,"['Animals', 'Awards and Prizes', '*Biomedical Research', '*Cardiology', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', '*Congresses as Topic', 'Humans', '*Societies, Medical', 'United Kingdom']",2018/12/14 06:00,2020/02/20 06:00,['2018/12/15 06:00'],"['2018/12/14 06:00 [pubmed]', '2020/02/20 06:00 [medline]', '2018/12/15 06:00 [entrez]']","['10.1007/s10557-018-6842-6 [pii]', '10.1007/s10557-018-6842-6 [doi]']",ppublish,Cardiovasc Drugs Ther. 2019 Apr;33(2):203-205. doi: 10.1007/s10557-018-6842-6.,2,,,,,,,,,,,,,,,,,,,,,
27083928,NLM,MEDLINE,20161213,20181202,1534-3111 (Electronic) 1522-6417 (Print) 1522-6417 (Linking),18,2016 Apr,Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill.,40,10.1007/s11906-016-0648-3 [doi] 40,"['Lafeber, M', 'Spiering, W', 'Visseren, F L J', 'Grobbee, D E']","['Lafeber M', 'Spiering W', 'Visseren FL', 'Grobbee DE']","['Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.', 'Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.', 'Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. w.spiering@umcutrecht.nl.', 'Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.', 'Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.']",['eng'],"['Journal Article', 'Review']",,United States,Curr Hypertens Rep,Current hypertension reports,100888982,IM,"['Antihypertensive Agents/therapeutic use', 'Blood Pressure/drug effects', 'Cardiovascular Diseases/complications/etiology/*physiopathology/*prevention & control', 'Humans', 'Hypertension/*complications/drug therapy', 'Risk Factors']",2016/04/17 06:00,2016/12/15 06:00,['2016/04/17 06:00'],"['2016/04/17 06:00 [entrez]', '2016/04/17 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['10.1007/s11906-016-0648-3 [pii]', '648 [pii]', '10.1007/s11906-016-0648-3 [doi]']",ppublish,Curr Hypertens Rep. 2016 Apr;18(5):40. doi: 10.1007/s11906-016-0648-3.,5,"Hypertension is a major, if not the most important, contributor to the disease burden and premature death globally which is largely related to cardiovascular disease. In both the primary and the secondary preventions of cardiovascular disease, blood pressure (BP) targets are often not achieved which is similar to achievement of cholesterol goals. Combining aspirin, cholesterol and blood pressure-lowering agents into a fixed-dose combination pill called the cardiovascular polypill has been proposed as complementary care in the prevention of cardiovascular diseases in both the primary and secondary preventions of cardiovascular disease. This review article focuses on the potential role of fixed-dose combination therapy in the treatment of hypertension, outlines the pros and cons of combination therapy and emphasizes the rationale for trialling their use. Current and planned future cardiovascular polypill trials are summarized, and the prerequisites for implementation of the polypill strategy are described.",,PMC4833798,,['NOTNLM'],"['Adherence', 'Cholesterol', 'Combination pill', 'Fixed-dose combination therapy', 'Hypertension', 'Polypill', 'Prevention']",,['0 (Antihypertensive Agents)'],,,,,,,,,,,,,
2750108,NLM,MEDLINE,19890815,20061115,0049-6804 (Print) 0049-6804 (Linking),,1989 Mar,[Errors in postmortem diagnosis in cardiovascular diseases].,16-8,,"['Bugaenko, V V', 'Dorogoi, A P']","['Bugaenko VV', 'Dorogoi AP']",,['rus'],"['English Abstract', 'Journal Article']",,Ukraine,Vrach Delo,Vrachebnoe delo,0413607,IM,"['Autopsy', 'Cardiovascular Diseases/*diagnosis/mortality/pathology', 'Cause of Death', 'Diagnostic Errors', 'Humans', 'Ukraine']",1989/03/01 00:00,1989/03/01 00:01,['1989/03/01 00:00'],"['1989/03/01 00:00 [pubmed]', '1989/03/01 00:01 [medline]', '1989/03/01 00:00 [entrez]']",,ppublish,Vrach Delo. 1989 Mar;(3):16-8.,3,An analysis of out-patients case histories and death certificates indicates that in 22.5-35% of cases the diagnoses in death certificates did not correspond with data of examinations carried out during life when pathological examination was not made; when pathological examination or forensic studies were carried these errors reduced to 10-20%. In another 11.5% the diagnosis of ischemic heart disease was not substantiated because additional examination with the purpose to verify the diagnosis were not carried out.,,,,,,,,,,,,,,Oshibki v posmertnoi diagnostike pri serdechno-sosudistykh zabolevaniiakh.,,,,,,
20447544,NLM,MEDLINE,20100610,20151119,1558-3597 (Electronic) 0735-1097 (Linking),55,2010 May 11,The mysteries of lipoprotein(a) and cardiovascular disease revisited.,2168-70,10.1016/j.jacc.2009.12.048 [doi],"['Kiechl, Stefan', 'Willeit, Johann']","['Kiechl S', 'Willeit J']",,['eng'],"['Comment', 'Editorial']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['Biomarkers/metabolism', 'Cardiovascular Diseases/*etiology/metabolism/pathology', 'Humans', 'Lipoprotein(a)/*physiology', 'Protein Isoforms/metabolism', 'Risk Factors']",2010/05/08 06:00,2010/06/11 06:00,['2010/05/08 06:00'],"['2009/11/23 00:00 [received]', '2009/12/01 00:00 [accepted]', '2010/05/08 06:00 [entrez]', '2010/05/08 06:00 [pubmed]', '2010/06/11 06:00 [medline]']","['S0735-1097(10)00905-8 [pii]', '10.1016/j.jacc.2009.12.048 [doi]']",ppublish,J Am Coll Cardiol. 2010 May 11;55(19):2168-70. doi: 10.1016/j.jacc.2009.12.048.,19,,,,,,,,"['0 (Biomarkers)', '0 (Lipoprotein(a))', '0 (Protein Isoforms)']",,,['J Am Coll Cardiol. 2010 May 11;55(19):2160-7. PMID: 20447543'],,,,,,,,,,
24079364,NLM,MEDLINE,20140711,20131001,1578-1879 (Electronic) 0214-9168 (Linking),25,2013 Jul-Aug,[Prevention of cardiovascular diseases needs prevention for arteriosclerosis development and its risk factors].,110-1,S0214-9168(13)00077-6 [pii] 10.1016/j.arteri.2013.08.001 [doi],"['Civeira, Fernando']",['Civeira F'],"['Unidad de Lipidos, Servicio de Medicina Interna, Hospital Universitario Miguel Servet, Universidad de Zaragoza, Zaragoza, Espana. Electronic address: Civeira@unizar.es.']",['spa'],['Editorial'],,Spain,Clin Investig Arterioscler,Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis,9208512,IM,"['Arteriosclerosis/etiology/*prevention & control', 'Cardiovascular Diseases/etiology/*prevention & control', 'Humans', 'Risk Factors']",2013/10/02 06:00,2014/07/12 06:00,['2013/10/02 06:00'],"['2013/07/31 00:00 [received]', '2013/08/22 00:00 [accepted]', '2013/10/02 06:00 [entrez]', '2013/10/02 06:00 [pubmed]', '2014/07/12 06:00 [medline]']","['S0214-9168(13)00077-6 [pii]', '10.1016/j.arteri.2013.08.001 [doi]']",ppublish,Clin Investig Arterioscler. 2013 Jul-Aug;25(3):110-1. doi: 10.1016/j.arteri.2013.08.001.,3,,,,,,,,,,,,,,,La prevencion de las enfermedades cardiovasculares requiere la prevencion del desarrollo de arteriosclerosis y sus factores de riesgo.,,,,,,
9855343,NLM,MEDLINE,19990212,20131121,0277-0008 (Print) 0277-0008 (Linking),18,1998 Nov-Dec,Amiodarone: the re-emergence of a unique antiarrhythmic drug. Introduction.,119S-120S,,"['Bauman, J L']",['Bauman JL'],"['Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago 60612-7230, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Pharmacotherapy,Pharmacotherapy,8111305,IM,"['Amiodarone/*therapeutic use', 'Anti-Arrhythmia Agents/*therapeutic use', 'Arrhythmias, Cardiac/*drug therapy/epidemiology', 'Cardiovascular Diseases/drug therapy/economics/epidemiology', 'Humans']",1998/12/17 00:00,1998/12/17 00:01,['1998/12/17 00:00'],"['1998/12/17 00:00 [pubmed]', '1998/12/17 00:01 [medline]', '1998/12/17 00:00 [entrez]']",,ppublish,Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):119S-120S.,6 Pt 2,,,,,,,,"['0 (Anti-Arrhythmia Agents)', 'N3RQ532IUT (Amiodarone)']",,3,,,,,,,,,,,
23482946,NLM,MEDLINE,20130503,20181023,1756-1833 (Electronic) 0959-8138 (Linking),346,2013 Mar 12,Health groups call for phase out of coal power stations.,f1635,bmj.f1635 [pii] 10.1136/bmj.f1635 [doi],"['Watson, Rory']",['Watson R'],,['eng'],['News'],20130312,England,BMJ,BMJ (Clinical research ed.),8900488,IM,"['Air Pollutants/*adverse effects/analysis', 'Cardiovascular Diseases/diagnosis/economics/etiology/*mortality/prevention & control', '*Coal', 'Environment', 'Environmental Monitoring', 'Environmental Pollutants/adverse effects', 'Europe/epidemiology', 'European Union/statistics & numerical data', 'Humans', '*Power Plants', '*Public Health', 'Respiratory Tract Diseases/diagnosis/economics/etiology/*mortality/prevention & control', 'Survival Rate']",2013/03/14 06:00,2013/05/04 06:00,['2013/03/14 06:00'],"['2013/03/14 06:00 [entrez]', '2013/03/14 06:00 [pubmed]', '2013/05/04 06:00 [medline]']","['bmj.f1635 [pii]', '10.1136/bmj.f1635 [doi]']",epublish,BMJ. 2013 Mar 12;346:f1635. doi: 10.1136/bmj.f1635.,,,,,,,,,"['0 (Air Pollutants)', '0 (Coal)', '0 (Environmental Pollutants)']",,,,,,,,,,,,,
8795470,NLM,MEDLINE,19970626,20190503,1355-6037 (Print) 1468-201X (Electronic) 1355-6037 (Linking),76,1996 Aug,The St Vincent Task Force for diabetes: report of the cardiovascular disease subgroup.,107-8,,"['Pentecost, B', 'Yudkin, J S']","['Pentecost B', 'Yudkin JS']","['British Heart Foundation, London.']",['eng'],['Journal Article'],,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Angioplasty, Balloon, Coronary', 'Cardiovascular Diseases/*etiology/prevention & control/therapy', '*Diabetes Complications', 'Diabetes Mellitus/drug therapy', 'Humans', 'Thrombolytic Therapy']",1996/08/01 00:00,1996/08/01 00:01,['1996/08/01 00:00'],"['1996/08/01 00:00 [pubmed]', '1996/08/01 00:01 [medline]', '1996/08/01 00:00 [entrez]']",['10.1136/hrt.76.2.107 [doi]'],ppublish,Heart. 1996 Aug;76(2):107-8. doi: 10.1136/hrt.76.2.107.,2,,,PMC484455,,,,,,,,,,,,,,,,,,
19188842,NLM,MEDLINE,20090515,20171116,1533-4023 (Electronic) 0160-2446 (Linking),53,2009 Feb,Role of the Fas/Fas-L pathway-mediated apoptosis in inflammatory heart diseases and vasculature diseases.,91-3,10.1097/FJC.0b013e31819aa304 [doi],"['Binah, Ofer']",['Binah O'],,['eng'],"['Comment', 'Editorial', 'Introductory Journal Article']",,United States,J Cardiovasc Pharmacol,Journal of cardiovascular pharmacology,7902492,IM,"['Animals', 'Cardiovascular Diseases/immunology/metabolism/*pathology', 'Cell Death/physiology', 'Fas Ligand Protein/*physiology', 'Inflammation/pathology', 'Myocarditis/immunology/metabolism/therapy', 'fas Receptor/*physiology']",2009/02/04 09:00,2009/05/16 09:00,['2009/02/04 09:00'],"['2009/02/04 09:00 [entrez]', '2009/02/04 09:00 [pubmed]', '2009/05/16 09:00 [medline]']",['10.1097/FJC.0b013e31819aa304 [doi]'],ppublish,J Cardiovasc Pharmacol. 2009 Feb;53(2):91-3. doi: 10.1097/FJC.0b013e31819aa304.,2,,,,,,,,"['0 (Fas Ligand Protein)', '0 (fas Receptor)']",,,"['J Cardiovasc Pharmacol. 2009 Feb;53(2):100-8. PMID: 19188840', 'J Cardiovasc Pharmacol. 2009 Feb;53(2):94-9. PMID: 19188841']",,,,,,,,,,
4250963,NLM,MEDLINE,19710413,20161122,0025-8458 (Print) 0025-8458 (Linking),66,1971 Jan 29,[Radiodiagnostic aspects of the cardiovascular diseases in tropical climate].,174-9,,"['Braband, H']",['Braband H'],,['ger'],['Journal Article'],,Germany,Med Klin,Medizinische Klinik,0376637,IM,"['Africa', 'Angiography', 'Arteritis/diagnostic imaging', 'Brazil', 'Cardiomegaly/diagnosis/diagnostic imaging', 'Cardiovascular Diseases/diagnosis/*diagnostic imaging', 'Diagnosis, Differential', 'Endomyocardial Fibrosis/diagnostic imaging/epidemiology', 'Heart Aneurysm/diagnostic imaging', 'Humans', 'Tropical Climate']",1971/01/29 00:00,2000/03/22 09:00,['1971/01/29 00:00'],"['1971/01/29 00:00 [pubmed]', '2000/03/22 09:00 [medline]', '1971/01/29 00:00 [entrez]']",,ppublish,Med Klin. 1971 Jan 29;66(5):174-9.,5,,,,,,,,,,,,,,,Rontgendiagnostische Aspekte kardiovaskularer Erkrankungen in den Tropen.,,,,,,
16645420,NLM,MEDLINE,20070228,20090528,1558-2027 (Print) 1558-2027 (Linking),7,2006 May,Cardiovascular monitoring of HIV-infected patients.,379; author reply 380,,"['Barbaro, Giuseppe']",['Barbaro G'],,['eng'],['Letter'],,United States,J Cardiovasc Med (Hagerstown),"Journal of cardiovascular medicine (Hagerstown, Md.)",101259752,IM,"['Cardiomyopathy, Dilated/diagnosis/virology', 'Cardiovascular Diseases/*diagnosis/physiopathology/*virology', 'Endocarditis/diagnosis/virology', 'HIV Infections/*complications', 'Humans', 'Hypertension, Pulmonary/diagnosis/virology', 'Myocarditis/diagnosis/virology', 'Pericardial Effusion/diagnosis/virology', 'Population Surveillance']",2006/04/29 09:00,2007/03/01 09:00,['2006/04/29 09:00'],"['2006/04/29 09:00 [pubmed]', '2007/03/01 09:00 [medline]', '2006/04/29 09:00 [entrez]']","['01244665-200605000-00014 [pii]', '10.2459/01.JCM.0000223264.85298.81 [doi]']",ppublish,J Cardiovasc Med (Hagerstown). 2006 May;7(5):379; author reply 380. doi: 10.2459/01.JCM.0000223264.85298.81.,5,,,,,,,,,,,,,,,,,,,,,
26875628,NLM,MEDLINE,20170410,20191210,1873-1740 (Electronic) 0033-0620 (Linking),58,2016 Mar-Apr,Preventing Cardiovascular Disease.,463,S0033-0620(16)00017-7 [pii] 10.1016/j.pcad.2016.02.002 [doi],"['DiNicolantonio, James J', ""O'Keefe, James H""]","['DiNicolantonio JJ', ""O'Keefe JH""]","[""Saint Luke's Mid America Heart Institute, Kansas City, MO, USA. Electronic address: jjdinicol@gmail.com."", ""Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.""]",['eng'],"['Editorial', 'Introductory Journal Article']",20160211,United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,IM,"['Cardiovascular Diseases/diagnosis/mortality/physiopathology/*prevention & control', 'Diet, Healthy', 'Humans', 'Nutritional Status', '*Primary Prevention/methods', 'Prognosis', 'Risk Factors', 'Risk Reduction Behavior', '*Secondary Prevention/methods']",2016/02/16 06:00,2017/04/11 06:00,['2016/02/16 06:00'],"['2016/02/16 06:00 [entrez]', '2016/02/16 06:00 [pubmed]', '2017/04/11 06:00 [medline]']","['S0033-0620(16)00017-7 [pii]', '10.1016/j.pcad.2016.02.002 [doi]']",ppublish,Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):463. doi: 10.1016/j.pcad.2016.02.002. Epub 2016 Feb 11.,5,,,,,,,,,,,,,,,,,,,,,
21137213,NLM,MEDLINE,20101223,20161021,1561-9125 (Print) 1561-9125 (Linking),23,2010,[Current problems in mutual relations of cerebral vascular and cardiovascular diseases in elderly and senile age].,409-20,,"['Borovkova, T A', 'Miakotnykh, V S']","['Borovkova TA', 'Miakotnykh VS']",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Adv Gerontol,Advances in gerontology = Uspekhi gerontologii,100971443,IM,"['Aged', 'Aging/*metabolism', 'Atherosclerosis/*complications', 'Cardiovascular Diseases/etiology/*metabolism/physiopathology', 'Cerebrovascular Disorders/etiology/*metabolism/physiopathology', 'Free Radicals/metabolism', 'Hemodynamics', 'Humans', 'Lipid Metabolism', 'Oxidation-Reduction']",2010/12/09 06:00,2010/12/25 06:00,['2010/12/09 06:00'],"['2010/12/09 06:00 [entrez]', '2010/12/09 06:00 [pubmed]', '2010/12/25 06:00 [medline]']",,ppublish,Adv Gerontol. 2010;23(3):409-20.,3,"The authors have been taking up the problems of the cardiovascular pathology caused by atherosclerosis for many years, and are supporters of universality of the specified pathology. The article demonstrates the results of the researches executed by authors, and other leaders of this direction in a medical science. Questions of mutual relations of various diseases of cardiovascular system on clinical, pathogenetic, pathomorphological, biochemical levels are considered. Aging of a human body, and also brain and heart vessels as leading ""targets"" of the atherosclerosis are supposed to be a pathogenetic basis of formation and development of universal atherosclerotic defeat processes. Therefore the gerontology plays a prior role in studying the strategic aspects of this field of a medical science, and tactical questions of diagnostics and treatment of cardiovascular diseases should be a prerogative of clinical disciplines, namely cardiology, neurology, cardiovascular surgery, etc.",,,,,,,['0 (Free Radicals)'],,,,,,,,,,,,,
34775712,NLM,MEDLINE,20211116,20211116,0253-3758 (Print) 0253-3758 (Linking),49,2021 Nov 24,[Value of artificial intelligence in the diagnosis and treatment of cardiovascular diseases].,1057-1060,10.3760/cma.j.cn112148-20210715-00594 [doi],"['Zhang, P']",['Zhang P'],"['Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.']",['chi'],['Journal Article'],,China,Zhonghua Xin Xue Guan Bing Za Zhi,Zhonghua xin xue guan bing za zhi,7910682,IM,"['*Artificial Intelligence', '*Cardiovascular Diseases/diagnosis/therapy', 'Humans']",2021/11/16 06:00,2021/11/17 06:00,['2021/11/15 02:09'],"['2021/11/15 02:09 [entrez]', '2021/11/16 06:00 [pubmed]', '2021/11/17 06:00 [medline]']",['10.3760/cma.j.cn112148-20210715-00594 [doi]'],ppublish,Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Nov 24;49(11):1057-1060. doi: 10.3760/cma.j.cn112148-20210715-00594.,11,,,,,,,,,,,,,,,,,,,,,
28131332,NLM,MEDLINE,20170227,20181202,1878-0938 (Electronic) 1878-0938 (Linking),18,2017 Jan-Feb,Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions.,70-74,S1553-8389(16)30338-4 [pii] 10.1016/j.carrev.2016.12.002 [doi],"['Buchanan, Kyle D', 'Alraies, M Chadi', 'Kajita, Alexandre H', 'Rogers, Toby', 'Koifman, Edward', 'Steinvil, Arie']","['Buchanan KD', 'Alraies MC', 'Kajita AH', 'Rogers T', 'Koifman E', 'Steinvil A']","['Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St NW, Suite 4B-1, Washington, DC, 20010. Electronic address: Kyle.D.Buchanan@medstar.net.', 'Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St NW, Suite 4B-1, Washington, DC, 20010.', 'Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St NW, Suite 4B-1, Washington, DC, 20010.', 'Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St NW, Suite 4B-1, Washington, DC, 20010.', 'Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St NW, Suite 4B-1, Washington, DC, 20010.', 'Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St NW, Suite 4B-1, Washington, DC, 20010.']",['eng'],['Congress'],20161213,United States,Cardiovasc Revasc Med,Cardiovascular revascularization medicine : including molecular interventions,101238551,IM,"['*Biomedical Research', '*Cardiology', 'Cardiovascular Diseases/diagnosis/mortality/physiopathology/*therapy', 'Clinical Trials as Topic', 'Humans', 'Treatment Outcome']",2017/01/31 06:00,2017/02/28 06:00,['2017/01/30 06:00'],"['2017/01/30 06:00 [entrez]', '2017/01/31 06:00 [pubmed]', '2017/02/28 06:00 [medline]']","['S1553-8389(16)30338-4 [pii]', '10.1016/j.carrev.2016.12.002 [doi]']",ppublish,Cardiovasc Revasc Med. 2017 Jan-Feb;18(1):70-74. doi: 10.1016/j.carrev.2016.12.002. Epub 2016 Dec 13.,1,"The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.",,,,['NOTNLM'],"['Atrial fibrillation', 'Coronary artery disease', 'Heart failure', 'Transcatheter aortic valve replacement']",,,['Copyright (c) 2016. Published by Elsevier Inc.'],,,,,,,,,,,,
11067401,NLM,MEDLINE,20001013,20051116,1096-5645 (Print) 1096-5645 (Linking),13,2000 May,The use of antiplatelet agents in cardiac disease.,76-8,,"['Tepper, D', 'Ip, R J', 'Ip, J H']","['Tepper D', 'Ip RJ', 'Ip JH']","['AV-MED HealthPlan, Fort Lauderdale, Florida, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Manag Care Interface,Managed care interface,9715194,,"['Acute Disease', 'Cardiovascular Diseases/blood/*drug therapy/physiopathology', 'Chronic Disease', 'Humans', 'Platelet Aggregation Inhibitors/*therapeutic use']",2000/11/07 11:00,2000/11/07 11:01,['2000/11/07 11:00'],"['2000/11/07 11:00 [pubmed]', '2000/11/07 11:01 [medline]', '2000/11/07 11:00 [entrez]']",,ppublish,Manag Care Interface. 2000 May;13(5):76-8.,5,"In this clinical review, the authors focus on the process of platelet activation and thrombosis in acute and chronic coronary syndromes. New antithrombotic therapies have emerged for various cardiovascular diseases, based on the evolving concept of vascular injury and platelets and the knowledge of the pathophysiology of the underlying disease states. An understanding of these mechanisms is crucial to therapeutic decision making with antiplatelet regimens, which are also discussed in detail.",,,,,,,['0 (Platelet Aggregation Inhibitors)'],,11,,,,,,,,,,,
23197444,NLM,MEDLINE,20130513,20220321,1468-201X (Electronic) 1355-6037 (Linking),99,2013 Apr,Run for your life ... at a comfortable speed and not too far.,516-9,10.1136/heartjnl-2012-302886 [doi],"[""O'Keefe, James H"", 'Lavie, Carl J']","[""O'Keefe JH"", 'Lavie CJ']",,['eng'],['Editorial'],20121129,England,Heart,Heart (British Cardiac Society),9602087,IM,"['Age Factors', 'Cardiovascular Diseases/mortality/pathology/physiopathology/*prevention & control', 'Hemodynamics', 'Humans', 'Longevity', 'Myocardium/pathology', '*Physical Endurance', 'Physical Fitness', 'Risk Factors', '*Running', 'Time Factors', 'Ventricular Function']",2012/12/01 06:00,2013/05/15 06:00,['2012/12/01 06:00'],"['2012/12/01 06:00 [entrez]', '2012/12/01 06:00 [pubmed]', '2013/05/15 06:00 [medline]']","['heartjnl-2012-302886 [pii]', '10.1136/heartjnl-2012-302886 [doi]']",ppublish,Heart. 2013 Apr;99(8):516-9. doi: 10.1136/heartjnl-2012-302886. Epub 2012 Nov 29.,8,,,,,,,,,,,,,"['Heart. 2013 Apr;99(8):588. PMID: 23512970', 'Heart. 2013 Apr;99(8):588-90. PMID: 23512971']",,,,,,,,
12457150,NLM,MEDLINE,20030206,20151119,1530-6550 (Print) 1530-6550 (Linking),1,2000 Summer,Noninvasive assessment of cardiovascular risk: from Framingham to the future.,34-42,,"['Vogel, R A', 'Benitez, R M']","['Vogel RA', 'Benitez RM']","['University of Maryland School of Medicine, Baltimore, USA.']",['eng'],"['Journal Article', 'Review']",,Singapore,Rev Cardiovasc Med,Reviews in cardiovascular medicine,100960007,IM,"['Biomarkers/blood', 'Cardiovascular Diseases/blood/*diagnosis/*etiology/prevention & control', 'Humans', 'Predictive Value of Tests', '*Risk Assessment', 'Risk Factors']",2002/11/29 04:00,2003/02/07 04:00,['2002/11/29 04:00'],"['2002/11/29 04:00 [pubmed]', '2003/02/07 04:00 [medline]', '2002/11/29 04:00 [entrez]']",,ppublish,Rev Cardiovasc Med. 2000 Summer;1(1):34-42.,1,"Risk assessment and risk factor modification have become essential tools in the management of cardiovascular disease. While the risk assessment defined by the Framingham Study researchers was a great leap forward, the search for additional and more precise markers of cardiovascular risk continues. Markers of thrombosis, abnormal endothelial function, plaque formation, and other events in atherosclerosis development are being evaluated. Some of the most promising for population screening are high-sensitivity C-reactive protein tests, degree of arterial stiffness (measured directly or as pulse pressure), and ankle-brachial index.",,,,,,,['0 (Biomarkers)'],,33,,,,,,,,,,,
10454840,NLM,MEDLINE,19990819,20181201,1357-4310 (Print) 1357-4310 (Linking),5,1999 May,"Genes and the heart: a quest for new therapeutic strategies. Cambridge Healthtech Institute's First Cardiovascular Genomics Conference. Orlando, FL, USA, 11-12 January 1999.",195-7,,"['Durham, N P', 'Hall, A S']","['Durham NP', 'Hall AS']","['British Heart Foundation Research Registrar, Institute for Cardiovascular Research, Leeds, UK.']",['eng'],['Congress'],,England,Mol Med Today,Molecular medicine today,9508560,IM,"['Animals', 'Cardiovascular Diseases/*genetics/physiopathology/*therapy', 'Genetic Predisposition to Disease', 'Humans', 'Rats', 'Risk Factors']",1999/08/24 00:00,1999/08/24 00:01,['1999/08/24 00:00'],"['1999/08/24 00:00 [pubmed]', '1999/08/24 00:01 [medline]', '1999/08/24 00:00 [entrez]']","['S1357-4310(99)01472-0 [pii]', '10.1016/S1357-4310(99)01472-0 [doi]']",ppublish,Mol Med Today. 1999 May;5(5):195-7. doi: 10.1016/S1357-4310(99)01472-0.,5,,,,,,,,,,,,,,,,,,,,,
11211469,NLM,MEDLINE,20010419,20041117,0009-9074 (Print) 0009-9074 (Linking),151,2000 Nov-Dec,[Treatment of hypertension in the prevention of cardiovascular damage].,387-9,,"['Spoto, S', 'Costantino, S']","['Spoto S', 'Costantino S']",,['ita'],['Editorial'],,Italy,Clin Ter,La Clinica terapeutica,0372604,IM,"['Cardiovascular Diseases/*etiology/*prevention & control', 'Humans', 'Hypertension/*complications/*drug therapy']",2001/02/24 12:00,2001/04/21 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/04/21 10:01 [medline]', '2001/02/24 12:00 [entrez]']",,ppublish,Clin Ter. 2000 Nov-Dec;151(6):387-9.,6,,,,,,,,,,,,,,,Terapia dell'ipertensione nella prevenzione del danno cardiovascolare.,,,,,,
35512406,NLM,MEDLINE,20220602,20220626,2047-4881 (Electronic) 2047-4873 (Linking),29,2022 May 25,Editor comment: Focus on cardiovascular rehabilitation and prevention.,993-996,10.1093/eurjpc/zwac088 [doi],"['Halasz, Geza', 'Piepoli, Massimo F']","['Halasz G', 'Piepoli MF']","['Cardiac Unit, G. da Saliceto Hospital, AUSL Piacenza, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy."", 'Department of Preventive Cardiology, Wroclaw Medical University, Wroclaw, Poland.']",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['*Cardiac Rehabilitation', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control', 'Humans', 'Secondary Prevention']",2022/05/06 06:00,2022/06/03 06:00,['2022/05/05 17:53'],"['2022/04/25 00:00 [accepted]', '2022/05/06 06:00 [pubmed]', '2022/06/03 06:00 [medline]', '2022/05/05 17:53 [entrez]']","['6581077 [pii]', '10.1093/eurjpc/zwac088 [doi]']",ppublish,Eur J Prev Cardiol. 2022 May 25;29(7):993-996. doi: 10.1093/eurjpc/zwac088.,7,,"['ORCID: 0000-0001-7220-123X', 'ORCID: 0000-0003-1124-234X']",,,,,,,,,,,,,,,,,,,
31804245,NLM,MEDLINE,20210610,20210610,1550-5049 (Electronic) 0889-4655 (Linking),35,2020 Jan/Feb,Council on Cardiovascular and Stroke Nursing Liaison Report on Global Engagement Activities.,4-5,10.1097/JCN.0000000000000633 [doi],"['Hayman, Laura L', 'Taylor-Piliae, Ruth E', 'Fink, Anne M']","['Hayman LL', 'Taylor-Piliae RE', 'Fink AM']",,['eng'],['Journal Article'],,United States,J Cardiovasc Nurs,The Journal of cardiovascular nursing,8703516,IM,"['Cardiovascular Diseases/diagnosis/*nursing/prevention & control', 'Cardiovascular Nursing/*standards', 'Humans', '*International Cooperation', 'Practice Guidelines as Topic', 'Societies, Nursing', 'Stroke/diagnosis/*nursing/prevention & control/therapy']",2019/12/06 06:00,2021/06/11 06:00,['2019/12/06 06:00'],"['2019/12/06 06:00 [entrez]', '2019/12/06 06:00 [pubmed]', '2021/06/11 06:00 [medline]']","['00005082-202001000-00002 [pii]', '10.1097/JCN.0000000000000633 [doi]']",ppublish,J Cardiovasc Nurs. 2020 Jan/Feb;35(1):4-5. doi: 10.1097/JCN.0000000000000633.,1,,,,,,,,,,,,,,,,,,,,,
15026967,NLM,MEDLINE,20040430,20061115,0012-0472 (Print) 0012-0472 (Linking),129,2004 Mar 26,[Comorbidity between cardiovascular disease and affective illness].,697-700,,"['Agelink, M W', 'Baumann, B', 'Sanner, D', 'Kavuk, I', 'Mueck-Weymann, M']","['Agelink MW', 'Baumann B', 'Sanner D', 'Kavuk I', 'Mueck-Weymann M']","['Institut fur Biologische Psychiatrie und Klinik fur Psychiatrie, Psychotherapie und Psychosomatik an den Evangelischen Kliniken Gelsenkirchen. mw.agelink.md@t-online.de']",['ger'],"['Comparative Study', 'Journal Article', 'Review']",,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/mortality/physiopathology', 'Comorbidity', 'Depressive Disorder/diagnosis/*epidemiology/physiopathology', 'Humans', 'Prognosis', 'Risk Factors', 'Stress, Psychological/complications']",2004/03/18 05:00,2004/05/01 05:00,['2004/03/18 05:00'],"['2004/03/18 05:00 [pubmed]', '2004/05/01 05:00 [medline]', '2004/03/18 05:00 [entrez]']",['10.1055/s-2004-821373 [doi]'],ppublish,Dtsch Med Wochenschr. 2004 Mar 26;129(13):697-700. doi: 10.1055/s-2004-821373.,13,,,,,,,,,,50,,,,,Komorbiditat zwischen kardiovaskularen Erkrankungen und Depressionen.,,,,,,
31166587,NLM,MEDLINE,20200706,20200706,1755-3245 (Electronic) 0008-6363 (Linking),115,2019 Sep 1,Is the digital revolution the dawn of a golden age or just the next fad?,e113-e114,10.1093/cvr/cvz115 [doi],"['Cowie, Martin R']",['Cowie MR'],"['Clinical Cardiology, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK.']",['eng'],['Journal Article'],,England,Cardiovasc Res,Cardiovascular research,0077427,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/therapy', 'Diffusion of Innovation', 'Forecasting', 'Humans', 'Telemedicine/*trends']",2019/06/06 06:00,2020/07/07 06:00,['2019/06/06 06:00'],"['2019/06/06 06:00 [pubmed]', '2020/07/07 06:00 [medline]', '2019/06/06 06:00 [entrez]']","['5511628 [pii]', '10.1093/cvr/cvz115 [doi]']",ppublish,Cardiovasc Res. 2019 Sep 1;115(11):e113-e114. doi: 10.1093/cvr/cvz115.,11,,,,,,,,,,,,,,,,,,,,,
32998527,NLM,MEDLINE,20210621,20210621,1941-7705 (Electronic) 1941-7713 (Print) 1941-7713 (Linking),13,2020 Oct,"True Negatives: Disseminating Research on Null, Inconclusive, and Confirmatory Findings in Cardiovascular Science.",e007448,10.1161/CIRCOUTCOMES.120.007448 [doi],"['Nallamothu, Brahmajee K', 'Schultz, Jonathan', 'Petty, Sandra']","['Nallamothu BK', 'Schultz J', 'Petty S']","['University of Michigan Medical School, Ann Arbor (B.K.N.).', 'American Heart Association, Dallas, TX (J.S.).', 'Center for Biomedical Research Transparency, New York, NY (S.P.).']",['eng'],['Editorial'],20201001,United States,Circ Cardiovasc Qual Outcomes,Circulation. Cardiovascular quality and outcomes,101489148,IM,"['*Biomedical Research', '*Cardiovascular Diseases/diagnosis/physiopathology/therapy', 'Editorial Policies', '*Evidence-Based Medicine', 'Humans', '*Information Dissemination', '*Negative Results', '*Periodicals as Topic']",2020/10/02 06:00,2021/06/22 06:00,['2020/10/01 05:24'],"['2020/10/02 06:00 [pubmed]', '2021/06/22 06:00 [medline]', '2020/10/01 05:24 [entrez]']",['10.1161/CIRCOUTCOMES.120.007448 [doi]'],ppublish,Circ Cardiovasc Qual Outcomes. 2020 Oct;13(10):e007448. doi: 10.1161/CIRCOUTCOMES.120.007448. Epub 2020 Oct 1.,10,,,PMC7571848,,,,,,,,,,,,,,,,,,
33906444,NLM,MEDLINE,20210503,20210503,1661-8157 (Print) 1661-8157 (Linking),110,2021 Apr,Travels to High Altitudes with Cardiovascular Diseases.,1-2,10.1024/1661-8157/a003654 [doi],"['Rexhaj, Emrush', 'Maldonado, Rodrigo Soria']","['Rexhaj E', 'Maldonado RS']","['Departments of Cardiology and Biomedical Research, University of Bern, Switzerland.', 'Departments of Cardiology and Biomedical Research, University of Bern, Switzerland.']",['eng'],"['Comment', 'Editorial']",,Switzerland,Praxis (Bern 1994),Praxis,101468093,IM,"['*Altitude', '*Cardiovascular Diseases/diagnosis/epidemiology', 'Humans', 'Travel']",2021/04/29 06:00,2021/05/04 06:00,['2021/04/28 05:27'],"['2021/04/28 05:27 [entrez]', '2021/04/29 06:00 [pubmed]', '2021/05/04 06:00 [medline]']",['10.1024/1661-8157/a003654 [doi]'],ppublish,Praxis (Bern 1994). 2021 Apr;110(6):1-2. doi: 10.1024/1661-8157/a003654.,6,,,,,,,,,,,['Praxis (Bern 1994). 2021 Apr;110(6):303-311. PMID: 33906438'],,,,,,,,,,
28574583,NLM,MEDLINE,20181211,20181211,1097-4652 (Electronic) 0021-9541 (Linking),233,2018 Apr,The significant role of the Golgi apparatus in cardiovascular diseases.,2911-2919,10.1002/jcp.26039 [doi],"['Lu, Liqun', 'Zhou, Qun', 'Chen, Zhe', 'Chen, Linxi']","['Lu L', 'Zhou Q', 'Chen Z', 'Chen L']","['Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Learning Key Laboratory for Pharmacoproteomics, University of South China, Hengyang, China.', 'College of Pharmacy, Hunan University of Medicine, Huaihua, China.', 'Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Learning Key Laboratory for Pharmacoproteomics, University of South China, Hengyang, China.', 'Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Learning Key Laboratory for Pharmacoproteomics, University of South China, Hengyang, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20170704,United States,J Cell Physiol,Journal of cellular physiology,0050222,IM,"['Animals', 'Cardiovascular Diseases/*metabolism/pathology/physiopathology', 'Glycosylation', 'Golgi Apparatus/*metabolism', 'Humans', 'Models, Biological', 'Proteins/metabolism']",2017/06/03 06:00,2018/12/12 06:00,['2017/06/03 06:00'],"['2017/04/07 00:00 [received]', '2017/06/01 00:00 [accepted]', '2017/06/03 06:00 [pubmed]', '2018/12/12 06:00 [medline]', '2017/06/03 06:00 [entrez]']",['10.1002/jcp.26039 [doi]'],ppublish,J Cell Physiol. 2018 Apr;233(4):2911-2919. doi: 10.1002/jcp.26039. Epub 2017 Jul 4.,4,"The Golgi apparatus (GA) is a ribbon-like system of stacks which consist of multiple closely apposed flattened cisternae and vesicles usually localized in the juxta-nuclear area. As for the biological functions, the GA plays a major role in protein biosynthesis, post-translational modification, and sorting protein from ER to plasma membrane and other destinations. Structural changes and functional disorder of the GA is associated with various diseases. Moreover, increasing evidence revealed that swelling, poor development, and other morphological alterations of the GA are linked to cardiovascular diseases such as heart failure (HF), arrhythmia, and dilated cardiomyopathy. Furthermore, dysfunction of the GA is also related to cardiovascular diseases since the GA is extremely responsible for transport, glycosylation, biosynthesis, and subcellular distribution of cardiovascular proteins. This review gives a brief overview of the intricate relationship between the GA and cardiovascular diseases. In addition, we provide a further prospective that the GA may provide diagnosis reference for cardiovascular diseases, and changes in the ultrastructure and morphology of the GA such as swelling, poor development, and fragmentation may serve as a reliable index for cardiovascular diseases.",['ORCID: 0000-0002-2787-3018'],,,['NOTNLM'],"['arrhythmia', 'cardiac hypertrophy', 'dilated cardiomyopathy', 'swelling', 'the Golgi apparatus']",,['0 (Proteins)'],"['(c) 2017 Wiley Periodicals, Inc.']",,,,,,,,,,,,
32172638,NLM,MEDLINE,20210111,20210111,2047-4881 (Electronic) 2047-4873 (Linking),27,2020 Mar,Editor's presentation: Modifiers in cardiovascular risk estimation.,451-453,10.1177/2047487320914178 [doi],"['Piepoli, Massimo F']",['Piepoli MF'],"['Heart Failure Unit, G da Saliceto Hospital, Italy.', ""Institute of Life Sciences, Sant'Anna School of Advanced Studies, Italy.""]",['eng'],['Editorial'],,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Cardiovascular Diseases/*diagnosis/epidemiology/physiopathology', 'Effect Modifier, Epidemiologic', '*Heart Disease Risk Factors', 'Humans', 'Prognosis', 'Risk Assessment']",2020/03/17 06:00,2021/01/12 06:00,['2020/03/17 06:00'],"['2020/03/17 06:00 [entrez]', '2020/03/17 06:00 [pubmed]', '2021/01/12 06:00 [medline]']",['10.1177/2047487320914178 [doi]'],ppublish,Eur J Prev Cardiol. 2020 Mar;27(5):451-453. doi: 10.1177/2047487320914178.,5,,,,,,,,,,,,,,,,,,,,,
17485004,NLM,MEDLINE,20070724,20151119,0895-7061 (Print) 0895-7061 (Linking),20,2007 May,Biomarkers: anatomical and physiological.,467-8,,"[""O'Rourke, Michael F"", ""O'Rourke, John G""]","[""O'Rourke MF"", ""O'Rourke JG""]",,['eng'],"['Comment', 'Editorial']",,United States,Am J Hypertens,American journal of hypertension,8803676,IM,"['*Biomarkers', 'Cardiovascular Diseases/*diagnosis/pathology', 'Humans', 'Hypertension/*diagnosis/pathology']",2007/05/09 09:00,2007/07/25 09:00,['2007/05/09 09:00'],"['2007/02/20 00:00 [received]', '2007/02/20 00:00 [revised]', '2007/02/24 00:00 [accepted]', '2007/05/09 09:00 [pubmed]', '2007/07/25 09:00 [medline]', '2007/05/09 09:00 [entrez]']","['S0895-7061(07)00166-5 [pii]', '10.1016/j.amjhyper.2007.02.013 [doi]']",ppublish,Am J Hypertens. 2007 May;20(5):467-8. doi: 10.1016/j.amjhyper.2007.02.013.,5,,,,,,,,['0 (Biomarkers)'],,,['Am J Hypertens. 2007 May;20(5):469-75. PMID: 17485005'],,,,,,,,,,
2700341,NLM,MEDLINE,19900726,20051116,0278-6133 (Print) 0278-6133 (Linking),8,1989,Biobehavioral aspects of cardiovascular disease: progress and prospects.,649-76,,"['Schneiderman, N', 'Chesney, M A', 'Krantz, D S']","['Schneiderman N', 'Chesney MA', 'Krantz DS']","['Department of Psychology, University of Miami, Coral Gables, FL 33124.']",['eng'],"['Journal Article', 'Review']",,United States,Health Psychol,"Health psychology : official journal of the Division of Health Psychology, American Psychological Association",8211523,IM,"['*Behavior', 'Cardiovascular Diseases/epidemiology/etiology/physiopathology/*psychology', 'Humans', 'Risk Factors', 'United States/epidemiology']",1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Health Psychol. 1989;8(6):649-76.,6,"Cardiovascular disorders pose a major health problem for industrialized societies in terms of excess morbidity and mortality. Hypertension (HT) is a major risk factor for coronary heart disease (CHD) and cerebrovascular disease. The impact of psychosocial factors, personality traits, genetic-behavioral interactions, sodium sensitivity, obesity, insulin metabolism, and psychophysiology on HT status is discussed. An understanding of pathophysiologic processes is needed to provide a better basis for risk factor reduction and other aspects of treatment. The study of myocardial ischemia appears to provide an important link between the development of coronary artery disease and the occurrence of CHD. Further studies are needed to assess the clinical significance of stress-induced myocardial ischemia as well as whether mental stress is predictive of future CHD. Associations have been made between behavioral risk factors and CHD, but the exact nature of the relationship remains to be clarified. Hostility has been identified as an important aspect of coronary-prone behavior, but considerable research will have to be completed before a comprehensive understanding of coronary-prone behavior and the manner in which it has an impact on disease can be fully understood.",,,,,,,,,150,,,,,,,,,,,
18249221,NLM,MEDLINE,20080327,20080205,0029-6465 (Print) 0029-6465 (Linking),43,2008 Mar,Chronic cardiac and pulmonary diseases.,xi-xii,10.1016/j.cnur.2007.11.004 [doi],"['Frazier, Susan K', 'Lennie, Terry A', 'Moser, Debra K']","['Frazier SK', 'Lennie TA', 'Moser DK']",,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,IM,"['Cardiovascular Diseases/epidemiology/mortality/*nursing', 'Chronic Disease', 'Humans', 'Lung Diseases/epidemiology/mortality/*nursing', ""*Nurse's Role""]",2008/02/06 09:00,2008/03/28 09:00,['2008/02/06 09:00'],"['2008/02/06 09:00 [pubmed]', '2008/03/28 09:00 [medline]', '2008/02/06 09:00 [entrez]']","['S0029-6465(07)00085-0 [pii]', '10.1016/j.cnur.2007.11.004 [doi]']",ppublish,Nurs Clin North Am. 2008 Mar;43(1):xi-xii. doi: 10.1016/j.cnur.2007.11.004.,1,,,,,,,,,,,,,,,,,,,,,
37418636,NLM,MEDLINE,20231027,20231112,2047-4881 (Electronic) 2047-4873 (Linking),30,2023 Oct 26,Is our destiny written in our genes? A sentence or an opportunity to prevent cardiovascular diseases?,1674-1675,10.1093/eurjpc/zwad220 [doi],"['Artola Arita, Vicente', 'Hernandez Vargas, Juliana Alexandra', 'Franco, Oscar H']","['Artola Arita V', 'Hernandez Vargas JA', 'Franco OH']","['Department of Global Public Health and Bioethics, Julius Center, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.', 'Department of Global Public Health and Bioethics, Julius Center, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.', 'Department of Global Public Health and Bioethics, Julius Center, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.']",['eng'],"['Comment', 'Editorial', ""Research Support, Non-U.S. Gov't""]",,England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,IM,"['Humans', '*Cardiovascular Diseases/diagnosis/genetics/prevention & control', 'Genetic Predisposition to Disease', 'Prospective Studies', '*Cardiovascular System', 'Heart']",2023/07/07 19:13,2023/10/27 06:42,['2023/07/07 15:13'],"['2023/10/27 06:42 [medline]', '2023/07/07 19:13 [pubmed]', '2023/07/07 15:13 [entrez]']","['7221290 [pii]', '10.1093/eurjpc/zwad220 [doi]']",ppublish,Eur J Prev Cardiol. 2023 Oct 26;30(15):1674-1675. doi: 10.1093/eurjpc/zwad220.,15,,"['ORCID: 0000-0002-3043-1675', 'ORCID: 0000-0001-6183-252X', 'ORCID: 0000-0002-4606-4929']",,['Conflict of interest: The authors declare no competing interests.'],,,,,,,['Eur J Prev Cardiol. 2023 Oct 26;30(15):1676-1685. PMID: 37228091'],,,,,,,,,,
35796576,NLM,MEDLINE,20220908,20230131,1941-7225 (Electronic) 0895-7061 (Linking),35,2022 Sep 1,Diastolic Blood Pressure Levels and Cardiovascular Risk in Elderly Women: The Need for a Personalized Approach.,790-791,10.1093/ajh/hpac080 [doi],"['Battistoni, Allegra', 'Tocci, Giuliano', 'Volpe, Massimo']","['Battistoni A', 'Tocci G', 'Volpe M']","['Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.', 'Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome ,Italy.', 'Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.']",['eng'],"['Comment', 'Editorial']",,United States,Am J Hypertens,American journal of hypertension,8803676,IM,"['Aged', 'Blood Pressure', '*Cardiovascular Diseases/diagnosis/epidemiology/etiology', 'Female', 'Heart Disease Risk Factors', 'Humans', '*Hypertension/diagnosis/epidemiology/physiopathology', '*Hypotension', 'Risk Factors', ""Women's Health""]",2022/07/08 06:00,2022/09/09 06:00,['2022/07/07 09:13'],"['2022/06/23 00:00 [received]', '2022/06/27 00:00 [accepted]', '2022/07/08 06:00 [pubmed]', '2022/09/09 06:00 [medline]', '2022/07/07 09:13 [entrez]']","['6633285 [pii]', '10.1093/ajh/hpac080 [doi]']",ppublish,Am J Hypertens. 2022 Sep 1;35(9):790-791. doi: 10.1093/ajh/hpac080.,9,,['ORCID: 0000-0002-9642-8380'],,,,,,,,,"['Am J Hypertens. 2022 Sep 1;35(9):795-802. PMID: 35522983', 'Am J Hypertens. 2022 Jul 21;:. PMID: 35861230']",,['Am J Hypertens. 2022 Jul 21;:. PMID: 35861230'],,,,,,,,
24964527,NLM,MEDLINE,20140825,20151119,1660-9379 (Print) 1660-9379 (Linking),10,2014 May 28,[Arterial stiffness: an index for forecasting cardiovascular disease risk?].,1191,,"['Schmidt-Trucksass, Arno']",['Schmidt-Trucksass A'],,['fre'],['Interview'],,Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,IM,"['Antihypertensive Agents/therapeutic use', 'Biomarkers', 'Blood Pressure/drug effects', 'Cardiovascular Diseases/*diagnosis/epidemiology/physiopathology/prevention & control', 'Diagnostic Techniques, Cardiovascular', 'Disease Susceptibility', '*Health Status Indicators', 'Humans', 'Predictive Value of Tests', 'Prognosis', 'Vascular Stiffness/drug effects/*physiology']",2014/06/27 06:00,2014/08/26 06:00,['2014/06/27 06:00'],"['2014/06/27 06:00 [entrez]', '2014/06/27 06:00 [pubmed]', '2014/08/26 06:00 [medline]']",,ppublish,Rev Med Suisse. 2014 May 28;10(432):1191.,432,,,,,,,,"['0 (Antihypertensive Agents)', '0 (Biomarkers)']",,,,,,,Rigidite arterielle: un parametre d'avenir pour evaluer le risque cardiovasculaire?,,,,,,
31973762,NLM,MEDLINE,20201013,20201013,1741-7015 (Electronic) 1741-7015 (Linking),18,2020 Jan 24,"Prevention and management of CVD in LMICs: why do ethnicity, culture, and context matter?",7,10.1186/s12916-019-1480-9 [doi] 7,"['Anand, Shuchi', 'Bradshaw, Christina', 'Prabhakaran, Dorairaj']","['Anand S', 'Bradshaw C', 'Prabhakaran D']","['Stanford University School of Medicine, Palo Alto, CA, USA.', 'Stanford University School of Medicine, Palo Alto, CA, USA.', 'Center for Chronic Condition and Injuries, Public Health Foundation of India, 6th Floor, Plot No. 47, Sector 44, Gurgaon, 122002, India. dprabhakaran@phfi.org.', 'Department of Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. dprabhakaran@phfi.org.', 'Rollins School of Public Health, Emory University, Atlanta, GA, USA. dprabhakaran@phfi.org.']",['eng'],['Journal Article'],20200124,England,BMC Med,BMC medicine,101190723,IM,"['Cardiovascular Diseases/ethnology/etiology/*prevention & control/therapy', 'Cultural Characteristics', 'Developing Countries', 'Diet', 'Female', 'Humans', 'Income', 'Life Style', 'Male', 'Risk Factors']",2020/01/25 06:00,2020/10/21 06:00,['2020/01/25 06:00'],"['2019/08/16 00:00 [received]', '2019/12/09 00:00 [accepted]', '2020/01/25 06:00 [entrez]', '2020/01/25 06:00 [pubmed]', '2020/10/21 06:00 [medline]']","['10.1186/s12916-019-1480-9 [pii]', '1480 [pii]', '10.1186/s12916-019-1480-9 [doi]']",epublish,BMC Med. 2020 Jan 24;18(1):7. doi: 10.1186/s12916-019-1480-9.,1,"BACKGROUND: Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease. MAIN TEXT: While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovascular disease risk factors, management strategies and service delivery, in diverse settings and diverse populations, are equally critical to improving outcomes in low- and middle-income countries. Focusing on examples drawn from four cardiovascular diseases - coronary artery disease, stroke, diabetes and kidney disease - we argue that ethnicity, culture and context matter in determining the risk factors for disease as well as the comparative effectiveness of medications and other interventions, particularly diet and lifestyle interventions. CONCLUSION: We believe that a host of cohort studies and randomized control trials currently being conducted or planned in low- and middle-income countries, focusing on previously understudied race/ethnic groups, have the potential to increase knowledge about the cause(s) and management of cardiovascular diseases across the world.",['ORCID: 0000-0002-3172-834X'],PMC6979081,['The authors declare that they have no competing interests.'],['NOTNLM'],"['Cardiovascular disorders', 'Low- and middle-income countries', 'Race/ethnicity']","['K24 DK085446/DK/NIDDK NIH HHS/United States', 'T32 DK007357/DK/NIDDK NIH HHS/United States']",,,,,,,,,,,,,,
16206386,NLM,MEDLINE,20051006,20161020,1052-1577 (Print) 1052-1577 (Linking),30,2005 Aug,"Type D personality and cardiovascular risk. Recent research suggests that, for heart health, it's better to be a gregarious Pooh Bear than a gloomy, isolated Eeyore.",3,,,,,['eng'],['Journal Article'],,United States,Harv Health Lett,Harvard health letter,9425764,,"['*Affect', 'Cardiovascular Diseases/etiology/metabolism/mortality/*psychology', 'Humans', 'Hydrocortisone/blood', 'Hypothalamo-Hypophyseal System/physiology', '*Personality', 'Pituitary-Adrenal System/physiology']",2005/10/07 09:00,2005/10/07 09:01,['2005/10/07 09:00'],"['2005/10/07 09:00 [pubmed]', '2005/10/07 09:01 [medline]', '2005/10/07 09:00 [entrez]']",,ppublish,Harv Health Lett. 2005 Aug;30(10):3.,10,,,,,,,,['WI4X0X7BPJ (Hydrocortisone)'],,,,,,,,,,,,,
4635551,NLM,MEDLINE,19730130,20170310,0022-9040 (Print) 0022-9040 (Linking),12,1972 Feb,[Prevention of cardiovascular disorders].,5-14,,"['Kositskii, G I']",['Kositskii GI'],,['rus'],['Journal Article'],,Russia (Federation),Kardiologiia,Kardiologiia,0376351,IM,"['Cardiovascular Diseases/epidemiology/etiology/mortality/*prevention & control', 'Diet, Atherogenic', 'Emotions', 'Humans', 'Noise/adverse effects', 'Physical Exertion', 'Physical Fitness', 'Smoking/complications', 'Stress, Psychological', 'USSR']",1972/02/01 00:00,1972/02/01 00:01,['1972/02/01 00:00'],"['1972/02/01 00:00 [pubmed]', '1972/02/01 00:01 [medline]', '1972/02/01 00:00 [entrez]']",,ppublish,Kardiologiia. 1972 Feb;12(2):5-14.,2,,,,,,,,,,,,,,,Preduprezhdenie porazhenii serdechno-sosudistoi sistemy.,,,,,,
6660590,NLM,MEDLINE,19840214,20061115,0003-3170 (Print) 0003-3170 (Linking),35,1983 Nov-Dec,[Socioeconomic importance of arterial diseases].,267-74,,"['Minguela Cantalejo, F', 'Hermoso Cuenca, V', 'Martinez Pinzolas, E', 'Alamo Salazar, O', 'Hernandez Diaz, A', 'Saez Martin, L', 'Sanchez Coll, S', 'Espana Caparros, G', 'Jimenez Cossio, J A']","['Minguela Cantalejo F', 'Hermoso Cuenca V', 'Martinez Pinzolas E', 'Alamo Salazar O', 'Hernandez Diaz A', 'Saez Martin L', 'Sanchez Coll S', 'Espana Caparros G', 'Jimenez Cossio JA']",,['spa'],"['English Abstract', 'Journal Article']",,Spain,Angiologia,Angiologia,0370545,IM,"['Adolescent', 'Adult', 'Aged', 'Cardiovascular Diseases/*epidemiology/pathology/therapy', 'Child', 'Combined Modality Therapy', 'Female', 'Humans', 'Length of Stay', 'Male', 'Middle Aged', 'Occupations', 'Socioeconomic Factors', 'Spain']",1983/11/01 00:00,1983/11/01 00:01,['1983/11/01 00:00'],"['1983/11/01 00:00 [pubmed]', '1983/11/01 00:01 [medline]', '1983/11/01 00:00 [entrez]']",,ppublish,Angiologia. 1983 Nov-Dec;35(6):267-74.,6,,,,,,,,,,,,,,,Importancia socio-economica de las enfermedades arteriales.,,,,,,
12797326,NLM,MEDLINE,20041007,20140226,0578-1426 (Print) 0578-1426 (Linking),38,1999 Sep,"[A review of cardiovascular studies in the recent decade in China. Writing Group on Cardiovascular Diseases, Editorial Board, Chinese Journal of Internal Medicine].",599-603,,,,,['chi'],"['Journal Article', 'Review']",,China,Zhonghua Nei Ke Za Zhi,Zhonghua nei ke za zhi,16210490R,IM,"['Arrhythmias, Cardiac/drug therapy', '*Cardiovascular Diseases/epidemiology/prevention & control', 'China/epidemiology', 'Coronary Disease/epidemiology/prevention & control', 'Humans', 'Hypertension/epidemiology/prevention & control']",2003/06/12 05:00,2004/10/08 09:00,['2003/06/12 05:00'],"['2003/06/12 05:00 [pubmed]', '2004/10/08 09:00 [medline]', '2003/06/12 05:00 [entrez]']",,ppublish,Zhonghua Nei Ke Za Zhi. 1999 Sep;38(9):599-603.,9,,,,,,,,,,0,,,,,,,,,,,
10976379,NLM,MEDLINE,20001228,20200825,0304-4602 (Print) 0304-4602 (Linking),29,2000 May,Cardiovascular disease: genes and public health.,279-83,,"['Harrap, S B']",['Harrap SB'],"['Department of Physiology, University of Melbourne, Australia. s.harrap@physiology.unimelb.edu.au']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,IM,"['Cardiovascular Diseases/diagnosis/*genetics/physiopathology/therapy', 'Case-Control Studies', 'Genetic Techniques', 'Humans', 'Mutation', 'Polymorphism, Genetic', 'Public Health']",2000/09/08 11:00,2001/02/28 10:01,['2000/09/08 11:00'],"['2000/09/08 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/09/08 11:00 [entrez]']",,ppublish,Ann Acad Med Singap. 2000 May;29(3):279-83.,3,"INTRODUCTION: The advances in molecular biology hold great promise for complex conditions such as cardiovascular disease. Early accurate diagnosis and new preventive and treatment strategies are among the potential benefits of genetic understanding. Many genes and mutations have been discovered that contribute to rare Mendelian forms of cardiovascular disease. However, there has been little tangible success in defining specific mutations that explain the more common forms of cardiovascular disease. Of the numerous genes tested, inconsistent results are a recurring theme. METHODS: This review addresses broader issues that touch on the clinical and epidemiological context in which the genetics of cardiovascular disease might develop. How do genes and environment interact in cardiovascular disease? What characteristics of a marker might make it useful? How will genetic understanding be used? What is the place of physiology in molecular biology? Is the future of genetics in patient management or public health? RESULTS: It is concluded that individuals and communities are unlikely to accept widespread DNA screening, and less likely to tolerate genetic manipulation. Genetic complexity will make the identification of specific mutations an expensive and potentially thankless task. CONCLUSIONS: Genetics may reveal new pathophysiological mechanisms against which simple, safe and effective public health measures can bring benefit to the greatest number.",,,,,,,,,25,,,,,,,,,,,
20666273,NLM,MEDLINE,20100916,20170511,0001-5385 (Print) 0001-5385 (Linking),65,2010 Jun,Psoriasis and cardiovascular diseases.,337-40,,"['Vizzardi, Enrico', 'Raddino, Riccardo', 'Teli, Melissa', 'Gorga, Elio', 'Brambilla, Giulio', 'Dei Cas, Livio']","['Vizzardi E', 'Raddino R', 'Teli M', 'Gorga E', 'Brambilla G', 'Dei Cas L']","['Dept. of Cardiology, University of Brescia, Italy. enrico.vizzardi@tin.it']",['eng'],"['Journal Article', 'Review']",,England,Acta Cardiol,Acta cardiologica,0370570,IM,"['Cardiovascular Diseases/*etiology/physiopathology/prevention & control', 'Humans', 'Psoriasis/*complications/physiopathology/therapy', 'Risk Factors']",2010/07/30 06:00,2010/09/18 06:00,['2010/07/30 06:00'],"['2010/07/30 06:00 [entrez]', '2010/07/30 06:00 [pubmed]', '2010/09/18 06:00 [medline]']",['10.2143/AC.65.3.2050351 [doi]'],ppublish,Acta Cardiol. 2010 Jun;65(3):337-40. doi: 10.2143/AC.65.3.2050351.,3,"Psoriasis is a chronic immune-mediated disorder that affects about 2% to 3% of the adult population. Several reports have demonstrated an association between psoriasis and cardiovascular diseases such as myocardial infarction, hypertension, valvular disease and arrhythmia. In this review we analysed the link between psoriasis and cardiovascular disease and the possible physiopathologic mechanism of this correlation.",,,,,,,,,27,,,,,,,,,,,
32792076,NLM,MEDLINE,20210115,20210115,1558-3597 (Electronic) 0735-1097 (Linking),76,2020 Aug 18,Family History and Lipoprotein(a) Contribute Independently to Risk Assessment and Clinical Management.,794-796,S0735-1097(20)35887-3 [pii] 10.1016/j.jacc.2020.07.003 [doi],"['Durrington, Paul N']",['Durrington PN'],"['University of Manchester, School of Medical Sciences, Division of Cardiovascular Sciences, Manchester, United Kingdom. Electronic address: pdurrington@manchester.ac.uk.']",['eng'],"['Comment', 'Editorial']",,United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,IM,"['*Cardiovascular Diseases/diagnosis/epidemiology/genetics', 'Cholesterol, LDL', 'Humans', '*Lipoprotein(a)', 'Risk Assessment']",2020/08/15 06:00,2021/01/16 06:00,['2020/08/15 06:00'],"['2020/06/22 00:00 [received]', '2020/07/01 00:00 [revised]', '2020/07/02 00:00 [accepted]', '2020/08/15 06:00 [entrez]', '2020/08/15 06:00 [pubmed]', '2021/01/16 06:00 [medline]']","['S0735-1097(20)35887-3 [pii]', '10.1016/j.jacc.2020.07.003 [doi]']",ppublish,J Am Coll Cardiol. 2020 Aug 18;76(7):794-796. doi: 10.1016/j.jacc.2020.07.003.,7,,,,,['NOTNLM'],"['atherosclerotic cardiovascular disease', 'cardiovascular risk', 'family history', 'lipoprotein(a)', 'primary CVD prevention']",,"['0 (Cholesterol, LDL)', '0 (Lipoprotein(a))']",,,['J Am Coll Cardiol. 2020 Aug 18;76(7):781-793. PMID: 32792075'],,,,,,,,,,
6920317,NLM,MEDLINE,19820917,20041117,0014-9772 (Print) 0014-9772 (Linking),47,1982,[Functional diagnostic methods in cardiovascular diseases].,57-61,,"['Makarov, V A']",['Makarov VA'],,['rus'],['Journal Article'],,Russia (Federation),Feldsher Akush,Fel'dsher i akusherka,16930040R,,"['Cardiovascular Diseases/*diagnosis/physiopathology', 'Heart Function Tests/methods', 'Humans']",1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,Feldsher Akush. 1982;47(6):57-61.,6,,,,,,,,,,,,,,,Funktsional'nye metody diagnostiki serdechno-sosudistykh zabolevanii.,,,,,,
24217038,NLM,MEDLINE,20140701,20211021,1680-0745 (Electronic) 1995-1892 (Print) 1015-9657 (Linking),24,2013 May,A snapshot of cardiovascular diseases in Africa in the new millennium.,104-5,,"['Kengne, A P', 'Mayosi, B M']","['Kengne AP', 'Mayosi BM']","['Department of Medicine, University of Cape Town and South African Medical Research Council, Cape Town, South Africa.']",['eng'],['Editorial'],,South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,IM,"['Africa South of the Sahara/epidemiology', 'Cardiovascular Diseases/diagnosis/*epidemiology/prevention & control', 'Comorbidity', '*Developing Countries', 'Humans', 'Life Style', 'Preventive Health Services', 'Risk Factors', 'Time Factors']",2013/11/13 06:00,2014/07/02 06:00,['2013/11/13 06:00'],"['2013/11/13 06:00 [entrez]', '2013/11/13 06:00 [pubmed]', '2014/07/02 06:00 [medline]']",,ppublish,Cardiovasc J Afr. 2013 May;24(4):104-5.,4,,,PMC3721265,,,,,,,,,,,,,,,,,,
12849311,NLM,MEDLINE,20030904,20191107,1474-4422 (Print) 1474-4422 (Linking),1,2002 Dec,World Health Report charts way forward on CV disease prevention.,461,,"['Kapp, Clare']",['Kapp C'],,['eng'],['News'],,England,Lancet Neurol,The Lancet. Neurology,101139309,IM,"['Cardiovascular Diseases/drug therapy/*epidemiology/*prevention & control', '*Cost of Illness', '*Global Health', 'Humans', 'Risk Factors', 'World Health Organization']",2003/07/10 05:00,2003/09/05 05:00,['2003/07/10 05:00'],"['2003/07/10 05:00 [pubmed]', '2003/09/05 05:00 [medline]', '2003/07/10 05:00 [entrez]']","['S1474442202002417 [pii]', '10.1016/s1474-4422(02)00241-7 [doi]']",ppublish,Lancet Neurol. 2002 Dec;1(8):461. doi: 10.1016/s1474-4422(02)00241-7.,8,,,,,,,,,,,,,,,,,,,,,
22757737,NLM,MEDLINE,20121113,20211021,1745-5065 (Electronic) 1745-5057 (Print) 1745-5057 (Linking),8,2012 Jul,Disparities in heart failure and other cardiovascular diseases among women.,473-85,10.2217/whe.12.22 [doi],"['McSweeney, Jean', 'Pettey, Christina', 'Lefler, Leanne L', 'Heo, Seongkum']","['McSweeney J', 'Pettey C', 'Lefler LL', 'Heo S']","['College of Nursing, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. mcsweeneyjeanc@uams.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",,United States,Womens Health (Lond),"Women's health (London, England)",101271249,IM,"['Adult', '*Cardiovascular Diseases/epidemiology/genetics/mortality/therapy', 'Comorbidity', 'Female', 'Healthcare Disparities/*standards', '*Heart Failure/epidemiology/genetics/mortality/therapy', 'Hospitalization', 'Humans', 'Male', 'Risk Factors', 'Sex Distribution', 'United States/epidemiology', ""Women's Health""]",2012/07/05 06:00,2012/11/14 06:00,['2012/07/05 06:00'],"['2012/07/05 06:00 [entrez]', '2012/07/05 06:00 [pubmed]', '2012/11/14 06:00 [medline]']",['10.2217/whe.12.22 [doi]'],ppublish,Womens Health (Lond). 2012 Jul;8(4):473-85. doi: 10.2217/whe.12.22.,4,"This article reviews literature pertinent to cardiovascular disparities in women, focusing primarily on heart failure (HF). It provides an in-depth look at causes, biological influences, self-management and lack of adherence to HF-treatment guidelines in women. Disparities in treatment of causative factors of HF, such as myocardial infarction and hypertension, contribute to women having poorer HF outcomes than men. This article discusses major contributing reasons for nonadherence to medication regimes for HF in women, including advanced age at time of diagnosis, likelihood of multiple comorbidities, lack of social support and low socioeconomic status. Limited inclusion of women in clinical trials and the scarcity of gender analyses for HF and other cardiovascular diseases continues to limit the applicability of research findings to women.",,PMC3459240,,,,"['F31 NR012347/NR/NINR NIH HHS/United States', '1-F31-NR012347-01A1/NR/NINR NIH HHS/United States']",,,,,['NIHMS406060'],,,,,,,,,
12221062,NLM,MEDLINE,20020923,20190623,1524-4539 (Electronic) 0009-7322 (Linking),106,2002 Sep 10,Cardiovascular manifestations of HIV infection.,1420-5,,"['Barbaro, Giuseppe']",['Barbaro G'],"['Department of Medical Pathophysiology, University La Sapienza, Rome, Italy. g.barbaro@tin.it']",['eng'],"['Journal Article', 'Review']",,United States,Circulation,Circulation,0147763,IM,"['Antiretroviral Therapy, Highly Active', 'Blood Coagulation Disorders/diagnosis/epidemiology/etiology', 'Cardiomyopathy, Dilated/diagnosis/epidemiology/etiology', 'Cardiovascular Diseases/*diagnosis/epidemiology/etiology/therapy', 'Coronary Artery Disease/diagnosis/epidemiology/etiology', 'Endocarditis/diagnosis/epidemiology/etiology', 'HIV Infections/*complications/drug therapy', 'Humans', 'Hypertension/diagnosis/epidemiology/etiology', 'Hypertension, Pulmonary/diagnosis/epidemiology/etiology', 'Neoplasms/diagnosis/epidemiology/etiology', 'Pericardial Effusion/diagnosis/epidemiology/etiology', 'Vasculitis/diagnosis/epidemiology/etiology']",2002/09/11 10:00,2002/09/24 06:00,['2002/09/11 10:00'],"['2002/09/11 10:00 [pubmed]', '2002/09/24 06:00 [medline]', '2002/09/11 10:00 [entrez]']",['10.1161/01.cir.0000031704.78200.59 [doi]'],ppublish,Circulation. 2002 Sep 10;106(11):1420-5. doi: 10.1161/01.cir.0000031704.78200.59.,11,,,,,,,,,,35,,,,,,,,,,,
32062790,NLM,MEDLINE,20200921,20200921,1573-7241 (Electronic) 0920-3206 (Linking),34,2020 Apr,The British Society for Cardiovascular Research Autumn 2019 Meeting Incorporating the Bernard and Joan Marshall Research Awards.,227-230,10.1007/s10557-020-06945-7 [doi],"['Sinha, Sanjay', 'Grieve, David J']","['Sinha S', 'Grieve DJ']","['Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.', 'British Society for Cardiovascular Research, London, UK.', 'British Society for Cardiovascular Research, London, UK. d.grieve@qub.ac.uk.', ""Queen's University Belfast, Wellcome-Wolfson Institute for Experimental Medicine, Belfast, BT9 7AE, UK. d.grieve@qub.ac.uk.""]",['eng'],"['Congress', 'Editorial', 'Introductory Journal Article']",,United States,Cardiovasc Drugs Ther,Cardiovascular drugs and therapy,8712220,IM,"['Animals', 'Awards and Prizes', '*Biomedical Research', 'Cardiovascular Agents/*therapeutic use', 'Cardiovascular Diseases/diagnosis/*drug therapy/physiopathology', 'Humans', 'Societies, Scientific']",2020/02/18 06:00,2020/09/22 06:00,['2020/02/17 06:00'],"['2020/02/18 06:00 [pubmed]', '2020/09/22 06:00 [medline]', '2020/02/17 06:00 [entrez]']","['10.1007/s10557-020-06945-7 [pii]', '10.1007/s10557-020-06945-7 [doi]']",ppublish,Cardiovasc Drugs Ther. 2020 Apr;34(2):227-230. doi: 10.1007/s10557-020-06945-7.,2,,,,,,,,['0 (Cardiovascular Agents)'],,,,,,,,,,,,,
37299444,NLM,MEDLINE,20230612,20230612,2072-6643 (Electronic) 2072-6643 (Linking),15,2023 May 26,Dietary Patterns and Cardiovascular Disease Risk in Asia.,,10.3390/nu15112481 [doi] 2481,"['Iso, Hiroyasu']",['Iso H'],"['Institute for Global Health Policy Research (iGHP), Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.']",['eng'],['Editorial'],20230526,Switzerland,Nutrients,Nutrients,101521595,IM,"['Humans', 'Risk Factors', '*Cardiovascular Diseases/epidemiology/etiology/prevention & control', '*Diet, Mediterranean', 'Asia/epidemiology']",2023/06/10 15:13,2023/06/12 06:42,['2023/06/10 01:18'],"['2023/05/18 00:00 [received]', '2023/05/24 00:00 [revised]', '2023/05/24 00:00 [accepted]', '2023/06/12 06:42 [medline]', '2023/06/10 15:13 [pubmed]', '2023/06/10 01:18 [entrez]']","['nu15112481 [pii]', 'nutrients-15-02481 [pii]', '10.3390/nu15112481 [doi]']",epublish,Nutrients. 2023 May 26;15(11):2481. doi: 10.3390/nu15112481.,11,"The most renowned dietary pattern associated with cardiovascular health is the Mediterranean diet, which is well accepted by Europeans and Americans [...].",,PMC10255313,['The author declares no conflict of interest.'],,,,,,,,,,,,,,,,,
37151167,NLM,MEDLINE,20230915,20231010,2212-3873 (Electronic) 1871-5303 (Linking),23,2023,Serum Uric Acid and Clinical Cardiovascular Diseases in Men and Women: A Perspective for the Drug Target and the Effect of Sex.,1368-1370,10.2174/1871530323666230505114734 [doi],"['Liu, Pang-Yen', 'Huang, Chen-Ming', 'Chen, Han-Hsing', 'Wang, Hui-Shang', 'Lin, Gen-Min']","['Liu PY', 'Huang CM', 'Chen HH', 'Wang HS', 'Lin GM']","['Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.', 'Department of Cardiovascular Surgery, Mennonite Christian Hospital, Hualien City, Taiwan.', 'Department of Cardiovascular Medicine, Mennonite Christian Hospital, Hualien City, Taiwan.', 'Department of Internal Medicine, Division of Cardiology, Hualien Tzu Chi Hospital, Hualien City, Taiwan.', 'Department of Internal Medicine, Hualien Armed Forces General Hospital, Hualien City, Taiwan.']",['eng'],['Journal Article'],,United Arab Emirates,Endocr Metab Immune Disord Drug Targets,"Endocrine, metabolic & immune disorders drug targets",101269157,IM,"['Male', 'Humans', 'Female', '*Cardiovascular Diseases/diagnosis/drug therapy/epidemiology', 'Uric Acid', 'Risk Factors', 'Sex Factors', 'Drug Delivery Systems']",2023/05/08 06:42,2023/09/15 06:43,['2023/05/08 03:45'],"['2023/01/02 00:00 [received]', '2023/02/28 00:00 [revised]', '2023/03/13 00:00 [accepted]', '2023/09/15 06:43 [medline]', '2023/05/08 06:42 [pubmed]', '2023/05/08 03:45 [entrez]']","['EMIDDT-EPUB-131534 [pii]', '10.2174/1871530323666230505114734 [doi]']",ppublish,Endocr Metab Immune Disord Drug Targets. 2023;23(11):1368-1370. doi: 10.2174/1871530323666230505114734.,11,,,,,,,,['268B43MJ25 (Uric Acid)'],,,,,,,,,,,,,
6509636,NLM,MEDLINE,19850219,20061115,0069-2328 (Print) 0069-2328 (Linking),39,1984 Nov,[Levels of serum lipids and blood pressure in children of families with a history of cardiovascular disease. I. Reference values].,652-5,,"['Pohanka, P', 'Rigo, V', 'Svac, J']","['Pohanka P', 'Rigo V', 'Svac J']",,['slo'],"['English Abstract', 'Journal Article']",,Czech Republic,Cesk Pediatr,Ceskoslovenska pediatrie,0403576,IM,"['Adolescent', '*Blood Pressure', 'Cardiovascular Diseases/blood/*genetics/physiopathology', 'Child', 'Female', 'Humans', 'Lipids/*blood', 'Male', 'Reference Values']",1984/11/01 00:00,1984/11/01 00:01,['1984/11/01 00:00'],"['1984/11/01 00:00 [pubmed]', '1984/11/01 00:01 [medline]', '1984/11/01 00:00 [entrez]']",,ppublish,Cesk Pediatr. 1984 Nov;39(11):652-5.,11,,,,,,,,['0 (Lipids)'],,,,,,,Hodnoty serovych lipidov a TK u deti z rodin s kardiovaskularnou anamnezou. I. Cast'--referencne hodnoty.,,,,,,
9465744,NLM,MEDLINE,19980327,20080212,0040-5930 (Print) 0040-5930 (Linking),54,1997 Dec,[Assessment of coronary heart diseases or the pitfalls of choice as the primary task].,668-9,,"['Luscher, T F']",['Luscher TF'],,['ger'],['Editorial'],,Switzerland,Ther Umsch,Therapeutische Umschau. Revue therapeutique,0407224,IM,"['Cardiovascular Diseases/*diagnosis/etiology', 'Coronary Disease/*diagnosis/etiology', 'Humans', 'Patient Care Team', 'Switzerland']",1998/02/18 00:00,1998/02/18 00:01,['1998/02/18 00:00'],"['1998/02/18 00:00 [pubmed]', '1998/02/18 00:01 [medline]', '1998/02/18 00:00 [entrez]']",,ppublish,Ther Umsch. 1997 Dec;54(12):668-9.,12,,,,,,,,,,,,,,,Abklarung von Herzerkrankungen oder die Qual der Wahl als Herzenssache.,,,,,,
31113733,NLM,MEDLINE,20200217,20200217,2211-8179 (Electronic) 2211-8160 (Linking),14,2019 Sep,The Neglected Component of Cardiovascular Care: Dispelling the Myths.,281-283,S2211-8160(19)30074-2 [pii] 10.1016/j.gheart.2019.04.006 [doi],"['Vervoort, Dominique']",['Vervoort D'],"['Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: vervoortdominique@hotmail.com.']",['eng'],['Journal Article'],20190518,England,Glob Heart,Global heart,101584391,IM,"['Capacity Building', 'Cardiovascular Diseases/mortality/prevention & control/*surgery', 'Global Health', 'Humans', 'Right to Health', '*Thoracic Surgical Procedures', 'Universal Health Insurance']",2019/05/23 06:00,2020/02/18 06:00,['2019/05/23 06:00'],"['2019/04/04 00:00 [received]', '2019/04/20 00:00 [accepted]', '2019/05/23 06:00 [pubmed]', '2020/02/18 06:00 [medline]', '2019/05/23 06:00 [entrez]']","['S2211-8160(19)30074-2 [pii]', '10.1016/j.gheart.2019.04.006 [doi]']",ppublish,Glob Heart. 2019 Sep;14(3):281-283. doi: 10.1016/j.gheart.2019.04.006. Epub 2019 May 18.,3,,,,,,,,,,,,,,,,,,,,,
17690193,NLM,MEDLINE,20071206,20130926,8750-7587 (Print) 0161-7567 (Linking),103,2007 Oct,Acquired and innate cardioprotection.,1436-7,,"['Terzic, Andre', 'Moore, Russell L', 'Waldman, Scott A']","['Terzic A', 'Moore RL', 'Waldman SA']",,['eng'],['Editorial'],20070809,United States,J Appl Physiol (1985),"Journal of applied physiology (Bethesda, Md. : 1985)",8502536,IM,"['*Cardiovascular Diseases/genetics/prevention & control/therapy', 'Genetic Predisposition to Disease', '*Genetic Therapy', 'Humans', '*Ischemic Preconditioning, Myocardial', 'Regenerative Medicine/*methods', '*Stem Cell Transplantation']",2007/08/11 09:00,2007/12/07 09:00,['2007/08/11 09:00'],"['2007/08/11 09:00 [pubmed]', '2007/12/07 09:00 [medline]', '2007/08/11 09:00 [entrez]']","['00834.2007 [pii]', '10.1152/japplphysiol.00834.2007 [doi]']",ppublish,J Appl Physiol (1985). 2007 Oct;103(4):1436-7. doi: 10.1152/japplphysiol.00834.2007. Epub 2007 Aug 9.,4,,,,,,,,,,,,,,,,,,,,,
1844676,NLM,MEDLINE,19930527,20051116,0892-8959 (Print) 0892-8959 (Linking),,1991 Aug,Diagnosis of cardiovascular disease in elderly populations.,59-64,,"['Higgins, M W']",['Higgins MW'],,['eng'],"['Journal Article', 'Review']",,United States,Vital Health Stat 5,"Vital and health statistics. Series 5, Comparative international vital and health statistics reports",8406579,IM,"['Adult', 'Age Factors', '*Aged', 'Cardiovascular Diseases/diagnosis/*epidemiology/mortality', 'Female', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Prevalence']",1991/08/01 00:00,1991/08/01 00:01,['1991/08/01 00:00'],"['1991/08/01 00:00 [pubmed]', '1991/08/01 00:01 [medline]', '1991/08/01 00:00 [entrez]']",,ppublish,Vital Health Stat 5. 1991 Aug;(6):59-64.,6,,,,,,,,,,16,,,,,,,,,,,
14909141,NLM,MEDLINE,20040215,20190221,0013-2411 (Print) 0013-2411 (Linking),34,1951,Heart disease in Egypt; Part III. The heart in essential hypertension.,509-21,,"['ELSHERIF, A', 'SOROUR, A', 'IBRAHIM, M']","['ELSHERIF A', 'SOROUR A', 'IBRAHIM M']",,['eng'],['Journal Article'],,Egypt,J Egypt Med Assoc,The Journal of the Egyptian Medical Association,0417734,OM,"['Cardiovascular Diseases/*etiology', 'Egypt', 'Essential Hypertension', '*Heart Diseases', 'Humans', 'Hypertension/*complications']",1951/01/01 00:00,1951/01/01 00:01,['1951/01/01 00:00'],"['1951/01/01 00:00 [pubmed]', '1951/01/01 00:01 [medline]', '1951/01/01 00:00 [entrez]']",,ppublish,J Egypt Med Assoc. 1951;34(8):509-21.,8,,,,,['NLM'],"['*CARDIOVASCULAR DISEASES/etiology and pathogenesis', '*HYPERTENSION/complications']",,,,,,,,,,,,,,['CLML: 5221:39732:72:180'],
37641929,NLM,MEDLINE,20230921,20230922,1941-7705 (Electronic) 1941-7713 (Linking),16,2023 Sep,Addressing Social Determinants of Health via Food as Medicine Interventions to Improve Cardiometabolic Health.,e010319,10.1161/CIRCOUTCOMES.123.010319 [doi],"['Myers, Candice A']",['Myers CA'],"['Pennington Biomedical Research Center, Baton Rouge, LA.']",['eng'],"['Comment', 'Editorial']",20230829,United States,Circ Cardiovasc Qual Outcomes,Circulation. Cardiovascular quality and outcomes,101489148,IM,"['United States', 'Humans', '*Social Determinants of Health', 'Diet', 'Prescriptions', 'Food Security', '*Cardiovascular Diseases/diagnosis/epidemiology/prevention & control']",2023/08/29 06:43,2023/09/21 06:42,['2023/08/29 05:26'],"['2023/09/21 06:42 [medline]', '2023/08/29 06:43 [pubmed]', '2023/08/29 05:26 [entrez]']",['10.1161/CIRCOUTCOMES.123.010319 [doi]'],ppublish,Circ Cardiovasc Qual Outcomes. 2023 Sep;16(9):e010319. doi: 10.1161/CIRCOUTCOMES.123.010319. Epub 2023 Aug 29.,9,,['ORCID: 0000-0003-1923-3448'],,['Disclosures None.'],['NOTNLM'],"['adult', 'biomarkers', 'body mass index', 'editorials', 'humans']",,,,,['Circ Cardiovasc Qual Outcomes. 2023 Sep;16(9):e009520. PMID: 37641928'],,,,,,,,,,
27444068,NLM,MEDLINE,20170411,20170817,1097-6787 (Electronic) 0190-9622 (Linking),75,2016 Aug,Dermatologic surgery emergencies: Complications caused by occlusion and blood pressure.,243-62,S0190-9622(15)02479-2 [pii] 10.1016/j.jaad.2015.11.013 [doi],"['Minkis, Kira', 'Whittington, Adam', 'Alam, Murad']","['Minkis K', 'Whittington A', 'Alam M']","['Department of Dermatology, Weill Cornell Medical College, New York, New York.', 'Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.', 'Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Electronic address: m-alam@northwestern.edu.']",['eng'],"['Journal Article', 'Review']",,United States,J Am Acad Dermatol,Journal of the American Academy of Dermatology,7907132,IM,"['Cardiovascular Diseases/*diagnosis/etiology/prevention & control/*therapy', 'Dermatologic Surgical Procedures/*adverse effects', 'Embolism, Air/diagnosis/etiology/therapy', 'Emergencies', 'Humans', 'Hypertension/diagnosis/etiology/therapy', 'Hypotension/etiology/therapy', 'Myocardial Infarction/diagnosis/etiology/therapy', 'Risk Factors', 'Stroke/diagnosis/etiology/therapy', 'Venous Thromboembolism/diagnosis/etiology/therapy']",2016/07/23 06:00,2017/04/12 06:00,['2016/07/23 06:00'],"['2015/01/08 00:00 [received]', '2015/10/20 00:00 [revised]', '2015/11/02 00:00 [accepted]', '2016/07/23 06:00 [entrez]', '2016/07/23 06:00 [pubmed]', '2017/04/12 06:00 [medline]']","['S0190-9622(15)02479-2 [pii]', '10.1016/j.jaad.2015.11.013 [doi]']",ppublish,J Am Acad Dermatol. 2016 Aug;75(2):243-62. doi: 10.1016/j.jaad.2015.11.013.,2,"While the overall incidence of emergencies in dermatologic surgery is low, emergent situations can occasionally pose a risk to patients undergoing such procedures. The clinical importance of several types of emergences related to vascular occlusion, hypertension, and hypotension are reviewed, and relevant epidemiology, clinical manifestations, diagnosis, work-up, management, and prevention are discussed. Early detection of these emergencies can mitigate or forestall associated adverse outcomes, thereby allowing the outstanding record of safety of dermatologic surgery to continue.",,,,['NOTNLM'],"['complication', 'dermatologic emergency', 'embolism', 'hypertension', 'hypotension', 'myocardial infarction', 'stroke', 'surgery']",,,"['Copyright (c) 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc.', 'All rights reserved.']",,,,,,,,,,,,
19320104,NLM,MEDLINE,20090330,20190724,0021-5384 (Print) 0021-5384 (Linking),97,2008 Dec 10,[New diagnostic tests that are necessary and those that are important to practitioners. 2. Cardiovascular diseases].,2936-42,,"['Takahashi, Nobuyuki', 'Doi, Tadafumi', 'Sugiura, Tetsuro']","['Takahashi N', 'Doi T', 'Sugiura T']",,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Cardiovascular Diseases/*diagnosis/diagnostic imaging', '*Clinical Laboratory Techniques', 'Humans', 'Ultrasonography']",2009/03/27 09:00,2009/03/31 09:00,['2009/03/27 09:00'],"['2009/03/27 09:00 [entrez]', '2009/03/27 09:00 [pubmed]', '2009/03/31 09:00 [medline]']",['10.2169/naika.97.2936 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2008 Dec 10;97(12):2936-42. doi: 10.2169/naika.97.2936.,12,,,,,,,,,,,,,,,,,,,,,
20220714,NLM,MEDLINE,20100930,20100311,1750-8460 (Print) 1750-8460 (Linking),71,2010 Mar,Treatment of cardiovascular disease: money well spent?,126-7,,"['Shakur, Rameen', 'Yu, Christopher']","['Shakur R', 'Yu C']",,['eng'],['Editorial'],,England,Br J Hosp Med (Lond),"British journal of hospital medicine (London, England : 2005)",101257109,IM,"['Cardiovascular Diseases/economics/*therapy', 'Forecasting', 'Heart Diseases/economics/therapy', 'Humans', '*Resource Allocation', 'State Medicine/economics']",2010/03/12 06:00,2010/10/01 06:00,['2010/03/12 06:00'],"['2010/03/12 06:00 [entrez]', '2010/03/12 06:00 [pubmed]', '2010/10/01 06:00 [medline]']",['10.12968/hmed.2010.71.3.46972 [doi]'],ppublish,Br J Hosp Med (Lond). 2010 Mar;71(3):126-7. doi: 10.12968/hmed.2010.71.3.46972.,3,,,,,,,,,,,,,,,,,,,,,
5385904,NLM,MEDLINE,19701012,20041117,0035-0583 (Print) 0035-0583 (Linking),34,1969 Jul-Dec,[Venezuelan Association for Cardiovascular Studies (ASOVINCAR)].,257-326,,,,,['spa'],['Journal Article'],,Venezuela,Rev Venez Sanid Asist Soc,Revista venezolana de sanidad y asistencia social,0421523,IM,"['Cardiovascular Diseases/etiology/*prevention & control/therapy', 'Community Health Services', 'Costs and Cost Analysis', 'Financing, Government', 'Humans', 'International Cooperation', 'Medical Assistance', 'Regional Medical Programs', 'Research', '*Societies, Medical', 'Venezuela']",1969/07/01 00:00,1969/07/01 00:01,['1969/07/01 00:00'],"['1969/07/01 00:00 [pubmed]', '1969/07/01 00:01 [medline]', '1969/07/01 00:00 [entrez]']",,ppublish,Rev Venez Sanid Asist Soc. 1969 Jul-Dec;34(3):257-326.,3,,,,,,,,,,,,,,,Asociacion Venezolana de Investigaciones Cardiovasculares (ASOVINCAR).,,,,,,
16416794,NLM,MEDLINE,20060307,20110727,0047-1852 (Print) 0047-1852 (Linking),63 Suppl 12,2005 Dec,[Molecular genetics of cardiovascular diseases].,196-206,,"['Miura, Naoyuki', 'Kumazawa, Toshiyasu']","['Miura N', 'Kumazawa T']","['Department of Biochemistry, Hamamatsu University School of Medicine.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Animals', 'Cardiovascular Diseases/congenital/diagnosis/*genetics', 'Cardiovascular System/embryology', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Morphogenesis/genetics', 'Mutation']",2006/01/19 09:00,2006/03/08 09:00,['2006/01/19 09:00'],"['2006/01/19 09:00 [pubmed]', '2006/03/08 09:00 [medline]', '2006/01/19 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2005 Dec;63 Suppl 12:196-206.,,,,,,,,,,,14,,,,,,,,,,,
